The table below lists the options of the executed module.
| Option | Value |
|---|---|
| analyze.sites | yes |
| differential.report.sites | yes |
| region.types | promoters, genes, cpgislands |
| differential.permutations | 0 |
| differential.comparison.columns | default |
| differential.comparison.columns.all.pairwise | default |
| columns.pairing | default |
| differential.site.test.method | limma |
| differential.variability | no |
| differential.variability.method | diffVar |
| covariate.adjustment.columns | default |
| differential.adjustment.sva | yes |
| differential.adjustment.celltype | yes |
| differential.enrichment.go | yes |
| differential.enrichment.lola | no |
| differential.enrichment.lola.dbs | ${LOLACore} |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
In the following anlyses, p-values on the site level were computed using the limma method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (limma or t-test depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
| Rank Cutoff | |
| R01C01 vs. non.R01C01 (based on Sentrix position) | 22259 |
| R01C02 vs. non.R01C02 (based on Sentrix position) | 108908 |
| R02C01 vs. non.R02C01 (based on Sentrix position) | 90162 |
| R02C02 vs. non.R02C02 (based on Sentrix position) | 3783 |
| R03C01 vs. non.R03C01 (based on Sentrix position) | 162 |
| R03C02 vs. non.R03C02 (based on Sentrix position) | 0 |
| R04C01 vs. non.R04C01 (based on Sentrix position) | 80 |
| R04C02 vs. non.R04C02 (based on Sentrix position) | 100032 |
| R05C01 vs. non.R05C01 (based on Sentrix position) | 75110 |
| R05C02 vs. non.R05C02 (based on Sentrix position) | 0 |
| R06C01 vs. non.R06C01 (based on Sentrix position) | 45377 |
| R06C02 vs. non.R06C02 (based on Sentrix position) | 49190 |
| Primary solid Tumor vs. Recurrent Solid Tumor (based on Type) | 95056 |
| FEMALE vs. MALE (based on Gender) | 92989 |
| HISPANIC OR LATINO vs. NOT HISPANIC OR LATINO (based on Ethnicity) | 106449 |
| BLACK OR AFRICAN AMERICAN vs. WHITE (based on Race) | 105040 |
| DECEASED vs. LIVING (based on Vital status) | 0 |
| mutated vs. wild type (based on IDH1) | 107977 |
| negative vs. positive (based on G-CIMP status) | 97450 |
| female vs. male (based on Predicted Gender) | 76805 |
| comparison | |
| differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
| comparison | |
| difference metric | |
| significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
The tables for the individual comparisons can be found here:
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [1]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
| promoters | genes | cpgislands | |
| R01C01 vs. non.R01C01 (based on Sentrix position) | 6 | 63 | 59 |
| R01C02 vs. non.R01C02 (based on Sentrix position) | 112 | 383 | 358 |
| R02C01 vs. non.R02C01 (based on Sentrix position) | 8 | 0 | 41 |
| R02C02 vs. non.R02C02 (based on Sentrix position) | 26 | 57 | 0 |
| R03C01 vs. non.R03C01 (based on Sentrix position) | 0 | 24 | 31 |
| R03C02 vs. non.R03C02 (based on Sentrix position) | 0 | 17 | 0 |
| R04C01 vs. non.R04C01 (based on Sentrix position) | 100 | 15 | 0 |
| R04C02 vs. non.R04C02 (based on Sentrix position) | 548 | 80 | 84 |
| R05C01 vs. non.R05C01 (based on Sentrix position) | 117 | 0 | 61 |
| R05C02 vs. non.R05C02 (based on Sentrix position) | 42 | 0 | 0 |
| R06C01 vs. non.R06C01 (based on Sentrix position) | 56 | 0 | 0 |
| R06C02 vs. non.R06C02 (based on Sentrix position) | 118 | 0 | 0 |
| Primary solid Tumor vs. Recurrent Solid Tumor (based on Type) | 1167 | 311 | 2083 |
| FEMALE vs. MALE (based on Gender) | 110 | 0 | 0 |
| HISPANIC OR LATINO vs. NOT HISPANIC OR LATINO (based on Ethnicity) | 485 | 355 | 626 |
| BLACK OR AFRICAN AMERICAN vs. WHITE (based on Race) | 2 | 0 | 28 |
| DECEASED vs. LIVING (based on Vital status) | 55 | 35 | 18 |
| mutated vs. wild type (based on IDH1) | 1761 | 3223 | 5247 |
| negative vs. positive (based on G-CIMP status) | 3956 | 1133 | 5012 |
| female vs. male (based on Predicted Gender) | 0 | 35 | 66 |
| comparison | |
| regions | |
| differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
| comparison | |
| regions | |
| difference metric | |
| significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
| promoters | genes | cpgislands | |
| R01C01 vs. non.R01C01 (based on Sentrix position) | csv | csv | csv |
| R01C02 vs. non.R01C02 (based on Sentrix position) | csv | csv | csv |
| R02C01 vs. non.R02C01 (based on Sentrix position) | csv | csv | csv |
| R02C02 vs. non.R02C02 (based on Sentrix position) | csv | csv | csv |
| R03C01 vs. non.R03C01 (based on Sentrix position) | csv | csv | csv |
| R03C02 vs. non.R03C02 (based on Sentrix position) | csv | csv | csv |
| R04C01 vs. non.R04C01 (based on Sentrix position) | csv | csv | csv |
| R04C02 vs. non.R04C02 (based on Sentrix position) | csv | csv | csv |
| R05C01 vs. non.R05C01 (based on Sentrix position) | csv | csv | csv |
| R05C02 vs. non.R05C02 (based on Sentrix position) | csv | csv | csv |
| R06C01 vs. non.R06C01 (based on Sentrix position) | csv | csv | csv |
| R06C02 vs. non.R06C02 (based on Sentrix position) | csv | csv | csv |
| Primary solid Tumor vs. Recurrent Solid Tumor (based on Type) | csv | csv | csv |
| FEMALE vs. MALE (based on Gender) | csv | csv | csv |
| HISPANIC OR LATINO vs. NOT HISPANIC OR LATINO (based on Ethnicity) | csv | csv | csv |
| BLACK OR AFRICAN AMERICAN vs. WHITE (based on Race) | csv | csv | csv |
| DECEASED vs. LIVING (based on Vital status) | csv | csv | csv |
| mutated vs. wild type (based on IDH1) | csv | csv | csv |
| negative vs. positive (based on G-CIMP status) | csv | csv | csv |
| female vs. male (based on Predicted Gender) | csv | csv | csv |
GO Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
Wordclouds for GO enrichment terms.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008037 | 0.001 | 17.681 | 0.1975 | 3 | 137 | cell recognition |
| GO:0048850 | 0.0043 | 361.9773 | 0.0043 | 1 | 3 | hypophysis morphogenesis |
| GO:0060370 | 0.0043 | 361.9773 | 0.0043 | 1 | 3 | susceptibility to T cell mediated cytotoxicity |
| GO:0042271 | 0.0058 | 241.303 | 0.0058 | 1 | 4 | susceptibility to natural killer cell mediated cytotoxicity |
| GO:0051464 | 0.0058 | 241.303 | 0.0058 | 1 | 4 | positive regulation of cortisol secretion |
| GO:0060126 | 0.0058 | 241.303 | 0.0058 | 1 | 4 | somatotropin secreting cell differentiation |
| GO:0007052 | 0.0084 | 16.0436 | 0.1384 | 2 | 96 | mitotic spindle organization |
| GO:0021979 | 0.0086 | 144.7636 | 0.0087 | 1 | 6 | hypothalamus cell differentiation |
| GO:0050911 | 0.0097 | 7.6076 | 0.4484 | 3 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000252 | 1e-04 | 212.2533 | 0.0135 | 2 | 8 | negative regulation of feeding behavior |
| GO:0046887 | 0.001 | 17.4912 | 0.1963 | 3 | 116 | positive regulation of hormone secretion |
| GO:0009914 | 0.0015 | 9.2144 | 0.5061 | 4 | 299 | hormone transport |
| GO:0019358 | 0.0017 | Inf | 0.0017 | 1 | 1 | nicotinate nucleotide salvage |
| GO:0046497 | 0.0017 | Inf | 0.0017 | 1 | 1 | nicotinate nucleotide metabolic process |
| GO:0051355 | 0.0017 | Inf | 0.0017 | 1 | 1 | proprioception involved in equilibrioception |
| GO:0052182 | 0.0017 | Inf | 0.0017 | 1 | 1 | modification by host of symbiont morphology or physiology via secreted substance |
| GO:2000836 | 0.0017 | Inf | 0.0017 | 1 | 1 | positive regulation of androgen secretion |
| GO:2001208 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of transcription elongation from RNA polymerase I promoter |
| GO:0044060 | 0.0023 | 31.77 | 0.0711 | 2 | 42 | regulation of endocrine process |
| GO:0046903 | 0.0025 | 4.1065 | 2.5202 | 8 | 1489 | secretion |
| GO:0060986 | 0.0027 | 28.8745 | 0.0779 | 2 | 46 | endocrine hormone secretion |
| GO:0070265 | 0.0033 | 25.92 | 0.0863 | 2 | 51 | necrotic cell death |
| GO:0052047 | 0.0034 | 612.4615 | 0.0034 | 1 | 2 | interaction with other organism via secreted substance involved in symbiotic interaction |
| GO:1902957 | 0.0034 | 612.4615 | 0.0034 | 1 | 2 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
| GO:0009593 | 0.0039 | 7.0385 | 0.6567 | 4 | 388 | detection of chemical stimulus |
| GO:0090276 | 0.0042 | 10.2971 | 0.3284 | 3 | 194 | regulation of peptide hormone secretion |
| GO:0023061 | 0.0045 | 6.75 | 0.6838 | 4 | 404 | signal release |
| GO:0051705 | 0.0047 | 21.5132 | 0.1032 | 2 | 61 | multi-organism behavior |
| GO:0021986 | 0.0051 | 306.2115 | 0.0051 | 1 | 3 | habenula development |
| GO:0035483 | 0.0051 | 306.2115 | 0.0051 | 1 | 3 | gastric emptying |
| GO:0071899 | 0.0051 | 306.2115 | 0.0051 | 1 | 3 | negative regulation of estrogen receptor binding |
| GO:1901856 | 0.0051 | 306.2115 | 0.0051 | 1 | 3 | negative regulation of cellular respiration |
| GO:0046888 | 0.0052 | 20.4684 | 0.1083 | 2 | 64 | negative regulation of hormone secretion |
| GO:0050795 | 0.0055 | 19.8263 | 0.1117 | 2 | 66 | regulation of behavior |
| GO:0001692 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | histamine metabolic process |
| GO:0014054 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | positive regulation of gamma-aminobutyric acid secretion |
| GO:0031064 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | negative regulation of histone deacetylation |
| GO:0032497 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | detection of lipopolysaccharide |
| GO:0051461 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | positive regulation of corticotropin secretion |
| GO:0051919 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | positive regulation of fibrinolysis |
| GO:2000048 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | negative regulation of cell-cell adhesion mediated by cadherin |
| GO:0014050 | 0.0084 | 153.0865 | 0.0085 | 1 | 5 | negative regulation of glutamate secretion |
| GO:0033132 | 0.0084 | 153.0865 | 0.0085 | 1 | 5 | negative regulation of glucokinase activity |
| GO:0048880 | 0.0084 | 153.0865 | 0.0085 | 1 | 5 | sensory system development |
| GO:0060455 | 0.0084 | 153.0865 | 0.0085 | 1 | 5 | negative regulation of gastric acid secretion |
| GO:2000987 | 0.0084 | 153.0865 | 0.0085 | 1 | 5 | positive regulation of behavioral fear response |
| GO:0071158 | 0.0092 | 15.0867 | 0.1456 | 2 | 86 | positive regulation of cell cycle arrest |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 0 | 58.8422 | 0.4661 | 16 | 169 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 52.9008 | 0.513 | 16 | 186 | DNA packaging |
| GO:0006335 | 0 | 212.3797 | 0.0883 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0071824 | 0 | 39.1241 | 0.6758 | 16 | 245 | protein-DNA complex subunit organization |
| GO:0000183 | 0 | 179.6606 | 0.0993 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 172.9956 | 0.1021 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 172.9956 | 0.1021 | 10 | 37 | response to interleukin-7 |
| GO:0051290 | 0 | 137.3183 | 0.1214 | 10 | 44 | protein heterotetramerization |
| GO:0045652 | 0 | 72.8125 | 0.2041 | 10 | 74 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 67.5149 | 0.2179 | 10 | 79 | positive regulation of gene expression, epigenetic |
| GO:0045814 | 0 | 49.2243 | 0.3255 | 11 | 118 | negative regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 51.1215 | 0.2786 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 48.9567 | 0.2896 | 10 | 105 | regulation of gene silencing by miRNA |
| GO:0060968 | 0 | 39.3569 | 0.3531 | 10 | 128 | regulation of gene silencing |
| GO:0032200 | 0 | 30.2864 | 0.4496 | 10 | 163 | telomere organization |
| GO:0035194 | 0 | 23.5526 | 0.6427 | 11 | 233 | posttranscriptional gene silencing by RNA |
| GO:0002244 | 0 | 26.2901 | 0.513 | 10 | 186 | hematopoietic progenitor cell differentiation |
| GO:0007596 | 0 | 19.015 | 0.7964 | 11 | 302 | blood coagulation |
| GO:0050878 | 0 | 13.8963 | 1.3212 | 13 | 479 | regulation of body fluid levels |
| GO:0009611 | 0 | 11.6241 | 1.7322 | 14 | 628 | response to wounding |
| GO:0017148 | 0 | 16.8274 | 0.8826 | 11 | 320 | negative regulation of translation |
| GO:0048863 | 0 | 18.6485 | 0.7089 | 10 | 257 | stem cell differentiation |
| GO:0002227 | 0 | 135.8376 | 0.0552 | 5 | 20 | innate immune response in mucosa |
| GO:0034622 | 0 | 8.9273 | 2.6838 | 16 | 973 | cellular macromolecular complex assembly |
| GO:0002251 | 0 | 75.4084 | 0.0883 | 5 | 32 | organ or tissue specific immune response |
| GO:0006334 | 0 | 38.4692 | 0.2008 | 6 | 94 | nucleosome assembly |
| GO:0030099 | 0 | 12.5246 | 1.0344 | 10 | 375 | myeloid cell differentiation |
| GO:0019731 | 0 | 61.6744 | 0.1048 | 5 | 38 | antibacterial humoral response |
| GO:0034248 | 0 | 9.767 | 1.4784 | 11 | 536 | regulation of cellular amide metabolic process |
| GO:1903706 | 0 | 10.8725 | 1.1833 | 10 | 429 | regulation of hemopoiesis |
| GO:0061844 | 0 | 44.2085 | 0.1407 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0010608 | 0 | 8.3312 | 1.7184 | 11 | 623 | posttranscriptional regulation of gene expression |
| GO:0043043 | 0 | 7.5263 | 2.1156 | 12 | 767 | peptide biosynthetic process |
| GO:0051259 | 0 | 9.0635 | 1.4067 | 10 | 510 | protein oligomerization |
| GO:0071345 | 0 | 6.7522 | 2.3418 | 12 | 849 | cellular response to cytokine stimulus |
| GO:0050830 | 0 | 26.0191 | 0.2289 | 5 | 83 | defense response to Gram-positive bacterium |
| GO:0048534 | 0 | 6.1176 | 2.2976 | 11 | 833 | hematopoietic or lymphoid organ development |
| GO:0006959 | 0 | 12.5923 | 0.5599 | 6 | 203 | humoral immune response |
| GO:0045892 | 0 | 5.1691 | 3.001 | 12 | 1088 | negative regulation of transcription, DNA-templated |
| GO:0010033 | 0 | 3.7761 | 7.988 | 20 | 2896 | response to organic substance |
| GO:0022607 | 0 | 3.7851 | 7.3894 | 19 | 2679 | cellular component assembly |
| GO:1902679 | 0 | 4.9993 | 3.0948 | 12 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0051248 | 1e-04 | 4.5107 | 3.401 | 12 | 1233 | negative regulation of protein metabolic process |
| GO:0071840 | 1e-04 | 3.2786 | 16.3566 | 29 | 5930 | cellular component organization or biogenesis |
| GO:0002376 | 1e-04 | 3.5193 | 7.2625 | 18 | 2633 | immune system process |
| GO:0045934 | 2e-04 | 4.0969 | 3.7126 | 12 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0009890 | 2e-04 | 3.8352 | 4.3608 | 13 | 1581 | negative regulation of biosynthetic process |
| GO:0070887 | 3e-04 | 3.2214 | 7.8114 | 18 | 2832 | cellular response to chemical stimulus |
| GO:0007166 | 3e-04 | 3.2571 | 7.155 | 17 | 2594 | cell surface receptor signaling pathway |
| GO:0009617 | 5e-04 | 5.7705 | 1.4122 | 7 | 512 | response to bacterium |
| GO:1901564 | 5e-04 | 2.873 | 17.7302 | 29 | 6428 | organonitrogen compound metabolic process |
| GO:0021542 | 8e-04 | 58.2234 | 0.0414 | 2 | 15 | dentate gyrus development |
| GO:0071822 | 0.001 | 3.3581 | 4.4408 | 12 | 1610 | protein complex subunit organization |
| GO:0032268 | 0.0019 | 2.81 | 6.8626 | 15 | 2488 | regulation of cellular protein metabolic process |
| GO:0072378 | 0.0021 | 32.8882 | 0.069 | 2 | 25 | blood coagulation, fibrin clot formation |
| GO:0030421 | 0.0028 | Inf | 0.0028 | 1 | 1 | defecation |
| GO:0030844 | 0.0028 | Inf | 0.0028 | 1 | 1 | positive regulation of intermediate filament depolymerization |
| GO:0045108 | 0.0028 | Inf | 0.0028 | 1 | 1 | regulation of intermediate filament polymerization or depolymerization |
| GO:0070392 | 0.0028 | Inf | 0.0028 | 1 | 1 | detection of lipoteichoic acid |
| GO:1903082 | 0.0028 | Inf | 0.0028 | 1 | 1 | positive regulation of C-C chemokine receptor CCR7 signaling pathway |
| GO:2000350 | 0.0028 | Inf | 0.0028 | 1 | 1 | positive regulation of CD40 signaling pathway |
| GO:0010604 | 0.0033 | 2.5784 | 8.0045 | 16 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0070271 | 0.0035 | 3.1411 | 3.7844 | 10 | 1372 | protein complex biogenesis |
| GO:0051276 | 0.0037 | 4.0585 | 2.0522 | 7 | 953 | chromosome organization |
| GO:0001662 | 0.0037 | 24.3886 | 0.091 | 2 | 33 | behavioral fear response |
| GO:0045595 | 0.004 | 2.9359 | 4.5043 | 11 | 1633 | regulation of cell differentiation |
| GO:0043207 | 0.0054 | 3.6644 | 2.1735 | 7 | 788 | response to external biotic stimulus |
| GO:0090382 | 0.0054 | 19.8872 | 0.1103 | 2 | 40 | phagosome maturation |
| GO:0002543 | 0.0055 | 369.9302 | 0.0055 | 1 | 2 | activation of blood coagulation via clotting cascade |
| GO:0002588 | 0.0055 | 369.9302 | 0.0055 | 1 | 2 | positive regulation of antigen processing and presentation of peptide antigen via MHC class II |
| GO:0007506 | 0.0055 | 369.9302 | 0.0055 | 1 | 2 | gonadal mesoderm development |
| GO:0032499 | 0.0055 | 369.9302 | 0.0055 | 1 | 2 | detection of peptidoglycan |
| GO:2000355 | 0.0055 | 369.9302 | 0.0055 | 1 | 2 | negative regulation of ovarian follicle development |
| GO:0016567 | 0.0062 | 3.5681 | 2.2287 | 7 | 808 | protein ubiquitination |
| GO:0098542 | 0.0067 | 4.6038 | 1.2026 | 5 | 436 | defense response to other organism |
| GO:0008347 | 0.0068 | 17.5692 | 0.1241 | 2 | 45 | glial cell migration |
| GO:2000179 | 0.0074 | 16.7862 | 0.1296 | 2 | 47 | positive regulation of neural precursor cell proliferation |
| GO:0001546 | 0.0083 | 184.9535 | 0.0083 | 1 | 3 | preantral ovarian follicle growth |
| GO:0002541 | 0.0083 | 184.9535 | 0.0083 | 1 | 3 | activation of plasma proteins involved in acute inflammatory response |
| GO:0044267 | 0.0088 | 2.8029 | 5.2035 | 11 | 2418 | cellular protein metabolic process |
| GO:2000242 | 0.009 | 15.1029 | 0.1434 | 2 | 52 | negative regulation of reproductive process |
| GO:0008152 | 0.0093 | 2.6029 | 29.5025 | 37 | 10696 | metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009593 | 0 | 22.4467 | 0.8999 | 13 | 388 | detection of chemical stimulus |
| GO:0050906 | 0 | 21.7339 | 0.9278 | 13 | 400 | detection of stimulus involved in sensory perception |
| GO:0050911 | 0 | 25.0692 | 0.7214 | 12 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0 | 21.3938 | 0.9417 | 13 | 406 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 7.6924 | 2.7393 | 14 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 7.0536 | 2.6627 | 13 | 1148 | nervous system process |
| GO:0006683 | 0.0023 | Inf | 0.0023 | 1 | 1 | galactosylceramide catabolic process |
| GO:0030200 | 0.0069 | 221.0139 | 0.007 | 1 | 3 | heparan sulfate proteoglycan catabolic process |
| GO:0043137 | 0.0092 | 147.3333 | 0.0093 | 1 | 4 | DNA replication, removal of RNA primer |
| GO:1902412 | 0.0092 | 147.3333 | 0.0093 | 1 | 4 | regulation of mitotic cytokinesis |
| GO:1904340 | 0.0092 | 147.3333 | 0.0093 | 1 | 4 | positive regulation of dopaminergic neuron differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0034120 | 0.0013 | Inf | 0.0013 | 1 | 1 | positive regulation of erythrocyte aggregation |
| GO:0048685 | 0.0013 | Inf | 0.0013 | 1 | 1 | negative regulation of collateral sprouting of intact axon in response to injury |
| GO:0060183 | 0.0013 | Inf | 0.0013 | 1 | 1 | apelin receptor signaling pathway |
| GO:1904022 | 0.0013 | Inf | 0.0013 | 1 | 1 | positive regulation of G-protein coupled receptor internalization |
| GO:0090134 | 0.0026 | 796.5 | 0.0026 | 1 | 2 | cell migration involved in mesendoderm migration |
| GO:2000866 | 0.0026 | 796.5 | 0.0026 | 1 | 2 | positive regulation of estradiol secretion |
| GO:0048678 | 0.0029 | 28.3176 | 0.0803 | 2 | 61 | response to axon injury |
| GO:0002317 | 0.0039 | 398.225 | 0.0039 | 1 | 3 | plasma cell differentiation |
| GO:0060337 | 0.0043 | 22.8666 | 0.0987 | 2 | 75 | type I interferon signaling pathway |
| GO:0034340 | 0.0049 | 21.3941 | 0.1053 | 2 | 80 | response to type I interferon |
| GO:0006710 | 0.0053 | 265.4667 | 0.0053 | 1 | 4 | androgen catabolic process |
| GO:0048382 | 0.0066 | 199.0875 | 0.0066 | 1 | 5 | mesendoderm development |
| GO:0070221 | 0.0066 | 199.0875 | 0.0066 | 1 | 5 | sulfide oxidation, using sulfide:quinone oxidoreductase |
| GO:0035900 | 0.0079 | 159.26 | 0.0079 | 1 | 6 | response to isolation stress |
| GO:0070459 | 0.0079 | 159.26 | 0.0079 | 1 | 6 | prolactin secretion |
| GO:0071394 | 0.0079 | 159.26 | 0.0079 | 1 | 6 | cellular response to testosterone stimulus |
| GO:0090481 | 0.0079 | 159.26 | 0.0079 | 1 | 6 | pyrimidine nucleotide-sugar transmembrane transport |
| GO:0034754 | 0.0092 | 15.2796 | 0.1461 | 2 | 111 | cellular hormone metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000183 | 0 | 264.023 | 0.1061 | 13 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 253.0061 | 0.109 | 13 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 253.0061 | 0.109 | 13 | 37 | response to interleukin-7 |
| GO:0045652 | 0 | 99.3115 | 0.218 | 13 | 74 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 91.7589 | 0.2328 | 13 | 79 | positive regulation of gene expression, epigenetic |
| GO:0006335 | 0 | 195.1229 | 0.0943 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:1902036 | 0 | 68.7236 | 0.2976 | 13 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 65.719 | 0.3094 | 13 | 105 | regulation of gene silencing by miRNA |
| GO:0045814 | 0 | 57.535 | 0.3477 | 13 | 118 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 52.4987 | 0.3771 | 13 | 128 | regulation of gene silencing |
| GO:0051290 | 0 | 126.1606 | 0.1296 | 10 | 44 | protein heterotetramerization |
| GO:0006333 | 0 | 38.6005 | 0.4979 | 13 | 169 | chromatin assembly or disassembly |
| GO:0002244 | 0 | 34.7698 | 0.548 | 13 | 186 | hematopoietic progenitor cell differentiation |
| GO:0006323 | 0 | 34.7698 | 0.548 | 13 | 186 | DNA packaging |
| GO:0035194 | 0 | 27.26 | 0.6865 | 13 | 233 | posttranscriptional gene silencing by RNA |
| GO:0071824 | 0 | 25.8302 | 0.7219 | 13 | 245 | protein-DNA complex subunit organization |
| GO:0048863 | 0 | 24.5411 | 0.7572 | 13 | 257 | stem cell differentiation |
| GO:0017148 | 0 | 19.4265 | 0.9428 | 13 | 320 | negative regulation of translation |
| GO:0007596 | 0 | 18.9849 | 0.9635 | 13 | 327 | blood coagulation |
| GO:0032200 | 0 | 27.8255 | 0.4803 | 10 | 163 | telomere organization |
| GO:0030099 | 0 | 16.4169 | 1.1049 | 13 | 375 | myeloid cell differentiation |
| GO:0050911 | 0 | 17.8951 | 0.9163 | 12 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:1903706 | 0 | 14.2362 | 1.264 | 13 | 429 | regulation of hemopoiesis |
| GO:0050878 | 0 | 12.6677 | 1.4113 | 13 | 479 | regulation of body fluid levels |
| GO:0009593 | 0 | 14.1602 | 1.1432 | 12 | 388 | detection of chemical stimulus |
| GO:0050906 | 0 | 13.7116 | 1.1785 | 12 | 400 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 13.4976 | 1.1962 | 12 | 406 | sensory perception of chemical stimulus |
| GO:0034248 | 0 | 11.2454 | 1.5792 | 13 | 536 | regulation of cellular amide metabolic process |
| GO:0010608 | 0 | 9.587 | 1.8356 | 13 | 623 | posttranscriptional regulation of gene expression |
| GO:0009611 | 0 | 9.506 | 1.8503 | 13 | 628 | response to wounding |
| GO:0071345 | 0 | 7.6567 | 2.5014 | 14 | 849 | cellular response to cytokine stimulus |
| GO:0043043 | 0 | 7.6831 | 2.2598 | 13 | 767 | peptide biosynthetic process |
| GO:0051248 | 0 | 6.2292 | 3.6328 | 16 | 1233 | negative regulation of protein metabolic process |
| GO:0048534 | 0 | 7.0339 | 2.4543 | 13 | 833 | hematopoietic or lymphoid organ development |
| GO:0051259 | 0 | 8.327 | 1.5026 | 10 | 510 | protein oligomerization |
| GO:0034622 | 0 | 5.9524 | 2.8668 | 13 | 973 | cellular macromolecular complex assembly |
| GO:0045892 | 0 | 5.2747 | 3.2056 | 13 | 1088 | negative regulation of transcription, DNA-templated |
| GO:1902679 | 0 | 5.1013 | 3.3058 | 13 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0050877 | 0 | 4.9756 | 3.3824 | 13 | 1148 | nervous system process |
| GO:0045934 | 0 | 4.6415 | 3.9658 | 14 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0031424 | 0 | 11.5499 | 0.604 | 6 | 205 | keratinization |
| GO:0007186 | 1e-04 | 4.3219 | 3.4796 | 12 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0009890 | 1e-04 | 3.8818 | 4.6582 | 14 | 1581 | negative regulation of biosynthetic process |
| GO:0045595 | 2e-04 | 3.7435 | 4.8114 | 14 | 1633 | regulation of cell differentiation |
| GO:0009913 | 4e-04 | 7.1046 | 0.9635 | 6 | 327 | epidermal cell differentiation |
| GO:0023052 | 6e-04 | 2.705 | 17.5779 | 29 | 5966 | signaling |
| GO:0007154 | 7e-04 | 2.6905 | 17.6368 | 29 | 5986 | cell communication |
| GO:0007166 | 7e-04 | 2.9307 | 7.6428 | 17 | 2594 | cell surface receptor signaling pathway |
| GO:0032501 | 9e-04 | 3.7277 | 7.8245 | 16 | 3927 | multicellular organismal process |
| GO:0002376 | 9e-04 | 2.8786 | 7.7577 | 17 | 2633 | immune system process |
| GO:0043588 | 9e-04 | 5.9788 | 1.1373 | 6 | 386 | skin development |
| GO:0006334 | 0.0013 | 15.3122 | 0.2185 | 3 | 94 | nucleosome assembly |
| GO:0032268 | 0.0014 | 2.8047 | 7.3305 | 16 | 2488 | regulation of cellular protein metabolic process |
| GO:0050896 | 0.002 | 2.5604 | 23.7799 | 34 | 8071 | response to stimulus |
| GO:0070887 | 0.002 | 2.6351 | 8.344 | 17 | 2832 | cellular response to chemical stimulus |
| GO:0048869 | 0.0024 | 2.4413 | 11.7117 | 21 | 3975 | cellular developmental process |
| GO:0048731 | 0.0034 | 2.3427 | 12.8608 | 22 | 4365 | system development |
| GO:0070271 | 0.0058 | 2.8859 | 4.0424 | 10 | 1372 | protein complex biogenesis |
| GO:1900176 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
| GO:0010033 | 0.0068 | 2.3342 | 8.5326 | 16 | 2896 | response to organic substance |
| GO:1900108 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | negative regulation of nodal signaling pathway |
| GO:0051239 | 0.0091 | 2.2905 | 8.0052 | 15 | 2717 | regulation of multicellular organismal process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009593 | 6e-04 | 8.453 | 0.7054 | 5 | 388 | detection of chemical stimulus |
| GO:0050906 | 7e-04 | 8.1899 | 0.7272 | 5 | 400 | detection of stimulus involved in sensory perception |
| GO:0007606 | 7e-04 | 8.0642 | 0.7381 | 5 | 406 | sensory perception of chemical stimulus |
| GO:0019358 | 0.0018 | Inf | 0.0018 | 1 | 1 | nicotinate nucleotide salvage |
| GO:0046497 | 0.0018 | Inf | 0.0018 | 1 | 1 | nicotinate nucleotide metabolic process |
| GO:0050911 | 0.0023 | 8.1386 | 0.5654 | 4 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0014839 | 0.0036 | 568.6429 | 0.0036 | 1 | 2 | myoblast migration involved in skeletal muscle regeneration |
| GO:0036292 | 0.0036 | 568.6429 | 0.0036 | 1 | 2 | DNA rewinding |
| GO:0007186 | 0.0044 | 3.9973 | 2.147 | 7 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0018149 | 0.0045 | 22.1803 | 0.1 | 2 | 55 | peptide cross-linking |
| GO:0051697 | 0.0054 | 284.3036 | 0.0055 | 1 | 3 | protein delipidation |
| GO:1900138 | 0.0054 | 284.3036 | 0.0055 | 1 | 3 | negative regulation of phospholipase A2 activity |
| GO:0031394 | 0.0073 | 189.5238 | 0.0073 | 1 | 4 | positive regulation of prostaglandin biosynthetic process |
| GO:0033031 | 0.0073 | 189.5238 | 0.0073 | 1 | 4 | positive regulation of neutrophil apoptotic process |
| GO:0045629 | 0.0073 | 189.5238 | 0.0073 | 1 | 4 | negative regulation of T-helper 2 cell differentiation |
| GO:0097350 | 0.0073 | 189.5238 | 0.0073 | 1 | 4 | neutrophil clearance |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0052548 | 6e-04 | 12.8021 | 0.4028 | 4 | 378 | regulation of endopeptidase activity |
| GO:0010952 | 7e-04 | 20.6067 | 0.178 | 3 | 167 | positive regulation of peptidase activity |
| GO:0019731 | 7e-04 | 58.8852 | 0.0405 | 2 | 38 | antibacterial humoral response |
| GO:0098542 | 0.001 | 11.042 | 0.4646 | 4 | 436 | defense response to other organism |
| GO:0051878 | 0.0011 | Inf | 0.0011 | 1 | 1 | lateral element assembly |
| GO:0045071 | 0.0013 | 44.1306 | 0.0533 | 2 | 50 | negative regulation of viral genome replication |
| GO:0014839 | 0.0021 | 995.875 | 0.0021 | 1 | 2 | myoblast migration involved in skeletal muscle regeneration |
| GO:0036292 | 0.0021 | 995.875 | 0.0021 | 1 | 2 | DNA rewinding |
| GO:0032652 | 0.0025 | 31.1118 | 0.0746 | 2 | 70 | regulation of interleukin-1 production |
| GO:0071103 | 0.0025 | 12.9697 | 0.2792 | 3 | 262 | DNA conformation change |
| GO:0000711 | 0.0032 | 497.9062 | 0.0032 | 1 | 3 | meiotic DNA repair synthesis |
| GO:1900005 | 0.0032 | 497.9062 | 0.0032 | 1 | 3 | positive regulation of serine-type endopeptidase activity |
| GO:1900138 | 0.0032 | 497.9062 | 0.0032 | 1 | 3 | negative regulation of phospholipase A2 activity |
| GO:1901318 | 0.0032 | 497.9062 | 0.0032 | 1 | 3 | negative regulation of flagellated sperm motility |
| GO:0097722 | 0.0035 | 26.0971 | 0.0885 | 2 | 83 | sperm motility |
| GO:0048525 | 0.0037 | 25.1603 | 0.0916 | 2 | 86 | negative regulation of viral process |
| GO:0031394 | 0.0043 | 331.9167 | 0.0043 | 1 | 4 | positive regulation of prostaglandin biosynthetic process |
| GO:0033031 | 0.0043 | 331.9167 | 0.0043 | 1 | 4 | positive regulation of neutrophil apoptotic process |
| GO:0045629 | 0.0043 | 331.9167 | 0.0043 | 1 | 4 | negative regulation of T-helper 2 cell differentiation |
| GO:0097350 | 0.0043 | 331.9167 | 0.0043 | 1 | 4 | neutrophil clearance |
| GO:0050790 | 0.005 | 4.4167 | 2.3307 | 7 | 2187 | regulation of catalytic activity |
| GO:0051704 | 0.0061 | 4.2422 | 2.4127 | 7 | 2264 | multi-organism process |
| GO:0045627 | 0.0064 | 199.125 | 0.0064 | 1 | 6 | positive regulation of T-helper 1 cell differentiation |
| GO:0070459 | 0.0064 | 199.125 | 0.0064 | 1 | 6 | prolactin secretion |
| GO:2000483 | 0.0064 | 199.125 | 0.0064 | 1 | 6 | negative regulation of interleukin-8 secretion |
| GO:2001279 | 0.0064 | 199.125 | 0.0064 | 1 | 6 | regulation of unsaturated fatty acid biosynthetic process |
| GO:0030162 | 0.0067 | 6.3541 | 0.7886 | 4 | 740 | regulation of proteolysis |
| GO:0048609 | 0.0074 | 6.1779 | 0.8099 | 4 | 760 | multicellular organismal reproductive process |
| GO:0031340 | 0.0074 | 165.9271 | 0.0075 | 1 | 7 | positive regulation of vesicle fusion |
| GO:0051026 | 0.0074 | 165.9271 | 0.0075 | 1 | 7 | chiasma assembly |
| GO:2001056 | 0.0077 | 17.1404 | 0.1332 | 2 | 125 | positive regulation of cysteine-type endopeptidase activity |
| GO:0050777 | 0.0078 | 17.0011 | 0.1343 | 2 | 126 | negative regulation of immune response |
| GO:1903900 | 0.0078 | 17.0011 | 0.1343 | 2 | 126 | regulation of viral life cycle |
| GO:0051346 | 0.008 | 8.4744 | 0.422 | 3 | 396 | negative regulation of hydrolase activity |
| GO:0043207 | 0.0084 | 5.9462 | 0.8398 | 4 | 788 | response to external biotic stimulus |
| GO:0000733 | 0.0085 | 142.2143 | 0.0085 | 1 | 8 | DNA strand renaturation |
| GO:0051256 | 0.0085 | 142.2143 | 0.0085 | 1 | 8 | mitotic spindle midzone assembly |
| GO:0045087 | 0.0093 | 5.768 | 0.8643 | 4 | 811 | innate immune response |
| GO:0035457 | 0.0096 | 124.4297 | 0.0096 | 1 | 9 | cellular response to interferon-alpha |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 33.4659 | 0.7019 | 14 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 26.4448 | 0.8756 | 14 | 388 | detection of chemical stimulus |
| GO:0050906 | 0 | 25.6029 | 0.9027 | 14 | 400 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 25.2013 | 0.9162 | 14 | 406 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 9.0358 | 2.6652 | 15 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 8.2952 | 2.5908 | 14 | 1148 | nervous system process |
| GO:0031424 | 0 | 15.796 | 0.4626 | 6 | 205 | keratinization |
| GO:0009913 | 1e-04 | 9.7165 | 0.738 | 6 | 327 | epidermal cell differentiation |
| GO:0043588 | 2e-04 | 8.1768 | 0.8711 | 6 | 386 | skin development |
| GO:0018149 | 3e-04 | 27.7343 | 0.1241 | 3 | 55 | peptide cross-linking |
| GO:0042742 | 0.0016 | 8.7965 | 0.5123 | 4 | 227 | defense response to bacterium |
| GO:0002152 | 0.0023 | Inf | 0.0023 | 1 | 1 | bile acid conjugation |
| GO:0045189 | 0.0023 | Inf | 0.0023 | 1 | 1 | connective tissue growth factor biosynthetic process |
| GO:0070351 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of white fat cell proliferation |
| GO:1903488 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of lactation |
| GO:0010831 | 0.0031 | 26.6908 | 0.0835 | 2 | 37 | positive regulation of myotube differentiation |
| GO:0002296 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | T-helper 1 cell lineage commitment |
| GO:2000424 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | positive regulation of eosinophil chemotaxis |
| GO:0032501 | 0.0057 | 2.7591 | 12.6215 | 20 | 6625 | multicellular organismal process |
| GO:0036112 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | medium-chain fatty-acyl-CoA metabolic process |
| GO:0071288 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | cellular response to mercury ion |
| GO:1903660 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | negative regulation of complement-dependent cytotoxicity |
| GO:0031296 | 0.009 | 151.5524 | 0.009 | 1 | 4 | B cell costimulation |
| GO:0048295 | 0.009 | 151.5524 | 0.009 | 1 | 4 | positive regulation of isotype switching to IgE isotypes |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006600 | 1e-04 | 234.1912 | 0.0119 | 2 | 10 | creatine metabolic process |
| GO:0052548 | 9e-04 | 11.0938 | 0.4502 | 4 | 378 | regulation of endopeptidase activity |
| GO:0019731 | 9e-04 | 51.951 | 0.0453 | 2 | 38 | antibacterial humoral response |
| GO:0051878 | 0.0012 | Inf | 0.0012 | 1 | 1 | lateral element assembly |
| GO:0051336 | 0.0015 | 6.1101 | 1.34 | 6 | 1125 | regulation of hydrolase activity |
| GO:0098542 | 0.0015 | 9.5685 | 0.5193 | 4 | 436 | defense response to other organism |
| GO:0045071 | 0.0016 | 38.9338 | 0.0596 | 2 | 50 | negative regulation of viral genome replication |
| GO:0043207 | 0.0019 | 6.9102 | 0.9386 | 5 | 788 | response to external biotic stimulus |
| GO:0014839 | 0.0024 | 885.1111 | 0.0024 | 1 | 2 | myoblast migration involved in skeletal muscle regeneration |
| GO:0036292 | 0.0024 | 885.1111 | 0.0024 | 1 | 2 | DNA rewinding |
| GO:0010466 | 0.0028 | 12.2602 | 0.2894 | 3 | 243 | negative regulation of peptidase activity |
| GO:0032481 | 0.0031 | 27.4481 | 0.0834 | 2 | 70 | positive regulation of type I interferon production |
| GO:0032652 | 0.0031 | 27.4481 | 0.0834 | 2 | 70 | regulation of interleukin-1 production |
| GO:0071103 | 0.0035 | 11.347 | 0.3121 | 3 | 262 | DNA conformation change |
| GO:0000711 | 0.0036 | 442.5278 | 0.0036 | 1 | 3 | meiotic DNA repair synthesis |
| GO:1900005 | 0.0036 | 442.5278 | 0.0036 | 1 | 3 | positive regulation of serine-type endopeptidase activity |
| GO:1900138 | 0.0036 | 442.5278 | 0.0036 | 1 | 3 | negative regulation of phospholipase A2 activity |
| GO:1901318 | 0.0036 | 442.5278 | 0.0036 | 1 | 3 | negative regulation of flagellated sperm motility |
| GO:0097722 | 0.0043 | 23.024 | 0.0989 | 2 | 83 | sperm motility |
| GO:0048525 | 0.0046 | 22.1975 | 0.1024 | 2 | 86 | negative regulation of viral process |
| GO:0031394 | 0.0048 | 295 | 0.0048 | 1 | 4 | positive regulation of prostaglandin biosynthetic process |
| GO:0033031 | 0.0048 | 295 | 0.0048 | 1 | 4 | positive regulation of neutrophil apoptotic process |
| GO:0045629 | 0.0048 | 295 | 0.0048 | 1 | 4 | negative regulation of T-helper 2 cell differentiation |
| GO:0097350 | 0.0048 | 295 | 0.0048 | 1 | 4 | neutrophil clearance |
| GO:2000117 | 0.0066 | 18.4415 | 0.1227 | 2 | 103 | negative regulation of cysteine-type endopeptidase activity |
| GO:0051098 | 0.0066 | 8.9764 | 0.3919 | 3 | 329 | regulation of binding |
| GO:0045627 | 0.0071 | 176.9778 | 0.0071 | 1 | 6 | positive regulation of T-helper 1 cell differentiation |
| GO:0070459 | 0.0071 | 176.9778 | 0.0071 | 1 | 6 | prolactin secretion |
| GO:2000483 | 0.0071 | 176.9778 | 0.0071 | 1 | 6 | negative regulation of interleukin-8 secretion |
| GO:2001279 | 0.0071 | 176.9778 | 0.0071 | 1 | 6 | regulation of unsaturated fatty acid biosynthetic process |
| GO:0031340 | 0.0083 | 147.4722 | 0.0083 | 1 | 7 | positive regulation of vesicle fusion |
| GO:0051026 | 0.0083 | 147.4722 | 0.0083 | 1 | 7 | chiasma assembly |
| GO:0043900 | 0.0092 | 7.9085 | 0.4431 | 3 | 372 | regulation of multi-organism process |
| GO:0000733 | 0.0095 | 126.3968 | 0.0095 | 1 | 8 | DNA strand renaturation |
| GO:0051256 | 0.0095 | 126.3968 | 0.0095 | 1 | 8 | mitotic spindle midzone assembly |
| GO:0050777 | 0.0097 | 14.9991 | 0.1501 | 2 | 126 | negative regulation of immune response |
| GO:1903900 | 0.0097 | 14.9991 | 0.1501 | 2 | 126 | regulation of viral life cycle |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 0 | 92.7936 | 0.3814 | 17 | 169 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 83.3694 | 0.4198 | 17 | 186 | DNA packaging |
| GO:0071824 | 0 | 61.5642 | 0.5529 | 17 | 245 | protein-DNA complex subunit organization |
| GO:0006335 | 0 | 277.8671 | 0.0722 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 235.0592 | 0.0812 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 226.339 | 0.0835 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 226.339 | 0.0835 | 10 | 37 | response to interleukin-7 |
| GO:0051290 | 0 | 179.6606 | 0.0993 | 10 | 44 | protein heterotetramerization |
| GO:0045652 | 0 | 95.2644 | 0.167 | 10 | 74 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 88.3333 | 0.1783 | 10 | 79 | positive regulation of gene expression, epigenetic |
| GO:0045814 | 0 | 65.009 | 0.2663 | 11 | 118 | negative regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 66.885 | 0.2279 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 64.0526 | 0.237 | 10 | 105 | regulation of gene silencing by miRNA |
| GO:0060968 | 0 | 51.4928 | 0.2889 | 10 | 128 | regulation of gene silencing |
| GO:0032200 | 0 | 39.6254 | 0.3679 | 10 | 163 | telomere organization |
| GO:0035194 | 0 | 31.1052 | 0.5258 | 11 | 233 | posttranscriptional gene silencing by RNA |
| GO:0034622 | 0 | 14.0013 | 2.1958 | 17 | 973 | cellular macromolecular complex assembly |
| GO:0002244 | 0 | 34.3969 | 0.4198 | 10 | 186 | hematopoietic progenitor cell differentiation |
| GO:0017148 | 0 | 22.2236 | 0.7222 | 11 | 320 | negative regulation of translation |
| GO:0006334 | 0 | 66.9383 | 0.1535 | 7 | 94 | nucleosome assembly |
| GO:0048863 | 0 | 24.3989 | 0.58 | 10 | 257 | stem cell differentiation |
| GO:0002227 | 0 | 170.9785 | 0.0451 | 5 | 20 | innate immune response in mucosa |
| GO:0007596 | 0 | 18.9262 | 0.738 | 10 | 327 | blood coagulation |
| GO:0050878 | 0 | 14.5238 | 1.081 | 11 | 479 | regulation of body fluid levels |
| GO:0030099 | 0 | 16.3867 | 0.8463 | 10 | 375 | myeloid cell differentiation |
| GO:0002251 | 0 | 94.9164 | 0.0722 | 5 | 32 | organ or tissue specific immune response |
| GO:0034248 | 0 | 12.8991 | 1.2096 | 11 | 536 | regulation of cellular amide metabolic process |
| GO:0019731 | 0 | 77.6295 | 0.0858 | 5 | 38 | antibacterial humoral response |
| GO:1903706 | 0 | 14.2253 | 0.9682 | 10 | 429 | regulation of hemopoiesis |
| GO:0010608 | 0 | 11.0029 | 1.406 | 11 | 623 | posttranscriptional regulation of gene expression |
| GO:0061844 | 0 | 55.6452 | 0.1151 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0051259 | 0 | 11.8585 | 1.151 | 10 | 510 | protein oligomerization |
| GO:0045892 | 0 | 7.8032 | 2.4554 | 13 | 1088 | negative regulation of transcription, DNA-templated |
| GO:1902679 | 0 | 7.5466 | 2.5321 | 13 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0043043 | 0 | 8.8233 | 1.7309 | 11 | 767 | peptide biosynthetic process |
| GO:0009611 | 0 | 9.5208 | 1.4173 | 10 | 628 | response to wounding |
| GO:0050830 | 0 | 32.7502 | 0.1873 | 5 | 83 | defense response to Gram-positive bacterium |
| GO:0048534 | 0 | 8.0795 | 1.8799 | 11 | 833 | hematopoietic or lymphoid organ development |
| GO:0045934 | 0 | 6.1835 | 3.0376 | 13 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0009890 | 0 | 5.8272 | 3.568 | 14 | 1581 | negative regulation of biosynthetic process |
| GO:0051248 | 0 | 6.0176 | 2.7826 | 12 | 1233 | negative regulation of protein metabolic process |
| GO:0071345 | 0 | 6.9116 | 1.916 | 10 | 849 | cellular response to cytokine stimulus |
| GO:0002376 | 0 | 4.5489 | 5.9421 | 17 | 2633 | immune system process |
| GO:0022607 | 0 | 4.4549 | 6.0459 | 17 | 2679 | cellular component assembly |
| GO:0045595 | 0 | 4.9879 | 3.6853 | 13 | 1633 | regulation of cell differentiation |
| GO:0006959 | 1e-04 | 12.8038 | 0.4581 | 5 | 203 | humoral immune response |
| GO:0051276 | 1e-04 | 6.9691 | 1.5693 | 8 | 953 | chromosome organization |
| GO:1903506 | 5e-04 | 3.2826 | 7.7317 | 17 | 3426 | regulation of nucleic acid-templated transcription |
| GO:0070271 | 7e-04 | 4.1099 | 3.0963 | 10 | 1372 | protein complex biogenesis |
| GO:2000112 | 8e-04 | 3.101 | 8.7991 | 18 | 3899 | regulation of cellular macromolecule biosynthetic process |
| GO:0051252 | 0.001 | 3.0654 | 8.1537 | 17 | 3613 | regulation of RNA metabolic process |
| GO:0097275 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular ammonia homeostasis |
| GO:0097276 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular creatinine homeostasis |
| GO:0097277 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular urea homeostasis |
| GO:0070887 | 0.0023 | 2.9578 | 6.3912 | 14 | 2832 | cellular response to chemical stimulus |
| GO:0071822 | 0.0023 | 3.4413 | 3.6334 | 10 | 1610 | protein complex subunit organization |
| GO:0098542 | 0.0028 | 5.7949 | 0.984 | 5 | 436 | defense response to other organism |
| GO:0010033 | 0.0028 | 2.878 | 6.5356 | 14 | 2896 | response to organic substance |
| GO:0048731 | 0.0032 | 2.6614 | 9.8508 | 18 | 4365 | system development |
| GO:0034654 | 0.0036 | 2.6477 | 9.1106 | 17 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0006583 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | melanin biosynthetic process from tyrosine |
| GO:0051239 | 0.0047 | 2.7617 | 6.1316 | 13 | 2717 | regulation of multicellular organismal process |
| GO:0009617 | 0.0055 | 4.902 | 1.1555 | 5 | 512 | response to bacterium |
| GO:0032268 | 0.0065 | 2.7141 | 5.6148 | 12 | 2488 | regulation of cellular protein metabolic process |
| GO:0006726 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | eye pigment biosynthetic process |
| GO:0043324 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | pigment metabolic process involved in developmental pigmentation |
| GO:0016567 | 0.0088 | 3.7691 | 1.8235 | 6 | 808 | protein ubiquitination |
| GO:1900738 | 0.009 | 151.5524 | 0.009 | 1 | 4 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 289 | 0.0702 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 244.4769 | 0.079 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 235.4074 | 0.0812 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 235.4074 | 0.0812 | 10 | 37 | response to interleukin-7 |
| GO:0051290 | 0 | 186.8588 | 0.0965 | 10 | 44 | protein heterotetramerization |
| GO:0045652 | 0 | 99.0812 | 0.1624 | 10 | 74 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 91.8725 | 0.1733 | 10 | 79 | positive regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 69.5648 | 0.2216 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 66.6189 | 0.2304 | 10 | 105 | regulation of gene silencing by miRNA |
| GO:0035194 | 0 | 37.0553 | 0.5112 | 12 | 233 | posttranscriptional gene silencing by RNA |
| GO:0060968 | 0 | 53.5559 | 0.2808 | 10 | 128 | regulation of gene silencing |
| GO:0031497 | 0 | 46.7615 | 0.3181 | 10 | 145 | chromatin assembly |
| GO:0034728 | 0 | 43.509 | 0.3401 | 10 | 155 | nucleosome organization |
| GO:0032200 | 0 | 41.2131 | 0.3576 | 10 | 163 | telomere organization |
| GO:0017148 | 0 | 26.441 | 0.7021 | 12 | 320 | negative regulation of translation |
| GO:0002244 | 0 | 35.775 | 0.4081 | 10 | 186 | hematopoietic progenitor cell differentiation |
| GO:0065004 | 0 | 30.8098 | 0.4695 | 10 | 214 | protein-DNA complex assembly |
| GO:1903507 | 0 | 12.6722 | 2.4596 | 17 | 1121 | negative regulation of nucleic acid-templated transcription |
| GO:1903706 | 0 | 19.3932 | 0.9413 | 12 | 429 | regulation of hemopoiesis |
| GO:0009890 | 0 | 10.9133 | 3.4688 | 19 | 1581 | negative regulation of biosynthetic process |
| GO:0051253 | 0 | 11.8168 | 2.6219 | 17 | 1195 | negative regulation of RNA metabolic process |
| GO:0048863 | 0 | 25.3765 | 0.5639 | 10 | 257 | stem cell differentiation |
| GO:0071103 | 0 | 24.8651 | 0.5748 | 10 | 262 | DNA conformation change |
| GO:0030099 | 0 | 19.5837 | 0.8228 | 11 | 375 | myeloid cell differentiation |
| GO:0006342 | 0 | 81.95 | 0.1052 | 6 | 67 | chromatin silencing |
| GO:0034248 | 0 | 15.3266 | 1.176 | 12 | 536 | regulation of cellular amide metabolic process |
| GO:0007596 | 0 | 19.6845 | 0.7175 | 10 | 327 | blood coagulation |
| GO:0031324 | 0 | 8.1272 | 5.4874 | 21 | 2501 | negative regulation of cellular metabolic process |
| GO:0010608 | 0 | 13.0699 | 1.3669 | 12 | 623 | posttranscriptional regulation of gene expression |
| GO:0040029 | 0 | 24.2244 | 0.4883 | 8 | 310 | regulation of gene expression, epigenetic |
| GO:0043043 | 0 | 10.4776 | 1.6829 | 12 | 767 | peptide biosynthetic process |
| GO:0050878 | 0 | 13.1753 | 1.051 | 10 | 479 | regulation of body fluid levels |
| GO:0051259 | 0 | 12.3336 | 1.119 | 10 | 510 | protein oligomerization |
| GO:0048534 | 0 | 9.5934 | 1.8277 | 12 | 833 | hematopoietic or lymphoid organ development |
| GO:0051248 | 0 | 8.0383 | 2.7053 | 14 | 1233 | negative regulation of protein metabolic process |
| GO:0071345 | 0 | 9.4 | 1.8628 | 12 | 849 | cellular response to cytokine stimulus |
| GO:0048519 | 0 | 5.8039 | 10.5689 | 25 | 4817 | negative regulation of biological process |
| GO:0009611 | 0 | 9.9023 | 1.3779 | 10 | 628 | response to wounding |
| GO:0006355 | 0 | 5.5533 | 7.473 | 21 | 3406 | regulation of transcription, DNA-templated |
| GO:2001141 | 0 | 5.4975 | 7.5323 | 21 | 3433 | regulation of RNA biosynthetic process |
| GO:0034654 | 0 | 5.0166 | 8.8575 | 22 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0019219 | 0 | 4.5292 | 8.7346 | 21 | 3981 | regulation of nucleobase-containing compound metabolic process |
| GO:0045595 | 0 | 5.215 | 3.5829 | 13 | 1633 | regulation of cell differentiation |
| GO:0032268 | 0 | 4.5801 | 5.4589 | 16 | 2488 | regulation of cellular protein metabolic process |
| GO:0009059 | 0 | 4.2403 | 10.9221 | 23 | 4978 | macromolecule biosynthetic process |
| GO:0065007 | 0 | 14.9046 | 24.3543 | 34 | 11100 | biological regulation |
| GO:0050794 | 1e-04 | 15.5763 | 12.6441 | 21 | 8183 | regulation of cellular process |
| GO:0044249 | 2e-04 | 3.6973 | 13.0131 | 24 | 5931 | cellular biosynthetic process |
| GO:0002376 | 2e-04 | 3.8099 | 5.777 | 15 | 2633 | immune system process |
| GO:0090304 | 3e-04 | 3.436 | 10.6589 | 21 | 4858 | nucleic acid metabolic process |
| GO:0034641 | 4e-04 | 3.434 | 13.6209 | 24 | 6208 | cellular nitrogen compound metabolic process |
| GO:0060255 | 4e-04 | 4.8379 | 4.5492 | 12 | 2827 | regulation of macromolecule metabolic process |
| GO:0070271 | 5e-04 | 4.2746 | 3.0103 | 10 | 1372 | protein complex biogenesis |
| GO:0051172 | 6e-04 | 6.1207 | 1.5937 | 7 | 1117 | negative regulation of nitrogen compound metabolic process |
| GO:2000113 | 8e-04 | 5.7933 | 1.6229 | 7 | 1103 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0046483 | 9e-04 | 3.0947 | 12.3944 | 22 | 5649 | heterocycle metabolic process |
| GO:0051276 | 9e-04 | 6.4185 | 1.1801 | 6 | 735 | chromosome organization |
| GO:0006725 | 9e-04 | 3.0643 | 12.4734 | 22 | 5685 | cellular aromatic compound metabolic process |
| GO:0044260 | 0.0012 | 3.2834 | 17.7611 | 27 | 8095 | cellular macromolecule metabolic process |
| GO:1901360 | 0.0016 | 2.8973 | 12.9253 | 22 | 5891 | organic cyclic compound metabolic process |
| GO:0071822 | 0.0018 | 3.5792 | 3.5325 | 10 | 1610 | protein complex subunit organization |
| GO:0010033 | 0.0021 | 3.0153 | 6.3541 | 14 | 2896 | response to organic substance |
| GO:0010604 | 0.0021 | 3.0076 | 6.3672 | 14 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0002737 | 0.0022 | Inf | 0.0022 | 1 | 1 | negative regulation of plasmacytoid dendritic cell cytokine production |
| GO:0065003 | 0.0029 | 3.3386 | 3.7585 | 10 | 1713 | macromolecular complex assembly |
| GO:0051239 | 0.0035 | 2.8875 | 5.9613 | 13 | 2717 | regulation of multicellular organismal process |
| GO:0010629 | 0.0037 | 4.3015 | 2.1305 | 7 | 1448 | negative regulation of gene expression |
| GO:0048015 | 0.0043 | 10.0574 | 0.3291 | 3 | 150 | phosphatidylinositol-mediated signaling |
| GO:0021569 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | rhombomere 3 development |
| GO:0021570 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | rhombomere 4 development |
| GO:0042231 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | interleukin-13 biosynthetic process |
| GO:1901253 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | negative regulation of intracellular transport of viral material |
| GO:0070887 | 0.0051 | 2.7456 | 6.2136 | 13 | 2832 | cellular response to chemical stimulus |
| GO:0007166 | 0.0071 | 2.6946 | 5.6914 | 12 | 2594 | cell surface receptor signaling pathway |
| GO:0019732 | 0.0087 | 156.0196 | 0.0088 | 1 | 4 | antifungal humoral response |
| GO:0051142 | 0.0087 | 156.0196 | 0.0088 | 1 | 4 | positive regulation of NK T cell proliferation |
| GO:0014068 | 0.0092 | 15.0123 | 0.1448 | 2 | 66 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 1686.4697 | 0.053 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:1904837 | 0 | 256.6164 | 0.1296 | 15 | 44 | beta-catenin-TCF complex assembly |
| GO:0006335 | 0 | 374.4411 | 0.0943 | 14 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 306.2837 | 0.1061 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 259.0979 | 0.1179 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:0051290 | 0 | 224.4949 | 0.1296 | 14 | 44 | protein heterotetramerization |
| GO:0034724 | 0 | 181.9427 | 0.1503 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0016233 | 0 | 164.1508 | 0.162 | 14 | 55 | telomere capping |
| GO:0006303 | 0 | 115.9133 | 0.2121 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 0 | 110.1918 | 0.221 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:0045815 | 0 | 103.3846 | 0.2328 | 14 | 79 | positive regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 77.1341 | 0.2976 | 14 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 73.7249 | 0.3094 | 14 | 105 | regulation of gene silencing by miRNA |
| GO:0031497 | 0 | 56.881 | 0.4272 | 15 | 145 | chromatin assembly |
| GO:0045814 | 0 | 64.4563 | 0.3477 | 14 | 118 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 58.765 | 0.3771 | 14 | 128 | regulation of gene silencing |
| GO:1903707 | 0 | 55.8056 | 0.3948 | 14 | 134 | negative regulation of hemopoiesis |
| GO:0032200 | 0 | 44.8615 | 0.4803 | 14 | 163 | telomere organization |
| GO:0065004 | 0 | 36.9959 | 0.6305 | 15 | 214 | protein-DNA complex assembly |
| GO:0035194 | 0 | 33.7306 | 0.6865 | 15 | 233 | posttranscriptional gene silencing by RNA |
| GO:0002244 | 0 | 38.8058 | 0.548 | 14 | 186 | hematopoietic progenitor cell differentiation |
| GO:0048863 | 0 | 30.339 | 0.7572 | 15 | 257 | stem cell differentiation |
| GO:0071103 | 0 | 29.7153 | 0.7719 | 15 | 262 | DNA conformation change |
| GO:0006352 | 0 | 30.8145 | 0.6777 | 14 | 230 | DNA-templated transcription, initiation |
| GO:0045637 | 0 | 30.2466 | 0.6894 | 14 | 234 | regulation of myeloid cell differentiation |
| GO:0017148 | 0 | 23.9754 | 0.9428 | 15 | 320 | negative regulation of translation |
| GO:0051259 | 0 | 16.1013 | 1.5026 | 16 | 510 | protein oligomerization |
| GO:0060249 | 0 | 18.6367 | 1.0843 | 14 | 368 | anatomical structure homeostasis |
| GO:0006325 | 0 | 12.61 | 2.0654 | 17 | 701 | chromatin organization |
| GO:0006281 | 0 | 14.8402 | 1.4791 | 15 | 502 | DNA repair |
| GO:0034248 | 0 | 13.8412 | 1.5792 | 15 | 536 | regulation of cellular amide metabolic process |
| GO:0048534 | 0 | 10.4785 | 2.4543 | 17 | 833 | hematopoietic or lymphoid organ development |
| GO:0010608 | 0 | 11.7935 | 1.8356 | 15 | 623 | posttranscriptional regulation of gene expression |
| GO:0045596 | 0 | 10.6012 | 1.8444 | 14 | 626 | negative regulation of cell differentiation |
| GO:0043043 | 0 | 9.4454 | 2.2598 | 15 | 767 | peptide biosynthetic process |
| GO:0045892 | 0 | 7.8487 | 3.2056 | 17 | 1088 | negative regulation of transcription, DNA-templated |
| GO:1902679 | 0 | 7.5897 | 3.3058 | 17 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0070271 | 0 | 6.6704 | 4.0424 | 18 | 1372 | protein complex biogenesis |
| GO:0045934 | 0 | 6.215 | 3.9658 | 17 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0065003 | 0 | 5.6925 | 5.0471 | 19 | 1713 | macromolecular complex assembly |
| GO:0009890 | 0 | 5.6954 | 4.6582 | 18 | 1581 | negative regulation of biosynthetic process |
| GO:0051248 | 0 | 6.2292 | 3.6328 | 16 | 1233 | negative regulation of protein metabolic process |
| GO:0071822 | 0 | 5.5804 | 4.7436 | 18 | 1610 | protein complex subunit organization |
| GO:0033554 | 0 | 4.8577 | 5.3623 | 18 | 1820 | cellular response to stress |
| GO:0002682 | 0 | 5.0867 | 3.9982 | 15 | 1357 | regulation of immune system process |
| GO:2000026 | 0 | 4.1061 | 5.2798 | 16 | 1792 | regulation of multicellular organismal development |
| GO:0032268 | 0 | 3.6927 | 7.3305 | 19 | 2488 | regulation of cellular protein metabolic process |
| GO:0010604 | 1e-04 | 3.3472 | 8.5503 | 20 | 2902 | positive regulation of macromolecule metabolic process |
| GO:1903506 | 1e-04 | 3.2318 | 10.0942 | 22 | 3426 | regulation of nucleic acid-templated transcription |
| GO:0032501 | 1e-04 | 3.1586 | 20.1235 | 33 | 6830 | multicellular organismal process |
| GO:0006996 | 1e-04 | 3.1281 | 10.3534 | 22 | 3514 | organelle organization |
| GO:0051252 | 2e-04 | 3.0176 | 10.6451 | 22 | 3613 | regulation of RNA metabolic process |
| GO:2000112 | 2e-04 | 2.9741 | 11.4878 | 23 | 3899 | regulation of cellular macromolecule biosynthetic process |
| GO:0048731 | 5e-04 | 2.7797 | 12.8608 | 24 | 4365 | system development |
| GO:0065008 | 7e-04 | 2.7782 | 9.9233 | 20 | 3368 | regulation of biological quality |
| GO:0080090 | 7e-04 | 2.6543 | 16.8118 | 28 | 5706 | regulation of primary metabolic process |
| GO:0034654 | 0.0011 | 2.606 | 11.8944 | 22 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0048518 | 0.0014 | 2.5063 | 15.5714 | 26 | 5285 | positive regulation of biological process |
| GO:0071840 | 0.0015 | 2.4977 | 17.4718 | 28 | 5930 | cellular component organization or biogenesis |
| GO:0048523 | 0.0023 | 2.9239 | 8.053 | 16 | 3740 | negative regulation of cellular process |
| GO:0048869 | 0.0025 | 2.5499 | 10.2114 | 19 | 3730 | cellular developmental process |
| GO:0003106 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of glomerular filtration by angiotensin |
| GO:1901208 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of heart looping |
| GO:1901211 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of cardiac chamber formation |
| GO:1901219 | 0.0029 | Inf | 0.0029 | 1 | 1 | regulation of cardiac chamber morphogenesis |
| GO:0050896 | 0.005 | 2.307 | 23.7799 | 33 | 8071 | response to stimulus |
| GO:0010467 | 0.0052 | 2.2184 | 15.0617 | 24 | 5112 | gene expression |
| GO:0019731 | 0.0056 | 19.5914 | 0.112 | 2 | 38 | antibacterial humoral response |
| GO:0045165 | 0.0058 | 6.0461 | 0.7219 | 4 | 245 | cell fate commitment |
| GO:0007521 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | muscle cell fate determination |
| GO:0014895 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | smooth muscle hypertrophy |
| GO:0060465 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | pharynx development |
| GO:1904044 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | response to aldosterone |
| GO:1904808 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | positive regulation of protein oxidation |
| GO:1904845 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | cellular response to L-glutamine |
| GO:0009059 | 0.0082 | 2.1178 | 14.6669 | 23 | 4978 | macromolecule biosynthetic process |
| GO:0002019 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | regulation of renal output by angiotensin |
| GO:0009957 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | epidermal cell fate specification |
| GO:0030538 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | embryonic genitalia morphogenesis |
| GO:0044336 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process |
| GO:0048619 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | embryonic hindgut morphogenesis |
| GO:0060596 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | mammary placode formation |
| GO:1900005 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | positive regulation of serine-type endopeptidase activity |
| GO:1901318 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | negative regulation of flagellated sperm motility |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 27.3892 | 0.5069 | 9 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 21.7171 | 0.6324 | 9 | 388 | detection of chemical stimulus |
| GO:0050906 | 0 | 21.0343 | 0.652 | 9 | 400 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 20.7084 | 0.6617 | 9 | 406 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 10.8202 | 1.9249 | 12 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 1e-04 | 6.8731 | 1.8711 | 9 | 1148 | nervous system process |
| GO:0018191 | 0.0016 | Inf | 0.0016 | 1 | 1 | peptidyl-serine octanoylation |
| GO:0032788 | 0.0016 | Inf | 0.0016 | 1 | 1 | saturated monocarboxylic acid metabolic process |
| GO:0032789 | 0.0016 | Inf | 0.0016 | 1 | 1 | unsaturated monocarboxylic acid metabolic process |
| GO:0006968 | 0.0035 | 25.4391 | 0.088 | 2 | 54 | cellular defense response |
| GO:0006104 | 0.0065 | 212.3067 | 0.0065 | 1 | 4 | succinyl-CoA metabolic process |
| GO:0060267 | 0.0097 | 127.368 | 0.0098 | 1 | 6 | positive regulation of respiratory burst |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003336 | 0.0013 | Inf | 0.0013 | 1 | 1 | corneocyte desquamation |
| GO:0009956 | 0.0013 | Inf | 0.0013 | 1 | 1 | radial pattern formation |
| GO:0061015 | 0.0013 | Inf | 0.0013 | 1 | 1 | snRNA import into nucleus |
| GO:1902480 | 0.0013 | Inf | 0.0013 | 1 | 1 | protein localization to mitotic spindle |
| GO:1905716 | 0.0013 | Inf | 0.0013 | 1 | 1 | negative regulation of cornification |
| GO:0060849 | 0.0025 | 838.4737 | 0.0025 | 1 | 2 | regulation of transcription involved in lymphatic endothelial cell fate commitment |
| GO:0007525 | 0.0038 | 419.2105 | 0.0038 | 1 | 3 | somatic muscle development |
| GO:0070995 | 0.0038 | 419.2105 | 0.0038 | 1 | 3 | NADPH oxidation |
| GO:0051464 | 0.005 | 279.4561 | 0.005 | 1 | 4 | positive regulation of cortisol secretion |
| GO:0072592 | 0.005 | 279.4561 | 0.005 | 1 | 4 | oxygen metabolic process |
| GO:1902416 | 0.0075 | 167.6526 | 0.0075 | 1 | 6 | positive regulation of mRNA binding |
| GO:0060839 | 0.0087 | 139.7018 | 0.0088 | 1 | 7 | endothelial cell fate commitment |
| GO:2000848 | 0.0087 | 139.7018 | 0.0088 | 1 | 7 | positive regulation of corticosteroid hormone secretion |
| GO:0060836 | 0.01 | 119.7368 | 0.01 | 1 | 8 | lymphatic endothelial cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031424 | 3e-04 | 14.9026 | 0.3213 | 4 | 205 | keratinization |
| GO:0035195 | 4e-04 | 13.4136 | 0.3558 | 4 | 227 | gene silencing by miRNA |
| GO:0016441 | 4e-04 | 12.9996 | 0.3667 | 4 | 234 | posttranscriptional gene silencing |
| GO:0043567 | 6e-04 | 65.8634 | 0.036 | 2 | 23 | regulation of insulin-like growth factor receptor signaling pathway |
| GO:0031047 | 6e-04 | 11.8005 | 0.4028 | 4 | 257 | gene silencing by RNA |
| GO:0009913 | 0.0016 | 9.2018 | 0.5125 | 4 | 327 | epidermal cell differentiation |
| GO:0034249 | 0.0017 | 9.0026 | 0.5234 | 4 | 334 | negative regulation of cellular amide metabolic process |
| GO:0045661 | 0.0027 | 29.3802 | 0.0768 | 2 | 49 | regulation of myoblast differentiation |
| GO:0043588 | 0.0029 | 7.7512 | 0.6049 | 4 | 386 | skin development |
| GO:0006742 | 0.0031 | 663.5833 | 0.0031 | 1 | 2 | NADP catabolic process |
| GO:1904379 | 0.0031 | 663.5833 | 0.0031 | 1 | 2 | protein localization to cytosolic proteasome complex involved in ERAD pathway |
| GO:0060221 | 0.0047 | 331.7708 | 0.0047 | 1 | 3 | retinal rod cell differentiation |
| GO:0072034 | 0.0047 | 331.7708 | 0.0047 | 1 | 3 | renal vesicle induction |
| GO:0072197 | 0.0047 | 331.7708 | 0.0047 | 1 | 3 | ureter morphogenesis |
| GO:0019674 | 0.0052 | 20.584 | 0.1081 | 2 | 69 | NAD metabolic process |
| GO:0043043 | 0.006 | 4.9754 | 1.202 | 5 | 767 | peptide biosynthetic process |
| GO:0043456 | 0.0063 | 221.1667 | 0.0063 | 1 | 4 | regulation of pentose-phosphate shunt |
| GO:0060018 | 0.0063 | 221.1667 | 0.0063 | 1 | 4 | astrocyte fate commitment |
| GO:0072289 | 0.0063 | 221.1667 | 0.0063 | 1 | 4 | metanephric nephron tubule formation |
| GO:0006417 | 0.0069 | 5.9882 | 0.7758 | 4 | 495 | regulation of translation |
| GO:0006032 | 0.0078 | 165.8646 | 0.0078 | 1 | 5 | chitin catabolic process |
| GO:0072526 | 0.0078 | 165.8646 | 0.0078 | 1 | 5 | pyridine-containing compound catabolic process |
| GO:0046533 | 0.0094 | 132.6833 | 0.0094 | 1 | 6 | negative regulation of photoreceptor cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 277.8671 | 0.0722 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 235.0592 | 0.0812 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 226.339 | 0.0835 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 226.339 | 0.0835 | 10 | 37 | response to interleukin-7 |
| GO:0051290 | 0 | 179.6606 | 0.0993 | 10 | 44 | protein heterotetramerization |
| GO:0045652 | 0 | 95.2644 | 0.167 | 10 | 74 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 88.3333 | 0.1783 | 10 | 79 | positive regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 66.885 | 0.2279 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 64.0526 | 0.237 | 10 | 105 | regulation of gene silencing by miRNA |
| GO:0045814 | 0 | 56.2963 | 0.2663 | 10 | 118 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 51.4928 | 0.2889 | 10 | 128 | regulation of gene silencing |
| GO:0031497 | 0 | 44.9601 | 0.3272 | 10 | 145 | chromatin assembly |
| GO:0034728 | 0 | 41.8329 | 0.3498 | 10 | 155 | nucleosome organization |
| GO:0032200 | 0 | 39.6254 | 0.3679 | 10 | 163 | telomere organization |
| GO:0007596 | 0 | 24.7635 | 0.738 | 12 | 327 | blood coagulation |
| GO:0002244 | 0 | 34.3969 | 0.4198 | 10 | 186 | hematopoietic progenitor cell differentiation |
| GO:0065004 | 0 | 29.6229 | 0.4829 | 10 | 214 | protein-DNA complex assembly |
| GO:0035194 | 0 | 27.0662 | 0.5258 | 10 | 233 | posttranscriptional gene silencing by RNA |
| GO:0048863 | 0 | 24.3989 | 0.58 | 10 | 257 | stem cell differentiation |
| GO:0071103 | 0 | 23.9072 | 0.5913 | 10 | 262 | DNA conformation change |
| GO:0050878 | 0 | 16.5407 | 1.081 | 12 | 479 | regulation of body fluid levels |
| GO:0030099 | 0 | 18.7991 | 0.8463 | 11 | 375 | myeloid cell differentiation |
| GO:0009611 | 0 | 14.0624 | 1.4173 | 13 | 628 | response to wounding |
| GO:0017148 | 0 | 19.3623 | 0.7222 | 10 | 320 | negative regulation of translation |
| GO:1903706 | 0 | 14.2253 | 0.9682 | 10 | 429 | regulation of hemopoiesis |
| GO:0051259 | 0 | 11.8585 | 1.151 | 10 | 510 | protein oligomerization |
| GO:0034248 | 0 | 11.2533 | 1.2096 | 10 | 536 | regulation of cellular amide metabolic process |
| GO:0045892 | 0 | 7.8032 | 2.4554 | 13 | 1088 | negative regulation of transcription, DNA-templated |
| GO:1902679 | 0 | 7.5466 | 2.5321 | 13 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0010608 | 0 | 9.6016 | 1.406 | 10 | 623 | posttranscriptional regulation of gene expression |
| GO:0048534 | 0 | 8.0795 | 1.8799 | 11 | 833 | hematopoietic or lymphoid organ development |
| GO:0071345 | 0 | 7.9168 | 1.916 | 11 | 849 | cellular response to cytokine stimulus |
| GO:0045934 | 0 | 6.1835 | 3.0376 | 13 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0043043 | 0 | 7.702 | 1.7309 | 10 | 767 | peptide biosynthetic process |
| GO:0007275 | 0 | 4.535 | 11.0469 | 24 | 4895 | multicellular organism development |
| GO:0010604 | 0 | 4.5187 | 6.5491 | 18 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0009890 | 0 | 5.172 | 3.568 | 13 | 1581 | negative regulation of biosynthetic process |
| GO:0050911 | 1e-04 | 10.2367 | 0.7019 | 6 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0023052 | 1e-04 | 3.8159 | 13.4639 | 25 | 5966 | signaling |
| GO:0007154 | 1e-04 | 3.7955 | 13.509 | 25 | 5986 | cell communication |
| GO:0048513 | 1e-04 | 5.0312 | 3.8891 | 12 | 2352 | animal organ development |
| GO:0032502 | 2e-04 | 3.568 | 12.9561 | 24 | 5741 | developmental process |
| GO:0050896 | 2e-04 | 4.0563 | 18.2144 | 29 | 8071 | response to stimulus |
| GO:0009593 | 2e-04 | 8.133 | 0.8756 | 6 | 388 | detection of chemical stimulus |
| GO:0050906 | 2e-04 | 7.8792 | 0.9027 | 6 | 400 | detection of stimulus involved in sensory perception |
| GO:0007166 | 3e-04 | 3.6938 | 5.8541 | 15 | 2594 | cell surface receptor signaling pathway |
| GO:0007606 | 3e-04 | 7.758 | 0.9162 | 6 | 406 | sensory perception of chemical stimulus |
| GO:0032501 | 3e-04 | 9.3234 | 1.5729 | 7 | 1376 | multicellular organismal process |
| GO:0051248 | 3e-04 | 4.6207 | 2.7826 | 10 | 1233 | negative regulation of protein metabolic process |
| GO:0060134 | 4e-04 | 85.0535 | 0.0293 | 2 | 13 | prepulse inhibition |
| GO:1903506 | 5e-04 | 3.2826 | 7.7317 | 17 | 3426 | regulation of nucleic acid-templated transcription |
| GO:0045595 | 7e-04 | 3.8775 | 3.6853 | 11 | 1633 | regulation of cell differentiation |
| GO:0070271 | 7e-04 | 4.1099 | 3.0963 | 10 | 1372 | protein complex biogenesis |
| GO:0050877 | 8e-04 | 4.3246 | 2.5908 | 9 | 1148 | nervous system process |
| GO:0048518 | 0.001 | 3.0379 | 11.5899 | 21 | 5281 | positive regulation of biological process |
| GO:0051252 | 0.001 | 3.0654 | 8.1537 | 17 | 3613 | regulation of RNA metabolic process |
| GO:0034654 | 0.0012 | 2.9602 | 9.1106 | 18 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0051239 | 0.0015 | 3.1107 | 6.1316 | 14 | 2717 | regulation of multicellular organismal process |
| GO:0032268 | 0.0021 | 3.0695 | 5.6148 | 13 | 2488 | regulation of cellular protein metabolic process |
| GO:0002152 | 0.0023 | Inf | 0.0023 | 1 | 1 | bile acid conjugation |
| GO:0052182 | 0.0023 | Inf | 0.0023 | 1 | 1 | modification by host of symbiont morphology or physiology via secreted substance |
| GO:0060678 | 0.0023 | Inf | 0.0023 | 1 | 1 | dichotomous subdivision of terminal units involved in ureteric bud branching |
| GO:0072127 | 0.0023 | Inf | 0.0023 | 1 | 1 | renal capsule development |
| GO:0072129 | 0.0023 | Inf | 0.0023 | 1 | 1 | renal capsule formation |
| GO:0072265 | 0.0023 | Inf | 0.0023 | 1 | 1 | metanephric capsule morphogenesis |
| GO:0072267 | 0.0023 | Inf | 0.0023 | 1 | 1 | metanephric capsule specification |
| GO:1902251 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of erythrocyte apoptotic process |
| GO:0070887 | 0.0023 | 2.9578 | 6.3912 | 14 | 2832 | cellular response to chemical stimulus |
| GO:0071822 | 0.0023 | 3.4413 | 3.6334 | 10 | 1610 | protein complex subunit organization |
| GO:2000112 | 0.0024 | 2.7736 | 8.7991 | 17 | 3899 | regulation of cellular macromolecule biosynthetic process |
| GO:0048523 | 0.0032 | 2.6605 | 9.8531 | 18 | 4366 | negative regulation of cellular process |
| GO:0065003 | 0.0037 | 3.2099 | 3.8658 | 10 | 1713 | macromolecular complex assembly |
| GO:0007186 | 0.0041 | 3.591 | 2.6652 | 8 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0046960 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | sensitization |
| GO:0051877 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | pigment granule aggregation in cell center |
| GO:0052047 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | interaction with other organism via secreted substance involved in symbiotic interaction |
| GO:0030154 | 0.005 | 3.4641 | 3.5021 | 9 | 1978 | cell differentiation |
| GO:0035106 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | operant conditioning |
| GO:0038162 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | erythropoietin-mediated signaling pathway |
| GO:0072076 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | nephrogenic mesenchyme development |
| GO:0010033 | 0.0081 | 2.5551 | 6.5356 | 13 | 2896 | response to organic substance |
| GO:0021853 | 0.009 | 151.5524 | 0.009 | 1 | 4 | cerebral cortex GABAergic interneuron migration |
| GO:0046959 | 0.009 | 151.5524 | 0.009 | 1 | 4 | habituation |
| GO:0051919 | 0.009 | 151.5524 | 0.009 | 1 | 4 | positive regulation of fibrinolysis |
| GO:2000048 | 0.009 | 151.5524 | 0.009 | 1 | 4 | negative regulation of cell-cell adhesion mediated by cadherin |
| GO:0060291 | 0.0091 | 15.0417 | 0.1444 | 2 | 64 | long-term synaptic potentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 1919.569 | 0.0485 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 0 | 426.1954 | 0.0863 | 14 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 348.6176 | 0.097 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 294.9098 | 0.1078 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:0051290 | 0 | 255.5241 | 0.1186 | 14 | 44 | protein heterotetramerization |
| GO:1904837 | 0 | 255.5241 | 0.1186 | 14 | 44 | beta-catenin-TCF complex assembly |
| GO:0034724 | 0 | 207.0904 | 0.1375 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0016233 | 0 | 186.8394 | 0.1483 | 14 | 55 | telomere capping |
| GO:0006303 | 0 | 131.9346 | 0.1941 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 0 | 125.4223 | 0.2022 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:0045815 | 0 | 117.6743 | 0.213 | 14 | 79 | positive regulation of gene expression, epigenetic |
| GO:0045814 | 0 | 82.2087 | 0.3181 | 15 | 118 | negative regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 87.7955 | 0.2723 | 14 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 83.9151 | 0.283 | 14 | 105 | regulation of gene silencing by miRNA |
| GO:0060968 | 0 | 66.8875 | 0.345 | 14 | 128 | regulation of gene silencing |
| GO:1903707 | 0 | 63.519 | 0.3612 | 14 | 134 | negative regulation of hemopoiesis |
| GO:0031497 | 0 | 58.1448 | 0.3909 | 14 | 145 | chromatin assembly |
| GO:0032200 | 0 | 51.0623 | 0.4394 | 14 | 163 | telomere organization |
| GO:0002244 | 0 | 44.1696 | 0.5014 | 14 | 186 | hematopoietic progenitor cell differentiation |
| GO:0048863 | 0 | 36.4203 | 0.6689 | 15 | 254 | stem cell differentiation |
| GO:0065004 | 0 | 37.9183 | 0.5769 | 14 | 214 | protein-DNA complex assembly |
| GO:0006352 | 0 | 35.0738 | 0.62 | 14 | 230 | DNA-templated transcription, initiation |
| GO:0035194 | 0 | 34.5867 | 0.6281 | 14 | 233 | posttranscriptional gene silencing by RNA |
| GO:0045637 | 0 | 34.4273 | 0.6308 | 14 | 234 | regulation of myeloid cell differentiation |
| GO:0071103 | 0 | 30.4858 | 0.7062 | 14 | 262 | DNA conformation change |
| GO:0017148 | 0 | 24.616 | 0.8626 | 14 | 320 | negative regulation of translation |
| GO:0045596 | 0 | 16.4267 | 1.6874 | 17 | 626 | negative regulation of cell differentiation |
| GO:0060249 | 0 | 21.2127 | 0.992 | 14 | 368 | anatomical structure homeostasis |
| GO:0006281 | 0 | 15.2554 | 1.3532 | 14 | 502 | DNA repair |
| GO:0034248 | 0 | 14.2303 | 1.4448 | 14 | 536 | regulation of cellular amide metabolic process |
| GO:0006325 | 0 | 11.888 | 1.8896 | 15 | 701 | chromatin organization |
| GO:0010608 | 0 | 12.1284 | 1.6794 | 14 | 623 | posttranscriptional regulation of gene expression |
| GO:0045892 | 0 | 9.0586 | 2.9328 | 17 | 1088 | negative regulation of transcription, DNA-templated |
| GO:1902679 | 0 | 8.7598 | 3.0244 | 17 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0070271 | 0 | 7.7397 | 3.6983 | 18 | 1372 | protein complex biogenesis |
| GO:0043043 | 0 | 9.7167 | 2.0675 | 14 | 767 | peptide biosynthetic process |
| GO:0048534 | 0 | 8.8948 | 2.2454 | 14 | 833 | hematopoietic or lymphoid organ development |
| GO:0045934 | 0 | 7.1731 | 3.6283 | 17 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0002682 | 0 | 7.1089 | 3.6579 | 17 | 1357 | regulation of immune system process |
| GO:0071822 | 0 | 6.475 | 4.3399 | 18 | 1610 | protein complex subunit organization |
| GO:0065003 | 0 | 6.0378 | 4.6175 | 18 | 1713 | macromolecular complex assembly |
| GO:0009890 | 0 | 5.9971 | 4.2617 | 17 | 1581 | negative regulation of biosynthetic process |
| GO:0051248 | 0 | 6.4616 | 3.3237 | 15 | 1233 | negative regulation of protein metabolic process |
| GO:2000026 | 0 | 5.8013 | 4.4937 | 17 | 1743 | regulation of multicellular organismal development |
| GO:0048519 | 0 | 4.3344 | 12.9846 | 28 | 4817 | negative regulation of biological process |
| GO:1903506 | 0 | 4.2262 | 9.2351 | 23 | 3426 | regulation of nucleic acid-templated transcription |
| GO:0033554 | 0 | 4.6333 | 4.906 | 16 | 1820 | cellular response to stress |
| GO:0051252 | 0 | 3.9462 | 9.7392 | 23 | 3613 | regulation of RNA metabolic process |
| GO:2000112 | 0 | 3.5702 | 10.5101 | 23 | 3899 | regulation of cellular macromolecule biosynthetic process |
| GO:0048518 | 1e-04 | 3.4183 | 14.2462 | 27 | 5285 | positive regulation of biological process |
| GO:0034654 | 1e-04 | 3.4079 | 10.8821 | 23 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0060179 | 1e-04 | 193.9634 | 0.0162 | 2 | 6 | male mating behavior |
| GO:0051602 | 2e-04 | 29.7544 | 0.1159 | 3 | 43 | response to electrical stimulus |
| GO:0010604 | 3e-04 | 3.2517 | 7.8226 | 18 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0032268 | 5e-04 | 3.2211 | 6.7066 | 16 | 2488 | regulation of cellular protein metabolic process |
| GO:0048869 | 6e-04 | 2.8861 | 10.715 | 21 | 3975 | cellular developmental process |
| GO:0015671 | 7e-04 | 59.6473 | 0.0404 | 2 | 15 | oxygen transport |
| GO:0006996 | 0.001 | 2.8119 | 9.4723 | 19 | 3514 | organelle organization |
| GO:0010467 | 0.0011 | 2.6864 | 13.7798 | 24 | 5112 | gene expression |
| GO:0090304 | 0.0014 | 2.6339 | 13.0952 | 23 | 4858 | nucleic acid metabolic process |
| GO:0090189 | 0.0014 | 40.7959 | 0.0566 | 2 | 21 | regulation of branching involved in ureteric bud morphogenesis |
| GO:0042744 | 0.0016 | 38.7537 | 0.0593 | 2 | 22 | hydrogen peroxide catabolic process |
| GO:0065008 | 0.0017 | 2.6992 | 9.0787 | 18 | 3368 | regulation of biological quality |
| GO:0009059 | 0.0019 | 2.5423 | 13.4186 | 23 | 4978 | macromolecule biosynthetic process |
| GO:0048731 | 0.0022 | 2.5413 | 11.7662 | 21 | 4365 | system development |
| GO:0080090 | 0.0023 | 2.5005 | 15.381 | 25 | 5706 | regulation of primary metabolic process |
| GO:0014739 | 0.0027 | Inf | 0.0027 | 1 | 1 | positive regulation of muscle hyperplasia |
| GO:0060450 | 0.0027 | Inf | 0.0027 | 1 | 1 | positive regulation of hindgut contraction |
| GO:0019098 | 0.0029 | 27.6672 | 0.0809 | 2 | 30 | reproductive behavior |
| GO:0048048 | 0.0038 | 24.2027 | 0.0916 | 2 | 34 | embryonic eye morphogenesis |
| GO:0097178 | 0.0038 | 24.2027 | 0.0916 | 2 | 34 | ruffle assembly |
| GO:0030431 | 0.0042 | 22.7762 | 0.097 | 2 | 36 | sleep |
| GO:0090596 | 0.0042 | 6.64 | 0.6631 | 4 | 246 | sensory organ morphogenesis |
| GO:0007618 | 0.0047 | 21.5081 | 0.1024 | 2 | 38 | mating |
| GO:0046483 | 0.0049 | 2.3094 | 15.2274 | 24 | 5649 | heterocycle metabolic process |
| GO:0003404 | 0.0054 | 378.7619 | 0.0054 | 1 | 2 | optic vesicle morphogenesis |
| GO:0097402 | 0.0054 | 378.7619 | 0.0054 | 1 | 2 | neuroblast migration |
| GO:0015701 | 0.006 | 18.8792 | 0.1159 | 2 | 43 | bicarbonate transport |
| GO:0090183 | 0.0077 | 16.4629 | 0.1321 | 2 | 49 | regulation of kidney development |
| GO:0002125 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | maternal aggressive behavior |
| GO:0009946 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | proximal/distal axis specification |
| GO:0014016 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | neuroblast differentiation |
| GO:0035880 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | embryonic nail plate morphogenesis |
| GO:0038123 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | toll-like receptor TLR1:TLR2 signaling pathway |
| GO:0045925 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | positive regulation of female receptivity |
| GO:0071673 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | positive regulation of smooth muscle cell chemotaxis |
| GO:0071727 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | cellular response to triacyl bacterial lipopeptide |
| GO:1902732 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | positive regulation of chondrocyte proliferation |
| GO:1903237 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | negative regulation of leukocyte tethering or rolling |
| GO:1904693 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | midbrain morphogenesis |
| GO:0051291 | 0.0086 | 15.6089 | 0.1404 | 2 | 77 | protein heterooligomerization |
| GO:1901360 | 0.0089 | 2.162 | 15.8797 | 24 | 5891 | organic cyclic compound metabolic process |
| GO:0071840 | 0.0098 | 2.1394 | 15.9848 | 24 | 5930 | cellular component organization or biogenesis |
| GO:0044249 | 0.0098 | 2.1388 | 15.9875 | 24 | 5931 | cellular biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 289 | 0.0702 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 244.4769 | 0.079 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 235.4074 | 0.0812 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 235.4074 | 0.0812 | 10 | 37 | response to interleukin-7 |
| GO:0051290 | 0 | 186.8588 | 0.0965 | 10 | 44 | protein heterotetramerization |
| GO:0045652 | 0 | 99.0812 | 0.1624 | 10 | 74 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 91.8725 | 0.1733 | 10 | 79 | positive regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 69.5648 | 0.2216 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 66.6189 | 0.2304 | 10 | 105 | regulation of gene silencing by miRNA |
| GO:0045814 | 0 | 58.5519 | 0.2589 | 10 | 118 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 53.5559 | 0.2808 | 10 | 128 | regulation of gene silencing |
| GO:0031497 | 0 | 46.7615 | 0.3181 | 10 | 145 | chromatin assembly |
| GO:0034728 | 0 | 43.509 | 0.3401 | 10 | 155 | nucleosome organization |
| GO:0032200 | 0 | 41.2131 | 0.3576 | 10 | 163 | telomere organization |
| GO:0035194 | 0 | 32.4033 | 0.5112 | 11 | 233 | posttranscriptional gene silencing by RNA |
| GO:0007596 | 0 | 25.8418 | 0.7175 | 12 | 327 | blood coagulation |
| GO:0002244 | 0 | 35.775 | 0.4081 | 10 | 186 | hematopoietic progenitor cell differentiation |
| GO:0065004 | 0 | 30.8098 | 0.4695 | 10 | 214 | protein-DNA complex assembly |
| GO:0017148 | 0 | 23.151 | 0.7021 | 11 | 320 | negative regulation of translation |
| GO:0048863 | 0 | 25.3765 | 0.5639 | 10 | 257 | stem cell differentiation |
| GO:0071103 | 0 | 24.8651 | 0.5748 | 10 | 262 | DNA conformation change |
| GO:0050878 | 0 | 17.261 | 1.051 | 12 | 479 | regulation of body fluid levels |
| GO:0030099 | 0 | 19.5837 | 0.8228 | 11 | 375 | myeloid cell differentiation |
| GO:0009611 | 0 | 14.7026 | 1.3779 | 13 | 628 | response to wounding |
| GO:0034248 | 0 | 13.4375 | 1.176 | 11 | 536 | regulation of cellular amide metabolic process |
| GO:1903706 | 0 | 14.7952 | 0.9413 | 10 | 429 | regulation of hemopoiesis |
| GO:0010608 | 0 | 11.4621 | 1.3669 | 11 | 623 | posttranscriptional regulation of gene expression |
| GO:0051259 | 0 | 12.3336 | 1.119 | 10 | 510 | protein oligomerization |
| GO:0043043 | 0 | 9.1915 | 1.6829 | 11 | 767 | peptide biosynthetic process |
| GO:0048534 | 0 | 8.4167 | 1.8277 | 11 | 833 | hematopoietic or lymphoid organ development |
| GO:0071345 | 0 | 8.2473 | 1.8628 | 11 | 849 | cellular response to cytokine stimulus |
| GO:0045892 | 0 | 7.1962 | 2.3872 | 12 | 1088 | negative regulation of transcription, DNA-templated |
| GO:1902679 | 0 | 6.9598 | 2.4618 | 12 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0050896 | 0 | 5.8769 | 17.7084 | 30 | 8071 | response to stimulus |
| GO:0009890 | 0 | 5.4075 | 3.4688 | 13 | 1581 | negative regulation of biosynthetic process |
| GO:0045934 | 0 | 5.7035 | 2.9532 | 12 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0051248 | 0 | 5.5116 | 2.7053 | 11 | 1233 | negative regulation of protein metabolic process |
| GO:0050911 | 1e-04 | 10.5904 | 0.6824 | 6 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 2e-04 | 8.414 | 0.8513 | 6 | 388 | detection of chemical stimulus |
| GO:0023052 | 2e-04 | 3.6627 | 13.0899 | 24 | 5966 | signaling |
| GO:0007154 | 2e-04 | 3.6431 | 13.1338 | 24 | 5986 | cell communication |
| GO:0050906 | 2e-04 | 8.1514 | 0.8776 | 6 | 400 | detection of stimulus involved in sensory perception |
| GO:0007606 | 2e-04 | 8.026 | 0.8908 | 6 | 406 | sensory perception of chemical stimulus |
| GO:0045595 | 5e-04 | 4.0394 | 3.5829 | 11 | 1633 | regulation of cell differentiation |
| GO:0070271 | 5e-04 | 4.2746 | 3.0103 | 10 | 1372 | protein complex biogenesis |
| GO:0050877 | 6e-04 | 4.4912 | 2.5188 | 9 | 1148 | nervous system process |
| GO:0007166 | 7e-04 | 3.4463 | 5.6914 | 14 | 2594 | cell surface receptor signaling pathway |
| GO:0048731 | 7e-04 | 3.1617 | 9.5772 | 19 | 4365 | system development |
| GO:0032268 | 0.0016 | 3.2093 | 5.4589 | 13 | 2488 | regulation of cellular protein metabolic process |
| GO:0032501 | 0.0016 | 3.8892 | 6.8392 | 14 | 4115 | multicellular organismal process |
| GO:0071822 | 0.0018 | 3.5792 | 3.5325 | 10 | 1610 | protein complex subunit organization |
| GO:0048869 | 0.0021 | 2.8536 | 8.7215 | 17 | 3975 | cellular developmental process |
| GO:0010604 | 0.0021 | 3.0076 | 6.3672 | 14 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0052182 | 0.0022 | Inf | 0.0022 | 1 | 1 | modification by host of symbiont morphology or physiology via secreted substance |
| GO:1902251 | 0.0022 | Inf | 0.0022 | 1 | 1 | negative regulation of erythrocyte apoptotic process |
| GO:0002376 | 0.0027 | 2.999 | 5.777 | 13 | 2633 | immune system process |
| GO:0065003 | 0.0029 | 3.3386 | 3.7585 | 10 | 1713 | macromolecular complex assembly |
| GO:0007186 | 0.0034 | 3.7243 | 2.5912 | 8 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0051239 | 0.0035 | 2.8875 | 5.9613 | 13 | 2717 | regulation of multicellular organismal process |
| GO:0051877 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | pigment granule aggregation in cell center |
| GO:0052047 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | interaction with other organism via secreted substance involved in symbiotic interaction |
| GO:0070887 | 0.0051 | 2.7456 | 6.2136 | 13 | 2832 | cellular response to chemical stimulus |
| GO:0048523 | 0.006 | 2.5121 | 9.5794 | 17 | 4366 | negative regulation of cellular process |
| GO:0038162 | 0.0066 | 234.0441 | 0.0066 | 1 | 3 | erythropoietin-mediated signaling pathway |
| GO:0051919 | 0.0087 | 156.0196 | 0.0088 | 1 | 4 | positive regulation of fibrinolysis |
| GO:2000048 | 0.0087 | 156.0196 | 0.0088 | 1 | 4 | negative regulation of cell-cell adhesion mediated by cadherin |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004068 | 0.0016 | Inf | 0.0016 | 1 | 1 | aspartate 1-decarboxylase activity |
| GO:0004782 | 0.0031 | 663.7083 | 0.0031 | 1 | 2 | sulfinoalanine decarboxylase activity |
| GO:0004169 | 0.0078 | 165.8958 | 0.0078 | 1 | 5 | dolichyl-phosphate-mannose-protein mannosyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047963 | 0.0016 | Inf | 0.0016 | 1 | 1 | glycine N-choloyltransferase activity |
| GO:0052817 | 0.0016 | Inf | 0.0016 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
| GO:0036461 | 0.0031 | 663.7083 | 0.0031 | 1 | 2 | BLOC-2 complex binding |
| GO:0052815 | 0.0031 | 663.7083 | 0.0031 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
| GO:0071885 | 0.0031 | 663.7083 | 0.0031 | 1 | 2 | N-terminal protein N-methyltransferase activity |
| GO:0032217 | 0.0047 | 331.8333 | 0.0047 | 1 | 3 | riboflavin transporter activity |
| GO:0035651 | 0.0047 | 331.8333 | 0.0047 | 1 | 3 | AP-3 adaptor complex binding |
| GO:0035650 | 0.0063 | 221.2083 | 0.0063 | 1 | 4 | AP-1 adaptor complex binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005540 | 6e-04 | 66.2875 | 0.0359 | 2 | 22 | hyaluronic acid binding |
| GO:0004516 | 0.0016 | Inf | 0.0016 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
| GO:0008437 | 0.0016 | Inf | 0.0016 | 1 | 1 | thyrotropin-releasing hormone activity |
| GO:0097162 | 0.0016 | Inf | 0.0016 | 1 | 1 | MADS box domain binding |
| GO:0004882 | 0.0033 | 637.12 | 0.0033 | 1 | 2 | androgen receptor activity |
| GO:0046811 | 0.0033 | 637.12 | 0.0033 | 1 | 2 | histone deacetylase inhibitor activity |
| GO:1904854 | 0.0033 | 637.12 | 0.0033 | 1 | 2 | proteasome core complex binding |
| GO:0004514 | 0.0049 | 318.54 | 0.0049 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
| GO:0051430 | 0.0065 | 212.3467 | 0.0065 | 1 | 4 | corticotropin-releasing hormone receptor 1 binding |
| GO:0051431 | 0.0065 | 212.3467 | 0.0065 | 1 | 4 | corticotropin-releasing hormone receptor 2 binding |
| GO:0001875 | 0.0081 | 159.25 | 0.0081 | 1 | 5 | lipopolysaccharide receptor activity |
| GO:0030284 | 0.0081 | 159.25 | 0.0081 | 1 | 5 | estrogen receptor activity |
| GO:1990405 | 0.0097 | 127.392 | 0.0098 | 1 | 6 | protein antigen binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 25.7888 | 0.4678 | 8 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 10.719 | 1.08 | 8 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 2e-04 | 6.4628 | 1.7329 | 8 | 1152 | transmembrane receptor activity |
| GO:0038023 | 3e-04 | 6.1269 | 1.8201 | 8 | 1210 | signaling receptor activity |
| GO:0031369 | 9e-04 | 53.5488 | 0.0436 | 2 | 29 | translation initiation factor binding |
| GO:0060089 | 0.001 | 4.9671 | 2.2037 | 8 | 1465 | molecular transducer activity |
| GO:0003743 | 0.0022 | 32.8244 | 0.0692 | 2 | 46 | translation initiation factor activity |
| GO:0004649 | 0.003 | 692.6087 | 0.003 | 1 | 2 | poly(ADP-ribose) glycohydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 137.3443 | 0.1213 | 10 | 44 | nucleosomal DNA binding |
| GO:0046982 | 0 | 23.8407 | 1.2879 | 18 | 467 | protein heterodimerization activity |
| GO:0042393 | 0 | 26.6007 | 0.5074 | 10 | 184 | histone binding |
| GO:0045296 | 0 | 15.8986 | 0.8246 | 10 | 299 | cadherin binding |
| GO:0003682 | 0 | 9.8132 | 1.3044 | 10 | 473 | chromatin binding |
| GO:0003677 | 0 | 4.0804 | 6.4145 | 18 | 2326 | DNA binding |
| GO:0044877 | 0 | 5.3269 | 2.6144 | 11 | 948 | macromolecular complex binding |
| GO:0031686 | 0.0028 | Inf | 0.0028 | 1 | 1 | A1 adenosine receptor binding |
| GO:0045032 | 0.0028 | Inf | 0.0028 | 1 | 1 | ADP-activated adenosine receptor activity |
| GO:0008260 | 0.0055 | 370 | 0.0055 | 1 | 2 | 3-oxoacid CoA-transferase activity |
| GO:0045031 | 0.0055 | 370 | 0.0055 | 1 | 2 | ATP-activated adenosine receptor activity |
| GO:0097110 | 0.0087 | 15.415 | 0.1406 | 2 | 51 | scaffold protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 1e-04 | 10.0659 | 0.761 | 6 | 467 | protein heterodimerization activity |
| GO:0004984 | 1e-04 | 12.1561 | 0.5068 | 5 | 311 | olfactory receptor activity |
| GO:0004930 | 9e-04 | 6.4117 | 1.17 | 6 | 718 | G-protein coupled receptor activity |
| GO:0004508 | 0.0016 | Inf | 0.0016 | 1 | 1 | steroid 17-alpha-monooxygenase activity |
| GO:0016412 | 0.0016 | Inf | 0.0016 | 1 | 1 | serine O-acyltransferase activity |
| GO:0022852 | 0.0016 | Inf | 0.0016 | 1 | 1 | glycine-gated chloride ion channel activity |
| GO:0047442 | 0.0016 | Inf | 0.0016 | 1 | 1 | 17-alpha-hydroxyprogesterone aldolase activity |
| GO:0099600 | 0.002 | 4.757 | 1.8773 | 7 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0.0026 | 4.5099 | 1.9718 | 7 | 1210 | signaling receptor activity |
| GO:0045519 | 0.0033 | 637.12 | 0.0033 | 1 | 2 | interleukin-23 receptor binding |
| GO:0016934 | 0.0049 | 318.54 | 0.0049 | 1 | 3 | extracellularly glycine-gated chloride channel activity |
| GO:0030345 | 0.0065 | 212.3467 | 0.0065 | 1 | 4 | structural constituent of tooth enamel |
| GO:0060089 | 0.0075 | 3.6567 | 2.3873 | 7 | 1465 | molecular transducer activity |
| GO:0030883 | 0.0081 | 159.25 | 0.0081 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0081 | 159.25 | 0.0081 | 1 | 5 | exogenous lipid antigen binding |
| GO:0004523 | 0.0097 | 127.392 | 0.0098 | 1 | 6 | RNA-DNA hybrid ribonuclease activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 26.1204 | 0.7017 | 12 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 12.1975 | 1.6201 | 13 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 7.3344 | 2.5993 | 13 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 6.9517 | 2.7302 | 13 | 1210 | signaling receptor activity |
| GO:0060089 | 0 | 5.6315 | 3.3055 | 13 | 1465 | molecular transducer activity |
| GO:0005549 | 5e-04 | 21.1912 | 0.1602 | 3 | 71 | odorant binding |
| GO:0004336 | 0.0023 | Inf | 0.0023 | 1 | 1 | galactosylceramidase activity |
| GO:0043394 | 0.003 | 27.4827 | 0.0812 | 2 | 36 | proteoglycan binding |
| GO:0001567 | 0.0045 | 454.8 | 0.0045 | 1 | 2 | cholesterol 25-hydroxylase activity |
| GO:0030305 | 0.0045 | 454.8 | 0.0045 | 1 | 2 | heparanase activity |
| GO:0004566 | 0.0068 | 227.3857 | 0.0068 | 1 | 3 | beta-glucuronidase activity |
| GO:0034875 | 0.009 | 151.581 | 0.009 | 1 | 4 | caffeine oxidase activity |
| GO:0042806 | 0.009 | 151.581 | 0.009 | 1 | 4 | fucose binding |
| GO:0090722 | 0.009 | 151.581 | 0.009 | 1 | 4 | receptor-receptor interaction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031704 | 0.0014 | Inf | 0.0014 | 1 | 1 | apelin receptor binding |
| GO:0050337 | 0.0014 | Inf | 0.0014 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
| GO:0050840 | 0.0021 | 33.0938 | 0.0689 | 2 | 50 | extracellular matrix binding |
| GO:0030395 | 0.0028 | 758.6667 | 0.0028 | 1 | 2 | lactose binding |
| GO:0034987 | 0.0082 | 151.6952 | 0.0083 | 1 | 6 | immunoglobulin receptor binding |
| GO:0015165 | 0.0096 | 126.4048 | 0.0097 | 1 | 7 | pyrimidine nucleotide-sugar transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 221.9925 | 0.1186 | 13 | 44 | nucleosomal DNA binding |
| GO:0042393 | 0 | 39.8895 | 0.4959 | 13 | 184 | histone binding |
| GO:0004984 | 0 | 20.2132 | 0.8382 | 12 | 311 | olfactory receptor activity |
| GO:0046982 | 0 | 14.7543 | 1.2586 | 13 | 467 | protein heterodimerization activity |
| GO:0003682 | 0 | 14.5562 | 1.2748 | 13 | 473 | chromatin binding |
| GO:0045296 | 0 | 16.3815 | 0.8058 | 10 | 299 | cadherin binding |
| GO:0004930 | 0 | 8.3374 | 1.9351 | 12 | 718 | G-protein coupled receptor activity |
| GO:0044877 | 0 | 6.9412 | 2.5549 | 13 | 948 | macromolecular complex binding |
| GO:0038023 | 0 | 5.94 | 3.261 | 14 | 1210 | signaling receptor activity |
| GO:0099600 | 0 | 5.6204 | 3.1047 | 13 | 1152 | transmembrane receptor activity |
| GO:0060089 | 0 | 4.8113 | 3.9483 | 14 | 1465 | molecular transducer activity |
| GO:0004745 | 9e-04 | 51.6976 | 0.0458 | 2 | 17 | retinol dehydrogenase activity |
| GO:0003677 | 0.0023 | 2.8398 | 6.2688 | 14 | 2326 | DNA binding |
| GO:0001567 | 0.0054 | 378.8333 | 0.0054 | 1 | 2 | cholesterol 25-hydroxylase activity |
| GO:0004866 | 0.0093 | 7.4782 | 0.4339 | 3 | 161 | endopeptidase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0055102 | 3e-04 | 90.9371 | 0.0271 | 2 | 16 | lipase inhibitor activity |
| GO:0004516 | 0.0017 | Inf | 0.0017 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
| GO:0033676 | 0.0017 | Inf | 0.0017 | 1 | 1 | double-stranded DNA-dependent ATPase activity |
| GO:1990595 | 0.0017 | Inf | 0.0017 | 1 | 1 | mast cell secretagogue receptor activity |
| GO:0004984 | 0.0017 | 8.8492 | 0.5263 | 4 | 311 | olfactory receptor activity |
| GO:0005544 | 0.0025 | 30.259 | 0.0745 | 2 | 44 | calcium-dependent phospholipid binding |
| GO:0038100 | 0.0034 | 612.5769 | 0.0034 | 1 | 2 | nodal binding |
| GO:0004514 | 0.0051 | 306.2692 | 0.0051 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
| GO:0004930 | 0.0054 | 5.0883 | 1.1685 | 5 | 717 | G-protein coupled receptor activity |
| GO:0019834 | 0.0068 | 204.1667 | 0.0068 | 1 | 4 | phospholipase A2 inhibitor activity |
| GO:0008508 | 0.0084 | 153.1154 | 0.0085 | 1 | 5 | bile acid:sodium symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033676 | 0.0011 | Inf | 0.0011 | 1 | 1 | double-stranded DNA-dependent ATPase activity |
| GO:0019834 | 0.0043 | 331.9792 | 0.0043 | 1 | 4 | phospholipase A2 inhibitor activity |
| GO:0003677 | 0.007 | 4.111 | 2.4783 | 7 | 2326 | DNA binding |
| GO:0036310 | 0.0074 | 165.9583 | 0.0075 | 1 | 7 | annealing helicase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031720 | 0 | 1179.6296 | 0.0055 | 2 | 3 | haptoglobin binding |
| GO:0046982 | 0 | 10.6978 | 0.8488 | 7 | 467 | protein heterodimerization activity |
| GO:0005344 | 3e-04 | 98.2346 | 0.0254 | 2 | 14 | oxygen carrier activity |
| GO:0003692 | 0.0018 | Inf | 0.0018 | 1 | 1 | left-handed Z-DNA binding |
| GO:0004601 | 0.0025 | 30.1747 | 0.0745 | 2 | 41 | peroxidase activity |
| GO:0019825 | 0.0029 | 28.0141 | 0.08 | 2 | 44 | oxygen binding |
| GO:0003726 | 0.0054 | 284.3571 | 0.0055 | 1 | 3 | double-stranded RNA adenosine deaminase activity |
| GO:0004332 | 0.0054 | 284.3571 | 0.0055 | 1 | 3 | fructose-bisphosphate aldolase activity |
| GO:0004886 | 0.0054 | 284.3571 | 0.0055 | 1 | 3 | 9-cis retinoic acid receptor activity |
| GO:0003677 | 0.006 | 3.0929 | 4.2278 | 10 | 2326 | DNA binding |
| GO:0015333 | 0.0073 | 189.5595 | 0.0073 | 1 | 4 | peptide:proton symporter activity |
| GO:0015198 | 0.0091 | 142.1607 | 0.0091 | 1 | 5 | oligopeptide transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 40.9211 | 0.6238 | 14 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 19.103 | 1.4401 | 15 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 11.4745 | 2.3105 | 15 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 10.8747 | 2.4268 | 15 | 1210 | signaling receptor activity |
| GO:0060089 | 0 | 8.8071 | 2.9383 | 15 | 1465 | molecular transducer activity |
| GO:0005549 | 4e-04 | 24.1202 | 0.1424 | 3 | 71 | odorant binding |
| GO:0047963 | 0.002 | Inf | 0.002 | 1 | 1 | glycine N-choloyltransferase activity |
| GO:0052817 | 0.002 | Inf | 0.002 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
| GO:0001567 | 0.004 | 513.6129 | 0.004 | 1 | 2 | cholesterol 25-hydroxylase activity |
| GO:0052815 | 0.004 | 513.6129 | 0.004 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
| GO:0005136 | 0.006 | 256.7903 | 0.006 | 1 | 3 | interleukin-4 receptor binding |
| GO:0015333 | 0.008 | 171.1828 | 0.008 | 1 | 4 | peptide:proton symporter activity |
| GO:0034875 | 0.008 | 171.1828 | 0.008 | 1 | 4 | caffeine oxidase activity |
| GO:0015198 | 0.01 | 128.379 | 0.01 | 1 | 5 | oligopeptide transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 14.3855 | 0.5854 | 6 | 467 | protein heterodimerization activity |
| GO:0042802 | 3e-04 | 6.2722 | 1.9292 | 8 | 1539 | identical protein binding |
| GO:0031369 | 6e-04 | 65.465 | 0.0364 | 2 | 29 | translation initiation factor binding |
| GO:0019115 | 0.0013 | Inf | 0.0013 | 1 | 1 | benzaldehyde dehydrogenase activity |
| GO:0003743 | 0.0015 | 40.1288 | 0.0577 | 2 | 46 | translation initiation factor activity |
| GO:0005503 | 0.0025 | 838.6316 | 0.0025 | 1 | 2 | all-trans retinal binding |
| GO:0036505 | 0.0025 | 838.6316 | 0.0025 | 1 | 2 | prosaposin receptor activity |
| GO:0035276 | 0.0038 | 419.2895 | 0.0038 | 1 | 3 | ethanol binding |
| GO:0003960 | 0.005 | 279.5088 | 0.005 | 1 | 4 | NADPH:quinone reductase activity |
| GO:0004024 | 0.0063 | 209.6184 | 0.0063 | 1 | 5 | alcohol dehydrogenase activity, zinc-dependent |
| GO:0061578 | 0.0075 | 167.6842 | 0.0075 | 1 | 6 | Lys63-specific deubiquitinase activity |
| GO:0004032 | 0.0087 | 139.7281 | 0.0088 | 1 | 7 | alditol:NADP+ 1-oxidoreductase activity |
| GO:1990380 | 0.01 | 119.7594 | 0.01 | 1 | 8 | Lys48-specific deubiquitinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 32.3874 | 0.6228 | 14 | 184 | histone binding |
| GO:0046982 | 0 | 13.1458 | 1.5806 | 15 | 467 | protein heterodimerization activity |
| GO:0019904 | 0 | 10.2947 | 2.1826 | 16 | 657 | protein domain specific binding |
| GO:0003723 | 0 | 4.0982 | 5.4829 | 17 | 1620 | RNA binding |
| GO:0003677 | 4e-04 | 2.9448 | 7.8724 | 18 | 2326 | DNA binding |
| GO:0008457 | 0.0034 | Inf | 0.0034 | 1 | 1 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity |
| GO:0017174 | 0.0034 | Inf | 0.0034 | 1 | 1 | glycine N-methyltransferase activity |
| GO:0031771 | 0.0034 | Inf | 0.0034 | 1 | 1 | type 1 hypocretin receptor binding |
| GO:0031772 | 0.0034 | Inf | 0.0034 | 1 | 1 | type 2 hypocretin receptor binding |
| GO:0047021 | 0.0034 | Inf | 0.0034 | 1 | 1 | 15-hydroxyprostaglandin dehydrogenase (NADP+) activity |
| GO:0047256 | 0.0034 | Inf | 0.0034 | 1 | 1 | lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity |
| GO:0050221 | 0.0034 | Inf | 0.0034 | 1 | 1 | prostaglandin-E2 9-reductase activity |
| GO:0070976 | 0.0034 | Inf | 0.0034 | 1 | 1 | TIR domain binding |
| GO:0003875 | 0.0068 | 300 | 0.0068 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
| GO:0004657 | 0.0068 | 300 | 0.0068 | 1 | 2 | proline dehydrogenase activity |
| GO:0008124 | 0.0068 | 300 | 0.0068 | 1 | 2 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity |
| GO:0030395 | 0.0068 | 300 | 0.0068 | 1 | 2 | lactose binding |
| GO:1901363 | 0.0083 | 1.998 | 18.9432 | 28 | 5597 | heterocyclic compound binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004111 | 0 | 442.5278 | 0.0075 | 2 | 6 | creatine kinase activity |
| GO:0033676 | 0.0013 | Inf | 0.0013 | 1 | 1 | double-stranded DNA-dependent ATPase activity |
| GO:0035438 | 0.0013 | Inf | 0.0013 | 1 | 1 | cyclic-di-GMP binding |
| GO:0061507 | 0.0013 | Inf | 0.0013 | 1 | 1 | cyclic-GMP-AMP binding |
| GO:0019834 | 0.005 | 279.5088 | 0.005 | 1 | 4 | phospholipase A2 inhibitor activity |
| GO:0036310 | 0.0087 | 139.7281 | 0.0088 | 1 | 7 | annealing helicase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 43.7481 | 0.9952 | 19 | 467 | protein heterodimerization activity |
| GO:0031492 | 0 | 194.6936 | 0.0938 | 10 | 44 | nucleosomal DNA binding |
| GO:0042393 | 0 | 37.7083 | 0.3921 | 10 | 184 | histone binding |
| GO:0003682 | 0 | 18.2923 | 1.008 | 12 | 473 | chromatin binding |
| GO:0003677 | 0 | 9.5423 | 4.9567 | 21 | 2326 | DNA binding |
| GO:0045296 | 0 | 22.5375 | 0.6372 | 10 | 299 | cadherin binding |
| GO:0044877 | 0 | 6.6556 | 2.0202 | 10 | 948 | macromolecular complex binding |
| GO:1901363 | 4e-04 | 3.4023 | 11.9272 | 22 | 5597 | heterocyclic compound binding |
| GO:0097159 | 5e-04 | 3.3282 | 12.0976 | 22 | 5677 | organic cyclic compound binding |
| GO:0004503 | 0.0021 | Inf | 0.0021 | 1 | 1 | monophenol monooxygenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 60.0051 | 0.6627 | 18 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 24.4623 | 1.5301 | 18 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 14.6696 | 2.4549 | 18 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 13.9011 | 2.5785 | 18 | 1210 | signaling receptor activity |
| GO:0060089 | 0 | 11.2531 | 3.1219 | 18 | 1465 | molecular transducer activity |
| GO:0005549 | 0 | 52.2725 | 0.1513 | 6 | 71 | odorant binding |
| GO:0030883 | 0 | 331.625 | 0.0107 | 2 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0 | 331.625 | 0.0107 | 2 | 5 | exogenous lipid antigen binding |
| GO:0030881 | 2e-04 | 142.0893 | 0.0192 | 2 | 9 | beta-2-microglobulin binding |
| GO:0003823 | 2e-04 | 32.002 | 0.1087 | 3 | 51 | antigen binding |
| GO:0071723 | 2e-04 | 124.3203 | 0.0213 | 2 | 10 | lipopeptide binding |
| GO:1904854 | 0.0043 | 482.4242 | 0.0043 | 1 | 2 | proteasome core complex binding |
| GO:0005136 | 0.0064 | 241.197 | 0.0064 | 1 | 3 | interleukin-4 receptor binding |
| GO:0046848 | 0.0064 | 241.197 | 0.0064 | 1 | 3 | hydroxyapatite binding |
| GO:0030197 | 0.0085 | 160.7879 | 0.0085 | 1 | 4 | extracellular matrix constituent, lubricant activity |
| GO:0030345 | 0.0085 | 160.7879 | 0.0085 | 1 | 4 | structural constituent of tooth enamel |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 57.0374 | 0.4483 | 12 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 23.5272 | 1.035 | 12 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 14.155 | 1.6607 | 12 | 1152 | transmembrane receptor activity |
| GO:0060089 | 0 | 10.8708 | 2.1119 | 12 | 1465 | molecular transducer activity |
| GO:0038023 | 0 | 12.0563 | 1.4837 | 10 | 1121 | signaling receptor activity |
| GO:0001591 | 0 | 303.3714 | 0.0101 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0035240 | 1e-04 | 168.4974 | 0.0159 | 2 | 11 | dopamine binding |
| GO:0005549 | 0.0047 | 21.8951 | 0.1024 | 2 | 71 | odorant binding |
| GO:0004867 | 0.0072 | 17.3454 | 0.1283 | 2 | 89 | serine-type endopeptidase inhibitor activity |
| GO:0030594 | 0.0072 | 17.3454 | 0.1283 | 2 | 89 | neurotransmitter receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031720 | 0 | 1274.16 | 0.0051 | 2 | 3 | haptoglobin binding |
| GO:0005506 | 1e-04 | 18.7993 | 0.2538 | 4 | 150 | iron ion binding |
| GO:0005344 | 2e-04 | 106.1067 | 0.0237 | 2 | 14 | oxygen carrier activity |
| GO:0003700 | 5e-04 | 5.3704 | 1.9732 | 8 | 1166 | DNA binding transcription factor activity |
| GO:0043565 | 0.001 | 5.3795 | 1.6584 | 7 | 980 | sequence-specific DNA binding |
| GO:0020037 | 0.0011 | 16.4667 | 0.2081 | 3 | 123 | heme binding |
| GO:0008403 | 0.0017 | Inf | 0.0017 | 1 | 1 | 25-hydroxycholecalciferol-24-hydroxylase activity |
| GO:0030342 | 0.0017 | Inf | 0.0017 | 1 | 1 | 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity |
| GO:0000975 | 0.002 | 5.3816 | 1.369 | 6 | 809 | regulatory region DNA binding |
| GO:0004601 | 0.0022 | 32.5928 | 0.0694 | 2 | 41 | peroxidase activity |
| GO:0005544 | 0.0025 | 30.259 | 0.0745 | 2 | 44 | calcium-dependent phospholipid binding |
| GO:0019825 | 0.0025 | 30.259 | 0.0745 | 2 | 44 | oxygen binding |
| GO:0001012 | 0.0027 | 6.0034 | 0.9917 | 5 | 586 | RNA polymerase II regulatory region DNA binding |
| GO:1901363 | 0.0029 | 3.1526 | 9.4716 | 17 | 5597 | heterocyclic compound binding |
| GO:0097159 | 0.0034 | 3.084 | 9.607 | 17 | 5677 | organic cyclic compound binding |
| GO:0001228 | 0.0041 | 6.9471 | 0.6651 | 4 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0000976 | 0.0046 | 5.2826 | 1.1203 | 5 | 662 | transcription regulatory region sequence-specific DNA binding |
| GO:0017077 | 0.0051 | 306.2692 | 0.0051 | 1 | 3 | oxidative phosphorylation uncoupler activity |
| GO:0000980 | 0.0059 | 19.2267 | 0.1151 | 2 | 68 | RNA polymerase II distal enhancer sequence-specific DNA binding |
| GO:0004704 | 0.0068 | 204.1667 | 0.0068 | 1 | 4 | NF-kappaB-inducing kinase activity |
| GO:0045569 | 0.0068 | 204.1667 | 0.0068 | 1 | 4 | TRAIL binding |
| GO:0048248 | 0.0084 | 153.1154 | 0.0085 | 1 | 5 | CXCR3 chemokine receptor binding |
| GO:1903136 | 0.0084 | 153.1154 | 0.0085 | 1 | 5 | cuprous ion binding |
| GO:0003690 | 0.0089 | 4.4679 | 1.3132 | 5 | 776 | double-stranded DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 166.8382 | 0.1048 | 10 | 44 | nucleosomal DNA binding |
| GO:0046982 | 0 | 24.9401 | 1.1123 | 16 | 467 | protein heterodimerization activity |
| GO:0042393 | 0 | 32.3132 | 0.4382 | 10 | 184 | histone binding |
| GO:0045296 | 0 | 19.3129 | 0.7121 | 10 | 299 | cadherin binding |
| GO:0003677 | 0 | 6.5583 | 5.5398 | 20 | 2326 | DNA binding |
| GO:0003682 | 0 | 11.9207 | 1.1265 | 10 | 473 | chromatin binding |
| GO:0044877 | 1e-04 | 5.7032 | 2.2579 | 10 | 948 | macromolecular complex binding |
| GO:1901363 | 1e-04 | 3.5704 | 13.3304 | 25 | 5597 | heterocyclic compound binding |
| GO:0097159 | 1e-04 | 3.4926 | 13.5209 | 25 | 5677 | organic cyclic compound binding |
| GO:0016503 | 0.0071 | 215.0676 | 0.0071 | 1 | 3 | pheromone receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 35.9951 | 0.5766 | 14 | 184 | histone binding |
| GO:0046982 | 0 | 17.6926 | 1.4635 | 17 | 467 | protein heterodimerization activity |
| GO:0019904 | 0 | 10.1724 | 2.062 | 15 | 658 | protein domain specific binding |
| GO:0003677 | 0 | 4.6382 | 7.2893 | 22 | 2326 | DNA binding |
| GO:0003723 | 1e-04 | 3.8184 | 5.0768 | 15 | 1620 | RNA binding |
| GO:0005119 | 0.0094 | 162.2755 | 0.0094 | 1 | 3 | smoothened binding |
| GO:0008158 | 0.0094 | 162.2755 | 0.0094 | 1 | 3 | hedgehog receptor activity |
| GO:0097108 | 0.0094 | 162.2755 | 0.0094 | 1 | 3 | hedgehog family protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 31.051 | 0.4678 | 9 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 18.2204 | 1.08 | 11 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 12.9746 | 1.7329 | 12 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 12.298 | 1.8201 | 12 | 1210 | signaling receptor activity |
| GO:0060089 | 0 | 9.9642 | 2.2037 | 12 | 1465 | molecular transducer activity |
| GO:0004778 | 0.0015 | Inf | 0.0015 | 1 | 1 | succinyl-CoA hydrolase activity |
| GO:0016412 | 0.0015 | Inf | 0.0015 | 1 | 1 | serine O-acyltransferase activity |
| GO:0019862 | 0.0045 | 346.2826 | 0.0045 | 1 | 3 | IgA binding |
| GO:0005549 | 0.0051 | 20.8986 | 0.1068 | 2 | 71 | odorant binding |
| GO:0048248 | 0.0075 | 173.1196 | 0.0075 | 1 | 5 | CXCR3 chemokine receptor binding |
| GO:0051373 | 0.0075 | 173.1196 | 0.0075 | 1 | 5 | FATZ binding |
| GO:0034987 | 0.009 | 138.487 | 0.009 | 1 | 6 | immunoglobulin receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031994 | 1e-04 | 187.3647 | 0.0143 | 2 | 12 | insulin-like growth factor I binding |
| GO:0001968 | 5e-04 | 74.8753 | 0.0322 | 2 | 27 | fibronectin binding |
| GO:0008160 | 0.0024 | 885.2778 | 0.0024 | 1 | 2 | protein tyrosine phosphatase activator activity |
| GO:0016401 | 0.0024 | 885.2778 | 0.0024 | 1 | 2 | palmitoyl-CoA oxidase activity |
| GO:1903231 | 0.0041 | 23.6143 | 0.0965 | 2 | 81 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004466 | 0.0059 | 221.2778 | 0.006 | 1 | 5 | long-chain-acyl-CoA dehydrogenase activity |
| GO:0019960 | 0.0059 | 221.2778 | 0.006 | 1 | 5 | C-X3-C chemokine binding |
| GO:0038132 | 0.0059 | 221.2778 | 0.006 | 1 | 5 | neuregulin binding |
| GO:0043184 | 0.0083 | 147.5 | 0.0083 | 1 | 7 | vascular endothelial growth factor receptor 2 binding |
| GO:0031995 | 0.0095 | 126.4206 | 0.0095 | 1 | 8 | insulin-like growth factor II binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031369 | 7e-04 | 62.0156 | 0.0382 | 2 | 29 | translation initiation factor binding |
| GO:0003743 | 0.0016 | 38.0144 | 0.0605 | 2 | 46 | translation initiation factor activity |
| GO:0004499 | 0.0066 | 199.125 | 0.0066 | 1 | 5 | N,N-dimethylaniline monooxygenase activity |
| GO:0004966 | 0.0092 | 132.7333 | 0.0092 | 1 | 7 | galanin receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 16.379 | 1.7269 | 19 | 467 | protein heterodimerization activity |
| GO:0042393 | 0 | 28.7796 | 0.6804 | 14 | 184 | histone binding |
| GO:0019904 | 0 | 9.6328 | 2.4332 | 17 | 658 | protein domain specific binding |
| GO:0003677 | 0 | 5.9413 | 3.5579 | 15 | 1199 | DNA binding |
| GO:0043565 | 0 | 5.2747 | 3.6239 | 15 | 980 | sequence-specific DNA binding |
| GO:0140110 | 0 | 4.2636 | 5.5542 | 18 | 1502 | transcription regulator activity |
| GO:0000976 | 0 | 5.3666 | 2.448 | 11 | 662 | transcription regulatory region sequence-specific DNA binding |
| GO:0000975 | 0 | 4.837 | 2.9916 | 12 | 809 | regulatory region DNA binding |
| GO:0001012 | 1e-04 | 5.428 | 2.167 | 10 | 586 | RNA polymerase II regulatory region DNA binding |
| GO:0003690 | 1e-04 | 4.5327 | 2.8696 | 11 | 776 | double-stranded DNA binding |
| GO:0097159 | 2e-04 | 2.6504 | 20.993 | 35 | 5677 | organic cyclic compound binding |
| GO:0000978 | 3e-04 | 6.159 | 1.2832 | 7 | 347 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:1901363 | 3e-04 | 2.5261 | 20.6971 | 34 | 5597 | heterocyclic compound binding |
| GO:0001159 | 4e-04 | 5.8931 | 1.3386 | 7 | 362 | core promoter proximal region DNA binding |
| GO:0001228 | 6e-04 | 5.409 | 1.4533 | 7 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0003723 | 6e-04 | 3.0355 | 5.9906 | 15 | 1620 | RNA binding |
| GO:0000981 | 8e-04 | 6.0374 | 1.1161 | 6 | 334 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0042813 | 0.0027 | 29.3204 | 0.0777 | 2 | 21 | Wnt-activated receptor activity |
| GO:0008892 | 0.0037 | Inf | 0.0037 | 1 | 1 | guanine deaminase activity |
| GO:0003713 | 0.0041 | 5.1267 | 1.0613 | 5 | 287 | transcription coactivator activity |
| GO:0000989 | 0.0047 | 3.7002 | 2.0893 | 7 | 565 | transcription factor activity, transcription factor binding |
| GO:0017147 | 0.0055 | 19.8847 | 0.1109 | 2 | 30 | Wnt-protein binding |
| GO:0005200 | 0.0064 | 8.5482 | 0.3772 | 3 | 102 | structural constituent of cytoskeleton |
| GO:0097604 | 0.0074 | 274.0517 | 0.0074 | 1 | 2 | temperature-gated cation channel activity |
| GO:0070888 | 0.0078 | 16.3695 | 0.1331 | 2 | 36 | E-box binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004516 | 0.0023 | Inf | 0.0023 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
| GO:0004778 | 0.0023 | Inf | 0.0023 | 1 | 1 | succinyl-CoA hydrolase activity |
| GO:0061501 | 0.0023 | Inf | 0.0023 | 1 | 1 | cyclic-GMP-AMP synthase activity |
| GO:0008188 | 0.0042 | 22.6829 | 0.0974 | 2 | 42 | neuropeptide receptor activity |
| GO:0031696 | 0.0046 | 442.1389 | 0.0046 | 1 | 2 | alpha-2C adrenergic receptor binding |
| GO:0045145 | 0.0046 | 442.1389 | 0.0046 | 1 | 2 | single-stranded DNA 5'-3' exodeoxyribonuclease activity |
| GO:0008227 | 0.0051 | 20.6156 | 0.1067 | 2 | 46 | G-protein coupled amine receptor activity |
| GO:0004514 | 0.0069 | 221.0556 | 0.007 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
| GO:0004938 | 0.0069 | 221.0556 | 0.007 | 1 | 3 | alpha2-adrenergic receptor activity |
| GO:0005275 | 0.0069 | 221.0556 | 0.007 | 1 | 3 | amine transmembrane transporter activity |
| GO:0031692 | 0.0069 | 221.0556 | 0.007 | 1 | 3 | alpha-1B adrenergic receptor binding |
| GO:0032795 | 0.0069 | 221.0556 | 0.007 | 1 | 3 | heterotrimeric G-protein binding |
| GO:0015226 | 0.0092 | 147.3611 | 0.0093 | 1 | 4 | carnitine transmembrane transporter activity |
| GO:0042806 | 0.0092 | 147.3611 | 0.0093 | 1 | 4 | fucose binding |
| GO:0051380 | 0.0092 | 147.3611 | 0.0093 | 1 | 4 | norepinephrine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 0 | 43.3493 | 0.1168 | 4 | 81 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0031995 | 1e-04 | 252.7937 | 0.0115 | 2 | 8 | insulin-like growth factor II binding |
| GO:0031994 | 1e-04 | 151.6381 | 0.0173 | 2 | 12 | insulin-like growth factor I binding |
| GO:0033735 | 0.0014 | Inf | 0.0014 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0008160 | 0.0029 | 724.1364 | 0.0029 | 1 | 2 | protein tyrosine phosphatase activator activity |
| GO:0004082 | 0.0043 | 362.0455 | 0.0043 | 1 | 3 | bisphosphoglycerate mutase activity |
| GO:0046538 | 0.0043 | 362.0455 | 0.0043 | 1 | 3 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
| GO:0004568 | 0.0072 | 181 | 0.0072 | 1 | 5 | chitinase activity |
| GO:0061578 | 0.0086 | 144.7909 | 0.0086 | 1 | 6 | Lys63-specific deubiquitinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 186.8941 | 0.0965 | 10 | 44 | nucleosomal DNA binding |
| GO:0042393 | 0 | 36.1977 | 0.4036 | 10 | 184 | histone binding |
| GO:0045296 | 0 | 21.6346 | 0.6559 | 10 | 299 | cadherin binding |
| GO:0003682 | 0 | 15.3353 | 1.0376 | 11 | 473 | chromatin binding |
| GO:0046982 | 0 | 13.5344 | 1.0244 | 10 | 467 | protein heterodimerization activity |
| GO:0044877 | 0 | 7.3289 | 2.0796 | 11 | 948 | macromolecular complex binding |
| GO:0003677 | 0 | 4.4166 | 5.1025 | 15 | 2326 | DNA binding |
| GO:0004984 | 1e-04 | 10.5924 | 0.6822 | 6 | 311 | olfactory receptor activity |
| GO:0004930 | 1e-04 | 6.3474 | 1.5751 | 8 | 718 | G-protein coupled receptor activity |
| GO:0047963 | 0.0022 | Inf | 0.0022 | 1 | 1 | glycine N-choloyltransferase activity |
| GO:0052817 | 0.0022 | Inf | 0.0022 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
| GO:0099600 | 0.0029 | 3.827 | 2.5271 | 8 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0.004 | 3.628 | 2.6543 | 8 | 1210 | signaling receptor activity |
| GO:0005128 | 0.0044 | 468.2059 | 0.0044 | 1 | 2 | erythropoietin receptor binding |
| GO:0052815 | 0.0044 | 468.2059 | 0.0044 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
| GO:1904854 | 0.0044 | 468.2059 | 0.0044 | 1 | 2 | proteasome core complex binding |
| GO:0001588 | 0.0087 | 156.049 | 0.0088 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GO:0015333 | 0.0087 | 156.049 | 0.0088 | 1 | 4 | peptide:proton symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004778 | 0.0014 | Inf | 0.0014 | 1 | 1 | succinyl-CoA hydrolase activity |
| GO:0044730 | 0.0014 | Inf | 0.0014 | 1 | 1 | bone sialoprotein binding |
| GO:1990081 | 0.0014 | Inf | 0.0014 | 1 | 1 | trimethylamine receptor activity |
| GO:1990595 | 0.0014 | Inf | 0.0014 | 1 | 1 | mast cell secretagogue receptor activity |
| GO:0005544 | 0.0017 | 37.8357 | 0.0607 | 2 | 44 | calcium-dependent phospholipid binding |
| GO:0004500 | 0.0028 | 758.6667 | 0.0028 | 1 | 2 | dopamine beta-monooxygenase activity |
| GO:0005094 | 0.0041 | 379.3095 | 0.0041 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
| GO:0008823 | 0.0041 | 379.3095 | 0.0041 | 1 | 3 | cupric reductase activity |
| GO:0052851 | 0.0041 | 379.3095 | 0.0041 | 1 | 3 | ferric-chelate reductase (NADPH) activity |
| GO:0030246 | 0.0048 | 9.9455 | 0.3475 | 3 | 252 | carbohydrate binding |
| GO:0019834 | 0.0055 | 252.8571 | 0.0055 | 1 | 4 | phospholipase A2 inhibitor activity |
| GO:0004859 | 0.0092 | 132.7 | 0.0092 | 1 | 7 | phospholipase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 40.5048 | 0.5305 | 14 | 184 | histone binding |
| GO:0046982 | 0 | 14.9272 | 1.3464 | 14 | 467 | protein heterodimerization activity |
| GO:0019904 | 0 | 10.3702 | 1.8971 | 14 | 658 | protein domain specific binding |
| GO:0003677 | 0 | 4.9576 | 6.7061 | 21 | 2326 | DNA binding |
| GO:0031720 | 0 | 723.0909 | 0.0086 | 2 | 3 | haptoglobin binding |
| GO:0003723 | 1e-04 | 3.8964 | 4.6706 | 14 | 1620 | RNA binding |
| GO:0005344 | 7e-04 | 60.2159 | 0.0404 | 2 | 14 | oxygen carrier activity |
| GO:0031855 | 0.0029 | Inf | 0.0029 | 1 | 1 | oxytocin receptor binding |
| GO:1990595 | 0.0029 | Inf | 0.0029 | 1 | 1 | mast cell secretagogue receptor activity |
| GO:0005185 | 0.0058 | 353.5111 | 0.0058 | 1 | 2 | neurohypophyseal hormone activity |
| GO:0004601 | 0.0062 | 18.4965 | 0.1182 | 2 | 41 | peroxidase activity |
| GO:0019825 | 0.0071 | 17.1721 | 0.1269 | 2 | 44 | oxygen binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 29.4356 | 0.6689 | 14 | 184 | histone binding |
| GO:0046982 | 0 | 11.9199 | 1.6976 | 15 | 467 | protein heterodimerization activity |
| GO:0019904 | 0 | 9.2879 | 2.3473 | 16 | 657 | protein domain specific binding |
| GO:0003723 | 0 | 3.6973 | 5.8891 | 17 | 1620 | RNA binding |
| GO:0003677 | 0.0029 | 2.44 | 8.4555 | 17 | 2326 | DNA binding |
| GO:0005476 | 0.0036 | Inf | 0.0036 | 1 | 1 | carnitine:acyl carnitine antiporter activity |
| GO:0008457 | 0.0036 | Inf | 0.0036 | 1 | 1 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity |
| GO:0017174 | 0.0036 | Inf | 0.0036 | 1 | 1 | glycine N-methyltransferase activity |
| GO:0031771 | 0.0036 | Inf | 0.0036 | 1 | 1 | type 1 hypocretin receptor binding |
| GO:0031772 | 0.0036 | Inf | 0.0036 | 1 | 1 | type 2 hypocretin receptor binding |
| GO:0047021 | 0.0036 | Inf | 0.0036 | 1 | 1 | 15-hydroxyprostaglandin dehydrogenase (NADP+) activity |
| GO:0047256 | 0.0036 | Inf | 0.0036 | 1 | 1 | lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity |
| GO:0050129 | 0.0036 | Inf | 0.0036 | 1 | 1 | N-formylglutamate deformylase activity |
| GO:0050221 | 0.0036 | Inf | 0.0036 | 1 | 1 | prostaglandin-E2 9-reductase activity |
| GO:0070976 | 0.0036 | Inf | 0.0036 | 1 | 1 | TIR domain binding |
| GO:0003875 | 0.0073 | 278.8772 | 0.0073 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
| GO:0004657 | 0.0073 | 278.8772 | 0.0073 | 1 | 2 | proline dehydrogenase activity |
| GO:0015227 | 0.0073 | 278.8772 | 0.0073 | 1 | 2 | acyl carnitine transmembrane transporter activity |
| GO:0030395 | 0.0073 | 278.8772 | 0.0073 | 1 | 2 | lactose binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 194.6936 | 0.0938 | 10 | 44 | nucleosomal DNA binding |
| GO:0042393 | 0 | 37.7083 | 0.3921 | 10 | 184 | histone binding |
| GO:0045296 | 0 | 22.5375 | 0.6372 | 10 | 299 | cadherin binding |
| GO:0003682 | 0 | 16.0031 | 1.008 | 11 | 473 | chromatin binding |
| GO:0046982 | 0 | 14.0992 | 0.9952 | 10 | 467 | protein heterodimerization activity |
| GO:0044877 | 0 | 7.6481 | 2.0202 | 11 | 948 | macromolecular complex binding |
| GO:0004984 | 0 | 10.9714 | 0.6627 | 6 | 311 | olfactory receptor activity |
| GO:0004930 | 1e-04 | 6.592 | 1.5301 | 8 | 718 | G-protein coupled receptor activity |
| GO:0003677 | 0.0022 | 3.2074 | 4.9567 | 12 | 2326 | DNA binding |
| GO:0099600 | 0.0024 | 3.9744 | 2.4549 | 8 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0.0033 | 3.7678 | 2.5785 | 8 | 1210 | signaling receptor activity |
| GO:0005128 | 0.0043 | 482.4242 | 0.0043 | 1 | 2 | erythropoietin receptor binding |
| GO:1904854 | 0.0043 | 482.4242 | 0.0043 | 1 | 2 | proteasome core complex binding |
| GO:0015333 | 0.0085 | 160.7879 | 0.0085 | 1 | 4 | peptide:proton symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0098911 | 0 | 64.3771 | 0.0609 | 3 | 15 | regulation of ventricular cardiac muscle cell action potential |
| GO:0007612 | 2e-04 | 10.9352 | 0.5117 | 5 | 126 | learning |
| GO:0086073 | 2e-04 | 126.675 | 0.0244 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0009887 | 3e-04 | 4.7911 | 2.1831 | 9 | 593 | animal organ morphogenesis |
| GO:0048167 | 3e-04 | 9.5078 | 0.5848 | 5 | 144 | regulation of synaptic plasticity |
| GO:0071772 | 3e-04 | 9.305 | 0.597 | 5 | 147 | response to BMP |
| GO:0098916 | 4e-04 | 4.5418 | 2.262 | 9 | 557 | anterograde trans-synaptic signaling |
| GO:0099536 | 4e-04 | 4.5333 | 2.2661 | 9 | 558 | synaptic signaling |
| GO:1903115 | 5e-04 | 22.0387 | 0.1543 | 3 | 38 | regulation of actin filament-based movement |
| GO:0050890 | 5e-04 | 6.6247 | 1.0071 | 6 | 248 | cognition |
| GO:0002934 | 6e-04 | 72.3714 | 0.0365 | 2 | 9 | desmosome organization |
| GO:0042428 | 6e-04 | 72.3714 | 0.0365 | 2 | 9 | serotonin metabolic process |
| GO:0032275 | 7e-04 | 63.3208 | 0.0406 | 2 | 10 | luteinizing hormone secretion |
| GO:0008542 | 8e-04 | 18.8061 | 0.1787 | 3 | 44 | visual learning |
| GO:0098900 | 8e-04 | 18.8061 | 0.1787 | 3 | 44 | regulation of action potential |
| GO:0086002 | 8e-04 | 18.3571 | 0.1827 | 3 | 45 | cardiac muscle cell action potential involved in contraction |
| GO:0003229 | 0.0012 | 16.0561 | 0.2071 | 3 | 51 | ventricular cardiac muscle tissue development |
| GO:0007610 | 0.0013 | 4.1921 | 2.1402 | 8 | 527 | behavior |
| GO:0060429 | 0.0019 | 2.9837 | 4.6458 | 12 | 1144 | epithelium development |
| GO:0055008 | 0.0019 | 13.2791 | 0.2477 | 3 | 61 | cardiac muscle tissue morphogenesis |
| GO:0055117 | 0.0021 | 12.8347 | 0.2558 | 3 | 63 | regulation of cardiac muscle contraction |
| GO:0030509 | 0.0023 | 7.8154 | 0.5564 | 4 | 137 | BMP signaling pathway |
| GO:0001501 | 0.0023 | 4.2117 | 1.8397 | 7 | 453 | skeletal system development |
| GO:0048729 | 0.0023 | 3.7762 | 2.3635 | 8 | 582 | tissue morphogenesis |
| GO:0061061 | 0.0024 | 3.7694 | 2.3676 | 8 | 583 | muscle structure development |
| GO:0014706 | 0.0024 | 4.8295 | 1.3645 | 6 | 336 | striated muscle tissue development |
| GO:0048148 | 0.0024 | 31.6438 | 0.0731 | 2 | 18 | behavioral response to cocaine |
| GO:2000810 | 0.0024 | 31.6438 | 0.0731 | 2 | 18 | regulation of bicellular tight junction assembly |
| GO:0007188 | 0.0025 | 7.6415 | 0.5685 | 4 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0003208 | 0.0026 | 11.8435 | 0.2762 | 3 | 68 | cardiac ventricle morphogenesis |
| GO:0045109 | 0.0027 | 29.7804 | 0.0772 | 2 | 19 | intermediate filament organization |
| GO:0086064 | 0.0027 | 29.7804 | 0.0772 | 2 | 19 | cell communication by electrical coupling involved in cardiac conduction |
| GO:0098664 | 0.0027 | 29.7804 | 0.0772 | 2 | 19 | G-protein coupled serotonin receptor signaling pathway |
| GO:0006937 | 0.0028 | 7.3681 | 0.5889 | 4 | 145 | regulation of muscle contraction |
| GO:1901379 | 0.0032 | 10.9939 | 0.2965 | 3 | 73 | regulation of potassium ion transmembrane transport |
| GO:0044057 | 0.0032 | 3.9554 | 1.9534 | 7 | 481 | regulation of system process |
| GO:0048169 | 0.0036 | 25.3083 | 0.0893 | 2 | 22 | regulation of long-term neuronal synaptic plasticity |
| GO:1903506 | 0.0038 | 2.1508 | 13.3811 | 23 | 3295 | regulation of nucleic acid-templated transcription |
| GO:0001572 | 0.0041 | Inf | 0.0041 | 1 | 1 | lactosylceramide biosynthetic process |
| GO:0007634 | 0.0041 | Inf | 0.0041 | 1 | 1 | optokinetic behavior |
| GO:0019358 | 0.0041 | Inf | 0.0041 | 1 | 1 | nicotinate nucleotide salvage |
| GO:0021509 | 0.0041 | Inf | 0.0041 | 1 | 1 | roof plate formation |
| GO:0021757 | 0.0041 | Inf | 0.0041 | 1 | 1 | caudate nucleus development |
| GO:0021758 | 0.0041 | Inf | 0.0041 | 1 | 1 | putamen development |
| GO:0046497 | 0.0041 | Inf | 0.0041 | 1 | 1 | nicotinate nucleotide metabolic process |
| GO:0060678 | 0.0041 | Inf | 0.0041 | 1 | 1 | dichotomous subdivision of terminal units involved in ureteric bud branching |
| GO:0060806 | 0.0041 | Inf | 0.0041 | 1 | 1 | negative regulation of cell differentiation involved in embryonic placenta development |
| GO:0072127 | 0.0041 | Inf | 0.0041 | 1 | 1 | renal capsule development |
| GO:0072129 | 0.0041 | Inf | 0.0041 | 1 | 1 | renal capsule formation |
| GO:0072265 | 0.0041 | Inf | 0.0041 | 1 | 1 | metanephric capsule morphogenesis |
| GO:0072267 | 0.0041 | Inf | 0.0041 | 1 | 1 | metanephric capsule specification |
| GO:0097326 | 0.0041 | Inf | 0.0041 | 1 | 1 | melanocyte adhesion |
| GO:0120063 | 0.0041 | Inf | 0.0041 | 1 | 1 | stomach smooth muscle contraction |
| GO:0120064 | 0.0041 | Inf | 0.0041 | 1 | 1 | stomach pylorus smooth muscle contraction |
| GO:0120072 | 0.0041 | Inf | 0.0041 | 1 | 1 | positive regulation of pyloric antrum smooth muscle contraction |
| GO:1903937 | 0.0041 | Inf | 0.0041 | 1 | 1 | response to acrylamide |
| GO:1904343 | 0.0041 | Inf | 0.0041 | 1 | 1 | positive regulation of colon smooth muscle contraction |
| GO:1904425 | 0.0041 | Inf | 0.0041 | 1 | 1 | negative regulation of GTP binding |
| GO:1990708 | 0.0041 | Inf | 0.0041 | 1 | 1 | conditioned place preference |
| GO:2001051 | 0.0041 | Inf | 0.0041 | 1 | 1 | positive regulation of tendon cell differentiation |
| GO:0048644 | 0.0042 | 9.9899 | 0.3249 | 3 | 80 | muscle organ morphogenesis |
| GO:0006366 | 0.0045 | 2.3588 | 8.0003 | 16 | 1970 | transcription from RNA polymerase II promoter |
| GO:0048562 | 0.0047 | 4.9454 | 1.0965 | 5 | 270 | embryonic organ morphogenesis |
| GO:0060021 | 0.0051 | 9.264 | 0.3493 | 3 | 86 | palate development |
| GO:0018146 | 0.0053 | 20.24 | 0.1096 | 2 | 27 | keratan sulfate biosynthetic process |
| GO:0045893 | 0.0059 | 2.5649 | 5.3322 | 12 | 1313 | positive regulation of transcription, DNA-templated |
| GO:1902680 | 0.006 | 2.5628 | 5.3362 | 12 | 1314 | positive regulation of RNA biosynthetic process |
| GO:0035637 | 0.006 | 5.9232 | 0.7269 | 4 | 179 | multicellular organismal signaling |
| GO:0086019 | 0.0061 | 18.7383 | 0.1178 | 2 | 29 | cell-cell signaling involved in cardiac conduction |
| GO:0007218 | 0.0062 | 8.6361 | 0.3736 | 3 | 92 | neuropeptide signaling pathway |
| GO:0042417 | 0.0066 | 18.0679 | 0.1218 | 2 | 30 | dopamine metabolic process |
| GO:0097009 | 0.0066 | 18.0679 | 0.1218 | 2 | 30 | energy homeostasis |
| GO:0070252 | 0.0068 | 8.3528 | 0.3858 | 3 | 95 | actin-mediated cell contraction |
| GO:0051930 | 0.007 | 17.4437 | 0.1259 | 2 | 31 | regulation of sensory perception of pain |
| GO:0071804 | 0.0074 | 5.5688 | 0.7716 | 4 | 190 | cellular potassium ion transport |
| GO:0051252 | 0.0075 | 2.0071 | 14.1162 | 23 | 3476 | regulation of RNA metabolic process |
| GO:0098815 | 0.0079 | 16.3161 | 0.134 | 2 | 33 | modulation of excitatory postsynaptic potential |
| GO:0043279 | 0.008 | 7.8383 | 0.4102 | 3 | 101 | response to alkaloid |
| GO:0003220 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | left ventricular cardiac muscle tissue morphogenesis |
| GO:0007509 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | mesoderm migration involved in gastrulation |
| GO:0021560 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | abducens nerve development |
| GO:0021599 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | abducens nerve formation |
| GO:0030860 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | regulation of polarized epithelial cell differentiation |
| GO:0031635 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | adenylate cyclase-inhibiting opioid receptor signaling pathway |
| GO:0034334 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | adherens junction maintenance |
| GO:0035992 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | tendon formation |
| GO:0036215 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | response to stem cell factor |
| GO:0038109 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | Kit signaling pathway |
| GO:0060876 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | semicircular canal formation |
| GO:0070352 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | positive regulation of white fat cell proliferation |
| GO:0072560 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | type B pancreatic cell maturation |
| GO:0097324 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | melanocyte migration |
| GO:0098582 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | innate vocalization behavior |
| GO:0098735 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | positive regulation of the force of heart contraction |
| GO:0098907 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | regulation of SA node cell action potential |
| GO:0098976 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | excitatory chemical synaptic transmission |
| GO:0099565 | 0.0082 | 7.7586 | 0.4142 | 3 | 102 | chemical synaptic transmission, postsynaptic |
| GO:0086091 | 0.0084 | 15.8052 | 0.1381 | 2 | 34 | regulation of heart rate by cardiac conduction |
| GO:0003002 | 0.0089 | 4.2287 | 1.2752 | 5 | 314 | regionalization |
| GO:0010959 | 0.0096 | 4.1465 | 1.2995 | 5 | 320 | regulation of metal ion transport |
| GO:0035239 | 0.0097 | 4.1331 | 1.3036 | 5 | 321 | tube morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 0 | 49.5164 | 0.598 | 18 | 166 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 44.3646 | 0.6593 | 18 | 183 | DNA packaging |
| GO:0071824 | 0 | 32.5512 | 0.8718 | 18 | 242 | protein-DNA complex subunit organization |
| GO:0006335 | 0 | 160.7513 | 0.1117 | 10 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 129.7949 | 0.1297 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 129.7949 | 0.1297 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 129.7949 | 0.1297 | 10 | 36 | response to interleukin-7 |
| GO:0051290 | 0 | 102.2155 | 0.1549 | 10 | 43 | protein heterotetramerization |
| GO:0045652 | 0 | 55.1949 | 0.2558 | 10 | 71 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 49.4902 | 0.281 | 10 | 78 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 37.7603 | 0.3567 | 10 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 37.3383 | 0.3603 | 10 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0060968 | 0 | 30.2322 | 0.4359 | 10 | 121 | regulation of gene silencing |
| GO:0006342 | 0 | 56.3952 | 0.195 | 8 | 66 | chromatin silencing |
| GO:0034622 | 0 | 8.8158 | 3.408 | 20 | 946 | cellular macromolecular complex assembly |
| GO:0051276 | 0 | 10.4693 | 2.7395 | 18 | 920 | chromosome organization |
| GO:0032200 | 0 | 23.0912 | 0.5584 | 10 | 155 | telomere organization |
| GO:0006334 | 0 | 38.4254 | 0.2747 | 8 | 93 | nucleosome assembly |
| GO:0002244 | 0 | 19.3179 | 0.6593 | 10 | 183 | hematopoietic progenitor cell differentiation |
| GO:0002227 | 0 | 116.9154 | 0.0648 | 5 | 18 | innate immune response in mucosa |
| GO:0051259 | 0 | 9.5615 | 1.7652 | 13 | 490 | protein oligomerization |
| GO:0048863 | 0 | 14.1626 | 0.8826 | 10 | 245 | stem cell differentiation |
| GO:1903507 | 0 | 6.5281 | 3.8655 | 18 | 1073 | negative regulation of nucleic acid-templated transcription |
| GO:0035194 | 0 | 12.8297 | 0.9691 | 10 | 269 | posttranscriptional gene silencing by RNA |
| GO:0002251 | 0 | 66.0391 | 0.1009 | 5 | 28 | organ or tissue specific immune response |
| GO:0051253 | 0 | 6.0742 | 4.1285 | 18 | 1146 | negative regulation of RNA metabolic process |
| GO:0007596 | 0 | 11.2759 | 1.0952 | 10 | 304 | blood coagulation |
| GO:0019731 | 0 | 52.3552 | 0.1225 | 5 | 34 | antibacterial humoral response |
| GO:0050878 | 0 | 8.5329 | 1.5995 | 11 | 444 | regulation of body fluid levels |
| GO:0061844 | 0 | 39.9316 | 0.1549 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0017148 | 0 | 9.6047 | 1.2753 | 10 | 354 | negative regulation of translation |
| GO:0030099 | 0 | 9.4917 | 1.2897 | 10 | 358 | myeloid cell differentiation |
| GO:0010558 | 0 | 4.6137 | 5.2921 | 18 | 1469 | negative regulation of macromolecule biosynthetic process |
| GO:1903706 | 0 | 8.0835 | 1.5023 | 10 | 417 | regulation of hemopoiesis |
| GO:0022607 | 0 | 3.8588 | 9.2441 | 24 | 2566 | cellular component assembly |
| GO:0031327 | 0 | 4.3631 | 5.5623 | 18 | 1544 | negative regulation of cellular biosynthetic process |
| GO:0040029 | 0 | 9.5 | 1.0221 | 8 | 345 | regulation of gene expression, epigenetic |
| GO:0050830 | 0 | 20.1827 | 0.2882 | 5 | 80 | defense response to Gram-positive bacterium |
| GO:0016567 | 0 | 5.2702 | 2.7992 | 12 | 777 | protein ubiquitination |
| GO:0034248 | 0 | 5.8468 | 2.0426 | 10 | 567 | regulation of cellular amide metabolic process |
| GO:0009611 | 0 | 5.5961 | 2.1291 | 10 | 591 | response to wounding |
| GO:0071840 | 1e-04 | 2.9675 | 20.4552 | 35 | 5678 | cellular component organization or biogenesis |
| GO:0010608 | 1e-04 | 5.0351 | 2.3525 | 10 | 653 | posttranscriptional regulation of gene expression |
| GO:0043043 | 1e-04 | 4.6256 | 2.8496 | 11 | 791 | peptide biosynthetic process |
| GO:0071345 | 1e-04 | 4.5038 | 2.9217 | 11 | 811 | cellular response to cytokine stimulus |
| GO:0070647 | 2e-04 | 3.92 | 3.6854 | 12 | 1023 | protein modification by small protein conjugation or removal |
| GO:0044238 | 5e-04 | 3.1208 | 34.1917 | 46 | 9491 | primary metabolic process |
| GO:0006959 | 5e-04 | 8.4944 | 0.6557 | 5 | 182 | humoral immune response |
| GO:0006355 | 5e-04 | 2.6434 | 11.7983 | 23 | 3275 | regulation of transcription, DNA-templated |
| GO:0048534 | 5e-04 | 4.0139 | 2.9109 | 10 | 808 | hematopoietic or lymphoid organ development |
| GO:2001141 | 6e-04 | 2.6157 | 11.8956 | 23 | 3302 | regulation of RNA biosynthetic process |
| GO:0070271 | 6e-04 | 3.3096 | 4.7337 | 13 | 1314 | protein complex biogenesis |
| GO:0002376 | 7e-04 | 2.7452 | 8.9055 | 19 | 2472 | immune system process |
| GO:0006807 | 9e-04 | 2.7737 | 32.5201 | 44 | 9027 | nitrogen compound metabolic process |
| GO:0034654 | 0.001 | 2.4533 | 13.9851 | 25 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:0009617 | 0.0014 | 4.6456 | 1.6932 | 7 | 470 | response to bacterium |
| GO:0009892 | 0.002 | 2.4713 | 9.7125 | 19 | 2696 | negative regulation of metabolic process |
| GO:0016338 | 0.0021 | 33.7292 | 0.0684 | 2 | 19 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0071822 | 0.0028 | 2.7659 | 5.5623 | 13 | 1544 | protein complex subunit organization |
| GO:1901360 | 0.0028 | 2.1946 | 20.4156 | 31 | 5667 | organic cyclic compound metabolic process |
| GO:0006725 | 0.0034 | 2.1556 | 19.7059 | 30 | 5470 | cellular aromatic compound metabolic process |
| GO:0018874 | 0.0036 | Inf | 0.0036 | 1 | 1 | benzoate metabolic process |
| GO:0019605 | 0.0036 | Inf | 0.0036 | 1 | 1 | butyrate metabolic process |
| GO:0061772 | 0.0036 | Inf | 0.0036 | 1 | 1 | drug transport across blood-nerve barrier |
| GO:1903545 | 0.0036 | Inf | 0.0036 | 1 | 1 | cellular response to butyrate |
| GO:0051248 | 0.0036 | 2.9034 | 4.3843 | 11 | 1217 | negative regulation of protein metabolic process |
| GO:0019219 | 0.0046 | 2.1608 | 13.7617 | 23 | 3820 | regulation of nucleobase-containing compound metabolic process |
| GO:0061028 | 0.0066 | 17.9009 | 0.1225 | 2 | 34 | establishment of endothelial barrier |
| GO:0046483 | 0.0069 | 2.0215 | 19.5906 | 29 | 5438 | heterocycle metabolic process |
| GO:0090304 | 0.0072 | 2.0289 | 16.8887 | 26 | 4688 | nucleic acid metabolic process |
| GO:1902595 | 0.0072 | 281.6852 | 0.0072 | 1 | 2 | regulation of DNA replication origin binding |
| GO:0044267 | 0.0075 | 2.0182 | 16.95 | 26 | 4705 | cellular protein metabolic process |
| GO:0010467 | 0.0076 | 2.0087 | 17.8722 | 27 | 4961 | gene expression |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006333 | 0 | 43.4277 | 0.5763 | 16 | 166 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 38.9629 | 0.6353 | 16 | 183 | DNA packaging |
| GO:0006335 | 0 | 168.2503 | 0.1076 | 10 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 135.8497 | 0.125 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 135.8497 | 0.125 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 135.8497 | 0.125 | 10 | 36 | response to interleukin-7 |
| GO:0071824 | 0 | 28.6783 | 0.8401 | 16 | 242 | protein-DNA complex subunit organization |
| GO:0051290 | 0 | 106.9838 | 0.1493 | 10 | 43 | protein heterotetramerization |
| GO:0045652 | 0 | 57.7697 | 0.2465 | 10 | 71 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 51.7989 | 0.2708 | 10 | 78 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 39.5218 | 0.3437 | 10 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 39.0801 | 0.3472 | 10 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0045814 | 0 | 32.8342 | 0.4062 | 10 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 31.6426 | 0.4201 | 10 | 121 | regulation of gene silencing |
| GO:0032200 | 0 | 24.1684 | 0.5381 | 10 | 155 | telomere organization |
| GO:0002244 | 0 | 20.2191 | 0.6353 | 10 | 183 | hematopoietic progenitor cell differentiation |
| GO:0034622 | 0 | 7.9171 | 3.2841 | 18 | 946 | cellular macromolecular complex assembly |
| GO:0002227 | 0 | 121.8029 | 0.0625 | 5 | 18 | innate immune response in mucosa |
| GO:0048863 | 0 | 14.8234 | 0.8505 | 10 | 245 | stem cell differentiation |
| GO:0035194 | 0 | 13.4282 | 0.9338 | 10 | 269 | posttranscriptional gene silencing by RNA |
| GO:0017148 | 0 | 11.3551 | 1.2289 | 11 | 354 | negative regulation of translation |
| GO:0002251 | 0 | 68.7998 | 0.0972 | 5 | 28 | organ or tissue specific immune response |
| GO:0007596 | 0 | 11.8019 | 1.0553 | 10 | 304 | blood coagulation |
| GO:0019731 | 0 | 54.5438 | 0.118 | 5 | 34 | antibacterial humoral response |
| GO:0006334 | 0 | 28.1566 | 0.2625 | 6 | 93 | nucleosome assembly |
| GO:0030099 | 0 | 9.9345 | 1.2428 | 10 | 358 | myeloid cell differentiation |
| GO:0061844 | 0 | 41.6009 | 0.1493 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:1903706 | 0 | 8.4607 | 1.4476 | 10 | 417 | regulation of hemopoiesis |
| GO:0050878 | 0 | 7.9198 | 1.5414 | 10 | 444 | regulation of body fluid levels |
| GO:0071345 | 0 | 5.8712 | 2.8154 | 13 | 811 | cellular response to cytokine stimulus |
| GO:0034248 | 0 | 6.9047 | 1.9684 | 11 | 567 | regulation of cellular amide metabolic process |
| GO:0009611 | 0 | 6.6081 | 2.0517 | 11 | 591 | response to wounding |
| GO:0051259 | 0 | 7.1386 | 1.7011 | 10 | 490 | protein oligomerization |
| GO:0050830 | 0 | 21.0264 | 0.2777 | 5 | 80 | defense response to Gram-positive bacterium |
| GO:0010608 | 0 | 5.9447 | 2.2669 | 11 | 653 | posttranscriptional regulation of gene expression |
| GO:0045595 | 0 | 4.1719 | 5.4295 | 17 | 1564 | regulation of cell differentiation |
| GO:0043043 | 1e-04 | 4.8466 | 2.746 | 11 | 791 | peptide biosynthetic process |
| GO:0006996 | 2e-04 | 2.9197 | 11.7477 | 24 | 3384 | organelle organization |
| GO:0051248 | 2e-04 | 3.7818 | 4.2249 | 13 | 1217 | negative regulation of protein metabolic process |
| GO:0022607 | 2e-04 | 3.0155 | 8.908 | 20 | 2566 | cellular component assembly |
| GO:0048534 | 4e-04 | 4.2012 | 2.805 | 10 | 808 | hematopoietic or lymphoid organ development |
| GO:0006959 | 4e-04 | 8.8495 | 0.6318 | 5 | 182 | humoral immune response |
| GO:0070647 | 7e-04 | 3.6755 | 3.5514 | 11 | 1023 | protein modification by small protein conjugation or removal |
| GO:0045892 | 8e-04 | 3.6067 | 3.6139 | 11 | 1041 | negative regulation of transcription, DNA-templated |
| GO:0090051 | 9e-04 | 54.1996 | 0.0451 | 2 | 13 | negative regulation of cell migration involved in sprouting angiogenesis |
| GO:1902679 | 0.001 | 3.4866 | 3.7284 | 11 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0016567 | 0.0011 | 3.9424 | 2.6433 | 9 | 776 | protein ubiquitination |
| GO:0002376 | 0.0012 | 2.6741 | 8.5816 | 18 | 2472 | immune system process |
| GO:0071840 | 0.0013 | 2.3872 | 19.7114 | 31 | 5678 | cellular component organization or biogenesis |
| GO:0051239 | 0.0019 | 2.5373 | 8.9635 | 18 | 2582 | regulation of multicellular organismal process |
| GO:0007014 | 0.0035 | Inf | 0.0035 | 1 | 1 | actin ubiquitination |
| GO:0030421 | 0.0035 | Inf | 0.0035 | 1 | 1 | defecation |
| GO:0043251 | 0.0035 | Inf | 0.0035 | 1 | 1 | sodium-dependent organic anion transport |
| GO:1903883 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of interleukin-17-mediated signaling pathway |
| GO:1903886 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of chemokine (C-C motif) ligand 20 production |
| GO:1905929 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of invadopodium disassembly |
| GO:0045934 | 0.0041 | 2.8633 | 4.4644 | 11 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0010604 | 0.0043 | 2.3289 | 9.6162 | 18 | 2770 | positive regulation of macromolecule metabolic process |
| GO:0070271 | 0.0048 | 2.7961 | 4.5616 | 11 | 1314 | protein complex biogenesis |
| GO:1903506 | 0.0054 | 2.2094 | 11.4387 | 20 | 3295 | regulation of nucleic acid-templated transcription |
| GO:0048869 | 0.006 | 2.1399 | 13.23 | 22 | 3811 | cellular developmental process |
| GO:0032268 | 0.0061 | 2.3215 | 8.3491 | 16 | 2405 | regulation of cellular protein metabolic process |
| GO:0009890 | 0.0062 | 2.5839 | 5.4156 | 12 | 1560 | negative regulation of biosynthetic process |
| GO:0010025 | 0.0069 | 292.5577 | 0.0069 | 1 | 2 | wax biosynthetic process |
| GO:0097498 | 0.0069 | 292.5577 | 0.0069 | 1 | 2 | endothelial tube lumen extension |
| GO:1905863 | 0.0069 | 292.5577 | 0.0069 | 1 | 2 | invadopodium organization |
| GO:0007166 | 0.0076 | 2.2595 | 8.54 | 16 | 2460 | cell surface receptor signaling pathway |
| GO:0048731 | 0.0088 | 2.0358 | 14.5284 | 23 | 4185 | system development |
| GO:0051252 | 0.0099 | 2.0619 | 12.0671 | 20 | 3476 | regulation of RNA metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048704 | 0.0023 | 12.5714 | 0.2623 | 3 | 89 | embryonic skeletal system morphogenesis |
| GO:0019417 | 0.0029 | Inf | 0.0029 | 1 | 1 | sulfur oxidation |
| GO:0045358 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of interferon-beta biosynthetic process |
| GO:0060007 | 0.0029 | Inf | 0.0029 | 1 | 1 | linear vestibuloocular reflex |
| GO:1903766 | 0.0029 | Inf | 0.0029 | 1 | 1 | positive regulation of potassium ion export across plasma membrane |
| GO:1903815 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of collecting lymphatic vessel constriction |
| GO:0008016 | 0.0036 | 6.9742 | 0.6308 | 4 | 214 | regulation of heart contraction |
| GO:0048598 | 0.0051 | 4.1829 | 1.6094 | 6 | 546 | embryonic morphogenesis |
| GO:0003015 | 0.0055 | 6.1422 | 0.7133 | 4 | 242 | heart process |
| GO:0045355 | 0.0059 | 345.9318 | 0.0059 | 1 | 2 | negative regulation of interferon-alpha biosynthetic process |
| GO:1902269 | 0.0059 | 345.9318 | 0.0059 | 1 | 2 | positive regulation of polyamine transmembrane transport |
| GO:1902524 | 0.0059 | 345.9318 | 0.0059 | 1 | 2 | positive regulation of protein K48-linked ubiquitination |
| GO:1990186 | 0.0059 | 345.9318 | 0.0059 | 1 | 2 | regulation of lymphatic vessel size |
| GO:0048568 | 0.006 | 4.729 | 1.1702 | 5 | 397 | embryonic organ development |
| GO:0021545 | 0.0074 | 16.8106 | 0.1297 | 2 | 44 | cranial nerve development |
| GO:0045933 | 0.0078 | 16.4186 | 0.1326 | 2 | 45 | positive regulation of muscle contraction |
| GO:0060042 | 0.0081 | 16.0444 | 0.1356 | 2 | 46 | retina morphogenesis in camera-type eye |
| GO:1901652 | 0.0087 | 4.3103 | 1.2792 | 5 | 434 | response to peptide |
| GO:0001712 | 0.0088 | 172.9545 | 0.0088 | 1 | 3 | ectodermal cell fate commitment |
| GO:0033387 | 0.0088 | 172.9545 | 0.0088 | 1 | 3 | putrescine biosynthetic process from ornithine |
| GO:0043010 | 0.009 | 5.3027 | 0.8224 | 4 | 279 | camera-type eye development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018149 | 0 | 39.9816 | 0.1215 | 4 | 53 | peptide cross-linking |
| GO:0050906 | 3e-04 | 7.5937 | 0.9399 | 6 | 410 | detection of stimulus involved in sensory perception |
| GO:0050911 | 8e-04 | 7.742 | 0.7474 | 5 | 326 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0031424 | 0.0014 | 9.3201 | 0.486 | 4 | 212 | keratinization |
| GO:0043588 | 0.0017 | 6.514 | 0.8826 | 5 | 385 | skin development |
| GO:0009593 | 0.0021 | 6.2441 | 0.9193 | 5 | 401 | detection of chemical stimulus |
| GO:0007606 | 0.0025 | 5.9802 | 0.9583 | 5 | 418 | sensory perception of chemical stimulus |
| GO:0050877 | 0.0033 | 3.755 | 2.5722 | 8 | 1122 | nervous system process |
| GO:0007186 | 0.0038 | 3.6626 | 2.6318 | 8 | 1148 | G-protein coupled receptor signaling pathway |
| GO:0006775 | 0.004 | 23.6099 | 0.094 | 2 | 41 | fat-soluble vitamin metabolic process |
| GO:0007468 | 0.0046 | 447.9706 | 0.0046 | 1 | 2 | regulation of rhodopsin gene expression |
| GO:0031444 | 0.0046 | 447.9706 | 0.0046 | 1 | 2 | slow-twitch skeletal muscle fiber contraction |
| GO:0070175 | 0.0046 | 447.9706 | 0.0046 | 1 | 2 | positive regulation of enamel mineralization |
| GO:0009913 | 0.0062 | 6.0129 | 0.7428 | 4 | 324 | epidermal cell differentiation |
| GO:0003010 | 0.0069 | 223.9706 | 0.0069 | 1 | 3 | voluntary skeletal muscle contraction |
| GO:0030574 | 0.0086 | 15.586 | 0.1398 | 2 | 61 | collagen catabolic process |
| GO:0002408 | 0.0091 | 149.3039 | 0.0092 | 1 | 4 | myeloid dendritic cell chemotaxis |
| GO:0032914 | 0.0091 | 149.3039 | 0.0092 | 1 | 4 | positive regulation of transforming growth factor beta1 production |
| GO:0098967 | 0.0091 | 149.3039 | 0.0092 | 1 | 4 | exocytic insertion of neurotransmitter receptor to postsynaptic membrane |
| GO:0032501 | 0.0098 | 2.5054 | 13.0507 | 20 | 6338 | multicellular organismal process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0034356 | 4e-04 | 86.7521 | 0.0285 | 2 | 15 | NAD biosynthesis via nicotinamide riboside salvage pathway |
| GO:0019359 | 0.0015 | 40.2381 | 0.057 | 2 | 30 | nicotinamide nucleotide biosynthetic process |
| GO:0072525 | 0.0018 | 36.3369 | 0.0627 | 2 | 33 | pyridine-containing compound biosynthetic process |
| GO:0019677 | 0.0019 | Inf | 0.0019 | 1 | 1 | NAD catabolic process |
| GO:0051041 | 0.0019 | Inf | 0.0019 | 1 | 1 | positive regulation of calcium-independent cell-cell adhesion |
| GO:0071329 | 0.0019 | Inf | 0.0019 | 1 | 1 | cellular response to sucrose stimulus |
| GO:0006742 | 0.0038 | 544.1786 | 0.0038 | 1 | 2 | NADP catabolic process |
| GO:0050902 | 0.0038 | 544.1786 | 0.0038 | 1 | 2 | leukocyte adhesive activation |
| GO:0055014 | 0.0057 | 272.0714 | 0.0057 | 1 | 3 | atrial cardiac muscle cell development |
| GO:0032914 | 0.0076 | 181.369 | 0.0076 | 1 | 4 | positive regulation of transforming growth factor beta1 production |
| GO:0042853 | 0.0076 | 181.369 | 0.0076 | 1 | 4 | L-alanine catabolic process |
| GO:0090238 | 0.0076 | 181.369 | 0.0076 | 1 | 4 | positive regulation of arachidonic acid secretion |
| GO:0006522 | 0.0095 | 136.0179 | 0.0095 | 1 | 5 | alanine metabolic process |
| GO:0009080 | 0.0095 | 136.0179 | 0.0095 | 1 | 5 | pyruvate family amino acid catabolic process |
| GO:0032049 | 0.0095 | 136.0179 | 0.0095 | 1 | 5 | cardiolipin biosynthetic process |
| GO:0034285 | 0.0095 | 136.0179 | 0.0095 | 1 | 5 | response to disaccharide |
| GO:0072526 | 0.0095 | 136.0179 | 0.0095 | 1 | 5 | pyridine-containing compound catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 1509.5177 | 0.0679 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 0 | 266.1402 | 0.1239 | 14 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 205.5861 | 0.1438 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 173.9116 | 0.1598 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 161.4681 | 0.1678 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0051290 | 0 | 155.8899 | 0.1718 | 14 | 43 | protein heterotetramerization |
| GO:0016233 | 0 | 125.5201 | 0.1998 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 125.5201 | 0.1998 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0006303 | 0 | 86.8069 | 0.2637 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 0 | 76.4724 | 0.2917 | 14 | 73 | ATP-dependent chromatin remodeling |
| GO:0045815 | 0 | 70.4747 | 0.3117 | 14 | 78 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 52.9897 | 0.3956 | 14 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 52.3701 | 0.3996 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0045814 | 0 | 43.6773 | 0.4675 | 14 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 42.0334 | 0.4835 | 14 | 121 | regulation of gene silencing |
| GO:1903707 | 0 | 39.7857 | 0.5074 | 14 | 127 | negative regulation of hemopoiesis |
| GO:0031497 | 0 | 34.8141 | 0.5714 | 14 | 143 | chromatin assembly |
| GO:0032200 | 0 | 31.8259 | 0.6193 | 14 | 155 | telomere organization |
| GO:0006352 | 0 | 23.2857 | 0.899 | 15 | 225 | DNA-templated transcription, initiation |
| GO:0045637 | 0 | 23.2857 | 0.899 | 15 | 225 | regulation of myeloid cell differentiation |
| GO:0002244 | 0 | 26.5036 | 0.7312 | 14 | 183 | hematopoietic progenitor cell differentiation |
| GO:0048863 | 0 | 21.2325 | 0.9789 | 15 | 245 | stem cell differentiation |
| GO:0065004 | 0 | 22.6942 | 0.8431 | 14 | 211 | protein-DNA complex assembly |
| GO:0051259 | 0 | 13.0672 | 1.9578 | 18 | 490 | protein oligomerization |
| GO:0071103 | 0 | 18.4965 | 1.0189 | 14 | 255 | DNA conformation change |
| GO:0035194 | 0 | 17.4647 | 1.0748 | 14 | 269 | posttranscriptional gene silencing by RNA |
| GO:0017148 | 0 | 14.3007 | 1.4144 | 15 | 354 | negative regulation of translation |
| GO:0060249 | 0 | 13.3863 | 1.3785 | 14 | 345 | anatomical structure homeostasis |
| GO:0034248 | 0 | 9.4567 | 2.2655 | 16 | 567 | regulation of cellular amide metabolic process |
| GO:0010608 | 0 | 8.132 | 2.6091 | 16 | 653 | posttranscriptional regulation of gene expression |
| GO:0006281 | 0 | 9.3188 | 1.9378 | 14 | 485 | DNA repair |
| GO:0045596 | 0 | 8.1355 | 2.4013 | 15 | 601 | negative regulation of cell differentiation |
| GO:0006325 | 0 | 7.1415 | 2.713 | 15 | 679 | chromatin organization |
| GO:0043043 | 0 | 6.6207 | 3.1605 | 16 | 791 | peptide biosynthetic process |
| GO:2000026 | 0 | 4.8407 | 6.8444 | 23 | 1713 | regulation of multicellular organismal development |
| GO:0048534 | 0 | 6.4709 | 3.2284 | 16 | 808 | hematopoietic or lymphoid organ development |
| GO:0070271 | 0 | 5.2445 | 5.2501 | 20 | 1314 | protein complex biogenesis |
| GO:0071822 | 0 | 4.3794 | 6.1691 | 20 | 1544 | protein complex subunit organization |
| GO:0051248 | 0 | 4.8669 | 4.5784 | 17 | 1182 | negative regulation of protein metabolic process |
| GO:0065003 | 0 | 4.0656 | 6.5887 | 20 | 1649 | macromolecular complex assembly |
| GO:0002682 | 0 | 4.2616 | 5.1183 | 17 | 1281 | regulation of immune system process |
| GO:0048869 | 0 | 2.9242 | 15.227 | 30 | 3811 | cellular developmental process |
| GO:0045892 | 0 | 4.1125 | 4.1594 | 14 | 1041 | negative regulation of transcription, DNA-templated |
| GO:1902679 | 1e-04 | 3.9752 | 4.2912 | 14 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0048731 | 1e-04 | 2.7493 | 16.7214 | 31 | 4185 | system development |
| GO:0048519 | 1e-04 | 2.7182 | 18.5074 | 33 | 4632 | negative regulation of biological process |
| GO:0033554 | 1e-04 | 3.265 | 6.9762 | 18 | 1746 | cellular response to stress |
| GO:0032268 | 3e-04 | 2.8236 | 9.6093 | 21 | 2405 | regulation of cellular protein metabolic process |
| GO:0097049 | 4e-04 | 85.8757 | 0.032 | 2 | 8 | motor neuron apoptotic process |
| GO:0045934 | 4e-04 | 3.263 | 5.1383 | 14 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:1990001 | 6e-04 | 73.6029 | 0.036 | 2 | 9 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0097341 | 8e-04 | 57.2392 | 0.044 | 2 | 11 | zymogen inhibition |
| GO:0009890 | 0.001 | 2.8833 | 6.2331 | 15 | 1560 | negative regulation of biosynthetic process |
| GO:0060547 | 0.0012 | 46.8259 | 0.0519 | 2 | 13 | negative regulation of necrotic cell death |
| GO:0021527 | 0.0014 | 42.9209 | 0.0559 | 2 | 14 | spinal cord association neuron differentiation |
| GO:0071294 | 0.0016 | 39.6167 | 0.0599 | 2 | 15 | cellular response to zinc ion |
| GO:0065008 | 0.0018 | 2.3119 | 12.6978 | 23 | 3178 | regulation of biological quality |
| GO:0071241 | 0.0037 | 6.8143 | 0.6353 | 4 | 159 | cellular response to inorganic substance |
| GO:0006211 | 0.004 | Inf | 0.004 | 1 | 1 | 5-methylcytosine catabolic process |
| GO:0014876 | 0.004 | Inf | 0.004 | 1 | 1 | response to injury involved in regulation of muscle adaptation |
| GO:0030421 | 0.004 | Inf | 0.004 | 1 | 1 | defecation |
| GO:0070367 | 0.004 | Inf | 0.004 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:0010604 | 0.0043 | 2.2095 | 11.0677 | 20 | 2770 | positive regulation of macromolecule metabolic process |
| GO:0048518 | 0.006 | 1.9789 | 20.0736 | 30 | 5024 | positive regulation of biological process |
| GO:0017144 | 0.0072 | 17.148 | 0.1279 | 2 | 32 | drug metabolic process |
| GO:0048665 | 0.0077 | 16.5938 | 0.1319 | 2 | 33 | neuron fate specification |
| GO:0006788 | 0.008 | 253.4167 | 0.008 | 1 | 2 | heme oxidation |
| GO:0009115 | 0.008 | 253.4167 | 0.008 | 1 | 2 | xanthine catabolic process |
| GO:0010025 | 0.008 | 253.4167 | 0.008 | 1 | 2 | wax biosynthetic process |
| GO:0014736 | 0.008 | 253.4167 | 0.008 | 1 | 2 | negative regulation of muscle atrophy |
| GO:0021526 | 0.008 | 253.4167 | 0.008 | 1 | 2 | medial motor column neuron differentiation |
| GO:0060163 | 0.008 | 253.4167 | 0.008 | 1 | 2 | subpallium neuron fate commitment |
| GO:0097498 | 0.008 | 253.4167 | 0.008 | 1 | 2 | endothelial tube lumen extension |
| GO:1900155 | 0.008 | 253.4167 | 0.008 | 1 | 2 | negative regulation of bone trabecula formation |
| GO:0070266 | 0.0086 | 15.586 | 0.1398 | 2 | 35 | necroptotic process |
| GO:1903318 | 0.0086 | 15.586 | 0.1398 | 2 | 35 | negative regulation of protein maturation |
| GO:0002042 | 0.0091 | 15.1266 | 0.1438 | 2 | 36 | cell migration involved in sprouting angiogenesis |
| GO:0046676 | 0.0096 | 14.6935 | 0.1478 | 2 | 37 | negative regulation of insulin secretion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0097120 | 0 | 51.6905 | 0.0715 | 3 | 21 | receptor localization to synapse |
| GO:0060078 | 1e-04 | 13.8472 | 0.4121 | 5 | 121 | regulation of postsynaptic membrane potential |
| GO:2000463 | 1e-04 | 46.5153 | 0.0783 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
| GO:0003148 | 1e-04 | 42.2811 | 0.0852 | 3 | 25 | outflow tract septum morphogenesis |
| GO:0021517 | 4e-04 | 23.8242 | 0.1431 | 3 | 42 | ventral spinal cord development |
| GO:0099565 | 4e-04 | 12.8546 | 0.3474 | 4 | 102 | chemical synaptic transmission, postsynaptic |
| GO:0046549 | 4e-04 | 86.9029 | 0.0307 | 2 | 9 | retinal cone cell development |
| GO:0030182 | 4e-04 | 3.6865 | 3.9408 | 12 | 1157 | neuron differentiation |
| GO:0120039 | 5e-04 | 4.9411 | 1.8665 | 8 | 548 | plasma membrane bounded cell projection morphogenesis |
| GO:0032990 | 6e-04 | 4.7581 | 1.9346 | 8 | 568 | cell part morphogenesis |
| GO:0003206 | 7e-04 | 11.1372 | 0.3985 | 4 | 117 | cardiac chamber morphogenesis |
| GO:0021520 | 9e-04 | 55.2873 | 0.0443 | 2 | 13 | spinal cord motor neuron cell fate specification |
| GO:0048667 | 0.0011 | 4.8801 | 1.6247 | 7 | 477 | cell morphogenesis involved in neuron differentiation |
| GO:0071695 | 0.0012 | 9.3787 | 0.47 | 4 | 138 | anatomical structure maturation |
| GO:2000026 | 0.0014 | 2.9309 | 5.8345 | 14 | 1713 | regulation of multicellular organismal development |
| GO:0048167 | 0.0014 | 8.9732 | 0.4905 | 4 | 144 | regulation of synaptic plasticity |
| GO:0060219 | 0.0015 | 40.5333 | 0.0579 | 2 | 17 | camera-type eye photoreceptor cell differentiation |
| GO:0006355 | 0.0015 | 2.49 | 11.1548 | 21 | 3275 | regulation of transcription, DNA-templated |
| GO:2001141 | 0.0017 | 2.464 | 11.2467 | 21 | 3302 | regulation of RNA biosynthetic process |
| GO:0010002 | 0.0019 | 35.76 | 0.0647 | 2 | 19 | cardioblast differentiation |
| GO:0051240 | 0.0019 | 3.0366 | 4.7003 | 12 | 1380 | positive regulation of multicellular organismal process |
| GO:0031016 | 0.002 | 13.2464 | 0.2486 | 3 | 73 | pancreas development |
| GO:0048638 | 0.0022 | 5.9786 | 0.923 | 5 | 271 | regulation of developmental growth |
| GO:0098916 | 0.0027 | 4.1477 | 1.8972 | 7 | 557 | anterograde trans-synaptic signaling |
| GO:0099536 | 0.0027 | 4.1399 | 1.9006 | 7 | 558 | synaptic signaling |
| GO:0010460 | 0.0027 | 28.941 | 0.0783 | 2 | 23 | positive regulation of heart rate |
| GO:0097659 | 0.0029 | 2.3345 | 11.727 | 21 | 3443 | nucleic acid-templated transcription |
| GO:0022603 | 0.003 | 3.385 | 3.0484 | 9 | 895 | regulation of anatomical structure morphogenesis |
| GO:0021511 | 0.003 | 27.6236 | 0.0817 | 2 | 24 | spinal cord patterning |
| GO:0061564 | 0.0031 | 4.6173 | 1.4442 | 6 | 424 | axon development |
| GO:0003309 | 0.0032 | 26.4209 | 0.0852 | 2 | 25 | type B pancreatic cell differentiation |
| GO:0048791 | 0.0032 | 26.4209 | 0.0852 | 2 | 25 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0006797 | 0.0034 | Inf | 0.0034 | 1 | 1 | polyphosphate metabolic process |
| GO:0032912 | 0.0034 | Inf | 0.0034 | 1 | 1 | negative regulation of transforming growth factor beta2 production |
| GO:0042404 | 0.0034 | Inf | 0.0034 | 1 | 1 | thyroid hormone catabolic process |
| GO:0043354 | 0.0034 | Inf | 0.0034 | 1 | 1 | enucleate erythrocyte maturation |
| GO:0060829 | 0.0034 | Inf | 0.0034 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation |
| GO:0061931 | 0.0034 | Inf | 0.0034 | 1 | 1 | positive regulation of erythrocyte enucleation |
| GO:0090601 | 0.0034 | Inf | 0.0034 | 1 | 1 | enucleation |
| GO:1902078 | 0.0034 | Inf | 0.0034 | 1 | 1 | positive regulation of lateral motor column neuron migration |
| GO:1902838 | 0.0034 | Inf | 0.0034 | 1 | 1 | regulation of nuclear migration along microtubule |
| GO:1903965 | 0.0034 | Inf | 0.0034 | 1 | 1 | monounsaturated fatty acid catabolic process |
| GO:1905483 | 0.0034 | Inf | 0.0034 | 1 | 1 | regulation of motor neuron migration |
| GO:0035418 | 0.0038 | 24.304 | 0.092 | 2 | 27 | protein localization to synapse |
| GO:0003279 | 0.004 | 10.1754 | 0.3202 | 3 | 94 | cardiac septum development |
| GO:0051094 | 0.0042 | 3.0109 | 3.8318 | 10 | 1125 | positive regulation of developmental process |
| GO:0003203 | 0.0044 | 22.5007 | 0.0988 | 2 | 29 | endocardial cushion morphogenesis |
| GO:0030513 | 0.005 | 20.9462 | 0.1056 | 2 | 31 | positive regulation of BMP signaling pathway |
| GO:0061001 | 0.0053 | 20.2467 | 0.109 | 2 | 32 | regulation of dendritic spine morphogenesis |
| GO:0045595 | 0.0054 | 2.641 | 5.327 | 12 | 1564 | regulation of cell differentiation |
| GO:1900449 | 0.0056 | 19.5923 | 0.1124 | 2 | 33 | regulation of glutamate receptor signaling pathway |
| GO:0050767 | 0.0057 | 3.5893 | 2.1765 | 7 | 639 | regulation of neurogenesis |
| GO:0007411 | 0.0057 | 6.0419 | 0.7187 | 4 | 211 | axon guidance |
| GO:0048468 | 0.0064 | 2.4921 | 6.1581 | 13 | 1808 | cell development |
| GO:0001709 | 0.0068 | 17.7015 | 0.1236 | 2 | 37 | cell fate determination |
| GO:0003220 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | left ventricular cardiac muscle tissue morphogenesis |
| GO:0007493 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | endodermal cell fate determination |
| GO:0035408 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | histone H3-T6 phosphorylation |
| GO:0051793 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | medium-chain fatty acid catabolic process |
| GO:0071657 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:0072560 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | type B pancreatic cell maturation |
| GO:0098735 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | positive regulation of the force of heart contraction |
| GO:0098886 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | modification of dendritic spine |
| GO:0098887 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | neurotransmitter receptor transport, endosome to postsynaptic membrane |
| GO:0098907 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | regulation of SA node cell action potential |
| GO:2001055 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | positive regulation of mesenchymal cell apoptotic process |
| GO:0007399 | 0.0069 | 2.4011 | 6.9415 | 14 | 2038 | nervous system development |
| GO:0042461 | 0.007 | 17.3486 | 0.126 | 2 | 37 | photoreceptor cell development |
| GO:0099601 | 0.007 | 17.3486 | 0.126 | 2 | 37 | regulation of neurotransmitter receptor activity |
| GO:0000902 | 0.0071 | 3.1431 | 2.8611 | 8 | 840 | cell morphogenesis |
| GO:0045927 | 0.0073 | 5.628 | 0.7698 | 4 | 226 | positive regulation of growth |
| GO:0010769 | 0.0074 | 5.6024 | 0.7732 | 4 | 227 | regulation of cell morphogenesis involved in differentiation |
| GO:0090287 | 0.0075 | 5.577 | 0.7766 | 4 | 228 | regulation of cellular response to growth factor stimulus |
| GO:0050808 | 0.0078 | 5.5022 | 0.7868 | 4 | 231 | synapse organization |
| GO:0035270 | 0.0079 | 7.9006 | 0.4087 | 3 | 120 | endocrine system development |
| GO:1990138 | 0.0088 | 7.5743 | 0.4258 | 3 | 125 | neuron projection extension |
| GO:0007612 | 0.009 | 7.5122 | 0.4292 | 3 | 126 | learning |
| GO:0010975 | 0.0093 | 4.2099 | 1.2943 | 5 | 380 | regulation of neuron projection development |
| GO:0001764 | 0.0094 | 7.391 | 0.436 | 3 | 128 | neuron migration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045660 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of neutrophil differentiation |
| GO:0080058 | 0.0016 | Inf | 0.0016 | 1 | 1 | protein deglutathionylation |
| GO:0039689 | 0.0049 | 317.5 | 0.0049 | 1 | 3 | negative stranded viral RNA replication |
| GO:0061739 | 0.0065 | 211.6528 | 0.0066 | 1 | 4 | protein lipidation involved in autophagosome assembly |
| GO:0048312 | 0.0098 | 126.975 | 0.0098 | 1 | 6 | intracellular distribution of mitochondria |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003206 | 0 | 19.6117 | 0.4292 | 7 | 117 | cardiac chamber morphogenesis |
| GO:0003231 | 0 | 17.1 | 0.4108 | 6 | 112 | cardiac ventricle development |
| GO:0007493 | 0 | Inf | 0.0073 | 2 | 2 | endodermal cell fate determination |
| GO:0021794 | 0 | 78.2161 | 0.0514 | 3 | 14 | thalamus development |
| GO:0007275 | 0 | 3.5473 | 12.2057 | 26 | 3710 | multicellular organism development |
| GO:0007399 | 0 | 3.632 | 7.4755 | 20 | 2038 | nervous system development |
| GO:0099565 | 0 | 15.2759 | 0.3741 | 5 | 102 | chemical synaptic transmission, postsynaptic |
| GO:0060913 | 0 | 563.3333 | 0.011 | 2 | 3 | cardiac cell fate determination |
| GO:2000463 | 1e-04 | 42.9934 | 0.0844 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
| GO:0060078 | 1e-04 | 12.7578 | 0.4438 | 5 | 121 | regulation of postsynaptic membrane potential |
| GO:0003148 | 1e-04 | 39.0798 | 0.0917 | 3 | 25 | outflow tract septum morphogenesis |
| GO:0048646 | 1e-04 | 4.1976 | 3.448 | 12 | 940 | anatomical structure formation involved in morphogenesis |
| GO:0048812 | 1e-04 | 5.3566 | 1.9587 | 9 | 534 | neuron projection morphogenesis |
| GO:0071205 | 1e-04 | 187.7531 | 0.0183 | 2 | 5 | protein localization to juxtaparanode region of axon |
| GO:0048858 | 2e-04 | 5.1826 | 2.0211 | 9 | 551 | cell projection morphogenesis |
| GO:0086073 | 2e-04 | 140.8056 | 0.022 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0048863 | 3e-04 | 7.5173 | 0.8987 | 6 | 245 | stem cell differentiation |
| GO:0048286 | 3e-04 | 26.8496 | 0.1284 | 3 | 35 | lung alveolus development |
| GO:0060537 | 3e-04 | 6.174 | 1.2875 | 7 | 351 | muscle tissue development |
| GO:0007420 | 4e-04 | 4.6309 | 2.2485 | 9 | 613 | brain development |
| GO:0003279 | 4e-04 | 12.9239 | 0.3448 | 4 | 94 | cardiac septum development |
| GO:0072359 | 4e-04 | 3.9008 | 3.3306 | 11 | 908 | circulatory system development |
| GO:0002934 | 5e-04 | 80.4444 | 0.033 | 2 | 9 | desmosome organization |
| GO:0003151 | 6e-04 | 20.6523 | 0.1634 | 3 | 47 | outflow tract morphogenesis |
| GO:0048699 | 6e-04 | 3.3359 | 4.6841 | 13 | 1277 | generation of neurons |
| GO:0008284 | 6e-04 | 3.9737 | 2.9308 | 10 | 799 | positive regulation of cell proliferation |
| GO:0007389 | 6e-04 | 5.4433 | 1.4525 | 7 | 396 | pattern specification process |
| GO:0021903 | 6e-04 | 70.3843 | 0.0367 | 2 | 10 | rostrocaudal neural tube patterning |
| GO:0060947 | 6e-04 | 70.3843 | 0.0367 | 2 | 10 | cardiac vascular smooth muscle cell differentiation |
| GO:0032502 | 6e-04 | 3.0042 | 10.9379 | 21 | 3812 | developmental process |
| GO:0055010 | 6e-04 | 19.9667 | 0.1687 | 3 | 46 | ventricular cardiac muscle tissue morphogenesis |
| GO:0060379 | 7e-04 | 62.5597 | 0.0403 | 2 | 11 | cardiac muscle cell myoblast differentiation |
| GO:0098916 | 9e-04 | 4.4511 | 2.0431 | 8 | 557 | anterograde trans-synaptic signaling |
| GO:0099536 | 9e-04 | 4.4427 | 2.0468 | 8 | 558 | synaptic signaling |
| GO:1901213 | 0.001 | 51.1785 | 0.0477 | 2 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
| GO:0032729 | 0.0011 | 16.1887 | 0.2054 | 3 | 56 | positive regulation of interferon-gamma production |
| GO:0000122 | 0.0012 | 3.8937 | 2.6483 | 9 | 722 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0098911 | 0.0013 | 43.2991 | 0.055 | 2 | 15 | regulation of ventricular cardiac muscle cell action potential |
| GO:0061180 | 0.0014 | 14.7882 | 0.2238 | 3 | 61 | mammary gland epithelium development |
| GO:0070848 | 0.0016 | 4.0376 | 2.2412 | 8 | 611 | response to growth factor |
| GO:0043066 | 0.0017 | 3.6716 | 2.7987 | 9 | 763 | negative regulation of apoptotic process |
| GO:0009887 | 0.0017 | 3.4164 | 3.3746 | 10 | 920 | animal organ morphogenesis |
| GO:0120036 | 0.0017 | 3.0567 | 4.6144 | 12 | 1258 | plasma membrane bounded cell projection organization |
| GO:0007517 | 0.0018 | 5.1555 | 1.2912 | 6 | 352 | muscle organ development |
| GO:0032989 | 0.0019 | 3.3691 | 3.4186 | 10 | 932 | cellular component morphogenesis |
| GO:0048167 | 0.0019 | 8.2808 | 0.5282 | 4 | 144 | regulation of synaptic plasticity |
| GO:0023019 | 0.0019 | 35.1736 | 0.066 | 2 | 18 | signal transduction involved in regulation of gene expression |
| GO:0045109 | 0.0022 | 33.1024 | 0.0697 | 2 | 19 | intermediate filament organization |
| GO:0051094 | 0.0023 | 3.0933 | 4.1265 | 11 | 1125 | positive regulation of developmental process |
| GO:0045844 | 0.0023 | 12.4217 | 0.2641 | 3 | 72 | positive regulation of striated muscle tissue development |
| GO:0060444 | 0.0024 | 31.2613 | 0.0734 | 2 | 20 | branching involved in mammary gland duct morphogenesis |
| GO:0035051 | 0.0024 | 31.1311 | 0.0734 | 2 | 21 | cardiocyte differentiation |
| GO:0060415 | 0.0025 | 12.0702 | 0.2714 | 3 | 74 | muscle tissue morphogenesis |
| GO:0050974 | 0.0029 | 28.1315 | 0.0807 | 2 | 22 | detection of mechanical stimulus involved in sensory perception |
| GO:0043009 | 0.0029 | 4.0602 | 1.9221 | 7 | 524 | chordate embryonic development |
| GO:0010575 | 0.0032 | 26.7901 | 0.0844 | 2 | 23 | positive regulation of vascular endothelial growth factor production |
| GO:0060914 | 0.0032 | 26.7901 | 0.0844 | 2 | 23 | heart formation |
| GO:0060548 | 0.0035 | 3.2761 | 3.1142 | 9 | 849 | negative regulation of cell death |
| GO:0009952 | 0.0036 | 6.9099 | 0.63 | 4 | 178 | anterior/posterior pattern specification |
| GO:0003142 | 0.0037 | Inf | 0.0037 | 1 | 1 | cardiogenic plate morphogenesis |
| GO:0003167 | 0.0037 | Inf | 0.0037 | 1 | 1 | atrioventricular bundle cell differentiation |
| GO:0021568 | 0.0037 | Inf | 0.0037 | 1 | 1 | rhombomere 2 development |
| GO:0032912 | 0.0037 | Inf | 0.0037 | 1 | 1 | negative regulation of transforming growth factor beta2 production |
| GO:0060807 | 0.0037 | Inf | 0.0037 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification |
| GO:0060931 | 0.0037 | Inf | 0.0037 | 1 | 1 | sinoatrial node cell development |
| GO:0061374 | 0.0037 | Inf | 0.0037 | 1 | 1 | mammillothalamic axonal tract development |
| GO:0061381 | 0.0037 | Inf | 0.0037 | 1 | 1 | cell migration in diencephalon |
| GO:1903965 | 0.0037 | Inf | 0.0037 | 1 | 1 | monounsaturated fatty acid catabolic process |
| GO:1904425 | 0.0037 | Inf | 0.0037 | 1 | 1 | negative regulation of GTP binding |
| GO:2000287 | 0.0037 | Inf | 0.0037 | 1 | 1 | positive regulation of myotome development |
| GO:0070528 | 0.0038 | 24.4573 | 0.0917 | 2 | 25 | protein kinase C signaling |
| GO:0048666 | 0.0038 | 3.2465 | 3.1544 | 9 | 890 | neuron development |
| GO:0048738 | 0.0038 | 10.36 | 0.3146 | 3 | 90 | cardiac muscle tissue development |
| GO:0035335 | 0.004 | 10.1934 | 0.3191 | 3 | 87 | peptidyl-tyrosine dephosphorylation |
| GO:0035282 | 0.0041 | 10.0728 | 0.3228 | 3 | 88 | segmentation |
| GO:0021761 | 0.0042 | 10.0285 | 0.3243 | 3 | 90 | limbic system development |
| GO:0007178 | 0.0043 | 5.08 | 1.0747 | 5 | 293 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0035116 | 0.0044 | 22.4978 | 0.099 | 2 | 27 | embryonic hindlimb morphogenesis |
| GO:0061311 | 0.0044 | 22.4978 | 0.099 | 2 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0003008 | 0.0044 | 2.52 | 6.5695 | 14 | 1791 | system process |
| GO:0007154 | 0.0046 | 2.0825 | 20.9372 | 31 | 5708 | cell communication |
| GO:0009790 | 0.0046 | 3.1298 | 3.2499 | 9 | 886 | embryo development |
| GO:0003203 | 0.005 | 20.8285 | 0.1064 | 2 | 29 | endocardial cushion morphogenesis |
| GO:0032735 | 0.005 | 20.8285 | 0.1064 | 2 | 29 | positive regulation of interleukin-12 production |
| GO:0035115 | 0.0054 | 20.0833 | 0.11 | 2 | 30 | embryonic forelimb morphogenesis |
| GO:0008038 | 0.0057 | 19.3895 | 0.1137 | 2 | 31 | neuron recognition |
| GO:0030513 | 0.0057 | 19.3895 | 0.1137 | 2 | 31 | positive regulation of BMP signaling pathway |
| GO:0035239 | 0.0063 | 4.6212 | 1.1774 | 5 | 321 | tube morphogenesis |
| GO:0001944 | 0.0064 | 3.4849 | 2.2228 | 7 | 606 | vasculature development |
| GO:0060795 | 0.0065 | 18.1362 | 0.121 | 2 | 33 | cell fate commitment involved in formation of primary germ layer |
| GO:0055007 | 0.0067 | 8.3846 | 0.3851 | 3 | 105 | cardiac muscle cell differentiation |
| GO:0051240 | 0.0068 | 2.6528 | 4.7715 | 11 | 1346 | positive regulation of multicellular organismal process |
| GO:0086091 | 0.0069 | 17.5683 | 0.1247 | 2 | 34 | regulation of heart rate by cardiac conduction |
| GO:1905209 | 0.0069 | 17.5683 | 0.1247 | 2 | 34 | positive regulation of cardiocyte differentiation |
| GO:0051101 | 0.0071 | 8.2222 | 0.3925 | 3 | 107 | regulation of DNA binding |
| GO:0001755 | 0.0073 | 17.0348 | 0.1284 | 2 | 35 | neural crest cell migration |
| GO:0043954 | 0.0073 | 17.0348 | 0.1284 | 2 | 35 | cellular component maintenance |
| GO:0030855 | 0.0073 | 3.4047 | 2.28 | 7 | 643 | epithelial cell differentiation |
| GO:0001828 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | inner cell mass cellular morphogenesis |
| GO:0003163 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | sinoatrial node development |
| GO:0021767 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | mammillary body development |
| GO:0034334 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | adherens junction maintenance |
| GO:0051793 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | medium-chain fatty acid catabolic process |
| GO:0061010 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | gall bladder development |
| GO:0061379 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | inferior colliculus development |
| GO:0070352 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | positive regulation of white fat cell proliferation |
| GO:0071109 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | superior temporal gyrus development |
| GO:0071657 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:2000043 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | regulation of cardiac cell fate specification |
| GO:2001055 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | positive regulation of mesenchymal cell apoptotic process |
| GO:0007411 | 0.0074 | 5.5756 | 0.774 | 4 | 211 | axon guidance |
| GO:0030029 | 0.0076 | 3.3676 | 2.2962 | 7 | 626 | actin filament-based process |
| GO:0046330 | 0.0078 | 7.9156 | 0.4072 | 3 | 111 | positive regulation of JNK cascade |
| GO:0007611 | 0.0082 | 5.4164 | 0.796 | 4 | 217 | learning or memory |
| GO:0007166 | 0.0084 | 2.2244 | 8.6209 | 16 | 2433 | cell surface receptor signaling pathway |
| GO:0030857 | 0.0085 | 15.6121 | 0.1394 | 2 | 38 | negative regulation of epithelial cell differentiation |
| GO:0045103 | 0.0085 | 15.6121 | 0.1394 | 2 | 38 | intermediate filament-based process |
| GO:1903115 | 0.0085 | 15.6121 | 0.1394 | 2 | 38 | regulation of actin filament-based movement |
| GO:0035113 | 0.0093 | 7.4304 | 0.4328 | 3 | 118 | embryonic appendage morphogenesis |
| GO:0048565 | 0.0093 | 7.4304 | 0.4328 | 3 | 118 | digestive tract development |
| GO:0023052 | 0.0093 | 1.9476 | 20.8675 | 30 | 5689 | signaling |
| GO:0090287 | 0.0097 | 5.1466 | 0.8363 | 4 | 228 | regulation of cellular response to growth factor stimulus |
| GO:0035987 | 0.0099 | 14.4084 | 0.1504 | 2 | 41 | endodermal cell differentiation |
| GO:0048514 | 0.0099 | 3.5601 | 1.8414 | 6 | 502 | blood vessel morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0018917 | 0.0025 | Inf | 0.0025 | 1 | 1 | fluorene metabolic process |
| GO:0042489 | 0.005 | 411.5676 | 0.005 | 1 | 2 | negative regulation of odontogenesis of dentin-containing tooth |
| GO:0070378 | 0.005 | 411.5676 | 0.005 | 1 | 2 | positive regulation of ERK5 cascade |
| GO:0018879 | 0.0074 | 205.7703 | 0.0075 | 1 | 3 | biphenyl metabolic process |
| GO:0060535 | 0.0099 | 137.1712 | 0.01 | 1 | 4 | trachea cartilage morphogenesis |
| GO:1904340 | 0.0099 | 137.1712 | 0.01 | 1 | 4 | positive regulation of dopaminergic neuron differentiation |
| GO:2000852 | 0.0099 | 137.1712 | 0.01 | 1 | 4 | regulation of corticosterone secretion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007611 | 5e-04 | 8.6338 | 0.6538 | 5 | 217 | learning or memory |
| GO:0071294 | 9e-04 | 53.1748 | 0.0452 | 2 | 15 | cellular response to zinc ion |
| GO:0071241 | 0.0013 | 9.2571 | 0.4791 | 4 | 159 | cellular response to inorganic substance |
| GO:0001525 | 0.0015 | 5.3649 | 1.2655 | 6 | 420 | angiogenesis |
| GO:0090023 | 0.0025 | 30.0356 | 0.0753 | 2 | 25 | positive regulation of neutrophil chemotaxis |
| GO:0048710 | 0.003 | 27.6291 | 0.0814 | 2 | 27 | regulation of astrocyte differentiation |
| GO:0014013 | 0.003 | 11.3488 | 0.2893 | 3 | 96 | regulation of gliogenesis |
| GO:0019242 | 0.003 | Inf | 0.003 | 1 | 1 | methylglyoxal biosynthetic process |
| GO:0061889 | 0.003 | Inf | 0.003 | 1 | 1 | negative regulation of astrocyte activation |
| GO:0071206 | 0.003 | Inf | 0.003 | 1 | 1 | establishment of protein localization to juxtaparanode region of axon |
| GO:0001953 | 0.0039 | 23.8119 | 0.0934 | 2 | 31 | negative regulation of cell-matrix adhesion |
| GO:1902622 | 0.0039 | 23.8119 | 0.0934 | 2 | 31 | regulation of neutrophil migration |
| GO:0007616 | 0.0042 | 23.0167 | 0.0964 | 2 | 32 | long-term memory |
| GO:0003165 | 0.006 | 338.2222 | 0.006 | 1 | 2 | Purkinje myocyte development |
| GO:0010899 | 0.006 | 338.2222 | 0.006 | 1 | 2 | regulation of phosphatidylcholine catabolic process |
| GO:0060163 | 0.006 | 338.2222 | 0.006 | 1 | 2 | subpallium neuron fate commitment |
| GO:1903979 | 0.006 | 338.2222 | 0.006 | 1 | 2 | negative regulation of microglial cell activation |
| GO:1904808 | 0.006 | 338.2222 | 0.006 | 1 | 2 | positive regulation of protein oxidation |
| GO:1905167 | 0.006 | 338.2222 | 0.006 | 1 | 2 | positive regulation of lysosomal protein catabolic process |
| GO:2000111 | 0.006 | 338.2222 | 0.006 | 1 | 2 | positive regulation of macrophage apoptotic process |
| GO:0032570 | 0.0068 | 17.6946 | 0.1235 | 2 | 41 | response to progesterone |
| GO:0071622 | 0.0074 | 16.8293 | 0.1296 | 2 | 43 | regulation of granulocyte chemotaxis |
| GO:0001568 | 0.0075 | 3.8346 | 1.7445 | 6 | 579 | blood vessel development |
| GO:0034113 | 0.0088 | 15.3293 | 0.1416 | 2 | 47 | heterotypic cell-cell adhesion |
| GO:0031133 | 0.009 | 169.1 | 0.009 | 1 | 3 | regulation of axon diameter |
| GO:0035986 | 0.009 | 169.1 | 0.009 | 1 | 3 | senescence-associated heterochromatin focus assembly |
| GO:0045163 | 0.009 | 169.1 | 0.009 | 1 | 3 | clustering of voltage-gated potassium channels |
| GO:0060168 | 0.009 | 169.1 | 0.009 | 1 | 3 | positive regulation of adenosine receptor signaling pathway |
| GO:0061771 | 0.009 | 169.1 | 0.009 | 1 | 3 | response to caloric restriction |
| GO:1905907 | 0.009 | 169.1 | 0.009 | 1 | 3 | negative regulation of amyloid fibril formation |
| GO:0021879 | 0.0095 | 14.675 | 0.1476 | 2 | 49 | forebrain neuron differentiation |
| GO:0046686 | 0.0095 | 14.675 | 0.1476 | 2 | 49 | response to cadmium ion |
| GO:0072358 | 0.0097 | 3.6176 | 1.844 | 6 | 612 | cardiovascular system development |
| GO:0043112 | 0.0098 | 7.3047 | 0.4429 | 3 | 147 | receptor metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0097120 | 1e-04 | 49.6569 | 0.0743 | 3 | 21 | receptor localization to synapse |
| GO:0060078 | 1e-04 | 13.2803 | 0.428 | 5 | 121 | regulation of postsynaptic membrane potential |
| GO:2000463 | 1e-04 | 44.6853 | 0.0814 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
| GO:0003148 | 1e-04 | 40.6176 | 0.0884 | 3 | 25 | outflow tract septum morphogenesis |
| GO:0006355 | 4e-04 | 2.7289 | 11.5838 | 23 | 3275 | regulation of transcription, DNA-templated |
| GO:2001141 | 4e-04 | 2.7003 | 11.6793 | 23 | 3302 | regulation of RNA biosynthetic process |
| GO:0046549 | 4e-04 | 83.5495 | 0.0318 | 2 | 9 | retinal cone cell development |
| GO:0021517 | 4e-04 | 22.8869 | 0.1486 | 3 | 42 | ventral spinal cord development |
| GO:0099565 | 5e-04 | 12.3388 | 0.3608 | 4 | 102 | chemical synaptic transmission, postsynaptic |
| GO:0120039 | 6e-04 | 4.7256 | 1.9383 | 8 | 548 | plasma membrane bounded cell projection morphogenesis |
| GO:0098916 | 7e-04 | 4.6453 | 1.9701 | 8 | 557 | anterograde trans-synaptic signaling |
| GO:0099536 | 7e-04 | 4.6365 | 1.9737 | 8 | 558 | synaptic signaling |
| GO:0003206 | 8e-04 | 10.6903 | 0.4138 | 4 | 117 | cardiac chamber morphogenesis |
| GO:0097659 | 8e-04 | 2.5584 | 12.178 | 23 | 3443 | nucleic acid-templated transcription |
| GO:0032990 | 8e-04 | 4.5506 | 2.009 | 8 | 568 | cell part morphogenesis |
| GO:0021520 | 9e-04 | 53.1538 | 0.046 | 2 | 13 | spinal cord motor neuron cell fate specification |
| GO:0048699 | 0.0014 | 3.1503 | 4.5168 | 12 | 1277 | generation of neurons |
| GO:0071695 | 0.0014 | 9.0024 | 0.4881 | 4 | 138 | anatomical structure maturation |
| GO:0019219 | 0.0014 | 2.4061 | 13.5115 | 24 | 3820 | regulation of nucleobase-containing compound metabolic process |
| GO:0060219 | 0.0016 | 38.9692 | 0.0601 | 2 | 17 | camera-type eye photoreceptor cell differentiation |
| GO:0048167 | 0.0017 | 8.6131 | 0.5093 | 4 | 144 | regulation of synaptic plasticity |
| GO:0008306 | 0.0018 | 13.7086 | 0.2405 | 3 | 68 | associative learning |
| GO:1904018 | 0.0019 | 8.2559 | 0.5306 | 4 | 150 | positive regulation of vasculature development |
| GO:0010002 | 0.002 | 34.3801 | 0.0672 | 2 | 19 | cardioblast differentiation |
| GO:0031016 | 0.0022 | 12.7252 | 0.2582 | 3 | 73 | pancreas development |
| GO:0045664 | 0.0023 | 4.2592 | 1.8428 | 7 | 521 | regulation of neuron differentiation |
| GO:0048638 | 0.0026 | 5.7338 | 0.9585 | 5 | 271 | regulation of developmental growth |
| GO:0007389 | 0.0026 | 4.751 | 1.4007 | 6 | 396 | pattern specification process |
| GO:0016070 | 0.0027 | 2.2575 | 14.9581 | 25 | 4229 | RNA metabolic process |
| GO:0010460 | 0.003 | 27.8242 | 0.0814 | 2 | 23 | positive regulation of heart rate |
| GO:0021511 | 0.0032 | 26.5577 | 0.0849 | 2 | 24 | spinal cord patterning |
| GO:0003309 | 0.0035 | 25.4013 | 0.0884 | 2 | 25 | type B pancreatic cell differentiation |
| GO:0048791 | 0.0035 | 25.4013 | 0.0884 | 2 | 25 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0021754 | 0.0035 | Inf | 0.0035 | 1 | 1 | facial nucleus development |
| GO:0032912 | 0.0035 | Inf | 0.0035 | 1 | 1 | negative regulation of transforming growth factor beta2 production |
| GO:0042404 | 0.0035 | Inf | 0.0035 | 1 | 1 | thyroid hormone catabolic process |
| GO:0043354 | 0.0035 | Inf | 0.0035 | 1 | 1 | enucleate erythrocyte maturation |
| GO:0060829 | 0.0035 | Inf | 0.0035 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation |
| GO:0061931 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of erythrocyte enucleation |
| GO:0090601 | 0.0035 | Inf | 0.0035 | 1 | 1 | enucleation |
| GO:1902078 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of lateral motor column neuron migration |
| GO:1902838 | 0.0035 | Inf | 0.0035 | 1 | 1 | regulation of nuclear migration along microtubule |
| GO:1903965 | 0.0035 | Inf | 0.0035 | 1 | 1 | monounsaturated fatty acid catabolic process |
| GO:1905483 | 0.0035 | Inf | 0.0035 | 1 | 1 | regulation of motor neuron migration |
| GO:0051960 | 0.0036 | 3.542 | 2.5467 | 8 | 720 | regulation of nervous system development |
| GO:0022603 | 0.0039 | 3.2341 | 3.1657 | 9 | 895 | regulation of anatomical structure morphogenesis |
| GO:0035418 | 0.0041 | 23.3662 | 0.0955 | 2 | 27 | protein localization to synapse |
| GO:0035886 | 0.0041 | 23.3662 | 0.0955 | 2 | 27 | vascular smooth muscle cell differentiation |
| GO:0034654 | 0.0043 | 2.1829 | 13.7308 | 23 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:0009889 | 0.0044 | 2.1626 | 14.6151 | 24 | 4132 | regulation of biosynthetic process |
| GO:0003279 | 0.0045 | 9.775 | 0.3325 | 3 | 94 | cardiac septum development |
| GO:0003203 | 0.0047 | 21.6325 | 0.1026 | 2 | 29 | endocardial cushion morphogenesis |
| GO:0032735 | 0.0047 | 21.6325 | 0.1026 | 2 | 29 | positive regulation of interleukin-12 production |
| GO:0030513 | 0.0053 | 20.1379 | 0.1096 | 2 | 31 | positive regulation of BMP signaling pathway |
| GO:0007420 | 0.0056 | 3.59 | 2.1682 | 7 | 613 | brain development |
| GO:0061001 | 0.0057 | 19.4654 | 0.1132 | 2 | 32 | regulation of dendritic spine morphogenesis |
| GO:1900449 | 0.006 | 18.8362 | 0.1167 | 2 | 33 | regulation of glutamate receptor signaling pathway |
| GO:0051240 | 0.0062 | 2.8375 | 4.0683 | 10 | 1230 | positive regulation of multicellular organismal process |
| GO:0048667 | 0.0065 | 3.9124 | 1.6872 | 6 | 477 | cell morphogenesis involved in neuron differentiation |
| GO:0031175 | 0.007 | 3.1415 | 2.8509 | 8 | 806 | neuron projection development |
| GO:0003220 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | left ventricular cardiac muscle tissue morphogenesis |
| GO:0007493 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | endodermal cell fate determination |
| GO:0021570 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | rhombomere 4 development |
| GO:0021571 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | rhombomere 5 development |
| GO:0035408 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | histone H3-T6 phosphorylation |
| GO:0051793 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | medium-chain fatty acid catabolic process |
| GO:0071657 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:0072560 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | type B pancreatic cell maturation |
| GO:0098735 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | positive regulation of the force of heart contraction |
| GO:0098886 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | modification of dendritic spine |
| GO:0098887 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | neurotransmitter receptor transport, endosome to postsynaptic membrane |
| GO:0098907 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | regulation of SA node cell action potential |
| GO:2001055 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | positive regulation of mesenchymal cell apoptotic process |
| GO:0007611 | 0.0072 | 5.6338 | 0.7675 | 4 | 217 | learning or memory |
| GO:0001709 | 0.0073 | 17.005 | 0.1285 | 2 | 37 | cell fate determination |
| GO:0042461 | 0.0076 | 16.6791 | 0.1309 | 2 | 37 | photoreceptor cell development |
| GO:0099601 | 0.0076 | 16.6791 | 0.1309 | 2 | 37 | regulation of neurotransmitter receptor activity |
| GO:0045597 | 0.0078 | 3.0844 | 2.9004 | 8 | 820 | positive regulation of cell differentiation |
| GO:0045927 | 0.0083 | 5.4022 | 0.7994 | 4 | 226 | positive regulation of growth |
| GO:0010769 | 0.0084 | 5.3776 | 0.8029 | 4 | 227 | regulation of cell morphogenesis involved in differentiation |
| GO:0048731 | 0.0086 | 2.074 | 13.6869 | 22 | 4065 | system development |
| GO:0035270 | 0.0088 | 7.5897 | 0.4244 | 3 | 120 | endocrine system development |
| GO:0000902 | 0.0089 | 3.0061 | 2.9711 | 8 | 840 | cell morphogenesis |
| GO:0050808 | 0.0089 | 5.2814 | 0.8171 | 4 | 231 | synapse organization |
| GO:0048468 | 0.009 | 2.3702 | 6.395 | 13 | 1808 | cell development |
| GO:1990138 | 0.0098 | 7.2763 | 0.4421 | 3 | 125 | neuron projection extension |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 1390.7582 | 0.0724 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 0 | 245.2018 | 0.132 | 14 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 189.4118 | 0.1533 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 160.2293 | 0.1703 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 148.7647 | 0.1788 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0051290 | 0 | 143.6254 | 0.1831 | 14 | 43 | protein heterotetramerization |
| GO:0016233 | 0 | 115.6449 | 0.2129 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 115.6449 | 0.2129 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0006303 | 0 | 79.9774 | 0.281 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 0 | 70.456 | 0.3108 | 14 | 73 | ATP-dependent chromatin remodeling |
| GO:0045815 | 0 | 64.9301 | 0.3321 | 14 | 78 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 48.8208 | 0.4215 | 14 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 48.2499 | 0.4258 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0045814 | 0 | 40.241 | 0.4981 | 14 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 38.7264 | 0.5152 | 14 | 121 | regulation of gene silencing |
| GO:1903707 | 0 | 36.6556 | 0.5407 | 14 | 127 | negative regulation of hemopoiesis |
| GO:0031497 | 0 | 32.0751 | 0.6088 | 14 | 143 | chromatin assembly |
| GO:0032200 | 0 | 29.3219 | 0.6599 | 14 | 155 | telomere organization |
| GO:0006352 | 0 | 21.4171 | 0.9579 | 15 | 225 | DNA-templated transcription, initiation |
| GO:0045637 | 0 | 21.4171 | 0.9579 | 15 | 225 | regulation of myeloid cell differentiation |
| GO:0002244 | 0 | 24.4184 | 0.7791 | 14 | 183 | hematopoietic progenitor cell differentiation |
| GO:0048863 | 0 | 19.5287 | 1.0431 | 15 | 245 | stem cell differentiation |
| GO:0051259 | 0 | 12.9184 | 2.0862 | 19 | 490 | protein oligomerization |
| GO:0065004 | 0 | 20.9087 | 0.8983 | 14 | 211 | protein-DNA complex assembly |
| GO:0071103 | 0 | 17.0412 | 1.0857 | 14 | 255 | DNA conformation change |
| GO:0035194 | 0 | 16.0906 | 1.1453 | 14 | 269 | posttranscriptional gene silencing by RNA |
| GO:0017148 | 0 | 13.1531 | 1.5072 | 15 | 354 | negative regulation of translation |
| GO:0060249 | 0 | 12.333 | 1.4689 | 14 | 345 | anatomical structure homeostasis |
| GO:0034248 | 0 | 7.962 | 2.414 | 15 | 567 | regulation of cellular amide metabolic process |
| GO:0006281 | 0 | 8.5856 | 2.0649 | 14 | 485 | DNA repair |
| GO:0006325 | 0 | 7.1605 | 2.8909 | 16 | 679 | chromatin organization |
| GO:0045596 | 0 | 7.4826 | 2.5588 | 15 | 601 | negative regulation of cell differentiation |
| GO:2000026 | 0 | 4.6833 | 7.2932 | 24 | 1713 | regulation of multicellular organismal development |
| GO:0010608 | 0 | 6.8483 | 2.7802 | 15 | 653 | posttranscriptional regulation of gene expression |
| GO:0048534 | 0 | 5.941 | 3.4401 | 16 | 808 | hematopoietic or lymphoid organ development |
| GO:0070271 | 0 | 4.7769 | 5.5944 | 20 | 1314 | protein complex biogenesis |
| GO:0043043 | 0 | 5.5771 | 3.3677 | 15 | 791 | peptide biosynthetic process |
| GO:0071822 | 0 | 3.9889 | 6.5737 | 20 | 1544 | protein complex subunit organization |
| GO:0045892 | 0 | 4.5163 | 4.4321 | 16 | 1041 | negative regulation of transcription, DNA-templated |
| GO:1902679 | 0 | 4.3653 | 4.5726 | 16 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0065003 | 0 | 3.7032 | 7.0207 | 20 | 1649 | macromolecular complex assembly |
| GO:0051248 | 0 | 4.0883 | 4.8888 | 16 | 1182 | negative regulation of protein metabolic process |
| GO:0048731 | 0 | 2.9199 | 17.8178 | 34 | 4185 | system development |
| GO:0048869 | 0 | 2.9312 | 16.2255 | 32 | 3811 | cellular developmental process |
| GO:0002682 | 1e-04 | 3.5975 | 5.4539 | 16 | 1281 | regulation of immune system process |
| GO:0045934 | 1e-04 | 3.5821 | 5.4752 | 16 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0048519 | 2e-04 | 2.5294 | 19.721 | 34 | 4632 | negative regulation of biological process |
| GO:0009890 | 2e-04 | 3.1352 | 6.6418 | 17 | 1560 | negative regulation of biosynthetic process |
| GO:0097049 | 5e-04 | 80.4021 | 0.0341 | 2 | 8 | motor neuron apoptotic process |
| GO:1990001 | 6e-04 | 68.9116 | 0.0383 | 2 | 9 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0010604 | 7e-04 | 2.4829 | 11.7934 | 23 | 2770 | positive regulation of macromolecule metabolic process |
| GO:0033554 | 8e-04 | 2.7598 | 7.4337 | 17 | 1746 | cellular response to stress |
| GO:0048518 | 9e-04 | 2.2445 | 21.3899 | 34 | 5024 | positive regulation of biological process |
| GO:0097341 | 0.001 | 53.5908 | 0.0468 | 2 | 11 | zymogen inhibition |
| GO:0060547 | 0.0014 | 43.8413 | 0.0553 | 2 | 13 | negative regulation of necrotic cell death |
| GO:0021527 | 0.0016 | 40.1852 | 0.0596 | 2 | 14 | spinal cord association neuron differentiation |
| GO:0032268 | 0.0018 | 2.3884 | 10.2394 | 20 | 2405 | regulation of cellular protein metabolic process |
| GO:0071294 | 0.0018 | 37.0916 | 0.0639 | 2 | 15 | cellular response to zinc ion |
| GO:0065008 | 0.002 | 2.236 | 13.5305 | 24 | 3178 | regulation of biological quality |
| GO:2001236 | 0.0032 | 7.106 | 0.6088 | 4 | 143 | regulation of extrinsic apoptotic signaling pathway |
| GO:0032501 | 0.004 | 2.0022 | 27.8869 | 39 | 6550 | multicellular organismal process |
| GO:0006211 | 0.0043 | Inf | 0.0043 | 1 | 1 | 5-methylcytosine catabolic process |
| GO:0014876 | 0.0043 | Inf | 0.0043 | 1 | 1 | response to injury involved in regulation of muscle adaptation |
| GO:0030421 | 0.0043 | Inf | 0.0043 | 1 | 1 | defecation |
| GO:0070367 | 0.0043 | Inf | 0.0043 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:1902045 | 0.0043 | Inf | 0.0043 | 1 | 1 | negative regulation of Fas signaling pathway |
| GO:0071241 | 0.0047 | 6.3657 | 0.677 | 4 | 159 | cellular response to inorganic substance |
| GO:0002040 | 0.0061 | 8.7085 | 0.3704 | 3 | 87 | sprouting angiogenesis |
| GO:0036337 | 0.0084 | 241.2857 | 0.0084 | 1 | 2 | Fas signaling pathway |
| GO:0006788 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | heme oxidation |
| GO:0009115 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | xanthine catabolic process |
| GO:0010025 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | wax biosynthetic process |
| GO:0014736 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | negative regulation of muscle atrophy |
| GO:0021526 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | medial motor column neuron differentiation |
| GO:0060163 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | subpallium neuron fate commitment |
| GO:0097498 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | endothelial tube lumen extension |
| GO:1900155 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | negative regulation of bone trabecula formation |
| GO:0048665 | 0.0087 | 15.5361 | 0.1405 | 2 | 33 | neuron fate specification |
| GO:1902042 | 0.0092 | 15.0496 | 0.1448 | 2 | 34 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0070266 | 0.0097 | 14.5926 | 0.149 | 2 | 35 | necroptotic process |
| GO:1903318 | 0.0097 | 14.5926 | 0.149 | 2 | 35 | negative regulation of protein maturation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032098 | 0.0014 | 42.1274 | 0.055 | 2 | 21 | regulation of appetite |
| GO:0006536 | 0.0024 | 30.7713 | 0.0734 | 2 | 28 | glutamate metabolic process |
| GO:0070378 | 0.0052 | 390.4103 | 0.0052 | 1 | 2 | positive regulation of ERK5 cascade |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004013 | 0.0032 | Inf | 0.0032 | 1 | 1 | adenosylhomocysteinase activity |
| GO:0004068 | 0.0032 | Inf | 0.0032 | 1 | 1 | aspartate 1-decarboxylase activity |
| GO:0004458 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | D-lactate dehydrogenase (cytochrome) activity |
| GO:0004782 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | sulfinoalanine decarboxylase activity |
| GO:0004873 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | asialoglycoprotein receptor activity |
| GO:0015275 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | stretch-activated, cation-selective, calcium channel activity |
| GO:0023030 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | MHC class Ib protein binding, via antigen binding groove |
| GO:0047710 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | bis(5'-adenosyl)-triphosphatase activity |
| GO:0086056 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | voltage-gated calcium channel activity involved in AV node cell action potential |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005267 | 0.0031 | 11.3008 | 0.2932 | 3 | 121 | potassium channel activity |
| GO:1901981 | 0.0032 | 11.2051 | 0.2957 | 3 | 122 | phosphatidylinositol phosphate binding |
| GO:0005250 | 0.0073 | 211.5139 | 0.0073 | 1 | 3 | A-type (transient outward) potassium channel activity |
| GO:0030348 | 0.0073 | 211.5139 | 0.0073 | 1 | 3 | syntaxin-3 binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 30.749 | 1.6463 | 26 | 457 | protein heterodimerization activity |
| GO:0031492 | 0 | 102.2222 | 0.1549 | 10 | 43 | nucleosomal DNA binding |
| GO:0003677 | 0 | 6.528 | 8.1016 | 29 | 2249 | DNA binding |
| GO:0042393 | 0 | 19.6641 | 0.6484 | 10 | 180 | histone binding |
| GO:0045296 | 0 | 11.9384 | 1.0375 | 10 | 288 | cadherin binding |
| GO:0003682 | 0 | 8.2775 | 1.6463 | 11 | 457 | chromatin binding |
| GO:1901363 | 0 | 3.7483 | 19.5425 | 37 | 5425 | heterocyclic compound binding |
| GO:0097159 | 0 | 3.6697 | 19.8091 | 37 | 5499 | organic cyclic compound binding |
| GO:0044877 | 0.0013 | 3.5551 | 3.2601 | 10 | 905 | macromolecular complex binding |
| GO:0004595 | 0.0036 | Inf | 0.0036 | 1 | 1 | pantetheine-phosphate adenylyltransferase activity |
| GO:0018455 | 0.0036 | Inf | 0.0036 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0102522 | 0.0036 | Inf | 0.0036 | 1 | 1 | tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity |
| GO:0004140 | 0.0072 | 281.7037 | 0.0072 | 1 | 2 | dephospho-CoA kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004516 | 0.0036 | Inf | 0.0036 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
| GO:0008437 | 0.0036 | Inf | 0.0036 | 1 | 1 | thyrotropin-releasing hormone activity |
| GO:0034189 | 0.0072 | 281.7037 | 0.0072 | 1 | 2 | very-low-density lipoprotein particle binding |
| GO:0070780 | 0.0072 | 281.7037 | 0.0072 | 1 | 2 | dihydrosphingosine-1-phosphate phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0099600 | 2e-04 | 5.2731 | 2.2456 | 9 | 1106 | transmembrane receptor activity |
| GO:0004930 | 3e-04 | 6.3381 | 1.3856 | 7 | 705 | G-protein coupled receptor activity |
| GO:0042166 | 4e-04 | 87.5 | 0.0284 | 2 | 14 | acetylcholine binding |
| GO:0004993 | 7e-04 | 61.7444 | 0.0386 | 2 | 19 | G-protein coupled serotonin receptor activity |
| GO:0015464 | 7e-04 | 61.7444 | 0.0386 | 2 | 19 | acetylcholine receptor activity |
| GO:0060089 | 0.0013 | 4.1013 | 2.8243 | 9 | 1391 | molecular transducer activity |
| GO:0004871 | 0.0019 | 3.8927 | 2.9603 | 9 | 1458 | signal transducer activity |
| GO:0004838 | 0.002 | Inf | 0.002 | 1 | 1 | L-tyrosine:2-oxoglutarate aminotransferase activity |
| GO:0001641 | 0.0041 | 507.8667 | 0.0041 | 1 | 2 | group II metabotropic glutamate receptor activity |
| GO:0004984 | 0.0041 | 6.8622 | 0.6619 | 4 | 326 | olfactory receptor activity |
| GO:0005516 | 0.005 | 9.5528 | 0.3492 | 3 | 172 | calmodulin binding |
| GO:0080130 | 0.0061 | 253.9167 | 0.0061 | 1 | 3 | L-phenylalanine:2-oxoglutarate aminotransferase activity |
| GO:0030594 | 0.0065 | 18.1099 | 0.1217 | 2 | 64 | neurotransmitter receptor activity |
| GO:0090722 | 0.0081 | 169.2667 | 0.0081 | 1 | 4 | receptor-receptor interaction |
| GO:0098988 | 0.0081 | 169.2667 | 0.0081 | 1 | 4 | G-protein coupled glutamate receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 104.5523 | 0.1521 | 10 | 43 | nucleosomal DNA binding |
| GO:0046982 | 0 | 14.1048 | 1.6163 | 16 | 457 | protein heterodimerization activity |
| GO:0045296 | 0 | 15.4638 | 1.0186 | 12 | 288 | cadherin binding |
| GO:0042393 | 0 | 20.1123 | 0.6366 | 10 | 180 | histone binding |
| GO:0003682 | 0 | 8.4705 | 1.6163 | 11 | 457 | chromatin binding |
| GO:0044877 | 0 | 5.0909 | 3.2008 | 13 | 905 | macromolecular complex binding |
| GO:0003677 | 0 | 3.7091 | 7.9543 | 21 | 2249 | DNA binding |
| GO:0032027 | 2e-04 | 146.25 | 0.0212 | 2 | 6 | myosin light chain binding |
| GO:0043250 | 0.0035 | Inf | 0.0035 | 1 | 1 | sodium-dependent organic anion transmembrane transporter activity |
| GO:0005178 | 0.0062 | 8.6299 | 0.3749 | 3 | 106 | integrin binding |
| GO:0001786 | 0.0068 | 17.6935 | 0.1238 | 2 | 35 | phosphatidylserine binding |
| GO:0008389 | 0.0071 | 287.0377 | 0.0071 | 1 | 2 | coumarin 7-hydroxylase activity |
| GO:0080019 | 0.0071 | 287.0377 | 0.0071 | 1 | 2 | fatty-acyl-CoA reductase (alcohol-forming) activity |
| GO:0102965 | 0.0071 | 287.0377 | 0.0071 | 1 | 2 | alcohol-forming fatty acyl-CoA reductase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 124.3898 | 0.1324 | 10 | 43 | nucleosomal DNA binding |
| GO:0042393 | 0 | 23.9285 | 0.5541 | 10 | 180 | histone binding |
| GO:0045296 | 0 | 16.4846 | 0.8866 | 11 | 288 | cadherin binding |
| GO:0003682 | 0 | 10.1224 | 1.4068 | 11 | 457 | chromatin binding |
| GO:0046982 | 0 | 10.1224 | 1.4068 | 11 | 457 | protein heterodimerization activity |
| GO:0044877 | 1e-04 | 4.8967 | 2.7859 | 11 | 905 | macromolecular complex binding |
| GO:0003677 | 2e-04 | 3.2977 | 6.9232 | 17 | 2249 | DNA binding |
| GO:0045519 | 0.0061 | 330.8696 | 0.0062 | 1 | 2 | interleukin-23 receptor binding |
| GO:0070851 | 0.0068 | 8.3692 | 0.3879 | 3 | 126 | growth factor receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008083 | 5e-04 | 12.1425 | 0.3729 | 4 | 146 | growth factor activity |
| GO:0030545 | 7e-04 | 6.3333 | 1.1009 | 6 | 431 | receptor regulator activity |
| GO:0005104 | 0.0018 | 35.7368 | 0.0639 | 2 | 25 | fibroblast growth factor receptor binding |
| GO:0001616 | 0.0026 | Inf | 0.0026 | 1 | 1 | growth hormone secretagogue receptor activity |
| GO:0004336 | 0.0026 | Inf | 0.0026 | 1 | 1 | galactosylceramidase activity |
| GO:0005144 | 0.0026 | Inf | 0.0026 | 1 | 1 | interleukin-13 receptor binding |
| GO:0008955 | 0.0026 | Inf | 0.0026 | 1 | 1 | peptidoglycan glycosyltransferase activity |
| GO:0030272 | 0.0026 | Inf | 0.0026 | 1 | 1 | 5-formyltetrahydrofolate cyclo-ligase activity |
| GO:0016303 | 0.0047 | 21.6088 | 0.1022 | 2 | 40 | 1-phosphatidylinositol-3-kinase activity |
| GO:0016520 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | growth hormone-releasing hormone receptor activity |
| GO:0047237 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity |
| GO:0004713 | 0.0092 | 7.516 | 0.4342 | 3 | 170 | protein tyrosine kinase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005158 | 0.002 | 33.942 | 0.0668 | 2 | 30 | insulin receptor binding |
| GO:0008613 | 0.0022 | Inf | 0.0022 | 1 | 1 | diuretic hormone activity |
| GO:0008843 | 0.0022 | Inf | 0.0022 | 1 | 1 | endochitinase activity |
| GO:0050337 | 0.0022 | Inf | 0.0022 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
| GO:0005102 | 0.0053 | 3.4921 | 2.7993 | 8 | 1333 | receptor binding |
| GO:0004351 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | glutamate decarboxylase activity |
| GO:0001875 | 0.0089 | 153.8485 | 0.0089 | 1 | 4 | lipopolysaccharide receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 14.0674 | 1.0249 | 11 | 326 | olfactory receptor activity |
| GO:0004930 | 0 | 6.1853 | 2.229 | 11 | 709 | G-protein coupled receptor activity |
| GO:0031492 | 3e-04 | 25.3 | 0.1352 | 3 | 43 | nucleosomal DNA binding |
| GO:0099600 | 5e-04 | 3.835 | 3.4771 | 11 | 1106 | transmembrane receptor activity |
| GO:0046982 | 5e-04 | 5.6038 | 1.4367 | 7 | 457 | protein heterodimerization activity |
| GO:0038023 | 8e-04 | 3.6271 | 3.6594 | 11 | 1164 | signaling receptor activity |
| GO:0005549 | 0.0019 | 13.4622 | 0.2452 | 3 | 78 | odorant binding |
| GO:0000210 | 0.0031 | Inf | 0.0031 | 1 | 1 | NAD+ diphosphatase activity |
| GO:0004838 | 0.0031 | Inf | 0.0031 | 1 | 1 | L-tyrosine:2-oxoglutarate aminotransferase activity |
| GO:0060089 | 0.0033 | 2.9816 | 4.3731 | 11 | 1391 | molecular transducer activity |
| GO:0003872 | 0.0094 | 161.8936 | 0.0094 | 1 | 3 | 6-phosphofructokinase activity |
| GO:0034714 | 0.0094 | 161.8936 | 0.0094 | 1 | 3 | type III transforming growth factor beta receptor binding |
| GO:0035939 | 0.0094 | 161.8936 | 0.0094 | 1 | 3 | microsatellite binding |
| GO:0080130 | 0.0094 | 161.8936 | 0.0094 | 1 | 3 | L-phenylalanine:2-oxoglutarate aminotransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 39.6807 | 0.5423 | 14 | 180 | histone binding |
| GO:0046982 | 0 | 14.5955 | 1.3769 | 14 | 457 | protein heterodimerization activity |
| GO:0019904 | 0 | 10.5339 | 1.871 | 14 | 621 | protein domain specific binding |
| GO:0003723 | 0 | 6.0164 | 4.8597 | 19 | 1613 | RNA binding |
| GO:0003677 | 0 | 4.899 | 6.7759 | 21 | 2249 | DNA binding |
| GO:1901363 | 0 | 3.4153 | 16.3446 | 30 | 5425 | heterocyclic compound binding |
| GO:0097159 | 1e-04 | 3.3437 | 16.5676 | 30 | 5499 | organic cyclic compound binding |
| GO:0004909 | 0.006 | 338.2444 | 0.006 | 1 | 2 | interleukin-1, Type I, activating receptor activity |
| GO:0071791 | 0.006 | 338.2444 | 0.006 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045127 | 0.0024 | Inf | 0.0024 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0030246 | 0.0024 | 7.8709 | 0.5695 | 4 | 235 | carbohydrate binding |
| GO:1990430 | 0.0073 | 211.5139 | 0.0073 | 1 | 3 | extracellular matrix protein binding |
| GO:0005518 | 0.009 | 15.212 | 0.143 | 2 | 59 | collagen binding |
| GO:0015333 | 0.0097 | 141 | 0.0097 | 1 | 4 | peptide:proton symporter activity |
| GO:0034584 | 0.0097 | 141 | 0.0097 | 1 | 4 | piRNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000224 | 0.003 | Inf | 0.003 | 1 | 1 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity |
| GO:0043914 | 0.003 | Inf | 0.003 | 1 | 1 | NADPH:sulfur oxidoreductase activity |
| GO:0004021 | 0.006 | 338.2444 | 0.006 | 1 | 2 | L-alanine:2-oxoglutarate aminotransferase activity |
| GO:0004674 | 0.0067 | 4.6016 | 1.1991 | 5 | 398 | protein serine/threonine kinase activity |
| GO:0004689 | 0.009 | 169.1111 | 0.009 | 1 | 3 | phosphorylase kinase activity |
| GO:0004937 | 0.009 | 169.1111 | 0.009 | 1 | 3 | alpha1-adrenergic receptor activity |
| GO:0042978 | 0.009 | 169.1111 | 0.009 | 1 | 3 | ornithine decarboxylase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 8e-04 | 7.7425 | 0.7473 | 5 | 326 | olfactory receptor activity |
| GO:0004744 | 0.0023 | Inf | 0.0023 | 1 | 1 | retinal isomerase activity |
| GO:0050479 | 0.0023 | Inf | 0.0023 | 1 | 1 | glyceryl-ether monooxygenase activity |
| GO:0052884 | 0.0023 | Inf | 0.0023 | 1 | 1 | all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity |
| GO:0052885 | 0.0023 | Inf | 0.0023 | 1 | 1 | all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity |
| GO:1902118 | 0.0023 | Inf | 0.0023 | 1 | 1 | calcidiol binding |
| GO:0005198 | 0.0028 | 4.8358 | 1.4465 | 6 | 631 | structural molecule activity |
| GO:0004458 | 0.0046 | 448 | 0.0046 | 1 | 2 | D-lactate dehydrogenase (cytochrome) activity |
| GO:0004930 | 0.005 | 4.2763 | 1.6253 | 6 | 709 | G-protein coupled receptor activity |
| GO:0008607 | 0.0091 | 149.3137 | 0.0092 | 1 | 4 | phosphorylase kinase regulator activity |
| GO:0010484 | 0.0091 | 149.3137 | 0.0092 | 1 | 4 | H3 histone acetyltransferase activity |
| GO:0015016 | 0.0091 | 149.3137 | 0.0092 | 1 | 4 | [heparan sulfate]-glucosamine N-sulfotransferase activity |
| GO:0031014 | 0.0091 | 149.3137 | 0.0092 | 1 | 4 | troponin T binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047961 | 1e-04 | 304.28 | 0.0136 | 2 | 4 | glycine N-acyltransferase activity |
| GO:0034237 | 0.0017 | 38 | 0.0613 | 2 | 18 | protein kinase A regulatory subunit binding |
| GO:0003677 | 0.0025 | 2.5841 | 7.6597 | 16 | 2249 | DNA binding |
| GO:0046872 | 0.0032 | 2.2898 | 12.6458 | 22 | 3713 | metal ion binding |
| GO:0015139 | 0.0034 | Inf | 0.0034 | 1 | 1 | alpha-ketoglutarate transmembrane transporter activity |
| GO:0030351 | 0.0034 | Inf | 0.0034 | 1 | 1 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity |
| GO:0033798 | 0.0034 | Inf | 0.0034 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:0034417 | 0.0034 | Inf | 0.0034 | 1 | 1 | bisphosphoglycerate 3-phosphatase activity |
| GO:0043924 | 0.0034 | Inf | 0.0034 | 1 | 1 | suramin binding |
| GO:0047946 | 0.0034 | Inf | 0.0034 | 1 | 1 | glutamine N-acyltransferase activity |
| GO:0052826 | 0.0034 | Inf | 0.0034 | 1 | 1 | inositol hexakisphosphate 2-phosphatase activity |
| GO:0005217 | 0.0038 | 24.3056 | 0.092 | 2 | 27 | intracellular ligand-gated ion channel activity |
| GO:0043167 | 0.0067 | 2.0692 | 18.7797 | 28 | 5514 | ion binding |
| GO:0031894 | 0.0068 | 298.3333 | 0.0068 | 1 | 2 | V1A vasopressin receptor binding |
| GO:0035403 | 0.0068 | 298.3333 | 0.0068 | 1 | 2 | histone kinase activity (H3-T6 specific) |
| GO:0051717 | 0.0068 | 298.3333 | 0.0068 | 1 | 2 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity |
| GO:0005080 | 0.009 | 15.176 | 0.143 | 2 | 42 | protein kinase C binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030246 | 0.0018 | 8.6597 | 0.5233 | 4 | 235 | carbohydrate binding |
| GO:0018455 | 0.0022 | Inf | 0.0022 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0035800 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | deubiquitinase activator activity |
| GO:0004090 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | carbonyl reductase (NADPH) activity |
| GO:0015252 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | hydrogen ion channel activity |
| GO:1990430 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | extracellular matrix protein binding |
| GO:0005518 | 0.0076 | 16.6414 | 0.1314 | 2 | 59 | collagen binding |
| GO:0000253 | 0.0089 | 153.8485 | 0.0089 | 1 | 4 | 3-keto sterol reductase activity |
| GO:0015333 | 0.0089 | 153.8485 | 0.0089 | 1 | 4 | peptide:proton symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009055 | 6e-04 | 20.8104 | 0.1662 | 3 | 94 | electron transfer activity |
| GO:0004964 | 0.0018 | Inf | 0.0018 | 1 | 1 | luteinizing hormone receptor activity |
| GO:0035472 | 0.0018 | Inf | 0.0018 | 1 | 1 | choriogonadotropin hormone receptor activity |
| GO:0038106 | 0.0018 | Inf | 0.0018 | 1 | 1 | choriogonadotropin hormone binding |
| GO:0004963 | 0.0035 | 586.1538 | 0.0035 | 1 | 2 | follicle-stimulating hormone receptor activity |
| GO:0000979 | 0.0041 | 23.3677 | 0.0955 | 2 | 54 | RNA polymerase II core promoter sequence-specific DNA binding |
| GO:0004471 | 0.0053 | 293.0577 | 0.0053 | 1 | 3 | malate dehydrogenase (decarboxylating) (NAD+) activity |
| GO:0004473 | 0.0053 | 293.0577 | 0.0053 | 1 | 3 | malate dehydrogenase (decarboxylating) (NADP+) activity |
| GO:0008948 | 0.0071 | 195.359 | 0.0071 | 1 | 4 | oxaloacetate decarboxylase activity |
| GO:0046982 | 0.0081 | 5.6773 | 0.8082 | 4 | 457 | protein heterodimerization activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016805 | 5e-04 | 73.1779 | 0.0334 | 2 | 15 | dipeptidase activity |
| GO:0043565 | 9e-04 | 4.6895 | 2.1066 | 8 | 946 | sequence-specific DNA binding |
| GO:0004181 | 0.0011 | 47.5438 | 0.049 | 2 | 22 | metallocarboxypeptidase activity |
| GO:0003721 | 0.0022 | Inf | 0.0022 | 1 | 1 | telomerase RNA reverse transcriptase activity |
| GO:0004102 | 0.0022 | Inf | 0.0022 | 1 | 1 | choline O-acetyltransferase activity |
| GO:0098680 | 0.0022 | Inf | 0.0022 | 1 | 1 | template-free RNA nucleotidyltransferase |
| GO:1904492 | 0.0022 | Inf | 0.0022 | 1 | 1 | Ac-Asp-Glu binding |
| GO:1904493 | 0.0022 | Inf | 0.0022 | 1 | 1 | tetrahydrofolyl-poly(glutamate) polymer binding |
| GO:0003700 | 0.0027 | 3.8962 | 2.5008 | 8 | 1123 | DNA binding transcription factor activity |
| GO:0070888 | 0.0027 | 28.7898 | 0.0779 | 2 | 35 | E-box binding |
| GO:0003968 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | RNA-directed 5'-3' RNA polymerase activity |
| GO:0052593 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | tryptamine:oxygen oxidoreductase (deaminating) activity |
| GO:0052594 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | aminoacetone:oxygen oxidoreductase(deaminating) activity |
| GO:0052595 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | aliphatic-amine oxidase activity |
| GO:0052596 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | phenethylamine:oxygen oxidoreductase (deaminating) activity |
| GO:0008237 | 0.0056 | 9.1173 | 0.363 | 3 | 163 | metallopeptidase activity |
| GO:0008131 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | primary amine oxidase activity |
| GO:0070139 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | SUMO-specific endopeptidase activity |
| GO:0000975 | 0.0069 | 3.9979 | 1.7392 | 6 | 781 | regulatory region DNA binding |
| GO:0001515 | 0.0089 | 153.8485 | 0.0089 | 1 | 4 | opioid peptide activity |
| GO:0001588 | 0.0089 | 153.8485 | 0.0089 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 27.8916 | 0.8114 | 14 | 326 | olfactory receptor activity |
| GO:0004930 | 0 | 12.1996 | 1.7646 | 14 | 709 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 8.452 | 2.7527 | 15 | 1106 | transmembrane receptor activity |
| GO:0038023 | 0 | 7.9924 | 2.897 | 15 | 1164 | signaling receptor activity |
| GO:0060089 | 0 | 6.5663 | 3.462 | 15 | 1391 | molecular transducer activity |
| GO:0005549 | 0 | 24.0954 | 0.1941 | 4 | 78 | odorant binding |
| GO:0039706 | 2e-04 | 120.8175 | 0.0224 | 2 | 9 | co-receptor binding |
| GO:0004744 | 0.0025 | Inf | 0.0025 | 1 | 1 | retinal isomerase activity |
| GO:0043250 | 0.0025 | Inf | 0.0025 | 1 | 1 | sodium-dependent organic anion transmembrane transporter activity |
| GO:0043914 | 0.0025 | Inf | 0.0025 | 1 | 1 | NADPH:sulfur oxidoreductase activity |
| GO:0052884 | 0.0025 | Inf | 0.0025 | 1 | 1 | all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity |
| GO:0052885 | 0.0025 | Inf | 0.0025 | 1 | 1 | all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity |
| GO:0008454 | 0.0074 | 205.7838 | 0.0075 | 1 | 3 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity |
| GO:0070405 | 0.0097 | 14.5326 | 0.1493 | 2 | 60 | ammonium ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 10.5549 | 0.8114 | 7 | 326 | olfactory receptor activity |
| GO:0001591 | 1e-04 | 211.4722 | 0.0149 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0004930 | 2e-04 | 5.7425 | 1.7112 | 8 | 706 | G-protein coupled receptor activity |
| GO:0035240 | 3e-04 | 105.7083 | 0.0249 | 2 | 10 | dopamine binding |
| GO:0099600 | 0.0013 | 3.9983 | 2.7527 | 9 | 1106 | transmembrane receptor activity |
| GO:0060089 | 0.0017 | 3.5815 | 3.462 | 10 | 1391 | molecular transducer activity |
| GO:0038023 | 0.0018 | 3.7819 | 2.897 | 9 | 1164 | signaling receptor activity |
| GO:0001605 | 0.0025 | Inf | 0.0025 | 1 | 1 | adrenomedullin receptor activity |
| GO:0001635 | 0.005 | 411.5946 | 0.005 | 1 | 2 | calcitonin gene-related peptide receptor activity |
| GO:0016509 | 0.005 | 411.5946 | 0.005 | 1 | 2 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
| GO:0004252 | 0.0073 | 8.2291 | 0.3982 | 3 | 160 | serine-type endopeptidase activity |
| GO:0003872 | 0.0074 | 205.7838 | 0.0075 | 1 | 3 | 6-phosphofructokinase activity |
| GO:0004948 | 0.0074 | 205.7838 | 0.0075 | 1 | 3 | calcitonin receptor activity |
| GO:0004965 | 0.0074 | 205.7838 | 0.0075 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0004321 | 0.0099 | 137.1802 | 0.01 | 1 | 4 | fatty-acyl-CoA synthase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001616 | 0.0032 | Inf | 0.0032 | 1 | 1 | growth hormone secretagogue receptor activity |
| GO:0005302 | 0.0032 | Inf | 0.0032 | 1 | 1 | L-tyrosine transmembrane transporter activity |
| GO:0017064 | 0.0032 | Inf | 0.0032 | 1 | 1 | fatty acid amide hydrolase activity |
| GO:0030977 | 0.0032 | Inf | 0.0032 | 1 | 1 | taurine binding |
| GO:0070287 | 0.0032 | Inf | 0.0032 | 1 | 1 | ferritin receptor activity |
| GO:0102077 | 0.0032 | Inf | 0.0032 | 1 | 1 | oleamide hydrolase activity |
| GO:0103073 | 0.0032 | Inf | 0.0032 | 1 | 1 | anandamide amidohydrolase activity |
| GO:0019785 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | ISG15-specific protease activity |
| GO:0031780 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | corticotropin hormone receptor binding |
| GO:0031783 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | type 5 melanocortin receptor binding |
| GO:0047057 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | vitamin-K-epoxide reductase (warfarin-sensitive) activity |
| GO:0005544 | 0.0069 | 17.4606 | 0.1252 | 2 | 39 | calcium-dependent phospholipid binding |
| GO:0052689 | 0.007 | 8.2755 | 0.3915 | 3 | 122 | carboxylic ester hydrolase activity |
| GO:0003872 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | 6-phosphofructokinase activity |
| GO:0004040 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | amidase activity |
| GO:0016520 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | growth hormone-releasing hormone receptor activity |
| GO:0016934 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | extracellularly glycine-gated chloride channel activity |
| GO:0031781 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | type 3 melanocortin receptor binding |
| GO:0031782 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | type 4 melanocortin receptor binding |
| GO:0070996 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | type 1 melanocortin receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070905 | 0.0043 | 476.0625 | 0.0043 | 1 | 2 | serine binding |
| GO:0001730 | 0.0065 | 238.0156 | 0.0065 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
| GO:0032190 | 0.0086 | 158.6667 | 0.0086 | 1 | 4 | acrosin binding |
| GO:0071987 | 0.0086 | 158.6667 | 0.0086 | 1 | 4 | WD40-repeat domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 32.5434 | 0.6248 | 14 | 180 | histone binding |
| GO:0019904 | 0 | 13.5649 | 2.1557 | 19 | 621 | protein domain specific binding |
| GO:0046982 | 0 | 15.857 | 1.5864 | 17 | 457 | protein heterodimerization activity |
| GO:0003677 | 0 | 3.8253 | 7.807 | 21 | 2249 | DNA binding |
| GO:0003723 | 1e-04 | 3.6875 | 5.5992 | 16 | 1613 | RNA binding |
| GO:1901363 | 5e-04 | 2.5656 | 18.8319 | 31 | 5425 | heterocyclic compound binding |
| GO:0097159 | 7e-04 | 2.5118 | 19.0887 | 31 | 5499 | organic cyclic compound binding |
| GO:0043027 | 0.0026 | 29.7941 | 0.0764 | 2 | 22 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
| GO:0001191 | 0.0065 | 18.0416 | 0.1215 | 2 | 35 | transcriptional repressor activity, RNA polymerase II transcription factor binding |
| GO:0005515 | 0.0083 | 3.0942 | 22.1879 | 29 | 9454 | protein binding |
| GO:0001228 | 0.0095 | 4.1793 | 1.3017 | 5 | 375 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060089 | 6e-04 | 3.3474 | 4.7375 | 13 | 1391 | molecular transducer activity |
| GO:0099600 | 0.0011 | 3.4599 | 3.7668 | 11 | 1106 | transmembrane receptor activity |
| GO:0038023 | 0.0016 | 3.2723 | 3.9644 | 11 | 1164 | signaling receptor activity |
| GO:0034237 | 0.0017 | 38 | 0.0613 | 2 | 18 | protein kinase A regulatory subunit binding |
| GO:0005516 | 0.0028 | 7.4643 | 0.5858 | 4 | 172 | calmodulin binding |
| GO:0034986 | 0.0034 | Inf | 0.0034 | 1 | 1 | iron chaperone activity |
| GO:0043924 | 0.0034 | Inf | 0.0034 | 1 | 1 | suramin binding |
| GO:0045127 | 0.0034 | Inf | 0.0034 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0005427 | 0.0068 | 298.3333 | 0.0068 | 1 | 2 | proton-dependent oligopeptide secondary active transmembrane transporter activity |
| GO:0008188 | 0.0086 | 15.5662 | 0.1396 | 2 | 41 | neuropeptide receptor activity |
| GO:0004930 | 0.0098 | 3.2161 | 2.4147 | 7 | 709 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047453 | 0.0016 | Inf | 0.0016 | 1 | 1 | ATP-dependent NAD(P)H-hydrate dehydratase activity |
| GO:0052855 | 0.0016 | Inf | 0.0016 | 1 | 1 | ADP-dependent NAD(P)H-hydrate dehydratase activity |
| GO:0097573 | 0.0016 | Inf | 0.0016 | 1 | 1 | glutathione oxidoreductase activity |
| GO:0008160 | 0.0033 | 635.0833 | 0.0033 | 1 | 2 | protein tyrosine phosphatase activator activity |
| GO:0004656 | 0.0065 | 211.6667 | 0.0065 | 1 | 4 | procollagen-proline 4-dioxygenase activity |
| GO:0015038 | 0.0065 | 211.6667 | 0.0065 | 1 | 4 | glutathione disulfide oxidoreductase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008331 | 3e-04 | 106.0488 | 0.0253 | 2 | 9 | high voltage-gated calcium channel activity |
| GO:0042923 | 0.0014 | 41.2114 | 0.0563 | 2 | 20 | neuropeptide binding |
| GO:0008843 | 0.0028 | Inf | 0.0028 | 1 | 1 | endochitinase activity |
| GO:0038062 | 0.0028 | Inf | 0.0028 | 1 | 1 | protein tyrosine kinase collagen receptor activity |
| GO:0047453 | 0.0028 | Inf | 0.0028 | 1 | 1 | ATP-dependent NAD(P)H-hydrate dehydratase activity |
| GO:0052855 | 0.0028 | Inf | 0.0028 | 1 | 1 | ADP-dependent NAD(P)H-hydrate dehydratase activity |
| GO:0086056 | 0.0056 | 362.4762 | 0.0056 | 1 | 2 | voltage-gated calcium channel activity involved in AV node cell action potential |
| GO:0008188 | 0.0059 | 18.9944 | 0.1155 | 2 | 41 | neuropeptide receptor activity |
| GO:0016618 | 0.0084 | 181.2262 | 0.0084 | 1 | 3 | hydroxypyruvate reductase activity |
| GO:0030267 | 0.0084 | 181.2262 | 0.0084 | 1 | 3 | glyoxylate reductase (NADP) activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003677 | 0.0028 | 2.6422 | 7.0705 | 15 | 2249 | DNA binding |
| GO:0061501 | 0.0031 | Inf | 0.0031 | 1 | 1 | cyclic-GMP-AMP synthase activity |
| GO:0061685 | 0.0031 | Inf | 0.0031 | 1 | 1 | diphthine methylesterase activity |
| GO:0004137 | 0.0063 | 323.8085 | 0.0063 | 1 | 2 | deoxycytidine kinase activity |
| GO:0045145 | 0.0063 | 323.8085 | 0.0063 | 1 | 2 | single-stranded DNA 5'-3' exodeoxyribonuclease activity |
| GO:0046899 | 0.0063 | 323.8085 | 0.0063 | 1 | 2 | nucleoside triphosphate adenylate kinase activity |
| GO:0003700 | 0.0075 | 2.9221 | 3.5305 | 9 | 1123 | DNA binding transcription factor activity |
| GO:0050682 | 0.0094 | 161.8936 | 0.0094 | 1 | 3 | AF-2 domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031995 | 2e-04 | 133.5263 | 0.021 | 2 | 8 | insulin-like growth factor II binding |
| GO:0031994 | 4e-04 | 80.0947 | 0.0314 | 2 | 12 | insulin-like growth factor I binding |
| GO:0031737 | 0.0026 | Inf | 0.0026 | 1 | 1 | CX3C chemokine receptor binding |
| GO:0036393 | 0.0026 | Inf | 0.0026 | 1 | 1 | thiocyanate peroxidase activity |
| GO:0047402 | 0.0026 | Inf | 0.0026 | 1 | 1 | protein-glucosylgalactosylhydroxylysine glucosidase activity |
| GO:0102797 | 0.0026 | Inf | 0.0026 | 1 | 1 | geranial:oxygen oxidoreductase activity |
| GO:0102798 | 0.0026 | Inf | 0.0026 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
| GO:0003989 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | acetyl-CoA carboxylase activity |
| GO:0004021 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | L-alanine:2-oxoglutarate aminotransferase activity |
| GO:0004031 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | aldehyde oxidase activity |
| GO:0008160 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | protein tyrosine phosphatase activator activity |
| GO:0008454 | 0.0078 | 195.2051 | 0.0079 | 1 | 3 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017064 | 0.0026 | Inf | 0.0026 | 1 | 1 | fatty acid amide hydrolase activity |
| GO:0018585 | 0.0026 | Inf | 0.0026 | 1 | 1 | fluorene oxygenase activity |
| GO:0050479 | 0.0026 | Inf | 0.0026 | 1 | 1 | glyceryl-ether monooxygenase activity |
| GO:0070287 | 0.0026 | Inf | 0.0026 | 1 | 1 | ferritin receptor activity |
| GO:0097655 | 0.0026 | Inf | 0.0026 | 1 | 1 | serpin family protein binding |
| GO:0102077 | 0.0026 | Inf | 0.0026 | 1 | 1 | oleamide hydrolase activity |
| GO:0103073 | 0.0026 | Inf | 0.0026 | 1 | 1 | anandamide amidohydrolase activity |
| GO:0043394 | 0.0026 | 29.3456 | 0.0766 | 2 | 30 | proteoglycan binding |
| GO:0001641 | 0.0051 | 400.7368 | 0.0051 | 1 | 2 | group II metabotropic glutamate receptor activity |
| GO:0042284 | 0.0051 | 400.7368 | 0.0051 | 1 | 2 | sphingolipid delta-4 desaturase activity |
| GO:0004040 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | amidase activity |
| GO:0030298 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | receptor signaling protein tyrosine kinase activator activity |
| GO:0031781 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 3 melanocortin receptor binding |
| GO:0031782 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 4 melanocortin receptor binding |
| GO:0070996 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 1 melanocortin receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050023 | 0.0022 | Inf | 0.0022 | 1 | 1 | L-fuconate dehydratase activity |
| GO:0008396 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | oxysterol 7-alpha-hydroxylase activity |
| GO:0008823 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | cupric reductase activity |
| GO:0033872 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity |
| GO:0052851 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | ferric-chelate reductase (NADPH) activity |
| GO:0030943 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | mitochondrion targeting sequence binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 115.0379 | 0.1408 | 10 | 43 | nucleosomal DNA binding |
| GO:0042393 | 0 | 22.1294 | 0.5895 | 10 | 180 | histone binding |
| GO:0045296 | 0 | 15.2135 | 0.9431 | 11 | 288 | cadherin binding |
| GO:0003682 | 0 | 9.3418 | 1.4966 | 11 | 457 | chromatin binding |
| GO:0046982 | 0 | 8.2612 | 1.4966 | 10 | 457 | protein heterodimerization activity |
| GO:0044877 | 0 | 5.0657 | 2.9637 | 12 | 905 | macromolecular complex binding |
| GO:0008569 | 0.0014 | 42.2306 | 0.0557 | 2 | 17 | ATP-dependent microtubule motor activity, minus-end-directed |
| GO:0003677 | 0.0016 | 2.7365 | 7.3651 | 16 | 2249 | DNA binding |
| GO:0045503 | 0.0025 | 30.1528 | 0.0753 | 2 | 23 | dynein light chain binding |
| GO:0045505 | 0.0032 | 26.3785 | 0.0851 | 2 | 26 | dynein intermediate chain binding |
| GO:0000334 | 0.0033 | Inf | 0.0033 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
| GO:0051959 | 0.0038 | 24.3462 | 0.0917 | 2 | 28 | dynein light intermediate chain binding |
| GO:0004909 | 0.0065 | 310.551 | 0.0065 | 1 | 2 | interleukin-1, Type I, activating receptor activity |
| GO:0008294 | 0.0065 | 310.551 | 0.0065 | 1 | 2 | calcium- and calmodulin-responsive adenylate cyclase activity |
| GO:0035800 | 0.0065 | 310.551 | 0.0065 | 1 | 2 | deubiquitinase activator activity |
| GO:0002020 | 0.0081 | 7.8334 | 0.4126 | 3 | 126 | protease binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004347 | 0.0026 | Inf | 0.0026 | 1 | 1 | glucose-6-phosphate isomerase activity |
| GO:0005509 | 0.0052 | 4.1931 | 1.6269 | 6 | 621 | calcium ion binding |
| GO:0005153 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | interleukin-8 receptor binding |
| GO:0008294 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | calcium- and calmodulin-responsive adenylate cyclase activity |
| GO:0008009 | 0.0056 | 19.4955 | 0.1127 | 2 | 43 | chemokine activity |
| GO:0047223 | 0.0078 | 195.2051 | 0.0079 | 1 | 3 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity |
| GO:0030276 | 0.0082 | 15.9768 | 0.1362 | 2 | 52 | clathrin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0047961 | 1e-04 | 292.5385 | 0.0141 | 2 | 4 | glycine N-acyltransferase activity |
| GO:0003677 | 5e-04 | 2.9097 | 7.9543 | 18 | 2249 | DNA binding |
| GO:0003700 | 0.0016 | 3.2441 | 3.9718 | 11 | 1123 | DNA binding transcription factor activity |
| GO:0034237 | 0.0018 | 36.5337 | 0.0637 | 2 | 18 | protein kinase A regulatory subunit binding |
| GO:0046872 | 0.0024 | 2.3171 | 13.1322 | 23 | 3713 | metal ion binding |
| GO:1990837 | 0.0024 | 3.787 | 2.3909 | 8 | 676 | sequence-specific double-stranded DNA binding |
| GO:0000977 | 0.0035 | 3.9338 | 1.9877 | 7 | 562 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0015139 | 0.0035 | Inf | 0.0035 | 1 | 1 | alpha-ketoglutarate transmembrane transporter activity |
| GO:0033798 | 0.0035 | Inf | 0.0035 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:0043924 | 0.0035 | Inf | 0.0035 | 1 | 1 | suramin binding |
| GO:0047946 | 0.0035 | Inf | 0.0035 | 1 | 1 | glutamine N-acyltransferase activity |
| GO:0005217 | 0.0041 | 23.3677 | 0.0955 | 2 | 27 | intracellular ligand-gated ion channel activity |
| GO:0044212 | 0.0057 | 3.2579 | 2.7552 | 8 | 779 | transcription regulatory region DNA binding |
| GO:0001067 | 0.0058 | 3.249 | 2.7622 | 8 | 781 | regulatory region nucleic acid binding |
| GO:0043167 | 0.0061 | 2.0575 | 19.502 | 29 | 5514 | ion binding |
| GO:0031894 | 0.0071 | 287.0377 | 0.0071 | 1 | 2 | V1A vasopressin receptor binding |
| GO:0035403 | 0.0071 | 287.0377 | 0.0071 | 1 | 2 | histone kinase activity (H3-T6 specific) |
| GO:0097159 | 0.0089 | 1.9951 | 19.0865 | 28 | 5498 | organic cyclic compound binding |
| GO:0000982 | 0.0096 | 4.1629 | 1.3051 | 5 | 369 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0005080 | 0.0097 | 14.5904 | 0.1485 | 2 | 42 | protein kinase C binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005184 | 0.0025 | 30.4344 | 0.0741 | 2 | 29 | neuropeptide hormone activity |
| GO:0004042 | 0.0026 | Inf | 0.0026 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
| GO:0004838 | 0.0026 | Inf | 0.0026 | 1 | 1 | L-tyrosine:2-oxoglutarate aminotransferase activity |
| GO:0017064 | 0.0026 | Inf | 0.0026 | 1 | 1 | fatty acid amide hydrolase activity |
| GO:0097655 | 0.0026 | Inf | 0.0026 | 1 | 1 | serpin family protein binding |
| GO:0102077 | 0.0026 | Inf | 0.0026 | 1 | 1 | oleamide hydrolase activity |
| GO:0103045 | 0.0026 | Inf | 0.0026 | 1 | 1 | methione N-acyltransferase activity |
| GO:0103073 | 0.0026 | Inf | 0.0026 | 1 | 1 | anandamide amidohydrolase activity |
| GO:0043394 | 0.0026 | 29.3456 | 0.0766 | 2 | 30 | proteoglycan binding |
| GO:0001641 | 0.0051 | 400.7368 | 0.0051 | 1 | 2 | group II metabotropic glutamate receptor activity |
| GO:0042284 | 0.0051 | 400.7368 | 0.0051 | 1 | 2 | sphingolipid delta-4 desaturase activity |
| GO:0098772 | 0.0058 | 2.9517 | 4.0946 | 10 | 1603 | molecular function regulator |
| GO:0016597 | 0.0069 | 17.4606 | 0.1252 | 2 | 49 | amino acid binding |
| GO:0004040 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | amidase activity |
| GO:0030298 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | receptor signaling protein tyrosine kinase activator activity |
| GO:0031781 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 3 melanocortin receptor binding |
| GO:0031782 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 4 melanocortin receptor binding |
| GO:0070996 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 1 melanocortin receptor binding |
| GO:0080130 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | L-phenylalanine:2-oxoglutarate aminotransferase activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019731 | 1e-04 | 13.4712 | 0.4336 | 5 | 38 | antibacterial humoral response |
| GO:0050832 | 1e-04 | 13.4712 | 0.4336 | 5 | 38 | defense response to fungus |
| GO:0051852 | 1e-04 | Inf | 0.0226 | 2 | 2 | disruption by host of symbiont cells |
| GO:0044657 | 1e-04 | Inf | 0.0228 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0052043 | 1e-04 | Inf | 0.0228 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 1e-04 | Inf | 0.0228 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 1e-04 | Inf | 0.0228 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0006955 | 3e-04 | 2.0322 | 19.9244 | 36 | 1782 | immune response |
| GO:1903238 | 4e-04 | 175.2111 | 0.0342 | 2 | 3 | positive regulation of leukocyte tethering or rolling |
| GO:0072676 | 4e-04 | 6.8584 | 0.9584 | 6 | 84 | lymphocyte migration |
| GO:0031640 | 4e-04 | 8.8814 | 0.6275 | 5 | 55 | killing of cells of other organism |
| GO:0002251 | 5e-04 | 12.634 | 0.3651 | 4 | 32 | organ or tissue specific immune response |
| GO:0050755 | 6e-04 | 22.0084 | 0.1711 | 3 | 15 | chemokine metabolic process |
| GO:0006952 | 0.001 | 1.9884 | 16.589 | 30 | 1454 | defense response |
| GO:0002227 | 0.0014 | 15.5304 | 0.2282 | 3 | 20 | innate immune response in mucosa |
| GO:0010818 | 0.0017 | 14.6667 | 0.2396 | 3 | 21 | T cell chemotaxis |
| GO:0043207 | 0.0017 | 2.2738 | 8.9905 | 19 | 788 | response to external biotic stimulus |
| GO:0001878 | 0.0019 | 43.7944 | 0.0685 | 2 | 6 | response to yeast |
| GO:0051673 | 0.0019 | 43.7944 | 0.0685 | 2 | 6 | membrane disruption in other organism |
| GO:0007606 | 0.0025 | 2.7547 | 4.6321 | 12 | 406 | sensory perception of chemical stimulus |
| GO:0042758 | 0.0026 | 35.0333 | 0.0799 | 2 | 7 | long-chain fatty acid catabolic process |
| GO:0070944 | 0.0026 | 35.0333 | 0.0799 | 2 | 7 | neutrophil mediated killing of bacterium |
| GO:0061844 | 0.0027 | 7.5176 | 0.5819 | 4 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0045730 | 0.0028 | 11.997 | 0.2852 | 3 | 25 | respiratory burst |
| GO:0050911 | 0.0031 | 2.9879 | 3.5483 | 10 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0070942 | 0.0035 | 29.1926 | 0.0913 | 2 | 8 | neutrophil mediated cytotoxicity |
| GO:0034368 | 0.0039 | 10.5553 | 0.3195 | 3 | 28 | protein-lipid complex remodeling |
| GO:0042742 | 0.0044 | 3.6403 | 2.0356 | 7 | 184 | defense response to bacterium |
| GO:0042355 | 0.0044 | 25.0206 | 0.1027 | 2 | 9 | L-fucose catabolic process |
| GO:0019730 | 0.0049 | 9.6583 | 0.3453 | 3 | 31 | antimicrobial humoral response |
| GO:0009593 | 0.005 | 2.6265 | 4.4268 | 11 | 388 | detection of chemical stimulus |
| GO:0070328 | 0.0057 | 9.0971 | 0.3651 | 3 | 32 | triglyceride homeostasis |
| GO:0050906 | 0.0063 | 2.5435 | 4.5637 | 11 | 400 | detection of stimulus involved in sensory perception |
| GO:0030595 | 0.0069 | 3.3333 | 2.2134 | 7 | 194 | leukocyte chemotaxis |
| GO:0045321 | 0.0073 | 1.8721 | 12.5616 | 22 | 1101 | leukocyte activation |
| GO:1904705 | 0.0073 | 8.2427 | 0.3993 | 3 | 35 | regulation of vascular smooth muscle cell proliferation |
| GO:0050801 | 0.0076 | 2.0875 | 8.1234 | 16 | 712 | ion homeostasis |
| GO:0051702 | 0.0076 | 5.5147 | 0.7758 | 4 | 68 | interaction with symbiont |
| GO:0051873 | 0.0079 | 17.5111 | 0.1369 | 2 | 12 | killing by host of symbiont cells |
| GO:0042119 | 0.0086 | 2.3285 | 5.4308 | 12 | 476 | neutrophil activation |
| GO:0034105 | 0.0092 | 7.5347 | 0.4336 | 3 | 38 | positive regulation of tissue remodeling |
| GO:0042398 | 0.0092 | 7.5347 | 0.4336 | 3 | 38 | cellular modified amino acid biosynthetic process |
| GO:0034374 | 0.0093 | 15.9182 | 0.1483 | 2 | 13 | low-density lipoprotein particle remodeling |
| GO:0045073 | 0.0093 | 15.9182 | 0.1483 | 2 | 13 | regulation of chemokine biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0098754 | 0 | 7.6542 | 1.1673 | 8 | 98 | detoxification |
| GO:0097237 | 0 | 7.249 | 1.2268 | 8 | 103 | cellular response to toxic substance |
| GO:0019430 | 1e-04 | 19.9178 | 0.2501 | 4 | 21 | removal of superoxide radicals |
| GO:0042744 | 1e-04 | 18.81 | 0.262 | 4 | 22 | hydrogen peroxide catabolic process |
| GO:0071450 | 1e-04 | 17.8189 | 0.2739 | 4 | 23 | cellular response to oxygen radical |
| GO:0000303 | 2e-04 | 15.3861 | 0.3097 | 4 | 26 | response to superoxide |
| GO:1902304 | 4e-04 | 167.6702 | 0.0357 | 2 | 3 | positive regulation of potassium ion export |
| GO:0042448 | 7e-04 | 21.0561 | 0.1787 | 3 | 15 | progesterone metabolic process |
| GO:0036293 | 7e-04 | 3.2122 | 4.002 | 12 | 336 | response to decreased oxygen levels |
| GO:0032835 | 7e-04 | 7.7184 | 0.7146 | 5 | 60 | glomerulus development |
| GO:1902949 | 8e-04 | 83.8298 | 0.0476 | 2 | 4 | positive regulation of tau-protein kinase activity |
| GO:0032024 | 0.0012 | 6.8439 | 0.798 | 5 | 67 | positive regulation of insulin secretion |
| GO:0070498 | 0.0016 | 14.8584 | 0.2382 | 3 | 20 | interleukin-1-mediated signaling pathway |
| GO:0000820 | 0.0021 | 41.9096 | 0.0715 | 2 | 6 | regulation of glutamine family amino acid metabolic process |
| GO:0007566 | 0.0025 | 7.6823 | 0.5717 | 4 | 48 | embryo implantation |
| GO:0002793 | 0.0027 | 3.2712 | 2.9181 | 9 | 245 | positive regulation of peptide secretion |
| GO:0033240 | 0.0028 | 33.5255 | 0.0834 | 2 | 7 | positive regulation of cellular amine metabolic process |
| GO:0051126 | 0.0028 | 33.5255 | 0.0834 | 2 | 7 | negative regulation of actin nucleation |
| GO:0071073 | 0.0028 | 33.5255 | 0.0834 | 2 | 7 | positive regulation of phospholipid biosynthetic process |
| GO:0071453 | 0.0034 | 3.4376 | 2.4655 | 8 | 207 | cellular response to oxygen levels |
| GO:0090594 | 0.0038 | 27.9362 | 0.0953 | 2 | 8 | inflammatory response to wounding |
| GO:0006979 | 0.004 | 2.5825 | 4.9191 | 12 | 413 | response to oxidative stress |
| GO:0042542 | 0.0046 | 4.1124 | 1.5484 | 6 | 130 | response to hydrogen peroxide |
| GO:0061314 | 0.0048 | 23.9438 | 0.1072 | 2 | 9 | Notch signaling involved in heart development |
| GO:0009749 | 0.0052 | 3.5293 | 2.0963 | 7 | 176 | response to glucose |
| GO:1902624 | 0.0053 | 9.3494 | 0.3573 | 3 | 30 | positive regulation of neutrophil migration |
| GO:0034284 | 0.007 | 3.33 | 2.2154 | 7 | 186 | response to monosaccharide |
| GO:0071456 | 0.0072 | 3.3113 | 2.2273 | 7 | 187 | cellular response to hypoxia |
| GO:1902514 | 0.0072 | 18.6206 | 0.131 | 2 | 11 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
| GO:0006699 | 0.0076 | 8.1409 | 0.405 | 3 | 34 | bile acid biosynthetic process |
| GO:1903532 | 0.0082 | 2.5741 | 4.0854 | 10 | 343 | positive regulation of secretion by cell |
| GO:0002090 | 0.0082 | 7.886 | 0.4169 | 3 | 35 | regulation of receptor internalization |
| GO:0051494 | 0.0084 | 4.2352 | 1.2498 | 5 | 106 | negative regulation of cytoskeleton organization |
| GO:0003184 | 0.0086 | 16.7574 | 0.1429 | 2 | 12 | pulmonary valve morphogenesis |
| GO:0098869 | 0.0086 | 5.3018 | 0.8056 | 4 | 69 | cellular oxidant detoxification |
| GO:0090276 | 0.0087 | 3.1859 | 2.3107 | 7 | 194 | regulation of peptide hormone secretion |
| GO:0047496 | 0.0089 | 7.6466 | 0.4288 | 3 | 36 | vesicle transport along microtubule |
| GO:1901700 | 0.0096 | 1.7021 | 17.6398 | 28 | 1481 | response to oxygen-containing compound |
| GO:0010817 | 0.0099 | 2.2783 | 5.5385 | 12 | 465 | regulation of hormone levels |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 235.8519 | 0.2787 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0034654 | 0 | 3.3001 | 62.5087 | 129 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0034645 | 0 | 3.0553 | 75.0817 | 140 | 4849 | cellular macromolecule biosynthetic process |
| GO:0007389 | 0 | 10.2194 | 3.4413 | 28 | 230 | pattern specification process |
| GO:0006335 | 0 | 52.3648 | 0.4955 | 14 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 42.833 | 0.5574 | 14 | 36 | chromatin silencing at rDNA |
| GO:2001141 | 0 | 3.6092 | 30.8549 | 78 | 2311 | regulation of RNA biosynthetic process |
| GO:0006355 | 0 | 3.6058 | 30.8776 | 78 | 2318 | regulation of transcription, DNA-templated |
| GO:0034080 | 0 | 36.2341 | 0.6194 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:0032502 | 0 | 3.2593 | 54.0503 | 107 | 3972 | developmental process |
| GO:0051290 | 0 | 31.3948 | 0.6813 | 14 | 44 | protein heterotetramerization |
| GO:1904837 | 0 | 31.3948 | 0.6813 | 14 | 44 | beta-catenin-TCF complex assembly |
| GO:0045944 | 0 | 4.0925 | 16.3975 | 54 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0009889 | 0 | 3.3257 | 35.3135 | 81 | 2671 | regulation of biosynthetic process |
| GO:0034724 | 0 | 25.4439 | 0.7897 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0009952 | 0 | 9.2727 | 3.0194 | 23 | 195 | anterior/posterior pattern specification |
| GO:0016233 | 0 | 22.9557 | 0.8516 | 14 | 55 | telomere capping |
| GO:1903508 | 0 | 3.4775 | 21.0427 | 59 | 1359 | positive regulation of nucleic acid-templated transcription |
| GO:0051254 | 0 | 3.3573 | 22.1421 | 60 | 1430 | positive regulation of RNA metabolic process |
| GO:0019219 | 0 | 3.0642 | 35.3594 | 78 | 2635 | regulation of nucleobase-containing compound metabolic process |
| GO:1901576 | 0 | 2.5054 | 93.1669 | 148 | 6017 | organic substance biosynthetic process |
| GO:0097659 | 0 | 3.225 | 28.6109 | 68 | 2221 | nucleic acid-templated transcription |
| GO:0006303 | 0 | 16.2097 | 1.1148 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0046483 | 0 | 2.4216 | 87.4688 | 140 | 5649 | heterocycle metabolic process |
| GO:0048863 | 0 | 9.0531 | 2.51 | 19 | 168 | stem cell differentiation |
| GO:0043044 | 0 | 15.4096 | 1.1613 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:0010628 | 0 | 3.1056 | 24.4259 | 61 | 1664 | positive regulation of gene expression |
| GO:0045596 | 0 | 4.371 | 9.693 | 36 | 626 | negative regulation of cell differentiation |
| GO:0010557 | 0 | 3.0472 | 24.573 | 61 | 1587 | positive regulation of macromolecule biosynthetic process |
| GO:0045815 | 0 | 14.4576 | 1.2232 | 14 | 79 | positive regulation of gene expression, epigenetic |
| GO:0006725 | 0 | 2.3576 | 88.0263 | 139 | 5685 | cellular aromatic compound metabolic process |
| GO:1902679 | 0 | 3.3747 | 17.373 | 49 | 1122 | negative regulation of RNA biosynthetic process |
| GO:1903707 | 0 | 9.8475 | 2.0748 | 17 | 134 | negative regulation of hemopoiesis |
| GO:1901360 | 0 | 2.342 | 91.216 | 142 | 5891 | organic cyclic compound metabolic process |
| GO:0034641 | 0 | 2.2995 | 96.1244 | 146 | 6208 | cellular nitrogen compound metabolic process |
| GO:0031497 | 0 | 8.9949 | 2.2452 | 17 | 145 | chromatin assembly |
| GO:0060173 | 0 | 8.0966 | 2.6168 | 18 | 169 | limb development |
| GO:0060255 | 0 | 2.6781 | 43.7501 | 83 | 3189 | regulation of macromolecule metabolic process |
| GO:0031328 | 0 | 2.7748 | 26.6479 | 61 | 1721 | positive regulation of cellular biosynthetic process |
| GO:0043009 | 0 | 4.2416 | 8.4388 | 31 | 545 | chordate embryonic development |
| GO:1902036 | 0 | 10.7864 | 1.5639 | 14 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 10.3097 | 1.6258 | 14 | 105 | regulation of gene silencing by miRNA |
| GO:0009890 | 0 | 2.7915 | 24.4801 | 57 | 1581 | negative regulation of biosynthetic process |
| GO:0045934 | 0 | 2.8954 | 20.8414 | 51 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0045814 | 0 | 9.0135 | 1.8271 | 14 | 118 | negative regulation of gene expression, epigenetic |
| GO:0001501 | 0 | 4.1796 | 7.3549 | 27 | 475 | skeletal system development |
| GO:0035107 | 0 | 7.7462 | 2.2452 | 15 | 145 | appendage morphogenesis |
| GO:0060968 | 0 | 8.2175 | 1.9819 | 14 | 128 | regulation of gene silencing |
| GO:0065007 | 0 | 2.5095 | 171.8719 | 210 | 11100 | biological regulation |
| GO:0000122 | 0 | 3.327 | 11.6594 | 34 | 753 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0035194 | 0 | 5.663 | 3.6078 | 18 | 233 | posttranscriptional gene silencing by RNA |
| GO:0045637 | 0 | 5.6365 | 3.6232 | 18 | 234 | regulation of myeloid cell differentiation |
| GO:0002244 | 0 | 6.3295 | 2.88 | 16 | 186 | hematopoietic progenitor cell differentiation |
| GO:0065004 | 0 | 5.8185 | 3.3136 | 17 | 214 | protein-DNA complex assembly |
| GO:0007399 | 0 | 2.7236 | 19.3677 | 45 | 1340 | nervous system development |
| GO:0016070 | 0 | 2.327 | 37.9588 | 69 | 2948 | RNA metabolic process |
| GO:0032200 | 0 | 6.2731 | 2.5239 | 14 | 163 | telomere organization |
| GO:2000026 | 0 | 2.9128 | 13.7544 | 35 | 963 | regulation of multicellular organismal development |
| GO:0071103 | 0 | 4.6641 | 4.0568 | 17 | 262 | DNA conformation change |
| GO:0048562 | 0 | 5.6581 | 2.7708 | 14 | 187 | embryonic organ morphogenesis |
| GO:0048731 | 0 | 2.8631 | 14.2544 | 34 | 1273 | system development |
| GO:0021953 | 0 | 5.6846 | 2.5549 | 13 | 165 | central nervous system neuron differentiation |
| GO:0051173 | 0 | 2.0037 | 43.2312 | 73 | 2792 | positive regulation of nitrogen compound metabolic process |
| GO:0048534 | 0 | 2.7694 | 12.8981 | 32 | 833 | hematopoietic or lymphoid organ development |
| GO:0030326 | 0 | 7.5719 | 1.5016 | 10 | 98 | embryonic limb morphogenesis |
| GO:0017148 | 0 | 4.009 | 4.9549 | 18 | 320 | negative regulation of translation |
| GO:0006352 | 0 | 4.6582 | 3.5613 | 15 | 230 | DNA-templated transcription, initiation |
| GO:0021517 | 0 | 12.6948 | 0.6658 | 7 | 43 | ventral spinal cord development |
| GO:0014031 | 0 | 9.3539 | 0.991 | 8 | 64 | mesenchymal cell development |
| GO:0048864 | 0 | 9.3539 | 0.991 | 8 | 64 | stem cell development |
| GO:0009954 | 0 | 15.6149 | 0.48 | 6 | 31 | proximal/distal pattern formation |
| GO:0048704 | 0 | 11.3518 | 0.7302 | 7 | 48 | embryonic skeletal system morphogenesis |
| GO:0021545 | 0 | 11.1431 | 0.7432 | 7 | 48 | cranial nerve development |
| GO:0048729 | 0 | 2.9262 | 9.3988 | 25 | 607 | tissue morphogenesis |
| GO:0014033 | 0 | 8.728 | 1.0529 | 8 | 68 | neural crest cell differentiation |
| GO:0048699 | 0 | 2.348 | 18.115 | 38 | 1199 | generation of neurons |
| GO:0010467 | 0 | 2.0228 | 40.791 | 66 | 3370 | gene expression |
| GO:0021515 | 0 | 10.3813 | 0.7897 | 7 | 51 | cell differentiation in spinal cord |
| GO:0007218 | 0 | 6.9491 | 1.4555 | 9 | 94 | neuropeptide signaling pathway |
| GO:0043388 | 0 | 9.9287 | 0.8206 | 7 | 53 | positive regulation of DNA binding |
| GO:0060485 | 0 | 4.2488 | 3.6078 | 14 | 233 | mesenchyme development |
| GO:0023061 | 0 | 3.316 | 6.2555 | 19 | 404 | signal release |
| GO:0051241 | 0 | 2.5253 | 13.1445 | 30 | 904 | negative regulation of multicellular organismal process |
| GO:0050794 | 0 | 2.0974 | 60.1076 | 84 | 4993 | regulation of cellular process |
| GO:0060850 | 0 | 32.5622 | 0.1843 | 4 | 12 | regulation of transcription involved in cell fate commitment |
| GO:0042475 | 0 | 7.0705 | 1.2697 | 8 | 82 | odontogenesis of dentin-containing tooth |
| GO:0006837 | 0 | 25.8354 | 0.2168 | 4 | 14 | serotonin transport |
| GO:0009888 | 1e-04 | 2.5259 | 11.8163 | 27 | 855 | tissue development |
| GO:0060537 | 1e-04 | 3.2713 | 5.6362 | 17 | 364 | muscle tissue development |
| GO:0048598 | 1e-04 | 3.7642 | 4.0434 | 14 | 288 | embryonic morphogenesis |
| GO:0044238 | 1e-04 | 1.7311 | 153.0898 | 182 | 9887 | primary metabolic process |
| GO:0060249 | 1e-04 | 3.2332 | 5.6981 | 17 | 368 | anatomical structure homeostasis |
| GO:0010605 | 1e-04 | 1.8285 | 39.3292 | 63 | 2540 | negative regulation of macromolecule metabolic process |
| GO:0048646 | 1e-04 | 2.3165 | 14.681 | 31 | 962 | anatomical structure formation involved in morphogenesis |
| GO:0051240 | 1e-04 | 2.1125 | 20.4676 | 39 | 1345 | positive regulation of multicellular organismal process |
| GO:0045892 | 1e-04 | 3.4721 | 4.6947 | 15 | 335 | negative regulation of transcription, DNA-templated |
| GO:0051094 | 1e-04 | 2.1493 | 18.4414 | 36 | 1191 | positive regulation of developmental process |
| GO:0006325 | 1e-04 | 2.5036 | 10.8543 | 25 | 701 | chromatin organization |
| GO:0034248 | 1e-04 | 2.7407 | 8.2994 | 21 | 536 | regulation of cellular amide metabolic process |
| GO:0042472 | 1e-04 | 6.0792 | 1.4555 | 8 | 94 | inner ear morphogenesis |
| GO:0003206 | 1e-04 | 5.2647 | 1.8736 | 9 | 121 | cardiac chamber morphogenesis |
| GO:0021536 | 1e-04 | 7.1281 | 1.0994 | 7 | 71 | diencephalon development |
| GO:0099537 | 1e-04 | 2.6249 | 9.0736 | 22 | 586 | trans-synaptic signaling |
| GO:1902866 | 1e-04 | 48.2613 | 0.1084 | 3 | 7 | regulation of retina development in camera-type eye |
| GO:0035050 | 1e-04 | 7.0179 | 1.1148 | 7 | 72 | embryonic heart tube development |
| GO:0009893 | 1e-04 | 3.4634 | 4.4161 | 14 | 334 | positive regulation of metabolic process |
| GO:0003215 | 2e-04 | 17.2181 | 0.2942 | 4 | 19 | cardiac right ventricle morphogenesis |
| GO:0015837 | 2e-04 | 39.2435 | 0.1219 | 3 | 8 | amine transport |
| GO:0035137 | 2e-04 | 39.0249 | 0.1226 | 3 | 8 | hindlimb morphogenesis |
| GO:0007610 | 2e-04 | 2.6565 | 8.119 | 20 | 530 | behavior |
| GO:0007492 | 2e-04 | 6.4224 | 1.2077 | 7 | 78 | endoderm development |
| GO:0033693 | 2e-04 | Inf | 0.031 | 2 | 2 | neurofilament bundle assembly |
| GO:0060577 | 2e-04 | Inf | 0.031 | 2 | 2 | pulmonary vein morphogenesis |
| GO:0061379 | 2e-04 | Inf | 0.031 | 2 | 2 | inferior colliculus development |
| GO:0002682 | 3e-04 | 1.983 | 21.0117 | 38 | 1357 | regulation of immune system process |
| GO:0048468 | 3e-04 | 1.8589 | 27.445 | 46 | 1824 | cell development |
| GO:0035136 | 3e-04 | 9.523 | 0.6039 | 5 | 39 | forelimb morphogenesis |
| GO:0072359 | 4e-04 | 2.1305 | 14.7407 | 29 | 952 | circulatory system development |
| GO:0021520 | 4e-04 | 27.7987 | 0.1536 | 3 | 10 | spinal cord motor neuron cell fate specification |
| GO:0048935 | 4e-04 | 27.7987 | 0.1536 | 3 | 10 | peripheral nervous system neuron development |
| GO:0007420 | 4e-04 | 2.375 | 9.9562 | 22 | 643 | brain development |
| GO:0046887 | 4e-04 | 4.834 | 1.7961 | 8 | 116 | positive regulation of hormone secretion |
| GO:0009790 | 5e-04 | 3.1748 | 4.3975 | 13 | 331 | embryo development |
| GO:0003231 | 5e-04 | 4.7455 | 1.8271 | 8 | 118 | cardiac ventricle development |
| GO:0022414 | 5e-04 | 1.9376 | 20.2375 | 36 | 1307 | reproductive process |
| GO:0060573 | 6e-04 | 24.1245 | 0.1703 | 3 | 11 | cell fate specification involved in pattern specification |
| GO:0048701 | 6e-04 | 8.2994 | 0.6813 | 5 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0033555 | 6e-04 | 6.3849 | 1.0374 | 6 | 67 | multicellular organismal response to stress |
| GO:0019233 | 6e-04 | 5.2971 | 1.44 | 7 | 93 | sensory perception of pain |
| GO:0030855 | 6e-04 | 2.2653 | 10.9007 | 23 | 704 | epithelial cell differentiation |
| GO:0009953 | 7e-04 | 5.1761 | 1.471 | 7 | 95 | dorsal/ventral pattern formation |
| GO:0050905 | 7e-04 | 5.1761 | 1.471 | 7 | 95 | neuromuscular process |
| GO:0035270 | 7e-04 | 4.4983 | 1.92 | 8 | 124 | endocrine system development |
| GO:0021524 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | visceral motor neuron differentiation |
| GO:0021912 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0035880 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | embryonic nail plate morphogenesis |
| GO:0048936 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | peripheral nervous system neuron axonogenesis |
| GO:0060913 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | cardiac cell fate determination |
| GO:0061031 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | endodermal digestive tract morphogenesis |
| GO:1902869 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | regulation of amacrine cell differentiation |
| GO:0051960 | 7e-04 | 2.192 | 11.7523 | 24 | 759 | regulation of nervous system development |
| GO:0060706 | 7e-04 | 11.2235 | 0.4181 | 4 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0045165 | 8e-04 | 3.65 | 2.9333 | 10 | 196 | cell fate commitment |
| GO:0050432 | 9e-04 | 7.5255 | 0.7432 | 5 | 48 | catecholamine secretion |
| GO:0060562 | 9e-04 | 2.974 | 4.6607 | 13 | 301 | epithelial tube morphogenesis |
| GO:0008217 | 0.001 | 3.8186 | 2.5239 | 9 | 163 | regulation of blood pressure |
| GO:0051259 | 0.001 | 2.4305 | 7.8968 | 18 | 510 | protein oligomerization |
| GO:0090596 | 0.001 | 4.7923 | 1.5787 | 7 | 104 | sensory organ morphogenesis |
| GO:0001755 | 0.0011 | 10.0057 | 0.461 | 4 | 30 | neural crest cell migration |
| GO:0001764 | 0.0011 | 4.1721 | 2.0594 | 8 | 133 | neuron migration |
| GO:0035150 | 0.0012 | 4.1387 | 2.0748 | 8 | 134 | regulation of tube size |
| GO:0008284 | 0.0013 | 2.0681 | 12.9446 | 25 | 836 | positive regulation of cell proliferation |
| GO:0001569 | 0.0013 | 9.5583 | 0.48 | 4 | 31 | branching involved in blood vessel morphogenesis |
| GO:0009887 | 0.0013 | 2.4487 | 7.4166 | 17 | 533 | animal organ morphogenesis |
| GO:0043583 | 0.0013 | 3.3736 | 3.1587 | 10 | 204 | ear development |
| GO:0007198 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0021855 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | hypothalamus cell migration |
| GO:0021913 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0034287 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | detection of monosaccharide stimulus |
| GO:0051594 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | detection of glucose |
| GO:0061325 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0070253 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | somatostatin secretion |
| GO:0060579 | 0.0015 | 16.0789 | 0.2323 | 3 | 15 | ventral spinal cord interneuron fate commitment |
| GO:0001662 | 0.0016 | 8.898 | 0.511 | 4 | 33 | behavioral fear response |
| GO:0061458 | 0.0017 | 2.539 | 6.271 | 15 | 405 | reproductive system development |
| GO:0010608 | 0.0017 | 2.2066 | 9.6465 | 20 | 623 | posttranscriptional regulation of gene expression |
| GO:0060413 | 0.0018 | 14.8411 | 0.2477 | 3 | 16 | atrial septum morphogenesis |
| GO:0060841 | 0.0018 | 14.8411 | 0.2477 | 3 | 16 | venous blood vessel development |
| GO:0048644 | 0.0018 | 5.053 | 1.2852 | 6 | 83 | muscle organ morphogenesis |
| GO:0007519 | 0.0018 | 3.835 | 2.2277 | 8 | 145 | skeletal muscle tissue development |
| GO:0007548 | 0.0018 | 3.0162 | 3.871 | 11 | 250 | sex differentiation |
| GO:0001667 | 0.0018 | 2.8499 | 4.4672 | 12 | 295 | ameboidal-type cell migration |
| GO:0001947 | 0.0019 | 6.2194 | 0.8826 | 5 | 57 | heart looping |
| GO:0007268 | 0.0019 | 2.2944 | 8.3372 | 18 | 546 | chemical synaptic transmission |
| GO:0007368 | 0.0019 | 4.2922 | 1.7497 | 7 | 113 | determination of left/right symmetry |
| GO:0003230 | 0.002 | 8.3228 | 0.5419 | 4 | 35 | cardiac atrium development |
| GO:0060795 | 0.002 | 8.3228 | 0.5419 | 4 | 35 | cell fate commitment involved in formation of primary germ layer |
| GO:0045995 | 0.0021 | 4.2122 | 1.7807 | 7 | 115 | regulation of embryonic development |
| GO:0033189 | 0.0021 | 13.7802 | 0.2632 | 3 | 17 | response to vitamin A |
| GO:0048486 | 0.0021 | 13.7802 | 0.2632 | 3 | 17 | parasympathetic nervous system development |
| GO:0051047 | 0.0021 | 2.5612 | 5.791 | 14 | 374 | positive regulation of secretion |
| GO:0071542 | 0.0022 | 8.0622 | 0.5574 | 4 | 36 | dopaminergic neuron differentiation |
| GO:0002074 | 0.0023 | 42.7265 | 0.0774 | 2 | 5 | extraocular skeletal muscle development |
| GO:0014060 | 0.0023 | 42.7265 | 0.0774 | 2 | 5 | regulation of epinephrine secretion |
| GO:0035609 | 0.0023 | 42.7265 | 0.0774 | 2 | 5 | C-terminal protein deglutamylation |
| GO:0048880 | 0.0023 | 42.7265 | 0.0774 | 2 | 5 | sensory system development |
| GO:0007498 | 0.0025 | 4.0607 | 1.8426 | 7 | 119 | mesoderm development |
| GO:0051932 | 0.0027 | 7.587 | 0.5884 | 4 | 38 | synaptic transmission, GABAergic |
| GO:0003018 | 0.0029 | 3.5427 | 2.4 | 8 | 155 | vascular process in circulatory system |
| GO:0010002 | 0.003 | 12.0561 | 0.2942 | 3 | 19 | cardioblast differentiation |
| GO:0009799 | 0.003 | 3.9196 | 1.9045 | 7 | 123 | specification of symmetry |
| GO:0035282 | 0.003 | 4.5216 | 1.4245 | 6 | 92 | segmentation |
| GO:0055008 | 0.0031 | 5.4791 | 0.991 | 5 | 64 | cardiac muscle tissue morphogenesis |
| GO:0048665 | 0.0033 | 11.5777 | 0.3037 | 3 | 20 | neuron fate specification |
| GO:1904888 | 0.0033 | 11.5548 | 0.3042 | 3 | 20 | cranial skeletal system development |
| GO:0097746 | 0.0033 | 3.8527 | 1.9355 | 7 | 125 | regulation of blood vessel diameter |
| GO:0003278 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0009996 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | negative regulation of cell fate specification |
| GO:0010871 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | negative regulation of receptor biosynthetic process |
| GO:0014062 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | regulation of serotonin secretion |
| GO:0021546 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | rhombomere development |
| GO:0038031 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
| GO:0048241 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | epinephrine transport |
| GO:0060022 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | hard palate development |
| GO:0007210 | 0.0034 | 11.3462 | 0.3097 | 3 | 20 | serotonin receptor signaling pathway |
| GO:0045109 | 0.0034 | 11.3462 | 0.3097 | 3 | 20 | intermediate filament organization |
| GO:0060039 | 0.0034 | 11.3462 | 0.3097 | 3 | 20 | pericardium development |
| GO:0021761 | 0.0036 | 4.3683 | 1.471 | 6 | 95 | limbic system development |
| GO:0048565 | 0.0036 | 3.788 | 1.9665 | 7 | 127 | digestive tract development |
| GO:0048514 | 0.0037 | 2.1933 | 8.191 | 17 | 529 | blood vessel morphogenesis |
| GO:0007517 | 0.0038 | 2.7307 | 4.2523 | 11 | 280 | muscle organ development |
| GO:0043433 | 0.0038 | 3.7565 | 1.9819 | 7 | 128 | negative regulation of DNA binding transcription factor activity |
| GO:0008406 | 0.0039 | 3.0879 | 3.0813 | 9 | 199 | gonad development |
| GO:0050768 | 0.0039 | 2.877 | 3.6697 | 10 | 237 | negative regulation of neurogenesis |
| GO:0045103 | 0.004 | 6.7867 | 0.6503 | 4 | 42 | intermediate filament-based process |
| GO:0003279 | 0.004 | 4.2718 | 1.5019 | 6 | 97 | cardiac septum development |
| GO:0010842 | 0.004 | 10.7152 | 0.3252 | 3 | 21 | retina layer formation |
| GO:0015874 | 0.004 | 10.7152 | 0.3252 | 3 | 21 | norepinephrine transport |
| GO:0031290 | 0.004 | 10.7152 | 0.3252 | 3 | 21 | retinal ganglion cell axon guidance |
| GO:0048485 | 0.004 | 10.7152 | 0.3252 | 3 | 21 | sympathetic nervous system development |
| GO:0043043 | 0.0041 | 1.9634 | 11.8762 | 22 | 767 | peptide biosynthetic process |
| GO:0010594 | 0.0043 | 3.6649 | 2.0284 | 7 | 131 | regulation of endothelial cell migration |
| GO:0050796 | 0.0045 | 3.2728 | 2.5858 | 8 | 167 | regulation of insulin secretion |
| GO:0007422 | 0.0046 | 4.9714 | 1.0839 | 5 | 70 | peripheral nervous system development |
| GO:0003253 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0003357 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | noradrenergic neuron differentiation |
| GO:0033504 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | floor plate development |
| GO:0098700 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | neurotransmitter loading into synaptic vesicle |
| GO:1902513 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | regulation of organelle transport along microtubule |
| GO:2000049 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:2000542 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | negative regulation of gastrulation |
| GO:0014013 | 0.0048 | 4.0908 | 1.5639 | 6 | 101 | regulation of gliogenesis |
| GO:0001707 | 0.0049 | 4.8958 | 1.0994 | 5 | 71 | mesoderm formation |
| GO:0090132 | 0.0051 | 2.7657 | 3.8091 | 10 | 246 | epithelium migration |
| GO:0003151 | 0.0051 | 6.2585 | 0.6991 | 4 | 46 | outflow tract morphogenesis |
| GO:0045686 | 0.0052 | 9.6424 | 0.3561 | 3 | 23 | negative regulation of glial cell differentiation |
| GO:0006281 | 0.0052 | 2.169 | 7.7729 | 16 | 502 | DNA repair |
| GO:0042310 | 0.0055 | 4.7512 | 1.1303 | 5 | 73 | vasoconstriction |
| GO:0051952 | 0.0055 | 4.7512 | 1.1303 | 5 | 73 | regulation of amine transport |
| GO:0035987 | 0.0055 | 6.1387 | 0.7123 | 4 | 46 | endodermal cell differentiation |
| GO:0030154 | 0.0055 | 1.905 | 13.0802 | 23 | 1081 | cell differentiation |
| GO:0032101 | 0.0056 | 1.971 | 10.7149 | 20 | 692 | regulation of response to external stimulus |
| GO:0035295 | 0.0056 | 2.3644 | 5.7882 | 13 | 387 | tube development |
| GO:0048522 | 0.0058 | 1.4628 | 56.8071 | 74 | 3868 | positive regulation of cellular process |
| GO:0009914 | 0.0058 | 2.5703 | 4.5018 | 11 | 293 | hormone transport |
| GO:0021511 | 0.0058 | 9.1827 | 0.3716 | 3 | 24 | spinal cord patterning |
| GO:0035640 | 0.0058 | 9.1827 | 0.3716 | 3 | 24 | exploration behavior |
| GO:0042481 | 0.0058 | 9.1827 | 0.3716 | 3 | 24 | regulation of odontogenesis |
| GO:0043279 | 0.0061 | 3.8851 | 1.6413 | 6 | 106 | response to alkaloid |
| GO:0007187 | 0.0062 | 3.0956 | 2.7252 | 8 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0022603 | 0.0063 | 1.8098 | 14.6323 | 25 | 945 | regulation of anatomical structure morphogenesis |
| GO:0045916 | 0.0063 | 21.3592 | 0.1239 | 2 | 8 | negative regulation of complement activation |
| GO:0007267 | 0.0064 | 1.7694 | 16.248 | 27 | 1108 | cell-cell signaling |
| GO:0008344 | 0.0065 | 4.5495 | 1.1768 | 5 | 76 | adult locomotory behavior |
| GO:0031016 | 0.0065 | 4.5495 | 1.1768 | 5 | 76 | pancreas development |
| GO:0001945 | 0.0066 | 8.7647 | 0.3871 | 3 | 25 | lymph vessel development |
| GO:0003148 | 0.0066 | 8.7647 | 0.3871 | 3 | 25 | outflow tract septum morphogenesis |
| GO:0048592 | 0.0067 | 3.3639 | 2.1987 | 7 | 142 | eye morphogenesis |
| GO:0050886 | 0.0068 | 4.4861 | 1.1923 | 5 | 77 | endocrine process |
| GO:0010575 | 0.0073 | 8.3831 | 0.4026 | 3 | 26 | positive regulation of vascular endothelial growth factor production |
| GO:0007275 | 0.0076 | 2.7983 | 3.4512 | 9 | 365 | multicellular organism development |
| GO:0002011 | 0.0079 | 5.4839 | 0.7897 | 4 | 51 | morphogenesis of an epithelial sheet |
| GO:0003158 | 0.0079 | 3.6637 | 1.7342 | 6 | 112 | endothelium development |
| GO:0001714 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | endodermal cell fate specification |
| GO:0003266 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | regulation of secondary heart field cardioblast proliferation |
| GO:0008343 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | adult feeding behavior |
| GO:0021603 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | cranial nerve formation |
| GO:0042363 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | fat-soluble vitamin catabolic process |
| GO:0048617 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | embryonic foregut morphogenesis |
| GO:0060100 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | positive regulation of phagocytosis, engulfment |
| GO:0060363 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | cranial suture morphogenesis |
| GO:0070472 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | regulation of uterine smooth muscle contraction |
| GO:2000543 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | positive regulation of gastrulation |
| GO:0034103 | 0.008 | 4.3058 | 1.2387 | 5 | 80 | regulation of tissue remodeling |
| GO:0003016 | 0.0082 | 8.0333 | 0.4181 | 3 | 27 | respiratory system process |
| GO:0061311 | 0.0082 | 8.0333 | 0.4181 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0071295 | 0.0082 | 8.0333 | 0.4181 | 3 | 27 | cellular response to vitamin |
| GO:1903530 | 0.0086 | 1.9584 | 9.6642 | 18 | 629 | regulation of secretion by cell |
| GO:0003008 | 0.0088 | 1.5746 | 26.5271 | 39 | 1759 | system process |
| GO:0010634 | 0.009 | 3.5622 | 1.7807 | 6 | 115 | positive regulation of epithelial cell migration |
| GO:0035116 | 0.009 | 7.7115 | 0.4336 | 3 | 28 | embryonic hindlimb morphogenesis |
| GO:0009798 | 0.0093 | 4.1394 | 1.2852 | 5 | 83 | axis specification |
| GO:0003263 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | cardioblast proliferation |
| GO:0010960 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | magnesium ion homeostasis |
| GO:0032769 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | negative regulation of monooxygenase activity |
| GO:0045713 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | low-density lipoprotein particle receptor biosynthetic process |
| GO:0061072 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | iris morphogenesis |
| GO:1905205 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | positive regulation of connective tissue replacement |
| GO:0048870 | 0.0099 | 1.6174 | 21.6775 | 33 | 1400 | cell motility |
| GO:0003203 | 0.01 | 7.4144 | 0.449 | 3 | 29 | endocardial cushion morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001141 | 0 | 4.7682 | 57.4606 | 149 | 3433 | regulation of RNA biosynthetic process |
| GO:0019219 | 0 | 4.1571 | 66.6328 | 153 | 3981 | regulation of nucleobase-containing compound metabolic process |
| GO:0034654 | 0 | 4.0778 | 67.5701 | 153 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0060255 | 0 | 3.3552 | 95.8904 | 173 | 5729 | regulation of macromolecule metabolic process |
| GO:0045944 | 0 | 4.8582 | 17.7252 | 66 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
| GO:1903508 | 0 | 4.2132 | 22.7466 | 73 | 1359 | positive regulation of nucleic acid-templated transcription |
| GO:0009889 | 0 | 3.8504 | 38.2872 | 95 | 2671 | regulation of biosynthetic process |
| GO:0051254 | 0 | 4.0516 | 23.9349 | 74 | 1430 | positive regulation of RNA metabolic process |
| GO:0031328 | 0 | 3.5938 | 28.8056 | 79 | 1721 | positive regulation of cellular biosynthetic process |
| GO:0009952 | 0 | 13.818 | 2.16 | 23 | 132 | anterior/posterior pattern specification |
| GO:0046483 | 0 | 2.8675 | 94.5513 | 162 | 5649 | heterocycle metabolic process |
| GO:0010557 | 0 | 3.6616 | 26.5628 | 75 | 1587 | positive regulation of macromolecule biosynthetic process |
| GO:0006725 | 0 | 2.8388 | 95.1539 | 162 | 5685 | cellular aromatic compound metabolic process |
| GO:1901360 | 0 | 2.8135 | 98.6019 | 165 | 5891 | organic cyclic compound metabolic process |
| GO:0010628 | 0 | 3.4102 | 29.1738 | 77 | 1743 | positive regulation of gene expression |
| GO:1901576 | 0 | 2.6321 | 100.7108 | 163 | 6017 | organic substance biosynthetic process |
| GO:0034641 | 0 | 2.5811 | 103.9077 | 165 | 6208 | cellular nitrogen compound metabolic process |
| GO:0034645 | 0 | 2.9073 | 49.3929 | 98 | 3436 | cellular macromolecule biosynthetic process |
| GO:1903507 | 0 | 3.5578 | 18.763 | 55 | 1121 | negative regulation of nucleic acid-templated transcription |
| GO:0000122 | 0 | 4.1677 | 12.6035 | 44 | 753 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0097659 | 0 | 3.7067 | 19.3346 | 54 | 1567 | nucleic acid-templated transcription |
| GO:0051173 | 0 | 2.6598 | 46.7317 | 95 | 2792 | positive regulation of nitrogen compound metabolic process |
| GO:0051253 | 0 | 3.3101 | 20.0016 | 55 | 1195 | negative regulation of RNA metabolic process |
| GO:0048704 | 0 | 20.7291 | 0.7936 | 12 | 48 | embryonic skeletal system morphogenesis |
| GO:0032502 | 0 | 2.7436 | 41.3415 | 80 | 3089 | developmental process |
| GO:2000113 | 0 | 2.9113 | 23.8178 | 58 | 1423 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0006355 | 0 | 3.5457 | 15.7489 | 44 | 1351 | regulation of transcription, DNA-templated |
| GO:0009890 | 0 | 2.7595 | 26.4623 | 61 | 1581 | negative regulation of biosynthetic process |
| GO:0007498 | 0 | 8.9177 | 1.9918 | 15 | 119 | mesoderm development |
| GO:0050793 | 0 | 2.352 | 38.6474 | 75 | 2309 | regulation of developmental process |
| GO:0035295 | 0 | 4.3973 | 6.1806 | 24 | 387 | tube development |
| GO:0035107 | 0 | 7.1223 | 2.427 | 15 | 145 | appendage morphogenesis |
| GO:0010629 | 0 | 2.4248 | 29.5923 | 61 | 1768 | negative regulation of gene expression |
| GO:0048729 | 0 | 3.8241 | 7.9684 | 27 | 491 | tissue morphogenesis |
| GO:0044238 | 0 | 2.0944 | 165.4858 | 206 | 9887 | primary metabolic process |
| GO:0060485 | 0 | 5.861 | 3.092 | 16 | 187 | mesenchyme development |
| GO:0060173 | 0 | 6.003 | 2.8287 | 15 | 169 | limb development |
| GO:0016070 | 0 | 2.4764 | 27.8197 | 55 | 2249 | RNA metabolic process |
| GO:0048562 | 0 | 5.7044 | 2.9595 | 15 | 187 | embryonic organ morphogenesis |
| GO:0010467 | 0 | 2.3638 | 28.5619 | 54 | 2303 | gene expression |
| GO:0021546 | 0 | 119.2624 | 0.1004 | 4 | 6 | rhombomere development |
| GO:0048935 | 0 | 37.3974 | 0.2176 | 5 | 13 | peripheral nervous system neuron development |
| GO:0007399 | 0 | 3.183 | 9.1747 | 26 | 631 | nervous system development |
| GO:0001763 | 0 | 5.244 | 2.9753 | 14 | 179 | morphogenesis of a branching structure |
| GO:0045165 | 0 | 4.8254 | 3.4492 | 15 | 212 | cell fate commitment |
| GO:0006837 | 0 | 33.24 | 0.2343 | 5 | 14 | serotonin transport |
| GO:0045596 | 0 | 2.9557 | 10.4778 | 28 | 626 | negative regulation of cell differentiation |
| GO:0021675 | 0 | 8.6501 | 1.2051 | 9 | 72 | nerve development |
| GO:0072358 | 0 | 2.8854 | 10.7121 | 28 | 640 | cardiovascular system development |
| GO:0019233 | 0 | 7.3142 | 1.5566 | 10 | 93 | sensory perception of pain |
| GO:0007218 | 0 | 7.2267 | 1.5733 | 10 | 94 | neuropeptide signaling pathway |
| GO:0001568 | 0 | 2.9298 | 10.1598 | 27 | 607 | blood vessel development |
| GO:0003151 | 0 | 8.3828 | 1.2386 | 9 | 74 | outflow tract morphogenesis |
| GO:0007420 | 0 | 3.0388 | 9.0611 | 25 | 555 | brain development |
| GO:0023061 | 0 | 3.4106 | 6.762 | 21 | 404 | signal release |
| GO:0022414 | 0 | 3.5252 | 6.2566 | 20 | 392 | reproductive process |
| GO:0048870 | 0 | 2.203 | 23.4328 | 46 | 1400 | cell motility |
| GO:0030855 | 0 | 2.7096 | 11.7834 | 29 | 704 | epithelial cell differentiation |
| GO:0009887 | 0 | 3.6625 | 5.4078 | 18 | 376 | animal organ morphogenesis |
| GO:0048565 | 0 | 5.7671 | 2.1257 | 11 | 127 | digestive tract development |
| GO:0009798 | 0 | 7.3591 | 1.3892 | 9 | 83 | axis specification |
| GO:0051172 | 0 | 1.9266 | 39.3336 | 66 | 2350 | negative regulation of nitrogen compound metabolic process |
| GO:0048522 | 0 | 1.8976 | 47.8277 | 75 | 3257 | positive regulation of cellular process |
| GO:0048598 | 0 | 4.6352 | 3.0832 | 13 | 209 | embryonic morphogenesis |
| GO:0007268 | 0 | 2.7954 | 9.7748 | 25 | 584 | chemical synaptic transmission |
| GO:0014033 | 0 | 8.0438 | 1.1382 | 8 | 68 | neural crest cell differentiation |
| GO:0090596 | 0 | 3.9822 | 4.1175 | 15 | 246 | sensory organ morphogenesis |
| GO:0099537 | 0 | 2.785 | 9.8083 | 25 | 586 | trans-synaptic signaling |
| GO:0034287 | 0 | 178.2273 | 0.067 | 3 | 4 | detection of monosaccharide stimulus |
| GO:0051594 | 0 | 178.2273 | 0.067 | 3 | 4 | detection of glucose |
| GO:0060021 | 0 | 6.6377 | 1.5231 | 9 | 91 | palate development |
| GO:0031324 | 0 | 1.8612 | 41.861 | 68 | 2501 | negative regulation of cellular metabolic process |
| GO:0001707 | 0 | 7.6593 | 1.1884 | 8 | 71 | mesoderm formation |
| GO:0030326 | 0 | 6.4913 | 1.5529 | 9 | 94 | embryonic limb morphogenesis |
| GO:0048646 | 0 | 3.3481 | 5.8706 | 18 | 385 | anatomical structure formation involved in morphogenesis |
| GO:0030182 | 0 | 2.3383 | 16.0414 | 34 | 994 | neuron differentiation |
| GO:0008284 | 0 | 2.428 | 13.9927 | 31 | 836 | positive regulation of cell proliferation |
| GO:0061061 | 0 | 2.7049 | 10.0761 | 25 | 602 | muscle structure development |
| GO:0048754 | 0 | 5.0628 | 2.3935 | 11 | 143 | branching morphogenesis of an epithelial tube |
| GO:0021510 | 0 | 7.3868 | 1.2263 | 8 | 74 | spinal cord development |
| GO:0021761 | 0 | 6.3273 | 1.5901 | 9 | 95 | limbic system development |
| GO:0021602 | 0 | 16.7361 | 0.3822 | 5 | 23 | cranial nerve morphogenesis |
| GO:0030878 | 0 | 15.7352 | 0.4017 | 5 | 24 | thyroid gland development |
| GO:0009914 | 0 | 3.4693 | 5.0046 | 16 | 299 | hormone transport |
| GO:0060429 | 0 | 3.3223 | 5.5731 | 17 | 370 | epithelium development |
| GO:0003002 | 0 | 10.5541 | 0.6603 | 6 | 46 | regionalization |
| GO:0001655 | 1e-04 | 3.3959 | 5.105 | 16 | 305 | urogenital system development |
| GO:0048483 | 1e-04 | 9.993 | 0.703 | 6 | 42 | autonomic nervous system development |
| GO:0022008 | 1e-04 | 2.1298 | 19.1259 | 37 | 1188 | neurogenesis |
| GO:0001764 | 1e-04 | 4.923 | 2.2261 | 10 | 133 | neuron migration |
| GO:0050794 | 1e-04 | 1.944 | 63.7121 | 86 | 5193 | regulation of cellular process |
| GO:0008595 | 1e-04 | 21.6716 | 0.2511 | 4 | 15 | anterior/posterior axis specification, embryo |
| GO:0060581 | 1e-04 | 21.6716 | 0.2511 | 4 | 15 | cell fate commitment involved in pattern specification |
| GO:0014031 | 1e-04 | 7.3816 | 1.0712 | 7 | 64 | mesenchymal cell development |
| GO:0048864 | 1e-04 | 7.3816 | 1.0712 | 7 | 64 | stem cell development |
| GO:0001892 | 1e-04 | 6.1804 | 1.4394 | 8 | 86 | embryonic placenta development |
| GO:0043009 | 1e-04 | 3.1847 | 5.4279 | 16 | 355 | chordate embryonic development |
| GO:0042472 | 1e-04 | 6.9661 | 1.1272 | 7 | 68 | inner ear morphogenesis |
| GO:0035148 | 1e-04 | 4.62 | 2.36 | 10 | 141 | tube formation |
| GO:0048608 | 1e-04 | 3.9086 | 3.3247 | 12 | 203 | reproductive structure development |
| GO:0032890 | 1e-04 | 8.5621 | 0.8034 | 6 | 48 | regulation of organic acid transport |
| GO:0050885 | 1e-04 | 8.5621 | 0.8034 | 6 | 48 | neuromuscular process controlling balance |
| GO:0021522 | 2e-04 | 11.4937 | 0.5189 | 5 | 31 | spinal cord motor neuron differentiation |
| GO:0021514 | 2e-04 | 18.3352 | 0.2845 | 4 | 17 | ventral spinal cord interneuron differentiation |
| GO:0098700 | 2e-04 | 44.5483 | 0.1172 | 3 | 7 | neurotransmitter loading into synaptic vesicle |
| GO:0003231 | 2e-04 | 4.9849 | 1.9751 | 9 | 118 | cardiac ventricle development |
| GO:0043583 | 2e-04 | 3.7973 | 3.4145 | 12 | 204 | ear development |
| GO:0007350 | 2e-04 | 17.0244 | 0.3013 | 4 | 18 | blastoderm segmentation |
| GO:0051241 | 2e-04 | 2.1914 | 14.859 | 30 | 904 | negative regulation of multicellular organismal process |
| GO:0009953 | 2e-04 | 6.4635 | 1.2052 | 7 | 73 | dorsal/ventral pattern formation |
| GO:0048732 | 2e-04 | 3.0287 | 5.6821 | 16 | 350 | gland development |
| GO:0009855 | 2e-04 | 4.8072 | 2.042 | 9 | 122 | determination of bilateral symmetry |
| GO:0045597 | 2e-04 | 2.2433 | 13.508 | 28 | 817 | positive regulation of cell differentiation |
| GO:0021560 | 3e-04 | Inf | 0.0335 | 2 | 2 | abducens nerve development |
| GO:0021599 | 3e-04 | Inf | 0.0335 | 2 | 2 | abducens nerve formation |
| GO:0060415 | 3e-04 | 6.0058 | 1.2888 | 7 | 77 | muscle tissue morphogenesis |
| GO:0048857 | 3e-04 | 7.3357 | 0.9206 | 6 | 55 | neural nucleus development |
| GO:0035137 | 3e-04 | 9.6368 | 0.6026 | 5 | 36 | hindlimb morphogenesis |
| GO:0007267 | 3e-04 | 2.0504 | 17.5307 | 33 | 1108 | cell-cell signaling |
| GO:0001755 | 4e-04 | 9.335 | 0.6193 | 5 | 37 | neural crest cell migration |
| GO:0042698 | 4e-04 | 5.0158 | 1.7407 | 8 | 104 | ovulation cycle |
| GO:0072048 | 4e-04 | 29.6951 | 0.1506 | 3 | 9 | renal system pattern specification |
| GO:0007617 | 4e-04 | 14.0174 | 0.3515 | 4 | 21 | mating behavior |
| GO:0048665 | 4e-04 | 13.4363 | 0.363 | 4 | 22 | neuron fate specification |
| GO:0051090 | 4e-04 | 2.8094 | 6.0925 | 16 | 364 | regulation of DNA binding transcription factor activity |
| GO:0051960 | 4e-04 | 2.2007 | 12.7039 | 26 | 759 | regulation of nervous system development |
| GO:0021513 | 4e-04 | 13.2379 | 0.3682 | 4 | 22 | spinal cord dorsal/ventral patterning |
| GO:0042475 | 4e-04 | 5.6036 | 1.3725 | 7 | 82 | odontogenesis of dentin-containing tooth |
| GO:0035051 | 4e-04 | 4.3076 | 2.2596 | 9 | 135 | cardiocyte differentiation |
| GO:0009888 | 5e-04 | 2.7864 | 6.1891 | 16 | 451 | tissue development |
| GO:0032275 | 5e-04 | 25.4513 | 0.1674 | 3 | 10 | luteinizing hormone secretion |
| GO:0001525 | 5e-04 | 2.5893 | 7.4315 | 18 | 444 | angiogenesis |
| GO:0021983 | 5e-04 | 8.5333 | 0.6695 | 5 | 40 | pituitary gland development |
| GO:0072210 | 5e-04 | 8.5333 | 0.6695 | 5 | 40 | metanephric nephron development |
| GO:0045686 | 5e-04 | 12.5403 | 0.385 | 4 | 23 | negative regulation of glial cell differentiation |
| GO:0030901 | 6e-04 | 5.387 | 1.4227 | 7 | 85 | midbrain development |
| GO:0021879 | 6e-04 | 8.3558 | 0.6815 | 5 | 41 | forebrain neuron differentiation |
| GO:0001501 | 6e-04 | 3.4904 | 3.3765 | 11 | 219 | skeletal system development |
| GO:0072080 | 6e-04 | 5.2517 | 1.4562 | 7 | 87 | nephron tubule development |
| GO:0060379 | 7e-04 | 22.2685 | 0.1841 | 3 | 11 | cardiac muscle cell myoblast differentiation |
| GO:0090009 | 7e-04 | 22.2685 | 0.1841 | 3 | 11 | primitive streak formation |
| GO:0006357 | 7e-04 | 3.4259 | 3.4521 | 11 | 277 | regulation of transcription from RNA polymerase II promoter |
| GO:0007631 | 7e-04 | 6.1149 | 1.0824 | 6 | 66 | feeding behavior |
| GO:0008283 | 8e-04 | 1.9878 | 16.9073 | 31 | 1083 | cell proliferation |
| GO:0044706 | 8e-04 | 3.3782 | 3.4814 | 11 | 208 | multi-multicellular organism process |
| GO:0060411 | 8e-04 | 5.9866 | 1.1047 | 6 | 66 | cardiac septum morphogenesis |
| GO:0021912 | 8e-04 | 118.3698 | 0.0502 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0060166 | 8e-04 | 118.3698 | 0.0502 | 2 | 3 | olfactory pit development |
| GO:0060913 | 8e-04 | 118.3698 | 0.0502 | 2 | 3 | cardiac cell fate determination |
| GO:0061031 | 8e-04 | 118.3698 | 0.0502 | 2 | 3 | endodermal digestive tract morphogenesis |
| GO:1902869 | 8e-04 | 118.3698 | 0.0502 | 2 | 3 | regulation of amacrine cell differentiation |
| GO:0009954 | 8e-04 | 10.9091 | 0.4321 | 4 | 26 | proximal/distal pattern formation |
| GO:0060536 | 9e-04 | 19.7929 | 0.2009 | 3 | 12 | cartilage morphogenesis |
| GO:0060707 | 9e-04 | 19.7929 | 0.2009 | 3 | 12 | trophoblast giant cell differentiation |
| GO:0048863 | 9e-04 | 3.5447 | 3.0173 | 10 | 185 | stem cell differentiation |
| GO:0007188 | 0.001 | 3.8456 | 2.5107 | 9 | 150 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0060986 | 0.001 | 7.2817 | 0.7699 | 5 | 46 | endocrine hormone secretion |
| GO:0043066 | 0.001 | 2.0643 | 13.4739 | 26 | 805 | negative regulation of apoptotic process |
| GO:0007548 | 0.0011 | 3.0543 | 4.1844 | 12 | 250 | sex differentiation |
| GO:0008306 | 0.0011 | 5.611 | 1.1716 | 6 | 70 | associative learning |
| GO:0048468 | 0.0011 | 1.9569 | 16.5595 | 30 | 1061 | cell development |
| GO:0072088 | 0.0012 | 5.5243 | 1.1884 | 6 | 71 | nephron epithelium morphogenesis |
| GO:0060324 | 0.0012 | 6.9421 | 0.8034 | 5 | 48 | face development |
| GO:0035050 | 0.0013 | 5.4403 | 1.2051 | 6 | 72 | embryonic heart tube development |
| GO:0021772 | 0.0013 | 9.527 | 0.4854 | 4 | 29 | olfactory bulb development |
| GO:0046545 | 0.0014 | 4.5632 | 1.657 | 7 | 99 | development of primary female sexual characteristics |
| GO:0051952 | 0.0014 | 5.3587 | 1.2219 | 6 | 73 | regulation of amine transport |
| GO:0061333 | 0.0014 | 5.3587 | 1.2219 | 6 | 73 | renal tubule morphogenesis |
| GO:0032101 | 0.0014 | 2.1158 | 11.5825 | 23 | 692 | regulation of response to external stimulus |
| GO:0003214 | 0.0015 | 16.1921 | 0.2343 | 3 | 14 | cardiac left ventricle morphogenesis |
| GO:0042074 | 0.0015 | 16.1921 | 0.2343 | 3 | 14 | cell migration involved in gastrulation |
| GO:0007409 | 0.0015 | 2.4739 | 6.8625 | 16 | 410 | axonogenesis |
| GO:0042220 | 0.0016 | 6.4881 | 0.8536 | 5 | 51 | response to cocaine |
| GO:0021536 | 0.0016 | 8.971 | 0.5104 | 4 | 31 | diencephalon development |
| GO:0043388 | 0.0016 | 8.9111 | 0.5137 | 4 | 31 | positive regulation of DNA binding |
| GO:0001992 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0003257 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
| GO:0007198 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0021615 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0021855 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | hypothalamus cell migration |
| GO:0021913 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0034653 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | retinoic acid catabolic process |
| GO:0048866 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | stem cell fate specification |
| GO:0061030 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | epithelial cell differentiation involved in mammary gland alveolus development |
| GO:0072086 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | specification of loop of Henle identity |
| GO:0072268 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | pattern specification involved in metanephros development |
| GO:0051047 | 0.0016 | 2.5411 | 6.2599 | 15 | 374 | positive regulation of secretion |
| GO:0050768 | 0.0017 | 6.3661 | 0.8672 | 5 | 53 | negative regulation of neurogenesis |
| GO:0001829 | 0.0018 | 14.8419 | 0.2511 | 3 | 15 | trophectodermal cell differentiation |
| GO:0007379 | 0.0018 | 14.8419 | 0.2511 | 3 | 15 | segment specification |
| GO:0021783 | 0.0018 | 14.8419 | 0.2511 | 3 | 15 | preganglionic parasympathetic fiber development |
| GO:0060284 | 0.0018 | 2.0038 | 13.2897 | 25 | 794 | regulation of cell development |
| GO:0035150 | 0.0019 | 3.8142 | 2.2429 | 8 | 134 | regulation of tube size |
| GO:0035115 | 0.0019 | 8.5046 | 0.5356 | 4 | 32 | embryonic forelimb morphogenesis |
| GO:0042755 | 0.0019 | 8.5046 | 0.5356 | 4 | 32 | eating behavior |
| GO:0001756 | 0.002 | 6.1338 | 0.8976 | 5 | 54 | somitogenesis |
| GO:0060562 | 0.0021 | 3.7386 | 2.2838 | 8 | 142 | epithelial tube morphogenesis |
| GO:0001541 | 0.0022 | 5.9676 | 0.9206 | 5 | 55 | ovarian follicle development |
| GO:0048731 | 0.0023 | 2.1058 | 11.4634 | 22 | 980 | system development |
| GO:0060548 | 0.0024 | 1.9111 | 15.0472 | 27 | 899 | negative regulation of cell death |
| GO:2000027 | 0.0024 | 2.9001 | 4.0171 | 11 | 240 | regulation of organ morphogenesis |
| GO:0007626 | 0.0026 | 4.0546 | 1.8483 | 7 | 112 | locomotory behavior |
| GO:0007625 | 0.0026 | 12.72 | 0.2845 | 3 | 17 | grooming behavior |
| GO:0061377 | 0.0026 | 12.72 | 0.2845 | 3 | 17 | mammary gland lobule development |
| GO:0010040 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | response to iron(II) ion |
| GO:0010957 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | negative regulation of vitamin D biosynthetic process |
| GO:0048880 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | sensory system development |
| GO:0061743 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | motor learning |
| GO:0072047 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
| GO:0097070 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | ductus arteriosus closure |
| GO:1900086 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | positive regulation of peptidyl-tyrosine autophosphorylation |
| GO:2000195 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | negative regulation of female gonad development |
| GO:0048536 | 0.003 | 7.4396 | 0.6026 | 4 | 36 | spleen development |
| GO:0071392 | 0.003 | 7.4396 | 0.6026 | 4 | 36 | cellular response to estradiol stimulus |
| GO:0071542 | 0.003 | 7.4396 | 0.6026 | 4 | 36 | dopaminergic neuron differentiation |
| GO:0001837 | 0.003 | 4.5423 | 1.4218 | 6 | 86 | epithelial to mesenchymal transition |
| GO:0001824 | 0.003 | 5.5241 | 0.9875 | 5 | 59 | blastocyst development |
| GO:0044703 | 0.003 | 1.8746 | 15.315 | 27 | 915 | multi-organism reproductive process |
| GO:0014706 | 0.0031 | 3.5099 | 2.4238 | 8 | 148 | striated muscle tissue development |
| GO:0030509 | 0.0032 | 3.4798 | 2.4437 | 8 | 146 | BMP signaling pathway |
| GO:0046717 | 0.0032 | 3.8832 | 1.9248 | 7 | 115 | acid secretion |
| GO:0090184 | 0.0033 | 7.2137 | 0.6193 | 4 | 37 | positive regulation of kidney development |
| GO:0002520 | 0.0033 | 1.8852 | 14.6455 | 26 | 875 | immune system development |
| GO:0033993 | 0.0033 | 1.8852 | 14.6455 | 26 | 875 | response to lipid |
| GO:0046887 | 0.0034 | 3.8473 | 1.9416 | 7 | 116 | positive regulation of hormone secretion |
| GO:0060993 | 0.0034 | 4.4286 | 1.4562 | 6 | 87 | kidney morphogenesis |
| GO:0051239 | 0.0034 | 1.6756 | 25.8931 | 40 | 1679 | regulation of multicellular organismal process |
| GO:0002573 | 0.0035 | 3.1462 | 3.0295 | 9 | 181 | myeloid leukocyte differentiation |
| GO:0002673 | 0.0036 | 4.3743 | 1.4729 | 6 | 88 | regulation of acute inflammatory response |
| GO:0060538 | 0.0036 | 3.4059 | 2.4931 | 8 | 150 | skeletal muscle organ development |
| GO:0007530 | 0.0037 | 11.1286 | 0.318 | 3 | 19 | sex determination |
| GO:0046641 | 0.0037 | 11.1286 | 0.318 | 3 | 19 | positive regulation of alpha-beta T cell proliferation |
| GO:0072079 | 0.0037 | 11.1286 | 0.318 | 3 | 19 | nephron tubule formation |
| GO:0072073 | 0.0038 | 6.9203 | 0.6419 | 4 | 39 | kidney epithelium development |
| GO:0061371 | 0.0038 | 5.2324 | 1.0377 | 5 | 62 | determination of heart left/right asymmetry |
| GO:0045665 | 0.0039 | 3.0917 | 3.0797 | 9 | 184 | negative regulation of neuron differentiation |
| GO:0014048 | 0.004 | 29.7985 | 0.0997 | 2 | 6 | regulation of glutamate secretion |
| GO:0015872 | 0.004 | 6.8007 | 0.6528 | 4 | 39 | dopamine transport |
| GO:0021532 | 0.004 | 6.8007 | 0.6528 | 4 | 39 | neural tube patterning |
| GO:0002865 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | negative regulation of acute inflammatory response to antigenic stimulus |
| GO:0014062 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | regulation of serotonin secretion |
| GO:0016115 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | terpenoid catabolic process |
| GO:0032229 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | negative regulation of synaptic transmission, GABAergic |
| GO:0090237 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | regulation of arachidonic acid secretion |
| GO:1990869 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | cellular response to chemokine |
| GO:0031018 | 0.0042 | 10.5788 | 0.3315 | 3 | 20 | endocrine pancreas development |
| GO:0030154 | 0.0042 | 2.0505 | 10.5216 | 20 | 827 | cell differentiation |
| GO:0007130 | 0.0043 | 10.4733 | 0.3348 | 3 | 20 | synaptonemal complex assembly |
| GO:0007210 | 0.0043 | 10.4733 | 0.3348 | 3 | 20 | serotonin receptor signaling pathway |
| GO:0023019 | 0.0043 | 10.4733 | 0.3348 | 3 | 20 | signal transduction involved in regulation of gene expression |
| GO:0034097 | 0.0043 | 1.8223 | 15.7167 | 27 | 939 | response to cytokine |
| GO:0003008 | 0.0044 | 1.5886 | 31.1824 | 46 | 1863 | system process |
| GO:0097485 | 0.0046 | 2.813 | 3.7492 | 10 | 224 | neuron projection guidance |
| GO:0003018 | 0.0046 | 3.2649 | 2.5943 | 8 | 155 | vascular process in circulatory system |
| GO:0007275 | 0.0047 | 2.4573 | 5.7176 | 13 | 530 | multicellular organism development |
| GO:0001657 | 0.0047 | 4.1215 | 1.5566 | 6 | 93 | ureteric bud development |
| GO:0007611 | 0.0049 | 2.7866 | 3.7827 | 10 | 226 | learning or memory |
| GO:0021516 | 0.0049 | 9.8908 | 0.3515 | 3 | 21 | dorsal spinal cord development |
| GO:0030539 | 0.0049 | 9.8908 | 0.3515 | 3 | 21 | male genitalia development |
| GO:0031290 | 0.0049 | 9.8908 | 0.3515 | 3 | 21 | retinal ganglion cell axon guidance |
| GO:0043586 | 0.0049 | 9.8908 | 0.3515 | 3 | 21 | tongue development |
| GO:0072163 | 0.005 | 4.0745 | 1.5733 | 6 | 94 | mesonephric epithelium development |
| GO:0071772 | 0.005 | 3.2206 | 2.6278 | 8 | 157 | response to BMP |
| GO:0097746 | 0.0051 | 3.5518 | 2.0922 | 7 | 125 | regulation of blood vessel diameter |
| GO:0006775 | 0.0052 | 6.2626 | 0.703 | 4 | 42 | fat-soluble vitamin metabolic process |
| GO:1903793 | 0.0052 | 6.2626 | 0.703 | 4 | 42 | positive regulation of anion transport |
| GO:0033555 | 0.0053 | 4.8089 | 1.1214 | 5 | 67 | multicellular organismal response to stress |
| GO:0043067 | 0.0053 | 1.6466 | 23.9851 | 37 | 1433 | regulation of programmed cell death |
| GO:0021521 | 0.0055 | 23.8449 | 0.1163 | 2 | 7 | ventral spinal cord interneuron specification |
| GO:0090276 | 0.0055 | 2.9227 | 3.2471 | 9 | 194 | regulation of peptide hormone secretion |
| GO:0021537 | 0.0055 | 2.7352 | 3.8497 | 10 | 230 | telencephalon development |
| GO:0032504 | 0.0055 | 1.8771 | 12.9383 | 23 | 773 | multicellular organism reproduction |
| GO:0001826 | 0.0055 | 23.6679 | 0.1172 | 2 | 7 | inner cell mass cell differentiation |
| GO:0002069 | 0.0055 | 23.6679 | 0.1172 | 2 | 7 | columnar/cuboidal epithelial cell maturation |
| GO:0048752 | 0.0055 | 23.6679 | 0.1172 | 2 | 7 | semicircular canal morphogenesis |
| GO:1902866 | 0.0055 | 23.6679 | 0.1172 | 2 | 7 | regulation of retina development in camera-type eye |
| GO:2000818 | 0.0055 | 23.6679 | 0.1172 | 2 | 7 | negative regulation of myoblast proliferation |
| GO:0009966 | 0.0056 | 1.4687 | 49.075 | 66 | 2932 | regulation of signal transduction |
| GO:2000679 | 0.0056 | 9.3696 | 0.3682 | 3 | 22 | positive regulation of transcription regulatory region DNA binding |
| GO:0010648 | 0.0057 | 1.6856 | 20.8217 | 33 | 1244 | negative regulation of cell communication |
| GO:0023057 | 0.0059 | 1.6795 | 20.8887 | 33 | 1248 | negative regulation of signaling |
| GO:0031644 | 0.0059 | 4.658 | 1.1549 | 5 | 69 | regulation of neurological system process |
| GO:0030073 | 0.006 | 2.8755 | 3.2973 | 9 | 197 | insulin secretion |
| GO:0048701 | 0.0062 | 5.9487 | 0.7365 | 4 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0048738 | 0.0062 | 2.8601 | 3.3141 | 9 | 198 | cardiac muscle tissue development |
| GO:0007422 | 0.0063 | 4.586 | 1.1716 | 5 | 70 | peripheral nervous system development |
| GO:0051354 | 0.0064 | 8.9006 | 0.385 | 3 | 23 | negative regulation of oxidoreductase activity |
| GO:0090103 | 0.0064 | 8.9006 | 0.385 | 3 | 23 | cochlea morphogenesis |
| GO:0008406 | 0.0064 | 2.8449 | 3.3308 | 9 | 199 | gonad development |
| GO:0051216 | 0.0065 | 3.0692 | 2.7493 | 8 | 166 | cartilage development |
| GO:0031348 | 0.0067 | 3.055 | 2.7617 | 8 | 165 | negative regulation of defense response |
| GO:0010718 | 0.0067 | 5.8032 | 0.7532 | 4 | 45 | positive regulation of epithelial to mesenchymal transition |
| GO:0001838 | 0.0067 | 3.8125 | 1.6735 | 6 | 101 | embryonic epithelial tube formation |
| GO:0015837 | 0.0071 | 20.0927 | 0.1315 | 2 | 8 | amine transport |
| GO:0001570 | 0.0071 | 4.4486 | 1.2051 | 5 | 72 | vasculogenesis |
| GO:0072132 | 0.0072 | 5.6647 | 0.7699 | 4 | 46 | mesenchyme morphogenesis |
| GO:0048169 | 0.0072 | 8.4762 | 0.4017 | 3 | 24 | regulation of long-term neuronal synaptic plasticity |
| GO:0042756 | 0.0073 | 19.722 | 0.1339 | 2 | 8 | drinking behavior |
| GO:0045647 | 0.0073 | 19.722 | 0.1339 | 2 | 8 | negative regulation of erythrocyte differentiation |
| GO:0045916 | 0.0073 | 19.722 | 0.1339 | 2 | 8 | negative regulation of complement activation |
| GO:0045924 | 0.0073 | 19.722 | 0.1339 | 2 | 8 | regulation of female receptivity |
| GO:0060539 | 0.0073 | 19.722 | 0.1339 | 2 | 8 | diaphragm development |
| GO:0050900 | 0.0073 | 2.2049 | 6.6616 | 14 | 398 | leukocyte migration |
| GO:1903707 | 0.0074 | 3.2982 | 2.2429 | 7 | 134 | negative regulation of hemopoiesis |
| GO:0006954 | 0.0075 | 1.9097 | 11.0134 | 20 | 658 | inflammatory response |
| GO:0016331 | 0.0075 | 8.3166 | 0.4074 | 3 | 25 | morphogenesis of embryonic epithelium |
| GO:0071495 | 0.0076 | 1.6602 | 20.4367 | 32 | 1221 | cellular response to endogenous stimulus |
| GO:0050789 | 0.0077 | 2.7491 | 4.1962 | 10 | 477 | regulation of biological process |
| GO:0006342 | 0.0077 | 3.6943 | 1.724 | 6 | 103 | chromatin silencing |
| GO:0002067 | 0.0078 | 5.5326 | 0.7867 | 4 | 47 | glandular epithelial cell differentiation |
| GO:0120039 | 0.008 | 1.9707 | 9.5907 | 18 | 573 | plasma membrane bounded cell projection morphogenesis |
| GO:0071363 | 0.0081 | 1.9295 | 10.3439 | 19 | 618 | cellular response to growth factor stimulus |
| GO:0001945 | 0.0081 | 8.0904 | 0.4184 | 3 | 25 | lymph vessel development |
| GO:0003309 | 0.0081 | 8.0904 | 0.4184 | 3 | 25 | type B pancreatic cell differentiation |
| GO:0048643 | 0.0081 | 8.0904 | 0.4184 | 3 | 25 | positive regulation of skeletal muscle tissue development |
| GO:0060037 | 0.0081 | 8.0904 | 0.4184 | 3 | 25 | pharyngeal system development |
| GO:0055010 | 0.0084 | 5.4065 | 0.8034 | 4 | 48 | ventricular cardiac muscle tissue morphogenesis |
| GO:0007610 | 0.0084 | 3.6159 | 1.7564 | 6 | 114 | behavior |
| GO:0045995 | 0.0085 | 3.6088 | 1.7619 | 6 | 106 | regulation of embryonic development |
| GO:0008344 | 0.0089 | 4.1969 | 1.2721 | 5 | 76 | adult locomotory behavior |
| GO:0042693 | 0.0092 | 17.0244 | 0.1496 | 2 | 9 | muscle cell fate commitment |
| GO:0001714 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | endodermal cell fate specification |
| GO:0008354 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | germ cell migration |
| GO:0010579 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
| GO:0014049 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | positive regulation of glutamate secretion |
| GO:0014807 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | regulation of somitogenesis |
| GO:0021892 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0030917 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | midbrain-hindbrain boundary development |
| GO:0042473 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | outer ear morphogenesis |
| GO:0046877 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | regulation of saliva secretion |
| GO:0048387 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | negative regulation of retinoic acid receptor signaling pathway |
| GO:0048617 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | embryonic foregut morphogenesis |
| GO:0048755 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | branching morphogenesis of a nerve |
| GO:0060923 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | cardiac muscle cell fate commitment |
| GO:2000543 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | positive regulation of gastrulation |
| GO:0048706 | 0.0096 | 7.5406 | 0.4431 | 3 | 28 | embryonic skeletal system development |
| GO:0007492 | 0.0099 | 4.0814 | 1.3055 | 5 | 78 | endoderm development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 265.3146 | 0.4052 | 24 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 176.8315 | 0.4559 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 106.0449 | 0.5572 | 24 | 44 | protein heterotetramerization |
| GO:0006323 | 0 | 19.9057 | 2.3553 | 33 | 186 | DNA packaging |
| GO:0045815 | 0 | 38.476 | 1.0004 | 24 | 79 | positive regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 29.1295 | 1.279 | 25 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0071824 | 0 | 14.3115 | 3.1024 | 33 | 245 | protein-DNA complex subunit organization |
| GO:0045653 | 0 | 293.1436 | 0.2279 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0060964 | 0 | 26.0824 | 1.3296 | 24 | 105 | regulation of gene silencing by miRNA |
| GO:0060968 | 0 | 20.2844 | 1.6209 | 24 | 128 | regulation of gene silencing |
| GO:0035194 | 0 | 12.7744 | 2.9505 | 29 | 233 | posttranscriptional gene silencing by RNA |
| GO:0032200 | 0 | 15.1428 | 2.0641 | 24 | 163 | telomere organization |
| GO:0002244 | 0 | 13.676 | 2.3553 | 25 | 186 | hematopoietic progenitor cell differentiation |
| GO:0034080 | 0 | 45.036 | 0.5065 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:0017148 | 0 | 8.9051 | 4.0522 | 29 | 320 | negative regulation of translation |
| GO:1904837 | 0 | 39.0213 | 0.5572 | 14 | 44 | beta-catenin-TCF complex assembly |
| GO:0006333 | 0 | 17.7315 | 1.3951 | 19 | 118 | chromatin assembly or disassembly |
| GO:0048863 | 0 | 9.9246 | 3.2544 | 26 | 257 | stem cell differentiation |
| GO:0034724 | 0 | 31.6248 | 0.6458 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0016233 | 0 | 28.5322 | 0.6965 | 14 | 55 | telomere capping |
| GO:0030099 | 0 | 7.1431 | 4.7486 | 28 | 375 | myeloid cell differentiation |
| GO:1903507 | 0 | 4.2634 | 14.1952 | 48 | 1121 | negative regulation of nucleic acid-templated transcription |
| GO:0009890 | 0 | 3.6695 | 20.0202 | 57 | 1581 | negative regulation of biosynthetic process |
| GO:0006303 | 0 | 20.1475 | 0.9117 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0051253 | 0 | 3.9683 | 15.1323 | 48 | 1195 | negative regulation of RNA metabolic process |
| GO:0043044 | 0 | 19.1529 | 0.9497 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:0051259 | 0 | 5.3213 | 6.4581 | 29 | 510 | protein oligomerization |
| GO:0038111 | 0 | 30.3299 | 0.4685 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 30.3299 | 0.4685 | 10 | 37 | response to interleukin-7 |
| GO:0034248 | 0 | 5.0398 | 6.7874 | 29 | 536 | regulation of cellular amide metabolic process |
| GO:1903707 | 0 | 10.5363 | 1.6968 | 15 | 134 | negative regulation of hemopoiesis |
| GO:0034622 | 0 | 3.6714 | 12.3211 | 38 | 973 | cellular macromolecular complex assembly |
| GO:0045652 | 0 | 19.1744 | 0.6607 | 10 | 56 | regulation of megakaryocyte differentiation |
| GO:0010608 | 0 | 4.2771 | 7.889 | 29 | 623 | posttranscriptional regulation of gene expression |
| GO:0043043 | 0 | 3.8454 | 9.7125 | 32 | 767 | peptide biosynthetic process |
| GO:0002227 | 0 | 43.4552 | 0.2533 | 7 | 20 | innate immune response in mucosa |
| GO:0048534 | 0 | 3.649 | 10.5483 | 33 | 833 | hematopoietic or lymphoid organ development |
| GO:0051248 | 0 | 2.9169 | 15.6135 | 39 | 1233 | negative regulation of protein metabolic process |
| GO:0002251 | 0 | 22.5795 | 0.4052 | 7 | 32 | organ or tissue specific immune response |
| GO:0031324 | 0 | 2.3599 | 31.6701 | 61 | 2501 | negative regulation of cellular metabolic process |
| GO:0019731 | 0 | 18.2023 | 0.4812 | 7 | 38 | antibacterial humoral response |
| GO:0006342 | 0 | 12.5057 | 0.7493 | 8 | 67 | chromatin silencing |
| GO:0002376 | 0 | 2.2166 | 33.3416 | 61 | 2633 | immune system process |
| GO:0006334 | 0 | 9.8095 | 1.051 | 9 | 94 | nucleosome assembly |
| GO:0006352 | 0 | 5.3555 | 2.9125 | 14 | 230 | DNA-templated transcription, initiation |
| GO:0061844 | 0 | 12.8138 | 0.6458 | 7 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0006355 | 0 | 1.9734 | 43.1301 | 70 | 3406 | regulation of transcription, DNA-templated |
| GO:0050830 | 0 | 8.6186 | 1.051 | 8 | 83 | defense response to Gram-positive bacterium |
| GO:2001141 | 0 | 1.9533 | 43.472 | 70 | 3433 | regulation of RNA biosynthetic process |
| GO:0040029 | 0 | 4.441 | 3.4763 | 14 | 310 | regulation of gene expression, epigenetic |
| GO:0060249 | 0 | 3.763 | 4.66 | 16 | 368 | anatomical structure homeostasis |
| GO:0045596 | 0 | 2.9044 | 7.927 | 21 | 626 | negative regulation of cell differentiation |
| GO:1903706 | 1e-04 | 4.0665 | 3.4875 | 13 | 295 | regulation of hemopoiesis |
| GO:0034654 | 1e-04 | 1.757 | 51.1205 | 75 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0019219 | 1e-04 | 1.7524 | 50.4114 | 74 | 3981 | regulation of nucleobase-containing compound metabolic process |
| GO:0050911 | 2e-04 | 3.5666 | 3.9382 | 13 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 4e-04 | 3.0616 | 4.9132 | 14 | 388 | detection of chemical stimulus |
| GO:0070271 | 5e-04 | 2.0242 | 17.3736 | 32 | 1372 | protein complex biogenesis |
| GO:0050906 | 6e-04 | 2.9641 | 5.0652 | 14 | 400 | detection of stimulus involved in sensory perception |
| GO:0010467 | 6e-04 | 1.6147 | 64.7332 | 87 | 5112 | gene expression |
| GO:0006281 | 7e-04 | 2.7017 | 6.3568 | 16 | 502 | DNA repair |
| GO:0006950 | 8e-04 | 1.6624 | 45.1056 | 65 | 3562 | response to stress |
| GO:0050793 | 0.001 | 1.7574 | 29.2388 | 46 | 2309 | regulation of developmental process |
| GO:0071822 | 0.001 | 1.8862 | 20.3874 | 35 | 1610 | protein complex subunit organization |
| GO:0051276 | 0.0011 | 2.2237 | 10.7438 | 22 | 953 | chromosome organization |
| GO:0009059 | 0.0011 | 1.5791 | 63.0364 | 84 | 4978 | macromolecule biosynthetic process |
| GO:2000113 | 0.0011 | 2.1467 | 12.2069 | 24 | 1103 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0031424 | 0.0012 | 3.7006 | 2.5959 | 9 | 205 | keratinization |
| GO:0090304 | 0.0013 | 1.5701 | 61.5168 | 82 | 4858 | nucleic acid metabolic process |
| GO:0007606 | 0.002 | 2.6878 | 5.1412 | 13 | 406 | sensory perception of chemical stimulus |
| GO:0071677 | 0.0029 | 11.8568 | 0.2912 | 3 | 23 | positive regulation of mononuclear cell migration |
| GO:0007596 | 0.0031 | 2.8129 | 4.1408 | 11 | 327 | blood coagulation |
| GO:0043588 | 0.0038 | 2.5966 | 4.8879 | 12 | 386 | skin development |
| GO:0044249 | 0.0039 | 1.4782 | 75.1042 | 94 | 5931 | cellular biosynthetic process |
| GO:0006959 | 0.0044 | 3.2895 | 2.5706 | 8 | 203 | humoral immune response |
| GO:0032268 | 0.0045 | 1.6069 | 31.5055 | 46 | 2488 | regulation of cellular protein metabolic process |
| GO:0002690 | 0.0045 | 4.9714 | 1.0764 | 5 | 85 | positive regulation of leukocyte chemotaxis |
| GO:1901360 | 0.0047 | 1.4645 | 74.5977 | 93 | 5891 | organic cyclic compound metabolic process |
| GO:0043950 | 0.0054 | 22.49 | 0.114 | 2 | 9 | positive regulation of cAMP-mediated signaling |
| GO:0000038 | 0.0057 | 9.1171 | 0.3672 | 3 | 29 | very long-chain fatty acid metabolic process |
| GO:0051172 | 0.0059 | 1.9181 | 12.3698 | 22 | 1117 | negative regulation of nitrogen compound metabolic process |
| GO:0048519 | 0.0062 | 1.4615 | 60.9976 | 78 | 4817 | negative regulation of biological process |
| GO:0016458 | 0.0065 | 3.8195 | 1.6602 | 6 | 154 | gene silencing |
| GO:0022607 | 0.0067 | 1.5542 | 33.9241 | 48 | 2679 | cellular component assembly |
| GO:0071346 | 0.0075 | 3.7069 | 1.7095 | 6 | 135 | cellular response to interferon-gamma |
| GO:0034641 | 0.0075 | 1.4281 | 78.6118 | 96 | 6208 | cellular nitrogen compound metabolic process |
| GO:0014898 | 0.0076 | 8.1724 | 0.4052 | 3 | 32 | cardiac muscle hypertrophy in response to stress |
| GO:0050878 | 0.0081 | 2.256 | 6.0656 | 13 | 479 | regulation of body fluid levels |
| GO:0048731 | 0.0089 | 1.446 | 55.2739 | 71 | 4365 | system development |
| GO:0009913 | 0.0089 | 2.5357 | 4.1408 | 10 | 327 | epidermal cell differentiation |
| GO:0098542 | 0.0097 | 2.2829 | 5.5211 | 12 | 436 | defense response to other organism |
| GO:0060255 | 0.0099 | 1.4118 | 72.5463 | 89 | 5729 | regulation of macromolecule metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 18.6854 | 3.9772 | 49 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0 | 14.4535 | 5.1921 | 51 | 406 | sensory perception of chemical stimulus |
| GO:0009593 | 0 | 14.8025 | 4.9619 | 50 | 388 | detection of chemical stimulus |
| GO:0050906 | 0 | 14.2839 | 5.1153 | 50 | 400 | detection of stimulus involved in sensory perception |
| GO:0007186 | 0 | 5.8469 | 15.1031 | 63 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 5.6143 | 14.681 | 60 | 1148 | nervous system process |
| GO:0006335 | 0 | 36.8463 | 0.4092 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 31.1697 | 0.4604 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 30.0134 | 0.4732 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 30.0134 | 0.4732 | 10 | 37 | response to interleukin-7 |
| GO:0051290 | 0 | 23.8235 | 0.5627 | 10 | 44 | protein heterotetramerization |
| GO:0045652 | 0 | 12.6321 | 0.9463 | 10 | 74 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 11.713 | 1.0103 | 10 | 79 | positive regulation of gene expression, epigenetic |
| GO:0031424 | 0 | 6.0016 | 2.6216 | 14 | 205 | keratinization |
| GO:1902036 | 0 | 8.8688 | 1.2916 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 8.4932 | 1.3428 | 10 | 105 | regulation of gene silencing by miRNA |
| GO:0032501 | 0 | 1.9939 | 79.9359 | 112 | 6625 | multicellular organismal process |
| GO:0031497 | 0 | 6.6412 | 1.8543 | 11 | 145 | chromatin assembly |
| GO:0045814 | 0 | 7.4647 | 1.509 | 10 | 118 | negative regulation of gene expression, epigenetic |
| GO:0034728 | 0 | 6.176 | 1.9822 | 11 | 155 | nucleosome organization |
| GO:0060968 | 0 | 6.8277 | 1.6369 | 10 | 128 | regulation of gene silencing |
| GO:0048863 | 0 | 4.3248 | 3.2866 | 13 | 257 | stem cell differentiation |
| GO:0035194 | 0 | 4.3911 | 2.9797 | 12 | 233 | posttranscriptional gene silencing by RNA |
| GO:0032200 | 0 | 5.254 | 2.0845 | 10 | 163 | telomere organization |
| GO:0050896 | 1e-04 | 1.7647 | 103.2149 | 131 | 8071 | response to stimulus |
| GO:0031640 | 1e-04 | 9.7087 | 0.7034 | 6 | 55 | killing of cells of other organism |
| GO:0009913 | 1e-04 | 3.6336 | 4.1818 | 14 | 327 | epidermal cell differentiation |
| GO:0065004 | 1e-04 | 4.3645 | 2.7367 | 11 | 214 | protein-DNA complex assembly |
| GO:0002227 | 1e-04 | 19.665 | 0.2558 | 4 | 20 | innate immune response in mucosa |
| GO:0050832 | 1e-04 | 11.9651 | 0.486 | 5 | 38 | defense response to fungus |
| GO:0002244 | 1e-04 | 4.5607 | 2.3786 | 10 | 186 | hematopoietic progenitor cell differentiation |
| GO:0044657 | 2e-04 | Inf | 0.0256 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0052043 | 2e-04 | Inf | 0.0256 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 2e-04 | Inf | 0.0256 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 2e-04 | Inf | 0.0256 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0042832 | 2e-04 | 16.5568 | 0.2941 | 4 | 23 | defense response to protozoan |
| GO:0023052 | 4e-04 | 1.6198 | 76.2954 | 100 | 5966 | signaling |
| GO:0043588 | 5e-04 | 3.0456 | 4.9363 | 14 | 386 | skin development |
| GO:0007154 | 5e-04 | 1.6111 | 76.5512 | 100 | 5986 | cell communication |
| GO:0071103 | 6e-04 | 3.5189 | 3.3506 | 11 | 262 | DNA conformation change |
| GO:0002251 | 7e-04 | 11.2286 | 0.4092 | 4 | 32 | organ or tissue specific immune response |
| GO:0017148 | 9e-04 | 3.1331 | 4.0923 | 12 | 320 | negative regulation of translation |
| GO:0002361 | 0.001 | 77.9505 | 0.0512 | 2 | 4 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
| GO:0007596 | 0.0011 | 3.0621 | 4.1818 | 12 | 327 | blood coagulation |
| GO:0030099 | 0.0011 | 2.8929 | 4.7956 | 13 | 375 | myeloid cell differentiation |
| GO:0019731 | 0.0014 | 9.2435 | 0.486 | 4 | 38 | antibacterial humoral response |
| GO:0043303 | 0.0022 | 8.0559 | 0.5499 | 4 | 43 | mast cell degranulation |
| GO:0051673 | 0.0024 | 38.9703 | 0.0767 | 2 | 6 | membrane disruption in other organism |
| GO:0060267 | 0.0024 | 38.9703 | 0.0767 | 2 | 6 | positive regulation of respiratory burst |
| GO:0042742 | 0.0027 | 3.5757 | 2.3753 | 8 | 189 | defense response to bacterium |
| GO:0050878 | 0.0035 | 2.4218 | 6.1256 | 14 | 479 | regulation of body fluid levels |
| GO:0061844 | 0.0041 | 6.6813 | 0.6522 | 4 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0045348 | 0.0043 | 25.9769 | 0.1023 | 2 | 8 | positive regulation of MHC class II biosynthetic process |
| GO:0045576 | 0.0047 | 6.4078 | 0.6778 | 4 | 53 | mast cell activation |
| GO:0002026 | 0.0048 | 9.7786 | 0.3453 | 3 | 27 | regulation of the force of heart contraction |
| GO:0051259 | 0.006 | 2.2658 | 6.5221 | 14 | 510 | protein oligomerization |
| GO:0051051 | 0.0067 | 2.3138 | 5.921 | 13 | 463 | negative regulation of transport |
| GO:0019730 | 0.0067 | 8.5621 | 0.3882 | 3 | 31 | antimicrobial humoral response |
| GO:0045080 | 0.0068 | 19.4802 | 0.1279 | 2 | 10 | positive regulation of chemokine biosynthetic process |
| GO:0048304 | 0.0068 | 19.4802 | 0.1279 | 2 | 10 | positive regulation of isotype switching to IgG isotypes |
| GO:0051937 | 0.0077 | 5.5056 | 0.7801 | 4 | 61 | catecholamine transport |
| GO:0007565 | 0.0083 | 3.2178 | 2.2891 | 7 | 179 | female pregnancy |
| GO:1903706 | 0.0093 | 2.2978 | 5.4862 | 12 | 429 | regulation of hemopoiesis |
| GO:0033604 | 0.0099 | 15.5822 | 0.1535 | 2 | 12 | negative regulation of catecholamine secretion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 262.3333 | 0.4092 | 24 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 174.8444 | 0.4604 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 104.8533 | 0.5627 | 24 | 44 | protein heterotetramerization |
| GO:0045815 | 0 | 40.5907 | 1.0103 | 25 | 79 | positive regulation of gene expression, epigenetic |
| GO:0006323 | 0 | 17.2325 | 2.3786 | 30 | 186 | DNA packaging |
| GO:1902036 | 0 | 27.1359 | 1.2916 | 24 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0045653 | 0 | 290.0211 | 0.2302 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0060964 | 0 | 25.7893 | 1.3428 | 24 | 105 | regulation of gene silencing by miRNA |
| GO:0060968 | 0 | 21.2141 | 1.6369 | 25 | 128 | regulation of gene silencing |
| GO:0071824 | 0 | 13.0072 | 3.1331 | 31 | 245 | protein-DNA complex subunit organization |
| GO:0032200 | 0 | 16.6442 | 2.0845 | 26 | 163 | telomere organization |
| GO:0035194 | 0 | 12.6268 | 2.9797 | 29 | 233 | posttranscriptional gene silencing by RNA |
| GO:0002244 | 0 | 13.5215 | 2.3786 | 25 | 186 | hematopoietic progenitor cell differentiation |
| GO:0017148 | 0 | 9.1902 | 4.0923 | 30 | 320 | negative regulation of translation |
| GO:0048863 | 0 | 10.292 | 3.2866 | 27 | 257 | stem cell differentiation |
| GO:0034080 | 0 | 44.5563 | 0.5115 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 38.6056 | 0.5627 | 14 | 44 | beta-catenin-TCF complex assembly |
| GO:0034724 | 0 | 31.2879 | 0.6522 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0016233 | 0 | 28.2282 | 0.7034 | 14 | 55 | telomere capping |
| GO:0006303 | 0 | 19.9328 | 0.9208 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 0 | 18.9489 | 0.9591 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:0006333 | 0 | 14.0717 | 1.41 | 16 | 118 | chromatin assembly or disassembly |
| GO:0034248 | 0 | 5.1935 | 6.8546 | 30 | 536 | regulation of cellular amide metabolic process |
| GO:0030099 | 0 | 6.1445 | 4.7956 | 25 | 375 | myeloid cell differentiation |
| GO:1903707 | 0 | 11.273 | 1.7136 | 16 | 134 | negative regulation of hemopoiesis |
| GO:0038111 | 0 | 30.0134 | 0.4732 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 30.0134 | 0.4732 | 10 | 37 | response to interleukin-7 |
| GO:0051259 | 0 | 5.0388 | 6.5221 | 28 | 510 | protein oligomerization |
| GO:0010608 | 0 | 4.5875 | 7.9672 | 31 | 623 | posttranscriptional regulation of gene expression |
| GO:0048534 | 0 | 3.8799 | 10.6527 | 35 | 833 | hematopoietic or lymphoid organ development |
| GO:0045652 | 0 | 18.9589 | 0.6678 | 10 | 56 | regulation of megakaryocyte differentiation |
| GO:0010558 | 0 | 3.0713 | 18.9524 | 48 | 1482 | negative regulation of macromolecule biosynthetic process |
| GO:1903507 | 0 | 3.3093 | 14.3358 | 40 | 1121 | negative regulation of nucleic acid-templated transcription |
| GO:0043043 | 0 | 3.8002 | 9.8087 | 32 | 767 | peptide biosynthetic process |
| GO:0051253 | 0 | 3.181 | 15.2821 | 41 | 1195 | negative regulation of RNA metabolic process |
| GO:0031327 | 0 | 2.8928 | 19.9754 | 48 | 1562 | negative regulation of cellular biosynthetic process |
| GO:0006352 | 0 | 6.6304 | 2.9413 | 17 | 230 | DNA-templated transcription, initiation |
| GO:0034622 | 0 | 3.3872 | 12.4431 | 36 | 973 | cellular macromolecular complex assembly |
| GO:0051248 | 0 | 3.0716 | 15.7681 | 41 | 1233 | negative regulation of protein metabolic process |
| GO:0045596 | 0 | 3.52 | 8.0055 | 25 | 626 | negative regulation of cell differentiation |
| GO:0006342 | 0 | 12.3587 | 0.7577 | 8 | 67 | chromatin silencing |
| GO:0009892 | 0 | 2.1496 | 35.4621 | 63 | 2773 | negative regulation of metabolic process |
| GO:0009611 | 0 | 3.343 | 8.0311 | 24 | 628 | response to wounding |
| GO:0002227 | 0 | 26.3534 | 0.2558 | 5 | 20 | innate immune response in mucosa |
| GO:0060249 | 0 | 3.7224 | 4.7061 | 16 | 368 | anatomical structure homeostasis |
| GO:0002376 | 0 | 1.9827 | 33.6718 | 57 | 2633 | immune system process |
| GO:2000179 | 0 | 11.609 | 0.6011 | 6 | 47 | positive regulation of neural precursor cell proliferation |
| GO:0007596 | 0 | 4.0131 | 3.8113 | 14 | 302 | blood coagulation |
| GO:0006355 | 0 | 1.8589 | 43.5572 | 68 | 3406 | regulation of transcription, DNA-templated |
| GO:0002251 | 0 | 14.6296 | 0.4092 | 5 | 32 | organ or tissue specific immune response |
| GO:0009889 | 1e-04 | 1.7901 | 54.3761 | 80 | 4252 | regulation of biosynthetic process |
| GO:2001141 | 1e-04 | 1.84 | 43.9025 | 68 | 3433 | regulation of RNA biosynthetic process |
| GO:0070271 | 1e-04 | 2.2323 | 17.5456 | 35 | 1372 | protein complex biogenesis |
| GO:0051239 | 1e-04 | 1.9079 | 34.746 | 57 | 2717 | regulation of multicellular organismal process |
| GO:0071822 | 1e-04 | 2.133 | 20.5893 | 39 | 1610 | protein complex subunit organization |
| GO:0021796 | 1e-04 | 58.7463 | 0.0895 | 3 | 7 | cerebral cortex regionalization |
| GO:0050830 | 1e-04 | 7.3273 | 1.0614 | 7 | 83 | defense response to Gram-positive bacterium |
| GO:0019731 | 1e-04 | 11.9651 | 0.486 | 5 | 38 | antibacterial humoral response |
| GO:0034645 | 1e-04 | 1.7155 | 62.0108 | 87 | 4849 | cellular macromolecule biosynthetic process |
| GO:0050878 | 1e-04 | 3.0079 | 6.1256 | 17 | 479 | regulation of body fluid levels |
| GO:0042704 | 2e-04 | Inf | 0.0256 | 2 | 2 | uterine wall breakdown |
| GO:0032268 | 2e-04 | 1.8695 | 31.8175 | 52 | 2488 | regulation of cellular protein metabolic process |
| GO:0040029 | 2e-04 | 3.7124 | 3.4959 | 12 | 310 | regulation of gene expression, epigenetic |
| GO:0006996 | 2e-04 | 1.7452 | 44.9383 | 67 | 3514 | organelle organization |
| GO:0048505 | 4e-04 | 26.1012 | 0.1535 | 3 | 12 | regulation of timing of cell differentiation |
| GO:0061844 | 5e-04 | 8.5766 | 0.6522 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0045595 | 6e-04 | 2.2402 | 11.7176 | 24 | 1003 | regulation of cell differentiation |
| GO:0006334 | 7e-04 | 6.1332 | 1.0628 | 6 | 94 | nucleosome assembly |
| GO:0006281 | 7e-04 | 2.6726 | 6.4198 | 16 | 502 | DNA repair |
| GO:0048665 | 8e-04 | 10.8407 | 0.422 | 4 | 33 | neuron fate specification |
| GO:0021542 | 8e-04 | 19.5721 | 0.1918 | 3 | 15 | dentate gyrus development |
| GO:0034654 | 9e-04 | 1.621 | 51.6266 | 72 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0022607 | 0.001 | 1.7087 | 34.26 | 52 | 2679 | cellular component assembly |
| GO:0019219 | 0.001 | 1.6162 | 50.9105 | 71 | 3981 | regulation of nucleobase-containing compound metabolic process |
| GO:0010604 | 0.0012 | 1.6727 | 37.1118 | 55 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0048714 | 0.0012 | 16.774 | 0.2174 | 3 | 17 | positive regulation of oligodendrocyte differentiation |
| GO:0045165 | 0.0012 | 3.4027 | 3.1331 | 10 | 245 | cell fate commitment |
| GO:0010936 | 0.0016 | 51.9637 | 0.0639 | 2 | 5 | negative regulation of macrophage cytokine production |
| GO:0021778 | 0.0016 | 51.9637 | 0.0639 | 2 | 5 | oligodendrocyte cell fate specification |
| GO:0051891 | 0.0016 | 51.9637 | 0.0639 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0003278 | 0.0024 | 38.9703 | 0.0767 | 2 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0021513 | 0.0027 | 12.3559 | 0.2813 | 3 | 22 | spinal cord dorsal/ventral patterning |
| GO:1903706 | 0.0028 | 3.0248 | 3.5061 | 10 | 295 | regulation of hemopoiesis |
| GO:0021798 | 0.0033 | 31.1743 | 0.0895 | 2 | 7 | forebrain dorsal/ventral pattern formation |
| GO:1901576 | 0.0038 | 1.4753 | 76.9476 | 96 | 6017 | organic substance biosynthetic process |
| GO:0072378 | 0.0039 | 10.6689 | 0.3197 | 3 | 25 | blood coagulation, fibrin clot formation |
| GO:0003310 | 0.0043 | 25.9769 | 0.1023 | 2 | 8 | pancreatic A cell differentiation |
| GO:0035270 | 0.0052 | 4.0139 | 1.5858 | 6 | 124 | endocrine system development |
| GO:1904753 | 0.0068 | 19.4802 | 0.1279 | 2 | 10 | negative regulation of vascular associated smooth muscle cell migration |
| GO:0045685 | 0.0077 | 5.5056 | 0.7801 | 4 | 61 | regulation of glial cell differentiation |
| GO:0090009 | 0.0083 | 17.3146 | 0.1407 | 2 | 11 | primitive streak formation |
| GO:0048869 | 0.0085 | 1.4806 | 46.0699 | 61 | 3730 | cellular developmental process |
| GO:0007435 | 0.0085 | 7.8199 | 0.422 | 3 | 33 | salivary gland morphogenesis |
| GO:0045823 | 0.0092 | 7.5672 | 0.4348 | 3 | 34 | positive regulation of heart contraction |
| GO:0017121 | 0.0099 | 15.5822 | 0.1535 | 2 | 12 | phospholipid scrambling |
| GO:0060391 | 0.0099 | 15.5822 | 0.1535 | 2 | 12 | positive regulation of SMAD protein import into nucleus |
| GO:0042596 | 0.01 | 7.3302 | 0.4476 | 3 | 35 | fear response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 27.9139 | 4.6595 | 72 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 21.4965 | 5.8132 | 73 | 388 | detection of chemical stimulus |
| GO:0007606 | 0 | 20.7775 | 6.0829 | 74 | 406 | sensory perception of chemical stimulus |
| GO:0050906 | 0 | 20.6915 | 5.993 | 73 | 400 | detection of stimulus involved in sensory perception |
| GO:0007186 | 0 | 7.0679 | 17.4774 | 82 | 1176 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 7.0369 | 17.1998 | 81 | 1148 | nervous system process |
| GO:0000183 | 0 | 39.2401 | 0.5394 | 13 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 37.6027 | 0.5544 | 13 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 37.6027 | 0.5544 | 13 | 37 | response to interleukin-7 |
| GO:0031424 | 0 | 9.0866 | 3.0714 | 23 | 205 | keratinization |
| GO:0032501 | 0 | 2.6231 | 90.8745 | 141 | 6625 | multicellular organismal process |
| GO:0006335 | 0 | 31.1453 | 0.4794 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0009913 | 0 | 5.9614 | 4.8993 | 25 | 327 | epidermal cell differentiation |
| GO:0045652 | 0 | 14.7596 | 1.1087 | 13 | 74 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 13.6371 | 1.1836 | 13 | 79 | positive regulation of gene expression, epigenetic |
| GO:0043588 | 0 | 5.2058 | 5.7832 | 26 | 386 | skin development |
| GO:0051290 | 0 | 20.1374 | 0.6592 | 10 | 44 | protein heterotetramerization |
| GO:1902036 | 0 | 10.2134 | 1.5132 | 13 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 9.7669 | 1.5732 | 13 | 105 | regulation of gene silencing by miRNA |
| GO:0007154 | 0 | 2.1137 | 89.6849 | 133 | 5986 | cell communication |
| GO:0023052 | 0 | 2.089 | 89.3853 | 132 | 5966 | signaling |
| GO:0031497 | 0 | 7.4011 | 2.1725 | 14 | 145 | chromatin assembly |
| GO:0060968 | 0 | 7.802 | 1.9178 | 13 | 128 | regulation of gene silencing |
| GO:0034728 | 0 | 6.8718 | 2.3223 | 14 | 155 | nucleosome organization |
| GO:0051716 | 0 | 1.892 | 100.7869 | 138 | 6727 | cellular response to stimulus |
| GO:0002244 | 0 | 5.6221 | 2.7867 | 14 | 186 | hematopoietic progenitor cell differentiation |
| GO:0065004 | 0 | 4.8263 | 3.2062 | 14 | 214 | protein-DNA complex assembly |
| GO:0035194 | 0 | 4.4022 | 3.4909 | 14 | 233 | posttranscriptional gene silencing by RNA |
| GO:1903706 | 0 | 3.2235 | 6.4275 | 19 | 429 | regulation of hemopoiesis |
| GO:0017148 | 0 | 3.6368 | 4.7944 | 16 | 320 | negative regulation of translation |
| GO:0032200 | 0 | 4.9391 | 2.4421 | 11 | 163 | telomere organization |
| GO:0071103 | 0 | 3.8801 | 3.9254 | 14 | 262 | DNA conformation change |
| GO:0030099 | 1e-04 | 3.2845 | 5.6184 | 17 | 375 | myeloid cell differentiation |
| GO:0007596 | 1e-04 | 3.3055 | 4.8993 | 15 | 327 | blood coagulation |
| GO:0048863 | 1e-04 | 3.6468 | 3.8505 | 13 | 257 | stem cell differentiation |
| GO:0018149 | 2e-04 | 8.2319 | 0.824 | 6 | 55 | peptide cross-linking |
| GO:1904628 | 2e-04 | 39.9356 | 0.1199 | 3 | 8 | cellular response to phorbol 13-acetate 12-myristate |
| GO:0009611 | 2e-04 | 2.5274 | 9.409 | 22 | 628 | response to wounding |
| GO:0006342 | 4e-04 | 6.9876 | 0.9514 | 6 | 67 | chromatin silencing |
| GO:0060429 | 8e-04 | 1.9521 | 17.7542 | 32 | 1185 | epithelium development |
| GO:0051967 | 8e-04 | 19.9614 | 0.1948 | 3 | 13 | negative regulation of synaptic transmission, glutamatergic |
| GO:0050878 | 9e-04 | 2.5279 | 7.1766 | 17 | 479 | regulation of body fluid levels |
| GO:0051248 | 0.0016 | 1.8679 | 18.4734 | 32 | 1233 | negative regulation of protein metabolic process |
| GO:0042699 | 0.0022 | 44.1913 | 0.0749 | 2 | 5 | follicle-stimulating hormone signaling pathway |
| GO:0019730 | 0.0027 | 4.6251 | 1.3934 | 6 | 93 | antimicrobial humoral response |
| GO:0010951 | 0.0028 | 3.0333 | 3.4909 | 10 | 233 | negative regulation of endopeptidase activity |
| GO:0006067 | 0.0031 | 11.7368 | 0.2996 | 3 | 20 | ethanol metabolic process |
| GO:0043152 | 0.0032 | 33.1414 | 0.0899 | 2 | 6 | induction of bacterial agglutination |
| GO:0097647 | 0.0032 | 33.1414 | 0.0899 | 2 | 6 | amylin receptor signaling pathway |
| GO:0071345 | 0.0044 | 1.9191 | 12.7201 | 23 | 849 | cellular response to cytokine stimulus |
| GO:0006701 | 0.0045 | 26.5114 | 0.1049 | 2 | 7 | progesterone biosynthetic process |
| GO:0035754 | 0.0045 | 26.5114 | 0.1049 | 2 | 7 | B cell chemotaxis |
| GO:0030814 | 0.0056 | 3.4817 | 2.1275 | 7 | 142 | regulation of cAMP metabolic process |
| GO:0071634 | 0.006 | 9.0664 | 0.3746 | 3 | 25 | regulation of transforming growth factor beta production |
| GO:0034103 | 0.007 | 4.4553 | 1.1986 | 5 | 80 | regulation of tissue remodeling |
| GO:0034248 | 0.007 | 2.0963 | 8.0306 | 16 | 536 | regulation of cellular amide metabolic process |
| GO:0014059 | 0.0074 | 8.3099 | 0.4045 | 3 | 27 | regulation of dopamine secretion |
| GO:0042554 | 0.0074 | 8.3099 | 0.4045 | 3 | 27 | superoxide anion generation |
| GO:0007195 | 0.0075 | 18.9343 | 0.1348 | 2 | 9 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
| GO:0048263 | 0.0075 | 18.9343 | 0.1348 | 2 | 9 | determination of dorsal identity |
| GO:0002376 | 0.0086 | 1.4865 | 39.4488 | 54 | 2633 | immune system process |
| GO:0050896 | 0.0092 | 1.8427 | 14.7148 | 24 | 1344 | response to stimulus |
| GO:0032963 | 0.0094 | 3.5236 | 1.7979 | 6 | 120 | collagen metabolic process |
| GO:0045861 | 0.0094 | 2.3893 | 4.8243 | 11 | 322 | negative regulation of proteolysis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045087 | 0 | 3.0613 | 8.4394 | 23 | 811 | innate immune response |
| GO:0040029 | 1e-04 | 3.7852 | 4.048 | 14 | 389 | regulation of gene expression, epigenetic |
| GO:0006342 | 1e-04 | 7.1954 | 1.0718 | 7 | 103 | chromatin silencing |
| GO:0044663 | 1e-04 | Inf | 0.0208 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
| GO:0070370 | 1e-04 | Inf | 0.0208 | 2 | 2 | cellular heat acclimation |
| GO:0038166 | 2e-04 | 36.2991 | 0.1145 | 3 | 11 | angiotensin-activated signaling pathway |
| GO:0090084 | 2e-04 | 36.2991 | 0.1145 | 3 | 11 | negative regulation of inclusion body assembly |
| GO:0051707 | 2e-04 | 2.6861 | 8.1793 | 20 | 786 | response to other organism |
| GO:0050778 | 2e-04 | 2.8458 | 6.9201 | 18 | 665 | positive regulation of immune response |
| GO:0070434 | 3e-04 | 192.5 | 0.0312 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0090063 | 3e-04 | 192.5 | 0.0312 | 2 | 3 | positive regulation of microtubule nucleation |
| GO:0051607 | 3e-04 | 4.4673 | 2.1749 | 9 | 209 | defense response to virus |
| GO:0009607 | 4e-04 | 2.536 | 8.6268 | 20 | 829 | response to biotic stimulus |
| GO:2000107 | 0.001 | 9.9696 | 0.4475 | 4 | 43 | negative regulation of leukocyte apoptotic process |
| GO:0060414 | 0.0011 | 64.1585 | 0.052 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
| GO:0007159 | 0.0011 | 3.2435 | 3.6318 | 11 | 349 | leukocyte cell-cell adhesion |
| GO:0007606 | 0.0011 | 3.0441 | 4.2249 | 12 | 406 | sensory perception of chemical stimulus |
| GO:0050863 | 0.0013 | 3.3896 | 3.1531 | 10 | 303 | regulation of T cell activation |
| GO:0002376 | 0.0013 | 1.7812 | 27.3996 | 43 | 2633 | immune system process |
| GO:1990776 | 0.0015 | 15.2732 | 0.2289 | 3 | 22 | response to angiotensin |
| GO:0045071 | 0.0018 | 8.4487 | 0.5203 | 4 | 50 | negative regulation of viral genome replication |
| GO:0042026 | 0.0019 | 13.8168 | 0.2497 | 3 | 24 | protein refolding |
| GO:1900239 | 0.0022 | 38.4902 | 0.0728 | 2 | 7 | regulation of phenotypic switching |
| GO:0001775 | 0.0024 | 2.0161 | 12.9557 | 24 | 1245 | cell activation |
| GO:0009593 | 0.0025 | 2.9006 | 4.0376 | 11 | 388 | detection of chemical stimulus |
| GO:0018149 | 0.0026 | 7.618 | 0.5723 | 4 | 55 | peptide cross-linking |
| GO:0042742 | 0.0026 | 3.5991 | 2.3622 | 8 | 227 | defense response to bacterium |
| GO:0036336 | 0.0027 | 12.0874 | 0.281 | 3 | 27 | dendritic cell migration |
| GO:0002694 | 0.0028 | 2.7177 | 4.7036 | 12 | 452 | regulation of leukocyte activation |
| GO:0002883 | 0.0029 | 32.0732 | 0.0832 | 2 | 8 | regulation of hypersensitivity |
| GO:0070424 | 0.0029 | 32.0732 | 0.0832 | 2 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:1903265 | 0.0029 | 32.0732 | 0.0832 | 2 | 8 | positive regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0002757 | 0.0031 | 2.6801 | 4.766 | 12 | 458 | immune response-activating signal transduction |
| GO:0050906 | 0.0032 | 2.809 | 4.1625 | 11 | 400 | detection of stimulus involved in sensory perception |
| GO:0032677 | 0.0035 | 6.9356 | 0.6244 | 4 | 60 | regulation of interleukin-8 production |
| GO:1902600 | 0.0036 | 5.2404 | 1.0198 | 5 | 98 | hydrogen ion transmembrane transport |
| GO:0001768 | 0.0037 | 27.4895 | 0.0937 | 2 | 9 | establishment of T cell polarity |
| GO:0006885 | 0.0037 | 5.1844 | 1.0302 | 5 | 99 | regulation of pH |
| GO:0006600 | 0.0046 | 24.0518 | 0.1041 | 2 | 10 | creatine metabolic process |
| GO:0050911 | 0.0053 | 2.9391 | 3.2363 | 9 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0050851 | 0.0054 | 3.5018 | 2.1125 | 7 | 203 | antigen receptor-mediated signaling pathway |
| GO:0001771 | 0.0056 | 21.378 | 0.1145 | 2 | 11 | immunological synapse formation |
| GO:0051451 | 0.0056 | 21.378 | 0.1145 | 2 | 11 | myoblast migration |
| GO:0097202 | 0.0056 | 21.378 | 0.1145 | 2 | 11 | activation of cysteine-type endopeptidase activity |
| GO:0098787 | 0.0056 | 21.378 | 0.1145 | 2 | 11 | mRNA cleavage involved in mRNA processing |
| GO:0052548 | 0.0063 | 2.6857 | 3.9336 | 10 | 378 | regulation of endopeptidase activity |
| GO:0002829 | 0.0066 | 19.239 | 0.1249 | 2 | 12 | negative regulation of type 2 immune response |
| GO:0019532 | 0.0066 | 19.239 | 0.1249 | 2 | 12 | oxalate transport |
| GO:0045060 | 0.0066 | 19.239 | 0.1249 | 2 | 12 | negative thymic T cell selection |
| GO:0045744 | 0.0071 | 8.2827 | 0.3954 | 3 | 38 | negative regulation of G-protein coupled receptor protein signaling pathway |
| GO:0006950 | 0.0073 | 1.5505 | 37.067 | 51 | 3562 | response to stress |
| GO:1902358 | 0.0078 | 17.4889 | 0.1353 | 2 | 13 | sulfate transmembrane transport |
| GO:0007155 | 0.0087 | 1.8212 | 13.5697 | 23 | 1304 | cell adhesion |
| GO:0006954 | 0.0089 | 2.1656 | 6.8473 | 14 | 658 | inflammatory response |
| GO:0010919 | 0.009 | 16.0305 | 0.1457 | 2 | 14 | regulation of inositol phosphate biosynthetic process |
| GO:0022407 | 0.0095 | 2.5173 | 4.1833 | 10 | 402 | regulation of cell-cell adhesion |
| GO:0002218 | 0.0096 | 2.8559 | 2.945 | 8 | 283 | activation of innate immune response |
| GO:0051250 | 0.0099 | 4.0543 | 1.3008 | 5 | 125 | negative regulation of lymphocyte activation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 40.4289 | 0.3751 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0051290 | 0 | 29.7955 | 0.5158 | 11 | 44 | protein heterotetramerization |
| GO:0000183 | 0 | 34.2003 | 0.422 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 32.9316 | 0.4337 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 32.9316 | 0.4337 | 10 | 37 | response to interleukin-7 |
| GO:1902679 | 0 | 3.3374 | 13.1528 | 37 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0009890 | 0 | 2.9357 | 18.5335 | 45 | 1581 | negative regulation of biosynthetic process |
| GO:0045652 | 0 | 13.8603 | 0.8675 | 10 | 74 | regulation of megakaryocyte differentiation |
| GO:0031497 | 0 | 8.8484 | 1.6998 | 13 | 145 | chromatin assembly |
| GO:0045815 | 0 | 12.8519 | 0.9261 | 10 | 79 | positive regulation of gene expression, epigenetic |
| GO:0034728 | 0 | 8.22 | 1.817 | 13 | 155 | nucleosome organization |
| GO:0035194 | 0 | 6.2195 | 2.7314 | 15 | 233 | posttranscriptional gene silencing by RNA |
| GO:0045934 | 0 | 2.8188 | 15.7787 | 38 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:1902036 | 0 | 9.7312 | 1.184 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 9.3191 | 1.2309 | 10 | 105 | regulation of gene silencing by miRNA |
| GO:0017148 | 0 | 4.7587 | 3.7513 | 16 | 320 | negative regulation of translation |
| GO:0065004 | 0 | 5.7852 | 2.5087 | 13 | 214 | protein-DNA complex assembly |
| GO:0060968 | 0 | 7.4916 | 1.5005 | 10 | 128 | regulation of gene silencing |
| GO:0002244 | 0 | 5.5679 | 2.1804 | 11 | 186 | hematopoietic progenitor cell differentiation |
| GO:0071103 | 0 | 4.6556 | 3.0713 | 13 | 262 | DNA conformation change |
| GO:0032200 | 0 | 5.7649 | 1.9108 | 10 | 163 | telomere organization |
| GO:0034248 | 1e-04 | 3.135 | 6.2834 | 18 | 536 | regulation of cellular amide metabolic process |
| GO:0006342 | 1e-04 | 9.0181 | 0.7451 | 6 | 67 | chromatin silencing |
| GO:0007596 | 1e-04 | 3.6764 | 3.8333 | 13 | 327 | blood coagulation |
| GO:0070370 | 1e-04 | Inf | 0.0234 | 2 | 2 | cellular heat acclimation |
| GO:0014013 | 2e-04 | 6.4833 | 1.184 | 7 | 101 | regulation of gliogenesis |
| GO:0048863 | 2e-04 | 3.9428 | 3.0127 | 11 | 257 | stem cell differentiation |
| GO:0007274 | 3e-04 | 14.3361 | 0.3282 | 4 | 28 | neuromuscular synaptic transmission |
| GO:0010608 | 4e-04 | 2.6689 | 7.3032 | 18 | 623 | posttranscriptional regulation of gene expression |
| GO:0035054 | 4e-04 | 170.4216 | 0.0352 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0061141 | 4e-04 | 170.4216 | 0.0352 | 2 | 3 | lung ciliated cell differentiation |
| GO:0070434 | 4e-04 | 170.4216 | 0.0352 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0071288 | 4e-04 | 170.4216 | 0.0352 | 2 | 3 | cellular response to mercury ion |
| GO:0090063 | 4e-04 | 170.4216 | 0.0352 | 2 | 3 | positive regulation of microtubule nucleation |
| GO:0030099 | 5e-04 | 3.179 | 4.396 | 13 | 375 | myeloid cell differentiation |
| GO:0050878 | 5e-04 | 2.8758 | 5.6152 | 15 | 479 | regulation of body fluid levels |
| GO:1903706 | 5e-04 | 2.9932 | 5.029 | 14 | 429 | regulation of hemopoiesis |
| GO:0048731 | 6e-04 | 1.6731 | 51.1694 | 72 | 4365 | system development |
| GO:0045687 | 7e-04 | 11.094 | 0.4103 | 4 | 35 | positive regulation of glial cell differentiation |
| GO:0040029 | 7e-04 | 3.4123 | 3.4568 | 11 | 310 | regulation of gene expression, epigenetic |
| GO:1903506 | 8e-04 | 1.6973 | 40.1619 | 59 | 3426 | regulation of nucleic acid-templated transcription |
| GO:0051259 | 9e-04 | 2.8305 | 5.3048 | 14 | 461 | protein oligomerization |
| GO:2000112 | 9e-04 | 1.658 | 45.7067 | 65 | 3899 | regulation of cellular macromolecule biosynthetic process |
| GO:0048523 | 0.001 | 1.6346 | 51.1812 | 71 | 4366 | negative regulation of cellular process |
| GO:0048708 | 0.001 | 7.1909 | 0.762 | 5 | 65 | astrocyte differentiation |
| GO:0051239 | 0.001 | 1.743 | 31.8505 | 49 | 2717 | regulation of multicellular organismal process |
| GO:0051248 | 0.0012 | 2.0372 | 14.454 | 27 | 1233 | negative regulation of protein metabolic process |
| GO:0072009 | 0.0013 | 5.3544 | 1.2074 | 6 | 103 | nephron epithelium development |
| GO:0015669 | 0.0013 | 16.0486 | 0.2227 | 3 | 19 | gas transport |
| GO:0015701 | 0.0016 | 8.8138 | 0.5041 | 4 | 43 | bicarbonate transport |
| GO:0045892 | 0.0022 | 2.1369 | 10.6275 | 21 | 985 | negative regulation of transcription, DNA-templated |
| GO:0071345 | 0.0023 | 2.1577 | 9.9525 | 20 | 849 | cellular response to cytokine stimulus |
| GO:0045662 | 0.0024 | 12.8356 | 0.2696 | 3 | 23 | negative regulation of myoblast differentiation |
| GO:0070206 | 0.0026 | 7.6357 | 0.5744 | 4 | 49 | protein trimerization |
| GO:0009611 | 0.003 | 2.3167 | 7.3618 | 16 | 628 | response to wounding |
| GO:0051252 | 0.003 | 1.5837 | 42.354 | 59 | 3613 | regulation of RNA metabolic process |
| GO:0060993 | 0.0036 | 5.2543 | 1.0199 | 5 | 87 | kidney morphogenesis |
| GO:0061101 | 0.0037 | 28.3946 | 0.0938 | 2 | 8 | neuroendocrine cell differentiation |
| GO:0070424 | 0.0037 | 28.3946 | 0.0938 | 2 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0071493 | 0.0037 | 28.3946 | 0.0938 | 2 | 8 | cellular response to UV-B |
| GO:0072201 | 0.0037 | 28.3946 | 0.0938 | 2 | 8 | negative regulation of mesenchymal cell proliferation |
| GO:1903265 | 0.0037 | 28.3946 | 0.0938 | 2 | 8 | positive regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0010605 | 0.0038 | 1.9179 | 14.2075 | 25 | 1307 | negative regulation of macromolecule metabolic process |
| GO:0061326 | 0.0039 | 5.1285 | 1.0433 | 5 | 89 | renal tubule development |
| GO:0042542 | 0.0043 | 4.1813 | 1.5239 | 6 | 130 | response to hydrogen peroxide |
| GO:0045595 | 0.0048 | 1.7568 | 19.1431 | 31 | 1633 | regulation of cell differentiation |
| GO:0033690 | 0.0058 | 21.2932 | 0.1172 | 2 | 10 | positive regulation of osteoblast proliferation |
| GO:0060236 | 0.0067 | 8.5516 | 0.3868 | 3 | 33 | regulation of mitotic spindle organization |
| GO:0061614 | 0.0067 | 8.5516 | 0.3868 | 3 | 33 | pri-miRNA transcription from RNA polymerase II promoter |
| GO:1901566 | 0.0068 | 1.6594 | 22.9295 | 35 | 1956 | organonitrogen compound biosynthetic process |
| GO:0090084 | 0.007 | 18.9261 | 0.1289 | 2 | 11 | negative regulation of inclusion body assembly |
| GO:0042221 | 0.0072 | 1.4933 | 47.6526 | 63 | 4065 | response to chemical |
| GO:0051962 | 0.0074 | 2.3772 | 5.3221 | 12 | 454 | positive regulation of nervous system development |
| GO:0014706 | 0.0078 | 2.5943 | 4.056 | 10 | 346 | striated muscle tissue development |
| GO:0072078 | 0.0087 | 5.2795 | 0.8089 | 4 | 69 | nephron tubule morphogenesis |
| GO:0007420 | 0.0088 | 2.102 | 7.5377 | 15 | 643 | brain development |
| GO:0034654 | 0.0096 | 1.4712 | 47.3244 | 62 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0021781 | 0.0098 | 15.483 | 0.1524 | 2 | 13 | glial cell fate commitment |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 27.8729 | 3.7627 | 60 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 21.2236 | 4.6943 | 60 | 388 | detection of chemical stimulus |
| GO:0050906 | 0 | 20.4586 | 4.8395 | 60 | 400 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 20.096 | 4.9121 | 60 | 406 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 7.5034 | 14.2887 | 70 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 7.0494 | 13.8894 | 66 | 1148 | nervous system process |
| GO:0031424 | 0 | 25.873 | 1.0862 | 20 | 93 | keratinization |
| GO:0009913 | 0 | 9.5817 | 3.9563 | 30 | 327 | epidermal cell differentiation |
| GO:0043588 | 0 | 7.9632 | 4.6701 | 30 | 386 | skin development |
| GO:0018149 | 0 | 29.9839 | 0.6654 | 14 | 55 | peptide cross-linking |
| GO:0042742 | 0 | 5.2462 | 2.7464 | 13 | 227 | defense response to bacterium |
| GO:0002548 | 0 | 11.5914 | 0.7017 | 7 | 58 | monocyte chemotaxis |
| GO:0032501 | 0 | 1.9784 | 69.418 | 97 | 6625 | multicellular organismal process |
| GO:0060429 | 0 | 2.4218 | 14.3371 | 31 | 1185 | epithelium development |
| GO:0070268 | 1e-04 | 6.5094 | 1.3551 | 8 | 112 | cornification |
| GO:0070098 | 3e-04 | 7.1913 | 0.9195 | 6 | 76 | chemokine-mediated signaling pathway |
| GO:0046968 | 4e-04 | 165.0052 | 0.0363 | 2 | 3 | peptide antigen transport |
| GO:0048247 | 4e-04 | 8.7051 | 0.6412 | 5 | 53 | lymphocyte chemotaxis |
| GO:0097530 | 6e-04 | 5.354 | 1.4156 | 7 | 117 | granulocyte migration |
| GO:0045087 | 0.002 | 2.1876 | 9.8121 | 20 | 811 | innate immune response |
| GO:0016098 | 0.0021 | 41.2435 | 0.0726 | 2 | 6 | monoterpenoid metabolic process |
| GO:0071677 | 0.0026 | 12.4255 | 0.2783 | 3 | 23 | positive regulation of mononuclear cell migration |
| GO:0019062 | 0.0029 | 32.9927 | 0.0847 | 2 | 7 | virion attachment to host cell |
| GO:0030593 | 0.0035 | 5.2788 | 1.0163 | 5 | 84 | neutrophil chemotaxis |
| GO:0071347 | 0.0037 | 5.2124 | 1.0284 | 5 | 85 | cellular response to interleukin-1 |
| GO:0060326 | 0.0037 | 3.1102 | 3.061 | 9 | 253 | cell chemotaxis |
| GO:1904628 | 0.0039 | 27.4921 | 0.0968 | 2 | 8 | cellular response to phorbol 13-acetate 12-myristate |
| GO:0031640 | 0.0044 | 6.5185 | 0.6654 | 4 | 55 | killing of cells of other organism |
| GO:0007195 | 0.005 | 23.5632 | 0.1089 | 2 | 9 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
| GO:0097267 | 0.005 | 23.5632 | 0.1089 | 2 | 9 | omega-hydroxylase P450 pathway |
| GO:0019730 | 0.0054 | 4.7362 | 1.1252 | 5 | 93 | antimicrobial humoral response |
| GO:0071624 | 0.0056 | 9.2 | 0.363 | 3 | 30 | positive regulation of granulocyte chemotaxis |
| GO:0042482 | 0.0061 | 20.6165 | 0.121 | 2 | 10 | positive regulation of odontogenesis |
| GO:0017144 | 0.0067 | 8.5644 | 0.3872 | 3 | 32 | drug metabolic process |
| GO:0035821 | 0.0069 | 3.7697 | 1.6817 | 6 | 139 | modification of morphology or physiology of other organism |
| GO:0050896 | 0.0072 | 1.446 | 97.6494 | 115 | 8071 | response to stimulus |
| GO:0042738 | 0.0075 | 18.3246 | 0.1331 | 2 | 11 | exogenous drug catabolic process |
| GO:0044406 | 0.0075 | 18.3246 | 0.1331 | 2 | 11 | adhesion of symbiont to host |
| GO:0006805 | 0.0076 | 4.3393 | 1.222 | 5 | 101 | xenobiotic metabolic process |
| GO:0060158 | 0.0089 | 16.4911 | 0.1452 | 2 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
| GO:0070989 | 0.0089 | 16.4911 | 0.1452 | 2 | 12 | oxidative demethylation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007218 | 0 | 10.9289 | 1.1844 | 11 | 94 | neuropeptide signaling pathway |
| GO:0007187 | 0 | 6.6128 | 2.2177 | 13 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0050877 | 0 | 2.675 | 14.4651 | 34 | 1148 | nervous system process |
| GO:0050794 | 0 | 1.9118 | 124.7052 | 152 | 9897 | regulation of cellular process |
| GO:0007268 | 1e-04 | 2.9754 | 7.3586 | 20 | 584 | chemical synaptic transmission |
| GO:0099537 | 1e-04 | 2.9645 | 7.3838 | 20 | 586 | trans-synaptic signaling |
| GO:0051241 | 1e-04 | 2.3997 | 12.9023 | 28 | 1034 | negative regulation of multicellular organismal process |
| GO:0072507 | 1e-04 | 3.1725 | 5.4685 | 16 | 434 | divalent inorganic cation homeostasis |
| GO:0006874 | 1e-04 | 3.2977 | 4.9267 | 15 | 391 | cellular calcium ion homeostasis |
| GO:0046877 | 2e-04 | 39.7601 | 0.1134 | 3 | 9 | regulation of saliva secretion |
| GO:0097746 | 2e-04 | 5.5388 | 1.575 | 8 | 125 | regulation of blood vessel diameter |
| GO:0009952 | 2e-04 | 4.4053 | 2.4571 | 10 | 195 | anterior/posterior pattern specification |
| GO:0033555 | 2e-04 | 7.9142 | 0.8442 | 6 | 67 | multicellular organismal response to stress |
| GO:0007606 | 2e-04 | 3.1681 | 5.1157 | 15 | 406 | sensory perception of chemical stimulus |
| GO:0007389 | 2e-04 | 3.1433 | 5.1535 | 15 | 409 | pattern specification process |
| GO:0030799 | 3e-04 | 4.6261 | 2.1043 | 9 | 167 | regulation of cyclic nucleotide metabolic process |
| GO:0035150 | 3e-04 | 5.1402 | 1.6884 | 8 | 134 | regulation of tube size |
| GO:0021559 | 3e-04 | 29.8163 | 0.1386 | 3 | 11 | trigeminal nerve development |
| GO:0042310 | 3e-04 | 7.2028 | 0.9198 | 6 | 73 | vasoconstriction |
| GO:0007200 | 3e-04 | 5.8841 | 1.2978 | 7 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0050885 | 3e-04 | 9.3189 | 0.6048 | 5 | 48 | neuromuscular process controlling balance |
| GO:0007631 | 3e-04 | 5.823 | 1.3104 | 7 | 104 | feeding behavior |
| GO:0007267 | 4e-04 | 2.2014 | 13.4687 | 27 | 1108 | cell-cell signaling |
| GO:0003203 | 5e-04 | 12.7724 | 0.3654 | 4 | 29 | endocardial cushion morphogenesis |
| GO:0021524 | 5e-04 | 158.2915 | 0.0378 | 2 | 3 | visceral motor neuron differentiation |
| GO:0060913 | 5e-04 | 158.2915 | 0.0378 | 2 | 3 | cardiac cell fate determination |
| GO:0065007 | 5e-04 | 1.7706 | 139.8633 | 161 | 11100 | biological regulation |
| GO:0019098 | 5e-04 | 12.2804 | 0.378 | 4 | 30 | reproductive behavior |
| GO:0007204 | 6e-04 | 3.4904 | 3.3769 | 11 | 268 | positive regulation of cytosolic calcium ion concentration |
| GO:0021545 | 6e-04 | 11.6292 | 0.3956 | 4 | 32 | cranial nerve development |
| GO:0042711 | 6e-04 | 21.6804 | 0.1764 | 3 | 14 | maternal behavior |
| GO:0001662 | 8e-04 | 11.0079 | 0.4158 | 4 | 33 | behavioral fear response |
| GO:0048665 | 8e-04 | 11.0079 | 0.4158 | 4 | 33 | neuron fate specification |
| GO:0003018 | 8e-04 | 4.4 | 1.953 | 8 | 155 | vascular process in circulatory system |
| GO:0060253 | 8e-04 | 19.8725 | 0.189 | 3 | 15 | negative regulation of glial cell proliferation |
| GO:0030816 | 9e-04 | 5.8083 | 1.1214 | 6 | 89 | positive regulation of cAMP metabolic process |
| GO:0001992 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0003308 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
| GO:0007198 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0021615 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0070253 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | somatostatin secretion |
| GO:0098664 | 0.001 | 18.5275 | 0.1996 | 3 | 16 | G-protein coupled serotonin receptor signaling pathway |
| GO:0045596 | 0.001 | 2.4498 | 7.8878 | 18 | 626 | negative regulation of cell differentiation |
| GO:0060193 | 0.001 | 7.1497 | 0.7686 | 5 | 61 | positive regulation of lipase activity |
| GO:0019932 | 0.0011 | 3.2342 | 3.6289 | 11 | 288 | second-messenger-mediated signaling |
| GO:0045777 | 0.0013 | 9.3861 | 0.4788 | 4 | 38 | positive regulation of blood pressure |
| GO:0009593 | 0.0013 | 2.8353 | 4.8889 | 13 | 388 | detection of chemical stimulus |
| GO:0080090 | 0.0013 | 1.5553 | 71.8973 | 93 | 5706 | regulation of primary metabolic process |
| GO:0050795 | 0.0014 | 6.5616 | 0.8316 | 5 | 66 | regulation of behavior |
| GO:0048880 | 0.0015 | 52.7571 | 0.063 | 2 | 5 | sensory system development |
| GO:0051970 | 0.0015 | 52.7571 | 0.063 | 2 | 5 | negative regulation of transmission of nerve impulse |
| GO:0007193 | 0.0017 | 6.3164 | 0.861 | 5 | 69 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0050906 | 0.0017 | 2.7452 | 5.0401 | 13 | 400 | detection of stimulus involved in sensory perception |
| GO:0008306 | 0.0019 | 6.1562 | 0.882 | 5 | 70 | associative learning |
| GO:0055065 | 0.0019 | 2.4223 | 7.0436 | 16 | 559 | metal ion homeostasis |
| GO:0021536 | 0.002 | 6.0625 | 0.8946 | 5 | 71 | diencephalon development |
| GO:0051171 | 0.0022 | 1.5231 | 70.0829 | 90 | 5562 | regulation of nitrogen compound metabolic process |
| GO:0014821 | 0.0022 | 13.2433 | 0.2646 | 3 | 21 | phasic smooth muscle contraction |
| GO:0031290 | 0.0022 | 13.2433 | 0.2646 | 3 | 21 | retinal ganglion cell axon guidance |
| GO:0050951 | 0.0022 | 13.2433 | 0.2646 | 3 | 21 | sensory perception of temperature stimulus |
| GO:0010840 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | regulation of circadian sleep/wake cycle, wakefulness |
| GO:0021546 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | rhombomere development |
| GO:0007611 | 0.0023 | 3.3556 | 2.8477 | 9 | 226 | learning or memory |
| GO:0007186 | 0.0024 | 2.1572 | 9.9841 | 20 | 883 | G-protein coupled receptor signaling pathway |
| GO:0030003 | 0.0025 | 2.3548 | 7.2326 | 16 | 574 | cellular cation homeostasis |
| GO:0050886 | 0.0029 | 5.5552 | 0.9702 | 5 | 77 | endocrine process |
| GO:0044062 | 0.0029 | 11.9174 | 0.2898 | 3 | 23 | regulation of excretion |
| GO:0050768 | 0.0032 | 3.1914 | 2.9863 | 9 | 237 | negative regulation of neurogenesis |
| GO:0060052 | 0.0032 | 31.6503 | 0.0882 | 2 | 7 | neurofilament cytoskeleton organization |
| GO:2000542 | 0.0032 | 31.6503 | 0.0882 | 2 | 7 | negative regulation of gastrulation |
| GO:0007202 | 0.0033 | 11.3492 | 0.3024 | 3 | 24 | activation of phospholipase C activity |
| GO:0035640 | 0.0033 | 11.3492 | 0.3024 | 3 | 24 | exploration behavior |
| GO:0046887 | 0.0035 | 4.3751 | 1.4616 | 6 | 116 | positive regulation of hormone secretion |
| GO:0003073 | 0.0036 | 5.2615 | 1.0206 | 5 | 81 | regulation of systemic arterial blood pressure |
| GO:0003148 | 0.0037 | 10.8326 | 0.315 | 3 | 25 | outflow tract septum morphogenesis |
| GO:0002118 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | aggressive behavior |
| GO:0045924 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | regulation of female receptivity |
| GO:0051094 | 0.0042 | 1.8601 | 15.007 | 26 | 1191 | positive regulation of developmental process |
| GO:0061311 | 0.0046 | 9.9287 | 0.3402 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0009914 | 0.0047 | 2.8011 | 3.7675 | 10 | 299 | hormone transport |
| GO:0034767 | 0.0049 | 4.0764 | 1.5624 | 6 | 124 | positive regulation of ion transmembrane transport |
| GO:0035270 | 0.0049 | 4.0764 | 1.5624 | 6 | 124 | endocrine system development |
| GO:1900542 | 0.0049 | 2.9791 | 3.1879 | 9 | 253 | regulation of purine nucleotide metabolic process |
| GO:0023061 | 0.0053 | 2.4877 | 5.0905 | 12 | 404 | signal release |
| GO:0001993 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
| GO:0010579 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
| GO:0021562 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | vestibulocochlear nerve development |
| GO:0043950 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | positive regulation of cAMP-mediated signaling |
| GO:0046549 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | retinal cone cell development |
| GO:0043266 | 0.0056 | 4.7017 | 1.134 | 5 | 90 | regulation of potassium ion transport |
| GO:0032355 | 0.0057 | 3.9417 | 1.6128 | 6 | 128 | response to estradiol |
| GO:0007417 | 0.0059 | 1.9689 | 10.7985 | 20 | 857 | central nervous system development |
| GO:0019933 | 0.0059 | 4.6383 | 1.1483 | 5 | 92 | cAMP-mediated signaling |
| GO:0050911 | 0.0062 | 2.6874 | 3.9187 | 10 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0019233 | 0.0064 | 4.5405 | 1.1718 | 5 | 93 | sensory perception of pain |
| GO:0051006 | 0.0067 | 19.7776 | 0.126 | 2 | 10 | positive regulation of lipoprotein lipase activity |
| GO:0032501 | 0.0071 | 1.4983 | 60.346 | 76 | 5469 | multicellular organismal process |
| GO:0043278 | 0.0075 | 8.2142 | 0.4032 | 3 | 32 | response to morphine |
| GO:0098801 | 0.0075 | 8.2142 | 0.4032 | 3 | 32 | regulation of renal system process |
| GO:0051960 | 0.0075 | 1.9924 | 9.5636 | 18 | 759 | regulation of nervous system development |
| GO:1901381 | 0.0081 | 7.9399 | 0.4158 | 3 | 33 | positive regulation of potassium ion transmembrane transport |
| GO:0045981 | 0.0084 | 3.6132 | 1.7514 | 6 | 139 | positive regulation of nucleotide metabolic process |
| GO:0055082 | 0.0085 | 2.0075 | 8.9462 | 17 | 710 | cellular chemical homeostasis |
| GO:0055008 | 0.0086 | 5.31 | 0.8064 | 4 | 64 | cardiac muscle tissue morphogenesis |
| GO:0007190 | 0.0088 | 7.6833 | 0.4284 | 3 | 34 | activation of adenylate cyclase activity |
| GO:0048562 | 0.009 | 2.6877 | 3.5155 | 9 | 279 | embryonic organ morphogenesis |
| GO:0014013 | 0.009 | 4.16 | 1.2726 | 5 | 101 | regulation of gliogenesis |
| GO:1900274 | 0.0096 | 7.4427 | 0.441 | 3 | 35 | regulation of phospholipase C activity |
| GO:0002862 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | negative regulation of inflammatory response to antigenic stimulus |
| GO:0033605 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | positive regulation of catecholamine secretion |
| GO:0035815 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | positive regulation of renal sodium excretion |
| GO:0071361 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | cellular response to ethanol |
| GO:0031326 | 0.0099 | 1.4443 | 52.7449 | 68 | 4186 | regulation of cellular biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038111 | 0 | 55.8023 | 0.385 | 13 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 55.8023 | 0.385 | 13 | 37 | response to interleukin-7 |
| GO:0006333 | 0 | 13.4732 | 1.7587 | 19 | 169 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 12.0885 | 1.9356 | 19 | 186 | DNA packaging |
| GO:0006335 | 0 | 45.9324 | 0.333 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 38.856 | 0.3746 | 10 | 36 | chromatin silencing at rDNA |
| GO:0071824 | 0 | 8.8989 | 2.5495 | 19 | 245 | protein-DNA complex subunit organization |
| GO:0051290 | 0 | 29.6983 | 0.4579 | 10 | 44 | protein heterotetramerization |
| GO:0045814 | 0 | 11.5266 | 1.2279 | 12 | 118 | negative regulation of gene expression, epigenetic |
| GO:0045652 | 0 | 15.7472 | 0.7701 | 10 | 74 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 14.6014 | 0.8221 | 10 | 79 | positive regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 11.0559 | 1.051 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 10.5877 | 1.0927 | 10 | 105 | regulation of gene silencing by miRNA |
| GO:0006334 | 0 | 11.2934 | 0.9211 | 9 | 94 | nucleosome assembly |
| GO:0060968 | 0 | 8.5115 | 1.332 | 10 | 128 | regulation of gene silencing |
| GO:0002227 | 0 | 32.6522 | 0.2081 | 5 | 20 | innate immune response in mucosa |
| GO:0035194 | 0 | 5.488 | 2.4246 | 12 | 233 | posttranscriptional gene silencing by RNA |
| GO:0032200 | 0 | 6.5498 | 1.6962 | 10 | 163 | telomere organization |
| GO:0048863 | 0 | 4.9428 | 2.6744 | 12 | 257 | stem cell differentiation |
| GO:0002251 | 0 | 18.1263 | 0.333 | 5 | 32 | organ or tissue specific immune response |
| GO:0071345 | 0 | 2.913 | 8.8349 | 23 | 849 | cellular response to cytokine stimulus |
| GO:0002244 | 0 | 5.6855 | 1.9356 | 10 | 186 | hematopoietic progenitor cell differentiation |
| GO:0050878 | 0 | 3.5301 | 4.9846 | 16 | 479 | regulation of body fluid levels |
| GO:0019731 | 0 | 14.825 | 0.3954 | 5 | 38 | antibacterial humoral response |
| GO:0006583 | 1e-04 | Inf | 0.0208 | 2 | 2 | melanin biosynthetic process from tyrosine |
| GO:0017148 | 1e-04 | 3.9158 | 3.33 | 12 | 320 | negative regulation of translation |
| GO:0045892 | 2e-04 | 2.4557 | 11.322 | 25 | 1088 | negative regulation of transcription, DNA-templated |
| GO:0061844 | 2e-04 | 10.6265 | 0.5307 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0034622 | 2e-04 | 2.5118 | 10.1253 | 23 | 973 | cellular macromolecular complex assembly |
| GO:1902679 | 2e-04 | 2.3741 | 11.6758 | 25 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0003166 | 3e-04 | 192.5 | 0.0312 | 2 | 3 | bundle of His development |
| GO:0099566 | 3e-04 | 192.5 | 0.0312 | 2 | 3 | regulation of postsynaptic cytosolic calcium ion concentration |
| GO:1903706 | 6e-04 | 3.1393 | 4.4643 | 13 | 429 | regulation of hemopoiesis |
| GO:0030099 | 6e-04 | 3.3107 | 3.9023 | 12 | 375 | myeloid cell differentiation |
| GO:0007596 | 6e-04 | 3.4743 | 3.4028 | 11 | 327 | blood coagulation |
| GO:0060364 | 6e-04 | 96.2439 | 0.0416 | 2 | 4 | frontal suture morphogenesis |
| GO:0045934 | 7e-04 | 2.1305 | 14.0068 | 27 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0009890 | 9e-04 | 2.0245 | 16.4522 | 30 | 1581 | negative regulation of biosynthetic process |
| GO:0097070 | 0.0011 | 64.1585 | 0.052 | 2 | 5 | ductus arteriosus closure |
| GO:0050830 | 0.0017 | 6.2542 | 0.8637 | 5 | 83 | defense response to Gram-positive bacterium |
| GO:0030879 | 0.0021 | 4.8549 | 1.3216 | 6 | 127 | mammary gland development |
| GO:0051791 | 0.0022 | 38.4902 | 0.0728 | 2 | 7 | medium-chain fatty acid metabolic process |
| GO:0051259 | 0.0026 | 2.6138 | 5.3072 | 13 | 510 | protein oligomerization |
| GO:0034248 | 0.004 | 2.4796 | 5.5777 | 13 | 536 | regulation of cellular amide metabolic process |
| GO:0035115 | 0.0044 | 10.0002 | 0.333 | 3 | 32 | embryonic forelimb morphogenesis |
| GO:0007200 | 0.0044 | 4.9715 | 1.0718 | 5 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0060411 | 0.0049 | 6.262 | 0.6868 | 4 | 66 | cardiac septum morphogenesis |
| GO:0003161 | 0.0056 | 21.378 | 0.1145 | 2 | 11 | cardiac conduction system development |
| GO:0009611 | 0.006 | 2.2759 | 6.5351 | 14 | 628 | response to wounding |
| GO:0035137 | 0.0061 | 8.7858 | 0.3746 | 3 | 36 | hindlimb morphogenesis |
| GO:2000648 | 0.0071 | 8.2827 | 0.3954 | 3 | 38 | positive regulation of stem cell proliferation |
| GO:0009593 | 0.0075 | 2.6129 | 4.0376 | 10 | 388 | detection of chemical stimulus |
| GO:0003197 | 0.0077 | 8.0521 | 0.4058 | 3 | 39 | endocardial cushion development |
| GO:0010033 | 0.008 | 1.5848 | 30.1364 | 43 | 2896 | response to organic substance |
| GO:0001938 | 0.0081 | 5.3889 | 0.7909 | 4 | 76 | positive regulation of endothelial cell proliferation |
| GO:0003214 | 0.009 | 16.0305 | 0.1457 | 2 | 14 | cardiac left ventricle morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009593 | 0 | 3.676 | 4.7673 | 16 | 388 | detection of chemical stimulus |
| GO:0050906 | 0 | 3.5583 | 4.9147 | 16 | 400 | detection of stimulus involved in sensory perception |
| GO:0007389 | 0 | 3.4748 | 5.0253 | 16 | 409 | pattern specification process |
| GO:2000035 | 1e-04 | 61.2124 | 0.086 | 3 | 7 | regulation of stem cell division |
| GO:0002686 | 1e-04 | 12.8632 | 0.4546 | 5 | 37 | negative regulation of leukocyte migration |
| GO:0050911 | 1e-04 | 3.6849 | 3.8212 | 13 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0061032 | 2e-04 | Inf | 0.0246 | 2 | 2 | visceral serous pericardium development |
| GO:0007606 | 2e-04 | 3.2566 | 4.9885 | 15 | 406 | sensory perception of chemical stimulus |
| GO:0007501 | 6e-04 | 22.2492 | 0.172 | 3 | 14 | mesodermal cell fate specification |
| GO:0060429 | 6e-04 | 2.103 | 14.5599 | 28 | 1185 | epithelium development |
| GO:0048333 | 7e-04 | 11.2981 | 0.4055 | 4 | 33 | mesodermal cell differentiation |
| GO:0001501 | 8e-04 | 2.7557 | 5.8363 | 15 | 475 | skeletal system development |
| GO:0007186 | 8e-04 | 2.0948 | 14.0643 | 27 | 1161 | G-protein coupled receptor signaling pathway |
| GO:0090027 | 9e-04 | 81.2062 | 0.0491 | 2 | 4 | negative regulation of monocyte chemotaxis |
| GO:0030326 | 9e-04 | 4.8668 | 1.5481 | 7 | 126 | embryonic limb morphogenesis |
| GO:0001657 | 0.001 | 5.6875 | 1.1427 | 6 | 93 | ureteric bud development |
| GO:0010469 | 0.0011 | 2.5839 | 6.6349 | 16 | 540 | regulation of receptor activity |
| GO:0072163 | 0.0011 | 5.6225 | 1.155 | 6 | 94 | mesonephric epithelium development |
| GO:0060173 | 0.0012 | 4.1218 | 2.0765 | 8 | 169 | limb development |
| GO:0097529 | 0.0013 | 4.0707 | 2.1011 | 8 | 171 | myeloid leukocyte migration |
| GO:0048729 | 0.0014 | 2.4413 | 7.4581 | 17 | 607 | tissue morphogenesis |
| GO:0035609 | 0.0015 | 54.134 | 0.0614 | 2 | 5 | C-terminal protein deglutamylation |
| GO:0071504 | 0.0015 | 54.134 | 0.0614 | 2 | 5 | cellular response to heparin |
| GO:0071672 | 0.0015 | 54.134 | 0.0614 | 2 | 5 | negative regulation of smooth muscle cell chemotaxis |
| GO:0071305 | 0.0015 | 15.2915 | 0.2335 | 3 | 19 | cellular response to vitamin D |
| GO:0071675 | 0.0016 | 8.8508 | 0.5038 | 4 | 41 | regulation of mononuclear cell migration |
| GO:0048568 | 0.0017 | 2.7412 | 5.0499 | 13 | 411 | embryonic organ development |
| GO:0002688 | 0.0018 | 5.0455 | 1.2778 | 6 | 104 | regulation of leukocyte chemotaxis |
| GO:0098664 | 0.0018 | 14.391 | 0.2457 | 3 | 20 | G-protein coupled serotonin receptor signaling pathway |
| GO:0072088 | 0.0018 | 6.2232 | 0.8724 | 5 | 71 | nephron epithelium morphogenesis |
| GO:2000401 | 0.0019 | 8.3958 | 0.5283 | 4 | 43 | regulation of lymphocyte migration |
| GO:0061333 | 0.002 | 6.0394 | 0.8969 | 5 | 73 | renal tubule morphogenesis |
| GO:0003008 | 0.0021 | 1.7752 | 22.8904 | 37 | 1863 | system process |
| GO:0035107 | 0.0021 | 4.1916 | 1.7816 | 7 | 145 | appendage morphogenesis |
| GO:0009952 | 0.0021 | 4.1788 | 1.7866 | 7 | 148 | anterior/posterior pattern specification |
| GO:2000406 | 0.0024 | 12.8746 | 0.2703 | 3 | 22 | positive regulation of T cell migration |
| GO:0032330 | 0.0024 | 7.7946 | 0.5652 | 4 | 46 | regulation of chondrocyte differentiation |
| GO:0070098 | 0.0024 | 5.7831 | 0.9338 | 5 | 76 | chemokine-mediated signaling pathway |
| GO:0009948 | 0.0026 | 7.6129 | 0.5775 | 4 | 47 | anterior/posterior axis specification |
| GO:0003357 | 0.003 | 32.4763 | 0.086 | 2 | 7 | noradrenergic neuron differentiation |
| GO:0061217 | 0.0031 | 11.6469 | 0.2949 | 3 | 24 | regulation of mesonephros development |
| GO:0035239 | 0.0031 | 2.8143 | 4.1407 | 11 | 337 | tube morphogenesis |
| GO:0001525 | 0.0034 | 2.5259 | 5.4554 | 13 | 444 | angiogenesis |
| GO:0072273 | 0.0034 | 11.1168 | 0.3072 | 3 | 25 | metanephric nephron morphogenesis |
| GO:0001656 | 0.0037 | 5.1948 | 1.0321 | 5 | 84 | metanephros development |
| GO:0051093 | 0.0038 | 2.0592 | 10.3701 | 20 | 844 | negative regulation of developmental process |
| GO:2000242 | 0.0038 | 6.8177 | 0.6389 | 4 | 52 | negative regulation of reproductive process |
| GO:0071347 | 0.0039 | 5.1296 | 1.0444 | 5 | 85 | cellular response to interleukin-1 |
| GO:2000270 | 0.004 | 27.0619 | 0.0983 | 2 | 8 | negative regulation of fibroblast apoptotic process |
| GO:0006968 | 0.0043 | 6.5442 | 0.6635 | 4 | 54 | cellular defense response |
| GO:2000146 | 0.0043 | 3.0344 | 3.1331 | 9 | 255 | negative regulation of cell motility |
| GO:0060993 | 0.0044 | 5.0038 | 1.069 | 5 | 87 | kidney morphogenesis |
| GO:0033273 | 0.0046 | 4.9432 | 1.0812 | 5 | 88 | response to vitamin |
| GO:0048598 | 0.0046 | 3.008 | 3.1625 | 9 | 269 | embryonic morphogenesis |
| GO:0001658 | 0.0046 | 6.4154 | 0.6758 | 4 | 55 | branching involved in ureteric bud morphogenesis |
| GO:0033689 | 0.0051 | 23.1944 | 0.1106 | 2 | 9 | negative regulation of osteoblast proliferation |
| GO:0048865 | 0.0051 | 23.1944 | 0.1106 | 2 | 9 | stem cell fate commitment |
| GO:2000501 | 0.0051 | 23.1944 | 0.1106 | 2 | 9 | regulation of natural killer cell chemotaxis |
| GO:0035051 | 0.0055 | 9.237 | 0.3616 | 3 | 30 | cardiocyte differentiation |
| GO:0048704 | 0.0055 | 4.7147 | 1.1304 | 5 | 92 | embryonic skeletal system morphogenesis |
| GO:0010667 | 0.0058 | 9.0553 | 0.3686 | 3 | 30 | negative regulation of cardiac muscle cell apoptotic process |
| GO:0072006 | 0.0058 | 3.9173 | 1.6219 | 6 | 132 | nephron development |
| GO:0072001 | 0.0063 | 2.8573 | 3.3175 | 9 | 270 | renal system development |
| GO:0050905 | 0.0063 | 4.5567 | 1.1673 | 5 | 95 | neuromuscular process |
| GO:0060346 | 0.0063 | 20.2938 | 0.1229 | 2 | 10 | bone trabecula formation |
| GO:0006355 | 0.0063 | 1.5192 | 41.849 | 57 | 3406 | regulation of transcription, DNA-templated |
| GO:0009954 | 0.0064 | 8.7313 | 0.3809 | 3 | 31 | proximal/distal pattern formation |
| GO:0072171 | 0.0067 | 5.7379 | 0.7495 | 4 | 61 | mesonephric tubule morphogenesis |
| GO:0007369 | 0.0071 | 3.3167 | 2.2239 | 7 | 181 | gastrulation |
| GO:2001141 | 0.0075 | 1.5038 | 42.1808 | 57 | 3433 | regulation of RNA biosynthetic process |
| GO:0000578 | 0.0076 | 8.1482 | 0.4055 | 3 | 33 | embryonic axis specification |
| GO:0003156 | 0.0076 | 8.1482 | 0.4055 | 3 | 33 | regulation of animal organ formation |
| GO:0003157 | 0.0077 | 18.0378 | 0.1352 | 2 | 11 | endocardium development |
| GO:0055123 | 0.0077 | 3.6815 | 1.7202 | 6 | 140 | digestive system development |
| GO:0065007 | 0.0079 | 1.5171 | 136.3842 | 152 | 11100 | biological regulation |
| GO:0046888 | 0.0079 | 5.45 | 0.7864 | 4 | 64 | negative regulation of hormone secretion |
| GO:0001568 | 0.0081 | 2.1228 | 7.4581 | 15 | 607 | blood vessel development |
| GO:1901342 | 0.0082 | 2.7296 | 3.4649 | 9 | 282 | regulation of vasculature development |
| GO:0051155 | 0.0083 | 5.3603 | 0.7986 | 4 | 65 | positive regulation of striated muscle cell differentiation |
| GO:0051241 | 0.0088 | 1.8343 | 12.7538 | 22 | 1038 | negative regulation of multicellular organismal process |
| GO:0060795 | 0.009 | 7.638 | 0.43 | 3 | 35 | cell fate commitment involved in formation of primary germ layer |
| GO:0016331 | 0.0091 | 3.548 | 1.7816 | 6 | 145 | morphogenesis of embryonic epithelium |
| GO:0003337 | 0.0091 | 16.233 | 0.1474 | 2 | 12 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO:0010454 | 0.0091 | 16.233 | 0.1474 | 2 | 12 | negative regulation of cell fate commitment |
| GO:0045835 | 0.0091 | 16.233 | 0.1474 | 2 | 12 | negative regulation of meiotic nuclear division |
| GO:0072017 | 0.0091 | 16.233 | 0.1474 | 2 | 12 | distal tubule development |
| GO:0055007 | 0.0095 | 4.0984 | 1.2901 | 5 | 105 | cardiac muscle cell differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 27.024 | 3.3338 | 53 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 22.6596 | 4.1592 | 56 | 388 | detection of chemical stimulus |
| GO:0007606 | 0 | 21.4692 | 4.3522 | 56 | 406 | sensory perception of chemical stimulus |
| GO:0050906 | 0 | 21.2139 | 4.2879 | 55 | 400 | detection of stimulus involved in sensory perception |
| GO:0050877 | 0 | 7.4963 | 12.3062 | 61 | 1148 | nervous system process |
| GO:0007186 | 0 | 6.52 | 12.6599 | 57 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0008544 | 0 | 6.8773 | 4.5773 | 26 | 427 | epidermis development |
| GO:0031424 | 0 | 16.7838 | 0.9629 | 13 | 93 | keratinization |
| GO:0018149 | 0 | 24.5891 | 0.5896 | 11 | 55 | peptide cross-linking |
| GO:0030855 | 0 | 3.9943 | 7.5466 | 26 | 704 | epithelial cell differentiation |
| GO:0032501 | 0 | 2.289 | 63.528 | 94 | 6625 | multicellular organismal process |
| GO:0019373 | 0 | 31.6586 | 0.2144 | 5 | 20 | epoxygenase P450 pathway |
| GO:0052695 | 0 | 31.475 | 0.1715 | 4 | 16 | cellular glucuronidation |
| GO:0042742 | 0 | 4.9541 | 2.4334 | 11 | 227 | defense response to bacterium |
| GO:0001676 | 1e-04 | 8.0727 | 0.9648 | 7 | 90 | long-chain fatty acid metabolic process |
| GO:0006063 | 1e-04 | 22.2106 | 0.2251 | 4 | 21 | uronic acid metabolic process |
| GO:0042738 | 2e-04 | 35.2076 | 0.1179 | 3 | 11 | exogenous drug catabolic process |
| GO:0070268 | 2e-04 | 6.3724 | 1.2006 | 7 | 112 | cornification |
| GO:0010951 | 2e-04 | 4.3333 | 2.4977 | 10 | 233 | negative regulation of endopeptidase activity |
| GO:0031640 | 3e-04 | 9.4765 | 0.5896 | 5 | 55 | killing of cells of other organism |
| GO:0033559 | 5e-04 | 6.4847 | 1.0076 | 6 | 94 | unsaturated fatty acid metabolic process |
| GO:0006690 | 8e-04 | 5.9413 | 1.0934 | 6 | 102 | icosanoid metabolic process |
| GO:0008202 | 0.0014 | 3.3651 | 3.173 | 10 | 296 | steroid metabolic process |
| GO:0071674 | 0.0015 | 6.4813 | 0.8361 | 5 | 78 | mononuclear cell migration |
| GO:0016098 | 0.0017 | 46.6775 | 0.0643 | 2 | 6 | monoterpenoid metabolic process |
| GO:0050896 | 0.0017 | 1.6003 | 86.5184 | 106 | 8071 | response to stimulus |
| GO:0061844 | 0.0022 | 8.0183 | 0.5467 | 4 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0048007 | 0.0023 | 37.3396 | 0.075 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:0045861 | 0.0025 | 3.0795 | 3.4517 | 10 | 322 | negative regulation of proteolysis |
| GO:0034308 | 0.0028 | 7.3876 | 0.5896 | 4 | 55 | primary alcohol metabolic process |
| GO:0035821 | 0.0039 | 4.2783 | 1.49 | 6 | 139 | modification of morphology or physiology of other organism |
| GO:0007195 | 0.0039 | 26.6678 | 0.0965 | 2 | 9 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
| GO:0090370 | 0.0039 | 26.6678 | 0.0965 | 2 | 9 | negative regulation of cholesterol efflux |
| GO:0097267 | 0.0039 | 26.6678 | 0.0965 | 2 | 9 | omega-hydroxylase P450 pathway |
| GO:0052547 | 0.0041 | 2.706 | 4.3093 | 11 | 402 | regulation of peptidase activity |
| GO:0006805 | 0.0046 | 4.9212 | 1.0827 | 5 | 101 | xenobiotic metabolic process |
| GO:0017144 | 0.0048 | 9.6995 | 0.343 | 3 | 32 | drug metabolic process |
| GO:0002475 | 0.0049 | 23.3328 | 0.1072 | 2 | 10 | antigen processing and presentation via MHC class Ib |
| GO:0030216 | 0.0053 | 6.1232 | 0.7 | 4 | 73 | keratinocyte differentiation |
| GO:0006069 | 0.0059 | 20.739 | 0.1179 | 2 | 11 | ethanol oxidation |
| GO:0048245 | 0.0059 | 20.739 | 0.1179 | 2 | 11 | eosinophil chemotaxis |
| GO:0034754 | 0.0069 | 4.4541 | 1.1899 | 5 | 111 | cellular hormone metabolic process |
| GO:0060158 | 0.007 | 18.6639 | 0.1286 | 2 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
| GO:0009410 | 0.0071 | 4.4122 | 1.2006 | 5 | 112 | response to xenobiotic stimulus |
| GO:0051481 | 0.0082 | 16.9661 | 0.1394 | 2 | 13 | negative regulation of cytosolic calcium ion concentration |
| GO:0051967 | 0.0082 | 16.9661 | 0.1394 | 2 | 13 | negative regulation of synaptic transmission, glutamatergic |
| GO:0048149 | 0.0096 | 15.5513 | 0.1501 | 2 | 14 | behavioral response to ethanol |
| GO:1900003 | 0.0096 | 15.5513 | 0.1501 | 2 | 14 | regulation of serine-type endopeptidase activity |
| GO:0045104 | 0.0096 | 7.398 | 0.4395 | 3 | 41 | intermediate filament cytoskeleton organization |
| GO:0019730 | 0.0097 | 7.3616 | 0.4411 | 3 | 42 | antimicrobial humoral response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 305.129 | 0.3591 | 24 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 203.3677 | 0.404 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 121.9587 | 0.4937 | 24 | 44 | protein heterotetramerization |
| GO:0045815 | 0 | 44.2501 | 0.8865 | 24 | 79 | positive regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 33.5291 | 1.1333 | 25 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 29.9967 | 1.1782 | 24 | 105 | regulation of gene silencing by miRNA |
| GO:0045653 | 0 | 334.4939 | 0.202 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0031497 | 0 | 22.3543 | 1.6271 | 26 | 145 | chromatin assembly |
| GO:0060968 | 0 | 23.3285 | 1.4363 | 24 | 128 | regulation of gene silencing |
| GO:0002244 | 0 | 16.5824 | 2.0871 | 26 | 186 | hematopoietic progenitor cell differentiation |
| GO:0032200 | 0 | 17.4155 | 1.829 | 24 | 163 | telomere organization |
| GO:0035194 | 0 | 13.4233 | 2.6145 | 27 | 233 | posttranscriptional gene silencing by RNA |
| GO:0065004 | 0 | 14.0874 | 2.4013 | 26 | 214 | protein-DNA complex assembly |
| GO:0048863 | 0 | 12.004 | 2.8838 | 27 | 257 | stem cell differentiation |
| GO:0034080 | 0 | 51.3888 | 0.4488 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:0071103 | 0 | 11.1876 | 2.9399 | 26 | 262 | DNA conformation change |
| GO:0017148 | 0 | 9.831 | 3.5908 | 28 | 320 | negative regulation of translation |
| GO:1904837 | 0 | 44.5257 | 0.4937 | 14 | 44 | beta-catenin-TCF complex assembly |
| GO:0034724 | 0 | 36.0858 | 0.5723 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0016233 | 0 | 32.557 | 0.6172 | 14 | 55 | telomere capping |
| GO:0030099 | 0 | 7.8735 | 4.2079 | 27 | 375 | myeloid cell differentiation |
| GO:0006303 | 0 | 22.9896 | 0.8079 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 0 | 21.8547 | 0.8416 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:1903707 | 0 | 13.0228 | 1.5036 | 16 | 134 | negative regulation of hemopoiesis |
| GO:1903507 | 0 | 4.1749 | 12.5789 | 42 | 1121 | negative regulation of nucleic acid-templated transcription |
| GO:0038111 | 0 | 34.508 | 0.4152 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 34.508 | 0.4152 | 10 | 37 | response to interleukin-7 |
| GO:0034248 | 0 | 5.572 | 6.0145 | 28 | 536 | regulation of cellular amide metabolic process |
| GO:0051253 | 0 | 3.8873 | 13.4093 | 42 | 1195 | negative regulation of RNA metabolic process |
| GO:0051259 | 0 | 5.368 | 5.7228 | 26 | 510 | protein oligomerization |
| GO:0010558 | 0 | 3.4531 | 16.6298 | 46 | 1482 | negative regulation of macromolecule biosynthetic process |
| GO:0048534 | 0 | 4.2304 | 9.3472 | 33 | 833 | hematopoietic or lymphoid organ development |
| GO:0045652 | 0 | 22.0519 | 0.5799 | 10 | 56 | regulation of megakaryocyte differentiation |
| GO:0010608 | 0 | 4.7302 | 6.9908 | 28 | 623 | posttranscriptional regulation of gene expression |
| GO:0031327 | 0 | 3.2526 | 17.5275 | 46 | 1562 | negative regulation of cellular biosynthetic process |
| GO:0034728 | 0 | 13.3367 | 1.0792 | 12 | 104 | nucleosome organization |
| GO:0043043 | 0 | 4.1077 | 8.6066 | 30 | 767 | peptide biosynthetic process |
| GO:0009593 | 0 | 5.2656 | 4.3538 | 20 | 388 | detection of chemical stimulus |
| GO:0051248 | 0 | 3.1758 | 13.8357 | 37 | 1233 | negative regulation of protein metabolic process |
| GO:0002376 | 0 | 2.5212 | 29.5453 | 59 | 2633 | immune system process |
| GO:0050911 | 0 | 5.525 | 3.4898 | 17 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0 | 4.7212 | 4.5558 | 19 | 406 | sensory perception of chemical stimulus |
| GO:0006352 | 0 | 6.1111 | 2.5809 | 14 | 230 | DNA-templated transcription, initiation |
| GO:0050906 | 0 | 4.5045 | 4.4885 | 18 | 400 | detection of stimulus involved in sensory perception |
| GO:0006342 | 0 | 12.3769 | 0.6525 | 7 | 67 | chromatin silencing |
| GO:0060249 | 0 | 4.3003 | 4.1294 | 16 | 368 | anatomical structure homeostasis |
| GO:0007186 | 0 | 2.6634 | 13.2522 | 31 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0009892 | 0 | 2.1304 | 31.1163 | 55 | 2773 | negative regulation of metabolic process |
| GO:1903706 | 0 | 4.7246 | 3.0399 | 13 | 295 | regulation of hemopoiesis |
| GO:0051239 | 0 | 2.0699 | 30.4879 | 53 | 2717 | regulation of multicellular organismal process |
| GO:0032268 | 0 | 2.0606 | 27.9183 | 49 | 2488 | regulation of cellular protein metabolic process |
| GO:0045596 | 1e-04 | 2.967 | 7.0244 | 19 | 626 | negative regulation of cell differentiation |
| GO:0070271 | 3e-04 | 2.1651 | 15.3954 | 30 | 1372 | protein complex biogenesis |
| GO:0003099 | 4e-04 | 178.2147 | 0.0337 | 2 | 3 | positive regulation of the force of heart contraction by chemical signal |
| GO:0071822 | 5e-04 | 2.0347 | 18.0661 | 33 | 1610 | protein complex subunit organization |
| GO:0048523 | 5e-04 | 1.7735 | 39.0448 | 58 | 3740 | negative regulation of cellular process |
| GO:0031424 | 5e-04 | 4.2075 | 2.3003 | 9 | 205 | keratinization |
| GO:0071345 | 6e-04 | 2.399 | 9.5268 | 21 | 849 | cellular response to cytokine stimulus |
| GO:0051790 | 7e-04 | 89.1017 | 0.0449 | 2 | 4 | short-chain fatty acid biosynthetic process |
| GO:0072086 | 7e-04 | 89.1017 | 0.0449 | 2 | 4 | specification of loop of Henle identity |
| GO:0040029 | 9e-04 | 3.5444 | 3.0272 | 10 | 310 | regulation of gene expression, epigenetic |
| GO:0046641 | 0.0012 | 16.7866 | 0.2132 | 3 | 19 | positive regulation of alpha-beta T cell proliferation |
| GO:0007596 | 0.0012 | 3.2027 | 3.6693 | 11 | 327 | blood coagulation |
| GO:0009913 | 0.0012 | 3.2027 | 3.6693 | 11 | 327 | epidermal cell differentiation |
| GO:0072047 | 0.0012 | 59.3974 | 0.0561 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
| GO:0010604 | 0.0015 | 1.7069 | 32.5638 | 49 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0006281 | 0.0016 | 2.6576 | 5.633 | 14 | 502 | DNA repair |
| GO:0002725 | 0.0018 | 44.5452 | 0.0673 | 2 | 6 | negative regulation of T cell cytokine production |
| GO:0035744 | 0.0018 | 44.5452 | 0.0673 | 2 | 6 | T-helper 1 cell cytokine production |
| GO:0071622 | 0.0019 | 8.3615 | 0.5274 | 4 | 47 | regulation of granulocyte chemotaxis |
| GO:0006950 | 0.002 | 1.6353 | 39.9698 | 57 | 3562 | response to stress |
| GO:0051716 | 0.002 | 1.5588 | 75.4848 | 95 | 6727 | cellular response to stimulus |
| GO:0006355 | 0.002 | 1.6442 | 38.2193 | 55 | 3406 | regulation of transcription, DNA-templated |
| GO:0097530 | 0.0021 | 4.8936 | 1.3129 | 6 | 117 | granulocyte migration |
| GO:0048869 | 0.0022 | 1.6061 | 44.6041 | 62 | 3975 | cellular developmental process |
| GO:2001141 | 0.0024 | 1.6275 | 38.5223 | 55 | 3433 | regulation of RNA biosynthetic process |
| GO:0065003 | 0.0026 | 1.8249 | 19.2219 | 32 | 1713 | macromolecular complex assembly |
| GO:0002690 | 0.0027 | 5.6369 | 0.9538 | 5 | 85 | positive regulation of leukocyte chemotaxis |
| GO:0009889 | 0.0027 | 1.5778 | 47.7124 | 65 | 4252 | regulation of biosynthetic process |
| GO:0003008 | 0.0028 | 1.7877 | 20.905 | 34 | 1863 | system process |
| GO:0050878 | 0.003 | 2.5724 | 5.3749 | 13 | 479 | regulation of body fluid levels |
| GO:0090023 | 0.0033 | 11.1854 | 0.303 | 3 | 27 | positive regulation of neutrophil chemotaxis |
| GO:0018149 | 0.0033 | 7.0463 | 0.6172 | 4 | 55 | peptide cross-linking |
| GO:0090281 | 0.0034 | 29.693 | 0.0898 | 2 | 8 | negative regulation of calcium ion import |
| GO:1990403 | 0.0034 | 29.693 | 0.0898 | 2 | 8 | embryonic brain development |
| GO:2001185 | 0.0034 | 29.693 | 0.0898 | 2 | 8 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0043588 | 0.0043 | 2.6885 | 4.3314 | 11 | 386 | skin development |
| GO:0072048 | 0.0043 | 25.4496 | 0.101 | 2 | 9 | renal system pattern specification |
| GO:0002385 | 0.0045 | 9.9407 | 0.3366 | 3 | 30 | mucosal immune response |
| GO:0002701 | 0.0045 | 9.9407 | 0.3366 | 3 | 30 | negative regulation of production of molecular mediator of immune response |
| GO:0042531 | 0.0049 | 6.3022 | 0.6845 | 4 | 61 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0042116 | 0.0052 | 6.1931 | 0.6957 | 4 | 62 | macrophage activation |
| GO:0048731 | 0.0053 | 1.5213 | 48.9804 | 65 | 4365 | system development |
| GO:0042535 | 0.0053 | 22.2669 | 0.1122 | 2 | 10 | positive regulation of tumor necrosis factor biosynthetic process |
| GO:0048246 | 0.0059 | 8.9449 | 0.3703 | 3 | 33 | macrophage chemotaxis |
| GO:1902622 | 0.0064 | 8.6558 | 0.3815 | 3 | 34 | regulation of neutrophil migration |
| GO:0006959 | 0.0081 | 3.2344 | 2.2779 | 7 | 203 | humoral immune response |
| GO:0019731 | 0.0088 | 7.6646 | 0.4264 | 3 | 38 | antibacterial humoral response |
| GO:0045595 | 0.0088 | 1.9337 | 10.5129 | 19 | 1007 | regulation of cell differentiation |
| GO:0050829 | 0.0091 | 5.2022 | 0.8191 | 4 | 73 | defense response to Gram-negative bacterium |
| GO:1904064 | 0.0092 | 4.1295 | 1.2792 | 5 | 114 | positive regulation of cation transmembrane transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 275.345 | 0.2415 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 0 | 61.1333 | 0.4293 | 14 | 32 | DNA replication-dependent nucleosome assembly |
| GO:1904837 | 0 | 40.8309 | 0.5903 | 15 | 44 | beta-catenin-TCF complex assembly |
| GO:0000183 | 0 | 50.0055 | 0.4829 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 42.3015 | 0.5366 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:0051290 | 0 | 36.652 | 0.5903 | 14 | 44 | protein heterotetramerization |
| GO:0034724 | 0 | 29.7046 | 0.6842 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0016233 | 0 | 26.7998 | 0.7378 | 14 | 55 | telomere capping |
| GO:0006303 | 0 | 18.9241 | 0.9659 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 0 | 17.99 | 1.0061 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:0045815 | 0 | 16.8786 | 1.0598 | 14 | 79 | positive regulation of gene expression, epigenetic |
| GO:0045814 | 0 | 12.3874 | 1.583 | 16 | 118 | negative regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 13.1055 | 1.4086 | 15 | 105 | regulation of gene silencing by miRNA |
| GO:1903707 | 0 | 10.6968 | 1.7976 | 16 | 134 | negative regulation of hemopoiesis |
| GO:0048863 | 0 | 7.1472 | 3.4477 | 21 | 257 | stem cell differentiation |
| GO:0007389 | 0 | 5.5446 | 5.4868 | 26 | 409 | pattern specification process |
| GO:1902036 | 0 | 12.5928 | 1.3549 | 14 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060968 | 0 | 10.4227 | 1.7172 | 15 | 128 | regulation of gene silencing |
| GO:1902679 | 0 | 3.3141 | 15.0519 | 42 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0031497 | 0 | 9.0499 | 1.9452 | 15 | 145 | chromatin assembly |
| GO:0009952 | 0 | 7.5435 | 2.616 | 17 | 195 | anterior/posterior pattern specification |
| GO:0035194 | 0 | 6.6306 | 3.1258 | 18 | 233 | posttranscriptional gene silencing by RNA |
| GO:0048704 | 0 | 11.6272 | 1.2342 | 12 | 92 | embryonic skeletal system morphogenesis |
| GO:0065004 | 0 | 6.8076 | 2.8709 | 17 | 214 | protein-DNA complex assembly |
| GO:0045934 | 0 | 2.9548 | 18.0569 | 45 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0006352 | 0 | 6.2898 | 3.0855 | 17 | 230 | DNA-templated transcription, initiation |
| GO:0045637 | 0 | 6.1722 | 3.1392 | 17 | 234 | regulation of myeloid cell differentiation |
| GO:0002244 | 0 | 6.8619 | 2.4952 | 15 | 186 | hematopoietic progenitor cell differentiation |
| GO:0032200 | 0 | 7.3237 | 2.1867 | 14 | 163 | telomere organization |
| GO:0009890 | 0 | 2.6794 | 21.2095 | 48 | 1581 | negative regulation of biosynthetic process |
| GO:0045892 | 0 | 5.1059 | 4.2319 | 19 | 335 | negative regulation of transcription, DNA-templated |
| GO:0045596 | 0 | 3.6492 | 8.3979 | 27 | 626 | negative regulation of cell differentiation |
| GO:0071103 | 0 | 5.457 | 3.5148 | 17 | 262 | DNA conformation change |
| GO:0009792 | 0 | 3.8405 | 7.365 | 25 | 549 | embryo development ending in birth or egg hatching |
| GO:0034654 | 0 | 2.085 | 54.1573 | 88 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0017148 | 0 | 4.694 | 4.2929 | 18 | 320 | negative regulation of translation |
| GO:0080090 | 0 | 1.9169 | 76.5474 | 110 | 5706 | regulation of primary metabolic process |
| GO:0060249 | 0 | 4.0377 | 4.9368 | 18 | 368 | anatomical structure homeostasis |
| GO:0048536 | 0 | 15.1038 | 0.4829 | 6 | 36 | spleen development |
| GO:0034248 | 0 | 3.2163 | 7.1906 | 21 | 536 | regulation of cellular amide metabolic process |
| GO:0045944 | 0 | 2.5185 | 14.2067 | 32 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0048736 | 0 | 5.3433 | 2.2672 | 11 | 169 | appendage development |
| GO:0051259 | 0 | 3.2081 | 6.8418 | 20 | 510 | protein oligomerization |
| GO:0035108 | 0 | 5.6656 | 1.9452 | 10 | 145 | limb morphogenesis |
| GO:0048562 | 0 | 5.0661 | 2.3817 | 11 | 187 | embryonic organ morphogenesis |
| GO:0010628 | 0 | 2.1627 | 20.9664 | 40 | 1664 | positive regulation of gene expression |
| GO:0060255 | 0 | 1.7324 | 76.8559 | 105 | 5729 | regulation of macromolecule metabolic process |
| GO:2000026 | 0 | 2.0715 | 24.0401 | 44 | 1792 | regulation of multicellular organismal development |
| GO:0035113 | 1e-04 | 5.8615 | 1.6903 | 9 | 126 | embryonic appendage morphogenesis |
| GO:0009893 | 1e-04 | 1.8476 | 41.9361 | 66 | 3126 | positive regulation of metabolic process |
| GO:0031016 | 1e-04 | 7.6793 | 1.0196 | 7 | 76 | pancreas development |
| GO:0048665 | 1e-04 | 13.4228 | 0.4427 | 5 | 33 | neuron fate specification |
| GO:0097659 | 1e-04 | 1.9896 | 27.3934 | 47 | 2221 | nucleic acid-templated transcription |
| GO:0010608 | 1e-04 | 2.7358 | 8.3577 | 21 | 623 | posttranscriptional regulation of gene expression |
| GO:0034645 | 1e-04 | 1.7073 | 65.0505 | 91 | 4849 | cellular macromolecule biosynthetic process |
| GO:0048534 | 1e-04 | 2.5201 | 10.4157 | 24 | 797 | hematopoietic or lymphoid organ development |
| GO:0006325 | 2e-04 | 2.5413 | 9.4041 | 22 | 701 | chromatin organization |
| GO:0050789 | 2e-04 | 1.7515 | 141.1016 | 165 | 10518 | regulation of biological process |
| GO:0031323 | 2e-04 | 1.6847 | 66.2154 | 90 | 5289 | regulation of cellular metabolic process |
| GO:1903508 | 3e-04 | 2.0547 | 18.2313 | 34 | 1359 | positive regulation of nucleic acid-templated transcription |
| GO:0051171 | 3e-04 | 1.673 | 62.9228 | 86 | 5026 | regulation of nitrogen compound metabolic process |
| GO:0051254 | 4e-04 | 2.0104 | 19.1838 | 35 | 1430 | positive regulation of RNA metabolic process |
| GO:0048731 | 4e-04 | 1.671 | 53.0327 | 75 | 4125 | system development |
| GO:0006281 | 4e-04 | 2.7139 | 6.7345 | 17 | 502 | DNA repair |
| GO:0090596 | 5e-04 | 3.5747 | 3.3002 | 11 | 246 | sensory organ morphogenesis |
| GO:0035116 | 5e-04 | 12.4714 | 0.3756 | 4 | 28 | embryonic hindlimb morphogenesis |
| GO:0000122 | 5e-04 | 2.3523 | 10.1017 | 22 | 753 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0030855 | 5e-04 | 2.3984 | 9.4443 | 21 | 704 | epithelial cell differentiation |
| GO:0036023 | 5e-04 | 148.4623 | 0.0402 | 2 | 3 | embryonic skeletal limb joint morphogenesis |
| GO:0055123 | 6e-04 | 4.5914 | 1.8781 | 8 | 140 | digestive system development |
| GO:0051248 | 6e-04 | 2.0473 | 15.9913 | 30 | 1207 | negative regulation of protein metabolic process |
| GO:0043043 | 7e-04 | 2.306 | 10.2895 | 22 | 767 | peptide biosynthetic process |
| GO:1901576 | 7e-04 | 1.571 | 80.7195 | 104 | 6017 | organic substance biosynthetic process |
| GO:0001709 | 7e-04 | 11.1852 | 0.4122 | 4 | 31 | cell fate determination |
| GO:0021522 | 7e-04 | 11.0836 | 0.4159 | 4 | 31 | spinal cord motor neuron differentiation |
| GO:0061448 | 0.0011 | 3.4418 | 3.0989 | 10 | 231 | connective tissue development |
| GO:0002009 | 0.0013 | 2.5253 | 6.7613 | 16 | 504 | morphogenesis of an epithelium |
| GO:0060021 | 0.0014 | 5.3121 | 1.2208 | 6 | 91 | palate development |
| GO:0090304 | 0.0015 | 1.544 | 65.1713 | 86 | 4858 | nucleic acid metabolic process |
| GO:0006111 | 0.0015 | 9.0649 | 0.4964 | 4 | 37 | regulation of gluconeogenesis |
| GO:0035295 | 0.0015 | 2.4148 | 7.5125 | 17 | 560 | tube development |
| GO:0045165 | 0.0015 | 3.5784 | 2.6797 | 9 | 205 | cell fate commitment |
| GO:0042733 | 0.0015 | 6.4676 | 0.8452 | 5 | 63 | embryonic digit morphogenesis |
| GO:0032682 | 0.0017 | 14.9033 | 0.2415 | 3 | 18 | negative regulation of chemokine production |
| GO:0021778 | 0.0017 | 49.4811 | 0.0671 | 2 | 5 | oligodendrocyte cell fate specification |
| GO:0034137 | 0.0017 | 49.4811 | 0.0671 | 2 | 5 | positive regulation of toll-like receptor 2 signaling pathway |
| GO:0021510 | 0.0018 | 5.0721 | 1.2744 | 6 | 95 | spinal cord development |
| GO:0007267 | 0.0019 | 1.8224 | 20.2839 | 34 | 1512 | cell-cell signaling |
| GO:0042474 | 0.002 | 13.971 | 0.2549 | 3 | 19 | middle ear morphogenesis |
| GO:0050678 | 0.002 | 2.9807 | 3.9173 | 11 | 292 | regulation of epithelial cell proliferation |
| GO:0010557 | 0.0022 | 1.7872 | 21.29 | 35 | 1587 | positive regulation of macromolecule biosynthetic process |
| GO:0065008 | 0.0024 | 1.5695 | 45.1825 | 63 | 3368 | regulation of biological quality |
| GO:0048869 | 0.0025 | 1.5675 | 47.2573 | 65 | 3730 | cellular developmental process |
| GO:0031328 | 0.0026 | 1.7446 | 23.0876 | 37 | 1721 | positive regulation of cellular biosynthetic process |
| GO:0021902 | 0.0026 | 37.1085 | 0.0805 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:1904995 | 0.0026 | 37.1085 | 0.0805 | 2 | 6 | negative regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0007200 | 0.0026 | 4.6514 | 1.3818 | 6 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
| GO:0021513 | 0.003 | 11.7628 | 0.2951 | 3 | 22 | spinal cord dorsal/ventral patterning |
| GO:0009889 | 0.0043 | 1.6398 | 30.8528 | 45 | 2671 | regulation of biosynthetic process |
| GO:0030168 | 0.0043 | 3.662 | 2.0257 | 7 | 151 | platelet activation |
| GO:0048596 | 0.0044 | 10.1568 | 0.3354 | 3 | 25 | embryonic camera-type eye morphogenesis |
| GO:0048546 | 0.0045 | 6.4977 | 0.6708 | 4 | 50 | digestive tract morphogenesis |
| GO:0003310 | 0.0048 | 24.7358 | 0.1073 | 2 | 8 | pancreatic A cell differentiation |
| GO:1900426 | 0.0048 | 24.7358 | 0.1073 | 2 | 8 | positive regulation of defense response to bacterium |
| GO:0045778 | 0.0049 | 4.8658 | 1.1001 | 5 | 82 | positive regulation of ossification |
| GO:0042036 | 0.0049 | 9.7146 | 0.3488 | 3 | 26 | negative regulation of cytokine biosynthetic process |
| GO:0048706 | 0.0053 | 9.4269 | 0.3566 | 3 | 28 | embryonic skeletal system development |
| GO:0043154 | 0.0054 | 4.742 | 1.1269 | 5 | 84 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0006355 | 0.0058 | 1.6388 | 26.9789 | 40 | 2318 | regulation of transcription, DNA-templated |
| GO:0043010 | 0.006 | 2.6964 | 3.9038 | 10 | 291 | camera-type eye development |
| GO:0048664 | 0.0061 | 21.2008 | 0.1207 | 2 | 9 | neuron fate determination |
| GO:0060349 | 0.0063 | 4.5676 | 1.1671 | 5 | 87 | bone morphogenesis |
| GO:0035270 | 0.0065 | 3.8184 | 1.6635 | 6 | 124 | endocrine system development |
| GO:0007548 | 0.0067 | 2.8231 | 3.3538 | 9 | 250 | sex differentiation |
| GO:0048646 | 0.0073 | 1.8374 | 13.2945 | 23 | 991 | anatomical structure formation involved in morphogenesis |
| GO:0061072 | 0.0075 | 18.5495 | 0.1342 | 2 | 10 | iris morphogenesis |
| GO:0035282 | 0.0079 | 4.3037 | 1.2342 | 5 | 92 | segmentation |
| GO:0034641 | 0.008 | 1.4096 | 83.2818 | 101 | 6208 | cellular nitrogen compound metabolic process |
| GO:0002062 | 0.0083 | 4.2546 | 1.2476 | 5 | 93 | chondrocyte differentiation |
| GO:0021872 | 0.0085 | 5.334 | 0.8049 | 4 | 60 | forebrain generation of neurons |
| GO:0046483 | 0.0087 | 1.4085 | 75.7827 | 93 | 5649 | heterocycle metabolic process |
| GO:2001141 | 0.0088 | 1.5986 | 26.8032 | 39 | 2311 | regulation of RNA biosynthetic process |
| GO:0003093 | 0.0091 | 16.4874 | 0.1476 | 2 | 11 | regulation of glomerular filtration |
| GO:0009886 | 0.0091 | 16.4874 | 0.1476 | 2 | 11 | post-embryonic animal morphogenesis |
| GO:0072567 | 0.0091 | 16.4874 | 0.1476 | 2 | 11 | chemokine (C-X-C motif) ligand 2 production |
| GO:0051241 | 0.0096 | 1.873 | 11.3157 | 20 | 904 | negative regulation of multicellular organismal process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007606 | 0 | 7.5839 | 4.1995 | 26 | 406 | sensory perception of chemical stimulus |
| GO:0050911 | 0 | 8.2502 | 3.2168 | 22 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 7.2121 | 4.0133 | 24 | 388 | detection of chemical stimulus |
| GO:0050906 | 0 | 6.2715 | 4.1374 | 22 | 400 | detection of stimulus involved in sensory perception |
| GO:0050877 | 0 | 3.4185 | 11.8744 | 34 | 1148 | nervous system process |
| GO:0007186 | 0 | 3.0632 | 10.9673 | 29 | 1087 | G-protein coupled receptor signaling pathway |
| GO:0036149 | 6e-04 | 22.4701 | 0.1655 | 3 | 16 | phosphatidylinositol acyl-chain remodeling |
| GO:0006824 | 0.001 | 64.5562 | 0.0517 | 2 | 5 | cobalt ion transport |
| GO:0031424 | 0.0013 | 4.0325 | 2.1204 | 8 | 205 | keratinization |
| GO:0051716 | 0.0015 | 1.614 | 69.5809 | 89 | 6727 | cellular response to stimulus |
| GO:0050830 | 0.0017 | 6.2937 | 0.8585 | 5 | 83 | defense response to Gram-positive bacterium |
| GO:0060430 | 0.0022 | 38.7288 | 0.0724 | 2 | 7 | lung saccule development |
| GO:0036152 | 0.0024 | 12.6924 | 0.2689 | 3 | 26 | phosphatidylethanolamine acyl-chain remodeling |
| GO:0036151 | 0.0026 | 12.1628 | 0.2793 | 3 | 27 | phosphatidylcholine acyl-chain remodeling |
| GO:0015889 | 0.0029 | 32.272 | 0.0827 | 2 | 8 | cobalamin transport |
| GO:1904628 | 0.0029 | 32.272 | 0.0827 | 2 | 8 | cellular response to phorbol 13-acetate 12-myristate |
| GO:0007218 | 0.0029 | 5.5119 | 0.9723 | 5 | 94 | neuropeptide signaling pathway |
| GO:0070886 | 0.0037 | 27.6599 | 0.0931 | 2 | 9 | positive regulation of calcineurin-NFAT signaling cascade |
| GO:0009954 | 0.0039 | 10.4226 | 0.3206 | 3 | 31 | proximal/distal pattern formation |
| GO:0002430 | 0.0045 | 24.2009 | 0.1034 | 2 | 10 | complement receptor mediated signaling pathway |
| GO:1905205 | 0.0045 | 24.2009 | 0.1034 | 2 | 10 | positive regulation of connective tissue replacement |
| GO:1903244 | 0.0055 | 21.5106 | 0.1138 | 2 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
| GO:0048469 | 0.0066 | 3.8057 | 1.6653 | 6 | 161 | cell maturation |
| GO:0050850 | 0.007 | 8.3344 | 0.3931 | 3 | 38 | positive regulation of calcium-mediated signaling |
| GO:0021520 | 0.0077 | 17.5973 | 0.1345 | 2 | 13 | spinal cord motor neuron cell fate specification |
| GO:0014744 | 0.0089 | 16.1299 | 0.1448 | 2 | 14 | positive regulation of muscle adaptation |
| GO:0032501 | 0.0098 | 1.4733 | 66.0523 | 81 | 6625 | multicellular organismal process |
| GO:0007154 | 0.0098 | 1.4627 | 61.9164 | 77 | 5986 | cell communication |
| GO:0001708 | 0.0099 | 5.069 | 0.8378 | 4 | 81 | cell fate specification |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 43.138 | 0.3531 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 36.4921 | 0.3972 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 35.1383 | 0.4082 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 35.1383 | 0.4082 | 10 | 37 | response to interleukin-7 |
| GO:0051290 | 0 | 27.8916 | 0.4855 | 10 | 44 | protein heterotetramerization |
| GO:0045652 | 0 | 16.6275 | 0.8164 | 11 | 74 | regulation of megakaryocyte differentiation |
| GO:1902036 | 0 | 11.6193 | 1.1143 | 11 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0045815 | 0 | 13.7131 | 0.8716 | 10 | 79 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 9.9436 | 1.1585 | 10 | 105 | regulation of gene silencing by miRNA |
| GO:0035194 | 0 | 6.139 | 2.5707 | 14 | 233 | posttranscriptional gene silencing by RNA |
| GO:0031497 | 0 | 7.7821 | 1.5998 | 11 | 145 | chromatin assembly |
| GO:0045814 | 0 | 8.7394 | 1.3019 | 10 | 118 | negative regulation of gene expression, epigenetic |
| GO:0002244 | 0 | 6.561 | 2.0522 | 12 | 186 | hematopoietic progenitor cell differentiation |
| GO:1903706 | 0 | 4.259 | 4.7332 | 18 | 429 | regulation of hemopoiesis |
| GO:0060968 | 0 | 7.9937 | 1.4122 | 10 | 128 | regulation of gene silencing |
| GO:0032200 | 0 | 6.8526 | 1.7984 | 11 | 163 | telomere organization |
| GO:0017148 | 0 | 4.7259 | 3.5306 | 15 | 320 | negative regulation of translation |
| GO:0030099 | 0 | 4.2944 | 4.1374 | 16 | 375 | myeloid cell differentiation |
| GO:0048863 | 0 | 5.0768 | 2.8355 | 13 | 257 | stem cell differentiation |
| GO:0034728 | 0 | 6.494 | 1.7101 | 10 | 155 | nucleosome organization |
| GO:0065004 | 0 | 5.1143 | 2.3611 | 11 | 214 | protein-DNA complex assembly |
| GO:0071103 | 2e-04 | 4.1235 | 2.8907 | 11 | 262 | DNA conformation change |
| GO:0034248 | 3e-04 | 2.9338 | 5.9137 | 16 | 536 | regulation of cellular amide metabolic process |
| GO:0043043 | 3e-04 | 2.5794 | 8.4624 | 20 | 767 | peptide biosynthetic process |
| GO:0048534 | 3e-04 | 2.4968 | 9.1906 | 21 | 833 | hematopoietic or lymphoid organ development |
| GO:0045595 | 4e-04 | 2.0446 | 18.0171 | 33 | 1633 | regulation of cell differentiation |
| GO:0051259 | 5e-04 | 2.8762 | 5.6269 | 15 | 510 | protein oligomerization |
| GO:0009611 | 6e-04 | 2.6537 | 6.9288 | 17 | 628 | response to wounding |
| GO:0008544 | 9e-04 | 2.9594 | 4.7111 | 13 | 427 | epidermis development |
| GO:0007596 | 0.001 | 3.2616 | 3.6078 | 11 | 327 | blood coagulation |
| GO:0010608 | 0.0015 | 2.499 | 6.8736 | 16 | 623 | posttranscriptional regulation of gene expression |
| GO:0031327 | 0.0018 | 1.9105 | 17.2337 | 30 | 1562 | negative regulation of cellular biosynthetic process |
| GO:0051450 | 0.002 | 13.6613 | 0.2538 | 3 | 23 | myoblast proliferation |
| GO:2000112 | 0.0024 | 1.6083 | 43.0181 | 60 | 3899 | regulation of cellular macromolecule biosynthetic process |
| GO:0002327 | 0.0025 | 36.2552 | 0.0772 | 2 | 7 | immature B cell differentiation |
| GO:0050878 | 0.0026 | 2.6203 | 5.2849 | 13 | 479 | regulation of body fluid levels |
| GO:0044271 | 0.0027 | 1.569 | 52.33 | 70 | 4743 | cellular nitrogen compound biosynthetic process |
| GO:0010558 | 0.0033 | 1.8635 | 16.3511 | 28 | 1482 | negative regulation of macromolecule biosynthetic process |
| GO:0043588 | 0.0038 | 2.738 | 4.2588 | 11 | 386 | skin development |
| GO:0045669 | 0.0038 | 6.7709 | 0.6399 | 4 | 58 | positive regulation of osteoblast differentiation |
| GO:1903506 | 0.0044 | 1.5845 | 37.7994 | 53 | 3426 | regulation of nucleic acid-templated transcription |
| GO:0002430 | 0.0051 | 22.6552 | 0.1103 | 2 | 10 | complement receptor mediated signaling pathway |
| GO:0006600 | 0.0051 | 22.6552 | 0.1103 | 2 | 10 | creatine metabolic process |
| GO:0009629 | 0.0051 | 22.6552 | 0.1103 | 2 | 10 | response to gravity |
| GO:0043097 | 0.0051 | 22.6552 | 0.1103 | 2 | 10 | pyrimidine nucleoside salvage |
| GO:1905065 | 0.0051 | 22.6552 | 0.1103 | 2 | 10 | positive regulation of vascular smooth muscle cell differentiation |
| GO:0043094 | 0.0056 | 9.1017 | 0.3641 | 3 | 33 | cellular metabolic compound salvage |
| GO:0032774 | 0.0074 | 1.5299 | 39.653 | 54 | 3594 | RNA biosynthetic process |
| GO:0045892 | 0.0087 | 1.8677 | 12.004 | 21 | 1088 | negative regulation of transcription, DNA-templated |
| GO:1901576 | 0.0096 | 1.4465 | 66.3862 | 82 | 6017 | organic substance biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 237.9242 | 0.2765 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 0 | 52.8249 | 0.4915 | 14 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 43.2094 | 0.5529 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 36.5524 | 0.6143 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:0051290 | 0 | 31.6707 | 0.6758 | 14 | 44 | protein heterotetramerization |
| GO:1904837 | 0 | 31.6707 | 0.6758 | 14 | 44 | beta-catenin-TCF complex assembly |
| GO:0034724 | 0 | 25.6675 | 0.7833 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0016233 | 0 | 23.1574 | 0.8447 | 14 | 55 | telomere capping |
| GO:0006303 | 0 | 16.3521 | 1.1058 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:1903507 | 0 | 3.504 | 17.217 | 50 | 1121 | negative regulation of nucleic acid-templated transcription |
| GO:0043044 | 0 | 15.545 | 1.1519 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:0045815 | 0 | 14.5846 | 1.2133 | 14 | 79 | positive regulation of gene expression, epigenetic |
| GO:1903707 | 0 | 9.9351 | 2.058 | 17 | 134 | negative regulation of hemopoiesis |
| GO:1902036 | 0 | 11.8461 | 1.5512 | 15 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0051253 | 0 | 3.261 | 18.3535 | 50 | 1195 | negative regulation of RNA metabolic process |
| GO:0060964 | 0 | 11.3167 | 1.6127 | 15 | 105 | regulation of gene silencing by miRNA |
| GO:0060968 | 0 | 9 | 1.9659 | 15 | 128 | regulation of gene silencing |
| GO:0048863 | 0 | 6.4564 | 3.3926 | 19 | 226 | stem cell differentiation |
| GO:0002244 | 0 | 6.8552 | 2.8567 | 17 | 186 | hematopoietic progenitor cell differentiation |
| GO:0006352 | 0 | 5.7957 | 3.5325 | 18 | 230 | DNA-templated transcription, initiation |
| GO:0006355 | 0 | 2.1697 | 52.3113 | 90 | 3406 | regulation of transcription, DNA-templated |
| GO:2001141 | 0 | 2.1475 | 52.726 | 90 | 3433 | regulation of RNA biosynthetic process |
| GO:0031497 | 0 | 7.2061 | 2.227 | 14 | 145 | chromatin assembly |
| GO:0009890 | 0 | 2.4984 | 24.2819 | 52 | 1581 | negative regulation of biosynthetic process |
| GO:0045596 | 0 | 3.3742 | 9.3217 | 28 | 614 | negative regulation of cell differentiation |
| GO:0032200 | 0 | 6.3282 | 2.5034 | 14 | 163 | telomere organization |
| GO:0009952 | 0 | 5.6257 | 2.9949 | 15 | 195 | anterior/posterior pattern specification |
| GO:0035194 | 0 | 4.9874 | 3.5785 | 16 | 233 | posttranscriptional gene silencing by RNA |
| GO:0045637 | 0 | 4.9642 | 3.5939 | 16 | 234 | regulation of myeloid cell differentiation |
| GO:0065004 | 0 | 5.0824 | 3.2867 | 15 | 214 | protein-DNA complex assembly |
| GO:0007389 | 0 | 3.8164 | 5.8011 | 20 | 385 | pattern specification process |
| GO:0045944 | 0 | 2.556 | 16.2647 | 37 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0034654 | 0 | 1.8573 | 62.0026 | 94 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0019219 | 0 | 1.8273 | 61.1425 | 92 | 3981 | regulation of nucleobase-containing compound metabolic process |
| GO:0032501 | 0 | 1.8031 | 88.7459 | 120 | 6312 | multicellular organismal process |
| GO:2000113 | 0 | 2.4215 | 16.1583 | 35 | 1103 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0000122 | 0 | 2.6664 | 11.565 | 28 | 753 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0048731 | 0 | 1.888 | 47.9172 | 75 | 3323 | system development |
| GO:0003206 | 0 | 5.9789 | 1.8584 | 10 | 121 | cardiac chamber morphogenesis |
| GO:0051172 | 0 | 1.9434 | 36.0927 | 61 | 2350 | negative regulation of nitrogen compound metabolic process |
| GO:0002682 | 0 | 2.1978 | 20.8416 | 41 | 1357 | regulation of immune system process |
| GO:0060415 | 0 | 7.6502 | 1.1826 | 8 | 77 | muscle tissue morphogenesis |
| GO:0050877 | 0 | 2.2608 | 17.6316 | 36 | 1148 | nervous system process |
| GO:0048534 | 0 | 2.4886 | 12.7937 | 29 | 833 | hematopoietic or lymphoid organ development |
| GO:0017148 | 0 | 3.5401 | 4.9147 | 16 | 320 | negative regulation of translation |
| GO:0071103 | 1e-04 | 3.7779 | 4.0239 | 14 | 262 | DNA conformation change |
| GO:0060249 | 1e-04 | 3.262 | 5.652 | 17 | 368 | anatomical structure homeostasis |
| GO:0048869 | 1e-04 | 1.7361 | 58.1487 | 85 | 3894 | cellular developmental process |
| GO:1904746 | 1e-04 | 64.8926 | 0.0922 | 3 | 6 | negative regulation of apoptotic process involved in development |
| GO:0043009 | 1e-04 | 3.053 | 6.389 | 18 | 425 | chordate embryonic development |
| GO:0003231 | 1e-04 | 5.4572 | 1.8123 | 9 | 118 | cardiac ventricle development |
| GO:0048636 | 1e-04 | 7.4217 | 1.0597 | 7 | 69 | positive regulation of muscle organ development |
| GO:0007498 | 1e-04 | 5.4073 | 1.8277 | 9 | 119 | mesoderm development |
| GO:1901863 | 1e-04 | 7.3035 | 1.0751 | 7 | 70 | positive regulation of muscle tissue development |
| GO:0007218 | 1e-04 | 6.1313 | 1.4437 | 8 | 94 | neuropeptide signaling pathway |
| GO:1903508 | 1e-04 | 2.0634 | 20.8723 | 39 | 1359 | positive regulation of nucleic acid-templated transcription |
| GO:0009593 | 1e-04 | 3.0821 | 5.9591 | 17 | 388 | detection of chemical stimulus |
| GO:0048562 | 1e-04 | 3.5316 | 4.285 | 14 | 279 | embryonic organ morphogenesis |
| GO:0031324 | 1e-04 | 1.8026 | 38.4118 | 61 | 2501 | negative regulation of cellular metabolic process |
| GO:0007369 | 1e-04 | 4.2963 | 2.7799 | 11 | 181 | gastrulation |
| GO:0051259 | 1e-04 | 2.7605 | 7.8329 | 20 | 510 | protein oligomerization |
| GO:0050906 | 2e-04 | 2.9832 | 6.1434 | 17 | 400 | detection of stimulus involved in sensory perception |
| GO:0001763 | 2e-04 | 4.1245 | 2.8874 | 11 | 188 | morphogenesis of a branching structure |
| GO:0010002 | 2e-04 | 17.3632 | 0.2918 | 4 | 19 | cardioblast differentiation |
| GO:0007606 | 2e-04 | 2.9361 | 6.2356 | 17 | 406 | sensory perception of chemical stimulus |
| GO:0033278 | 2e-04 | 38.9306 | 0.1229 | 3 | 8 | cell proliferation in midbrain |
| GO:0007492 | 2e-04 | 6.4772 | 1.198 | 7 | 78 | endoderm development |
| GO:0007493 | 2e-04 | Inf | 0.0307 | 2 | 2 | endodermal cell fate determination |
| GO:1902257 | 2e-04 | Inf | 0.0307 | 2 | 2 | negative regulation of apoptotic process involved in outflow tract morphogenesis |
| GO:2000026 | 3e-04 | 1.9157 | 24.2488 | 42 | 1637 | regulation of multicellular organismal development |
| GO:0001714 | 3e-04 | 32.4401 | 0.1382 | 3 | 9 | endodermal cell fate specification |
| GO:0030917 | 3e-04 | 32.4401 | 0.1382 | 3 | 9 | midbrain-hindbrain boundary development |
| GO:0051254 | 3e-04 | 1.9485 | 21.9628 | 39 | 1430 | positive regulation of RNA metabolic process |
| GO:0021532 | 3e-04 | 9.6036 | 0.599 | 5 | 39 | neural tube patterning |
| GO:0050911 | 3e-04 | 3.1446 | 4.7765 | 14 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0048754 | 4e-04 | 4.432 | 2.1963 | 9 | 143 | branching morphogenesis of an epithelial tube |
| GO:1902337 | 4e-04 | 27.804 | 0.1536 | 3 | 10 | regulation of apoptotic process involved in morphogenesis |
| GO:0007187 | 4e-04 | 3.9839 | 2.7031 | 10 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0006342 | 4e-04 | 6.8302 | 0.9724 | 6 | 67 | chromatin silencing |
| GO:0035295 | 4e-04 | 2.4966 | 8.6008 | 20 | 560 | tube development |
| GO:0009893 | 4e-04 | 1.6559 | 48.0109 | 70 | 3126 | positive regulation of metabolic process |
| GO:0010628 | 5e-04 | 1.8639 | 24.2162 | 41 | 1664 | positive regulation of gene expression |
| GO:0003148 | 5e-04 | 12.3975 | 0.384 | 4 | 25 | outflow tract septum morphogenesis |
| GO:0035282 | 5e-04 | 5.4055 | 1.413 | 7 | 92 | segmentation |
| GO:0021521 | 5e-04 | 24.327 | 0.1689 | 3 | 11 | ventral spinal cord interneuron specification |
| GO:0019233 | 6e-04 | 5.3423 | 1.4283 | 7 | 93 | sensory perception of pain |
| GO:0010629 | 6e-04 | 1.911 | 21.2124 | 37 | 1448 | negative regulation of gene expression |
| GO:0060255 | 6e-04 | 1.5382 | 87.9893 | 113 | 5729 | regulation of macromolecule metabolic process |
| GO:0048663 | 6e-04 | 6.3349 | 1.0444 | 6 | 68 | neuron fate commitment |
| GO:0010557 | 6e-04 | 1.8409 | 24.3741 | 41 | 1587 | positive regulation of macromolecule biosynthetic process |
| GO:0035987 | 7e-04 | 7.9604 | 0.7065 | 5 | 46 | endodermal cell differentiation |
| GO:0055025 | 7e-04 | 7.9604 | 0.7065 | 5 | 46 | positive regulation of cardiac muscle tissue development |
| GO:0002877 | 7e-04 | 129.2675 | 0.0461 | 2 | 3 | regulation of acute inflammatory response to non-antigenic stimulus |
| GO:0021524 | 7e-04 | 129.2675 | 0.0461 | 2 | 3 | visceral motor neuron differentiation |
| GO:0048936 | 7e-04 | 129.2675 | 0.0461 | 2 | 3 | peripheral nervous system neuron axonogenesis |
| GO:0060913 | 7e-04 | 129.2675 | 0.0461 | 2 | 3 | cardiac cell fate determination |
| GO:0010454 | 7e-04 | 21.6226 | 0.1843 | 3 | 12 | negative regulation of cell fate commitment |
| GO:0065007 | 8e-04 | 1.6334 | 170.4802 | 193 | 11100 | biological regulation |
| GO:0021536 | 8e-04 | 6.0413 | 1.0905 | 6 | 71 | diencephalon development |
| GO:0055010 | 8e-04 | 7.5891 | 0.7372 | 5 | 48 | ventricular cardiac muscle tissue morphogenesis |
| GO:0003151 | 8e-04 | 7.5318 | 0.7414 | 5 | 49 | outflow tract morphogenesis |
| GO:0031328 | 9e-04 | 1.7797 | 26.4321 | 43 | 1721 | positive regulation of cellular biosynthetic process |
| GO:0048934 | 9e-04 | 19.4591 | 0.1997 | 3 | 13 | peripheral nervous system neuron differentiation |
| GO:0048608 | 0.001 | 3.5132 | 3.0412 | 10 | 203 | reproductive structure development |
| GO:0032725 | 0.0011 | 17.689 | 0.215 | 3 | 14 | positive regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0043388 | 0.0013 | 6.7964 | 0.814 | 5 | 53 | positive regulation of DNA binding |
| GO:0061047 | 0.0014 | 64.6296 | 0.0614 | 2 | 4 | positive regulation of branching involved in lung morphogenesis |
| GO:0072095 | 0.0014 | 64.6296 | 0.0614 | 2 | 4 | regulation of branch elongation involved in ureteric bud branching |
| GO:1904954 | 0.0014 | 64.6296 | 0.0614 | 2 | 4 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation |
| GO:0060581 | 0.0014 | 16.2138 | 0.2304 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:0008015 | 0.0015 | 2.4067 | 7.5103 | 17 | 489 | blood circulation |
| GO:0040019 | 0.0016 | 8.973 | 0.5068 | 4 | 33 | positive regulation of embryonic development |
| GO:0060795 | 0.0017 | 15.1381 | 0.243 | 3 | 16 | cell fate commitment involved in formation of primary germ layer |
| GO:0021515 | 0.0017 | 8.7748 | 0.5163 | 4 | 34 | cell differentiation in spinal cord |
| GO:0007548 | 0.0017 | 3.0424 | 3.8396 | 11 | 250 | sex differentiation |
| GO:0060850 | 0.0017 | 14.9657 | 0.2457 | 3 | 16 | regulation of transcription involved in cell fate commitment |
| GO:0009790 | 0.0019 | 2.1042 | 11.1627 | 22 | 756 | embryo development |
| GO:2000826 | 0.002 | 8.393 | 0.5376 | 4 | 35 | regulation of heart morphogenesis |
| GO:0021514 | 0.0021 | 13.8958 | 0.2611 | 3 | 17 | ventral spinal cord interneuron differentiation |
| GO:1904948 | 0.0021 | 13.8958 | 0.2611 | 3 | 17 | midbrain dopaminergic neuron differentiation |
| GO:2000738 | 0.0021 | 13.8958 | 0.2611 | 3 | 17 | positive regulation of stem cell differentiation |
| GO:0001892 | 0.0021 | 4.9039 | 1.3208 | 6 | 86 | embryonic placenta development |
| GO:0048286 | 0.0022 | 8.1302 | 0.5529 | 4 | 36 | lung alveolus development |
| GO:0007507 | 0.0022 | 2.3155 | 7.7868 | 17 | 507 | heart development |
| GO:0007519 | 0.0022 | 3.7 | 2.3038 | 8 | 150 | skeletal muscle tissue development |
| GO:0014032 | 0.0023 | 5.9288 | 0.9215 | 5 | 60 | neural crest cell development |
| GO:0045110 | 0.0023 | 43.0837 | 0.0768 | 2 | 5 | intermediate filament bundle assembly |
| GO:0061743 | 0.0023 | 43.0837 | 0.0768 | 2 | 5 | motor learning |
| GO:0072179 | 0.0023 | 43.0837 | 0.0768 | 2 | 5 | nephric duct formation |
| GO:0048706 | 0.0025 | 4.0588 | 1.843 | 7 | 120 | embryonic skeletal system development |
| GO:0014855 | 0.0026 | 5.72 | 0.9522 | 5 | 62 | striated muscle cell proliferation |
| GO:0071542 | 0.0028 | 12.2989 | 0.2885 | 3 | 19 | dopaminergic neuron differentiation |
| GO:0001710 | 0.0029 | 12.1573 | 0.2918 | 3 | 19 | mesodermal cell fate commitment |
| GO:0060602 | 0.0029 | 12.1573 | 0.2918 | 3 | 19 | branch elongation of an epithelium |
| GO:0001707 | 0.0029 | 5.5701 | 0.9754 | 5 | 64 | mesoderm formation |
| GO:0001657 | 0.0031 | 4.5073 | 1.4283 | 6 | 93 | ureteric bud development |
| GO:0072001 | 0.0031 | 2.8038 | 4.1468 | 11 | 270 | renal system development |
| GO:0016202 | 0.0032 | 3.8856 | 1.9198 | 7 | 125 | regulation of striated muscle tissue development |
| GO:0007186 | 0.0032 | 1.9193 | 13.8987 | 25 | 937 | G-protein coupled receptor signaling pathway |
| GO:0042472 | 0.0033 | 4.4558 | 1.4437 | 6 | 94 | inner ear morphogenesis |
| GO:0072163 | 0.0033 | 4.4558 | 1.4437 | 6 | 94 | mesonephric epithelium development |
| GO:0007417 | 0.0033 | 1.9391 | 13.1623 | 24 | 857 | central nervous system development |
| GO:0072010 | 0.0034 | 11.4414 | 0.3072 | 3 | 20 | glomerular epithelium development |
| GO:0003180 | 0.0034 | 32.3107 | 0.0922 | 2 | 6 | aortic valve morphogenesis |
| GO:0003278 | 0.0034 | 32.3107 | 0.0922 | 2 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0021546 | 0.0034 | 32.3107 | 0.0922 | 2 | 6 | rhombomere development |
| GO:0061218 | 0.0034 | 32.3107 | 0.0922 | 2 | 6 | negative regulation of mesonephros development |
| GO:0086073 | 0.0034 | 32.3107 | 0.0922 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0050794 | 0.0034 | 1.4847 | 141.9913 | 162 | 9769 | regulation of cellular process |
| GO:0048729 | 0.0035 | 2.267 | 7.4642 | 16 | 499 | tissue morphogenesis |
| GO:0008406 | 0.0037 | 3.1145 | 3.0564 | 9 | 199 | gonad development |
| GO:0031290 | 0.0039 | 10.8051 | 0.3225 | 3 | 21 | retinal ganglion cell axon guidance |
| GO:0034248 | 0.0039 | 2.182 | 8.2322 | 17 | 536 | regulation of cellular amide metabolic process |
| GO:1901576 | 0.0041 | 1.4214 | 92.4126 | 113 | 6017 | organic substance biosynthetic process |
| GO:0048699 | 0.0042 | 1.7265 | 20.4576 | 33 | 1332 | generation of neurons |
| GO:0048646 | 0.0043 | 1.8479 | 14.9674 | 26 | 982 | anatomical structure formation involved in morphogenesis |
| GO:0021513 | 0.0044 | 10.2358 | 0.3379 | 3 | 22 | spinal cord dorsal/ventral patterning |
| GO:0001826 | 0.0047 | 25.8469 | 0.1075 | 2 | 7 | inner cell mass cell differentiation |
| GO:0048341 | 0.0047 | 25.8469 | 0.1075 | 2 | 7 | paraxial mesoderm formation |
| GO:0060687 | 0.0047 | 25.8469 | 0.1075 | 2 | 7 | regulation of branching involved in prostate gland morphogenesis |
| GO:2000328 | 0.0047 | 25.8469 | 0.1075 | 2 | 7 | regulation of T-helper 17 cell lineage commitment |
| GO:0090304 | 0.0047 | 1.4299 | 74.612 | 94 | 4858 | nucleic acid metabolic process |
| GO:0001708 | 0.0047 | 4.9229 | 1.0929 | 5 | 72 | cell fate specification |
| GO:0090596 | 0.0048 | 2.7896 | 3.7782 | 10 | 246 | sensory organ morphogenesis |
| GO:0007517 | 0.0049 | 2.6304 | 4.4055 | 11 | 294 | muscle organ development |
| GO:0031018 | 0.0049 | 6.3419 | 0.6911 | 4 | 45 | endocrine pancreas development |
| GO:0007193 | 0.0053 | 4.7914 | 1.1212 | 5 | 73 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
| GO:0072132 | 0.0053 | 6.1905 | 0.7065 | 4 | 46 | mesenchyme morphogenesis |
| GO:0007267 | 0.0053 | 1.6608 | 23.2222 | 36 | 1512 | cell-cell signaling |
| GO:0021871 | 0.0057 | 9.2597 | 0.3686 | 3 | 24 | forebrain regionalization |
| GO:0060914 | 0.0057 | 9.2597 | 0.3686 | 3 | 24 | heart formation |
| GO:0000003 | 0.0058 | 1.6991 | 20.089 | 32 | 1308 | reproduction |
| GO:0040008 | 0.0061 | 2.0317 | 9.338 | 18 | 608 | regulation of growth |
| GO:0060677 | 0.0062 | 21.5377 | 0.1229 | 2 | 8 | ureteric bud elongation |
| GO:0061303 | 0.0062 | 21.5377 | 0.1229 | 2 | 8 | cornea development in camera-type eye |
| GO:0071420 | 0.0062 | 21.5377 | 0.1229 | 2 | 8 | cellular response to histamine |
| GO:0072217 | 0.0062 | 21.5377 | 0.1229 | 2 | 8 | negative regulation of metanephros development |
| GO:1990403 | 0.0062 | 21.5377 | 0.1229 | 2 | 8 | embryonic brain development |
| GO:0021545 | 0.0062 | 5.9083 | 0.7372 | 4 | 48 | cranial nerve development |
| GO:0050885 | 0.0062 | 5.9083 | 0.7372 | 4 | 48 | neuromuscular process controlling balance |
| GO:0046483 | 0.0063 | 1.3983 | 86.7606 | 106 | 5649 | heterocycle metabolic process |
| GO:0060571 | 0.0064 | 8.8383 | 0.384 | 3 | 25 | morphogenesis of an epithelial fold |
| GO:1905207 | 0.0067 | 5.7767 | 0.7526 | 4 | 49 | regulation of cardiocyte differentiation |
| GO:0021517 | 0.0069 | 8.5519 | 0.3949 | 3 | 26 | ventral spinal cord development |
| GO:0016331 | 0.0071 | 3.3182 | 2.227 | 7 | 145 | morphogenesis of embryonic epithelium |
| GO:0060045 | 0.0072 | 8.4535 | 0.3993 | 3 | 26 | positive regulation of cardiac muscle cell proliferation |
| GO:0048546 | 0.0072 | 5.6507 | 0.7679 | 4 | 50 | digestive tract morphogenesis |
| GO:0048762 | 0.0076 | 2.9787 | 2.826 | 8 | 184 | mesenchymal cell differentiation |
| GO:0055017 | 0.0077 | 4.3422 | 1.2287 | 5 | 80 | cardiac muscle tissue growth |
| GO:0006725 | 0.0078 | 1.3844 | 87.3135 | 106 | 5685 | cellular aromatic compound metabolic process |
| GO:0001574 | 0.0079 | 18.4597 | 0.1382 | 2 | 9 | ganglioside biosynthetic process |
| GO:0003139 | 0.0079 | 18.4597 | 0.1382 | 2 | 9 | secondary heart field specification |
| GO:0003149 | 0.0079 | 18.4597 | 0.1382 | 2 | 9 | membranous septum morphogenesis |
| GO:0021603 | 0.0079 | 18.4597 | 0.1382 | 2 | 9 | cranial nerve formation |
| GO:0061004 | 0.0079 | 18.4597 | 0.1382 | 2 | 9 | pattern specification involved in kidney development |
| GO:0045995 | 0.0081 | 4.2926 | 1.2414 | 5 | 82 | regulation of embryonic development |
| GO:0061053 | 0.0082 | 4.2848 | 1.244 | 5 | 81 | somite development |
| GO:2000242 | 0.0083 | 5.4146 | 0.7986 | 4 | 52 | negative regulation of reproductive process |
| GO:0010591 | 0.0088 | 7.7762 | 0.43 | 3 | 28 | regulation of lamellipodium assembly |
| GO:0022602 | 0.009 | 4.1744 | 1.2748 | 5 | 83 | ovulation cycle process |
| GO:0060429 | 0.0092 | 1.713 | 16.6946 | 27 | 1104 | epithelium development |
| GO:0030510 | 0.0095 | 4.1213 | 1.2901 | 5 | 84 | regulation of BMP signaling pathway |
| GO:0010092 | 0.0097 | 7.4766 | 0.4454 | 3 | 29 | specification of animal organ identity |
| GO:0031128 | 0.0097 | 7.4766 | 0.4454 | 3 | 29 | developmental induction |
| GO:0002430 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | complement receptor mediated signaling pathway |
| GO:0002934 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | desmosome organization |
| GO:0046838 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | phosphorylated carbohydrate dephosphorylation |
| GO:0060502 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | epithelial cell proliferation involved in lung morphogenesis |
| GO:0060947 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | cardiac vascular smooth muscle cell differentiation |
| GO:0061072 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | iris morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 306.3278 | 0.2189 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 0 | 68.0123 | 0.3892 | 14 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 55.6323 | 0.4378 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 47.0615 | 0.4865 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:0051290 | 0 | 40.7763 | 0.5351 | 14 | 44 | protein heterotetramerization |
| GO:1904837 | 0 | 40.7763 | 0.5351 | 14 | 44 | beta-catenin-TCF complex assembly |
| GO:0034724 | 0 | 33.0471 | 0.6202 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0016233 | 0 | 29.8154 | 0.6689 | 14 | 55 | telomere capping |
| GO:0006303 | 0 | 21.0536 | 0.8756 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 0 | 20.0144 | 0.9121 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:0045815 | 0 | 18.7779 | 0.9608 | 14 | 79 | positive regulation of gene expression, epigenetic |
| GO:0016441 | 0 | 8.859 | 2.8458 | 21 | 234 | posttranscriptional gene silencing |
| GO:0031047 | 0 | 7.9838 | 3.1255 | 21 | 257 | gene silencing by RNA |
| GO:1903707 | 0 | 11.9139 | 1.6296 | 16 | 134 | negative regulation of hemopoiesis |
| GO:0034249 | 0 | 6.6806 | 4.0619 | 23 | 334 | negative regulation of cellular amide metabolic process |
| GO:1902036 | 0 | 14.0098 | 1.2283 | 14 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 13.3906 | 1.277 | 14 | 105 | regulation of gene silencing by miRNA |
| GO:0045814 | 0 | 11.7071 | 1.4351 | 14 | 118 | negative regulation of gene expression, epigenetic |
| GO:0031497 | 0 | 10.0739 | 1.7634 | 15 | 145 | chromatin assembly |
| GO:0060968 | 0 | 10.6733 | 1.5567 | 14 | 128 | regulation of gene silencing |
| GO:0002244 | 0 | 8.2422 | 2.262 | 16 | 186 | hematopoietic progenitor cell differentiation |
| GO:0032200 | 0 | 8.8385 | 1.9823 | 15 | 163 | telomere organization |
| GO:0048863 | 0 | 6.6409 | 3.1255 | 18 | 257 | stem cell differentiation |
| GO:0006352 | 0 | 7.0095 | 2.7971 | 17 | 230 | DNA-templated transcription, initiation |
| GO:0065004 | 0 | 7.0639 | 2.6026 | 16 | 214 | protein-DNA complex assembly |
| GO:0045596 | 0 | 4.0916 | 7.6131 | 27 | 626 | negative regulation of cell differentiation |
| GO:0071103 | 0 | 6.0814 | 3.1863 | 17 | 262 | DNA conformation change |
| GO:0045637 | 0 | 5.9459 | 2.8458 | 15 | 234 | regulation of myeloid cell differentiation |
| GO:0045892 | 0 | 2.8565 | 13.2317 | 33 | 1088 | negative regulation of transcription, DNA-templated |
| GO:1902679 | 0 | 2.761 | 13.6452 | 33 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0060249 | 0 | 4.2159 | 4.4754 | 17 | 368 | anatomical structure homeostasis |
| GO:0032269 | 0 | 2.6134 | 14.3384 | 33 | 1179 | negative regulation of cellular protein metabolic process |
| GO:1901566 | 0 | 2.2743 | 23.0621 | 45 | 1922 | organonitrogen compound biosynthetic process |
| GO:0043604 | 0 | 2.8266 | 10.2643 | 26 | 844 | amide biosynthetic process |
| GO:0006412 | 0 | 2.9529 | 9.036 | 24 | 743 | translation |
| GO:0048869 | 0 | 1.8743 | 48.3419 | 74 | 3975 | cellular developmental process |
| GO:0045934 | 0 | 2.3398 | 16.3694 | 34 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0032501 | 0 | 1.7991 | 83.0629 | 111 | 6830 | multicellular organismal process |
| GO:0006518 | 0 | 2.626 | 10.9818 | 26 | 903 | peptide metabolic process |
| GO:0048513 | 0 | 1.9003 | 38.7343 | 62 | 3185 | animal organ development |
| GO:0048519 | 1e-04 | 1.7413 | 58.5819 | 83 | 4817 | negative regulation of biological process |
| GO:0010605 | 1e-04 | 1.9013 | 30.8902 | 51 | 2540 | negative regulation of macromolecule metabolic process |
| GO:0070370 | 1e-04 | Inf | 0.0243 | 2 | 2 | cellular heat acclimation |
| GO:0051259 | 2e-04 | 2.9739 | 6.2024 | 17 | 510 | protein oligomerization |
| GO:2000026 | 2e-04 | 2.0102 | 21.7934 | 39 | 1792 | regulation of multicellular organismal development |
| GO:0006281 | 4e-04 | 2.8246 | 6.1051 | 16 | 502 | DNA repair |
| GO:0070434 | 4e-04 | 164.1354 | 0.0365 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0090063 | 4e-04 | 164.1354 | 0.0365 | 2 | 3 | positive regulation of microtubule nucleation |
| GO:0035195 | 5e-04 | 5.4719 | 1.3858 | 7 | 122 | gene silencing by miRNA |
| GO:0009408 | 7e-04 | 4.5057 | 1.9094 | 8 | 157 | response to heat |
| GO:0014706 | 0.0011 | 3.0448 | 4.2079 | 12 | 346 | striated muscle tissue development |
| GO:0003241 | 0.0014 | 54.7049 | 0.0608 | 2 | 5 | growth involved in heart morphogenesis |
| GO:0042816 | 0.0014 | 54.7049 | 0.0608 | 2 | 5 | vitamin B6 metabolic process |
| GO:1903672 | 0.002 | 13.7347 | 0.2554 | 3 | 21 | positive regulation of sprouting angiogenesis |
| GO:0003160 | 0.0021 | 41.026 | 0.073 | 2 | 6 | endocardium morphogenesis |
| GO:0046533 | 0.0021 | 41.026 | 0.073 | 2 | 6 | negative regulation of photoreceptor cell differentiation |
| GO:0060956 | 0.0021 | 41.026 | 0.073 | 2 | 6 | endocardial cell differentiation |
| GO:0009218 | 0.0023 | 13.011 | 0.2676 | 3 | 22 | pyrimidine ribonucleotide metabolic process |
| GO:0003158 | 0.0025 | 4.7126 | 1.3621 | 6 | 112 | endothelium development |
| GO:0051246 | 0.0025 | 1.6554 | 32.3374 | 48 | 2659 | regulation of protein metabolic process |
| GO:0042692 | 0.0025 | 2.7421 | 4.6457 | 12 | 382 | muscle cell differentiation |
| GO:0045662 | 0.0026 | 12.3597 | 0.2797 | 3 | 23 | negative regulation of myoblast differentiation |
| GO:0045686 | 0.0026 | 12.3597 | 0.2797 | 3 | 23 | negative regulation of glial cell differentiation |
| GO:0042026 | 0.003 | 11.7704 | 0.2919 | 3 | 24 | protein refolding |
| GO:0060538 | 0.0032 | 3.869 | 1.9215 | 7 | 158 | skeletal muscle organ development |
| GO:0046134 | 0.0033 | 11.2347 | 0.304 | 3 | 25 | pyrimidine nucleoside biosynthetic process |
| GO:0060836 | 0.0039 | 27.3472 | 0.0973 | 2 | 8 | lymphatic endothelial cell differentiation |
| GO:0070424 | 0.0039 | 27.3472 | 0.0973 | 2 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:1903265 | 0.0039 | 27.3472 | 0.0973 | 2 | 8 | positive regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0070271 | 0.0046 | 1.809 | 16.6856 | 28 | 1372 | protein complex biogenesis |
| GO:0048731 | 0.0046 | 1.9822 | 12.2002 | 22 | 1180 | system development |
| GO:0006221 | 0.0046 | 9.8846 | 0.3405 | 3 | 28 | pyrimidine nucleotide biosynthetic process |
| GO:0006228 | 0.005 | 23.439 | 0.1095 | 2 | 9 | UTP biosynthetic process |
| GO:0031652 | 0.005 | 23.439 | 0.1095 | 2 | 9 | positive regulation of heat generation |
| GO:0090370 | 0.005 | 23.439 | 0.1095 | 2 | 9 | negative regulation of cholesterol efflux |
| GO:0006325 | 0.0053 | 2.1166 | 8.5252 | 17 | 701 | chromatin organization |
| GO:0046131 | 0.0056 | 9.1513 | 0.3648 | 3 | 30 | pyrimidine ribonucleoside metabolic process |
| GO:0007565 | 0.0063 | 3.3921 | 2.1769 | 7 | 179 | female pregnancy |
| GO:0042246 | 0.0064 | 5.7991 | 0.7419 | 4 | 61 | tissue regeneration |
| GO:0033554 | 0.0071 | 1.6624 | 22.1339 | 34 | 1820 | cellular response to stress |
| GO:0006183 | 0.0075 | 18.228 | 0.1338 | 2 | 11 | GTP biosynthetic process |
| GO:0046689 | 0.0075 | 18.228 | 0.1338 | 2 | 11 | response to mercury ion |
| GO:0090084 | 0.0075 | 18.228 | 0.1338 | 2 | 11 | negative regulation of inclusion body assembly |
| GO:0009058 | 0.0075 | 1.4392 | 74.0026 | 91 | 6085 | biosynthetic process |
| GO:0072525 | 0.008 | 7.9684 | 0.4135 | 3 | 34 | pyridine-containing compound biosynthetic process |
| GO:0048754 | 0.0081 | 3.639 | 1.7391 | 6 | 143 | branching morphogenesis of an epithelial tube |
| GO:0035914 | 0.0085 | 5.3297 | 0.8027 | 4 | 66 | skeletal muscle cell differentiation |
| GO:0031327 | 0.0086 | 2.4342 | 4.7768 | 11 | 440 | negative regulation of cellular biosynthetic process |
| GO:0006068 | 0.009 | 16.4042 | 0.1459 | 2 | 12 | ethanol catabolic process |
| GO:0010666 | 0.009 | 16.4042 | 0.1459 | 2 | 12 | positive regulation of cardiac muscle cell apoptotic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000183 | 0 | 309.0784 | 0.4062 | 27 | 36 | chromatin silencing at rDNA |
| GO:0006335 | 0 | 303.1538 | 0.3611 | 24 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0051290 | 0 | 121.1692 | 0.4965 | 24 | 44 | protein heterotetramerization |
| GO:0045815 | 0 | 53.3484 | 0.8914 | 27 | 79 | positive regulation of gene expression, epigenetic |
| GO:0045814 | 0 | 33.8423 | 1.3315 | 29 | 118 | negative regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 37.4356 | 1.1397 | 27 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 35.5068 | 1.1848 | 27 | 105 | regulation of gene silencing by miRNA |
| GO:0060968 | 0 | 27.3809 | 1.4443 | 27 | 128 | regulation of gene silencing |
| GO:0031497 | 0 | 23.4108 | 1.6362 | 27 | 145 | chromatin assembly |
| GO:0045653 | 0 | 332.4578 | 0.2031 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0035194 | 0 | 16.0366 | 2.6291 | 31 | 233 | posttranscriptional gene silencing by RNA |
| GO:0002244 | 0 | 18.2042 | 2.0988 | 28 | 186 | hematopoietic progenitor cell differentiation |
| GO:0017148 | 0 | 11.6246 | 3.6108 | 32 | 320 | negative regulation of translation |
| GO:0065004 | 0 | 14.7075 | 2.4147 | 27 | 214 | protein-DNA complex assembly |
| GO:0032200 | 0 | 17.3027 | 1.8393 | 24 | 163 | telomere organization |
| GO:0048863 | 0 | 12.503 | 2.8999 | 28 | 257 | stem cell differentiation |
| GO:0071103 | 0 | 11.6673 | 2.9564 | 27 | 262 | DNA conformation change |
| GO:0034080 | 0 | 51.076 | 0.4514 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 44.2546 | 0.4965 | 14 | 44 | beta-catenin-TCF complex assembly |
| GO:0038111 | 0 | 51.0788 | 0.4175 | 13 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 51.0788 | 0.4175 | 13 | 37 | response to interleukin-7 |
| GO:0034724 | 0 | 35.8662 | 0.5755 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0016233 | 0 | 32.3588 | 0.6206 | 14 | 55 | telomere capping |
| GO:0050911 | 0 | 9.1743 | 3.5093 | 26 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0030099 | 0 | 8.1886 | 4.2314 | 28 | 375 | myeloid cell differentiation |
| GO:0034248 | 0 | 6.55 | 6.0481 | 32 | 536 | regulation of cellular amide metabolic process |
| GO:0045652 | 0 | 31.0724 | 0.5834 | 13 | 56 | regulation of megakaryocyte differentiation |
| GO:0006303 | 0 | 22.8496 | 0.8124 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0050906 | 0 | 7.2854 | 4.5135 | 27 | 400 | detection of stimulus involved in sensory perception |
| GO:0043044 | 0 | 21.7217 | 0.8463 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:0009593 | 0 | 7.187 | 4.3781 | 26 | 388 | detection of chemical stimulus |
| GO:0010608 | 0 | 5.5539 | 7.0298 | 32 | 623 | posttranscriptional regulation of gene expression |
| GO:0051259 | 0 | 6.1054 | 5.7548 | 29 | 510 | protein oligomerization |
| GO:0007606 | 0 | 6.8386 | 4.5812 | 26 | 406 | sensory perception of chemical stimulus |
| GO:0034728 | 0 | 14.6069 | 1.0857 | 13 | 104 | nucleosome organization |
| GO:0043043 | 0 | 4.4235 | 8.6547 | 32 | 767 | peptide biosynthetic process |
| GO:1903707 | 0 | 11.0004 | 1.512 | 14 | 134 | negative regulation of hemopoiesis |
| GO:0007186 | 0 | 3.3085 | 13.3262 | 37 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0048534 | 0 | 3.7283 | 9.3994 | 30 | 833 | hematopoietic or lymphoid organ development |
| GO:0032501 | 0 | 2.6453 | 41.3458 | 72 | 4115 | multicellular organismal process |
| GO:0045892 | 0 | 3.1316 | 12.2768 | 33 | 1088 | negative regulation of transcription, DNA-templated |
| GO:0050877 | 0 | 3.0642 | 12.9539 | 34 | 1148 | nervous system process |
| GO:1902679 | 0 | 3.0268 | 12.6605 | 33 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0006352 | 0 | 6.0739 | 2.5953 | 14 | 230 | DNA-templated transcription, initiation |
| GO:0009890 | 0 | 2.6385 | 17.8398 | 40 | 1581 | negative regulation of biosynthetic process |
| GO:0051248 | 0 | 2.8305 | 13.913 | 34 | 1233 | negative regulation of protein metabolic process |
| GO:0007596 | 0 | 4.8501 | 3.6898 | 16 | 327 | blood coagulation |
| GO:0045934 | 0 | 2.5666 | 15.1881 | 34 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:1903706 | 0 | 4.631 | 3.0958 | 13 | 295 | regulation of hemopoiesis |
| GO:0060249 | 0 | 3.9709 | 4.1525 | 15 | 368 | anatomical structure homeostasis |
| GO:0048731 | 0 | 1.9118 | 49.254 | 75 | 4365 | system development |
| GO:0070271 | 1e-04 | 2.3287 | 15.4814 | 32 | 1372 | protein complex biogenesis |
| GO:0009611 | 1e-04 | 2.9383 | 7.0863 | 19 | 628 | response to wounding |
| GO:0050878 | 1e-04 | 3.2258 | 5.405 | 16 | 479 | regulation of body fluid levels |
| GO:0001694 | 1e-04 | Inf | 0.0226 | 2 | 2 | histamine biosynthetic process |
| GO:0048869 | 2e-04 | 1.8 | 44.8533 | 67 | 3975 | cellular developmental process |
| GO:0006281 | 2e-04 | 3.0686 | 5.6645 | 16 | 502 | DNA repair |
| GO:0065003 | 4e-04 | 2.0274 | 19.3292 | 35 | 1713 | macromolecular complex assembly |
| GO:0051716 | 6e-04 | 1.6484 | 75.9065 | 98 | 6727 | cellular response to stimulus |
| GO:0015671 | 6e-04 | 22.2599 | 0.1693 | 3 | 15 | oxygen transport |
| GO:0045596 | 7e-04 | 2.5967 | 7.0637 | 17 | 626 | negative regulation of cell differentiation |
| GO:0021853 | 7e-04 | 88.5955 | 0.0451 | 2 | 4 | cerebral cortex GABAergic interneuron migration |
| GO:0071822 | 0.0011 | 1.9448 | 18.167 | 32 | 1610 | protein complex subunit organization |
| GO:0048148 | 0.0012 | 16.6907 | 0.2144 | 3 | 19 | behavioral response to cocaine |
| GO:0051239 | 0.0013 | 1.7341 | 30.6582 | 47 | 2717 | regulation of multicellular organismal process |
| GO:0015701 | 0.0014 | 9.1684 | 0.4852 | 4 | 43 | bicarbonate transport |
| GO:0050793 | 0.0018 | 1.7563 | 26.0544 | 41 | 2309 | regulation of developmental process |
| GO:0021843 | 0.0026 | 35.4315 | 0.079 | 2 | 7 | substrate-independent telencephalic tangential interneuron migration |
| GO:1903506 | 0.0026 | 1.6186 | 38.6585 | 55 | 3426 | regulation of nucleic acid-templated transcription |
| GO:0051252 | 0.0032 | 1.592 | 40.7686 | 57 | 3613 | regulation of RNA metabolic process |
| GO:2000112 | 0.0043 | 1.5542 | 43.9957 | 60 | 3899 | regulation of cellular macromolecule biosynthetic process |
| GO:0021892 | 0.0043 | 25.305 | 0.1016 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0010604 | 0.0051 | 1.5988 | 32.7457 | 47 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0021548 | 0.0054 | 22.1404 | 0.1128 | 2 | 10 | pons development |
| GO:0070328 | 0.0055 | 9.2011 | 0.3611 | 3 | 32 | triglyceride homeostasis |
| GO:0071345 | 0.0075 | 1.9977 | 9.58 | 18 | 849 | cellular response to cytokine stimulus |
| GO:0052803 | 0.0078 | 17.7101 | 0.1354 | 2 | 12 | imidazole-containing compound metabolic process |
| GO:0060158 | 0.0078 | 17.7101 | 0.1354 | 2 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
| GO:0007618 | 0.0089 | 7.6208 | 0.4288 | 3 | 38 | mating |
| GO:0060134 | 0.0091 | 16.0991 | 0.1467 | 2 | 13 | prepulse inhibition |
| GO:0015872 | 0.0096 | 7.4087 | 0.4401 | 3 | 39 | dopamine transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 244.4611 | 0.4353 | 24 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 162.9326 | 0.4897 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 97.7098 | 0.5985 | 24 | 44 | protein heterotetramerization |
| GO:0045815 | 0 | 35.4517 | 1.0747 | 24 | 79 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 25.4801 | 1.4283 | 25 | 105 | regulation of gene silencing by miRNA |
| GO:0045814 | 0 | 23.1458 | 1.6052 | 26 | 118 | negative regulation of gene expression, epigenetic |
| GO:0045653 | 0 | 271.2241 | 0.2449 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:1902036 | 0 | 25.2871 | 1.3739 | 24 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060968 | 0 | 19.7613 | 1.7412 | 25 | 128 | regulation of gene silencing |
| GO:0031497 | 0 | 17.8633 | 1.9725 | 26 | 145 | chromatin assembly |
| GO:0048863 | 0 | 11.9236 | 3.4961 | 32 | 257 | stem cell differentiation |
| GO:0002244 | 0 | 13.921 | 2.5302 | 27 | 186 | hematopoietic progenitor cell differentiation |
| GO:0032200 | 0 | 14.7164 | 2.2173 | 25 | 163 | telomere organization |
| GO:0035194 | 0 | 11.2231 | 3.1696 | 28 | 233 | posttranscriptional gene silencing by RNA |
| GO:0034080 | 0 | 46.6634 | 0.5441 | 15 | 40 | CENP-A containing nucleosome assembly |
| GO:0065004 | 0 | 11.2572 | 2.9111 | 26 | 214 | protein-DNA complex assembly |
| GO:0071103 | 0 | 9.8139 | 3.5641 | 28 | 262 | DNA conformation change |
| GO:0034724 | 0 | 32.3824 | 0.6938 | 15 | 51 | DNA replication-independent nucleosome organization |
| GO:1904837 | 0 | 36.1034 | 0.5985 | 14 | 44 | beta-catenin-TCF complex assembly |
| GO:0043044 | 0 | 21.1498 | 1.0202 | 16 | 75 | ATP-dependent chromatin remodeling |
| GO:0017148 | 0 | 7.8351 | 4.3531 | 28 | 320 | negative regulation of translation |
| GO:0016233 | 0 | 26.3987 | 0.7482 | 14 | 55 | telomere capping |
| GO:0030099 | 0 | 6.8608 | 5.1012 | 29 | 375 | myeloid cell differentiation |
| GO:0006303 | 0 | 20.4247 | 0.9794 | 15 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0038111 | 0 | 32.2627 | 0.5033 | 11 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 32.2627 | 0.5033 | 11 | 37 | response to interleukin-7 |
| GO:0051259 | 0 | 5.0986 | 6.9377 | 30 | 510 | protein oligomerization |
| GO:1902679 | 0 | 3.5608 | 15.2629 | 45 | 1122 | negative regulation of RNA biosynthetic process |
| GO:1903707 | 0 | 10.5351 | 1.8228 | 16 | 134 | negative regulation of hemopoiesis |
| GO:0048534 | 0 | 3.9895 | 11.3316 | 38 | 833 | hematopoietic or lymphoid organ development |
| GO:0045892 | 0 | 3.579 | 14.8004 | 44 | 1088 | negative regulation of transcription, DNA-templated |
| GO:0034248 | 0 | 4.4407 | 7.2914 | 28 | 536 | regulation of cellular amide metabolic process |
| GO:0045652 | 0 | 17.6673 | 0.7134 | 10 | 56 | regulation of megakaryocyte differentiation |
| GO:0009890 | 0 | 2.8524 | 21.5068 | 51 | 1581 | negative regulation of biosynthetic process |
| GO:0045934 | 0 | 2.987 | 18.3101 | 46 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0010608 | 0 | 3.7697 | 8.4749 | 28 | 623 | posttranscriptional regulation of gene expression |
| GO:0034728 | 0 | 9.6642 | 1.3212 | 11 | 104 | nucleosome organization |
| GO:0097659 | 0 | 2.1684 | 48.6862 | 83 | 3579 | nucleic acid-templated transcription |
| GO:0045596 | 0 | 3.5908 | 8.5157 | 27 | 626 | negative regulation of cell differentiation |
| GO:0051252 | 0 | 2.1416 | 49.1488 | 83 | 3613 | regulation of RNA metabolic process |
| GO:0031326 | 0 | 2.0928 | 56.9435 | 92 | 4186 | regulation of cellular biosynthetic process |
| GO:0002376 | 0 | 2.1926 | 35.8175 | 65 | 2633 | immune system process |
| GO:0034654 | 0 | 2.036 | 54.9166 | 88 | 4037 | nucleobase-containing compound biosynthetic process |
| GO:0006352 | 0 | 5.3603 | 3.1288 | 15 | 230 | DNA-templated transcription, initiation |
| GO:0010556 | 0 | 2.0274 | 54.3044 | 87 | 3992 | regulation of macromolecule biosynthetic process |
| GO:0070271 | 0 | 2.521 | 18.6637 | 41 | 1372 | protein complex biogenesis |
| GO:0051248 | 0 | 2.583 | 16.7729 | 38 | 1233 | negative regulation of protein metabolic process |
| GO:0043043 | 0 | 3.0063 | 10.4337 | 28 | 767 | peptide biosynthetic process |
| GO:0048869 | 0 | 1.9873 | 49.3945 | 79 | 3730 | cellular developmental process |
| GO:0060249 | 0 | 3.976 | 5.006 | 18 | 368 | anatomical structure homeostasis |
| GO:0009952 | 0 | 5.3456 | 2.4817 | 12 | 184 | anterior/posterior pattern specification |
| GO:0090191 | 0 | 220.5701 | 0.0544 | 3 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:0080090 | 0 | 1.7942 | 77.6205 | 108 | 5706 | regulation of primary metabolic process |
| GO:0010604 | 0 | 1.9442 | 39.4768 | 65 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0050878 | 0 | 3.262 | 6.3775 | 19 | 473 | regulation of body fluid levels |
| GO:0009790 | 0 | 2.5456 | 12.6239 | 29 | 928 | embryo development |
| GO:0048518 | 0 | 1.7721 | 71.8935 | 101 | 5285 | positive regulation of biological process |
| GO:0007389 | 0 | 3.7962 | 4.3141 | 15 | 326 | pattern specification process |
| GO:0007596 | 0 | 3.6707 | 4.4483 | 15 | 327 | blood coagulation |
| GO:0021978 | 0 | 74.184 | 0.0809 | 3 | 6 | telencephalon regionalization |
| GO:0065003 | 1e-04 | 2.0813 | 23.3025 | 43 | 1713 | macromolecular complex assembly |
| GO:0071822 | 1e-04 | 2.1033 | 21.9013 | 41 | 1610 | protein complex subunit organization |
| GO:0010467 | 1e-04 | 1.6954 | 69.5401 | 96 | 5112 | gene expression |
| GO:0048519 | 2e-04 | 1.6901 | 63.833 | 89 | 4765 | negative regulation of biological process |
| GO:0035107 | 2e-04 | 4.9629 | 1.9725 | 9 | 145 | appendage morphogenesis |
| GO:0007166 | 2e-04 | 1.8086 | 35.287 | 56 | 2594 | cell surface receptor signaling pathway |
| GO:0061217 | 3e-04 | 14.7559 | 0.3265 | 4 | 24 | regulation of mesonephros development |
| GO:0048701 | 3e-04 | 9.492 | 0.5985 | 5 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0009611 | 4e-04 | 2.5259 | 8.5429 | 20 | 628 | response to wounding |
| GO:0032330 | 4e-04 | 9.0278 | 0.6258 | 5 | 46 | regulation of chondrocyte differentiation |
| GO:0010463 | 4e-04 | 8.8123 | 0.6394 | 5 | 47 | mesenchymal cell proliferation |
| GO:0003337 | 5e-04 | 24.4953 | 0.1632 | 3 | 12 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO:0048505 | 5e-04 | 24.4953 | 0.1632 | 3 | 12 | regulation of timing of cell differentiation |
| GO:0060173 | 5e-04 | 4.212 | 2.299 | 9 | 169 | limb development |
| GO:0060441 | 5e-04 | 12.2934 | 0.3809 | 4 | 28 | epithelial tube branching involved in lung morphogenesis |
| GO:0009946 | 5e-04 | 146.3628 | 0.0408 | 2 | 3 | proximal/distal axis specification |
| GO:0060688 | 6e-04 | 8.2233 | 0.6802 | 5 | 50 | regulation of morphogenesis of a branching structure |
| GO:0032268 | 8e-04 | 1.7205 | 33.845 | 52 | 2488 | regulation of cellular protein metabolic process |
| GO:0016331 | 8e-04 | 4.358 | 1.9725 | 8 | 145 | morphogenesis of embryonic epithelium |
| GO:0034645 | 9e-04 | 1.5724 | 65.9624 | 88 | 4849 | cellular macromolecule biosynthetic process |
| GO:0090304 | 9e-04 | 1.5681 | 66.0849 | 88 | 4858 | nucleic acid metabolic process |
| GO:0021764 | 0.0011 | 73.1767 | 0.0544 | 2 | 4 | amygdala development |
| GO:0060235 | 0.0011 | 73.1767 | 0.0544 | 2 | 4 | lens induction in camera-type eye |
| GO:0061325 | 0.0011 | 73.1767 | 0.0544 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0007420 | 0.0013 | 2.3238 | 8.7469 | 19 | 643 | brain development |
| GO:0071345 | 0.0013 | 2.1399 | 11.5492 | 23 | 849 | cellular response to cytokine stimulus |
| GO:0006281 | 0.0014 | 2.4976 | 6.8289 | 16 | 502 | DNA repair |
| GO:0090185 | 0.0015 | 15.742 | 0.2313 | 3 | 17 | negative regulation of kidney development |
| GO:0048729 | 0.0016 | 2.326 | 8.2572 | 18 | 607 | tissue morphogenesis |
| GO:0030326 | 0.0017 | 5.1195 | 1.2636 | 6 | 94 | embryonic limb morphogenesis |
| GO:0072077 | 0.0017 | 14.6916 | 0.2449 | 3 | 18 | renal vesicle morphogenesis |
| GO:0035609 | 0.0018 | 48.7814 | 0.068 | 2 | 5 | C-terminal protein deglutamylation |
| GO:0060455 | 0.0018 | 48.7814 | 0.068 | 2 | 5 | negative regulation of gastric acid secretion |
| GO:0051171 | 0.0019 | 1.5595 | 61.6187 | 81 | 5026 | regulation of nitrogen compound metabolic process |
| GO:0001667 | 0.002 | 2.8198 | 4.5163 | 12 | 332 | ameboidal-type cell migration |
| GO:0001710 | 0.002 | 13.7725 | 0.2585 | 3 | 19 | mesodermal cell fate commitment |
| GO:0048557 | 0.002 | 13.7725 | 0.2585 | 3 | 19 | embryonic digestive tract morphogenesis |
| GO:0048562 | 0.0021 | 3.725 | 2.2858 | 8 | 175 | embryonic organ morphogenesis |
| GO:0001501 | 0.0022 | 2.4658 | 6.4616 | 15 | 475 | skeletal system development |
| GO:0030183 | 0.0022 | 4.8351 | 1.3331 | 6 | 98 | B cell differentiation |
| GO:0043009 | 0.0022 | 2.6623 | 5.1845 | 13 | 390 | chordate embryonic development |
| GO:0060562 | 0.0023 | 3.6896 | 2.3068 | 8 | 173 | epithelial tube morphogenesis |
| GO:0065007 | 0.0024 | 1.5901 | 150.9967 | 170 | 11100 | biological regulation |
| GO:0072078 | 0.0025 | 5.775 | 0.9386 | 5 | 69 | nephron tubule morphogenesis |
| GO:2000026 | 0.0025 | 1.8784 | 16.7708 | 29 | 1363 | regulation of multicellular organismal development |
| GO:0021902 | 0.0027 | 36.5837 | 0.0816 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0060179 | 0.0027 | 36.5837 | 0.0816 | 2 | 6 | male mating behavior |
| GO:0090186 | 0.0027 | 36.5837 | 0.0816 | 2 | 6 | regulation of pancreatic juice secretion |
| GO:0015701 | 0.0027 | 7.558 | 0.5849 | 4 | 43 | bicarbonate transport |
| GO:0061138 | 0.0027 | 3.5683 | 2.3806 | 8 | 175 | morphogenesis of a branching epithelium |
| GO:0021536 | 0.0028 | 5.5993 | 0.9658 | 5 | 71 | diencephalon development |
| GO:0055123 | 0.0031 | 3.9103 | 1.9045 | 7 | 140 | digestive system development |
| GO:1901576 | 0.0031 | 1.4725 | 81.8511 | 102 | 6017 | organic substance biosynthetic process |
| GO:1901360 | 0.0034 | 1.4676 | 80.1371 | 100 | 5891 | organic cyclic compound metabolic process |
| GO:0003253 | 0.0037 | 29.2651 | 0.0952 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0021796 | 0.0037 | 29.2651 | 0.0952 | 2 | 7 | cerebral cortex regionalization |
| GO:0021798 | 0.0037 | 29.2651 | 0.0952 | 2 | 7 | forebrain dorsal/ventral pattern formation |
| GO:0072161 | 0.0037 | 29.2651 | 0.0952 | 2 | 7 | mesenchymal cell differentiation involved in kidney development |
| GO:0048762 | 0.0037 | 3.3839 | 2.503 | 8 | 184 | mesenchymal cell differentiation |
| GO:0031016 | 0.0038 | 5.2033 | 1.0339 | 5 | 76 | pancreas development |
| GO:0048704 | 0.0038 | 6.8409 | 0.6397 | 4 | 48 | embryonic skeletal system morphogenesis |
| GO:0048856 | 0.0039 | 2.7687 | 4.322 | 11 | 455 | anatomical structure development |
| GO:0060485 | 0.004 | 6.7269 | 0.6495 | 4 | 49 | mesenchyme development |
| GO:0007492 | 0.0042 | 5.0601 | 1.0611 | 5 | 78 | endoderm development |
| GO:0009798 | 0.0045 | 4.9711 | 1.0784 | 5 | 80 | axis specification |
| GO:1903706 | 0.0045 | 2.8166 | 3.7486 | 10 | 295 | regulation of hemopoiesis |
| GO:0048596 | 0.0046 | 10.0125 | 0.3401 | 3 | 25 | embryonic camera-type eye morphogenesis |
| GO:0060571 | 0.0046 | 10.0125 | 0.3401 | 3 | 25 | morphogenesis of an epithelial fold |
| GO:0072273 | 0.0046 | 10.0125 | 0.3401 | 3 | 25 | metanephric nephron morphogenesis |
| GO:0030334 | 0.0046 | 2.0519 | 9.8216 | 19 | 722 | regulation of cell migration |
| GO:0002118 | 0.0049 | 24.386 | 0.1088 | 2 | 8 | aggressive behavior |
| GO:0072205 | 0.0049 | 24.386 | 0.1088 | 2 | 8 | metanephric collecting duct development |
| GO:0021846 | 0.0051 | 9.5766 | 0.3537 | 3 | 26 | cell proliferation in forebrain |
| GO:0021915 | 0.0053 | 3.5106 | 2.1085 | 7 | 155 | neural tube development |
| GO:0072359 | 0.0054 | 1.8895 | 12.9504 | 23 | 952 | circulatory system development |
| GO:2000242 | 0.0054 | 6.1373 | 0.7074 | 4 | 52 | negative regulation of reproductive process |
| GO:0007498 | 0.0057 | 3.9312 | 1.6188 | 6 | 119 | mesoderm development |
| GO:0051270 | 0.0058 | 1.9339 | 11.522 | 21 | 847 | regulation of cellular component movement |
| GO:0009954 | 0.0062 | 8.8919 | 0.3775 | 3 | 28 | proximal/distal pattern formation |
| GO:0046483 | 0.0063 | 1.4274 | 76.8451 | 95 | 5649 | heterocycle metabolic process |
| GO:0045165 | 0.0065 | 2.8417 | 3.3328 | 9 | 245 | cell fate commitment |
| GO:0048513 | 0.0065 | 1.7768 | 17.2361 | 28 | 1609 | animal organ development |
| GO:0051716 | 0.0066 | 1.4166 | 91.5095 | 110 | 6727 | cellular response to stimulus |
| GO:0090596 | 0.0066 | 2.8295 | 3.3464 | 9 | 246 | sensory organ morphogenesis |
| GO:0060993 | 0.0067 | 4.5021 | 1.1835 | 5 | 87 | kidney morphogenesis |
| GO:0009953 | 0.0067 | 4.4885 | 1.1866 | 5 | 88 | dorsal/ventral pattern formation |
| GO:0061326 | 0.0073 | 4.3944 | 1.2107 | 5 | 89 | renal tubule development |
| GO:0060021 | 0.008 | 4.2916 | 1.2379 | 5 | 91 | palate development |
| GO:0072175 | 0.0081 | 3.6391 | 1.7412 | 6 | 128 | epithelial tube formation |
| GO:0048546 | 0.0081 | 7.9677 | 0.4164 | 3 | 31 | digestive tract morphogenesis |
| GO:0007275 | 0.0083 | 1.6259 | 26.9087 | 39 | 2541 | multicellular organism development |
| GO:0014020 | 0.0084 | 4.242 | 1.2515 | 5 | 92 | primary neural tube formation |
| GO:0001893 | 0.0084 | 7.864 | 0.4217 | 3 | 31 | maternal placenta development |
| GO:0030858 | 0.0085 | 5.3538 | 0.8026 | 4 | 59 | positive regulation of epithelial cell differentiation |
| GO:0048645 | 0.0085 | 5.3538 | 0.8026 | 4 | 59 | animal organ formation |
| GO:0060393 | 0.0085 | 5.3538 | 0.8026 | 4 | 59 | regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0048870 | 0.0085 | 1.6821 | 19.0446 | 30 | 1400 | cell motility |
| GO:0034641 | 0.0089 | 1.3987 | 84.4493 | 102 | 6208 | cellular nitrogen compound metabolic process |
| GO:0021872 | 0.009 | 5.2579 | 0.8162 | 4 | 60 | forebrain generation of neurons |
| GO:0060675 | 0.009 | 5.2579 | 0.8162 | 4 | 60 | ureteric bud morphogenesis |
| GO:0001655 | 0.0091 | 2.5285 | 4.149 | 10 | 305 | urogenital system development |
| GO:0035115 | 0.0092 | 7.5923 | 0.4353 | 3 | 32 | embryonic forelimb morphogenesis |
| GO:0021903 | 0.0093 | 16.2543 | 0.1496 | 2 | 11 | rostrocaudal neural tube patterning |
| GO:0061308 | 0.0093 | 16.2543 | 0.1496 | 2 | 11 | cardiac neural crest cell development involved in heart development |
| GO:0071223 | 0.0093 | 16.2543 | 0.1496 | 2 | 11 | cellular response to lipoteichoic acid |
| GO:0090009 | 0.0093 | 16.2543 | 0.1496 | 2 | 11 | primitive streak formation |
| GO:0045595 | 0.0094 | 1.8499 | 12.0771 | 21 | 983 | regulation of cell differentiation |
| GO:0045944 | 0.0097 | 1.7662 | 14.4059 | 24 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0006355 | 0.0098 | 1.5851 | 26.9789 | 39 | 2318 | regulation of transcription, DNA-templated |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 37.4322 | 0.4032 | 10 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0051290 | 0 | 27.5754 | 0.5544 | 11 | 44 | protein heterotetramerization |
| GO:0000183 | 0 | 31.6653 | 0.4536 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 30.4906 | 0.4662 | 10 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 30.4906 | 0.4662 | 10 | 37 | response to interleukin-7 |
| GO:0045652 | 0 | 12.833 | 0.9324 | 10 | 74 | regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 11.8992 | 0.9954 | 10 | 79 | positive regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 10.0743 | 1.2726 | 11 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 8.6283 | 1.323 | 10 | 105 | regulation of gene silencing by miRNA |
| GO:0007596 | 0 | 4.602 | 4.1203 | 17 | 327 | blood coagulation |
| GO:0032200 | 0 | 6.5594 | 2.0538 | 12 | 163 | telomere organization |
| GO:0071310 | 0 | 2.2315 | 29.3587 | 55 | 2330 | cellular response to organic substance |
| GO:0031497 | 0 | 6.7473 | 1.827 | 11 | 145 | chromatin assembly |
| GO:0045814 | 0 | 7.5834 | 1.4868 | 10 | 118 | negative regulation of gene expression, epigenetic |
| GO:0002244 | 0 | 5.684 | 2.3437 | 12 | 186 | hematopoietic progenitor cell differentiation |
| GO:0034728 | 0 | 6.2747 | 1.953 | 11 | 155 | nucleosome organization |
| GO:0048863 | 0 | 4.7779 | 3.2383 | 14 | 257 | stem cell differentiation |
| GO:0060968 | 0 | 6.9363 | 1.6128 | 10 | 128 | regulation of gene silencing |
| GO:0051259 | 0 | 3.4414 | 6.4262 | 20 | 510 | protein oligomerization |
| GO:0002376 | 0 | 2.0754 | 33.1766 | 58 | 2633 | immune system process |
| GO:0050878 | 0 | 3.4702 | 6.0355 | 19 | 479 | regulation of body fluid levels |
| GO:0009611 | 0 | 3.0716 | 7.913 | 22 | 628 | response to wounding |
| GO:0030099 | 0 | 3.7081 | 4.7251 | 16 | 375 | myeloid cell differentiation |
| GO:0035194 | 0 | 4.4617 | 2.9359 | 12 | 233 | posttranscriptional gene silencing by RNA |
| GO:0048534 | 1e-04 | 2.627 | 10.4961 | 25 | 833 | hematopoietic or lymphoid organ development |
| GO:0065004 | 1e-04 | 4.4342 | 2.6965 | 11 | 214 | protein-DNA complex assembly |
| GO:1903706 | 1e-04 | 3.2119 | 5.4055 | 16 | 429 | regulation of hemopoiesis |
| GO:0071103 | 1e-04 | 3.9368 | 3.3013 | 12 | 262 | DNA conformation change |
| GO:0003165 | 2e-04 | Inf | 0.0252 | 2 | 2 | Purkinje myocyte development |
| GO:0051094 | 2e-04 | 2.2047 | 15.007 | 30 | 1191 | positive regulation of developmental process |
| GO:0022037 | 2e-04 | 6.3497 | 1.2096 | 7 | 96 | metencephalon development |
| GO:0090023 | 3e-04 | 13.8848 | 0.3402 | 4 | 27 | positive regulation of neutrophil chemotaxis |
| GO:0051248 | 4e-04 | 2.1216 | 15.5362 | 30 | 1233 | negative regulation of protein metabolic process |
| GO:0002457 | 5e-04 | 158.2915 | 0.0378 | 2 | 3 | T cell antigen processing and presentation |
| GO:1900138 | 5e-04 | 158.2915 | 0.0378 | 2 | 3 | negative regulation of phospholipase A2 activity |
| GO:0021527 | 6e-04 | 21.6804 | 0.1764 | 3 | 14 | spinal cord association neuron differentiation |
| GO:0050896 | 7e-04 | 1.6574 | 78.6759 | 100 | 6644 | response to stimulus |
| GO:0017148 | 8e-04 | 3.1835 | 4.0321 | 12 | 320 | negative regulation of translation |
| GO:1902622 | 8e-04 | 10.6403 | 0.4284 | 4 | 34 | regulation of neutrophil migration |
| GO:0009913 | 9e-04 | 3.1113 | 4.1203 | 12 | 327 | epidermal cell differentiation |
| GO:1904431 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | positive regulation of t-circle formation |
| GO:0002697 | 9e-04 | 3.1013 | 4.1329 | 12 | 328 | regulation of immune effector process |
| GO:0051270 | 0.001 | 2.2236 | 10.6725 | 22 | 847 | regulation of cellular component movement |
| GO:0050777 | 0.0011 | 4.7398 | 1.5876 | 7 | 126 | negative regulation of immune response |
| GO:0014855 | 0.0011 | 7.0238 | 0.7812 | 5 | 62 | striated muscle cell proliferation |
| GO:0071294 | 0.0012 | 17.0314 | 0.2142 | 3 | 17 | cellular response to zinc ion |
| GO:0031424 | 0.0012 | 3.7201 | 2.5831 | 9 | 205 | keratinization |
| GO:0046649 | 0.0014 | 2.4385 | 7.4594 | 17 | 592 | lymphocyte activation |
| GO:0021697 | 0.0014 | 15.8949 | 0.2268 | 3 | 18 | cerebellar cortex formation |
| GO:0001819 | 0.0014 | 2.8122 | 4.9267 | 13 | 391 | positive regulation of cytokine production |
| GO:0010604 | 0.0014 | 1.6643 | 36.5661 | 54 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0042743 | 0.0016 | 8.8635 | 0.504 | 4 | 40 | hydrogen peroxide metabolic process |
| GO:0048519 | 0.0016 | 1.5771 | 56.5434 | 76 | 4614 | negative regulation of biological process |
| GO:0060043 | 0.0017 | 8.6234 | 0.5166 | 4 | 41 | regulation of cardiac muscle cell proliferation |
| GO:0090278 | 0.0019 | 8.3959 | 0.5292 | 4 | 42 | negative regulation of peptide hormone secretion |
| GO:0045766 | 0.0019 | 4.2695 | 1.7514 | 7 | 139 | positive regulation of angiogenesis |
| GO:0030334 | 0.002 | 2.2346 | 9.0974 | 19 | 722 | regulation of cell migration |
| GO:0001890 | 0.002 | 4.2371 | 1.764 | 7 | 140 | placenta development |
| GO:0040012 | 0.0021 | 2.1326 | 10.5591 | 21 | 838 | regulation of locomotion |
| GO:0019221 | 0.0022 | 2.5678 | 5.8121 | 14 | 495 | cytokine-mediated signaling pathway |
| GO:0048869 | 0.0022 | 1.5778 | 47.94 | 66 | 3878 | cellular developmental process |
| GO:0002583 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | regulation of antigen processing and presentation of peptide antigen |
| GO:0003278 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | apoptotic process involved in heart morphogenesis |
| GO:0010792 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | DNA double-strand break processing involved in repair via single-strand annealing |
| GO:0021937 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
| GO:0086073 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0051240 | 0.0024 | 2.0065 | 12.9151 | 24 | 1069 | positive regulation of multicellular organismal process |
| GO:0060337 | 0.0026 | 5.7147 | 0.945 | 5 | 75 | type I interferon signaling pathway |
| GO:0006952 | 0.0026 | 1.8361 | 18.3208 | 31 | 1454 | defense response |
| GO:0022408 | 0.0026 | 4.0235 | 1.8522 | 7 | 147 | negative regulation of cell-cell adhesion |
| GO:0071622 | 0.0029 | 7.4173 | 0.5922 | 4 | 47 | regulation of granulocyte chemotaxis |
| GO:0031579 | 0.0029 | 11.9174 | 0.2898 | 3 | 23 | membrane raft organization |
| GO:0046631 | 0.0029 | 4.5414 | 1.4112 | 6 | 112 | alpha-beta T cell activation |
| GO:0050709 | 0.0029 | 4.5414 | 1.4112 | 6 | 112 | negative regulation of protein secretion |
| GO:0012501 | 0.0032 | 1.7139 | 24.243 | 38 | 1924 | programmed cell death |
| GO:0031340 | 0.0032 | 31.6503 | 0.0882 | 2 | 7 | positive regulation of vesicle fusion |
| GO:0051048 | 0.0032 | 3.4687 | 2.4445 | 8 | 194 | negative regulation of secretion |
| GO:0021871 | 0.0033 | 11.3492 | 0.3024 | 3 | 24 | forebrain regionalization |
| GO:0002821 | 0.0034 | 5.332 | 1.008 | 5 | 80 | positive regulation of adaptive immune response |
| GO:0034340 | 0.0034 | 5.332 | 1.008 | 5 | 80 | response to type I interferon |
| GO:0055017 | 0.0034 | 5.332 | 1.008 | 5 | 80 | cardiac muscle tissue growth |
| GO:0007165 | 0.0036 | 1.4907 | 69.2135 | 88 | 5493 | signal transduction |
| GO:0030073 | 0.0036 | 3.413 | 2.4823 | 8 | 197 | insulin secretion |
| GO:0050670 | 0.0036 | 3.413 | 2.4823 | 8 | 197 | regulation of lymphocyte proliferation |
| GO:0043588 | 0.0037 | 2.6105 | 4.8637 | 12 | 386 | skin development |
| GO:0002687 | 0.0038 | 4.2964 | 1.4868 | 6 | 118 | positive regulation of leukocyte migration |
| GO:0002822 | 0.0038 | 4.2964 | 1.4868 | 6 | 118 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0032479 | 0.0038 | 4.2964 | 1.4868 | 6 | 118 | regulation of type I interferon production |
| GO:0022610 | 0.004 | 1.8267 | 16.5064 | 28 | 1310 | biological adhesion |
| GO:0002483 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | antigen processing and presentation of endogenous peptide antigen |
| GO:0021702 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | cerebellar Purkinje cell differentiation |
| GO:1900122 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | positive regulation of receptor binding |
| GO:1904996 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | positive regulation of leukocyte adhesion to vascular endothelial cell |
| GO:2000252 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | negative regulation of feeding behavior |
| GO:2001185 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:1904950 | 0.0043 | 3.3067 | 2.5579 | 8 | 203 | negative regulation of establishment of protein localization |
| GO:0045595 | 0.0043 | 1.7373 | 20.5763 | 33 | 1633 | regulation of cell differentiation |
| GO:0048522 | 0.0043 | 1.4929 | 59.2718 | 77 | 4704 | positive regulation of cellular process |
| GO:0060706 | 0.0046 | 9.9287 | 0.3402 | 3 | 27 | cell differentiation involved in embryonic placenta development |
| GO:0070663 | 0.0048 | 3.2394 | 2.6083 | 8 | 207 | regulation of leukocyte proliferation |
| GO:0007159 | 0.0048 | 2.64 | 4.3975 | 11 | 349 | leukocyte cell-cell adhesion |
| GO:0048518 | 0.0049 | 2.5423 | 5.0961 | 12 | 465 | positive regulation of biological process |
| GO:0018149 | 0.0051 | 6.2506 | 0.693 | 4 | 55 | peptide cross-linking |
| GO:0051607 | 0.0051 | 3.2068 | 2.6335 | 8 | 209 | defense response to virus |
| GO:0048731 | 0.0051 | 1.4897 | 55.0003 | 72 | 4365 | system development |
| GO:0050863 | 0.0052 | 2.7622 | 3.8179 | 10 | 303 | regulation of T cell activation |
| GO:0048870 | 0.0053 | 1.7684 | 17.6404 | 29 | 1400 | cell motility |
| GO:0061179 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | negative regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO:0061820 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | telomeric D-loop disassembly |
| GO:0032892 | 0.0057 | 9.1638 | 0.3654 | 3 | 29 | positive regulation of organic acid transport |
| GO:0050727 | 0.0063 | 2.6783 | 3.9313 | 10 | 312 | regulation of inflammatory response |
| GO:0043066 | 0.0064 | 1.9876 | 10.1432 | 19 | 805 | negative regulation of apoptotic process |
| GO:0021936 | 0.0067 | 19.7776 | 0.126 | 2 | 10 | regulation of cerebellar granule cell precursor proliferation |
| GO:1903530 | 0.0067 | 2.1142 | 8.0012 | 16 | 635 | regulation of secretion by cell |
| GO:0032835 | 0.0069 | 5.6907 | 0.756 | 4 | 60 | glomerulus development |
| GO:0060420 | 0.0069 | 5.6907 | 0.756 | 4 | 60 | regulation of heart growth |
| GO:0009719 | 0.0069 | 1.731 | 17.9806 | 29 | 1427 | response to endogenous stimulus |
| GO:0009749 | 0.007 | 3.3268 | 2.2177 | 7 | 176 | response to glucose |
| GO:0042102 | 0.007 | 4.4391 | 1.197 | 5 | 95 | positive regulation of T cell proliferation |
| GO:0032101 | 0.0071 | 2.4974 | 4.6407 | 11 | 380 | regulation of response to external stimulus |
| GO:0030155 | 0.0074 | 2.0896 | 8.0894 | 16 | 642 | regulation of cell adhesion |
| GO:0001775 | 0.0075 | 1.7712 | 15.6874 | 26 | 1245 | cell activation |
| GO:0045907 | 0.0075 | 8.2142 | 0.4032 | 3 | 32 | positive regulation of vasoconstriction |
| GO:0007569 | 0.0076 | 4.342 | 1.2222 | 5 | 97 | cell aging |
| GO:0007565 | 0.0076 | 3.2682 | 2.2555 | 7 | 179 | female pregnancy |
| GO:0070887 | 0.0078 | 2.3733 | 5.3804 | 12 | 502 | cellular response to chemical stimulus |
| GO:0051047 | 0.008 | 2.4542 | 4.7125 | 11 | 374 | positive regulation of secretion |
| GO:0002791 | 0.008 | 2.3463 | 5.3803 | 12 | 427 | regulation of peptide secretion |
| GO:0003161 | 0.0081 | 17.579 | 0.1386 | 2 | 11 | cardiac conduction system development |
| GO:0021681 | 0.0081 | 17.579 | 0.1386 | 2 | 11 | cerebellar granular layer development |
| GO:0043374 | 0.0081 | 17.579 | 0.1386 | 2 | 11 | CD8-positive, alpha-beta T cell differentiation |
| GO:2000774 | 0.0081 | 17.579 | 0.1386 | 2 | 11 | positive regulation of cellular senescence |
| GO:0007369 | 0.0081 | 3.2302 | 2.2807 | 7 | 181 | gastrulation |
| GO:0043122 | 0.0082 | 2.9398 | 2.8603 | 8 | 227 | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0098742 | 0.0086 | 2.9128 | 2.8855 | 8 | 229 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0034284 | 0.0093 | 3.139 | 2.3437 | 7 | 186 | response to monosaccharide |
| GO:0010035 | 0.0095 | 2.2094 | 6.1867 | 13 | 491 | response to inorganic substance |
| GO:0021587 | 0.0096 | 7.4427 | 0.441 | 3 | 35 | cerebellum morphogenesis |
| GO:0021692 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | cerebellar Purkinje cell layer morphogenesis |
| GO:0044090 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | positive regulation of vacuole organization |
| GO:0060670 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | branching involved in labyrinthine layer morphogenesis |
| GO:0090197 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | positive regulation of chemokine secretion |
| GO:1901298 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | regulation of hydrogen peroxide-mediated programmed cell death |
| GO:0050795 | 0.0096 | 5.138 | 0.8316 | 4 | 66 | regulation of behavior |
| GO:0060548 | 0.0097 | 1.8695 | 11.3277 | 20 | 899 | negative regulation of cell death |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0021675 | 0 | 11.6726 | 0.9072 | 9 | 72 | nerve development |
| GO:0050877 | 0 | 2.8723 | 14.4651 | 36 | 1148 | nervous system process |
| GO:0021524 | 0 | Inf | 0.0378 | 3 | 3 | visceral motor neuron differentiation |
| GO:0009593 | 0 | 4.0889 | 4.8889 | 18 | 388 | detection of chemical stimulus |
| GO:0050911 | 0 | 4.5313 | 3.9187 | 16 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0050906 | 0 | 3.9573 | 5.0401 | 18 | 400 | detection of stimulus involved in sensory perception |
| GO:0007389 | 0 | 3.864 | 5.1535 | 18 | 409 | pattern specification process |
| GO:0009952 | 0 | 5.4013 | 2.4571 | 12 | 195 | anterior/posterior pattern specification |
| GO:0048935 | 0 | 35.5149 | 0.1638 | 4 | 13 | peripheral nervous system neuron development |
| GO:0032501 | 1e-04 | 1.8545 | 60.7209 | 85 | 5469 | multicellular organismal process |
| GO:0021570 | 2e-04 | Inf | 0.0252 | 2 | 2 | rhombomere 4 development |
| GO:0033555 | 2e-04 | 7.9142 | 0.8442 | 6 | 67 | multicellular organismal response to stress |
| GO:0048663 | 2e-04 | 7.7861 | 0.8568 | 6 | 68 | neuron fate commitment |
| GO:0007186 | 2e-04 | 2.2981 | 12.935 | 27 | 1067 | G-protein coupled receptor signaling pathway |
| GO:0021559 | 3e-04 | 29.8163 | 0.1386 | 3 | 11 | trigeminal nerve development |
| GO:0001501 | 3e-04 | 2.8814 | 5.9851 | 16 | 475 | skeletal system development |
| GO:0021515 | 4e-04 | 8.7095 | 0.6426 | 5 | 51 | cell differentiation in spinal cord |
| GO:0003203 | 5e-04 | 12.7724 | 0.3654 | 4 | 29 | endocardial cushion morphogenesis |
| GO:0021520 | 5e-04 | 23.85 | 0.1638 | 3 | 13 | spinal cord motor neuron cell fate specification |
| GO:0001662 | 8e-04 | 11.0079 | 0.4158 | 4 | 33 | behavioral fear response |
| GO:0060253 | 8e-04 | 19.8725 | 0.189 | 3 | 15 | negative regulation of glial cell proliferation |
| GO:0001992 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0021615 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | glossopharyngeal nerve morphogenesis |
| GO:0070253 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | somatostatin secretion |
| GO:0050789 | 0.001 | 1.6689 | 129.6137 | 150 | 10452 | regulation of biological process |
| GO:0048704 | 0.0011 | 5.6047 | 1.1592 | 6 | 92 | embryonic skeletal system morphogenesis |
| GO:0007268 | 0.0012 | 2.4742 | 7.3586 | 17 | 584 | chemical synaptic transmission |
| GO:0007218 | 0.0012 | 5.4766 | 1.1844 | 6 | 94 | neuropeptide signaling pathway |
| GO:0099537 | 0.0012 | 2.4652 | 7.3838 | 17 | 586 | trans-synaptic signaling |
| GO:0045777 | 0.0013 | 9.3861 | 0.4788 | 4 | 38 | positive regulation of blood pressure |
| GO:0051241 | 0.0014 | 2.0666 | 13.0791 | 25 | 1038 | negative regulation of multicellular organismal process |
| GO:0048880 | 0.0015 | 52.7571 | 0.063 | 2 | 5 | sensory system development |
| GO:0021983 | 0.0016 | 8.8635 | 0.504 | 4 | 40 | pituitary gland development |
| GO:0098664 | 0.0019 | 14.0232 | 0.252 | 3 | 20 | G-protein coupled serotonin receptor signaling pathway |
| GO:0021517 | 0.0021 | 8.1801 | 0.5418 | 4 | 43 | ventral spinal cord development |
| GO:0031290 | 0.0022 | 13.2433 | 0.2646 | 3 | 21 | retinal ganglion cell axon guidance |
| GO:0042310 | 0.0023 | 5.8835 | 0.9198 | 5 | 73 | vasoconstriction |
| GO:0010840 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | regulation of circadian sleep/wake cycle, wakefulness |
| GO:0045596 | 0.0025 | 2.2972 | 7.8878 | 17 | 626 | negative regulation of cell differentiation |
| GO:0021602 | 0.0028 | 12.0375 | 0.287 | 3 | 23 | cranial nerve morphogenesis |
| GO:0044062 | 0.0029 | 11.9174 | 0.2898 | 3 | 23 | regulation of excretion |
| GO:0007608 | 0.0031 | 11.5639 | 0.2957 | 3 | 25 | sensory perception of smell |
| GO:0050768 | 0.0032 | 3.1914 | 2.9863 | 9 | 237 | negative regulation of neurogenesis |
| GO:0021612 | 0.0032 | 31.6503 | 0.0882 | 2 | 7 | facial nerve structural organization |
| GO:0060052 | 0.0032 | 31.6503 | 0.0882 | 2 | 7 | neurofilament cytoskeleton organization |
| GO:0035640 | 0.0033 | 11.3492 | 0.3024 | 3 | 24 | exploration behavior |
| GO:0072507 | 0.0035 | 2.5179 | 5.4685 | 13 | 434 | divalent inorganic cation homeostasis |
| GO:0046887 | 0.0035 | 4.3751 | 1.4616 | 6 | 116 | positive regulation of hormone secretion |
| GO:0001708 | 0.0036 | 5.2615 | 1.0206 | 5 | 81 | cell fate specification |
| GO:0003148 | 0.0037 | 10.8326 | 0.315 | 3 | 25 | outflow tract septum morphogenesis |
| GO:0002011 | 0.0039 | 6.7843 | 0.6426 | 4 | 51 | morphogenesis of an epithelial sheet |
| GO:0006874 | 0.0041 | 2.5752 | 4.9267 | 12 | 391 | cellular calcium ion homeostasis |
| GO:0002118 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | aggressive behavior |
| GO:0045924 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | regulation of female receptivity |
| GO:0006355 | 0.0045 | 1.5398 | 42.9166 | 59 | 3406 | regulation of transcription, DNA-templated |
| GO:0007267 | 0.0046 | 1.757 | 19.0517 | 31 | 1512 | cell-cell signaling |
| GO:0097746 | 0.005 | 4.0419 | 1.575 | 6 | 125 | regulation of blood vessel diameter |
| GO:0048857 | 0.0051 | 6.2506 | 0.693 | 4 | 55 | neural nucleus development |
| GO:2001141 | 0.0053 | 1.5242 | 43.2568 | 59 | 3433 | regulation of RNA biosynthetic process |
| GO:0010579 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
| GO:0021561 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | facial nerve development |
| GO:0021562 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | vestibulocochlear nerve development |
| GO:0046549 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | retinal cone cell development |
| GO:0046877 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | regulation of saliva secretion |
| GO:0007417 | 0.0059 | 1.9689 | 10.7985 | 20 | 857 | central nervous system development |
| GO:0009889 | 0.0062 | 1.4782 | 53.5765 | 70 | 4252 | regulation of biosynthetic process |
| GO:0019098 | 0.0062 | 8.8238 | 0.378 | 3 | 30 | reproductive behavior |
| GO:0051006 | 0.0067 | 19.7776 | 0.126 | 2 | 10 | positive regulation of lipoprotein lipase activity |
| GO:0009790 | 0.0068 | 1.9094 | 11.6931 | 21 | 928 | embryo development |
| GO:0035150 | 0.007 | 3.7555 | 1.6884 | 6 | 134 | regulation of tube size |
| GO:0060193 | 0.0073 | 5.5905 | 0.7686 | 4 | 61 | positive regulation of lipase activity |
| GO:0098801 | 0.0075 | 8.2142 | 0.4032 | 3 | 32 | regulation of renal system process |
| GO:0051960 | 0.0075 | 1.9924 | 9.5636 | 18 | 759 | regulation of nervous system development |
| GO:0080090 | 0.0075 | 1.4337 | 71.8973 | 89 | 5706 | regulation of primary metabolic process |
| GO:0003156 | 0.0081 | 7.9399 | 0.4158 | 3 | 33 | regulation of animal organ formation |
| GO:0051094 | 0.0082 | 1.7768 | 15.007 | 25 | 1191 | positive regulation of developmental process |
| GO:0055008 | 0.0086 | 5.31 | 0.8064 | 4 | 64 | cardiac muscle tissue morphogenesis |
| GO:0014013 | 0.009 | 4.16 | 1.2726 | 5 | 101 | regulation of gliogenesis |
| GO:0048699 | 0.0094 | 1.7177 | 16.7836 | 27 | 1332 | generation of neurons |
| GO:0031323 | 0.0094 | 1.4161 | 73.3968 | 90 | 5825 | regulation of cellular metabolic process |
| GO:0035815 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | positive regulation of renal sodium excretion |
| GO:0050795 | 0.0096 | 5.138 | 0.8316 | 4 | 66 | regulation of behavior |
| GO:0009887 | 0.01 | 1.8362 | 12.1215 | 21 | 962 | animal organ morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000183 | 0 | 291.7407 | 0.4265 | 27 | 36 | chromatin silencing at rDNA |
| GO:0006335 | 0 | 286.4545 | 0.3791 | 24 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0051290 | 0 | 114.4945 | 0.5213 | 24 | 44 | protein heterotetramerization |
| GO:0045815 | 0 | 50.3558 | 0.936 | 27 | 79 | positive regulation of gene expression, epigenetic |
| GO:0045814 | 0 | 31.9204 | 1.3981 | 29 | 118 | negative regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 35.3356 | 1.1967 | 27 | 101 | regulation of hematopoietic stem cell differentiation |
| GO:0060964 | 0 | 33.515 | 1.244 | 27 | 105 | regulation of gene silencing by miRNA |
| GO:0060968 | 0 | 25.8449 | 1.5165 | 27 | 128 | regulation of gene silencing |
| GO:0031497 | 0 | 22.0975 | 1.718 | 27 | 145 | chromatin assembly |
| GO:0045653 | 0 | 315.18 | 0.2133 | 14 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0035194 | 0 | 15.1144 | 2.7606 | 31 | 233 | posttranscriptional gene silencing by RNA |
| GO:0002244 | 0 | 17.1767 | 2.2037 | 28 | 186 | hematopoietic progenitor cell differentiation |
| GO:0017148 | 0 | 11.4069 | 3.7914 | 33 | 320 | negative regulation of translation |
| GO:0048863 | 0 | 12.3496 | 3.0449 | 29 | 257 | stem cell differentiation |
| GO:0065004 | 0 | 13.8824 | 2.5355 | 27 | 214 | protein-DNA complex assembly |
| GO:0032200 | 0 | 16.3495 | 1.9312 | 24 | 163 | telomere organization |
| GO:0071103 | 0 | 11.0128 | 3.1042 | 27 | 262 | DNA conformation change |
| GO:0034080 | 0 | 48.4215 | 0.4739 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 41.9547 | 0.5213 | 14 | 44 | beta-catenin-TCF complex assembly |
| GO:0038111 | 0 | 48.4392 | 0.4384 | 13 | 37 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 48.4392 | 0.4384 | 13 | 37 | response to interleukin-7 |
| GO:0034724 | 0 | 34.0022 | 0.6043 | 14 | 51 | DNA replication-independent nucleosome organization |
| GO:0030099 | 0 | 8.0761 | 4.443 | 29 | 375 | myeloid cell differentiation |
| GO:0016233 | 0 | 30.6771 | 0.6516 | 14 | 55 | telomere capping |
| GO:0050911 | 0 | 8.6627 | 3.6847 | 26 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0034248 | 0 | 6.4176 | 6.3506 | 33 | 536 | regulation of cellular amide metabolic process |
| GO:0045652 | 0 | 29.3293 | 0.615 | 13 | 56 | regulation of megakaryocyte differentiation |
| GO:0050906 | 0 | 7.1954 | 4.7392 | 28 | 400 | detection of stimulus involved in sensory perception |
| GO:0006303 | 0 | 21.6621 | 0.8531 | 14 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0009593 | 0 | 7.1108 | 4.597 | 27 | 388 | detection of chemical stimulus |
| GO:0043044 | 0 | 20.5928 | 0.8886 | 14 | 75 | ATP-dependent chromatin remodeling |
| GO:0007606 | 0 | 6.7652 | 4.8103 | 27 | 406 | sensory perception of chemical stimulus |
| GO:0010608 | 0 | 5.4401 | 7.3813 | 33 | 623 | posttranscriptional regulation of gene expression |
| GO:0051259 | 0 | 5.7585 | 6.0425 | 29 | 510 | protein oligomerization |
| GO:1903707 | 0 | 11.3329 | 1.5876 | 15 | 134 | negative regulation of hemopoiesis |
| GO:0043043 | 0 | 4.3314 | 9.0874 | 33 | 767 | peptide biosynthetic process |
| GO:0034728 | 0 | 13.7875 | 1.1446 | 13 | 104 | nucleosome organization |
| GO:0032501 | 0 | 2.742 | 43.5219 | 77 | 4115 | multicellular organismal process |
| GO:0048534 | 0 | 3.6601 | 9.8694 | 31 | 833 | hematopoietic or lymphoid organ development |
| GO:0045892 | 0 | 3.1749 | 12.8907 | 35 | 1088 | negative regulation of transcription, DNA-templated |
| GO:1902679 | 0 | 3.0685 | 13.2935 | 35 | 1122 | negative regulation of RNA biosynthetic process |
| GO:0009890 | 0 | 2.724 | 18.7318 | 43 | 1581 | negative regulation of biosynthetic process |
| GO:0050877 | 0 | 2.9915 | 13.6016 | 35 | 1148 | nervous system process |
| GO:0007186 | 0 | 2.8988 | 13.9925 | 35 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0006352 | 0 | 5.7581 | 2.7251 | 14 | 230 | DNA-templated transcription, initiation |
| GO:0051248 | 0 | 2.7631 | 14.6086 | 35 | 1233 | negative regulation of protein metabolic process |
| GO:0045934 | 0 | 2.6879 | 15.9475 | 37 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0007596 | 0 | 4.5951 | 3.8743 | 16 | 327 | blood coagulation |
| GO:0048731 | 0 | 1.966 | 51.7167 | 80 | 4365 | system development |
| GO:0060249 | 0 | 4.0491 | 4.3601 | 16 | 368 | anatomical structure homeostasis |
| GO:1903706 | 0 | 4.3986 | 3.245 | 13 | 295 | regulation of hemopoiesis |
| GO:0048869 | 0 | 1.87 | 47.096 | 72 | 3975 | cellular developmental process |
| GO:0070271 | 2e-04 | 2.1938 | 16.2555 | 32 | 1372 | protein complex biogenesis |
| GO:0009611 | 2e-04 | 2.7811 | 7.4406 | 19 | 628 | response to wounding |
| GO:0050878 | 2e-04 | 3.0562 | 5.6752 | 16 | 479 | regulation of body fluid levels |
| GO:0010604 | 3e-04 | 1.8139 | 34.383 | 54 | 2902 | positive regulation of macromolecule metabolic process |
| GO:0006281 | 3e-04 | 2.9072 | 5.9477 | 16 | 502 | DNA repair |
| GO:0051716 | 4e-04 | 1.6524 | 79.7018 | 103 | 6727 | cellular response to stimulus |
| GO:0065003 | 4e-04 | 1.9764 | 20.2957 | 36 | 1713 | macromolecular complex assembly |
| GO:0015671 | 7e-04 | 21.1707 | 0.1777 | 3 | 15 | oxygen transport |
| GO:0021853 | 8e-04 | 84.2834 | 0.0474 | 2 | 4 | cerebral cortex GABAergic interneuron migration |
| GO:0015872 | 0.0011 | 9.7161 | 0.4621 | 4 | 39 | dopamine transport |
| GO:0051239 | 0.0013 | 1.7179 | 32.1911 | 49 | 2717 | regulation of multicellular organismal process |
| GO:0045596 | 0.0013 | 2.4594 | 7.4169 | 17 | 626 | negative regulation of cell differentiation |
| GO:0048148 | 0.0014 | 15.874 | 0.2251 | 3 | 19 | behavioral response to cocaine |
| GO:0050793 | 0.0015 | 1.7543 | 27.3571 | 43 | 2309 | regulation of developmental process |
| GO:0015701 | 0.0016 | 8.7174 | 0.5095 | 4 | 43 | bicarbonate transport |
| GO:0048518 | 0.002 | 1.5554 | 62.6169 | 82 | 5285 | positive regulation of biological process |
| GO:0021546 | 0.002 | 42.1364 | 0.0711 | 2 | 6 | rhombomere development |
| GO:0071822 | 0.0024 | 1.8322 | 19.0754 | 32 | 1610 | protein complex subunit organization |
| GO:0021843 | 0.0028 | 33.707 | 0.0829 | 2 | 7 | substrate-independent telencephalic tangential interneuron migration |
| GO:0021884 | 0.0035 | 11.0379 | 0.308 | 3 | 26 | forebrain neuron development |
| GO:0014059 | 0.0039 | 10.5773 | 0.3199 | 3 | 27 | regulation of dopamine secretion |
| GO:0021892 | 0.0048 | 24.0733 | 0.1066 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
| GO:0021548 | 0.0059 | 21.0628 | 0.1185 | 2 | 10 | pons development |
| GO:0070328 | 0.0063 | 8.7508 | 0.3791 | 3 | 32 | triglyceride homeostasis |
| GO:1903506 | 0.0081 | 1.5088 | 40.5914 | 55 | 3426 | regulation of nucleic acid-templated transcription |
| GO:0060158 | 0.0085 | 16.8481 | 0.1422 | 2 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
| GO:0060536 | 0.0085 | 16.8481 | 0.1422 | 2 | 12 | cartilage morphogenesis |
| GO:0009952 | 0.0087 | 3.1864 | 2.3104 | 7 | 195 | anterior/posterior pattern specification |
| GO:2000112 | 0.0087 | 1.4807 | 46.1955 | 61 | 3899 | regulation of cellular macromolecule biosynthetic process |
| GO:0002376 | 0.0097 | 1.5441 | 31.1959 | 44 | 2633 | immune system process |
| GO:0032268 | 0.0098 | 1.5555 | 29.4779 | 42 | 2488 | regulation of cellular protein metabolic process |
| GO:0051252 | 0.0099 | 1.4823 | 42.807 | 57 | 3613 | regulation of RNA metabolic process |
| GO:0060134 | 0.01 | 15.3155 | 0.154 | 2 | 13 | prepulse inhibition |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060089 | 3e-04 | 2.1387 | 16.1605 | 31 | 1465 | molecular transducer activity |
| GO:0030246 | 5e-04 | 3.8676 | 2.7798 | 10 | 252 | carbohydrate binding |
| GO:0099600 | 9e-04 | 2.1525 | 12.7077 | 25 | 1152 | transmembrane receptor activity |
| GO:0019825 | 0.0014 | 9.1506 | 0.4854 | 4 | 44 | oxygen binding |
| GO:0038023 | 0.002 | 2.0479 | 12.7383 | 24 | 1172 | signaling receptor activity |
| GO:0004984 | 0.0024 | 3.0977 | 3.4306 | 10 | 311 | olfactory receptor activity |
| GO:0004966 | 0.0025 | 36.2621 | 0.0772 | 2 | 7 | galanin receptor activity |
| GO:0032393 | 0.0025 | 36.2621 | 0.0772 | 2 | 7 | MHC class I receptor activity |
| GO:0002020 | 0.0031 | 4.4924 | 1.423 | 6 | 129 | protease binding |
| GO:0001968 | 0.0032 | 11.3837 | 0.2978 | 3 | 27 | fibronectin binding |
| GO:0046920 | 0.0032 | 30.2165 | 0.0882 | 2 | 8 | alpha-(1->3)-fucosyltransferase activity |
| GO:0015926 | 0.0074 | 18.1253 | 0.1324 | 2 | 12 | glucosidase activity |
| GO:0015026 | 0.0084 | 7.8005 | 0.4192 | 3 | 38 | coreceptor activity |
| GO:0004866 | 0.0089 | 3.5576 | 1.776 | 6 | 161 | endopeptidase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004601 | 1e-04 | 11.7443 | 0.4908 | 5 | 41 | peroxidase activity |
| GO:0031720 | 4e-04 | 166.8042 | 0.0359 | 2 | 3 | haptoglobin binding |
| GO:0016918 | 6e-04 | 22.8525 | 0.1676 | 3 | 14 | retinal binding |
| GO:0019841 | 6e-04 | 22.8525 | 0.1676 | 3 | 14 | retinol binding |
| GO:0004887 | 0.0029 | 33.3524 | 0.0838 | 2 | 7 | thyroid hormone receptor activity |
| GO:0005507 | 0.0032 | 7.153 | 0.6105 | 4 | 51 | copper ion binding |
| GO:0004866 | 0.0033 | 3.8562 | 1.9274 | 7 | 161 | endopeptidase inhibitor activity |
| GO:0032052 | 0.0049 | 23.8201 | 0.1077 | 2 | 9 | bile acid binding |
| GO:0019840 | 0.0077 | 8.0987 | 0.407 | 3 | 34 | isoprenoid binding |
| GO:0005246 | 0.009 | 7.6069 | 0.431 | 3 | 36 | calcium channel regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 9.9025 | 6.0003 | 44 | 467 | protein heterodimerization activity |
| GO:0042393 | 0 | 14.3339 | 2.3641 | 26 | 184 | histone binding |
| GO:0031492 | 0 | 23.7044 | 0.5653 | 10 | 44 | nucleosomal DNA binding |
| GO:0003677 | 0 | 2.6441 | 29.8859 | 63 | 2326 | DNA binding |
| GO:0102991 | 1e-04 | 46.7673 | 0.1028 | 3 | 8 | myristoyl-CoA hydrolase activity |
| GO:0004984 | 2e-04 | 3.5108 | 3.9959 | 13 | 311 | olfactory receptor activity |
| GO:0016290 | 3e-04 | 29.224 | 0.1413 | 3 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0000253 | 0.001 | 77.5764 | 0.0514 | 2 | 4 | 3-keto sterol reductase activity |
| GO:1901363 | 0.0014 | 1.5458 | 71.9138 | 93 | 5597 | heterocyclic compound binding |
| GO:0008508 | 0.0016 | 51.7143 | 0.0642 | 2 | 5 | bile acid:sodium symporter activity |
| GO:0016289 | 0.0017 | 14.6046 | 0.2441 | 3 | 19 | CoA hydrolase activity |
| GO:0019904 | 0.0021 | 2.2726 | 8.4544 | 18 | 658 | protein domain specific binding |
| GO:0097159 | 0.0023 | 1.5117 | 72.9417 | 93 | 5677 | organic cyclic compound binding |
| GO:1903231 | 0.0039 | 5.1559 | 1.0407 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004930 | 0.0053 | 2.0695 | 9.2253 | 18 | 718 | G-protein coupled receptor activity |
| GO:0045296 | 0.0054 | 2.7435 | 3.8417 | 10 | 299 | cadherin binding |
| GO:0003682 | 0.0083 | 2.2506 | 6.0774 | 13 | 473 | chromatin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 6.1884 | 5.4442 | 28 | 467 | protein heterodimerization activity |
| GO:0004930 | 0 | 3.8728 | 8.3703 | 28 | 718 | G-protein coupled receptor activity |
| GO:0004984 | 0 | 5.6592 | 3.6256 | 18 | 311 | olfactory receptor activity |
| GO:0042393 | 0 | 7.4687 | 2.145 | 14 | 184 | histone binding |
| GO:0003677 | 0 | 2.6702 | 14.8307 | 34 | 1346 | DNA binding |
| GO:0038023 | 0 | 2.475 | 14.1059 | 31 | 1210 | signaling receptor activity |
| GO:0019904 | 0 | 3.0234 | 7.6708 | 21 | 658 | protein domain specific binding |
| GO:0099600 | 1e-04 | 2.409 | 13.4298 | 29 | 1152 | transmembrane receptor activity |
| GO:0033872 | 1e-04 | Inf | 0.0233 | 2 | 2 | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity |
| GO:0048018 | 1e-04 | 3.2861 | 4.9546 | 15 | 425 | receptor ligand activity |
| GO:0001664 | 2e-04 | 4.033 | 2.9494 | 11 | 253 | G-protein coupled receptor binding |
| GO:0060089 | 4e-04 | 2.0788 | 17.0787 | 32 | 1465 | molecular transducer activity |
| GO:0008201 | 0.0025 | 4.072 | 1.8303 | 7 | 157 | heparin binding |
| GO:0004966 | 0.0027 | 34.2696 | 0.0816 | 2 | 7 | galanin receptor activity |
| GO:0008467 | 0.0027 | 34.2696 | 0.0816 | 2 | 7 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity |
| GO:0005184 | 0.0046 | 9.9262 | 0.3381 | 3 | 29 | neuropeptide hormone activity |
| GO:0031369 | 0.0046 | 9.9262 | 0.3381 | 3 | 29 | translation initiation factor binding |
| GO:0043565 | 0.0051 | 1.9655 | 11.4246 | 21 | 980 | sequence-specific DNA binding |
| GO:0001228 | 0.0065 | 2.5319 | 4.5815 | 11 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 21.978 | 3.5281 | 49 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 9.6758 | 8.1453 | 54 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 6.1622 | 13.0688 | 57 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 5.8291 | 13.7267 | 57 | 1210 | signaling receptor activity |
| GO:0060089 | 0 | 5.2028 | 16.6196 | 61 | 1465 | molecular transducer activity |
| GO:0005549 | 0 | 25.3625 | 0.8055 | 15 | 71 | odorant binding |
| GO:0031492 | 0 | 27.0726 | 0.4992 | 10 | 44 | nucleosomal DNA binding |
| GO:0042393 | 0 | 5.243 | 2.0874 | 10 | 184 | histone binding |
| GO:0046982 | 9e-04 | 2.8353 | 5.2978 | 14 | 467 | protein heterodimerization activity |
| GO:0019865 | 0.0022 | 13.2758 | 0.2609 | 3 | 23 | immunoglobulin binding |
| GO:0045296 | 0.0022 | 3.1334 | 3.392 | 10 | 299 | cadherin binding |
| GO:0030414 | 0.003 | 3.9259 | 1.8945 | 7 | 167 | peptidase inhibitor activity |
| GO:0061135 | 0.003 | 3.9259 | 1.8945 | 7 | 167 | endopeptidase regulator activity |
| GO:0004869 | 0.0033 | 7.1069 | 0.6126 | 4 | 54 | cysteine-type endopeptidase inhibitor activity |
| GO:0003682 | 0.0078 | 2.3586 | 5.3659 | 12 | 473 | chromatin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 10.0925 | 5.9125 | 44 | 467 | protein heterodimerization activity |
| GO:0042393 | 0 | 13.1402 | 2.3296 | 24 | 184 | histone binding |
| GO:0031492 | 0 | 24.0794 | 0.5571 | 10 | 44 | nucleosomal DNA binding |
| GO:0003677 | 0 | 2.6386 | 29.4486 | 62 | 2326 | DNA binding |
| GO:0019904 | 3e-04 | 2.6034 | 8.3307 | 20 | 658 | protein domain specific binding |
| GO:0045296 | 4e-04 | 3.4035 | 3.7855 | 12 | 299 | cadherin binding |
| GO:0034714 | 5e-04 | 157.52 | 0.038 | 2 | 3 | type III transforming growth factor beta receptor binding |
| GO:0004583 | 9e-04 | 78.755 | 0.0506 | 2 | 4 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity |
| GO:0030151 | 9e-04 | 78.755 | 0.0506 | 2 | 4 | molybdenum ion binding |
| GO:0003682 | 0.001 | 2.6788 | 5.9885 | 15 | 473 | chromatin binding |
| GO:0004459 | 0.0016 | 52.5 | 0.0633 | 2 | 5 | L-lactate dehydrogenase activity |
| GO:0032027 | 0.0023 | 39.3725 | 0.076 | 2 | 6 | myosin light chain binding |
| GO:0043546 | 0.0023 | 39.3725 | 0.076 | 2 | 6 | molybdopterin cofactor binding |
| GO:0005114 | 0.0032 | 31.496 | 0.0886 | 2 | 7 | type II transforming growth factor beta receptor binding |
| GO:1901363 | 0.0034 | 1.4933 | 70.111 | 89 | 5591 | heterocyclic compound binding |
| GO:0097159 | 0.0035 | 1.4906 | 71.1142 | 90 | 5671 | organic cyclic compound binding |
| GO:0030548 | 0.0067 | 19.6812 | 0.1266 | 2 | 10 | acetylcholine receptor regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 9.823 | 3.5866 | 28 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 4.6294 | 8.2803 | 32 | 718 | G-protein coupled receptor activity |
| GO:0031492 | 0 | 26.6007 | 0.5074 | 10 | 44 | nucleosomal DNA binding |
| GO:0099600 | 0 | 3.7833 | 13.2854 | 41 | 1152 | transmembrane receptor activity |
| GO:0060089 | 0 | 3.1738 | 16.895 | 44 | 1465 | molecular transducer activity |
| GO:0038023 | 0 | 3.3332 | 12.0425 | 34 | 1083 | signaling receptor activity |
| GO:0005549 | 0 | 13.0305 | 0.8188 | 9 | 71 | odorant binding |
| GO:0046982 | 0 | 3.9385 | 5.3856 | 19 | 467 | protein heterodimerization activity |
| GO:0042393 | 1e-04 | 5.1516 | 2.122 | 10 | 184 | histone binding |
| GO:0005125 | 1e-04 | 4.7382 | 2.295 | 10 | 199 | cytokine activity |
| GO:0016934 | 4e-04 | 173.2967 | 0.0346 | 2 | 3 | extracellularly glycine-gated chloride channel activity |
| GO:0030545 | 8e-04 | 2.8829 | 5.2127 | 14 | 452 | receptor regulator activity |
| GO:0030345 | 8e-04 | 86.6429 | 0.0461 | 2 | 4 | structural constituent of tooth enamel |
| GO:0045569 | 8e-04 | 86.6429 | 0.0461 | 2 | 4 | TRAIL binding |
| GO:1903231 | 0.0024 | 5.7685 | 0.9341 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0045296 | 0.0025 | 3.0788 | 3.4482 | 10 | 299 | cadherin binding |
| GO:0099589 | 0.0036 | 10.875 | 0.3114 | 3 | 27 | serotonin receptor activity |
| GO:0030594 | 0.0037 | 5.2165 | 1.0264 | 5 | 89 | neurotransmitter receptor activity |
| GO:0019911 | 0.0045 | 24.7473 | 0.1038 | 2 | 9 | structural constituent of myelin sheath |
| GO:0005154 | 0.0064 | 8.6967 | 0.3806 | 3 | 33 | epidermal growth factor receptor binding |
| GO:0004062 | 0.0081 | 17.3198 | 0.1384 | 2 | 12 | aryl sulfotransferase activity |
| GO:0016594 | 0.0081 | 17.3198 | 0.1384 | 2 | 12 | glycine binding |
| GO:0015026 | 0.0095 | 7.4519 | 0.4382 | 3 | 38 | coreceptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 13.0512 | 4.0739 | 39 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 6.7085 | 9.4053 | 48 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 4.7692 | 15.0904 | 55 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 4.6281 | 15.8502 | 56 | 1210 | signaling receptor activity |
| GO:0060089 | 0 | 4.1102 | 19.1905 | 60 | 1465 | molecular transducer activity |
| GO:0046982 | 0 | 4.7044 | 6.1174 | 25 | 467 | protein heterodimerization activity |
| GO:0042393 | 0 | 7.6871 | 2.4103 | 16 | 184 | histone binding |
| GO:0005549 | 0 | 9.9079 | 0.9301 | 8 | 71 | odorant binding |
| GO:0019904 | 0.0021 | 2.2695 | 8.4622 | 18 | 652 | protein domain specific binding |
| GO:0055131 | 0.0025 | 38.0242 | 0.0786 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0042813 | 0.0025 | 12.7249 | 0.2751 | 3 | 21 | Wnt-activated receptor activity |
| GO:0001591 | 0.0034 | 30.4174 | 0.0917 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0044183 | 0.0051 | 9.54 | 0.3537 | 3 | 27 | protein binding involved in protein folding |
| GO:0031419 | 0.0058 | 21.7239 | 0.1179 | 2 | 9 | cobalamin binding |
| GO:0017147 | 0.0069 | 8.4784 | 0.393 | 3 | 30 | Wnt-protein binding |
| GO:0008395 | 0.0083 | 7.8927 | 0.4192 | 3 | 32 | steroid hydroxylase activity |
| GO:0035240 | 0.0087 | 16.8943 | 0.1441 | 2 | 11 | dopamine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 1e-04 | 9.9194 | 0.6752 | 6 | 81 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0050840 | 8e-04 | 10.6343 | 0.4168 | 4 | 50 | extracellular matrix binding |
| GO:0034987 | 0.001 | 60.374 | 0.05 | 2 | 6 | immunoglobulin receptor binding |
| GO:0102991 | 0.0019 | 40.2443 | 0.0667 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0005549 | 0.0029 | 7.2914 | 0.5919 | 4 | 71 | odorant binding |
| GO:0016290 | 0.0036 | 26.8244 | 0.0917 | 2 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0016614 | 0.0044 | 4.9857 | 1.067 | 5 | 128 | oxidoreductase activity, acting on CH-OH group of donors |
| GO:0004984 | 0.0046 | 3.2779 | 2.5925 | 8 | 311 | olfactory receptor activity |
| GO:0015172 | 0.0059 | 20.1145 | 0.1167 | 2 | 14 | acidic amino acid transmembrane transporter activity |
| GO:0008106 | 0.0077 | 17.2388 | 0.1334 | 2 | 16 | alcohol dehydrogenase (NADP+) activity |
| GO:0004070 | 0.0083 | Inf | 0.0083 | 1 | 1 | aspartate carbamoyltransferase activity |
| GO:0004151 | 0.0083 | Inf | 0.0083 | 1 | 1 | dihydroorotase activity |
| GO:0008336 | 0.0083 | Inf | 0.0083 | 1 | 1 | gamma-butyrobetaine dioxygenase activity |
| GO:0008859 | 0.0083 | Inf | 0.0083 | 1 | 1 | exoribonuclease II activity |
| GO:0008891 | 0.0083 | Inf | 0.0083 | 1 | 1 | glycolate oxidase activity |
| GO:0015327 | 0.0083 | Inf | 0.0083 | 1 | 1 | cystine:glutamate antiporter activity |
| GO:0018455 | 0.0083 | Inf | 0.0083 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0019115 | 0.0083 | Inf | 0.0083 | 1 | 1 | benzaldehyde dehydrogenase activity |
| GO:0031686 | 0.0083 | Inf | 0.0083 | 1 | 1 | A1 adenosine receptor binding |
| GO:0031704 | 0.0083 | Inf | 0.0083 | 1 | 1 | apelin receptor binding |
| GO:0045032 | 0.0083 | Inf | 0.0083 | 1 | 1 | ADP-activated adenosine receptor activity |
| GO:0047963 | 0.0083 | Inf | 0.0083 | 1 | 1 | glycine N-choloyltransferase activity |
| GO:0047969 | 0.0083 | Inf | 0.0083 | 1 | 1 | glyoxylate oxidase activity |
| GO:0050337 | 0.0083 | Inf | 0.0083 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
| GO:0052817 | 0.0083 | Inf | 0.0083 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
| GO:0070335 | 0.0083 | Inf | 0.0083 | 1 | 1 | aspartate binding |
| GO:1901680 | 0.0083 | Inf | 0.0083 | 1 | 1 | sulfur-containing amino acid secondary active transmembrane transporter activity |
| GO:0004745 | 0.0086 | 16.0885 | 0.1417 | 2 | 17 | retinol dehydrogenase activity |
| GO:0005149 | 0.0086 | 16.0885 | 0.1417 | 2 | 17 | interleukin-1 receptor binding |
| GO:0005507 | 0.0088 | 7.5837 | 0.4251 | 3 | 51 | copper ion binding |
| GO:0008157 | 0.0097 | 15.0821 | 0.15 | 2 | 18 | protein phosphatase 1 binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 28.0893 | 4.6392 | 72 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 11.0159 | 10.7104 | 76 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 7.0553 | 17.1843 | 81 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 6.7984 | 18.0495 | 82 | 1210 | signaling receptor activity |
| GO:0005549 | 0 | 39.9852 | 1.0591 | 25 | 71 | odorant binding |
| GO:0060089 | 0 | 5.448 | 21.8533 | 82 | 1465 | molecular transducer activity |
| GO:0031492 | 0 | 29.2356 | 0.6563 | 13 | 44 | nucleosomal DNA binding |
| GO:0042393 | 0 | 5.2527 | 2.7447 | 13 | 184 | histone binding |
| GO:0046982 | 0 | 3.134 | 6.9662 | 20 | 467 | protein heterodimerization activity |
| GO:0004867 | 1e-04 | 6.7143 | 1.3276 | 8 | 89 | serine-type endopeptidase inhibitor activity |
| GO:0030414 | 2e-04 | 4.3469 | 2.4911 | 10 | 167 | peptidase inhibitor activity |
| GO:0061135 | 2e-04 | 4.3469 | 2.4911 | 10 | 167 | endopeptidase regulator activity |
| GO:0004024 | 0.0022 | 44.3898 | 0.0746 | 2 | 5 | alcohol dehydrogenase activity, zinc-dependent |
| GO:0005134 | 0.0022 | 44.3898 | 0.0746 | 2 | 5 | interleukin-2 receptor binding |
| GO:0019103 | 0.0022 | 44.3898 | 0.0746 | 2 | 5 | pyrimidine nucleotide binding |
| GO:0001591 | 0.0044 | 26.6305 | 0.1044 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0048018 | 0.0048 | 2.3276 | 6.3397 | 14 | 425 | receptor ligand activity |
| GO:0045296 | 0.0054 | 2.596 | 4.4602 | 11 | 299 | cadherin binding |
| GO:0031628 | 0.0058 | 22.1907 | 0.1193 | 2 | 8 | opioid receptor binding |
| GO:0015143 | 0.0092 | 16.6409 | 0.1492 | 2 | 10 | urate transmembrane transporter activity |
| GO:0036122 | 0.0092 | 16.6409 | 0.1492 | 2 | 10 | BMP binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 16.2781 | 1.9374 | 24 | 184 | histone binding |
| GO:0046982 | 0 | 6.6791 | 4.9173 | 27 | 467 | protein heterodimerization activity |
| GO:0031492 | 0 | 29.3243 | 0.4633 | 10 | 44 | nucleosomal DNA binding |
| GO:0004984 | 0 | 6.3457 | 3.2747 | 18 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 3.2672 | 7.5603 | 22 | 718 | G-protein coupled receptor activity |
| GO:0019904 | 1e-04 | 3.0229 | 6.9285 | 19 | 658 | protein domain specific binding |
| GO:0003677 | 1e-04 | 2.0348 | 24.4919 | 43 | 2326 | DNA binding |
| GO:0099600 | 2e-04 | 2.384 | 12.1301 | 26 | 1152 | transmembrane receptor activity |
| GO:0004522 | 7e-04 | 95.0904 | 0.0421 | 2 | 4 | ribonuclease A activity |
| GO:0045296 | 7e-04 | 3.6903 | 2.9093 | 10 | 281 | cadherin binding |
| GO:1901618 | 8e-04 | 10.6714 | 0.4212 | 4 | 40 | organic hydroxy compound transmembrane transporter activity |
| GO:0098641 | 8e-04 | 19.1176 | 0.1895 | 3 | 18 | cadherin binding involved in cell-cell adhesion |
| GO:0038023 | 9e-04 | 2.1543 | 12.7408 | 25 | 1210 | signaling receptor activity |
| GO:0008508 | 0.0011 | 63.3896 | 0.0526 | 2 | 5 | bile acid:sodium symporter activity |
| GO:0004993 | 0.0011 | 16.8663 | 0.2106 | 3 | 20 | G-protein coupled serotonin receptor activity |
| GO:0003682 | 0.0015 | 2.7945 | 4.9805 | 13 | 473 | chromatin binding |
| GO:0016894 | 0.0015 | 15.089 | 0.2317 | 3 | 22 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters |
| GO:0004468 | 0.0016 | 47.5392 | 0.0632 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0016628 | 0.002 | 13.6502 | 0.2527 | 3 | 24 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor |
| GO:0060089 | 0.0029 | 1.9108 | 15.4259 | 27 | 1465 | molecular transducer activity |
| GO:0003723 | 0.0031 | 1.8616 | 17.058 | 29 | 1620 | RNA binding |
| GO:0004859 | 0.0057 | 21.1218 | 0.1158 | 2 | 11 | phospholipase inhibitor activity |
| GO:0098631 | 0.0069 | 8.4241 | 0.3896 | 3 | 37 | cell adhesion mediator activity |
| GO:0008028 | 0.0097 | 7.3417 | 0.4422 | 3 | 42 | monocarboxylic acid transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 0.0014 | 6.544 | 0.8275 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004111 | 0.0015 | 49.0311 | 0.0613 | 2 | 6 | creatine kinase activity |
| GO:0055131 | 0.0015 | 49.0311 | 0.0613 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0004129 | 0.0016 | 14.7863 | 0.235 | 3 | 23 | cytochrome-c oxidase activity |
| GO:0016675 | 0.0018 | 14.0813 | 0.2452 | 3 | 24 | oxidoreductase activity, acting on a heme group of donors |
| GO:0060089 | 0.0038 | 1.8929 | 14.9668 | 26 | 1465 | molecular transducer activity |
| GO:0004984 | 0.0047 | 2.9975 | 3.1772 | 9 | 311 | olfactory receptor activity |
| GO:0019531 | 0.0054 | 21.7847 | 0.1124 | 2 | 11 | oxalate transmembrane transporter activity |
| GO:0038023 | 0.0059 | 1.918 | 12.3616 | 22 | 1210 | signaling receptor activity |
| GO:0099600 | 0.0069 | 1.917 | 11.7691 | 21 | 1152 | transmembrane receptor activity |
| GO:0008271 | 0.0075 | 17.8216 | 0.1328 | 2 | 13 | secondary active sulfate transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 27.2336 | 0.4964 | 10 | 44 | nucleosomal DNA binding |
| GO:0046982 | 0 | 5.3245 | 5.2686 | 24 | 467 | protein heterodimerization activity |
| GO:0042393 | 0 | 6.4797 | 2.0758 | 12 | 184 | histone binding |
| GO:0045296 | 2e-04 | 3.8547 | 3.3732 | 12 | 299 | cadherin binding |
| GO:0003682 | 3e-04 | 3.0403 | 5.3363 | 15 | 473 | chromatin binding |
| GO:0031720 | 4e-04 | 177.236 | 0.0338 | 2 | 3 | haptoglobin binding |
| GO:0055131 | 0.0018 | 44.3006 | 0.0677 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0003677 | 0.0021 | 1.7414 | 26.2413 | 41 | 2326 | DNA binding |
| GO:0042043 | 0.0026 | 35.4382 | 0.079 | 2 | 7 | neurexin family protein binding |
| GO:0005125 | 0.0075 | 3.284 | 2.2451 | 7 | 199 | cytokine activity |
| GO:0004062 | 0.0078 | 17.7135 | 0.1354 | 2 | 12 | aryl sulfotransferase activity |
| GO:0005092 | 0.0078 | 17.7135 | 0.1354 | 2 | 12 | GDP-dissociation inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 29.2066 | 3.6451 | 60 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 11.4261 | 8.4153 | 62 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 7.3742 | 13.502 | 66 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 7.144 | 14.1818 | 67 | 1210 | signaling receptor activity |
| GO:0060089 | 0 | 6.02 | 17.1705 | 69 | 1465 | molecular transducer activity |
| GO:0005549 | 0 | 16.3625 | 0.8322 | 11 | 71 | odorant binding |
| GO:0048020 | 7e-04 | 11.0961 | 0.4102 | 4 | 35 | CCR chemokine receptor binding |
| GO:0034875 | 8e-04 | 85.2216 | 0.0469 | 2 | 4 | caffeine oxidase activity |
| GO:0008009 | 0.0017 | 8.5945 | 0.5157 | 4 | 44 | chemokine activity |
| GO:0005198 | 0.0022 | 2.3221 | 7.8293 | 17 | 668 | structural molecule activity |
| GO:0001591 | 0.0028 | 34.0822 | 0.082 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0030414 | 0.0036 | 3.7936 | 1.9573 | 7 | 167 | peptidase inhibitor activity |
| GO:0061135 | 0.0036 | 3.7936 | 1.9573 | 7 | 167 | endopeptidase regulator activity |
| GO:0046790 | 0.0037 | 28.4 | 0.0938 | 2 | 8 | virion binding |
| GO:0004867 | 0.0039 | 5.1295 | 1.0431 | 5 | 89 | serine-type endopeptidase inhibitor activity |
| GO:0042056 | 0.0046 | 9.8717 | 0.3399 | 3 | 29 | chemoattractant activity |
| GO:0016725 | 0.0047 | 24.3413 | 0.1055 | 2 | 9 | oxidoreductase activity, acting on CH or CH2 groups |
| GO:0035240 | 0.007 | 18.9297 | 0.1289 | 2 | 11 | dopamine binding |
| GO:0004062 | 0.0083 | 17.0357 | 0.1406 | 2 | 12 | aryl sulfotransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 33.3728 | 0.4109 | 10 | 44 | nucleosomal DNA binding |
| GO:0046982 | 0 | 5.6502 | 4.3612 | 21 | 467 | protein heterodimerization activity |
| GO:0042393 | 0 | 6.4632 | 1.7183 | 10 | 184 | histone binding |
| GO:1903231 | 0 | 10.48 | 0.7564 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0045296 | 5e-04 | 3.8627 | 2.7923 | 10 | 299 | cadherin binding |
| GO:0061578 | 0.0013 | 53.7483 | 0.056 | 2 | 6 | Lys63-specific deubiquitinase activity |
| GO:0004683 | 0.0016 | 14.7422 | 0.2335 | 3 | 25 | calmodulin-dependent protein kinase activity |
| GO:0102991 | 0.0023 | 35.8277 | 0.0747 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:1990380 | 0.0023 | 35.8277 | 0.0747 | 2 | 8 | Lys48-specific deubiquitinase activity |
| GO:0071723 | 0.0037 | 26.8673 | 0.0934 | 2 | 10 | lipopeptide binding |
| GO:0016782 | 0.0039 | 6.6805 | 0.6444 | 4 | 69 | transferase activity, transferring sulfur-containing groups |
| GO:0016290 | 0.0045 | 23.8806 | 0.1027 | 2 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0003682 | 0.0049 | 2.6473 | 4.4172 | 11 | 473 | chromatin binding |
| GO:0045504 | 0.0073 | 17.907 | 0.1307 | 2 | 14 | dynein heavy chain binding |
| GO:0004984 | 0.0089 | 2.903 | 2.9044 | 8 | 311 | olfactory receptor activity |
| GO:0000210 | 0.0093 | Inf | 0.0093 | 1 | 1 | NAD+ diphosphatase activity |
| GO:0003692 | 0.0093 | Inf | 0.0093 | 1 | 1 | left-handed Z-DNA binding |
| GO:0004587 | 0.0093 | Inf | 0.0093 | 1 | 1 | ornithine-oxo-acid transaminase activity |
| GO:0004607 | 0.0093 | Inf | 0.0093 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
| GO:0008459 | 0.0093 | Inf | 0.0093 | 1 | 1 | chondroitin 6-sulfotransferase activity |
| GO:0008891 | 0.0093 | Inf | 0.0093 | 1 | 1 | glycolate oxidase activity |
| GO:0019115 | 0.0093 | Inf | 0.0093 | 1 | 1 | benzaldehyde dehydrogenase activity |
| GO:0033735 | 0.0093 | Inf | 0.0093 | 1 | 1 | aspartate dehydrogenase activity |
| GO:0047963 | 0.0093 | Inf | 0.0093 | 1 | 1 | glycine N-choloyltransferase activity |
| GO:0047969 | 0.0093 | Inf | 0.0093 | 1 | 1 | glyoxylate oxidase activity |
| GO:0050337 | 0.0093 | Inf | 0.0093 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
| GO:0052817 | 0.0093 | Inf | 0.0093 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
| GO:1904265 | 0.0093 | Inf | 0.0093 | 1 | 1 | ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 10.6241 | 2.9408 | 25 | 184 | histone binding |
| GO:0031492 | 0 | 18.8067 | 0.7032 | 10 | 44 | nucleosomal DNA binding |
| GO:0046982 | 0 | 3.9285 | 7.4638 | 26 | 467 | protein heterodimerization activity |
| GO:0005123 | 1e-04 | 22.7294 | 0.2397 | 4 | 15 | death receptor binding |
| GO:0019904 | 4e-04 | 2.352 | 10.5165 | 23 | 658 | protein domain specific binding |
| GO:0045296 | 0.0011 | 2.8952 | 4.7788 | 13 | 299 | cadherin binding |
| GO:0047617 | 0.0023 | 13.3384 | 0.2717 | 3 | 17 | acyl-CoA hydrolase activity |
| GO:0017108 | 0.0037 | 31.0198 | 0.0959 | 2 | 6 | 5'-flap endonuclease activity |
| GO:0043546 | 0.0037 | 31.0198 | 0.0959 | 2 | 6 | molybdopterin cofactor binding |
| GO:0030742 | 0.0056 | 9.3333 | 0.3676 | 3 | 23 | GTP-dependent protein binding |
| GO:0102991 | 0.0067 | 20.6772 | 0.1279 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0050840 | 0.0083 | 5.4232 | 0.7991 | 4 | 50 | extracellular matrix binding |
| GO:0008821 | 0.0085 | 17.7222 | 0.1438 | 2 | 9 | crossover junction endodeoxyribonuclease activity |
| GO:0030881 | 0.0085 | 17.7222 | 0.1438 | 2 | 9 | beta-2-microglobulin binding |
| GO:0003682 | 0.0093 | 2.08 | 7.5597 | 15 | 473 | chromatin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0099600 | 0 | 3.3099 | 13.6464 | 38 | 1152 | transmembrane receptor activity |
| GO:0060089 | 0 | 2.6146 | 17.3541 | 39 | 1465 | molecular transducer activity |
| GO:0004993 | 0 | 28.5344 | 0.2369 | 5 | 20 | G-protein coupled serotonin receptor activity |
| GO:0004930 | 0 | 3.5309 | 6.6553 | 21 | 585 | G-protein coupled receptor activity |
| GO:0051378 | 0 | 56.7928 | 0.1185 | 4 | 10 | serotonin binding |
| GO:0030594 | 0 | 8.5588 | 1.0543 | 8 | 89 | neurotransmitter receptor activity |
| GO:0038023 | 0 | 2.5496 | 12.7884 | 29 | 1121 | signaling receptor activity |
| GO:0043565 | 0 | 2.5906 | 11.6089 | 27 | 980 | sequence-specific DNA binding |
| GO:0003700 | 3e-04 | 2.2355 | 13.8122 | 28 | 1166 | DNA binding transcription factor activity |
| GO:0005184 | 4e-04 | 13.6138 | 0.3435 | 4 | 29 | neuropeptide hormone activity |
| GO:0008528 | 6e-04 | 5.3278 | 1.4215 | 7 | 120 | G-protein coupled peptide receptor activity |
| GO:0001664 | 0.0013 | 3.6547 | 2.6276 | 9 | 225 | G-protein coupled receptor binding |
| GO:0048248 | 0.0014 | 56.1961 | 0.0592 | 2 | 5 | CXCR3 chemokine receptor binding |
| GO:0008009 | 0.0018 | 8.5005 | 0.5212 | 4 | 44 | chemokine activity |
| GO:0042923 | 0.0019 | 14.1111 | 0.2488 | 3 | 21 | neuropeptide binding |
| GO:0001228 | 0.0026 | 2.7377 | 4.6554 | 12 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0003676 | 0.0033 | 1.5637 | 45.1681 | 62 | 3813 | nucleic acid binding |
| GO:0070405 | 0.0038 | 6.8071 | 0.6381 | 4 | 55 | ammonium ion binding |
| GO:0004984 | 0.004 | 2.8703 | 3.684 | 10 | 311 | olfactory receptor activity |
| GO:0071855 | 0.0043 | 10.1555 | 0.3317 | 3 | 28 | neuropeptide receptor binding |
| GO:0048018 | 0.0048 | 2.5203 | 5.0345 | 12 | 425 | receptor ligand activity |
| GO:0039706 | 0.0059 | 21.0668 | 0.1185 | 2 | 10 | co-receptor binding |
| GO:0000982 | 0.0064 | 2.5363 | 4.5725 | 11 | 386 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0045125 | 0.01 | 15.3184 | 0.154 | 2 | 13 | bioactive lipid receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 1e-04 | 8.3861 | 0.792 | 6 | 81 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004111 | 0.0014 | 51.2825 | 0.0587 | 2 | 6 | creatine kinase activity |
| GO:0004129 | 0.0014 | 15.4696 | 0.2249 | 3 | 23 | cytochrome-c oxidase activity |
| GO:0016675 | 0.0016 | 14.732 | 0.2347 | 3 | 24 | oxidoreductase activity, acting on a heme group of donors |
| GO:0004872 | 0.0028 | 1.969 | 13.8938 | 25 | 1421 | receptor activity |
| GO:0019531 | 0.0049 | 22.785 | 0.1076 | 2 | 11 | oxalate transmembrane transporter activity |
| GO:0004888 | 0.0057 | 1.9904 | 10.8237 | 20 | 1107 | transmembrane signaling receptor activity |
| GO:0008271 | 0.0069 | 18.6399 | 0.1271 | 2 | 13 | secondary active sulfate transmembrane transporter activity |
| GO:0004336 | 0.0098 | Inf | 0.0098 | 1 | 1 | galactosylceramidase activity |
| GO:0004352 | 0.0098 | Inf | 0.0098 | 1 | 1 | glutamate dehydrogenase (NAD+) activity |
| GO:0018455 | 0.0098 | Inf | 0.0098 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0031370 | 0.0098 | Inf | 0.0098 | 1 | 1 | eukaryotic initiation factor 4G binding |
| GO:0031687 | 0.0098 | Inf | 0.0098 | 1 | 1 | A2A adenosine receptor binding |
| GO:0032003 | 0.0098 | Inf | 0.0098 | 1 | 1 | interleukin-28 receptor binding |
| GO:0033676 | 0.0098 | Inf | 0.0098 | 1 | 1 | double-stranded DNA-dependent ATPase activity |
| GO:0035438 | 0.0098 | Inf | 0.0098 | 1 | 1 | cyclic-di-GMP binding |
| GO:0035757 | 0.0098 | Inf | 0.0098 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
| GO:0035758 | 0.0098 | Inf | 0.0098 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
| GO:0038117 | 0.0098 | Inf | 0.0098 | 1 | 1 | C-C motif chemokine 19 receptor activity |
| GO:0038121 | 0.0098 | Inf | 0.0098 | 1 | 1 | C-C motif chemokine 21 receptor activity |
| GO:0046817 | 0.0098 | Inf | 0.0098 | 1 | 1 | chemokine receptor antagonist activity |
| GO:0061507 | 0.0098 | Inf | 0.0098 | 1 | 1 | cyclic-GMP-AMP binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 6.9786 | 4.7417 | 27 | 467 | protein heterodimerization activity |
| GO:0031492 | 0 | 30.4934 | 0.4468 | 10 | 44 | nucleosomal DNA binding |
| GO:0042393 | 0 | 5.9056 | 1.8683 | 10 | 184 | histone binding |
| GO:0003677 | 0 | 2.2077 | 23.6172 | 44 | 2326 | DNA binding |
| GO:0003682 | 1e-04 | 3.4166 | 4.8026 | 15 | 473 | chromatin binding |
| GO:0099583 | 3e-04 | 197.4 | 0.0305 | 2 | 3 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
| GO:0047961 | 6e-04 | 98.6937 | 0.0406 | 2 | 4 | glycine N-acyltransferase activity |
| GO:0045296 | 0.001 | 3.5294 | 3.0359 | 10 | 299 | cadherin binding |
| GO:0038023 | 0.0026 | 2.0361 | 12.2858 | 23 | 1210 | signaling receptor activity |
| GO:0004930 | 0.0026 | 2.3559 | 7.2903 | 16 | 718 | G-protein coupled receptor activity |
| GO:0001102 | 0.0062 | 8.7453 | 0.3757 | 3 | 37 | RNA polymerase II activating transcription factor binding |
| GO:0099600 | 0.0064 | 1.9308 | 11.6969 | 21 | 1152 | transmembrane receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 0 | 3.2752 | 8.5953 | 25 | 718 | G-protein coupled receptor activity |
| GO:0043565 | 0 | 2.9057 | 11.7317 | 30 | 980 | sequence-specific DNA binding |
| GO:0000981 | 0 | 2.9287 | 8.703 | 23 | 727 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0004984 | 1e-04 | 3.7904 | 3.723 | 13 | 311 | olfactory receptor activity |
| GO:0099600 | 1e-04 | 2.3339 | 13.7908 | 29 | 1152 | transmembrane receptor activity |
| GO:0005125 | 1e-04 | 4.5529 | 2.3823 | 10 | 199 | cytokine activity |
| GO:0140110 | 2e-04 | 2.109 | 17.9807 | 34 | 1502 | transcription regulator activity |
| GO:0060089 | 3e-04 | 2.0904 | 17.5378 | 33 | 1465 | molecular transducer activity |
| GO:0000978 | 0.001 | 3.0876 | 4.154 | 12 | 347 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0030545 | 0.0011 | 2.7676 | 5.411 | 14 | 452 | receptor regulator activity |
| GO:0001077 | 0.0013 | 3.4009 | 3.1364 | 10 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0019960 | 0.0014 | 55.5944 | 0.0599 | 2 | 5 | C-X3-C chemokine binding |
| GO:0001159 | 0.0014 | 2.9524 | 4.3336 | 12 | 362 | core promoter proximal region DNA binding |
| GO:0038023 | 0.0014 | 2.0662 | 13.1417 | 25 | 1121 | signaling receptor activity |
| GO:0004993 | 0.0017 | 14.7813 | 0.2394 | 3 | 20 | G-protein coupled serotonin receptor activity |
| GO:0030594 | 0.0043 | 5.0179 | 1.0654 | 5 | 89 | neurotransmitter receptor activity |
| GO:0019864 | 0.0073 | 18.5244 | 0.1317 | 2 | 11 | IgG binding |
| GO:0000975 | 0.0085 | 1.9695 | 9.6847 | 18 | 809 | regulatory region DNA binding |
| GO:0005126 | 0.0095 | 2.864 | 2.9329 | 8 | 245 | cytokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 27.4988 | 3.2942 | 53 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 10.6939 | 7.6053 | 54 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 6.6423 | 12.2023 | 56 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 6.2836 | 12.8167 | 56 | 1210 | signaling receptor activity |
| GO:0060089 | 0 | 5.0567 | 15.5177 | 56 | 1465 | molecular transducer activity |
| GO:0005549 | 0 | 18.2475 | 0.7521 | 11 | 71 | odorant binding |
| GO:0008395 | 0 | 27.2412 | 0.339 | 7 | 32 | steroid hydroxylase activity |
| GO:0019825 | 0 | 18.3922 | 0.4661 | 7 | 44 | oxygen binding |
| GO:0008392 | 0 | 43.7223 | 0.1695 | 5 | 16 | arachidonic acid epoxygenase activity |
| GO:0020037 | 0 | 7.7329 | 1.3029 | 9 | 123 | heme binding |
| GO:0005506 | 0 | 6.2414 | 1.5888 | 9 | 150 | iron ion binding |
| GO:0030414 | 1e-04 | 5.5638 | 1.7689 | 9 | 167 | peptidase inhibitor activity |
| GO:0061135 | 1e-04 | 5.5638 | 1.7689 | 9 | 167 | endopeptidase regulator activity |
| GO:0015020 | 3e-04 | 14.1495 | 0.3284 | 4 | 31 | glucuronosyltransferase activity |
| GO:0004867 | 4e-04 | 6.9642 | 0.9427 | 6 | 89 | serine-type endopeptidase inhibitor activity |
| GO:0005198 | 7e-04 | 2.6002 | 7.0757 | 17 | 668 | structural molecule activity |
| GO:0004024 | 0.0011 | 63.006 | 0.053 | 2 | 5 | alcohol dehydrogenase activity, zinc-dependent |
| GO:0030883 | 0.0011 | 63.006 | 0.053 | 2 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0011 | 63.006 | 0.053 | 2 | 5 | exogenous lipid antigen binding |
| GO:0016712 | 0.002 | 13.5671 | 0.2542 | 3 | 24 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
| GO:0001591 | 0.0023 | 37.7988 | 0.0741 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0030881 | 0.0038 | 26.9957 | 0.0953 | 2 | 9 | beta-2-microglobulin binding |
| GO:0071723 | 0.0047 | 23.6198 | 0.1059 | 2 | 10 | lipopeptide binding |
| GO:0035240 | 0.0058 | 20.994 | 0.1165 | 2 | 11 | dopamine binding |
| GO:0016705 | 0.0093 | 4.1181 | 1.2817 | 5 | 123 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 23.8315 | 3.1772 | 47 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 10.9601 | 7.3353 | 53 | 718 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 7.2174 | 11.7691 | 57 | 1152 | transmembrane receptor activity |
| GO:0060089 | 0 | 6.1286 | 14.9668 | 61 | 1465 | molecular transducer activity |
| GO:0038023 | 0 | 6.9862 | 11.0927 | 53 | 1121 | signaling receptor activity |
| GO:0005549 | 0 | 18.975 | 0.7254 | 11 | 71 | odorant binding |
| GO:0030594 | 3e-04 | 7.2331 | 0.9092 | 6 | 89 | neurotransmitter receptor activity |
| GO:1903231 | 0.0014 | 6.544 | 0.8275 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0034987 | 0.0015 | 49.0311 | 0.0613 | 2 | 6 | immunoglobulin receptor binding |
| GO:0001591 | 0.0021 | 39.2224 | 0.0715 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0052689 | 0.0024 | 4.7139 | 1.3588 | 6 | 133 | carboxylic ester hydrolase activity |
| GO:0035240 | 0.0054 | 21.7847 | 0.1124 | 2 | 11 | dopamine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005506 | 0 | 6.5693 | 1.6923 | 10 | 150 | iron ion binding |
| GO:0004984 | 0 | 4.3952 | 3.5086 | 14 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 3.1048 | 7.893 | 22 | 707 | G-protein coupled receptor activity |
| GO:0038023 | 0 | 2.4737 | 13.6509 | 30 | 1210 | signaling receptor activity |
| GO:0099600 | 0 | 2.5058 | 12.9966 | 29 | 1152 | transmembrane receptor activity |
| GO:0016015 | 0 | 66.8263 | 0.079 | 3 | 7 | morphogen activity |
| GO:0060089 | 2e-04 | 2.164 | 16.5277 | 32 | 1465 | molecular transducer activity |
| GO:0031720 | 4e-04 | 177.236 | 0.0338 | 2 | 3 | haptoglobin binding |
| GO:0005125 | 4e-04 | 4.3172 | 2.2451 | 9 | 199 | cytokine activity |
| GO:0020037 | 5e-04 | 5.4621 | 1.3877 | 7 | 123 | heme binding |
| GO:0030545 | 6e-04 | 2.9532 | 5.0993 | 14 | 452 | receptor regulator activity |
| GO:0045236 | 7e-04 | 20.5502 | 0.1805 | 3 | 16 | CXCR chemokine receptor binding |
| GO:0016705 | 0.0014 | 4.5188 | 1.6584 | 7 | 147 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0140110 | 0.0014 | 1.9433 | 16.9452 | 30 | 1502 | transcription regulator activity |
| GO:0043565 | 0.0016 | 2.1536 | 11.0561 | 22 | 980 | sequence-specific DNA binding |
| GO:0055131 | 0.0018 | 44.3006 | 0.0677 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0000975 | 0.002 | 2.2385 | 9.1269 | 19 | 809 | regulatory region DNA binding |
| GO:0043208 | 0.0034 | 29.53 | 0.0903 | 2 | 8 | glycosphingolipid binding |
| GO:0004497 | 0.0039 | 6.7189 | 0.6447 | 4 | 58 | monooxygenase activity |
| GO:0003810 | 0.0043 | 25.3098 | 0.1015 | 2 | 9 | protein-glutamine gamma-glutamyltransferase activity |
| GO:0039706 | 0.0054 | 22.1447 | 0.1128 | 2 | 10 | co-receptor binding |
| GO:0008395 | 0.0055 | 9.2028 | 0.361 | 3 | 32 | steroid hydroxylase activity |
| GO:0004952 | 0.0065 | 19.6829 | 0.1241 | 2 | 11 | dopamine neurotransmitter receptor activity |
| GO:0008239 | 0.0065 | 19.6829 | 0.1241 | 2 | 11 | dipeptidyl-peptidase activity |
| GO:0035240 | 0.0065 | 19.6829 | 0.1241 | 2 | 11 | dopamine binding |
| GO:0000977 | 0.0066 | 2.2456 | 6.5998 | 14 | 585 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0070888 | 0.0077 | 8.0853 | 0.4061 | 3 | 36 | E-box binding |
| GO:0008236 | 0.0081 | 3.2328 | 2.2789 | 7 | 202 | serine-type peptidase activity |
| GO:0000981 | 0.0082 | 2.067 | 8.2018 | 16 | 727 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0070696 | 0.0091 | 16.1021 | 0.1467 | 2 | 13 | transmembrane receptor protein serine/threonine kinase binding |
| GO:0005539 | 0.0094 | 3.1351 | 2.3466 | 7 | 208 | glycosaminoglycan binding |
| GO:0001077 | 0.0099 | 2.8422 | 2.9558 | 8 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 8.2844 | 5.4149 | 35 | 467 | protein heterodimerization activity |
| GO:0042393 | 0 | 14.5435 | 2.1335 | 24 | 184 | histone binding |
| GO:0031492 | 0 | 26.4471 | 0.5102 | 10 | 44 | nucleosomal DNA binding |
| GO:0004984 | 0 | 5.3266 | 3.6061 | 17 | 311 | olfactory receptor activity |
| GO:0005549 | 0 | 11.2686 | 0.8233 | 8 | 71 | odorant binding |
| GO:0004930 | 0 | 2.9232 | 8.3253 | 22 | 718 | G-protein coupled receptor activity |
| GO:0003677 | 0 | 2.0751 | 26.9702 | 48 | 2326 | DNA binding |
| GO:0038023 | 3e-04 | 2.2011 | 14.0301 | 28 | 1210 | signaling receptor activity |
| GO:0060089 | 3e-04 | 2.0925 | 16.9868 | 32 | 1465 | molecular transducer activity |
| GO:0099600 | 0.0018 | 2.0301 | 13.3576 | 25 | 1152 | transmembrane receptor activity |
| GO:0045296 | 0.0026 | 3.061 | 3.4669 | 10 | 299 | cadherin binding |
| GO:0003682 | 0.0035 | 2.5155 | 5.4845 | 13 | 473 | chromatin binding |
| GO:1990459 | 0.0036 | 28.714 | 0.0928 | 2 | 8 | transferrin receptor binding |
| GO:0019904 | 0.0042 | 2.2309 | 7.6296 | 16 | 658 | protein domain specific binding |
| GO:0048020 | 0.0076 | 8.1068 | 0.4058 | 3 | 35 | CCR chemokine receptor binding |
| GO:0005125 | 0.0086 | 3.1907 | 2.3074 | 7 | 199 | cytokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038023 | 0 | 4.4958 | 12.0583 | 42 | 1210 | signaling receptor activity |
| GO:0004984 | 0 | 8.6165 | 3.0993 | 22 | 311 | olfactory receptor activity |
| GO:0099600 | 0 | 4.4387 | 11.4803 | 40 | 1152 | transmembrane receptor activity |
| GO:0060089 | 0 | 3.8705 | 14.5995 | 44 | 1465 | molecular transducer activity |
| GO:0004930 | 0 | 5.408 | 5.778 | 26 | 598 | G-protein coupled receptor activity |
| GO:0005549 | 0 | 13.2307 | 0.7076 | 8 | 71 | odorant binding |
| GO:0001847 | 3e-04 | 202.5 | 0.0297 | 2 | 3 | opsonin receptor activity |
| GO:0019862 | 3e-04 | 201.2102 | 0.0299 | 2 | 3 | IgA binding |
| GO:0016019 | 0.001 | 67.0616 | 0.0498 | 2 | 5 | peptidoglycan receptor activity |
| GO:0008528 | 0.0013 | 5.3946 | 1.1959 | 6 | 120 | G-protein coupled peptide receptor activity |
| GO:0004966 | 0.002 | 40.2318 | 0.0698 | 2 | 7 | galanin receptor activity |
| GO:0031419 | 0.0034 | 28.7334 | 0.0897 | 2 | 9 | cobalamin binding |
| GO:0004623 | 0.0043 | 10.1064 | 0.3289 | 3 | 33 | phospholipase A2 activity |
| GO:0001228 | 0.0061 | 2.7009 | 3.9165 | 10 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0042834 | 0.0072 | 18.2803 | 0.1296 | 2 | 13 | peptidoglycan binding |
| GO:0043565 | 0.0089 | 1.9685 | 9.7662 | 18 | 980 | sequence-specific DNA binding |
| GO:0001605 | 0.01 | Inf | 0.01 | 1 | 1 | adrenomedullin receptor activity |
| GO:0001856 | 0.01 | Inf | 0.01 | 1 | 1 | complement component C5a binding |
| GO:0001861 | 0.01 | Inf | 0.01 | 1 | 1 | complement component C4b receptor activity |
| GO:0004131 | 0.01 | Inf | 0.01 | 1 | 1 | cytosine deaminase activity |
| GO:0004778 | 0.01 | Inf | 0.01 | 1 | 1 | succinyl-CoA hydrolase activity |
| GO:0004877 | 0.01 | Inf | 0.01 | 1 | 1 | complement component C3b receptor activity |
| GO:0016412 | 0.01 | Inf | 0.01 | 1 | 1 | serine O-acyltransferase activity |
| GO:0047444 | 0.01 | Inf | 0.01 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
| GO:0050462 | 0.01 | Inf | 0.01 | 1 | 1 | N-acetylneuraminate synthase activity |
| GO:0099038 | 0.01 | Inf | 0.01 | 1 | 1 | ceramide-translocating ATPase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 4.127 | 4.8881 | 18 | 467 | protein heterodimerization activity |
| GO:0004111 | 0.0016 | 47.8303 | 0.0628 | 2 | 6 | creatine kinase activity |
| GO:0055131 | 0.0016 | 47.8303 | 0.0628 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0015450 | 0.0029 | 31.8828 | 0.0837 | 2 | 8 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity |
| GO:0003677 | 0.003 | 1.7381 | 24.3461 | 38 | 2326 | DNA binding |
| GO:0004984 | 0.0055 | 2.9209 | 3.2552 | 9 | 311 | olfactory receptor activity |
| GO:0015266 | 0.0056 | 21.2512 | 0.1151 | 2 | 11 | protein channel activity |
| GO:0001077 | 0.0064 | 3.0771 | 2.7423 | 8 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0031994 | 0.0067 | 19.1248 | 0.1256 | 2 | 12 | insulin-like growth factor I binding |
| GO:0005179 | 0.008 | 4.2814 | 1.2351 | 5 | 118 | hormone activity |
| GO:0034236 | 0.0091 | 15.9354 | 0.1465 | 2 | 14 | protein kinase A catalytic subunit binding |
| GO:0050700 | 0.0091 | 15.9354 | 0.1465 | 2 | 14 | CARD domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 28.7724 | 0.4716 | 10 | 44 | nucleosomal DNA binding |
| GO:0042393 | 0 | 5.5722 | 1.972 | 10 | 184 | histone binding |
| GO:0003677 | 7e-04 | 1.8632 | 24.9292 | 41 | 2326 | DNA binding |
| GO:0045296 | 0.0015 | 3.3302 | 3.2046 | 10 | 299 | cadherin binding |
| GO:0046982 | 0.0016 | 2.7783 | 5.0051 | 13 | 467 | protein heterodimerization activity |
| GO:0004111 | 0.0017 | 46.6864 | 0.0643 | 2 | 6 | creatine kinase activity |
| GO:0004875 | 0.0039 | 26.6729 | 0.0965 | 2 | 9 | complement receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 22.6456 | 0.5902 | 10 | 44 | nucleosomal DNA binding |
| GO:0042393 | 0 | 4.8762 | 2.4679 | 11 | 184 | histone binding |
| GO:0003677 | 1e-04 | 2.2381 | 17.0778 | 34 | 1346 | DNA binding |
| GO:0004966 | 1e-04 | 55.9372 | 0.0939 | 3 | 7 | galanin receptor activity |
| GO:0004983 | 1e-04 | 44.7469 | 0.1073 | 3 | 8 | neuropeptide Y receptor activity |
| GO:0003700 | 2e-04 | 2.1799 | 15.6392 | 31 | 1166 | DNA binding transcription factor activity |
| GO:0008528 | 2e-04 | 5.4192 | 1.6095 | 8 | 120 | G-protein coupled peptide receptor activity |
| GO:0003682 | 2e-04 | 2.8926 | 6.3442 | 17 | 473 | chromatin binding |
| GO:0046982 | 6e-04 | 2.7396 | 6.2637 | 16 | 467 | protein heterodimerization activity |
| GO:0045296 | 7e-04 | 3.1988 | 4.0104 | 12 | 299 | cadherin binding |
| GO:0017046 | 8e-04 | 10.6891 | 0.4292 | 4 | 32 | peptide hormone binding |
| GO:0045569 | 0.0011 | 74.2406 | 0.0537 | 2 | 4 | TRAIL binding |
| GO:0051380 | 0.0011 | 74.2406 | 0.0537 | 2 | 4 | norepinephrine binding |
| GO:0008310 | 0.0017 | 49.4906 | 0.0671 | 2 | 5 | single-stranded DNA 3'-5' exodeoxyribonuclease activity |
| GO:0055131 | 0.0026 | 37.1156 | 0.0805 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0043565 | 0.0032 | 1.9535 | 13.1445 | 24 | 980 | sequence-specific DNA binding |
| GO:0051379 | 0.0036 | 29.6906 | 0.0939 | 2 | 7 | epinephrine binding |
| GO:0001106 | 0.0044 | 10.1588 | 0.3353 | 3 | 25 | RNA polymerase II transcription corepressor activity |
| GO:0004935 | 0.0061 | 21.2049 | 0.1207 | 2 | 9 | adrenergic receptor activity |
| GO:0001228 | 0.0069 | 2.3949 | 5.2712 | 12 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0072349 | 0.0091 | 16.4906 | 0.1475 | 2 | 11 | modified amino acid transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 4.7681 | 5.7954 | 24 | 467 | protein heterodimerization activity |
| GO:0042393 | 0 | 7.5604 | 2.2834 | 15 | 184 | histone binding |
| GO:1903231 | 1e-04 | 7.7672 | 1.0052 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0019904 | 0.0012 | 2.4115 | 8.0125 | 18 | 652 | protein domain specific binding |
| GO:0008483 | 0.0021 | 13.4521 | 0.2606 | 3 | 21 | transaminase activity |
| GO:0055131 | 0.0022 | 40.1862 | 0.0745 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0005160 | 0.0029 | 7.3632 | 0.5957 | 4 | 48 | transforming growth factor beta receptor binding |
| GO:0030170 | 0.0039 | 6.7479 | 0.6453 | 4 | 52 | pyridoxal phosphate binding |
| GO:0031995 | 0.0041 | 26.7874 | 0.0993 | 2 | 8 | insulin-like growth factor II binding |
| GO:0044183 | 0.0044 | 10.0853 | 0.3351 | 3 | 27 | protein binding involved in protein folding |
| GO:0004062 | 0.0093 | 16.0684 | 0.1489 | 2 | 12 | aryl sulfotransferase activity |
| GO:0005092 | 0.0093 | 16.0684 | 0.1489 | 2 | 12 | GDP-dissociation inhibitor activity |
| GO:0031994 | 0.0093 | 16.0684 | 0.1489 | 2 | 12 | insulin-like growth factor I binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 19.6252 | 1.8913 | 27 | 184 | histone binding |
| GO:0046982 | 0 | 8.2087 | 4.8003 | 31 | 467 | protein heterodimerization activity |
| GO:0004984 | 0 | 10.2506 | 3.1967 | 26 | 311 | olfactory receptor activity |
| GO:0031492 | 0 | 43.7684 | 0.4523 | 13 | 44 | nucleosomal DNA binding |
| GO:0004930 | 0 | 4.8575 | 7.1835 | 29 | 707 | G-protein coupled receptor activity |
| GO:0003677 | 0 | 2.6814 | 23.9087 | 51 | 2326 | DNA binding |
| GO:0099600 | 0 | 3.1755 | 11.8413 | 32 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 3.0073 | 12.4375 | 32 | 1210 | signaling receptor activity |
| GO:0003682 | 0 | 3.8891 | 4.8619 | 17 | 473 | chromatin binding |
| GO:0060089 | 0 | 2.5259 | 15.0586 | 33 | 1465 | molecular transducer activity |
| GO:0019904 | 1e-04 | 2.9186 | 6.7635 | 18 | 658 | protein domain specific binding |
| GO:0031720 | 3e-04 | 194.9383 | 0.0308 | 2 | 3 | haptoglobin binding |
| GO:0005344 | 4e-04 | 26.7307 | 0.1439 | 3 | 14 | oxygen carrier activity |
| GO:0045296 | 0.0011 | 3.4831 | 3.0734 | 10 | 299 | cadherin binding |
| GO:0102991 | 0.0028 | 32.4794 | 0.0822 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0004952 | 0.0054 | 21.6488 | 0.1131 | 2 | 11 | dopamine neurotransmitter receptor activity |
| GO:0016290 | 0.0054 | 21.6488 | 0.1131 | 2 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0035240 | 0.0054 | 21.6488 | 0.1131 | 2 | 11 | dopamine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0 | 4.7553 | 6.2274 | 25 | 658 | calcium ion binding |
| GO:0004930 | 0 | 3.5337 | 6.7413 | 21 | 717 | G-protein coupled receptor activity |
| GO:0038023 | 0 | 2.8161 | 11.4516 | 28 | 1210 | signaling receptor activity |
| GO:0060089 | 0 | 2.5887 | 13.8649 | 31 | 1465 | molecular transducer activity |
| GO:0099600 | 0 | 2.7114 | 10.9027 | 26 | 1152 | transmembrane receptor activity |
| GO:0004984 | 0 | 4.4768 | 2.9433 | 12 | 311 | olfactory receptor activity |
| GO:0055102 | 4e-04 | 24.6221 | 0.1514 | 3 | 16 | lipase inhibitor activity |
| GO:0019834 | 5e-04 | 106.0537 | 0.0379 | 2 | 4 | phospholipase A2 inhibitor activity |
| GO:0005329 | 9e-04 | 70.698 | 0.0473 | 2 | 5 | dopamine transmembrane transporter activity |
| GO:0015651 | 0.0024 | 35.3423 | 0.0757 | 2 | 8 | quaternary ammonium group transmembrane transporter activity |
| GO:0031406 | 0.0066 | 3.8054 | 1.6657 | 6 | 176 | carboxylic acid binding |
| GO:0005544 | 0.0083 | 7.7932 | 0.4164 | 3 | 44 | calcium-dependent phospholipid binding |
| GO:0004778 | 0.0095 | Inf | 0.0095 | 1 | 1 | succinyl-CoA hydrolase activity |
| GO:0005307 | 0.0095 | Inf | 0.0095 | 1 | 1 | choline:sodium symporter activity |
| GO:0008265 | 0.0095 | Inf | 0.0095 | 1 | 1 | Mo-molybdopterin cofactor sulfurase activity |
| GO:0030977 | 0.0095 | Inf | 0.0095 | 1 | 1 | taurine binding |
| GO:0031857 | 0.0095 | Inf | 0.0095 | 1 | 1 | type 1 parathyroid hormone receptor binding |
| GO:0033676 | 0.0095 | Inf | 0.0095 | 1 | 1 | double-stranded DNA-dependent ATPase activity |
| GO:0035438 | 0.0095 | Inf | 0.0095 | 1 | 1 | cyclic-di-GMP binding |
| GO:0035757 | 0.0095 | Inf | 0.0095 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
| GO:0035758 | 0.0095 | Inf | 0.0095 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
| GO:0038117 | 0.0095 | Inf | 0.0095 | 1 | 1 | C-C motif chemokine 19 receptor activity |
| GO:0038121 | 0.0095 | Inf | 0.0095 | 1 | 1 | C-C motif chemokine 21 receptor activity |
| GO:0044730 | 0.0095 | Inf | 0.0095 | 1 | 1 | bone sialoprotein binding |
| GO:0047444 | 0.0095 | Inf | 0.0095 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
| GO:0050462 | 0.0095 | Inf | 0.0095 | 1 | 1 | N-acetylneuraminate synthase activity |
| GO:0061507 | 0.0095 | Inf | 0.0095 | 1 | 1 | cyclic-GMP-AMP binding |
| GO:0102867 | 0.0095 | Inf | 0.0095 | 1 | 1 | molybdenum cofactor sulfurtransferase activity |
| GO:1990081 | 0.0095 | Inf | 0.0095 | 1 | 1 | trimethylamine receptor activity |
| GO:1990595 | 0.0095 | Inf | 0.0095 | 1 | 1 | mast cell secretagogue receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 13.2466 | 2.4218 | 25 | 184 | histone binding |
| GO:0046982 | 0 | 5.8383 | 6.1467 | 30 | 467 | protein heterodimerization activity |
| GO:0031492 | 0 | 23.1044 | 0.5791 | 10 | 44 | nucleosomal DNA binding |
| GO:0003677 | 0 | 2.5538 | 15.8194 | 35 | 1346 | DNA binding |
| GO:0000977 | 0 | 2.9907 | 7.6998 | 21 | 585 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0043565 | 2e-04 | 3.751 | 3.4628 | 12 | 281 | sequence-specific DNA binding |
| GO:0000981 | 3e-04 | 2.8096 | 6.5335 | 17 | 509 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0019904 | 4e-04 | 2.4925 | 8.6606 | 20 | 658 | protein domain specific binding |
| GO:0031720 | 5e-04 | 151.3846 | 0.0395 | 2 | 3 | haptoglobin binding |
| GO:1990837 | 7e-04 | 2.3889 | 9.0129 | 20 | 691 | sequence-specific double-stranded DNA binding |
| GO:0000253 | 0.001 | 75.6875 | 0.0526 | 2 | 4 | 3-keto sterol reductase activity |
| GO:0070891 | 0.001 | 75.6875 | 0.0526 | 2 | 4 | lipoteichoic acid binding |
| GO:0008508 | 0.0017 | 50.4551 | 0.0658 | 2 | 5 | bile acid:sodium symporter activity |
| GO:0045296 | 0.0021 | 2.9667 | 3.9354 | 11 | 299 | cadherin binding |
| GO:0044212 | 0.0023 | 2.1146 | 10.6217 | 21 | 807 | transcription regulatory region DNA binding |
| GO:0140110 | 0.0023 | 1.8119 | 19.7694 | 33 | 1502 | transcription regulator activity |
| GO:0001067 | 0.0024 | 2.1062 | 10.6612 | 21 | 810 | regulatory region nucleic acid binding |
| GO:0016015 | 0.0035 | 30.2692 | 0.0921 | 2 | 7 | morphogen activity |
| GO:0043184 | 0.0035 | 30.2692 | 0.0921 | 2 | 7 | vascular endothelial growth factor receptor 2 binding |
| GO:0005160 | 0.0036 | 6.9289 | 0.6318 | 4 | 48 | transforming growth factor beta receptor binding |
| GO:0003682 | 0.004 | 2.3788 | 6.2256 | 14 | 473 | chromatin binding |
| GO:0004181 | 0.0042 | 10.3577 | 0.3291 | 3 | 25 | metallocarboxypeptidase activity |
| GO:0003680 | 0.0046 | 25.2228 | 0.1053 | 2 | 8 | AT DNA binding |
| GO:0019869 | 0.0046 | 25.2228 | 0.1053 | 2 | 8 | chloride channel inhibitor activity |
| GO:1901363 | 0.0052 | 1.4503 | 73.6678 | 92 | 5597 | heterocyclic compound binding |
| GO:0097159 | 0.0054 | 1.4464 | 74.7208 | 93 | 5677 | organic cyclic compound binding |
| GO:0099106 | 0.0064 | 4.5473 | 1.1714 | 5 | 89 | ion channel regulator activity |
| GO:0044877 | 0.007 | 1.8727 | 12.4776 | 22 | 948 | macromolecular complex binding |
| GO:0001077 | 0.008 | 2.7418 | 3.4484 | 9 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0001227 | 0.0083 | 2.9298 | 2.8693 | 8 | 218 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0004952 | 0.0088 | 16.812 | 0.1448 | 2 | 11 | dopamine neurotransmitter receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 24.4662 | 0.5488 | 10 | 44 | nucleosomal DNA binding |
| GO:0045296 | 0 | 4.108 | 3.7293 | 14 | 299 | cadherin binding |
| GO:0042393 | 1e-04 | 4.7382 | 2.295 | 10 | 184 | histone binding |
| GO:0038100 | 2e-04 | Inf | 0.0249 | 2 | 2 | nodal binding |
| GO:0046982 | 3e-04 | 2.9671 | 5.8247 | 16 | 467 | protein heterodimerization activity |
| GO:0003682 | 3e-04 | 2.927 | 5.8995 | 16 | 473 | chromatin binding |
| GO:0031720 | 5e-04 | 159.9492 | 0.0374 | 2 | 3 | haptoglobin binding |
| GO:0098632 | 5e-04 | 12.4103 | 0.3742 | 4 | 30 | cell-cell adhesion mediator activity |
| GO:0019834 | 9e-04 | 79.9695 | 0.0499 | 2 | 4 | phospholipase A2 inhibitor activity |
| GO:0017108 | 0.0022 | 39.9797 | 0.0748 | 2 | 6 | 5'-flap endonuclease activity |
| GO:0032027 | 0.0022 | 39.9797 | 0.0748 | 2 | 6 | myosin light chain binding |
| GO:0086083 | 0.0022 | 39.9797 | 0.0748 | 2 | 6 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication |
| GO:0008821 | 0.0053 | 22.8412 | 0.1123 | 2 | 9 | crossover junction endodeoxyribonuclease activity |
| GO:0030881 | 0.0053 | 22.8412 | 0.1123 | 2 | 9 | beta-2-microglobulin binding |
| GO:0046703 | 0.0053 | 22.8412 | 0.1123 | 2 | 9 | natural killer cell lectin-like receptor binding |
| GO:0004062 | 0.0094 | 15.9858 | 0.1497 | 2 | 12 | aryl sulfotransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043565 | 0 | 3.3318 | 11.5475 | 33 | 980 | sequence-specific DNA binding |
| GO:0099600 | 0 | 2.8928 | 13.5742 | 34 | 1152 | transmembrane receptor activity |
| GO:0004930 | 0 | 3.4426 | 8.2254 | 25 | 705 | G-protein coupled receptor activity |
| GO:0004984 | 0 | 4.8788 | 3.6646 | 16 | 311 | olfactory receptor activity |
| GO:0060089 | 0 | 2.2935 | 17.2623 | 35 | 1465 | molecular transducer activity |
| GO:0038023 | 1e-04 | 2.4114 | 12.9297 | 28 | 1121 | signaling receptor activity |
| GO:0000981 | 4e-04 | 2.5359 | 8.5663 | 20 | 727 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0001012 | 6e-04 | 2.6554 | 6.9049 | 17 | 586 | RNA polymerase II regulatory region DNA binding |
| GO:0000976 | 8e-04 | 2.4864 | 7.8004 | 18 | 662 | transcription regulatory region sequence-specific DNA binding |
| GO:0004993 | 0.0016 | 15.0238 | 0.2357 | 3 | 20 | G-protein coupled serotonin receptor activity |
| GO:0000975 | 0.0033 | 2.1314 | 9.5326 | 19 | 809 | regulatory region DNA binding |
| GO:0003700 | 0.0035 | 2.6361 | 4.8432 | 12 | 439 | DNA binding transcription factor activity |
| GO:0070405 | 0.0038 | 6.7692 | 0.6416 | 4 | 55 | ammonium ion binding |
| GO:0001077 | 0.0039 | 3.0831 | 3.0872 | 9 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| GO:0030594 | 0.004 | 5.1012 | 1.0487 | 5 | 89 | neurotransmitter receptor activity |
| GO:0071855 | 0.0042 | 10.211 | 0.3299 | 3 | 28 | neuropeptide receptor binding |
| GO:0005184 | 0.0047 | 9.8177 | 0.3417 | 3 | 29 | neuropeptide hormone activity |
| GO:0003690 | 0.0048 | 2.0966 | 9.1437 | 18 | 776 | double-stranded DNA binding |
| GO:0039706 | 0.0058 | 21.1815 | 0.1178 | 2 | 10 | co-receptor binding |
| GO:0051378 | 0.0058 | 21.1815 | 0.1178 | 2 | 10 | serotonin binding |
| GO:0003677 | 0.0068 | 1.8967 | 12.5334 | 22 | 1199 | DNA binding |
| GO:0000978 | 0.0082 | 2.5723 | 4.0887 | 10 | 347 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
| GO:0045125 | 0.0099 | 15.4018 | 0.1532 | 2 | 13 | bioactive lipid receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 10.7187 | 2.9177 | 25 | 184 | histone binding |
| GO:0031492 | 0 | 18.9639 | 0.6977 | 10 | 44 | nucleosomal DNA binding |
| GO:0046982 | 0 | 3.9636 | 7.4053 | 26 | 467 | protein heterodimerization activity |
| GO:0005123 | 1e-04 | 22.9149 | 0.2379 | 4 | 15 | death receptor binding |
| GO:0019904 | 3e-04 | 2.3728 | 10.434 | 23 | 658 | protein domain specific binding |
| GO:0047617 | 0.0023 | 13.4469 | 0.2696 | 3 | 17 | acyl-CoA hydrolase activity |
| GO:0045296 | 0.003 | 2.6744 | 4.7413 | 12 | 299 | cadherin binding |
| GO:0017108 | 0.0036 | 31.2709 | 0.0951 | 2 | 6 | 5'-flap endonuclease activity |
| GO:0043546 | 0.0036 | 31.2709 | 0.0951 | 2 | 6 | molybdopterin cofactor binding |
| GO:0003682 | 0.0037 | 2.2521 | 7.5004 | 16 | 473 | chromatin binding |
| GO:0102991 | 0.0066 | 20.8446 | 0.1269 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0008821 | 0.0084 | 17.8657 | 0.1427 | 2 | 9 | crossover junction endodeoxyribonuclease activity |
| GO:0016208 | 0.0084 | 17.8657 | 0.1427 | 2 | 9 | AMP binding |
| GO:0019911 | 0.0084 | 17.8657 | 0.1427 | 2 | 9 | structural constituent of myelin sheath |
| GO:0030881 | 0.0084 | 17.8657 | 0.1427 | 2 | 9 | beta-2-microglobulin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 17.4398 | 2.0874 | 27 | 184 | histone binding |
| GO:0031492 | 0 | 39.297 | 0.4992 | 13 | 44 | nucleosomal DNA binding |
| GO:0046982 | 0 | 7.2703 | 5.2978 | 31 | 467 | protein heterodimerization activity |
| GO:0004984 | 0 | 9.1163 | 3.5281 | 26 | 311 | olfactory receptor activity |
| GO:0004930 | 0 | 4.3021 | 7.9373 | 29 | 707 | G-protein coupled receptor activity |
| GO:0003677 | 0 | 2.3931 | 26.3871 | 52 | 2326 | DNA binding |
| GO:0099600 | 0 | 2.9202 | 13.0688 | 33 | 1152 | transmembrane receptor activity |
| GO:0038023 | 0 | 2.7653 | 13.7267 | 33 | 1210 | signaling receptor activity |
| GO:0003682 | 0 | 3.4821 | 5.3659 | 17 | 473 | chromatin binding |
| GO:0060089 | 0 | 2.3183 | 16.6196 | 34 | 1465 | molecular transducer activity |
| GO:0019904 | 1e-04 | 2.9471 | 7.4646 | 20 | 658 | protein domain specific binding |
| GO:0031720 | 4e-04 | 176.2346 | 0.034 | 2 | 3 | haptoglobin binding |
| GO:0005344 | 5e-04 | 24.1517 | 0.1588 | 3 | 14 | oxygen carrier activity |
| GO:0045296 | 0.0022 | 3.1334 | 3.392 | 10 | 299 | cadherin binding |
| GO:0102991 | 0.0034 | 29.3631 | 0.0908 | 2 | 8 | myristoyl-CoA hydrolase activity |
| GO:0044877 | 0.0055 | 1.9873 | 10.7545 | 20 | 948 | macromolecular complex binding |
| GO:0004952 | 0.0066 | 19.5717 | 0.1248 | 2 | 11 | dopamine neurotransmitter receptor activity |
| GO:0016290 | 0.0066 | 19.5717 | 0.1248 | 2 | 11 | palmitoyl-CoA hydrolase activity |
| GO:0035240 | 0.0066 | 19.5717 | 0.1248 | 2 | 11 | dopamine binding |
| GO:0008195 | 0.0092 | 16.0112 | 0.1475 | 2 | 13 | phosphatidate phosphatase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 230.9845 | 0.3519 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 0 | 40.7238 | 0.6416 | 14 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 31.4579 | 0.7451 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 26.6111 | 0.8279 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 24.707 | 0.8693 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0051290 | 0 | 23.8534 | 0.89 | 14 | 43 | protein heterotetramerization |
| GO:0016233 | 0 | 19.2062 | 1.0349 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 19.2062 | 1.0349 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0006303 | 0 | 13.2823 | 1.3661 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0032501 | 0 | 2.1339 | 121.3992 | 175 | 6203 | multicellular organismal process |
| GO:0043044 | 0 | 11.701 | 1.511 | 14 | 73 | ATP-dependent chromatin remodeling |
| GO:0048863 | 0 | 5.4782 | 5.0711 | 24 | 245 | stem cell differentiation |
| GO:0045815 | 0 | 10.7832 | 1.6145 | 14 | 78 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 8.82 | 2.0491 | 15 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 8.0129 | 2.0698 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0045814 | 0 | 7.2547 | 2.4217 | 15 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 6.9791 | 2.5045 | 15 | 121 | regulation of gene silencing |
| GO:1903707 | 0 | 6.6025 | 2.6287 | 15 | 127 | negative regulation of hemopoiesis |
| GO:0097659 | 0 | 1.8881 | 71.264 | 111 | 3443 | nucleic acid-templated transcription |
| GO:0099537 | 0 | 3.09 | 11.5496 | 32 | 558 | trans-synaptic signaling |
| GO:0031497 | 0 | 5.771 | 2.9598 | 15 | 143 | chromatin assembly |
| GO:0034654 | 0 | 1.7713 | 80.3506 | 118 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:1902679 | 0 | 2.3075 | 22.2299 | 46 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0045934 | 0 | 2.1895 | 26.6179 | 52 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0048731 | 0 | 2.1762 | 29.701 | 55 | 1748 | system development |
| GO:2000026 | 0 | 2.4132 | 18.0064 | 39 | 928 | regulation of multicellular organismal development |
| GO:0006837 | 0 | 30.0301 | 0.2691 | 5 | 13 | serotonin transport |
| GO:0032200 | 0 | 4.8692 | 3.2082 | 14 | 155 | telomere organization |
| GO:0006352 | 0 | 4.03 | 4.6571 | 17 | 225 | DNA-templated transcription, initiation |
| GO:0002244 | 0 | 4.3851 | 3.7878 | 15 | 183 | hematopoietic progenitor cell differentiation |
| GO:0045596 | 0 | 2.6417 | 12.4396 | 30 | 601 | negative regulation of cell differentiation |
| GO:0007267 | 0 | 2.2174 | 20.9681 | 42 | 1054 | cell-cell signaling |
| GO:0035194 | 0 | 3.5375 | 5.5678 | 18 | 269 | posttranscriptional gene silencing by RNA |
| GO:0015837 | 0 | 8.1612 | 1.146 | 8 | 56 | amine transport |
| GO:0045637 | 0 | 3.7619 | 4.6571 | 16 | 225 | regulation of myeloid cell differentiation |
| GO:0065004 | 0 | 3.7515 | 4.3673 | 15 | 211 | protein-DNA complex assembly |
| GO:0007198 | 0 | 143.2907 | 0.0828 | 3 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0034287 | 0 | 143.2907 | 0.0828 | 3 | 4 | detection of monosaccharide stimulus |
| GO:0051594 | 0 | 143.2907 | 0.0828 | 3 | 4 | detection of glucose |
| GO:0003013 | 0 | 2.7043 | 9.6247 | 24 | 465 | circulatory system process |
| GO:0031644 | 0 | 6.9086 | 1.3247 | 8 | 64 | regulation of neurological system process |
| GO:0060255 | 1e-04 | 1.5718 | 114.2129 | 148 | 5518 | regulation of macromolecule metabolic process |
| GO:0050880 | 1e-04 | 4.5726 | 2.6494 | 11 | 128 | regulation of blood vessel size |
| GO:0006325 | 1e-04 | 2.3116 | 14.0541 | 30 | 679 | chromatin organization |
| GO:0007218 | 1e-04 | 5.2514 | 1.9042 | 9 | 92 | neuropeptide signaling pathway |
| GO:0006355 | 1e-04 | 1.7504 | 42.5569 | 66 | 2234 | regulation of transcription, DNA-templated |
| GO:0009952 | 2e-04 | 3.6226 | 3.8913 | 13 | 188 | anterior/posterior pattern specification |
| GO:0003206 | 2e-04 | 4.5336 | 2.4217 | 10 | 117 | cardiac chamber morphogenesis |
| GO:0007188 | 2e-04 | 4.1439 | 2.8978 | 11 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0016070 | 2e-04 | 1.5498 | 87.5328 | 117 | 4229 | RNA metabolic process |
| GO:0023061 | 2e-04 | 2.6775 | 8.0309 | 20 | 388 | signal release |
| GO:0007268 | 2e-04 | 3.7626 | 3.4604 | 12 | 174 | chemical synaptic transmission |
| GO:0035270 | 2e-04 | 4.4091 | 2.4838 | 10 | 120 | endocrine system development |
| GO:0009890 | 2e-04 | 1.7978 | 32.2893 | 53 | 1560 | negative regulation of biosynthetic process |
| GO:2001141 | 2e-04 | 1.7239 | 42.3843 | 65 | 2228 | regulation of RNA biosynthetic process |
| GO:0045892 | 2e-04 | 2.8987 | 6.3164 | 17 | 319 | negative regulation of transcription, DNA-templated |
| GO:0035296 | 2e-04 | 4.3298 | 2.5252 | 10 | 122 | regulation of tube diameter |
| GO:0051259 | 2e-04 | 2.4346 | 10.1421 | 23 | 490 | protein oligomerization |
| GO:0050433 | 2e-04 | 7.8016 | 0.89 | 6 | 43 | regulation of catecholamine secretion |
| GO:0051046 | 3e-04 | 2.2027 | 13.6608 | 28 | 660 | regulation of secretion |
| GO:0071103 | 3e-04 | 3.0546 | 5.2781 | 15 | 255 | DNA conformation change |
| GO:0051584 | 3e-04 | 35.8155 | 0.1449 | 3 | 7 | regulation of dopamine uptake involved in synaptic transmission |
| GO:0006936 | 3e-04 | 2.7957 | 6.5199 | 17 | 315 | muscle contraction |
| GO:0060249 | 3e-04 | 2.7013 | 7.1409 | 18 | 345 | anatomical structure homeostasis |
| GO:0007399 | 3e-04 | 2.1751 | 13.9325 | 28 | 746 | nervous system development |
| GO:0035637 | 4e-04 | 3.4945 | 3.705 | 12 | 179 | multicellular organismal signaling |
| GO:0006812 | 4e-04 | 1.9457 | 20.512 | 37 | 991 | cation transport |
| GO:0034645 | 4e-04 | 1.4984 | 97.5508 | 126 | 4713 | cellular macromolecule biosynthetic process |
| GO:0007517 | 4e-04 | 2.6434 | 7.2858 | 18 | 352 | muscle organ development |
| GO:0017148 | 4e-04 | 2.6273 | 7.3272 | 18 | 354 | negative regulation of translation |
| GO:0042391 | 5e-04 | 3.0378 | 4.9415 | 14 | 243 | regulation of membrane potential |
| GO:0003231 | 5e-04 | 4.2261 | 2.3182 | 9 | 112 | cardiac ventricle development |
| GO:0007210 | 5e-04 | 12.7658 | 0.3933 | 4 | 19 | serotonin receptor signaling pathway |
| GO:0015844 | 6e-04 | 6.5128 | 1.0398 | 6 | 51 | monoamine transport |
| GO:0009889 | 6e-04 | 1.618 | 49.3497 | 71 | 2572 | regulation of biosynthetic process |
| GO:0030154 | 6e-04 | 1.6544 | 42.4788 | 63 | 2247 | cell differentiation |
| GO:0009887 | 7e-04 | 2.148 | 12.4399 | 25 | 625 | animal organ morphogenesis |
| GO:0009893 | 8e-04 | 1.5337 | 61.6394 | 85 | 2978 | positive regulation of metabolic process |
| GO:0035295 | 8e-04 | 2.2137 | 11.0736 | 23 | 535 | tube development |
| GO:0065008 | 8e-04 | 1.6476 | 40.2961 | 60 | 2130 | regulation of biological quality |
| GO:0051953 | 8e-04 | 11.2624 | 0.4347 | 4 | 21 | negative regulation of amine transport |
| GO:0060415 | 8e-04 | 5.0325 | 1.5317 | 7 | 74 | muscle tissue morphogenesis |
| GO:0050794 | 0.001 | 1.48 | 186.1725 | 212 | 9368 | regulation of cellular process |
| GO:0009914 | 0.001 | 2.6694 | 5.9818 | 15 | 289 | hormone transport |
| GO:0060537 | 0.0011 | 2.4882 | 7.2651 | 17 | 351 | muscle tissue development |
| GO:0000122 | 0.0011 | 1.9973 | 14.9441 | 28 | 722 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0019219 | 0.0012 | 1.5829 | 47.8489 | 68 | 2534 | regulation of nucleobase-containing compound metabolic process |
| GO:2000463 | 0.0012 | 10.0756 | 0.4761 | 4 | 23 | positive regulation of excitatory postsynaptic potential |
| GO:0002009 | 0.0012 | 2.2275 | 10.0179 | 21 | 484 | morphogenesis of an epithelium |
| GO:0021524 | 0.0013 | 95.2229 | 0.0621 | 2 | 3 | visceral motor neuron differentiation |
| GO:0061364 | 0.0013 | 95.2229 | 0.0621 | 2 | 3 | apoptotic process involved in luteolysis |
| GO:1905333 | 0.0013 | 95.2229 | 0.0621 | 2 | 3 | regulation of gastric motility |
| GO:0051580 | 0.0013 | 17.903 | 0.2277 | 3 | 11 | regulation of neurotransmitter uptake |
| GO:0051934 | 0.0013 | 17.903 | 0.2277 | 3 | 11 | catecholamine uptake involved in synaptic transmission |
| GO:0090494 | 0.0013 | 17.903 | 0.2277 | 3 | 11 | dopamine uptake |
| GO:0001708 | 0.0013 | 4.617 | 1.6559 | 7 | 80 | cell fate specification |
| GO:0015872 | 0.0013 | 9.6589 | 0.4924 | 4 | 24 | dopamine transport |
| GO:0048699 | 0.0013 | 2.1223 | 11.5443 | 23 | 580 | generation of neurons |
| GO:0001764 | 0.0014 | 3.6539 | 2.6494 | 9 | 128 | neuron migration |
| GO:0045666 | 0.0014 | 2.5829 | 6.1681 | 15 | 298 | positive regulation of neuron differentiation |
| GO:0048534 | 0.0014 | 1.9109 | 16.7242 | 30 | 808 | hematopoietic or lymphoid organ development |
| GO:0048562 | 0.0015 | 2.661 | 5.5885 | 14 | 270 | embryonic organ morphogenesis |
| GO:0048666 | 0.0016 | 1.8785 | 17.5891 | 31 | 860 | neuron development |
| GO:0003148 | 0.0016 | 9.1148 | 0.5175 | 4 | 25 | outflow tract septum morphogenesis |
| GO:0003309 | 0.0016 | 9.1148 | 0.5175 | 4 | 25 | type B pancreatic cell differentiation |
| GO:0099531 | 0.0016 | 3.5633 | 2.7115 | 9 | 131 | presynaptic process involved in chemical synaptic transmission |
| GO:0021517 | 0.0017 | 6.4804 | 0.8693 | 5 | 42 | ventral spinal cord development |
| GO:1901576 | 0.0018 | 1.4058 | 120.381 | 146 | 5816 | organic substance biosynthetic process |
| GO:0090276 | 0.0018 | 3.0277 | 3.8706 | 11 | 187 | regulation of peptide hormone secretion |
| GO:0022603 | 0.0018 | 1.8394 | 18.5249 | 32 | 895 | regulation of anatomical structure morphogenesis |
| GO:0033555 | 0.0019 | 5.0574 | 1.304 | 6 | 63 | multicellular organismal response to stress |
| GO:0045944 | 0.0021 | 1.7718 | 21.0501 | 35 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0003214 | 0.0022 | 14.3204 | 0.2691 | 3 | 13 | cardiac left ventricle morphogenesis |
| GO:0021520 | 0.0022 | 14.3204 | 0.2691 | 3 | 13 | spinal cord motor neuron cell fate specification |
| GO:0003016 | 0.0022 | 8.3211 | 0.5589 | 4 | 27 | respiratory system process |
| GO:0048754 | 0.0022 | 3.3949 | 2.8357 | 9 | 137 | branching morphogenesis of an epithelial tube |
| GO:0002067 | 0.0023 | 5.9932 | 0.9314 | 5 | 45 | glandular epithelial cell differentiation |
| GO:0031016 | 0.0023 | 4.8331 | 1.3581 | 6 | 66 | pancreas development |
| GO:0021675 | 0.0024 | 4.8035 | 1.3661 | 6 | 66 | nerve development |
| GO:0032024 | 0.0024 | 4.8035 | 1.3661 | 6 | 66 | positive regulation of insulin secretion |
| GO:0000038 | 0.0025 | 7.9738 | 0.5796 | 4 | 28 | very long-chain fatty acid metabolic process |
| GO:0002865 | 0.0025 | 47.6083 | 0.0828 | 2 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
| GO:0032100 | 0.0025 | 47.6083 | 0.0828 | 2 | 4 | positive regulation of appetite |
| GO:0051414 | 0.0025 | 47.6083 | 0.0828 | 2 | 4 | response to cortisol |
| GO:0055010 | 0.0025 | 5.8466 | 0.9521 | 5 | 46 | ventricular cardiac muscle tissue morphogenesis |
| GO:0040011 | 0.0026 | 1.6133 | 31.9167 | 48 | 1542 | locomotion |
| GO:0014048 | 0.0027 | 13.0177 | 0.2898 | 3 | 14 | regulation of glutamate secretion |
| GO:0021794 | 0.0027 | 13.0177 | 0.2898 | 3 | 14 | thalamus development |
| GO:0042711 | 0.0027 | 13.0177 | 0.2898 | 3 | 14 | maternal behavior |
| GO:0007417 | 0.0027 | 2.8635 | 4.0789 | 11 | 204 | central nervous system development |
| GO:0042472 | 0.0028 | 4.0094 | 1.8835 | 7 | 91 | inner ear morphogenesis |
| GO:0008306 | 0.0028 | 4.648 | 1.4075 | 6 | 68 | associative learning |
| GO:0048663 | 0.0028 | 4.648 | 1.4075 | 6 | 68 | neuron fate commitment |
| GO:0001525 | 0.003 | 2.1861 | 8.6933 | 18 | 420 | angiogenesis |
| GO:0042755 | 0.0032 | 7.3595 | 0.6209 | 4 | 30 | eating behavior |
| GO:0042310 | 0.0032 | 4.5021 | 1.4489 | 6 | 70 | vasoconstriction |
| GO:0098911 | 0.0033 | 11.9321 | 0.3105 | 3 | 15 | regulation of ventricular cardiac muscle cell action potential |
| GO:0051962 | 0.0034 | 2.1585 | 8.7968 | 18 | 425 | positive regulation of nervous system development |
| GO:0019932 | 0.0035 | 2.5127 | 5.4643 | 13 | 264 | second-messenger-mediated signaling |
| GO:0034248 | 0.0036 | 1.978 | 11.7359 | 22 | 567 | regulation of cellular amide metabolic process |
| GO:0010517 | 0.0036 | 5.3255 | 1.0349 | 5 | 50 | regulation of phospholipase activity |
| GO:0060078 | 0.0037 | 3.4106 | 2.5045 | 8 | 121 | regulation of postsynaptic membrane potential |
| GO:0048646 | 0.0038 | 2.086 | 9.6148 | 19 | 481 | anatomical structure formation involved in morphogenesis |
| GO:0048812 | 0.0038 | 2.0035 | 11.0529 | 21 | 534 | neuron projection morphogenesis |
| GO:0048598 | 0.004 | 2.4684 | 5.5579 | 13 | 276 | embryonic morphogenesis |
| GO:0060413 | 0.004 | 11.0135 | 0.3312 | 3 | 16 | atrial septum morphogenesis |
| GO:1904018 | 0.004 | 3.0792 | 3.1047 | 9 | 150 | positive regulation of vasculature development |
| GO:0043270 | 0.0041 | 2.7043 | 4.3002 | 11 | 209 | positive regulation of ion transport |
| GO:0010040 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | response to iron(II) ion |
| GO:0035609 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | C-terminal protein deglutamylation |
| GO:0045110 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | intermediate filament bundle assembly |
| GO:0051891 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0051970 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | negative regulation of transmission of nerve impulse |
| GO:0070100 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
| GO:0090237 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | regulation of arachidonic acid secretion |
| GO:0001662 | 0.0041 | 6.8329 | 0.6623 | 4 | 32 | behavioral fear response |
| GO:0008344 | 0.0043 | 4.2361 | 1.5317 | 6 | 74 | adult locomotory behavior |
| GO:0007420 | 0.0045 | 1.9107 | 12.688 | 23 | 613 | brain development |
| GO:0032879 | 0.0045 | 1.471 | 49.2411 | 67 | 2379 | regulation of localization |
| GO:0008284 | 0.0046 | 1.7881 | 16.5379 | 28 | 799 | positive regulation of cell proliferation |
| GO:0015849 | 0.0046 | 2.4243 | 5.6506 | 13 | 273 | organic acid transport |
| GO:0042053 | 0.0048 | 10.2262 | 0.3519 | 3 | 17 | regulation of dopamine metabolic process |
| GO:1901700 | 0.005 | 1.5908 | 28.7706 | 43 | 1390 | response to oxygen-containing compound |
| GO:0043279 | 0.005 | 3.5805 | 2.0905 | 7 | 101 | response to alkaloid |
| GO:0007626 | 0.0051 | 3.5585 | 2.1016 | 7 | 103 | locomotory behavior |
| GO:0048856 | 0.0052 | 1.89 | 13.7966 | 24 | 938 | anatomical structure development |
| GO:0099565 | 0.0053 | 3.5426 | 2.1112 | 7 | 102 | chemical synaptic transmission, postsynaptic |
| GO:0048858 | 0.0054 | 1.9369 | 11.4047 | 21 | 551 | cell projection morphogenesis |
| GO:0007611 | 0.0056 | 2.5815 | 4.4915 | 11 | 217 | learning or memory |
| GO:0051094 | 0.0056 | 2.9156 | 3.2679 | 9 | 167 | positive regulation of developmental process |
| GO:0061041 | 0.0057 | 3.1571 | 2.6908 | 8 | 130 | regulation of wound healing |
| GO:0043954 | 0.0057 | 6.1704 | 0.7244 | 4 | 35 | cellular component maintenance |
| GO:0021854 | 0.0057 | 9.5438 | 0.3726 | 3 | 18 | hypothalamus development |
| GO:0048148 | 0.0057 | 9.5438 | 0.3726 | 3 | 18 | behavioral response to cocaine |
| GO:0097755 | 0.0059 | 4.6971 | 1.1591 | 5 | 56 | positive regulation of blood vessel diameter |
| GO:0014062 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | regulation of serotonin secretion |
| GO:0021800 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | cerebral cortex tangential migration |
| GO:0032109 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | positive regulation of response to nutrient levels |
| GO:0032229 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | negative regulation of synaptic transmission, GABAergic |
| GO:0033603 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | positive regulation of dopamine secretion |
| GO:0060430 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | lung saccule development |
| GO:0071313 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | cellular response to caffeine |
| GO:0086073 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0110022 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | regulation of cardiac muscle myoblast proliferation |
| GO:0090066 | 0.0061 | 2.0736 | 8.6105 | 17 | 416 | regulation of anatomical structure size |
| GO:0021537 | 0.0062 | 2.5439 | 4.5536 | 11 | 220 | telencephalon development |
| GO:0006725 | 0.0062 | 1.3444 | 113.2194 | 135 | 5470 | cellular aromatic compound metabolic process |
| GO:0048645 | 0.0064 | 4.6064 | 1.1798 | 5 | 57 | animal organ formation |
| GO:0010628 | 0.0064 | 1.545 | 31.7528 | 46 | 1597 | positive regulation of gene expression |
| GO:1904064 | 0.0065 | 3.3985 | 2.194 | 7 | 106 | positive regulation of cation transmembrane transport |
| GO:0045597 | 0.0065 | 1.7381 | 16.9726 | 28 | 820 | positive regulation of cell differentiation |
| GO:0051384 | 0.0065 | 3.0756 | 2.7567 | 8 | 134 | response to glucocorticoid |
| GO:0034505 | 0.0067 | 8.9467 | 0.3933 | 3 | 19 | tooth mineralization |
| GO:0032844 | 0.0067 | 2.0525 | 8.6933 | 17 | 420 | regulation of homeostatic process |
| GO:0051960 | 0.0067 | 5.8455 | 0.7582 | 4 | 38 | regulation of nervous system development |
| GO:0046483 | 0.0069 | 1.3391 | 112.557 | 134 | 5438 | heterocycle metabolic process |
| GO:0050804 | 0.007 | 2.2982 | 5.9404 | 13 | 287 | modulation of chemical synaptic transmission |
| GO:0006835 | 0.007 | 3.7882 | 1.6973 | 6 | 82 | dicarboxylic acid transport |
| GO:0006813 | 0.0071 | 2.4955 | 4.6364 | 11 | 224 | potassium ion transport |
| GO:0050767 | 0.0073 | 1.8267 | 13.2262 | 23 | 639 | regulation of neurogenesis |
| GO:0048545 | 0.0073 | 2.1415 | 7.3479 | 15 | 355 | response to steroid hormone |
| GO:0061564 | 0.0073 | 2.0317 | 8.7761 | 17 | 424 | axon development |
| GO:0048738 | 0.0075 | 2.6084 | 4.0362 | 10 | 195 | cardiac muscle tissue development |
| GO:0007214 | 0.0077 | 8.4198 | 0.414 | 3 | 20 | gamma-aminobutyric acid signaling pathway |
| GO:0015874 | 0.0077 | 8.4198 | 0.414 | 3 | 20 | norepinephrine transport |
| GO:0031290 | 0.0077 | 8.4198 | 0.414 | 3 | 20 | retinal ganglion cell axon guidance |
| GO:0051968 | 0.0077 | 8.4198 | 0.414 | 3 | 20 | positive regulation of synaptic transmission, glutamatergic |
| GO:0060039 | 0.0077 | 8.4198 | 0.414 | 3 | 20 | pericardium development |
| GO:0046717 | 0.0079 | 3.2657 | 2.2768 | 7 | 110 | acid secretion |
| GO:0043583 | 0.008 | 2.5801 | 4.0776 | 10 | 197 | ear development |
| GO:0045995 | 0.0083 | 3.234 | 2.2975 | 7 | 111 | regulation of embryonic development |
| GO:0001676 | 0.0084 | 3.6436 | 1.7594 | 6 | 85 | long-chain fatty acid metabolic process |
| GO:0001574 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | ganglioside biosynthetic process |
| GO:0010700 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | negative regulation of norepinephrine secretion |
| GO:0031017 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | exocrine pancreas development |
| GO:0035385 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | Roundabout signaling pathway |
| GO:0071420 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | cellular response to histamine |
| GO:0072608 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | interleukin-10 secretion |
| GO:0098700 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | neurotransmitter loading into synaptic vesicle |
| GO:2000049 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:0003197 | 0.0084 | 5.4637 | 0.8072 | 4 | 39 | endocardial cushion development |
| GO:0003002 | 0.0084 | 3.2205 | 2.3049 | 7 | 115 | regionalization |
| GO:0006940 | 0.0085 | 4.2762 | 1.2626 | 5 | 61 | regulation of smooth muscle contraction |
| GO:0021954 | 0.0085 | 4.2762 | 1.2626 | 5 | 61 | central nervous system neuron development |
| GO:0009719 | 0.0085 | 1.5499 | 28.0047 | 41 | 1353 | response to endogenous stimulus |
| GO:0030534 | 0.0086 | 5.4044 | 0.8142 | 4 | 40 | adult behavior |
| GO:0046887 | 0.0087 | 3.203 | 2.3182 | 7 | 112 | positive regulation of hormone secretion |
| GO:0072358 | 0.0087 | 1.8214 | 12.6673 | 22 | 612 | cardiovascular system development |
| GO:0014821 | 0.0089 | 7.9515 | 0.4347 | 3 | 21 | phasic smooth muscle contraction |
| GO:1903672 | 0.0089 | 7.9515 | 0.4347 | 3 | 21 | positive regulation of sprouting angiogenesis |
| GO:2000191 | 0.0089 | 7.9515 | 0.4347 | 3 | 21 | regulation of fatty acid transport |
| GO:0015711 | 0.0091 | 2.0286 | 8.2586 | 16 | 399 | organic anion transport |
| GO:0034105 | 0.0092 | 5.3116 | 0.8279 | 4 | 40 | positive regulation of tissue remodeling |
| GO:0010608 | 0.0093 | 1.7844 | 13.5159 | 23 | 653 | posttranscriptional regulation of gene expression |
| GO:0001568 | 0.0093 | 1.8362 | 11.9843 | 21 | 579 | blood vessel development |
| GO:0002793 | 0.0094 | 2.3928 | 4.8227 | 11 | 233 | positive regulation of peptide secretion |
| GO:0019233 | 0.0098 | 3.5096 | 1.8214 | 6 | 88 | sensory perception of pain |
| GO:0035282 | 0.0098 | 3.5096 | 1.8214 | 6 | 88 | segmentation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009952 | 0 | 10.5192 | 2.5076 | 21 | 125 | anterior/posterior pattern specification |
| GO:0007389 | 0 | 7.2551 | 4.491 | 27 | 226 | pattern specification process |
| GO:0034654 | 0 | 2.3927 | 79.5877 | 139 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:0009790 | 0 | 3.3059 | 17.321 | 49 | 854 | embryo development |
| GO:0045944 | 0 | 2.9583 | 20.8503 | 53 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0035107 | 0 | 7.6716 | 2.7882 | 18 | 136 | appendage morphogenesis |
| GO:0060255 | 0 | 2.026 | 113.1286 | 166 | 5518 | regulation of macromolecule metabolic process |
| GO:1902679 | 0 | 2.7818 | 22.0189 | 53 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0034645 | 0 | 1.9884 | 96.6247 | 146 | 4713 | cellular macromolecule biosynthetic process |
| GO:2001141 | 0 | 2.3488 | 40.8145 | 78 | 2228 | regulation of RNA biosynthetic process |
| GO:0060173 | 0 | 6.3647 | 3.2803 | 18 | 160 | limb development |
| GO:1903508 | 0 | 2.5377 | 26.9188 | 59 | 1313 | positive regulation of nucleic acid-templated transcription |
| GO:0019219 | 0 | 2.2213 | 46.7615 | 84 | 2534 | regulation of nucleobase-containing compound metabolic process |
| GO:0003206 | 0 | 7.3293 | 2.3987 | 15 | 117 | cardiac chamber morphogenesis |
| GO:0009889 | 0 | 2.2045 | 47.8485 | 85 | 2572 | regulation of biosynthetic process |
| GO:0031328 | 0 | 2.2908 | 33.9509 | 67 | 1656 | positive regulation of cellular biosynthetic process |
| GO:0051254 | 0 | 2.3913 | 28.3539 | 59 | 1383 | positive regulation of RNA metabolic process |
| GO:0097659 | 0 | 2.2368 | 38.7871 | 72 | 2131 | nucleic acid-templated transcription |
| GO:0006355 | 0 | 2.2736 | 35.8469 | 68 | 1998 | regulation of transcription, DNA-templated |
| GO:0045934 | 0 | 2.3765 | 26.3652 | 55 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0010557 | 0 | 2.259 | 31.4907 | 62 | 1536 | positive regulation of macromolecule biosynthetic process |
| GO:0048332 | 0 | 8.8928 | 1.4761 | 11 | 72 | mesoderm morphogenesis |
| GO:0072359 | 0 | 2.594 | 18.6156 | 43 | 908 | circulatory system development |
| GO:0051173 | 0 | 1.9384 | 54.6781 | 90 | 2667 | positive regulation of nitrogen compound metabolic process |
| GO:1901576 | 0 | 1.7647 | 119.2381 | 162 | 5816 | organic substance biosynthetic process |
| GO:0010628 | 0 | 2.1288 | 34.3404 | 64 | 1675 | positive regulation of gene expression |
| GO:0000122 | 0 | 2.7031 | 14.8023 | 36 | 722 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0048562 | 0 | 5.0461 | 3.3319 | 15 | 169 | embryonic organ morphogenesis |
| GO:0007267 | 0 | 2.337 | 21.0389 | 44 | 1054 | cell-cell signaling |
| GO:0048935 | 0 | 34.6637 | 0.246 | 5 | 12 | peripheral nervous system neuron development |
| GO:0032502 | 0 | 1.8493 | 66.7493 | 99 | 3812 | developmental process |
| GO:0048704 | 0 | 9.885 | 0.9741 | 8 | 48 | embryonic skeletal system morphogenesis |
| GO:0009890 | 0 | 2.0371 | 31.9827 | 58 | 1560 | negative regulation of biosynthetic process |
| GO:0001944 | 0 | 2.6461 | 12.4241 | 30 | 606 | vasculature development |
| GO:0060021 | 0 | 6.4608 | 1.7631 | 10 | 86 | palate development |
| GO:0001708 | 0 | 7.4183 | 1.4021 | 9 | 69 | cell fate specification |
| GO:2000027 | 0 | 4.1388 | 3.9902 | 15 | 198 | regulation of organ morphogenesis |
| GO:0099537 | 0 | 2.6738 | 11.44 | 28 | 558 | trans-synaptic signaling |
| GO:0048468 | 0 | 1.9075 | 37.0671 | 63 | 1808 | cell development |
| GO:0003151 | 0 | 6.9977 | 1.4761 | 9 | 72 | outflow tract morphogenesis |
| GO:0042472 | 0 | 6.06 | 1.8657 | 10 | 91 | inner ear morphogenesis |
| GO:0006725 | 0 | 1.6234 | 112.1445 | 148 | 5470 | cellular aromatic compound metabolic process |
| GO:0001763 | 0 | 4.2488 | 3.6288 | 14 | 177 | morphogenesis of a branching structure |
| GO:0021517 | 0 | 9.751 | 0.8611 | 7 | 42 | ventral spinal cord development |
| GO:0046483 | 0 | 1.5962 | 111.4884 | 146 | 5438 | heterocycle metabolic process |
| GO:0090596 | 0 | 3.575 | 4.8794 | 16 | 238 | sensory organ morphogenesis |
| GO:0007275 | 0 | 1.888 | 39.718 | 64 | 2343 | multicellular organism development |
| GO:0048646 | 0 | 3.0141 | 7.2161 | 20 | 379 | anatomical structure formation involved in morphogenesis |
| GO:0001756 | 0 | 7.1053 | 1.2916 | 8 | 63 | somitogenesis |
| GO:0071772 | 1e-04 | 4.3762 | 3.0138 | 12 | 147 | response to BMP |
| GO:0034641 | 1e-04 | 1.5645 | 123.2359 | 157 | 6011 | cellular nitrogen compound metabolic process |
| GO:0021953 | 1e-04 | 4.61 | 2.6275 | 11 | 130 | central nervous system neuron differentiation |
| GO:0035050 | 1e-04 | 6.511 | 1.3941 | 8 | 68 | embryonic heart tube development |
| GO:0030154 | 1e-04 | 2.0753 | 22.1263 | 41 | 1248 | cell differentiation |
| GO:0010454 | 1e-04 | 24.1845 | 0.246 | 4 | 12 | negative regulation of cell fate commitment |
| GO:0021515 | 1e-04 | 9.8112 | 0.7317 | 6 | 36 | cell differentiation in spinal cord |
| GO:1901360 | 1e-04 | 1.5536 | 116.1833 | 149 | 5667 | organic cyclic compound metabolic process |
| GO:0065007 | 1e-04 | 1.737 | 140.9537 | 168 | 7441 | biological regulation |
| GO:0003231 | 1e-04 | 4.8055 | 2.2962 | 10 | 112 | cardiac ventricle development |
| GO:0003214 | 1e-04 | 21.4959 | 0.2665 | 4 | 13 | cardiac left ventricle morphogenesis |
| GO:0008595 | 1e-04 | 21.4959 | 0.2665 | 4 | 13 | anterior/posterior axis specification, embryo |
| GO:0051094 | 1e-04 | 3.2107 | 5.3973 | 16 | 280 | positive regulation of developmental process |
| GO:0060537 | 1e-04 | 2.8463 | 7.1961 | 19 | 351 | muscle tissue development |
| GO:0001704 | 1e-04 | 4.5794 | 2.3987 | 10 | 117 | formation of primary germ layer |
| GO:0048732 | 1e-04 | 2.7131 | 7.9342 | 20 | 387 | gland development |
| GO:0009887 | 2e-04 | 3.1151 | 5.5484 | 16 | 308 | animal organ morphogenesis |
| GO:0016331 | 2e-04 | 4.1534 | 2.8907 | 11 | 141 | morphogenesis of embryonic epithelium |
| GO:0007611 | 2e-04 | 3.4024 | 4.4489 | 14 | 217 | learning or memory |
| GO:0086073 | 2e-04 | 48.229 | 0.123 | 3 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0048699 | 2e-04 | 2.3064 | 12.6483 | 27 | 638 | generation of neurons |
| GO:0048729 | 2e-04 | 2.541 | 9.318 | 22 | 474 | tissue morphogenesis |
| GO:0061311 | 2e-04 | 11.0183 | 0.5535 | 5 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0007350 | 2e-04 | 17.5852 | 0.3075 | 4 | 15 | blastoderm segmentation |
| GO:0061377 | 2e-04 | 17.5852 | 0.3075 | 4 | 15 | mammary gland lobule development |
| GO:0098911 | 2e-04 | 17.5852 | 0.3075 | 4 | 15 | regulation of ventricular cardiac muscle cell action potential |
| GO:0016477 | 2e-04 | 1.8974 | 24.6226 | 43 | 1201 | cell migration |
| GO:0072001 | 2e-04 | 3.0991 | 5.2074 | 15 | 254 | renal system development |
| GO:0072132 | 3e-04 | 7.287 | 0.9431 | 6 | 46 | mesenchyme morphogenesis |
| GO:0016070 | 4e-04 | 1.6414 | 52.0805 | 75 | 2847 | RNA metabolic process |
| GO:0060429 | 4e-04 | 2.0142 | 17.6758 | 33 | 910 | epithelium development |
| GO:0051892 | 4e-04 | Inf | 0.041 | 2 | 2 | negative regulation of cardioblast differentiation |
| GO:0061032 | 4e-04 | Inf | 0.041 | 2 | 2 | visceral serous pericardium development |
| GO:2000043 | 4e-04 | Inf | 0.041 | 2 | 2 | regulation of cardiac cell fate specification |
| GO:0001710 | 4e-04 | 13.8141 | 0.369 | 4 | 18 | mesodermal cell fate commitment |
| GO:0033278 | 4e-04 | 28.9335 | 0.164 | 3 | 8 | cell proliferation in midbrain |
| GO:0048754 | 5e-04 | 4.3194 | 2.2706 | 9 | 112 | branching morphogenesis of an epithelial tube |
| GO:0008306 | 5e-04 | 5.5851 | 1.3941 | 7 | 68 | associative learning |
| GO:2000026 | 5e-04 | 1.7792 | 28.7805 | 47 | 1482 | regulation of multicellular organismal development |
| GO:0030509 | 5e-04 | 3.8531 | 2.8087 | 10 | 137 | BMP signaling pathway |
| GO:0061448 | 6e-04 | 3.1332 | 4.4489 | 13 | 217 | connective tissue development |
| GO:0030539 | 6e-04 | 12.0858 | 0.41 | 4 | 20 | male genitalia development |
| GO:0002934 | 7e-04 | 24.1097 | 0.1845 | 3 | 9 | desmosome organization |
| GO:0060923 | 7e-04 | 24.1097 | 0.1845 | 3 | 9 | cardiac muscle cell fate commitment |
| GO:1905770 | 7e-04 | 24.1097 | 0.1845 | 3 | 9 | regulation of mesodermal cell differentiation |
| GO:1905330 | 7e-04 | 3.4551 | 3.4238 | 11 | 167 | regulation of morphogenesis of an epithelium |
| GO:0035137 | 7e-04 | 8.0758 | 0.7176 | 5 | 35 | hindlimb morphogenesis |
| GO:0043583 | 8e-04 | 3.1827 | 4.0388 | 12 | 197 | ear development |
| GO:0002065 | 8e-04 | 4.431 | 1.9682 | 8 | 96 | columnar/cuboidal epithelial cell differentiation |
| GO:0001947 | 8e-04 | 6.0692 | 1.1071 | 6 | 54 | heart looping |
| GO:0090287 | 9e-04 | 2.9707 | 4.6744 | 13 | 228 | regulation of cellular response to growth factor stimulus |
| GO:0021520 | 9e-04 | 20.7968 | 0.2037 | 3 | 10 | spinal cord motor neuron cell fate specification |
| GO:0001841 | 9e-04 | 4.3319 | 2.0092 | 8 | 98 | neural tube formation |
| GO:0032275 | 9e-04 | 20.6641 | 0.205 | 3 | 10 | luteinizing hormone secretion |
| GO:0051674 | 0.001 | 1.7444 | 27.1853 | 44 | 1326 | localization of cell |
| GO:0007399 | 0.001 | 1.8408 | 21.7423 | 37 | 1168 | nervous system development |
| GO:0060828 | 0.001 | 2.9292 | 4.7359 | 13 | 231 | regulation of canonical Wnt signaling pathway |
| GO:0048483 | 0.001 | 7.3401 | 0.7791 | 5 | 38 | autonomic nervous system development |
| GO:0010467 | 0.001 | 1.5533 | 60.2121 | 82 | 3287 | gene expression |
| GO:0008284 | 0.001 | 1.9554 | 16.3809 | 30 | 799 | positive regulation of cell proliferation |
| GO:0042733 | 0.001 | 5.7481 | 1.1614 | 6 | 57 | embryonic digit morphogenesis |
| GO:0009798 | 0.0011 | 4.7952 | 1.5991 | 7 | 78 | axis specification |
| GO:0001525 | 0.0011 | 2.3454 | 8.6107 | 19 | 420 | angiogenesis |
| GO:0042127 | 0.0011 | 2.0854 | 12.8102 | 25 | 657 | regulation of cell proliferation |
| GO:0060571 | 0.0011 | 10.1754 | 0.4715 | 4 | 23 | morphogenesis of an epithelial fold |
| GO:0060914 | 0.0011 | 10.1754 | 0.4715 | 4 | 23 | heart formation |
| GO:0035637 | 0.0012 | 3.2057 | 3.6698 | 11 | 179 | multicellular organismal signaling |
| GO:0045892 | 0.0012 | 2.6298 | 6.0751 | 15 | 319 | negative regulation of transcription, DNA-templated |
| GO:0021912 | 0.0012 | 96.1608 | 0.0615 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0035880 | 0.0012 | 96.1608 | 0.0615 | 2 | 3 | embryonic nail plate morphogenesis |
| GO:0044691 | 0.0012 | 96.1608 | 0.0615 | 2 | 3 | tooth eruption |
| GO:0060913 | 0.0012 | 96.1608 | 0.0615 | 2 | 3 | cardiac cell fate determination |
| GO:0060379 | 0.0012 | 18.0798 | 0.2255 | 3 | 11 | cardiac muscle cell myoblast differentiation |
| GO:0060536 | 0.0012 | 18.0798 | 0.2255 | 3 | 11 | cartilage morphogenesis |
| GO:0060573 | 0.0012 | 18.0798 | 0.2255 | 3 | 11 | cell fate specification involved in pattern specification |
| GO:0030326 | 0.0013 | 6.9216 | 0.8178 | 5 | 41 | embryonic limb morphogenesis |
| GO:0021511 | 0.0013 | 9.666 | 0.492 | 4 | 24 | spinal cord patterning |
| GO:0072089 | 0.0013 | 4.0596 | 2.1322 | 8 | 104 | stem cell proliferation |
| GO:0044238 | 0.0015 | 1.4501 | 194.582 | 220 | 9491 | primary metabolic process |
| GO:0097485 | 0.0015 | 2.9262 | 4.3669 | 12 | 213 | neuron projection guidance |
| GO:0061180 | 0.0015 | 5.2943 | 1.2506 | 6 | 61 | mammary gland epithelium development |
| GO:0045597 | 0.0015 | 1.9006 | 16.8114 | 30 | 820 | positive regulation of cell differentiation |
| GO:0006928 | 0.0016 | 1.6651 | 31.1317 | 48 | 1557 | movement of cell or subcellular component |
| GO:0060292 | 0.0016 | 9.2051 | 0.5125 | 4 | 25 | long term synaptic depression |
| GO:0060441 | 0.0016 | 9.2051 | 0.5125 | 4 | 25 | epithelial tube branching involved in lung morphogenesis |
| GO:0007368 | 0.0016 | 3.9358 | 2.1937 | 8 | 107 | determination of left/right symmetry |
| GO:0060291 | 0.0017 | 5.1994 | 1.2711 | 6 | 62 | long-term synaptic potentiation |
| GO:0048863 | 0.0017 | 2.7498 | 5.0229 | 13 | 245 | stem cell differentiation |
| GO:0035051 | 0.0017 | 3.5407 | 2.7267 | 9 | 133 | cardiocyte differentiation |
| GO:0048546 | 0.0018 | 8.8627 | 0.5286 | 4 | 26 | digestive tract morphogenesis |
| GO:0048706 | 0.0019 | 8.698 | 0.5354 | 4 | 27 | embryonic skeletal system development |
| GO:0007420 | 0.0019 | 2.0254 | 12.5676 | 24 | 613 | brain development |
| GO:0048333 | 0.002 | 14.6353 | 0.2635 | 3 | 13 | mesodermal cell differentiation |
| GO:0006837 | 0.0021 | 14.4619 | 0.2665 | 3 | 13 | serotonin transport |
| GO:0042074 | 0.0021 | 14.4619 | 0.2665 | 3 | 13 | cell migration involved in gastrulation |
| GO:0007422 | 0.0021 | 4.934 | 1.3326 | 6 | 65 | peripheral nervous system development |
| GO:0050905 | 0.0022 | 4.2004 | 1.8042 | 7 | 88 | neuromuscular process |
| GO:0009712 | 0.0022 | 6.0528 | 0.9226 | 5 | 45 | catechol-containing compound metabolic process |
| GO:0031018 | 0.0022 | 6.0528 | 0.9226 | 5 | 45 | endocrine pancreas development |
| GO:0086002 | 0.0022 | 6.0528 | 0.9226 | 5 | 45 | cardiac muscle cell action potential involved in contraction |
| GO:0000902 | 0.0022 | 1.8511 | 17.2215 | 30 | 840 | cell morphogenesis |
| GO:0003008 | 0.0023 | 1.5865 | 36.7186 | 54 | 1791 | system process |
| GO:0031175 | 0.0024 | 1.8631 | 16.5244 | 29 | 806 | neuron projection development |
| GO:0007188 | 0.0024 | 3.3499 | 2.8702 | 9 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0003164 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | His-Purkinje system development |
| GO:0021913 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0034287 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | detection of monosaccharide stimulus |
| GO:0042662 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0048105 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | establishment of body hair planar orientation |
| GO:0051594 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | detection of glucose |
| GO:0060214 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | endocardium formation |
| GO:0061030 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | epithelial cell differentiation involved in mammary gland alveolus development |
| GO:0061183 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | regulation of dermatome development |
| GO:0097070 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | ductus arteriosus closure |
| GO:0097476 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | spinal cord motor neuron migration |
| GO:1905903 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0007519 | 0.0025 | 3.3243 | 2.8907 | 9 | 141 | skeletal muscle tissue development |
| GO:0007517 | 0.0026 | 2.3438 | 7.2166 | 16 | 352 | muscle organ development |
| GO:0021527 | 0.0026 | 13.1463 | 0.287 | 3 | 14 | spinal cord association neuron differentiation |
| GO:0021794 | 0.0026 | 13.1463 | 0.287 | 3 | 14 | thalamus development |
| GO:0071625 | 0.0026 | 13.1463 | 0.287 | 3 | 14 | vocalization behavior |
| GO:0099054 | 0.0026 | 13.1463 | 0.287 | 3 | 14 | presynapse assembly |
| GO:0072164 | 0.0026 | 4.0496 | 1.8657 | 7 | 91 | mesonephric tubule development |
| GO:0035295 | 0.0028 | 2.4857 | 5.9577 | 14 | 309 | tube development |
| GO:0042330 | 0.0028 | 2.0619 | 10.7634 | 21 | 525 | taxis |
| GO:0021761 | 0.0028 | 4.0017 | 1.8862 | 7 | 92 | limbic system development |
| GO:0009799 | 0.0028 | 3.5723 | 2.3987 | 8 | 117 | specification of symmetry |
| GO:0035115 | 0.0031 | 7.4324 | 0.6151 | 4 | 30 | embryonic forelimb morphogenesis |
| GO:0003156 | 0.0032 | 12.1555 | 0.3049 | 3 | 15 | regulation of animal organ formation |
| GO:0007632 | 0.0032 | 5.501 | 1.0046 | 5 | 49 | visual behavior |
| GO:0086065 | 0.0032 | 5.501 | 1.0046 | 5 | 49 | cell communication involved in cardiac conduction |
| GO:0060579 | 0.0032 | 12.05 | 0.3075 | 3 | 15 | ventral spinal cord interneuron fate commitment |
| GO:0007215 | 0.0033 | 4.4768 | 1.4556 | 6 | 71 | glutamate receptor signaling pathway |
| GO:0001823 | 0.0034 | 3.8645 | 1.9477 | 7 | 95 | mesonephros development |
| GO:0048565 | 0.0035 | 4.4325 | 1.4675 | 6 | 73 | digestive tract development |
| GO:0010517 | 0.0035 | 5.3784 | 1.0251 | 5 | 50 | regulation of phospholipase activity |
| GO:0043009 | 0.0035 | 2.3331 | 6.7858 | 15 | 352 | chordate embryonic development |
| GO:0007626 | 0.0036 | 2.9223 | 3.6288 | 10 | 177 | locomotory behavior |
| GO:0010647 | 0.0036 | 1.5996 | 30.7526 | 46 | 1500 | positive regulation of cell communication |
| GO:0045165 | 0.0036 | 3.1324 | 3.0532 | 9 | 154 | cell fate commitment |
| GO:0023056 | 0.0038 | 1.5948 | 30.8346 | 46 | 1504 | positive regulation of signaling |
| GO:0001837 | 0.0038 | 3.3845 | 2.5217 | 8 | 123 | epithelial to mesenchymal transition |
| GO:0036342 | 0.0039 | 11.1223 | 0.328 | 3 | 16 | post-anal tail morphogenesis |
| GO:1904948 | 0.0039 | 11.1223 | 0.328 | 3 | 16 | midbrain dopaminergic neuron differentiation |
| GO:2000380 | 0.0039 | 11.1223 | 0.328 | 3 | 16 | regulation of mesoderm development |
| GO:0040019 | 0.004 | 6.9006 | 0.6561 | 4 | 32 | positive regulation of embryonic development |
| GO:0010040 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | response to iron(II) ion |
| GO:0010957 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | negative regulation of vitamin D biosynthetic process |
| GO:0045110 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | intermediate filament bundle assembly |
| GO:0060374 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | mast cell differentiation |
| GO:0060539 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | diaphragm development |
| GO:0071205 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | protein localization to juxtaparanode region of axon |
| GO:0090237 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | regulation of arachidonic acid secretion |
| GO:0043066 | 0.0041 | 1.8237 | 15.6428 | 27 | 763 | negative regulation of apoptotic process |
| GO:0007167 | 0.0042 | 1.7476 | 18.7796 | 31 | 916 | enzyme linked receptor protein signaling pathway |
| GO:0048519 | 0.0042 | 1.3802 | 94.964 | 117 | 4632 | negative regulation of biological process |
| GO:0016055 | 0.0044 | 2.1012 | 9.0208 | 18 | 440 | Wnt signaling pathway |
| GO:0072175 | 0.0044 | 3.2978 | 2.5832 | 8 | 126 | epithelial tube formation |
| GO:0098815 | 0.0044 | 6.6622 | 0.6766 | 4 | 33 | modulation of excitatory postsynaptic potential |
| GO:0120039 | 0.0046 | 1.9688 | 11.235 | 21 | 548 | plasma membrane bounded cell projection morphogenesis |
| GO:0045778 | 0.0046 | 4.1556 | 1.5581 | 6 | 76 | positive regulation of ossification |
| GO:0042053 | 0.0047 | 10.3272 | 0.3485 | 3 | 17 | regulation of dopamine metabolic process |
| GO:0044342 | 0.0047 | 10.3272 | 0.3485 | 3 | 17 | type B pancreatic cell proliferation |
| GO:0072074 | 0.0047 | 10.3272 | 0.3485 | 3 | 17 | kidney mesenchyme development |
| GO:0043279 | 0.0047 | 3.6163 | 2.0707 | 7 | 101 | response to alkaloid |
| GO:0001738 | 0.0049 | 3.2424 | 2.6242 | 8 | 128 | morphogenesis of a polarized epithelium |
| GO:0072073 | 0.0049 | 3.2424 | 2.6242 | 8 | 128 | kidney epithelium development |
| GO:0060548 | 0.0049 | 1.7601 | 17.406 | 29 | 849 | negative regulation of cell death |
| GO:0046189 | 0.0049 | 6.4397 | 0.6971 | 4 | 34 | phenol-containing compound biosynthetic process |
| GO:0086091 | 0.0049 | 6.4397 | 0.6971 | 4 | 34 | regulation of heart rate by cardiac conduction |
| GO:0099565 | 0.005 | 3.578 | 2.0912 | 7 | 102 | chemical synaptic transmission, postsynaptic |
| GO:0051090 | 0.005 | 2.2376 | 7.0526 | 15 | 344 | regulation of DNA binding transcription factor activity |
| GO:0060562 | 0.0051 | 4.8694 | 1.1185 | 5 | 57 | epithelial tube morphogenesis |
| GO:0050794 | 0.0054 | 1.4925 | 78.8282 | 96 | 4736 | regulation of cellular process |
| GO:0007417 | 0.0055 | 2.9285 | 3.2524 | 9 | 168 | central nervous system development |
| GO:0001755 | 0.0055 | 6.2315 | 0.7176 | 4 | 35 | neural crest cell migration |
| GO:0010464 | 0.0055 | 6.2315 | 0.7176 | 4 | 35 | regulation of mesenchymal cell proliferation |
| GO:0001759 | 0.0055 | 9.6381 | 0.369 | 3 | 18 | organ induction |
| GO:0010884 | 0.0055 | 9.6381 | 0.369 | 3 | 18 | positive regulation of lipid storage |
| GO:0023019 | 0.0055 | 9.6381 | 0.369 | 3 | 18 | signal transduction involved in regulation of gene expression |
| GO:0030318 | 0.0055 | 9.6381 | 0.369 | 3 | 18 | melanocyte differentiation |
| GO:0048148 | 0.0055 | 9.6381 | 0.369 | 3 | 18 | behavioral response to cocaine |
| GO:0048514 | 0.0057 | 3.9685 | 1.6238 | 6 | 82 | blood vessel morphogenesis |
| GO:0050804 | 0.0058 | 2.4515 | 5.152 | 12 | 254 | modulation of chemical synaptic transmission |
| GO:0035136 | 0.0058 | 24.3062 | 0.1217 | 2 | 6 | forelimb morphogenesis |
| GO:0065008 | 0.0059 | 1.4061 | 65.1545 | 84 | 3178 | regulation of biological quality |
| GO:0002069 | 0.006 | 24.0354 | 0.123 | 2 | 6 | columnar/cuboidal epithelial cell maturation |
| GO:0002318 | 0.006 | 24.0354 | 0.123 | 2 | 6 | myeloid progenitor cell differentiation |
| GO:0003402 | 0.006 | 24.0354 | 0.123 | 2 | 6 | planar cell polarity pathway involved in axis elongation |
| GO:0042297 | 0.006 | 24.0354 | 0.123 | 2 | 6 | vocal learning |
| GO:0060501 | 0.006 | 24.0354 | 0.123 | 2 | 6 | positive regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO:0050731 | 0.006 | 2.883 | 3.3008 | 9 | 161 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0018212 | 0.006 | 2.1899 | 7.1961 | 15 | 351 | peptidyl-tyrosine modification |
| GO:0071363 | 0.0061 | 2.1894 | 7.2013 | 15 | 361 | cellular response to growth factor stimulus |
| GO:0010470 | 0.0061 | 6.0364 | 0.7381 | 4 | 36 | regulation of gastrulation |
| GO:0040012 | 0.0062 | 1.7631 | 16.1349 | 27 | 787 | regulation of locomotion |
| GO:0009888 | 0.0064 | 2.5369 | 4.5736 | 11 | 254 | tissue development |
| GO:0051101 | 0.0065 | 3.398 | 2.1937 | 7 | 107 | regulation of DNA binding |
| GO:0034505 | 0.0065 | 9.0351 | 0.3895 | 3 | 19 | tooth mineralization |
| GO:0042423 | 0.0065 | 9.0351 | 0.3895 | 3 | 19 | catecholamine biosynthetic process |
| GO:0048557 | 0.0065 | 9.0351 | 0.3895 | 3 | 19 | embryonic digestive tract morphogenesis |
| GO:0050767 | 0.0065 | 1.846 | 13.1006 | 23 | 639 | regulation of neurogenesis |
| GO:0023061 | 0.0065 | 2.1117 | 7.9547 | 16 | 388 | signal release |
| GO:0006836 | 0.0065 | 2.8452 | 3.3418 | 9 | 163 | neurotransmitter transport |
| GO:0007268 | 0.0067 | 2.5193 | 4.5959 | 11 | 232 | chemical synaptic transmission |
| GO:0060349 | 0.0067 | 3.826 | 1.6811 | 6 | 82 | bone morphogenesis |
| GO:0060840 | 0.0067 | 3.826 | 1.6811 | 6 | 82 | artery development |
| GO:0032990 | 0.0068 | 1.8942 | 11.645 | 21 | 568 | cell part morphogenesis |
| GO:0030534 | 0.0068 | 3.3605 | 2.2159 | 7 | 109 | adult behavior |
| GO:0060675 | 0.0071 | 4.4793 | 1.2096 | 5 | 59 | ureteric bud morphogenesis |
| GO:1903115 | 0.0074 | 5.6806 | 0.7791 | 4 | 38 | regulation of actin filament-based movement |
| GO:0031290 | 0.0075 | 8.503 | 0.41 | 3 | 20 | retinal ganglion cell axon guidance |
| GO:0043586 | 0.0075 | 8.503 | 0.41 | 3 | 20 | tongue development |
| GO:0050951 | 0.0075 | 8.503 | 0.41 | 3 | 20 | sensory perception of temperature stimulus |
| GO:0072080 | 0.0075 | 3.7274 | 1.7221 | 6 | 84 | nephron tubule development |
| GO:0098655 | 0.0077 | 1.7703 | 14.8433 | 25 | 724 | cation transmembrane transport |
| GO:0003197 | 0.0081 | 5.5179 | 0.7996 | 4 | 39 | endocardial cushion development |
| GO:0022414 | 0.0082 | 1.5809 | 25.4222 | 38 | 1240 | reproductive process |
| GO:0055008 | 0.0082 | 4.3188 | 1.2506 | 5 | 61 | cardiac muscle tissue morphogenesis |
| GO:0001826 | 0.0082 | 19.227 | 0.1435 | 2 | 7 | inner cell mass cell differentiation |
| GO:0048341 | 0.0082 | 19.227 | 0.1435 | 2 | 7 | paraxial mesoderm formation |
| GO:0060028 | 0.0082 | 19.227 | 0.1435 | 2 | 7 | convergent extension involved in axis elongation |
| GO:0098597 | 0.0082 | 19.227 | 0.1435 | 2 | 7 | observational learning |
| GO:2000035 | 0.0082 | 19.227 | 0.1435 | 2 | 7 | regulation of stem cell division |
| GO:0050808 | 0.0083 | 2.4394 | 4.7359 | 11 | 231 | synapse organization |
| GO:0048522 | 0.0083 | 1.491 | 39.4151 | 54 | 2141 | positive regulation of cellular process |
| GO:0009966 | 0.0085 | 1.4063 | 56.0638 | 73 | 2764 | regulation of signal transduction |
| GO:0010842 | 0.0086 | 8.0301 | 0.4305 | 3 | 21 | retina layer formation |
| GO:0048103 | 0.0086 | 8.0301 | 0.4305 | 3 | 21 | somatic stem cell division |
| GO:0051953 | 0.0086 | 8.0301 | 0.4305 | 3 | 21 | negative regulation of amine transport |
| GO:0097120 | 0.0086 | 8.0301 | 0.4305 | 3 | 21 | receptor localization to synapse |
| GO:2000191 | 0.0086 | 8.0301 | 0.4305 | 3 | 21 | regulation of fatty acid transport |
| GO:0045596 | 0.0089 | 1.8458 | 11.9306 | 21 | 589 | negative regulation of cell differentiation |
| GO:0072210 | 0.0089 | 5.3643 | 0.8201 | 4 | 40 | metanephric nephron development |
| GO:0060541 | 0.0094 | 2.6706 | 3.5457 | 9 | 174 | respiratory system development |
| GO:0043303 | 0.0097 | 5.2189 | 0.8406 | 4 | 41 | mast cell degranulation |
| GO:0048701 | 0.0097 | 5.2189 | 0.8406 | 4 | 41 | embryonic cranial skeleton morphogenesis |
| GO:0048705 | 0.0098 | 5.1904 | 0.8422 | 4 | 43 | skeletal system morphogenesis |
| GO:0048169 | 0.0098 | 7.607 | 0.451 | 3 | 22 | regulation of long-term neuronal synaptic plasticity |
| GO:0051354 | 0.0098 | 7.607 | 0.451 | 3 | 22 | negative regulation of oxidoreductase activity |
| GO:2000679 | 0.0098 | 7.607 | 0.451 | 3 | 22 | positive regulation of transcription regulatory region DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 246.5126 | 0.4731 | 24 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 143.7512 | 0.5494 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 90.7479 | 0.6563 | 24 | 43 | protein heterotetramerization |
| GO:0006323 | 0 | 16.3724 | 2.7929 | 33 | 183 | DNA packaging |
| GO:0045815 | 0 | 31.8554 | 1.1904 | 24 | 78 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 24.2983 | 1.5109 | 25 | 99 | regulation of gene silencing by miRNA |
| GO:0045653 | 0 | 320.2953 | 0.2594 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0071824 | 0 | 12.1783 | 3.6933 | 34 | 242 | protein-DNA complex subunit organization |
| GO:1902036 | 0 | 22.6009 | 1.5262 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0060968 | 0 | 18.7024 | 1.8467 | 25 | 121 | regulation of gene silencing |
| GO:0035194 | 0 | 9.1483 | 4.1054 | 30 | 269 | posttranscriptional gene silencing by RNA |
| GO:0032200 | 0 | 13.0637 | 2.3656 | 24 | 155 | telomere organization |
| GO:0002244 | 0 | 11.3163 | 2.7929 | 25 | 183 | hematopoietic progenitor cell differentiation |
| GO:0034080 | 0 | 36.9006 | 0.6105 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 34.2603 | 0.641 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0006333 | 0 | 14.5938 | 1.6694 | 19 | 116 | chromatin assembly or disassembly |
| GO:0016233 | 0 | 26.6327 | 0.7631 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 26.6327 | 0.7631 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0017148 | 0 | 6.7095 | 5.4026 | 30 | 354 | negative regulation of translation |
| GO:0034622 | 0 | 4.0843 | 14.4375 | 48 | 946 | cellular macromolecular complex assembly |
| GO:0051259 | 0 | 5.4621 | 7.4782 | 34 | 490 | protein oligomerization |
| GO:0048863 | 0 | 7.6969 | 3.7391 | 24 | 245 | stem cell differentiation |
| GO:0006303 | 0 | 18.4183 | 1.0073 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 0 | 16.2255 | 1.1141 | 14 | 73 | ATP-dependent chromatin remodeling |
| GO:0030099 | 0 | 5.5621 | 5.4637 | 26 | 358 | myeloid cell differentiation |
| GO:0038111 | 0 | 25.8848 | 0.5494 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 25.8848 | 0.5494 | 10 | 36 | response to interleukin-7 |
| GO:1903507 | 0 | 3.355 | 16.3758 | 46 | 1073 | negative regulation of nucleic acid-templated transcription |
| GO:0034248 | 0 | 4.3146 | 8.6534 | 32 | 567 | regulation of cellular amide metabolic process |
| GO:1903707 | 0 | 9.1673 | 1.9382 | 15 | 127 | negative regulation of hemopoiesis |
| GO:0051253 | 0 | 3.116 | 17.4899 | 46 | 1146 | negative regulation of RNA metabolic process |
| GO:0010608 | 0 | 3.836 | 9.9659 | 33 | 653 | posttranscriptional regulation of gene expression |
| GO:0006342 | 0 | 15.1182 | 0.9057 | 11 | 66 | chromatin silencing |
| GO:0045652 | 0 | 16.2973 | 0.7755 | 10 | 54 | regulation of megakaryocyte differentiation |
| GO:0010558 | 0 | 2.7608 | 22.4194 | 52 | 1469 | negative regulation of macromolecule biosynthetic process |
| GO:0043043 | 0 | 3.3385 | 12.072 | 35 | 791 | peptide biosynthetic process |
| GO:0031327 | 0 | 2.6076 | 23.564 | 52 | 1544 | negative regulation of cellular biosynthetic process |
| GO:0070271 | 0 | 2.6706 | 20.0538 | 46 | 1314 | protein complex biogenesis |
| GO:0071822 | 0 | 2.285 | 23.564 | 47 | 1544 | protein complex subunit organization |
| GO:0006334 | 0 | 8.0052 | 1.2757 | 9 | 93 | nucleosome assembly |
| GO:0002227 | 0 | 25.3391 | 0.2747 | 5 | 18 | innate immune response in mucosa |
| GO:0040029 | 0 | 3.9552 | 4.7472 | 17 | 345 | regulation of gene expression, epigenetic |
| GO:0048534 | 0 | 2.708 | 12.3314 | 30 | 808 | hematopoietic or lymphoid organ development |
| GO:0006352 | 0 | 4.4909 | 3.4339 | 14 | 225 | DNA-templated transcription, initiation |
| GO:0006355 | 0 | 1.8632 | 49.982 | 78 | 3275 | regulation of transcription, DNA-templated |
| GO:2001141 | 0 | 1.8434 | 50.3941 | 78 | 3302 | regulation of RNA biosynthetic process |
| GO:0022607 | 1e-04 | 1.8553 | 39.1615 | 63 | 2566 | cellular component assembly |
| GO:0002251 | 1e-04 | 14.3125 | 0.4273 | 5 | 28 | organ or tissue specific immune response |
| GO:0060249 | 1e-04 | 3.2956 | 5.2653 | 16 | 345 | anatomical structure homeostasis |
| GO:0051248 | 1e-04 | 2.1435 | 18.5735 | 36 | 1217 | negative regulation of protein metabolic process |
| GO:0019219 | 1e-04 | 1.7049 | 58.2996 | 84 | 3820 | regulation of nucleobase-containing compound metabolic process |
| GO:0019731 | 2e-04 | 11.3468 | 0.5189 | 5 | 34 | antibacterial humoral response |
| GO:0051276 | 2e-04 | 2.3274 | 12.7237 | 27 | 920 | chromosome organization |
| GO:0009889 | 2e-04 | 1.6493 | 63.0612 | 88 | 4132 | regulation of biosynthetic process |
| GO:0034654 | 3e-04 | 1.6364 | 59.2458 | 83 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:0061844 | 5e-04 | 8.6542 | 0.6563 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0006281 | 5e-04 | 2.6115 | 7.4019 | 18 | 485 | DNA repair |
| GO:1903706 | 0.001 | 3.0685 | 4.1757 | 12 | 290 | regulation of hemopoiesis |
| GO:0090304 | 0.001 | 1.5368 | 71.5467 | 94 | 4688 | nucleic acid metabolic process |
| GO:0010467 | 0.0013 | 1.5183 | 75.7132 | 98 | 4961 | gene expression |
| GO:0050830 | 0.0014 | 5.3435 | 1.2209 | 6 | 80 | defense response to Gram-positive bacterium |
| GO:0034645 | 0.002 | 1.4974 | 71.9283 | 93 | 4713 | cellular macromolecule biosynthetic process |
| GO:0045596 | 0.0022 | 2.2047 | 9.1723 | 19 | 601 | negative regulation of cell differentiation |
| GO:0034641 | 0.004 | 1.4334 | 91.7379 | 112 | 6011 | cellular nitrogen compound metabolic process |
| GO:0006725 | 0.0048 | 1.4271 | 83.4814 | 103 | 5470 | cellular aromatic compound metabolic process |
| GO:1901360 | 0.0051 | 1.4218 | 86.4879 | 106 | 5667 | organic cyclic compound metabolic process |
| GO:0009892 | 0.0052 | 1.5211 | 41.1455 | 57 | 2696 | negative regulation of metabolic process |
| GO:0002376 | 0.0054 | 1.5355 | 37.7269 | 53 | 2472 | immune system process |
| GO:0046483 | 0.0058 | 1.4151 | 82.993 | 102 | 5438 | heterocycle metabolic process |
| GO:0014888 | 0.0065 | 5.8181 | 0.7478 | 4 | 49 | striated muscle adaptation |
| GO:0060045 | 0.0087 | 7.8308 | 0.4273 | 3 | 28 | positive regulation of cardiac muscle cell proliferation |
| GO:0050793 | 0.0096 | 1.5126 | 33.5604 | 47 | 2199 | regulation of developmental process |
| GO:0000098 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | sulfur amino acid catabolic process |
| GO:0014819 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | regulation of skeletal muscle contraction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 242.9757 | 0.4792 | 24 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 141.6887 | 0.5565 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 89.4459 | 0.6647 | 24 | 43 | protein heterotetramerization |
| GO:0045653 | 0 | 510.0339 | 0.2628 | 15 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0045815 | 0 | 31.3983 | 1.2057 | 24 | 78 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 23.9481 | 1.5304 | 25 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 23.6272 | 1.5458 | 25 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0031497 | 0 | 17.4602 | 2.2105 | 28 | 143 | chromatin assembly |
| GO:0045814 | 0 | 20.3265 | 1.8086 | 26 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 18.4328 | 1.8704 | 25 | 121 | regulation of gene silencing |
| GO:0032200 | 0 | 14.3024 | 2.396 | 26 | 155 | telomere organization |
| GO:0065004 | 0 | 10.9222 | 3.2617 | 28 | 211 | protein-DNA complex assembly |
| GO:0034080 | 0 | 40.7403 | 0.6183 | 15 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 37.7174 | 0.6492 | 15 | 42 | beta-catenin-TCF complex assembly |
| GO:0002244 | 0 | 11.1532 | 2.8288 | 25 | 183 | hematopoietic progenitor cell differentiation |
| GO:0030099 | 0 | 7.3558 | 5.534 | 33 | 358 | myeloid cell differentiation |
| GO:0071103 | 0 | 8.7791 | 3.9418 | 28 | 255 | DNA conformation change |
| GO:0034724 | 0 | 29.0808 | 0.7729 | 15 | 50 | DNA replication-independent nucleosome organization |
| GO:0048863 | 0 | 8.7782 | 3.7873 | 27 | 245 | stem cell differentiation |
| GO:0016233 | 0 | 26.2675 | 0.7729 | 14 | 50 | telomere capping |
| GO:0035194 | 0 | 7.5345 | 4.1582 | 26 | 269 | posttranscriptional gene silencing by RNA |
| GO:0017148 | 0 | 6.3393 | 5.4722 | 29 | 354 | negative regulation of translation |
| GO:0043044 | 0 | 17.5218 | 1.1284 | 15 | 73 | ATP-dependent chromatin remodeling |
| GO:0006303 | 0 | 18.1658 | 1.0202 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:1903707 | 0 | 10.5296 | 1.9632 | 17 | 127 | negative regulation of hemopoiesis |
| GO:0038111 | 0 | 25.5361 | 0.5565 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 25.5361 | 0.5565 | 10 | 36 | response to interleukin-7 |
| GO:1902679 | 0 | 3.2979 | 16.6021 | 46 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0045892 | 0 | 3.32 | 16.092 | 45 | 1041 | negative regulation of transcription, DNA-templated |
| GO:0045934 | 0 | 3.0795 | 19.8792 | 51 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0034728 | 0 | 11.3281 | 1.4959 | 14 | 103 | nucleosome organization |
| GO:0048534 | 0 | 3.5545 | 12.4902 | 38 | 808 | hematopoietic or lymphoid organ development |
| GO:0051259 | 0 | 4.245 | 7.5745 | 28 | 490 | protein oligomerization |
| GO:0034248 | 0 | 3.9307 | 8.7648 | 30 | 567 | regulation of cellular amide metabolic process |
| GO:0045652 | 0 | 16.1407 | 0.7826 | 10 | 54 | regulation of megakaryocyte differentiation |
| GO:0010608 | 0 | 3.6399 | 10.0942 | 32 | 653 | posttranscriptional regulation of gene expression |
| GO:0051252 | 0 | 2.1989 | 53.7326 | 92 | 3476 | regulation of RNA metabolic process |
| GO:0006352 | 0 | 5.913 | 3.4781 | 18 | 225 | DNA-templated transcription, initiation |
| GO:0051239 | 0 | 2.2809 | 39.913 | 74 | 2582 | regulation of multicellular organismal process |
| GO:1903506 | 0 | 2.1519 | 50.9347 | 87 | 3295 | regulation of nucleic acid-templated transcription |
| GO:0045596 | 0 | 3.5414 | 9.2904 | 29 | 601 | negative regulation of cell differentiation |
| GO:0009890 | 0 | 2.5343 | 24.1148 | 52 | 1560 | negative regulation of biosynthetic process |
| GO:0043043 | 0 | 3.061 | 12.2274 | 33 | 791 | peptide biosynthetic process |
| GO:0034654 | 0 | 2.0005 | 60.0086 | 95 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:2000112 | 0 | 1.9496 | 58.772 | 92 | 3802 | regulation of cellular macromolecule biosynthetic process |
| GO:1903706 | 0 | 4.2133 | 4.1948 | 16 | 290 | regulation of hemopoiesis |
| GO:0060249 | 0 | 3.7128 | 5.3331 | 18 | 345 | anatomical structure homeostasis |
| GO:0048869 | 0 | 1.8396 | 58.9111 | 89 | 3811 | cellular developmental process |
| GO:0010604 | 0 | 1.9259 | 42.8192 | 70 | 2770 | positive regulation of macromolecule metabolic process |
| GO:0009059 | 0 | 1.7148 | 74.7557 | 104 | 4836 | macromolecule biosynthetic process |
| GO:0048731 | 1e-04 | 1.7527 | 58.3903 | 85 | 3931 | system development |
| GO:0044249 | 1e-04 | 1.6774 | 88.6063 | 118 | 5732 | cellular biosynthetic process |
| GO:0002376 | 2e-04 | 1.7836 | 38.2126 | 60 | 2472 | immune system process |
| GO:0065003 | 2e-04 | 1.917 | 25.4905 | 44 | 1649 | macromolecular complex assembly |
| GO:0090304 | 3e-04 | 1.6154 | 72.4679 | 98 | 4688 | nucleic acid metabolic process |
| GO:0070271 | 3e-04 | 2.0026 | 20.312 | 37 | 1314 | protein complex biogenesis |
| GO:0051248 | 3e-04 | 2.0402 | 18.8126 | 35 | 1217 | negative regulation of protein metabolic process |
| GO:0007596 | 3e-04 | 3.2056 | 4.6993 | 14 | 304 | blood coagulation |
| GO:1901360 | 4e-04 | 1.5676 | 87.6015 | 113 | 5667 | organic cyclic compound metabolic process |
| GO:0007218 | 6e-04 | 5.3749 | 1.4222 | 7 | 92 | neuropeptide signaling pathway |
| GO:0065008 | 8e-04 | 1.6729 | 40.5775 | 60 | 2734 | regulation of biological quality |
| GO:0046483 | 8e-04 | 1.5357 | 84.0616 | 108 | 5438 | heterocycle metabolic process |
| GO:0080090 | 8e-04 | 1.5347 | 85.02 | 109 | 5500 | regulation of primary metabolic process |
| GO:0006725 | 0.001 | 1.5215 | 84.5562 | 108 | 5470 | cellular aromatic compound metabolic process |
| GO:0007268 | 0.0011 | 2.3587 | 8.6102 | 19 | 557 | chemical synaptic transmission |
| GO:0045595 | 0.0011 | 2.073 | 13.592 | 26 | 963 | regulation of cell differentiation |
| GO:0099537 | 0.0011 | 2.3541 | 8.6257 | 19 | 558 | trans-synaptic signaling |
| GO:0060535 | 0.0014 | 64.2265 | 0.0618 | 2 | 4 | trachea cartilage morphogenesis |
| GO:0071651 | 0.0014 | 64.2265 | 0.0618 | 2 | 4 | positive regulation of chemokine (C-C motif) ligand 5 production |
| GO:0072268 | 0.0014 | 64.2265 | 0.0618 | 2 | 4 | pattern specification involved in metanephros development |
| GO:0001662 | 0.0014 | 9.2383 | 0.4947 | 4 | 32 | behavioral fear response |
| GO:0072001 | 0.0014 | 3.1177 | 3.7574 | 11 | 245 | renal system development |
| GO:0006281 | 0.0015 | 2.4155 | 7.4972 | 17 | 485 | DNA repair |
| GO:0050878 | 0.0015 | 2.4814 | 6.8634 | 16 | 444 | regulation of body fluid levels |
| GO:0001819 | 0.0016 | 2.6452 | 5.6268 | 14 | 364 | positive regulation of cytokine production |
| GO:0009914 | 0.0018 | 2.8534 | 4.4674 | 12 | 289 | hormone transport |
| GO:0060008 | 0.0021 | 13.8109 | 0.2628 | 3 | 17 | Sertoli cell differentiation |
| GO:0045666 | 0.0024 | 2.7619 | 4.6065 | 12 | 298 | positive regulation of neuron differentiation |
| GO:0032268 | 0.0025 | 1.6003 | 37.1769 | 54 | 2405 | regulation of cellular protein metabolic process |
| GO:0051716 | 0.0025 | 1.4582 | 99.257 | 121 | 6421 | cellular response to stimulus |
| GO:0060438 | 0.0025 | 12.8893 | 0.2782 | 3 | 18 | trachea development |
| GO:1900120 | 0.0025 | 12.8893 | 0.2782 | 3 | 18 | regulation of receptor binding |
| GO:0071822 | 0.0026 | 1.7236 | 23.8674 | 38 | 1544 | protein complex subunit organization |
| GO:0019932 | 0.0027 | 2.8557 | 4.081 | 11 | 264 | second-messenger-mediated signaling |
| GO:0048519 | 0.0029 | 1.4978 | 62.701 | 82 | 4186 | negative regulation of biological process |
| GO:0023061 | 0.0029 | 2.4714 | 5.9978 | 14 | 388 | signal release |
| GO:0048518 | 0.0034 | 1.5315 | 51.4074 | 69 | 3520 | positive regulation of biological process |
| GO:0002793 | 0.0034 | 2.9382 | 3.6018 | 10 | 233 | positive regulation of peptide secretion |
| GO:0072073 | 0.0038 | 3.7666 | 1.9786 | 7 | 128 | kidney epithelium development |
| GO:0010468 | 0.0042 | 1.5192 | 49.0852 | 66 | 3512 | regulation of gene expression |
| GO:0034641 | 0.0046 | 1.4226 | 92.9191 | 113 | 6011 | cellular nitrogen compound metabolic process |
| GO:0060986 | 0.0047 | 6.4616 | 0.6802 | 4 | 44 | endocrine hormone secretion |
| GO:0031666 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0034127 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | regulation of MyD88-independent toll-like receptor signaling pathway |
| GO:0035385 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | Roundabout signaling pathway |
| GO:0048007 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:0050957 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | equilibrioception |
| GO:0060290 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | transdifferentiation |
| GO:0002761 | 0.0048 | 4.1014 | 1.5613 | 6 | 101 | regulation of myeloid leukocyte differentiation |
| GO:0009611 | 0.0049 | 2.0834 | 9.1358 | 18 | 591 | response to wounding |
| GO:0002067 | 0.005 | 6.3036 | 0.6956 | 4 | 45 | glandular epithelial cell differentiation |
| GO:0060384 | 0.0051 | 9.6637 | 0.3555 | 3 | 23 | innervation |
| GO:1903532 | 0.0052 | 2.4866 | 5.0857 | 12 | 329 | positive regulation of secretion by cell |
| GO:0051384 | 0.0057 | 3.4768 | 2.1332 | 7 | 138 | response to glucocorticoid |
| GO:0015824 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | proline transport |
| GO:0070445 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | regulation of oligodendrocyte progenitor proliferation |
| GO:0090557 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | establishment of endothelial intestinal barrier |
| GO:2000252 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | negative regulation of feeding behavior |
| GO:2000833 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | positive regulation of steroid hormone secretion |
| GO:0006357 | 0.0063 | 1.5967 | 27.6701 | 41 | 1790 | regulation of transcription from RNA polymerase II promoter |
| GO:0048588 | 0.0063 | 3.0856 | 2.7361 | 8 | 177 | developmental cell growth |
| GO:0048791 | 0.0065 | 8.784 | 0.3865 | 3 | 25 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0071345 | 0.0075 | 1.8557 | 12.5366 | 22 | 811 | cellular response to cytokine stimulus |
| GO:0001714 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | endodermal cell fate specification |
| GO:0002024 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | diet induced thermogenesis |
| GO:0010579 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
| GO:0072048 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | renal system pattern specification |
| GO:0007166 | 0.0081 | 1.5024 | 37.6148 | 52 | 2453 | cell surface receptor signaling pathway |
| GO:0030816 | 0.0084 | 4.2592 | 1.2521 | 5 | 81 | positive regulation of cAMP metabolic process |
| GO:0051966 | 0.0084 | 5.3818 | 0.8038 | 4 | 52 | regulation of synaptic transmission, glutamatergic |
| GO:0090276 | 0.0087 | 2.9113 | 2.8907 | 8 | 187 | regulation of peptide hormone secretion |
| GO:0010647 | 0.0089 | 1.6124 | 23.1873 | 35 | 1500 | positive regulation of cell communication |
| GO:0048265 | 0.009 | 7.7284 | 0.4328 | 3 | 28 | response to pain |
| GO:0023056 | 0.0092 | 1.6076 | 23.2491 | 35 | 1504 | positive regulation of signaling |
| GO:0006351 | 0.0093 | 1.5553 | 30.2521 | 43 | 2242 | transcription, DNA-templated |
| GO:0002250 | 0.0094 | 2.3925 | 4.823 | 11 | 312 | adaptive immune response |
| GO:0051051 | 0.0097 | 2.1312 | 6.8943 | 14 | 446 | negative regulation of transport |
| GO:0002475 | 0.0099 | 16.0502 | 0.1546 | 2 | 10 | antigen processing and presentation via MHC class Ib |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 246.5126 | 0.4731 | 24 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 143.7512 | 0.5494 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 90.7479 | 0.6563 | 24 | 43 | protein heterotetramerization |
| GO:0045815 | 0 | 31.8554 | 1.1904 | 24 | 78 | positive regulation of gene expression, epigenetic |
| GO:0006323 | 0 | 15.0255 | 2.7929 | 31 | 183 | DNA packaging |
| GO:0045653 | 0 | 320.2953 | 0.2594 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0060964 | 0 | 22.9037 | 1.5109 | 24 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 22.6009 | 1.5262 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0060968 | 0 | 17.683 | 1.8467 | 24 | 121 | regulation of gene silencing |
| GO:0071824 | 0 | 10.7811 | 3.6933 | 31 | 242 | protein-DNA complex subunit organization |
| GO:0032200 | 0 | 14.5126 | 2.3656 | 26 | 155 | telomere organization |
| GO:0002244 | 0 | 11.3163 | 2.7929 | 25 | 183 | hematopoietic progenitor cell differentiation |
| GO:0048863 | 0 | 9.3262 | 3.7391 | 28 | 245 | stem cell differentiation |
| GO:0034080 | 0 | 36.9006 | 0.6105 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 34.2603 | 0.641 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0016233 | 0 | 26.6327 | 0.7631 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 26.6327 | 0.7631 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0035194 | 0 | 7.2854 | 4.1054 | 25 | 269 | posttranscriptional gene silencing by RNA |
| GO:0006333 | 0 | 12.6654 | 1.6694 | 17 | 116 | chromatin assembly or disassembly |
| GO:0006303 | 0 | 18.4183 | 1.0073 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0030099 | 0 | 6.0859 | 5.4637 | 28 | 358 | myeloid cell differentiation |
| GO:0043044 | 0 | 16.2255 | 1.1141 | 14 | 73 | ATP-dependent chromatin remodeling |
| GO:0017148 | 0 | 5.6315 | 5.4026 | 26 | 354 | negative regulation of translation |
| GO:0038111 | 0 | 25.8848 | 0.5494 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 25.8848 | 0.5494 | 10 | 36 | response to interleukin-7 |
| GO:1903707 | 0 | 9.1673 | 1.9382 | 15 | 127 | negative regulation of hemopoiesis |
| GO:0051259 | 0 | 4.3081 | 7.4782 | 28 | 490 | protein oligomerization |
| GO:0045652 | 0 | 16.2973 | 0.7755 | 10 | 54 | regulation of megakaryocyte differentiation |
| GO:0034622 | 0 | 3.1312 | 14.4375 | 39 | 946 | cellular macromolecular complex assembly |
| GO:0034248 | 0 | 3.6731 | 8.6534 | 28 | 567 | regulation of cellular amide metabolic process |
| GO:0006352 | 0 | 5.6099 | 3.4339 | 17 | 225 | DNA-templated transcription, initiation |
| GO:0048534 | 0 | 3.0358 | 12.3314 | 33 | 808 | hematopoietic or lymphoid organ development |
| GO:1903507 | 0 | 2.7219 | 16.3758 | 39 | 1073 | negative regulation of nucleic acid-templated transcription |
| GO:0051253 | 0 | 2.61 | 17.4899 | 40 | 1146 | negative regulation of RNA metabolic process |
| GO:0051248 | 0 | 2.5164 | 18.5735 | 41 | 1217 | negative regulation of protein metabolic process |
| GO:0006281 | 0 | 3.4545 | 7.4019 | 23 | 485 | DNA repair |
| GO:0010608 | 0 | 3.0167 | 9.9659 | 27 | 653 | posttranscriptional regulation of gene expression |
| GO:0006996 | 0 | 1.9294 | 51.6455 | 82 | 3384 | organelle organization |
| GO:0045596 | 0 | 3.0169 | 9.1723 | 25 | 601 | negative regulation of cell differentiation |
| GO:0002227 | 0 | 25.3391 | 0.2747 | 5 | 18 | innate immune response in mucosa |
| GO:0060249 | 0 | 3.7654 | 5.2653 | 18 | 345 | anatomical structure homeostasis |
| GO:0043043 | 0 | 2.5547 | 12.072 | 28 | 791 | peptide biosynthetic process |
| GO:0006342 | 0 | 8.7885 | 0.9057 | 7 | 66 | chromatin silencing |
| GO:0031327 | 0 | 2.1005 | 23.564 | 44 | 1544 | negative regulation of cellular biosynthetic process |
| GO:0010558 | 0 | 2.0968 | 22.4194 | 42 | 1469 | negative regulation of macromolecule biosynthetic process |
| GO:0002251 | 1e-04 | 14.3125 | 0.4273 | 5 | 28 | organ or tissue specific immune response |
| GO:0051239 | 1e-04 | 1.8412 | 39.4056 | 63 | 2582 | regulation of multicellular organismal process |
| GO:0010604 | 1e-04 | 1.7635 | 42.2748 | 65 | 2770 | positive regulation of macromolecule metabolic process |
| GO:0019731 | 2e-04 | 11.3468 | 0.5189 | 5 | 34 | antibacterial humoral response |
| GO:0070271 | 2e-04 | 2.0337 | 20.0538 | 37 | 1314 | protein complex biogenesis |
| GO:0048731 | 2e-04 | 1.6505 | 63.8701 | 89 | 4185 | system development |
| GO:0071840 | 2e-04 | 1.6023 | 86.6558 | 113 | 5678 | cellular component organization or biogenesis |
| GO:0006334 | 3e-04 | 6.0204 | 1.2757 | 7 | 93 | nucleosome assembly |
| GO:2001141 | 3e-04 | 1.668 | 50.3941 | 73 | 3302 | regulation of RNA biosynthetic process |
| GO:0002376 | 4e-04 | 1.7327 | 37.7269 | 58 | 2472 | immune system process |
| GO:0009892 | 4e-04 | 1.7069 | 41.1455 | 62 | 2696 | negative regulation of metabolic process |
| GO:0006355 | 4e-04 | 1.6519 | 49.982 | 72 | 3275 | regulation of transcription, DNA-templated |
| GO:0061844 | 5e-04 | 8.6542 | 0.6563 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0071822 | 6e-04 | 1.8645 | 23.564 | 40 | 1544 | protein complex subunit organization |
| GO:0003285 | 7e-04 | 130.1558 | 0.0458 | 2 | 3 | septum secundum development |
| GO:0019249 | 7e-04 | 130.1558 | 0.0458 | 2 | 3 | lactate biosynthetic process |
| GO:0042126 | 7e-04 | 130.1558 | 0.0458 | 2 | 3 | nitrate metabolic process |
| GO:0048869 | 8e-04 | 1.584 | 58.1622 | 80 | 3811 | cellular developmental process |
| GO:0007596 | 8e-04 | 2.9937 | 4.6395 | 13 | 304 | blood coagulation |
| GO:0022607 | 0.001 | 1.6553 | 39.1615 | 58 | 2566 | cellular component assembly |
| GO:0032268 | 0.0011 | 1.6678 | 36.7043 | 55 | 2405 | regulation of cellular protein metabolic process |
| GO:0050878 | 0.0013 | 2.5162 | 6.7762 | 16 | 444 | regulation of body fluid levels |
| GO:0034654 | 0.0014 | 1.5447 | 59.2458 | 80 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:0045595 | 0.0021 | 2.0589 | 12.0202 | 23 | 867 | regulation of cell differentiation |
| GO:0019219 | 0.0022 | 1.5186 | 58.2996 | 78 | 3820 | regulation of nucleobase-containing compound metabolic process |
| GO:0051410 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | detoxification of nitrogen compound |
| GO:0051891 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:1902961 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
| GO:0055001 | 0.0028 | 3.552 | 2.3961 | 8 | 157 | muscle cell development |
| GO:0021902 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0032808 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | lacrimal gland development |
| GO:0061061 | 0.0037 | 2.144 | 8.8976 | 18 | 583 | muscle structure development |
| GO:1902991 | 0.0038 | 10.8812 | 0.3205 | 3 | 21 | regulation of amyloid precursor protein catabolic process |
| GO:0009611 | 0.0042 | 2.1129 | 9.0197 | 18 | 591 | response to wounding |
| GO:0021796 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | cerebral cortex regionalization |
| GO:0043652 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | engulfment of apoptotic cell |
| GO:1905245 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | regulation of aspartic-type peptidase activity |
| GO:0009889 | 0.0056 | 1.4448 | 63.0612 | 81 | 4132 | regulation of biosynthetic process |
| GO:0051147 | 0.0073 | 3.0016 | 2.8081 | 8 | 184 | regulation of muscle cell differentiation |
| GO:0050830 | 0.0075 | 4.374 | 1.2209 | 5 | 80 | defense response to Gram-positive bacterium |
| GO:0006089 | 0.0077 | 18.7473 | 0.1362 | 2 | 9 | lactate metabolic process |
| GO:0008354 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | germ cell migration |
| GO:0051639 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | actin filament network formation |
| GO:1903706 | 0.0094 | 2.5141 | 4.1757 | 10 | 290 | regulation of hemopoiesis |
| GO:0051764 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | actin crosslink formation |
| GO:1902004 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | positive regulation of amyloid-beta formation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 32.0585 | 0.4731 | 10 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0051290 | 0 | 23.2294 | 0.6563 | 11 | 43 | protein heterotetramerization |
| GO:0000183 | 0 | 25.8848 | 0.5494 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 25.8848 | 0.5494 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 25.8848 | 0.5494 | 10 | 36 | response to interleukin-7 |
| GO:0006333 | 0 | 7.8624 | 2.5334 | 17 | 166 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 7.0492 | 2.7929 | 17 | 183 | DNA packaging |
| GO:0045652 | 0 | 12.3659 | 1.0836 | 11 | 71 | regulation of megakaryocyte differentiation |
| GO:0071824 | 0 | 5.1801 | 3.6933 | 17 | 242 | protein-DNA complex subunit organization |
| GO:0045814 | 0 | 7.7202 | 1.7856 | 12 | 117 | negative regulation of gene expression, epigenetic |
| GO:0045815 | 0 | 9.8694 | 1.1904 | 10 | 78 | positive regulation of gene expression, epigenetic |
| GO:0002244 | 0 | 5.6229 | 2.7929 | 14 | 183 | hematopoietic progenitor cell differentiation |
| GO:0007596 | 0 | 4.3172 | 4.6395 | 18 | 304 | blood coagulation |
| GO:0050878 | 0 | 3.6103 | 6.7762 | 22 | 444 | regulation of body fluid levels |
| GO:0060964 | 0 | 7.5301 | 1.5109 | 10 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 7.4459 | 1.5262 | 10 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0002251 | 0 | 18.036 | 0.4273 | 6 | 28 | organ or tissue specific immune response |
| GO:0002227 | 0 | 25.3391 | 0.2747 | 5 | 18 | innate immune response in mucosa |
| GO:0048534 | 0 | 2.708 | 12.3314 | 30 | 808 | hematopoietic or lymphoid organ development |
| GO:0002376 | 0 | 1.9856 | 37.7269 | 64 | 2472 | immune system process |
| GO:0060968 | 0 | 6.0288 | 1.8467 | 10 | 121 | regulation of gene silencing |
| GO:1903706 | 0 | 3.265 | 6.3641 | 19 | 417 | regulation of hemopoiesis |
| GO:0061844 | 0 | 10.7134 | 0.6563 | 6 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0048863 | 1e-04 | 3.7701 | 3.7391 | 13 | 245 | stem cell differentiation |
| GO:0030099 | 1e-04 | 3.1675 | 5.4637 | 16 | 358 | myeloid cell differentiation |
| GO:0032200 | 1e-04 | 4.6046 | 2.3656 | 10 | 155 | telomere organization |
| GO:0019731 | 2e-04 | 11.3468 | 0.5189 | 5 | 34 | antibacterial humoral response |
| GO:0034622 | 3e-04 | 2.1885 | 14.4375 | 29 | 946 | cellular macromolecular complex assembly |
| GO:0009611 | 3e-04 | 2.5136 | 9.0197 | 21 | 591 | response to wounding |
| GO:0006334 | 4e-04 | 5.6249 | 1.3612 | 7 | 93 | nucleosome assembly |
| GO:0002215 | 7e-04 | 130.1558 | 0.0458 | 2 | 3 | defense response to nematode |
| GO:0016339 | 7e-04 | 11.4 | 0.4121 | 4 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0002369 | 0.0011 | 10.0826 | 0.4579 | 4 | 30 | T cell cytokine production |
| GO:0048486 | 0.0011 | 17.8138 | 0.2137 | 3 | 14 | parasympathetic nervous system development |
| GO:0050830 | 0.0014 | 5.3435 | 1.2209 | 6 | 80 | defense response to Gram-positive bacterium |
| GO:0060696 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | regulation of phospholipid catabolic process |
| GO:0032613 | 0.0026 | 7.7061 | 0.5799 | 4 | 38 | interleukin-10 production |
| GO:0002825 | 0.0028 | 12.2429 | 0.29 | 3 | 19 | regulation of T-helper 1 type immune response |
| GO:0035194 | 0.0029 | 2.8378 | 4.1054 | 11 | 269 | posttranscriptional gene silencing by RNA |
| GO:0002250 | 0.0031 | 2.6668 | 4.7616 | 12 | 312 | adaptive immune response |
| GO:0043382 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | positive regulation of memory T cell differentiation |
| GO:0002606 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | positive regulation of dendritic cell antigen processing and presentation |
| GO:0021610 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | facial nerve morphogenesis |
| GO:0032615 | 0.0048 | 6.3875 | 0.6868 | 4 | 45 | interleukin-12 production |
| GO:0009617 | 0.0058 | 2.2047 | 7.173 | 15 | 470 | response to bacterium |
| GO:0006570 | 0.0061 | 21.6854 | 0.1221 | 2 | 8 | tyrosine metabolic process |
| GO:0090023 | 0.0063 | 8.9004 | 0.3815 | 3 | 25 | positive regulation of neutrophil chemotaxis |
| GO:0045621 | 0.0064 | 4.5571 | 1.1751 | 5 | 77 | positive regulation of lymphocyte differentiation |
| GO:0051901 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | positive regulation of mitochondrial depolarization |
| GO:0090331 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | negative regulation of platelet aggregation |
| GO:0090715 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | immunological memory formation process |
| GO:0007166 | 0.0078 | 1.5064 | 37.5437 | 52 | 2460 | cell surface receptor signaling pathway |
| GO:0098609 | 0.0079 | 1.9056 | 11.08 | 20 | 726 | cell-cell adhesion |
| GO:0045595 | 0.008 | 1.6152 | 23.8693 | 36 | 1564 | regulation of cell differentiation |
| GO:0017148 | 0.0083 | 2.3326 | 5.4026 | 12 | 354 | negative regulation of translation |
| GO:0051259 | 0.0084 | 2.109 | 7.4782 | 15 | 490 | protein oligomerization |
| GO:0050866 | 0.0085 | 3.2027 | 2.3045 | 7 | 151 | negative regulation of cell activation |
| GO:0018149 | 0.0086 | 5.3418 | 0.8089 | 4 | 53 | peptide cross-linking |
| GO:0002449 | 0.0094 | 2.8696 | 2.9302 | 8 | 192 | lymphocyte mediated immunity |
| GO:0045580 | 0.0095 | 3.5216 | 1.8009 | 6 | 118 | regulation of T cell differentiation |
| GO:0031115 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | negative regulation of microtubule polymerization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 6.7541 | 4.9753 | 28 | 326 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0 | 5.8083 | 6.3794 | 31 | 418 | sensory perception of chemical stimulus |
| GO:0009593 | 0 | 5.603 | 6.1199 | 29 | 401 | detection of chemical stimulus |
| GO:0050906 | 0 | 5.4673 | 6.2573 | 29 | 410 | detection of stimulus involved in sensory perception |
| GO:0050877 | 0 | 2.8411 | 17.1236 | 42 | 1122 | nervous system process |
| GO:0007186 | 0 | 2.6865 | 17.5204 | 41 | 1148 | G-protein coupled receptor signaling pathway |
| GO:0045919 | 0 | 54.9269 | 0.1679 | 5 | 11 | positive regulation of cytolysis |
| GO:0032501 | 0 | 1.786 | 99.964 | 133 | 6550 | multicellular organismal process |
| GO:2000821 | 0 | 98.0348 | 0.0763 | 3 | 5 | regulation of grooming behavior |
| GO:2000252 | 2e-04 | 39.2061 | 0.1221 | 3 | 8 | negative regulation of feeding behavior |
| GO:0051729 | 2e-04 | Inf | 0.0305 | 2 | 2 | germline cell cycle switching, mitotic to meiotic cell cycle |
| GO:0060184 | 2e-04 | Inf | 0.0305 | 2 | 2 | cell cycle switching |
| GO:0015844 | 4e-04 | 6.8249 | 0.9767 | 6 | 64 | monoamine transport |
| GO:0051952 | 6e-04 | 6.2811 | 1.0531 | 6 | 69 | regulation of amine transport |
| GO:0071673 | 7e-04 | 130.1558 | 0.0458 | 2 | 3 | positive regulation of smooth muscle cell chemotaxis |
| GO:0001963 | 0.0011 | 10.0826 | 0.4579 | 4 | 30 | synaptic transmission, dopaminergic |
| GO:0014744 | 0.0011 | 17.8138 | 0.2137 | 3 | 14 | positive regulation of muscle adaptation |
| GO:0007356 | 0.0014 | 65.0736 | 0.061 | 2 | 4 | thorax and anterior abdomen determination |
| GO:0015872 | 0.0019 | 8.4536 | 0.5342 | 4 | 35 | dopamine transport |
| GO:0007155 | 0.002 | 1.8437 | 18.7261 | 32 | 1227 | cell adhesion |
| GO:0044117 | 0.002 | 13.9938 | 0.2594 | 3 | 17 | growth of symbiont in host |
| GO:0051446 | 0.002 | 13.9938 | 0.2594 | 3 | 17 | positive regulation of meiotic cell cycle |
| GO:0002309 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | T cell proliferation involved in immune response |
| GO:0006824 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | cobalt ion transport |
| GO:0014805 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | smooth muscle adaptation |
| GO:0044110 | 0.0024 | 13.06 | 0.2747 | 3 | 18 | growth involved in symbiotic interaction |
| GO:0018108 | 0.0028 | 2.5849 | 5.3263 | 13 | 349 | peptidyl-tyrosine phosphorylation |
| GO:0050778 | 0.0028 | 2.1546 | 9.3707 | 19 | 614 | positive regulation of immune response |
| GO:0002697 | 0.0029 | 2.6943 | 4.7159 | 12 | 309 | regulation of immune effector process |
| GO:0034105 | 0.0031 | 7.277 | 0.6105 | 4 | 40 | positive regulation of tissue remodeling |
| GO:0051716 | 0.0032 | 1.4464 | 97.9952 | 119 | 6421 | cellular response to stimulus |
| GO:0001878 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | response to yeast |
| GO:0042536 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | negative regulation of tumor necrosis factor biosynthetic process |
| GO:2001179 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | regulation of interleukin-10 secretion |
| GO:0014821 | 0.0038 | 10.8812 | 0.3205 | 3 | 21 | phasic smooth muscle contraction |
| GO:0009607 | 0.0039 | 1.9719 | 11.8583 | 22 | 777 | response to biotic stimulus |
| GO:0023052 | 0.0042 | 1.4939 | 61.1322 | 79 | 4247 | signaling |
| GO:0032496 | 0.0043 | 2.6791 | 4.3343 | 11 | 284 | response to lipopolysaccharide |
| GO:0051707 | 0.0044 | 1.9838 | 11.2326 | 21 | 736 | response to other organism |
| GO:0071447 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | cellular response to hydroperoxide |
| GO:0050432 | 0.0048 | 6.3875 | 0.6868 | 4 | 45 | catecholamine secretion |
| GO:0002366 | 0.005 | 2.0789 | 9.157 | 18 | 600 | leukocyte activation involved in immune response |
| GO:0042633 | 0.0052 | 4.0284 | 1.5872 | 6 | 104 | hair cycle |
| GO:0002709 | 0.0052 | 6.235 | 0.702 | 4 | 46 | regulation of T cell mediated immunity |
| GO:0014059 | 0.0056 | 9.3248 | 0.3663 | 3 | 24 | regulation of dopamine secretion |
| GO:0034698 | 0.0056 | 9.3248 | 0.3663 | 3 | 24 | response to gonadotropin |
| GO:0002443 | 0.0059 | 2.0001 | 10.0422 | 19 | 658 | leukocyte mediated immunity |
| GO:0007195 | 0.0061 | 21.6854 | 0.1221 | 2 | 8 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
| GO:0033860 | 0.0061 | 21.6854 | 0.1221 | 2 | 8 | regulation of NAD(P)H oxidase activity |
| GO:0045630 | 0.0061 | 21.6854 | 0.1221 | 2 | 8 | positive regulation of T-helper 2 cell differentiation |
| GO:0061140 | 0.0061 | 21.6854 | 0.1221 | 2 | 8 | lung secretory cell differentiation |
| GO:0043588 | 0.0063 | 2.329 | 5.8757 | 13 | 385 | skin development |
| GO:0032649 | 0.0064 | 4.5571 | 1.1751 | 5 | 77 | regulation of interferon-gamma production |
| GO:0032635 | 0.0065 | 3.8316 | 1.6635 | 6 | 109 | interleukin-6 production |
| GO:0002283 | 0.0067 | 2.2353 | 6.593 | 14 | 432 | neutrophil activation involved in immune response |
| GO:0007267 | 0.007 | 1.6535 | 22.0073 | 34 | 1442 | cell-cell signaling |
| GO:1903428 | 0.007 | 5.6913 | 0.7631 | 4 | 50 | positive regulation of reactive oxygen species biosynthetic process |
| GO:0007610 | 0.0071 | 2.0955 | 8.0429 | 16 | 527 | behavior |
| GO:0007154 | 0.0072 | 1.4527 | 61.4057 | 78 | 4266 | cell communication |
| GO:0002218 | 0.0076 | 2.599 | 4.0443 | 10 | 265 | activation of innate immune response |
| GO:0007088 | 0.0077 | 3.2715 | 2.2587 | 7 | 148 | regulation of mitotic nuclear division |
| GO:0046877 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | regulation of saliva secretion |
| GO:0072124 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | regulation of glomerular mesangial cell proliferation |
| GO:0007160 | 0.0078 | 2.9675 | 2.8387 | 8 | 186 | cell-matrix adhesion |
| GO:0050670 | 0.0081 | 2.9507 | 2.8539 | 8 | 187 | regulation of lymphocyte proliferation |
| GO:0036230 | 0.0087 | 2.1608 | 6.8067 | 14 | 446 | granulocyte activation |
| GO:0002224 | 0.0091 | 3.5535 | 1.7856 | 6 | 117 | toll-like receptor signaling pathway |
| GO:0006600 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | creatine metabolic process |
| GO:0021559 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | trigeminal nerve development |
| GO:0035878 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | nail development |
| GO:0070486 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | leukocyte aggregation |
| GO:0022600 | 0.0097 | 4.0992 | 1.2972 | 5 | 85 | digestive system process |
| GO:0031532 | 0.0097 | 4.0992 | 1.2972 | 5 | 85 | actin cytoskeleton reorganization |
| GO:0051896 | 0.01 | 2.8383 | 2.9608 | 8 | 194 | regulation of protein kinase B signaling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000026 | 1e-04 | 2.0942 | 21.6551 | 40 | 1713 | regulation of multicellular organismal development |
| GO:0010594 | 2e-04 | 5.5281 | 1.5802 | 8 | 125 | regulation of endothelial cell migration |
| GO:0070527 | 4e-04 | 8.8824 | 0.6321 | 5 | 50 | platelet aggregation |
| GO:0001973 | 5e-04 | 23.7853 | 0.1643 | 3 | 13 | adenosine receptor signaling pathway |
| GO:0006026 | 6e-04 | 8.1551 | 0.6826 | 5 | 54 | aminoglycan catabolic process |
| GO:0043537 | 6e-04 | 11.7946 | 0.3919 | 4 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0010469 | 8e-04 | 2.6679 | 6.4472 | 16 | 510 | regulation of receptor activity |
| GO:0090132 | 8e-04 | 3.6391 | 2.9455 | 10 | 233 | epithelium migration |
| GO:0048295 | 9e-04 | 78.911 | 0.0506 | 2 | 4 | positive regulation of isotype switching to IgE isotypes |
| GO:0045765 | 9e-04 | 3.5424 | 3.0214 | 10 | 239 | regulation of angiogenesis |
| GO:0040012 | 0.001 | 2.2806 | 9.949 | 21 | 787 | regulation of locomotion |
| GO:0030334 | 0.001 | 2.3772 | 8.609 | 19 | 681 | regulation of cell migration |
| GO:0051270 | 0.0011 | 2.2588 | 10.0375 | 21 | 794 | regulation of cellular component movement |
| GO:0007178 | 0.0013 | 3.1703 | 3.704 | 11 | 293 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:2000181 | 0.0014 | 5.3419 | 1.2136 | 6 | 96 | negative regulation of blood vessel morphogenesis |
| GO:0010633 | 0.0014 | 6.6551 | 0.8217 | 5 | 65 | negative regulation of epithelial cell migration |
| GO:0097709 | 0.0014 | 15.8516 | 0.2275 | 3 | 18 | connective tissue replacement |
| GO:0035025 | 0.0017 | 14.8599 | 0.2402 | 3 | 19 | positive regulation of Rho protein signal transduction |
| GO:0048646 | 0.0018 | 2.0887 | 11.8831 | 23 | 940 | anatomical structure formation involved in morphogenesis |
| GO:0001667 | 0.0022 | 2.9464 | 3.9695 | 11 | 314 | ameboidal-type cell migration |
| GO:0045595 | 0.0022 | 1.8245 | 19.7715 | 33 | 1564 | regulation of cell differentiation |
| GO:0043382 | 0.0023 | 39.4503 | 0.0758 | 2 | 6 | positive regulation of memory T cell differentiation |
| GO:0042330 | 0.0028 | 2.4065 | 6.6369 | 15 | 525 | taxis |
| GO:0042692 | 0.0028 | 2.7021 | 4.7153 | 12 | 373 | muscle cell differentiation |
| GO:0042346 | 0.0029 | 11.8847 | 0.2908 | 3 | 23 | positive regulation of NF-kappaB import into nucleus |
| GO:0097090 | 0.0032 | 31.5581 | 0.0885 | 2 | 7 | presynaptic membrane organization |
| GO:0034308 | 0.0034 | 7.0683 | 0.6194 | 4 | 49 | primary alcohol metabolic process |
| GO:0009611 | 0.0035 | 2.2794 | 7.4712 | 16 | 591 | response to wounding |
| GO:0032733 | 0.0037 | 10.8029 | 0.316 | 3 | 25 | positive regulation of interleukin-10 production |
| GO:1903671 | 0.0042 | 10.3325 | 0.3287 | 3 | 26 | negative regulation of sprouting angiogenesis |
| GO:1900182 | 0.0042 | 4.2105 | 1.517 | 6 | 120 | positive regulation of protein localization to nucleus |
| GO:0032071 | 0.0042 | 26.2967 | 0.1011 | 2 | 8 | regulation of endodeoxyribonuclease activity |
| GO:2000544 | 0.0042 | 26.2967 | 0.1011 | 2 | 8 | regulation of endothelial cell chemotaxis to fibroblast growth factor |
| GO:0035587 | 0.0047 | 9.9013 | 0.3413 | 3 | 27 | purinergic receptor signaling pathway |
| GO:0048710 | 0.0047 | 9.9013 | 0.3413 | 3 | 27 | regulation of astrocyte differentiation |
| GO:0072358 | 0.0048 | 2.1959 | 7.7367 | 16 | 612 | cardiovascular system development |
| GO:0048870 | 0.0049 | 1.801 | 16.7628 | 28 | 1326 | cell motility |
| GO:0030198 | 0.005 | 2.776 | 3.8051 | 10 | 301 | extracellular matrix organization |
| GO:0035766 | 0.0054 | 22.5385 | 0.1138 | 2 | 9 | cell chemotaxis to fibroblast growth factor |
| GO:0090715 | 0.0054 | 22.5385 | 0.1138 | 2 | 9 | immunological memory formation process |
| GO:0035303 | 0.0055 | 3.9651 | 1.6055 | 6 | 127 | regulation of dephosphorylation |
| GO:0032735 | 0.0057 | 9.1385 | 0.3666 | 3 | 29 | positive regulation of interleukin-12 production |
| GO:0042221 | 0.0061 | 1.4987 | 49.0496 | 65 | 3880 | response to chemical |
| GO:0002312 | 0.0062 | 5.8867 | 0.7332 | 4 | 58 | B cell activation involved in immune response |
| GO:0043122 | 0.0062 | 3.0906 | 2.7306 | 8 | 216 | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0070306 | 0.0063 | 8.7994 | 0.3792 | 3 | 30 | lens fiber cell differentiation |
| GO:0045664 | 0.0065 | 2.2472 | 6.5863 | 14 | 521 | regulation of neuron differentiation |
| GO:0007165 | 0.0069 | 1.454 | 66.1537 | 83 | 5233 | signal transduction |
| GO:0071363 | 0.0079 | 2.1288 | 7.4459 | 15 | 589 | cellular response to growth factor stimulus |
| GO:0006068 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | ethanol catabolic process |
| GO:0030207 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | chondroitin sulfate catabolic process |
| GO:0032700 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | negative regulation of interleukin-17 production |
| GO:0046607 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | positive regulation of centrosome cycle |
| GO:0035307 | 0.0089 | 7.662 | 0.4298 | 3 | 34 | positive regulation of protein dephosphorylation |
| GO:0050922 | 0.0089 | 7.662 | 0.4298 | 3 | 34 | negative regulation of chemotaxis |
| GO:0007167 | 0.0091 | 2.0954 | 7.5722 | 15 | 623 | enzyme linked receptor protein signaling pathway |
| GO:0001937 | 0.0097 | 7.422 | 0.4425 | 3 | 35 | negative regulation of endothelial cell proliferation |
| GO:1903510 | 0.0099 | 4.0643 | 1.3021 | 5 | 103 | mucopolysaccharide metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 15.39 | 4.9967 | 52 | 326 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0 | 11.7673 | 6.4068 | 53 | 418 | sensory perception of chemical stimulus |
| GO:0009593 | 0 | 12.0213 | 6.1462 | 52 | 401 | detection of chemical stimulus |
| GO:0050906 | 0 | 11.7119 | 6.2841 | 52 | 410 | detection of stimulus involved in sensory perception |
| GO:0007186 | 0 | 4.6865 | 17.1038 | 61 | 1129 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0 | 4.5363 | 17.1971 | 60 | 1122 | nervous system process |
| GO:0000183 | 0 | 38.3887 | 0.5518 | 13 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 38.3887 | 0.5518 | 13 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 38.3887 | 0.5518 | 13 | 36 | response to interleukin-7 |
| GO:0045815 | 0 | 14.8839 | 1.1955 | 14 | 78 | positive regulation of gene expression, epigenetic |
| GO:0006335 | 0 | 31.9133 | 0.4751 | 10 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0045652 | 0 | 15.1876 | 1.0882 | 13 | 71 | regulation of megakaryocyte differentiation |
| GO:0032501 | 0 | 2.3863 | 93.0608 | 140 | 6243 | multicellular organismal process |
| GO:1902036 | 0 | 11.0601 | 1.5327 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0051290 | 0 | 20.2922 | 0.6591 | 10 | 43 | protein heterotetramerization |
| GO:0060964 | 0 | 10.2237 | 1.5174 | 13 | 99 | regulation of gene silencing by miRNA |
| GO:0006333 | 0 | 7.2822 | 2.5443 | 16 | 166 | chromatin assembly or disassembly |
| GO:0002244 | 0 | 6.5334 | 2.8049 | 16 | 183 | hematopoietic progenitor cell differentiation |
| GO:0006323 | 0 | 6.5334 | 2.8049 | 16 | 183 | DNA packaging |
| GO:0045814 | 0 | 8.444 | 1.7933 | 13 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 8.1291 | 1.8546 | 13 | 121 | regulation of gene silencing |
| GO:0007154 | 0 | 1.9753 | 87.4875 | 126 | 5708 | cell communication |
| GO:0071824 | 0 | 5.1559 | 3.7092 | 17 | 242 | protein-DNA complex subunit organization |
| GO:0023052 | 0 | 1.9179 | 87.1963 | 124 | 5689 | signaling |
| GO:0048863 | 0 | 4.7447 | 3.7552 | 16 | 245 | stem cell differentiation |
| GO:0051716 | 0 | 1.8314 | 98.4158 | 133 | 6421 | cellular response to stimulus |
| GO:0030099 | 0 | 3.6012 | 5.4871 | 18 | 358 | myeloid cell differentiation |
| GO:0050878 | 0 | 3.2201 | 6.8053 | 20 | 444 | regulation of body fluid levels |
| GO:0007596 | 1e-04 | 3.4943 | 4.6595 | 15 | 304 | blood coagulation |
| GO:1903706 | 1e-04 | 3.0564 | 6.3914 | 18 | 417 | regulation of hemopoiesis |
| GO:0032200 | 1e-04 | 4.5837 | 2.3757 | 10 | 155 | telomere organization |
| GO:0035194 | 3e-04 | 3.3955 | 4.123 | 13 | 269 | posttranscriptional gene silencing by RNA |
| GO:0048534 | 3e-04 | 2.278 | 12.3844 | 26 | 808 | hematopoietic or lymphoid organ development |
| GO:0061383 | 6e-04 | 8.184 | 0.6897 | 5 | 45 | trabecula morphogenesis |
| GO:0009611 | 8e-04 | 2.3671 | 9.0584 | 20 | 591 | response to wounding |
| GO:0060347 | 0.0011 | 17.7355 | 0.2146 | 3 | 14 | heart trabecula formation |
| GO:0017148 | 0.0012 | 2.75 | 5.4258 | 14 | 354 | negative regulation of translation |
| GO:0018149 | 0.0013 | 6.8163 | 0.8123 | 5 | 53 | peptide cross-linking |
| GO:0035910 | 0.0014 | 64.7888 | 0.0613 | 2 | 4 | ascending aorta morphogenesis |
| GO:0055093 | 0.0021 | 13.9323 | 0.2606 | 3 | 17 | response to hyperoxia |
| GO:0061436 | 0.0021 | 13.9323 | 0.2606 | 3 | 17 | establishment of skin barrier |
| GO:0006334 | 0.0025 | 4.7216 | 1.3673 | 6 | 93 | nucleosome assembly |
| GO:0098664 | 0.0029 | 12.1891 | 0.2912 | 3 | 19 | G-protein coupled serotonin receptor signaling pathway |
| GO:0006701 | 0.0034 | 32.3901 | 0.092 | 2 | 6 | progesterone biosynthetic process |
| GO:0036018 | 0.0034 | 32.3901 | 0.092 | 2 | 6 | cellular response to erythropoietin |
| GO:2001258 | 0.0038 | 6.8627 | 0.6437 | 4 | 42 | negative regulation of cation channel activity |
| GO:0032410 | 0.0046 | 4.9514 | 1.0882 | 5 | 71 | negative regulation of transporter activity |
| GO:0006953 | 0.0049 | 6.3593 | 0.6897 | 4 | 45 | acute-phase response |
| GO:0007009 | 0.0049 | 4.8771 | 1.1036 | 5 | 72 | plasma membrane organization |
| GO:0007195 | 0.0062 | 21.5905 | 0.1226 | 2 | 8 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
| GO:0097084 | 0.0062 | 21.5905 | 0.1226 | 2 | 8 | vascular smooth muscle cell development |
| GO:0046320 | 0.0064 | 8.8613 | 0.3832 | 3 | 25 | regulation of fatty acid oxidation |
| GO:0065007 | 0.0072 | 1.4669 | 162.7593 | 180 | 10619 | biological regulation |
| GO:0002682 | 0.0076 | 1.8575 | 12.5673 | 22 | 864 | regulation of immune system process |
| GO:0034766 | 0.0077 | 4.3546 | 1.2262 | 5 | 80 | negative regulation of ion transmembrane transport |
| GO:0048871 | 0.0079 | 2.4559 | 4.7054 | 11 | 307 | multicellular organismal homeostasis |
| GO:0051259 | 0.0087 | 2.0992 | 7.5103 | 15 | 490 | protein oligomerization |
| GO:0051926 | 0.01 | 5.109 | 0.843 | 4 | 55 | negative regulation of calcium ion transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 231.8764 | 0.4995 | 24 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 135.2162 | 0.5801 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 94.2873 | 0.6929 | 25 | 43 | protein heterotetramerization |
| GO:0045815 | 0 | 29.964 | 1.2568 | 24 | 78 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 22.8492 | 1.5952 | 25 | 99 | regulation of gene silencing by miRNA |
| GO:0045653 | 0 | 302.0862 | 0.2739 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0006323 | 0 | 14.1046 | 2.9487 | 31 | 183 | DNA packaging |
| GO:0060968 | 0 | 18.5682 | 1.9497 | 26 | 121 | regulation of gene silencing |
| GO:1902036 | 0 | 21.2589 | 1.6113 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0032200 | 0 | 14.3447 | 2.4975 | 27 | 155 | telomere organization |
| GO:0045814 | 0 | 17.3531 | 1.8852 | 24 | 117 | negative regulation of gene expression, epigenetic |
| GO:0002244 | 0 | 12.3187 | 2.9487 | 28 | 183 | hematopoietic progenitor cell differentiation |
| GO:0071824 | 0 | 10.1204 | 3.8994 | 31 | 242 | protein-DNA complex subunit organization |
| GO:0048863 | 0 | 9.9765 | 3.9477 | 31 | 245 | stem cell differentiation |
| GO:0016233 | 0 | 30.6639 | 0.8057 | 16 | 50 | telomere capping |
| GO:0035194 | 0 | 8.5902 | 4.3344 | 30 | 269 | posttranscriptional gene silencing by RNA |
| GO:0034080 | 0 | 34.8027 | 0.6445 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 32.3125 | 0.6768 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0030099 | 0 | 7.762 | 4.2225 | 27 | 267 | myeloid cell differentiation |
| GO:0034724 | 0 | 25.1185 | 0.8057 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0017148 | 0 | 6.3002 | 5.7041 | 30 | 354 | negative regulation of translation |
| GO:0048534 | 0 | 4.0648 | 13.0195 | 44 | 808 | hematopoietic or lymphoid organ development |
| GO:0051248 | 0 | 3.4344 | 19.6097 | 55 | 1217 | negative regulation of protein metabolic process |
| GO:0006333 | 0 | 11.8892 | 1.7685 | 17 | 116 | chromatin assembly or disassembly |
| GO:0006303 | 0 | 17.3712 | 1.0635 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0034248 | 0 | 4.5176 | 9.1362 | 35 | 567 | regulation of cellular amide metabolic process |
| GO:0043044 | 0 | 15.303 | 1.1763 | 14 | 73 | ATP-dependent chromatin remodeling |
| GO:1903707 | 0 | 10.063 | 2.0464 | 17 | 127 | negative regulation of hemopoiesis |
| GO:0034622 | 0 | 3.5085 | 15.2431 | 45 | 946 | cellular macromolecular complex assembly |
| GO:0051259 | 0 | 4.5744 | 7.8955 | 31 | 490 | protein oligomerization |
| GO:0038111 | 0 | 24.4377 | 0.5801 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 24.4377 | 0.5801 | 10 | 36 | response to interleukin-7 |
| GO:0006352 | 0 | 6.0195 | 3.6255 | 19 | 225 | DNA-templated transcription, initiation |
| GO:0010608 | 0 | 3.5986 | 10.5219 | 33 | 653 | posttranscriptional regulation of gene expression |
| GO:0045652 | 0 | 15.3296 | 0.8215 | 10 | 54 | regulation of megakaryocyte differentiation |
| GO:0043043 | 0 | 3.2392 | 12.7455 | 36 | 791 | peptide biosynthetic process |
| GO:0060249 | 0 | 4.2337 | 5.559 | 21 | 345 | anatomical structure homeostasis |
| GO:0006950 | 0 | 2.4723 | 24.6224 | 51 | 1624 | response to stress |
| GO:0071360 | 0 | 38.9341 | 0.2095 | 5 | 13 | cellular response to exogenous dsRNA |
| GO:0032268 | 0 | 2.0734 | 38.7522 | 68 | 2405 | regulation of cellular protein metabolic process |
| GO:0022607 | 0 | 2.0247 | 40.9172 | 70 | 2559 | cellular component assembly |
| GO:0097659 | 0 | 1.8676 | 55.4777 | 86 | 3443 | nucleic acid-templated transcription |
| GO:0070271 | 0 | 2.2916 | 21.1727 | 43 | 1314 | protein complex biogenesis |
| GO:0002227 | 0 | 23.9515 | 0.29 | 5 | 18 | innate immune response in mucosa |
| GO:0010604 | 0 | 1.89 | 44.6335 | 72 | 2770 | positive regulation of macromolecule metabolic process |
| GO:0045596 | 0 | 2.8369 | 9.684 | 25 | 601 | negative regulation of cell differentiation |
| GO:0019731 | 0 | 13.3866 | 0.5478 | 6 | 34 | antibacterial humoral response |
| GO:0048869 | 0 | 1.7835 | 61.4073 | 91 | 3811 | cellular developmental process |
| GO:0034645 | 0 | 1.7406 | 75.9414 | 107 | 4713 | cellular macromolecule biosynthetic process |
| GO:0006996 | 0 | 1.8079 | 54.527 | 83 | 3384 | organelle organization |
| GO:1902679 | 0 | 2.3093 | 17.3056 | 36 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0016070 | 0 | 1.7456 | 68.1427 | 98 | 4229 | RNA metabolic process |
| GO:0071822 | 0 | 2.0763 | 24.8788 | 46 | 1544 | protein complex subunit organization |
| GO:0034654 | 0 | 1.7391 | 62.5514 | 91 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:1901564 | 0 | 1.6775 | 99.0316 | 130 | 6146 | organonitrogen compound metabolic process |
| GO:0045892 | 0 | 2.2715 | 16.5183 | 34 | 1033 | negative regulation of transcription, DNA-templated |
| GO:0002251 | 1e-04 | 13.5288 | 0.4512 | 5 | 28 | organ or tissue specific immune response |
| GO:0045934 | 1e-04 | 2.0811 | 20.7216 | 39 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0002682 | 1e-04 | 2.3675 | 12.5091 | 27 | 864 | regulation of immune system process |
| GO:1903706 | 1e-04 | 3.4528 | 4.3864 | 14 | 290 | regulation of hemopoiesis |
| GO:0006725 | 2e-04 | 1.6111 | 88.1391 | 116 | 5470 | cellular aromatic compound metabolic process |
| GO:0006959 | 2e-04 | 4.0649 | 2.9326 | 11 | 182 | humoral immune response |
| GO:0046483 | 2e-04 | 1.5994 | 87.6235 | 115 | 5438 | heterocycle metabolic process |
| GO:0048519 | 2e-04 | 1.6126 | 74.6363 | 101 | 4632 | negative regulation of biological process |
| GO:0009889 | 2e-04 | 1.792 | 38.0912 | 59 | 2572 | regulation of biosynthetic process |
| GO:1901360 | 3e-04 | 1.5736 | 91.3134 | 118 | 5667 | organic cyclic compound metabolic process |
| GO:0009890 | 3e-04 | 1.8856 | 25.1366 | 43 | 1560 | negative regulation of biosynthetic process |
| GO:0006281 | 3e-04 | 2.6143 | 7.8149 | 19 | 485 | DNA repair |
| GO:0098542 | 4e-04 | 2.7704 | 6.5903 | 17 | 409 | defense response to other organism |
| GO:0034641 | 4e-04 | 1.5511 | 96.8564 | 123 | 6011 | cellular nitrogen compound metabolic process |
| GO:0071345 | 4e-04 | 2.2071 | 12.7274 | 26 | 799 | cellular response to cytokine stimulus |
| GO:0050793 | 5e-04 | 1.7295 | 35.4329 | 55 | 2199 | regulation of developmental process |
| GO:0070887 | 5e-04 | 1.666 | 43.2156 | 64 | 2682 | cellular response to chemical stimulus |
| GO:0010033 | 6e-04 | 1.6529 | 44.2468 | 65 | 2746 | response to organic substance |
| GO:0061844 | 6e-04 | 8.1803 | 0.6929 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0034344 | 8e-04 | 123.1148 | 0.0483 | 2 | 3 | regulation of type III interferon production |
| GO:0045658 | 8e-04 | 123.1148 | 0.0483 | 2 | 3 | regulation of neutrophil differentiation |
| GO:0070340 | 8e-04 | 123.1148 | 0.0483 | 2 | 3 | detection of bacterial lipopeptide |
| GO:0032481 | 8e-04 | 6.0319 | 1.0957 | 6 | 68 | positive regulation of type I interferon production |
| GO:0071840 | 8e-04 | 1.5175 | 91.4907 | 116 | 5678 | cellular component organization or biogenesis |
| GO:0033160 | 8e-04 | 20.5926 | 0.1934 | 3 | 12 | positive regulation of protein import into nucleus, translocation |
| GO:0035458 | 8e-04 | 20.5926 | 0.1934 | 3 | 12 | cellular response to interferon-beta |
| GO:1901576 | 9e-04 | 1.5084 | 93.7143 | 118 | 5816 | organic substance biosynthetic process |
| GO:0051239 | 0.001 | 1.6349 | 41.6042 | 61 | 2582 | regulation of multicellular organismal process |
| GO:0045838 | 0.001 | 18.5321 | 0.2095 | 3 | 13 | positive regulation of membrane potential |
| GO:0042987 | 0.0011 | 9.9147 | 0.4673 | 4 | 29 | amyloid precursor protein catabolic process |
| GO:0032675 | 0.0012 | 4.7013 | 1.6113 | 7 | 100 | regulation of interleukin-6 production |
| GO:0042107 | 0.0013 | 4.6017 | 1.6435 | 7 | 102 | cytokine metabolic process |
| GO:2001141 | 0.0013 | 1.6938 | 32.9655 | 50 | 2228 | regulation of RNA biosynthetic process |
| GO:0006355 | 0.0013 | 1.693 | 32.9776 | 50 | 2234 | regulation of transcription, DNA-templated |
| GO:1990511 | 0.0015 | 61.5533 | 0.0645 | 2 | 4 | piRNA biosynthetic process |
| GO:0051348 | 0.0016 | 2.6454 | 5.6235 | 14 | 349 | negative regulation of transferase activity |
| GO:0043508 | 0.0016 | 15.4414 | 0.2417 | 3 | 15 | negative regulation of JUN kinase activity |
| GO:0006955 | 0.0017 | 1.7757 | 23.2599 | 38 | 1492 | immune response |
| GO:0030888 | 0.0017 | 6.3392 | 0.8701 | 5 | 54 | regulation of B cell proliferation |
| GO:0060333 | 0.0018 | 5.0497 | 1.2891 | 6 | 80 | interferon-gamma-mediated signaling pathway |
| GO:0044238 | 0.0018 | 1.5094 | 152.9302 | 175 | 9491 | primary metabolic process |
| GO:0043331 | 0.002 | 4.982 | 1.3052 | 6 | 81 | response to dsRNA |
| GO:0002076 | 0.002 | 14.2526 | 0.2578 | 3 | 16 | osteoblast development |
| GO:0032677 | 0.002 | 6.0898 | 0.9023 | 5 | 56 | regulation of interleukin-8 production |
| GO:0048731 | 0.0024 | 1.4851 | 67.4337 | 88 | 4185 | system development |
| GO:0006334 | 0.0024 | 4.766 | 1.3551 | 6 | 93 | nucleosome assembly |
| GO:0009597 | 0.0025 | 41.0328 | 0.0806 | 2 | 5 | detection of virus |
| GO:0042035 | 0.0031 | 4.4994 | 1.4341 | 6 | 89 | regulation of cytokine biosynthetic process |
| GO:0031324 | 0.0032 | 1.8389 | 17.0267 | 29 | 1150 | negative regulation of cellular metabolic process |
| GO:0034123 | 0.0033 | 11.5779 | 0.3062 | 3 | 19 | positive regulation of toll-like receptor signaling pathway |
| GO:0002757 | 0.0034 | 2.3434 | 6.7675 | 15 | 420 | immune response-activating signal transduction |
| GO:0002262 | 0.0035 | 3.8299 | 1.9497 | 7 | 121 | myeloid cell homeostasis |
| GO:0032944 | 0.0035 | 3.1487 | 3.0293 | 9 | 188 | regulation of mononuclear cell proliferation |
| GO:0030218 | 0.0035 | 4.3929 | 1.4663 | 6 | 91 | erythrocyte differentiation |
| GO:0000395 | 0.0037 | 30.7725 | 0.0967 | 2 | 6 | mRNA 5'-splice site recognition |
| GO:0002371 | 0.0037 | 30.7725 | 0.0967 | 2 | 6 | dendritic cell cytokine production |
| GO:0071221 | 0.0037 | 30.7725 | 0.0967 | 2 | 6 | cellular response to bacterial lipopeptide |
| GO:2000483 | 0.0037 | 30.7725 | 0.0967 | 2 | 6 | negative regulation of interleukin-8 secretion |
| GO:0007596 | 0.0039 | 2.5868 | 4.8984 | 12 | 304 | blood coagulation |
| GO:0043207 | 0.0041 | 1.9622 | 11.8915 | 22 | 738 | response to external biotic stimulus |
| GO:0019219 | 0.0044 | 1.5665 | 37.5179 | 53 | 2534 | regulation of nucleobase-containing compound metabolic process |
| GO:0001816 | 0.0046 | 2.0509 | 9.7968 | 19 | 608 | cytokine production |
| GO:0050871 | 0.0048 | 4.9259 | 1.0957 | 5 | 68 | positive regulation of B cell activation |
| GO:0006469 | 0.005 | 2.7739 | 3.8027 | 10 | 236 | negative regulation of protein kinase activity |
| GO:0032493 | 0.0051 | 24.6164 | 0.1128 | 2 | 7 | response to bacterial lipoprotein |
| GO:0051026 | 0.0051 | 24.6164 | 0.1128 | 2 | 7 | chiasma assembly |
| GO:0002252 | 0.0053 | 1.7958 | 15.9843 | 27 | 992 | immune effector process |
| GO:0045577 | 0.0058 | 9.2599 | 0.3706 | 3 | 23 | regulation of B cell differentiation |
| GO:0045736 | 0.0058 | 9.2599 | 0.3706 | 3 | 23 | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0032608 | 0.0063 | 5.8949 | 0.7412 | 4 | 46 | interferon-beta production |
| GO:0010629 | 0.0065 | 2.3258 | 5.9051 | 13 | 401 | negative regulation of gene expression |
| GO:0010944 | 0.0068 | 20.5123 | 0.1289 | 2 | 8 | negative regulation of transcription by competitive promoter binding |
| GO:0034135 | 0.0068 | 20.5123 | 0.1289 | 2 | 8 | regulation of toll-like receptor 2 signaling pathway |
| GO:0042135 | 0.0068 | 20.5123 | 0.1289 | 2 | 8 | neurotransmitter catabolic process |
| GO:0045410 | 0.0068 | 20.5123 | 0.1289 | 2 | 8 | positive regulation of interleukin-6 biosynthetic process |
| GO:0045088 | 0.0068 | 2.305 | 5.9297 | 13 | 368 | regulation of innate immune response |
| GO:0048518 | 0.0069 | 1.4087 | 75.6983 | 94 | 4807 | positive regulation of biological process |
| GO:0070661 | 0.0076 | 2.5986 | 4.0444 | 10 | 251 | leukocyte proliferation |
| GO:0033554 | 0.0085 | 1.562 | 28.1336 | 41 | 1746 | cellular response to stress |
| GO:0045861 | 0.0087 | 2.4202 | 4.7695 | 11 | 296 | negative regulation of proteolysis |
| GO:0051091 | 0.0087 | 2.7044 | 3.4966 | 9 | 217 | positive regulation of DNA binding transcription factor activity |
| GO:0045321 | 0.0091 | 1.7139 | 16.6771 | 27 | 1035 | leukocyte activation |
| GO:0065008 | 0.0092 | 1.433 | 51.2077 | 67 | 3178 | regulation of biological quality |
| GO:0009617 | 0.0094 | 2.0788 | 7.5732 | 15 | 470 | response to bacterium |
| GO:0050830 | 0.0094 | 4.1344 | 1.2891 | 5 | 80 | defense response to Gram-positive bacterium |
| GO:0001824 | 0.0097 | 5.156 | 0.8379 | 4 | 52 | blastocyst development |
| GO:1903902 | 0.0097 | 5.156 | 0.8379 | 4 | 52 | positive regulation of viral life cycle |
| GO:0044092 | 0.0098 | 1.703 | 16.7738 | 27 | 1041 | negative regulation of molecular function |
| GO:0034341 | 0.0098 | 3.1132 | 2.3686 | 7 | 147 | response to interferon-gamma |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 6.8192 | 1.9891 | 12 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0018003 | 2e-04 | Inf | 0.0272 | 2 | 2 | peptidyl-lysine N6-acetylation |
| GO:0001816 | 2e-04 | 2.6181 | 8.2835 | 20 | 608 | cytokine production |
| GO:0002764 | 4e-04 | 2.8216 | 6.1036 | 16 | 448 | immune response-regulating signaling pathway |
| GO:0045658 | 5e-04 | 146.1942 | 0.0409 | 2 | 3 | regulation of neutrophil differentiation |
| GO:0060244 | 5e-04 | 146.1942 | 0.0409 | 2 | 3 | negative regulation of cell proliferation involved in contact inhibition |
| GO:0022610 | 6e-04 | 2.0227 | 16.7713 | 31 | 1231 | biological adhesion |
| GO:0045354 | 0.0011 | 73.0922 | 0.0545 | 2 | 4 | regulation of interferon-alpha biosynthetic process |
| GO:0045087 | 0.0016 | 2.1854 | 10.3135 | 21 | 757 | innate immune response |
| GO:0048584 | 0.0017 | 1.7475 | 25.8314 | 41 | 1896 | positive regulation of response to stimulus |
| GO:0051607 | 0.0018 | 3.502 | 2.7385 | 9 | 201 | defense response to virus |
| GO:0045409 | 0.0018 | 48.7249 | 0.0681 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
| GO:0007130 | 0.0021 | 13.7588 | 0.2589 | 3 | 19 | synaptonemal complex assembly |
| GO:0098609 | 0.0022 | 2.1628 | 9.8911 | 20 | 726 | cell-cell adhesion |
| GO:0002253 | 0.0026 | 2.4231 | 6.5805 | 15 | 483 | activation of immune response |
| GO:0032687 | 0.0027 | 36.5413 | 0.0817 | 2 | 6 | negative regulation of interferon-alpha production |
| GO:0045357 | 0.0027 | 36.5413 | 0.0817 | 2 | 6 | regulation of interferon-beta biosynthetic process |
| GO:0002684 | 0.0035 | 1.9971 | 11.7713 | 22 | 864 | positive regulation of immune system process |
| GO:0039536 | 0.0037 | 29.2311 | 0.0954 | 2 | 7 | negative regulation of RIG-I signaling pathway |
| GO:0045656 | 0.0037 | 29.2311 | 0.0954 | 2 | 7 | negative regulation of monocyte differentiation |
| GO:0046598 | 0.0037 | 29.2311 | 0.0954 | 2 | 7 | positive regulation of viral entry into host cell |
| GO:2000035 | 0.0037 | 29.2311 | 0.0954 | 2 | 7 | regulation of stem cell division |
| GO:0045621 | 0.004 | 5.1269 | 1.0491 | 5 | 77 | positive regulation of lymphocyte differentiation |
| GO:0090023 | 0.0046 | 10.0024 | 0.3406 | 3 | 25 | positive regulation of neutrophil chemotaxis |
| GO:0002792 | 0.0047 | 4.1119 | 1.5532 | 6 | 114 | negative regulation of peptide secretion |
| GO:0043124 | 0.0047 | 6.3994 | 0.6812 | 4 | 50 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0009607 | 0.0048 | 2.0099 | 10.586 | 20 | 777 | response to biotic stimulus |
| GO:0050710 | 0.0051 | 6.2628 | 0.6948 | 4 | 51 | negative regulation of cytokine secretion |
| GO:0032479 | 0.0051 | 4.0366 | 1.5804 | 6 | 116 | regulation of type I interferon production |
| GO:0006950 | 0.0054 | 1.5085 | 45.9134 | 62 | 3370 | response to stress |
| GO:1901222 | 0.0054 | 6.1319 | 0.7085 | 4 | 52 | regulation of NIK/NF-kappaB signaling |
| GO:0050900 | 0.0056 | 2.4647 | 5.1363 | 12 | 377 | leukocyte migration |
| GO:0051707 | 0.0057 | 2.0109 | 10.0274 | 19 | 736 | response to other organism |
| GO:0002429 | 0.0062 | 2.6853 | 3.9238 | 10 | 288 | immune response-activating cell surface receptor signaling pathway |
| GO:0032728 | 0.0064 | 8.8004 | 0.3815 | 3 | 28 | positive regulation of interferon-beta production |
| GO:0007585 | 0.0075 | 5.5516 | 0.7766 | 4 | 57 | respiratory gaseous exchange |
| GO:0097009 | 0.0077 | 8.1474 | 0.4087 | 3 | 30 | energy homeostasis |
| GO:1903131 | 0.0077 | 8.1474 | 0.4087 | 3 | 30 | mononuclear cell differentiation |
| GO:0045351 | 0.0077 | 18.2658 | 0.1362 | 2 | 10 | type I interferon biosynthetic process |
| GO:0042742 | 0.0078 | 2.9718 | 2.8338 | 8 | 208 | defense response to bacterium |
| GO:0048147 | 0.0085 | 7.8559 | 0.4223 | 3 | 31 | negative regulation of fibroblast proliferation |
| GO:1902622 | 0.0085 | 7.8559 | 0.4223 | 3 | 31 | regulation of neutrophil migration |
| GO:0050776 | 0.0086 | 2.4292 | 4.7679 | 11 | 368 | regulation of immune response |
| GO:0050435 | 0.0092 | 7.5845 | 0.436 | 3 | 32 | amyloid-beta metabolic process |
| GO:0070897 | 0.0092 | 7.5845 | 0.436 | 3 | 32 | DNA-templated transcriptional preinitiation complex assembly |
| GO:0034384 | 0.0094 | 16.2352 | 0.1499 | 2 | 11 | high-density lipoprotein particle clearance |
| GO:0044546 | 0.0094 | 16.2352 | 0.1499 | 2 | 11 | NLRP3 inflammasome complex assembly |
| GO:1903827 | 0.0099 | 2.0698 | 7.6295 | 15 | 560 | regulation of cellular protein localization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070370 | 2e-04 | Inf | 0.0301 | 2 | 2 | cellular heat acclimation |
| GO:0070434 | 7e-04 | 131.8947 | 0.0452 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0090063 | 7e-04 | 131.8947 | 0.0452 | 2 | 3 | positive regulation of microtubule nucleation |
| GO:0089711 | 0.0011 | 18.0529 | 0.2109 | 3 | 14 | L-glutamate transmembrane transport |
| GO:0043010 | 0.0011 | 3.045 | 4.2032 | 12 | 279 | camera-type eye development |
| GO:1902261 | 0.0013 | 65.943 | 0.0603 | 2 | 4 | positive regulation of delayed rectifier potassium channel activity |
| GO:2000741 | 0.0013 | 65.943 | 0.0603 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
| GO:0003407 | 0.0018 | 6.2826 | 0.8738 | 5 | 58 | neural retina development |
| GO:0030049 | 0.0018 | 8.5675 | 0.5273 | 4 | 35 | muscle filament sliding |
| GO:0048706 | 0.0019 | 4.299 | 1.7476 | 7 | 116 | embryonic skeletal system development |
| GO:0046604 | 0.0022 | 43.9591 | 0.0753 | 2 | 5 | positive regulation of mitotic centrosome separation |
| GO:0015800 | 0.0023 | 13.2352 | 0.2712 | 3 | 18 | acidic amino acid transport |
| GO:0007218 | 0.0027 | 4.6567 | 1.386 | 6 | 92 | neuropeptide signaling pathway |
| GO:0048562 | 0.0027 | 2.8659 | 4.0676 | 11 | 270 | embryonic organ morphogenesis |
| GO:0050808 | 0.0027 | 3.0473 | 3.4801 | 10 | 231 | synapse organization |
| GO:0048701 | 0.0033 | 7.1753 | 0.6177 | 4 | 41 | embryonic cranial skeleton morphogenesis |
| GO:0060047 | 0.0033 | 2.9524 | 3.5855 | 10 | 238 | heart contraction |
| GO:0006342 | 0.0044 | 4.1688 | 1.5366 | 6 | 102 | chromatin silencing |
| GO:0060463 | 0.0045 | 26.3719 | 0.1055 | 2 | 7 | lung lobe morphogenesis |
| GO:1903265 | 0.0045 | 26.3719 | 0.1055 | 2 | 7 | positive regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0001964 | 0.0048 | 9.9231 | 0.3465 | 3 | 23 | startle response |
| GO:1901379 | 0.0049 | 4.8918 | 1.0998 | 5 | 73 | regulation of potassium ion transmembrane transport |
| GO:0060042 | 0.005 | 6.319 | 0.693 | 4 | 46 | retina morphogenesis in camera-type eye |
| GO:0007399 | 0.005 | 1.592 | 30.7028 | 45 | 2038 | nervous system development |
| GO:0031112 | 0.0054 | 9.45 | 0.3616 | 3 | 24 | positive regulation of microtubule polymerization or depolymerization |
| GO:0042026 | 0.0054 | 9.45 | 0.3616 | 3 | 24 | protein refolding |
| GO:1900034 | 0.0055 | 4.7514 | 1.1299 | 5 | 75 | regulation of cellular response to heat |
| GO:0018210 | 0.0059 | 3.922 | 1.627 | 6 | 108 | peptidyl-threonine modification |
| GO:0006776 | 0.006 | 21.9751 | 0.1205 | 2 | 8 | vitamin A metabolic process |
| GO:0070424 | 0.006 | 21.9751 | 0.1205 | 2 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0070207 | 0.0068 | 8.6271 | 0.3917 | 3 | 26 | protein homotrimerization |
| GO:0038003 | 0.0076 | 18.8346 | 0.1356 | 2 | 9 | opioid receptor signaling pathway |
| GO:0042574 | 0.0076 | 18.8346 | 0.1356 | 2 | 9 | retinal metabolic process |
| GO:0009408 | 0.0077 | 3.2694 | 2.2598 | 7 | 150 | response to heat |
| GO:0051965 | 0.0083 | 5.4138 | 0.7985 | 4 | 53 | positive regulation of synapse assembly |
| GO:0010959 | 0.0094 | 2.3941 | 4.8209 | 11 | 320 | regulation of metal ion transport |
| GO:0090084 | 0.0094 | 16.4792 | 0.1507 | 2 | 10 | negative regulation of inclusion body assembly |
| GO:0051239 | 0.0098 | 1.481 | 38.8983 | 53 | 2582 | regulation of multicellular organismal process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 17.1749 | 4.6977 | 53 | 326 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0 | 13.4839 | 6.0234 | 55 | 418 | sensory perception of chemical stimulus |
| GO:0050906 | 0 | 13.4242 | 5.9082 | 54 | 410 | detection of stimulus involved in sensory perception |
| GO:0009593 | 0 | 13.405 | 5.7785 | 53 | 401 | detection of chemical stimulus |
| GO:0050877 | 0 | 5.5504 | 16.1682 | 65 | 1122 | nervous system process |
| GO:0007186 | 0 | 5.2845 | 16.5429 | 64 | 1148 | G-protein coupled receptor signaling pathway |
| GO:0018149 | 0 | 21.1154 | 0.7637 | 12 | 53 | peptide cross-linking |
| GO:0009913 | 0 | 4.5689 | 4.6689 | 19 | 324 | epidermal cell differentiation |
| GO:0032501 | 0 | 1.9599 | 86.3029 | 120 | 6338 | multicellular organismal process |
| GO:1901750 | 0 | 69.6435 | 0.1153 | 4 | 8 | leukotriene D4 biosynthetic process |
| GO:0043588 | 0 | 3.7917 | 5.5479 | 19 | 385 | skin development |
| GO:0006751 | 0 | 55.7111 | 0.1297 | 4 | 9 | glutathione catabolic process |
| GO:0070268 | 1e-04 | 5.7563 | 1.5275 | 8 | 106 | cornification |
| GO:0050896 | 6e-04 | 1.5788 | 110.6845 | 135 | 7681 | response to stimulus |
| GO:0031424 | 7e-04 | 5.122 | 1.4822 | 7 | 106 | keratinization |
| GO:0006691 | 8e-04 | 11.1274 | 0.4179 | 4 | 29 | leukotriene metabolic process |
| GO:0046604 | 0.002 | 46.0061 | 0.0721 | 2 | 5 | positive regulation of mitotic centrosome separation |
| GO:0046456 | 0.0036 | 6.9477 | 0.634 | 4 | 44 | icosanoid biosynthetic process |
| GO:1901568 | 0.0043 | 3.6575 | 2.0318 | 7 | 141 | fatty acid derivative metabolic process |
| GO:0007601 | 0.0049 | 3.2255 | 2.6227 | 8 | 182 | visual perception |
| GO:1904628 | 0.0055 | 22.9985 | 0.1153 | 2 | 8 | cellular response to phorbol 13-acetate 12-myristate |
| GO:0023052 | 0.0074 | 1.4102 | 81.9794 | 100 | 5689 | signaling |
| GO:0007154 | 0.0082 | 1.4026 | 82.2532 | 100 | 5708 | cell communication |
| GO:0042340 | 0.0086 | 17.2466 | 0.1441 | 2 | 10 | keratan sulfate catabolic process |
| GO:0002548 | 0.0097 | 5.1416 | 0.8358 | 4 | 58 | monocyte chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1901750 | 0 | 79.7354 | 0.1011 | 4 | 8 | leukotriene D4 biosynthetic process |
| GO:0006751 | 0 | 63.7841 | 0.1138 | 4 | 9 | glutathione catabolic process |
| GO:0006742 | 2e-04 | Inf | 0.0253 | 2 | 2 | NADP catabolic process |
| GO:0060326 | 2e-04 | 3.9355 | 3.0214 | 11 | 239 | cell chemotaxis |
| GO:0032501 | 3e-04 | 1.6667 | 82.8028 | 107 | 6550 | multicellular organismal process |
| GO:0006691 | 5e-04 | 12.7399 | 0.3666 | 4 | 29 | leukotriene metabolic process |
| GO:0032914 | 9e-04 | 78.911 | 0.0506 | 2 | 4 | positive regulation of transforming growth factor beta1 production |
| GO:2000741 | 9e-04 | 78.911 | 0.0506 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
| GO:0006790 | 0.0012 | 3.0182 | 4.2476 | 12 | 336 | sulfur compound metabolic process |
| GO:0072526 | 0.0016 | 52.6038 | 0.0632 | 2 | 5 | pyridine-containing compound catabolic process |
| GO:0035025 | 0.0017 | 14.8599 | 0.2402 | 3 | 19 | positive regulation of Rho protein signal transduction |
| GO:0007420 | 0.002 | 2.3464 | 7.7493 | 17 | 613 | brain development |
| GO:0008347 | 0.0023 | 7.9545 | 0.5562 | 4 | 44 | glial cell migration |
| GO:0046456 | 0.0023 | 7.9545 | 0.5562 | 4 | 44 | icosanoid biosynthetic process |
| GO:0070098 | 0.0024 | 5.7836 | 0.9355 | 5 | 74 | chemokine-mediated signaling pathway |
| GO:2000179 | 0.0027 | 7.5747 | 0.5815 | 4 | 46 | positive regulation of neural precursor cell proliferation |
| GO:0021801 | 0.0029 | 11.8847 | 0.2908 | 3 | 23 | cerebral cortex radial glia guided migration |
| GO:0071604 | 0.0033 | 11.318 | 0.3034 | 3 | 24 | transforming growth factor beta production |
| GO:0048731 | 0.0033 | 1.5697 | 45.3463 | 62 | 3732 | system development |
| GO:0032502 | 0.0034 | 1.5019 | 69.3647 | 88 | 5487 | developmental process |
| GO:0009435 | 0.0042 | 10.3325 | 0.3287 | 3 | 26 | NAD biosynthetic process |
| GO:0006570 | 0.0042 | 26.2967 | 0.1011 | 2 | 8 | tyrosine metabolic process |
| GO:2000304 | 0.0042 | 26.2967 | 0.1011 | 2 | 8 | positive regulation of ceramide biosynthetic process |
| GO:0032370 | 0.0045 | 6.4896 | 0.67 | 4 | 53 | positive regulation of lipid transport |
| GO:0001501 | 0.0051 | 2.402 | 5.7267 | 13 | 453 | skeletal system development |
| GO:0007186 | 0.0053 | 1.8487 | 14.5126 | 25 | 1148 | G-protein coupled receptor signaling pathway |
| GO:0034145 | 0.0054 | 22.5385 | 0.1138 | 2 | 9 | positive regulation of toll-like receptor 4 signaling pathway |
| GO:0002548 | 0.0062 | 5.8867 | 0.7332 | 4 | 58 | monocyte chemotaxis |
| GO:0019363 | 0.0063 | 8.7994 | 0.3792 | 3 | 30 | pyridine nucleotide biosynthetic process |
| GO:0042340 | 0.0067 | 19.7199 | 0.1264 | 2 | 10 | keratan sulfate catabolic process |
| GO:1904627 | 0.0067 | 19.7199 | 0.1264 | 2 | 10 | response to phorbol 13-acetate 12-myristate |
| GO:0008038 | 0.0069 | 8.4846 | 0.3919 | 3 | 31 | neuron recognition |
| GO:0042330 | 0.007 | 2.229 | 6.6369 | 14 | 525 | taxis |
| GO:0045665 | 0.0071 | 3.3192 | 2.2249 | 7 | 176 | negative regulation of neuron differentiation |
| GO:0060322 | 0.0071 | 8.3514 | 0.3963 | 3 | 33 | head development |
| GO:0031345 | 0.0074 | 3.7172 | 1.7066 | 6 | 135 | negative regulation of cell projection organization |
| GO:0051962 | 0.0079 | 2.3535 | 5.3727 | 12 | 425 | positive regulation of nervous system development |
| GO:0009109 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | coenzyme catabolic process |
| GO:0055057 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | neuroblast division |
| GO:0018107 | 0.0095 | 4.1064 | 1.2894 | 5 | 102 | peptidyl-threonine phosphorylation |
| GO:0002523 | 0.0097 | 15.7738 | 0.1517 | 2 | 12 | leukocyte migration involved in inflammatory response |
| GO:0006047 | 0.0097 | 15.7738 | 0.1517 | 2 | 12 | UDP-N-acetylglucosamine metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 256.0171 | 0.3196 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 0 | 45.1373 | 0.5828 | 14 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 34.8671 | 0.6768 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 29.4951 | 0.7519 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 27.3846 | 0.7895 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0051290 | 0 | 26.4385 | 0.8083 | 14 | 43 | protein heterotetramerization |
| GO:0016233 | 0 | 21.2877 | 0.9399 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 21.2877 | 0.9399 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0043044 | 0 | 14.188 | 1.3723 | 15 | 73 | ATP-dependent chromatin remodeling |
| GO:0006303 | 0 | 14.7219 | 1.2407 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0045815 | 0 | 11.9519 | 1.4663 | 14 | 78 | positive regulation of gene expression, epigenetic |
| GO:0031497 | 0 | 7.4226 | 2.6882 | 17 | 143 | chromatin assembly |
| GO:0060964 | 0 | 8.9864 | 1.8611 | 14 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 8.8813 | 1.8799 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:1903707 | 0 | 7.3208 | 2.3874 | 15 | 127 | negative regulation of hemopoiesis |
| GO:0045814 | 0 | 7.407 | 2.1994 | 14 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 7.1282 | 2.2746 | 14 | 121 | regulation of gene silencing |
| GO:0045637 | 0 | 4.7755 | 4.2297 | 18 | 225 | regulation of myeloid cell differentiation |
| GO:0032200 | 0 | 5.397 | 2.9138 | 14 | 155 | telomere organization |
| GO:0065004 | 0 | 4.4765 | 3.9665 | 16 | 211 | protein-DNA complex assembly |
| GO:0006352 | 0 | 4.1727 | 4.2297 | 16 | 225 | DNA-templated transcription, initiation |
| GO:0071103 | 0 | 3.9 | 4.7937 | 17 | 255 | DNA conformation change |
| GO:0002244 | 0 | 4.4943 | 3.4402 | 14 | 183 | hematopoietic progenitor cell differentiation |
| GO:0051259 | 0 | 2.8422 | 9.2114 | 24 | 490 | protein oligomerization |
| GO:0045596 | 0 | 2.6063 | 11.298 | 27 | 601 | negative regulation of cell differentiation |
| GO:0048863 | 1e-04 | 3.5366 | 4.6057 | 15 | 245 | stem cell differentiation |
| GO:0035194 | 2e-04 | 3.1972 | 5.0569 | 15 | 269 | posttranscriptional gene silencing by RNA |
| GO:0043652 | 2e-04 | 39.5493 | 0.1316 | 3 | 7 | engulfment of apoptotic cell |
| GO:2000026 | 3e-04 | 1.7743 | 32.2022 | 52 | 1713 | regulation of multicellular organismal development |
| GO:0010812 | 4e-04 | 6.9321 | 0.9775 | 6 | 52 | negative regulation of cell-substrate adhesion |
| GO:0045602 | 5e-04 | 26.3627 | 0.1692 | 3 | 9 | negative regulation of endothelial cell differentiation |
| GO:0030198 | 6e-04 | 2.8333 | 5.6584 | 15 | 301 | extracellular matrix organization |
| GO:0060249 | 9e-04 | 2.6292 | 6.4856 | 16 | 345 | anatomical structure homeostasis |
| GO:0035987 | 0.001 | 7.3601 | 0.7707 | 5 | 41 | endodermal cell differentiation |
| GO:0030574 | 0.001 | 5.7942 | 1.1467 | 6 | 61 | collagen catabolic process |
| GO:0036337 | 0.001 | 105.1158 | 0.0564 | 2 | 3 | Fas signaling pathway |
| GO:0017148 | 0.0011 | 2.5576 | 6.6547 | 16 | 354 | negative regulation of translation |
| GO:2000108 | 0.0011 | 10.0683 | 0.47 | 4 | 25 | positive regulation of leukocyte apoptotic process |
| GO:1901606 | 0.0016 | 4.4333 | 1.7107 | 7 | 91 | alpha-amino acid catabolic process |
| GO:0051895 | 0.0021 | 14.3748 | 0.2632 | 3 | 14 | negative regulation of focal adhesion assembly |
| GO:0044571 | 0.0021 | 52.5544 | 0.0752 | 2 | 4 | [2Fe-2S] cluster assembly |
| GO:0006281 | 0.0021 | 2.2081 | 9.1174 | 19 | 485 | DNA repair |
| GO:0007492 | 0.0023 | 4.825 | 1.3535 | 6 | 72 | endoderm development |
| GO:0071294 | 0.0025 | 13.1761 | 0.282 | 3 | 15 | cellular response to zinc ion |
| GO:0043537 | 0.0026 | 7.8278 | 0.5828 | 4 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:1902041 | 0.0037 | 5.2943 | 1.0339 | 5 | 55 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0032502 | 0.0044 | 1.3841 | 103.1486 | 125 | 5487 | developmental process |
| GO:0070482 | 0.0047 | 2.3344 | 6.3164 | 14 | 336 | response to oxygen levels |
| GO:0002578 | 0.005 | 26.2737 | 0.1128 | 2 | 6 | negative regulation of antigen processing and presentation |
| GO:0002040 | 0.0059 | 3.9275 | 1.6355 | 6 | 87 | sprouting angiogenesis |
| GO:0007264 | 0.006 | 2.0806 | 8.591 | 17 | 457 | small GTPase mediated signal transduction |
| GO:0001666 | 0.0061 | 2.3376 | 5.8464 | 13 | 311 | response to hypoxia |
| GO:0051716 | 0.0063 | 1.3571 | 120.7066 | 142 | 6421 | cellular response to stimulus |
| GO:0045926 | 0.0067 | 2.6544 | 3.9665 | 10 | 211 | negative regulation of growth |
| GO:0006538 | 0.0069 | 21.0175 | 0.1316 | 2 | 7 | glutamate catabolic process |
| GO:0097428 | 0.0069 | 21.0175 | 0.1316 | 2 | 7 | protein maturation by iron-sulfur cluster transfer |
| GO:0001952 | 0.0077 | 3.6979 | 1.7295 | 6 | 92 | regulation of cell-matrix adhesion |
| GO:0017015 | 0.0086 | 3.6134 | 1.7671 | 6 | 94 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0033860 | 0.0091 | 17.5135 | 0.1504 | 2 | 8 | regulation of NAD(P)H oxidase activity |
| GO:0060155 | 0.0091 | 17.5135 | 0.1504 | 2 | 8 | platelet dense granule organization |
| GO:0097049 | 0.0091 | 17.5135 | 0.1504 | 2 | 8 | motor neuron apoptotic process |
| GO:0098711 | 0.0091 | 17.5135 | 0.1504 | 2 | 8 | iron ion import across plasma membrane |
| GO:0034109 | 0.0096 | 4.1323 | 1.2971 | 5 | 69 | homotypic cell-cell adhesion |
| GO:0048731 | 0.0096 | 1.3602 | 78.6726 | 97 | 4185 | system development |
| GO:0006584 | 0.01 | 5.15 | 0.8459 | 4 | 45 | catecholamine metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060322 | 0 | 3.0826 | 9.7744 | 27 | 646 | head development |
| GO:0007389 | 0 | 3.6957 | 5.9917 | 20 | 396 | pattern specification process |
| GO:0099537 | 0 | 3.1487 | 8.4429 | 24 | 558 | trans-synaptic signaling |
| GO:0007218 | 0 | 7.3036 | 1.392 | 9 | 92 | neuropeptide signaling pathway |
| GO:0021517 | 0 | 11.1111 | 0.6355 | 6 | 42 | ventral spinal cord development |
| GO:0002067 | 1e-04 | 10.2544 | 0.6809 | 6 | 45 | glandular epithelial cell differentiation |
| GO:0060078 | 1e-04 | 5.402 | 1.8308 | 9 | 121 | regulation of postsynaptic membrane potential |
| GO:0060219 | 1e-04 | 20.3633 | 0.2572 | 4 | 17 | camera-type eye photoreceptor cell differentiation |
| GO:0045597 | 1e-04 | 2.3772 | 12.4072 | 27 | 820 | positive regulation of cell differentiation |
| GO:0048665 | 1e-04 | 11.8584 | 0.4993 | 5 | 33 | neuron fate specification |
| GO:0009952 | 1e-04 | 4.1975 | 2.8446 | 11 | 188 | anterior/posterior pattern specification |
| GO:0021953 | 1e-04 | 4.5518 | 2.3906 | 10 | 158 | central nervous system neuron differentiation |
| GO:0099565 | 2e-04 | 5.7025 | 1.5433 | 8 | 102 | chemical synaptic transmission, postsynaptic |
| GO:0048699 | 2e-04 | 2.1363 | 17.0009 | 33 | 1149 | generation of neurons |
| GO:0048644 | 2e-04 | 6.4054 | 1.2105 | 7 | 80 | muscle organ morphogenesis |
| GO:0120039 | 3e-04 | 2.6045 | 8.2916 | 20 | 548 | plasma membrane bounded cell projection morphogenesis |
| GO:0046877 | 3e-04 | 32.9605 | 0.1362 | 3 | 9 | regulation of saliva secretion |
| GO:0007417 | 3e-04 | 2.4733 | 9.6392 | 22 | 659 | central nervous system development |
| GO:0007267 | 3e-04 | 2.1483 | 15.301 | 30 | 1054 | cell-cell signaling |
| GO:0055008 | 3e-04 | 7.2635 | 0.923 | 6 | 61 | cardiac muscle tissue morphogenesis |
| GO:0021559 | 4e-04 | 28.25 | 0.1513 | 3 | 10 | trigeminal nerve development |
| GO:0007187 | 4e-04 | 13.5927 | 0.3538 | 4 | 24 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0032990 | 4e-04 | 2.506 | 8.5942 | 20 | 568 | cell part morphogenesis |
| GO:0009914 | 5e-04 | 3.1891 | 4.3728 | 13 | 289 | hormone transport |
| GO:0021675 | 5e-04 | 6.656 | 0.9986 | 6 | 66 | nerve development |
| GO:0003148 | 5e-04 | 12.5991 | 0.3783 | 4 | 25 | outflow tract septum morphogenesis |
| GO:0003309 | 5e-04 | 12.5991 | 0.3783 | 4 | 25 | type B pancreatic cell differentiation |
| GO:0008306 | 6e-04 | 6.4404 | 1.0289 | 6 | 68 | associative learning |
| GO:0061061 | 6e-04 | 2.4367 | 8.8212 | 20 | 583 | muscle structure development |
| GO:0006813 | 6e-04 | 3.4796 | 3.3893 | 11 | 224 | potassium ion transport |
| GO:0010159 | 7e-04 | 131.31 | 0.0454 | 2 | 3 | specification of animal organ position |
| GO:0021524 | 7e-04 | 131.31 | 0.0454 | 2 | 3 | visceral motor neuron differentiation |
| GO:0003016 | 7e-04 | 11.502 | 0.4085 | 4 | 27 | respiratory system process |
| GO:0003206 | 8e-04 | 7.6764 | 0.7286 | 5 | 49 | cardiac chamber morphogenesis |
| GO:0023061 | 9e-04 | 2.7299 | 5.8707 | 15 | 388 | signal release |
| GO:0021819 | 9e-04 | 19.7711 | 0.1967 | 3 | 13 | layer formation in cerebral cortex |
| GO:0021515 | 9e-04 | 7.3702 | 0.7565 | 5 | 50 | cell differentiation in spinal cord |
| GO:0007409 | 9e-04 | 2.7076 | 5.9161 | 15 | 391 | axonogenesis |
| GO:0006355 | 9e-04 | 1.605 | 49.553 | 70 | 3275 | regulation of transcription, DNA-templated |
| GO:0003229 | 0.001 | 7.2095 | 0.7717 | 5 | 51 | ventricular cardiac muscle tissue development |
| GO:0048593 | 0.001 | 4.8128 | 1.5736 | 7 | 104 | camera-type eye morphogenesis |
| GO:0050793 | 0.001 | 1.7 | 33.2724 | 51 | 2199 | regulation of developmental process |
| GO:0030900 | 0.0011 | 3.4718 | 3.0788 | 10 | 209 | forebrain development |
| GO:0021794 | 0.0011 | 17.9725 | 0.2118 | 3 | 14 | thalamus development |
| GO:0050884 | 0.0011 | 17.9725 | 0.2118 | 3 | 14 | neuromuscular process controlling posture |
| GO:0007268 | 0.0011 | 2.5652 | 6.6622 | 16 | 453 | chemical synaptic transmission |
| GO:2001141 | 0.0012 | 1.5879 | 49.9615 | 70 | 3302 | regulation of RNA biosynthetic process |
| GO:0071695 | 0.0012 | 4.1134 | 2.088 | 8 | 138 | anatomical structure maturation |
| GO:0031175 | 0.0012 | 2.1133 | 12.1953 | 24 | 806 | neuron projection development |
| GO:0043388 | 0.0012 | 6.9082 | 0.8019 | 5 | 53 | positive regulation of DNA binding |
| GO:0050794 | 0.0013 | 1.563 | 140.0563 | 162 | 9416 | regulation of cellular process |
| GO:0007188 | 0.0013 | 4.0506 | 2.1183 | 8 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0001992 | 0.0013 | 65.6507 | 0.0605 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0007198 | 0.0013 | 65.6507 | 0.0605 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0034287 | 0.0013 | 65.6507 | 0.0605 | 2 | 4 | detection of monosaccharide stimulus |
| GO:0048880 | 0.0013 | 65.6507 | 0.0605 | 2 | 4 | sensory system development |
| GO:0051594 | 0.0013 | 65.6507 | 0.0605 | 2 | 4 | detection of glucose |
| GO:0048646 | 0.0015 | 2.0178 | 13.8558 | 26 | 927 | anatomical structure formation involved in morphogenesis |
| GO:0035637 | 0.0016 | 3.5452 | 2.7084 | 9 | 179 | multicellular organismal signaling |
| GO:0060428 | 0.0017 | 8.8141 | 0.5144 | 4 | 34 | lung epithelium development |
| GO:0071396 | 0.002 | 2.3434 | 7.7166 | 17 | 510 | cellular response to lipid |
| GO:0051241 | 0.0021 | 1.9406 | 14.934 | 27 | 987 | negative regulation of multicellular organismal process |
| GO:0048639 | 0.0022 | 3.71 | 2.2999 | 8 | 152 | positive regulation of developmental growth |
| GO:0051970 | 0.0022 | 43.7642 | 0.0757 | 2 | 5 | negative regulation of transmission of nerve impulse |
| GO:0060012 | 0.0022 | 43.7642 | 0.0757 | 2 | 5 | synaptic transmission, glycinergic |
| GO:0071205 | 0.0022 | 43.7642 | 0.0757 | 2 | 5 | protein localization to juxtaparanode region of axon |
| GO:0061180 | 0.0023 | 5.9181 | 0.923 | 5 | 61 | mammary gland epithelium development |
| GO:0035270 | 0.0023 | 4.1269 | 1.8157 | 7 | 120 | endocrine system development |
| GO:0050768 | 0.0024 | 3.1046 | 3.4195 | 10 | 226 | negative regulation of neurogenesis |
| GO:0007631 | 0.0025 | 4.7307 | 1.3657 | 6 | 91 | feeding behavior |
| GO:0019219 | 0.0027 | 1.5085 | 57.7992 | 77 | 3820 | regulation of nucleobase-containing compound metabolic process |
| GO:0021761 | 0.0027 | 4.6357 | 1.392 | 6 | 92 | limbic system development |
| GO:0007210 | 0.0028 | 12.352 | 0.2875 | 3 | 19 | serotonin receptor signaling pathway |
| GO:0010002 | 0.0028 | 12.352 | 0.2875 | 3 | 19 | cardioblast differentiation |
| GO:0048562 | 0.0028 | 2.8527 | 4.0853 | 11 | 270 | embryonic organ morphogenesis |
| GO:0001709 | 0.0028 | 7.5524 | 0.5901 | 4 | 39 | cell fate determination |
| GO:0031644 | 0.0028 | 5.6161 | 0.9684 | 5 | 64 | regulation of neurological system process |
| GO:0051960 | 0.0031 | 2.0511 | 10.8941 | 21 | 720 | regulation of nervous system development |
| GO:0031290 | 0.0032 | 11.6246 | 0.3026 | 3 | 20 | retinal ganglion cell axon guidance |
| GO:0050951 | 0.0032 | 11.6246 | 0.3026 | 3 | 20 | sensory perception of temperature stimulus |
| GO:0051482 | 0.0032 | 11.6246 | 0.3026 | 3 | 20 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
| GO:0048705 | 0.0032 | 3.1847 | 2.9959 | 9 | 198 | skeletal system morphogenesis |
| GO:0002069 | 0.0033 | 32.821 | 0.0908 | 2 | 6 | columnar/cuboidal epithelial cell maturation |
| GO:0060430 | 0.0033 | 32.821 | 0.0908 | 2 | 6 | lung saccule development |
| GO:0001764 | 0.0033 | 3.852 | 1.9367 | 7 | 128 | neuron migration |
| GO:0090596 | 0.0034 | 2.9388 | 3.6011 | 10 | 238 | sensory organ morphogenesis |
| GO:0003208 | 0.0037 | 5.2581 | 1.0289 | 5 | 68 | cardiac ventricle morphogenesis |
| GO:0097659 | 0.0037 | 1.5034 | 52.0949 | 70 | 3443 | nucleic acid-templated transcription |
| GO:0097120 | 0.0037 | 10.9781 | 0.3177 | 3 | 21 | receptor localization to synapse |
| GO:0042310 | 0.0041 | 5.0956 | 1.0591 | 5 | 70 | vasoconstriction |
| GO:0050877 | 0.0042 | 1.8353 | 15.7277 | 27 | 1058 | nervous system process |
| GO:0060479 | 0.0043 | 10.3996 | 0.3329 | 3 | 22 | lung cell differentiation |
| GO:0006811 | 0.0043 | 1.7147 | 21.3191 | 34 | 1409 | ion transport |
| GO:0060986 | 0.0043 | 6.6062 | 0.6657 | 4 | 44 | endocrine hormone secretion |
| GO:0090066 | 0.0045 | 2.3486 | 6.2944 | 14 | 416 | regulation of anatomical structure size |
| GO:0001574 | 0.0046 | 26.255 | 0.1059 | 2 | 7 | ganglioside biosynthetic process |
| GO:0003223 | 0.0046 | 26.255 | 0.1059 | 2 | 7 | ventricular compact myocardium morphogenesis |
| GO:0044851 | 0.0046 | 26.255 | 0.1059 | 2 | 7 | hair cycle phase |
| GO:0048819 | 0.0046 | 26.255 | 0.1059 | 2 | 7 | regulation of hair follicle maturation |
| GO:0090394 | 0.0046 | 26.255 | 0.1059 | 2 | 7 | negative regulation of excitatory postsynaptic potential |
| GO:0050885 | 0.0047 | 6.4446 | 0.6809 | 4 | 45 | neuromuscular process controlling balance |
| GO:0019935 | 0.0048 | 4.1069 | 1.5585 | 6 | 103 | cyclic-nucleotide-mediated signaling |
| GO:0010460 | 0.0048 | 9.8789 | 0.348 | 3 | 23 | positive regulation of heart rate |
| GO:0021602 | 0.0048 | 9.8789 | 0.348 | 3 | 23 | cranial nerve morphogenesis |
| GO:0022030 | 0.0048 | 9.8789 | 0.348 | 3 | 23 | telencephalon glial cell migration |
| GO:0045662 | 0.0048 | 9.8789 | 0.348 | 3 | 23 | negative regulation of myoblast differentiation |
| GO:2000463 | 0.0048 | 9.8789 | 0.348 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
| GO:0031016 | 0.005 | 4.8699 | 1.1045 | 5 | 73 | pancreas development |
| GO:1901379 | 0.005 | 4.8699 | 1.1045 | 5 | 73 | regulation of potassium ion transmembrane transport |
| GO:0048869 | 0.005 | 1.4841 | 52.8811 | 70 | 3625 | cellular developmental process |
| GO:0051384 | 0.005 | 3.5556 | 2.088 | 7 | 138 | response to glucocorticoid |
| GO:0014706 | 0.0052 | 2.4881 | 5.0839 | 12 | 336 | striated muscle tissue development |
| GO:0021511 | 0.0055 | 9.4079 | 0.3631 | 3 | 24 | spinal cord patterning |
| GO:0003310 | 0.006 | 21.8777 | 0.121 | 2 | 8 | pancreatic A cell differentiation |
| GO:0008343 | 0.006 | 21.8777 | 0.121 | 2 | 8 | adult feeding behavior |
| GO:0045924 | 0.006 | 21.8777 | 0.121 | 2 | 8 | regulation of female receptivity |
| GO:0061140 | 0.006 | 21.8777 | 0.121 | 2 | 8 | lung secretory cell differentiation |
| GO:0060441 | 0.0062 | 8.9797 | 0.3783 | 3 | 25 | epithelial tube branching involved in lung morphogenesis |
| GO:0048666 | 0.0062 | 3.8738 | 1.6462 | 6 | 115 | neuron development |
| GO:0015837 | 0.0062 | 4.5981 | 1.1651 | 5 | 77 | amine transport |
| GO:0061387 | 0.0062 | 4.5981 | 1.1651 | 5 | 77 | regulation of extent of cell growth |
| GO:0055025 | 0.0064 | 5.8702 | 0.7414 | 4 | 49 | positive regulation of cardiac muscle tissue development |
| GO:0060485 | 0.0064 | 2.8484 | 3.3287 | 9 | 220 | mesenchyme development |
| GO:0046887 | 0.0071 | 3.756 | 1.6946 | 6 | 112 | positive regulation of hormone secretion |
| GO:1901701 | 0.0073 | 1.8104 | 14.0564 | 24 | 929 | cellular response to oxygen-containing compound |
| GO:0021562 | 0.0077 | 18.7511 | 0.1362 | 2 | 9 | vestibulocochlear nerve development |
| GO:0046549 | 0.0077 | 18.7511 | 0.1362 | 2 | 9 | retinal cone cell development |
| GO:0046855 | 0.0077 | 18.7511 | 0.1362 | 2 | 9 | inositol phosphate dephosphorylation |
| GO:0098598 | 0.0077 | 18.7511 | 0.1362 | 2 | 9 | learned vocalization behavior or vocal learning |
| GO:0010769 | 0.0078 | 2.7556 | 3.4347 | 9 | 227 | regulation of cell morphogenesis involved in differentiation |
| GO:0065008 | 0.0078 | 1.4986 | 40.2983 | 55 | 2757 | regulation of biological quality |
| GO:0046530 | 0.0078 | 5.5022 | 0.7868 | 4 | 52 | photoreceptor cell differentiation |
| GO:1904018 | 0.0079 | 3.2546 | 2.2696 | 7 | 150 | positive regulation of vasculature development |
| GO:0071805 | 0.0081 | 3.6504 | 1.7403 | 6 | 117 | potassium ion transmembrane transport |
| GO:0021885 | 0.0084 | 5.3896 | 0.8019 | 4 | 53 | forebrain cell migration |
| GO:0060045 | 0.0085 | 7.9005 | 0.4237 | 3 | 28 | positive regulation of cardiac muscle cell proliferation |
| GO:0000902 | 0.0087 | 1.8296 | 12.7098 | 22 | 840 | cell morphogenesis |
| GO:0048469 | 0.0087 | 3.1871 | 2.315 | 7 | 153 | cell maturation |
| GO:0030073 | 0.0089 | 2.8957 | 2.9051 | 8 | 192 | insulin secretion |
| GO:0050886 | 0.009 | 7.7112 | 0.4324 | 3 | 29 | endocrine process |
| GO:0021543 | 0.009 | 3.1652 | 2.3301 | 7 | 154 | pallium development |
| GO:0003203 | 0.0093 | 7.5962 | 0.4388 | 3 | 29 | endocardial cushion morphogenesis |
| GO:0019098 | 0.0093 | 7.5962 | 0.4388 | 3 | 29 | reproductive behavior |
| GO:0021799 | 0.0093 | 7.5962 | 0.4388 | 3 | 29 | cerebral cortex radially oriented cell migration |
| GO:0006874 | 0.0094 | 2.2925 | 5.4924 | 12 | 363 | cellular calcium ion homeostasis |
| GO:0032275 | 0.0095 | 16.4061 | 0.1513 | 2 | 10 | luteinizing hormone secretion |
| GO:0048845 | 0.0095 | 16.4061 | 0.1513 | 2 | 10 | venous blood vessel morphogenesis |
| GO:0060947 | 0.0095 | 16.4061 | 0.1513 | 2 | 10 | cardiac vascular smooth muscle cell differentiation |
| GO:0097050 | 0.0095 | 16.4061 | 0.1513 | 2 | 10 | type B pancreatic cell apoptotic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 7.0751 | 1.9222 | 12 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0045658 | 5e-04 | 151.407 | 0.0395 | 2 | 3 | regulation of neutrophil differentiation |
| GO:0002376 | 5e-04 | 1.7758 | 32.5455 | 51 | 2472 | immune system process |
| GO:0045354 | 0.001 | 75.6985 | 0.0527 | 2 | 4 | regulation of interferon-alpha biosynthetic process |
| GO:0050776 | 0.0011 | 3.7822 | 2.5503 | 9 | 202 | regulation of immune response |
| GO:0022610 | 0.0016 | 1.9447 | 16.2069 | 29 | 1231 | biological adhesion |
| GO:0045409 | 0.0017 | 50.4623 | 0.0658 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
| GO:0002761 | 0.0022 | 4.8489 | 1.3297 | 6 | 101 | regulation of myeloid leukocyte differentiation |
| GO:0045087 | 0.0024 | 2.1483 | 9.9664 | 20 | 757 | innate immune response |
| GO:0032687 | 0.0025 | 37.8442 | 0.079 | 2 | 6 | negative regulation of interferon-alpha production |
| GO:0045357 | 0.0025 | 37.8442 | 0.079 | 2 | 6 | regulation of interferon-beta biosynthetic process |
| GO:0098609 | 0.0034 | 2.1202 | 9.5583 | 19 | 726 | cell-cell adhesion |
| GO:0045656 | 0.0035 | 30.2734 | 0.0922 | 2 | 7 | negative regulation of monocyte differentiation |
| GO:0046598 | 0.0035 | 30.2734 | 0.0922 | 2 | 7 | positive regulation of viral entry into host cell |
| GO:0051256 | 0.0035 | 30.2734 | 0.0922 | 2 | 7 | mitotic spindle midzone assembly |
| GO:2000035 | 0.0035 | 30.2734 | 0.0922 | 2 | 7 | regulation of stem cell division |
| GO:0006950 | 0.0037 | 1.5481 | 44.3682 | 61 | 3370 | response to stress |
| GO:0002757 | 0.0038 | 2.4906 | 5.5296 | 13 | 420 | immune response-activating signal transduction |
| GO:0060333 | 0.0041 | 5.099 | 1.0533 | 5 | 80 | interferon-gamma-mediated signaling pathway |
| GO:0080154 | 0.0042 | 10.3609 | 0.3291 | 3 | 25 | regulation of fertilization |
| GO:0090023 | 0.0042 | 10.3609 | 0.3291 | 3 | 25 | positive regulation of neutrophil chemotaxis |
| GO:0051607 | 0.0052 | 3.1943 | 2.6463 | 8 | 201 | defense response to virus |
| GO:1902107 | 0.0053 | 4.0003 | 1.593 | 6 | 121 | positive regulation of leukocyte differentiation |
| GO:0000910 | 0.0057 | 3.9314 | 1.6194 | 6 | 123 | cytokinesis |
| GO:0032728 | 0.0058 | 9.1158 | 0.3686 | 3 | 28 | positive regulation of interferon-beta production |
| GO:0097529 | 0.006 | 3.4265 | 2.1592 | 7 | 164 | myeloid leukocyte migration |
| GO:0007585 | 0.0067 | 5.7516 | 0.7504 | 4 | 57 | respiratory gaseous exchange |
| GO:0009607 | 0.007 | 1.9706 | 10.2297 | 19 | 777 | response to biotic stimulus |
| GO:0097009 | 0.007 | 8.4394 | 0.395 | 3 | 30 | energy homeostasis |
| GO:1903131 | 0.007 | 8.4394 | 0.395 | 3 | 30 | mononuclear cell differentiation |
| GO:0001818 | 0.0071 | 3.0198 | 2.7911 | 8 | 212 | negative regulation of cytokine production |
| GO:0045351 | 0.0072 | 18.9171 | 0.1317 | 2 | 10 | type I interferon biosynthetic process |
| GO:0051231 | 0.0072 | 18.9171 | 0.1317 | 2 | 10 | spindle elongation |
| GO:1900004 | 0.0072 | 18.9171 | 0.1317 | 2 | 10 | negative regulation of serine-type endopeptidase activity |
| GO:0050778 | 0.0073 | 2.0925 | 8.0837 | 16 | 614 | positive regulation of immune response |
| GO:0048147 | 0.0077 | 8.1374 | 0.4081 | 3 | 31 | negative regulation of fibroblast proliferation |
| GO:1902622 | 0.0077 | 8.1374 | 0.4081 | 3 | 31 | regulation of neutrophil migration |
| GO:0043122 | 0.0079 | 2.9609 | 2.8438 | 8 | 216 | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0070897 | 0.0084 | 7.8563 | 0.4213 | 3 | 32 | DNA-templated transcriptional preinitiation complex assembly |
| GO:0051707 | 0.0086 | 1.9656 | 9.6899 | 18 | 736 | response to other organism |
| GO:0034384 | 0.0088 | 16.8141 | 0.1448 | 2 | 11 | high-density lipoprotein particle clearance |
| GO:0051246 | 0.0097 | 1.5216 | 33.7567 | 47 | 2564 | regulation of protein metabolic process |
| GO:0071621 | 0.0099 | 4.0632 | 1.3034 | 5 | 99 | granulocyte chemotaxis |
| GO:0019731 | 0.01 | 7.3485 | 0.4476 | 3 | 34 | antibacterial humoral response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 41.2206 | 0.3736 | 10 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 33.2825 | 0.4339 | 10 | 36 | chromatin silencing at rDNA |
| GO:0038111 | 0 | 33.2825 | 0.4339 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 33.2825 | 0.4339 | 10 | 36 | response to interleukin-7 |
| GO:0051290 | 0 | 26.2104 | 0.5182 | 10 | 43 | protein heterotetramerization |
| GO:0006333 | 0 | 9.4813 | 2.0007 | 16 | 166 | chromatin assembly or disassembly |
| GO:0006323 | 0 | 8.5064 | 2.2055 | 16 | 183 | DNA packaging |
| GO:0045652 | 0 | 15.9203 | 0.8557 | 11 | 71 | regulation of megakaryocyte differentiation |
| GO:0071824 | 0 | 6.7222 | 2.9166 | 17 | 242 | protein-DNA complex subunit organization |
| GO:0045815 | 0 | 12.6902 | 0.9401 | 10 | 78 | positive regulation of gene expression, epigenetic |
| GO:1902036 | 0 | 10.7121 | 1.2052 | 11 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0045814 | 0 | 8.9839 | 1.4101 | 11 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 9.6823 | 1.1932 | 10 | 99 | regulation of gene silencing by miRNA |
| GO:0002244 | 0 | 6.669 | 2.2055 | 13 | 183 | hematopoietic progenitor cell differentiation |
| GO:0030099 | 0 | 4.7019 | 4.3147 | 18 | 358 | myeloid cell differentiation |
| GO:0048863 | 0 | 5.2948 | 2.9528 | 14 | 245 | stem cell differentiation |
| GO:0060968 | 0 | 7.7519 | 1.4583 | 10 | 121 | regulation of gene silencing |
| GO:1903706 | 0 | 3.9906 | 5.0257 | 18 | 417 | regulation of hemopoiesis |
| GO:0032200 | 0 | 5.9207 | 1.8681 | 10 | 155 | telomere organization |
| GO:0035194 | 0 | 4.4031 | 3.242 | 13 | 269 | posttranscriptional gene silencing by RNA |
| GO:0048534 | 0 | 2.7358 | 9.7381 | 24 | 808 | hematopoietic or lymphoid organ development |
| GO:0050878 | 1e-04 | 3.261 | 5.3511 | 16 | 444 | regulation of body fluid levels |
| GO:0097274 | 1e-04 | Inf | 0.0241 | 2 | 2 | urea homeostasis |
| GO:0072505 | 3e-04 | 31.2327 | 0.1326 | 3 | 11 | divalent inorganic anion homeostasis |
| GO:0072506 | 3e-04 | 31.2327 | 0.1326 | 3 | 11 | trivalent inorganic anion homeostasis |
| GO:0007596 | 3e-04 | 3.534 | 3.6639 | 12 | 304 | blood coagulation |
| GO:0017148 | 4e-04 | 3.2866 | 4.2665 | 13 | 354 | negative regulation of translation |
| GO:1902679 | 5e-04 | 2.2038 | 12.944 | 26 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0006334 | 7e-04 | 6.1474 | 1.0621 | 6 | 93 | nucleosome assembly |
| GO:0045892 | 7e-04 | 2.177 | 12.5463 | 25 | 1041 | negative regulation of transcription, DNA-templated |
| GO:0045934 | 7e-04 | 2.0579 | 15.4991 | 29 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0071345 | 8e-04 | 2.3309 | 9.7743 | 21 | 811 | cellular response to cytokine stimulus |
| GO:0055083 | 9e-04 | 19.2138 | 0.1928 | 3 | 16 | monovalent inorganic anion homeostasis |
| GO:0051259 | 9e-04 | 2.7296 | 5.9055 | 15 | 490 | protein oligomerization |
| GO:0045595 | 0.001 | 1.9345 | 18.8495 | 33 | 1564 | regulation of cell differentiation |
| GO:0072507 | 0.0012 | 2.8641 | 4.857 | 13 | 403 | divalent inorganic cation homeostasis |
| GO:0007611 | 0.0013 | 3.6779 | 2.6153 | 9 | 217 | learning or memory |
| GO:0030539 | 0.0017 | 14.689 | 0.241 | 3 | 20 | male genitalia development |
| GO:0021902 | 0.0021 | 41.4258 | 0.0723 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0034248 | 0.0036 | 2.3365 | 6.8336 | 15 | 567 | regulation of cellular amide metabolic process |
| GO:1902253 | 0.0037 | 10.8528 | 0.3134 | 3 | 26 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0055065 | 0.0042 | 2.3724 | 6.2671 | 14 | 520 | metal ion homeostasis |
| GO:0071230 | 0.0043 | 6.5499 | 0.6629 | 4 | 55 | cellular response to amino acid stimulus |
| GO:0048731 | 0.0046 | 1.5248 | 50.4382 | 67 | 4185 | system development |
| GO:0006935 | 0.0046 | 2.3484 | 6.3274 | 14 | 525 | chemotaxis |
| GO:0006874 | 0.0046 | 2.6609 | 4.3749 | 11 | 363 | cellular calcium ion homeostasis |
| GO:0042472 | 0.0049 | 4.8711 | 1.0967 | 5 | 91 | inner ear morphogenesis |
| GO:0030643 | 0.0049 | 23.6672 | 0.1085 | 2 | 9 | cellular phosphate ion homeostasis |
| GO:0060546 | 0.0049 | 23.6672 | 0.1085 | 2 | 9 | negative regulation of necroptotic process |
| GO:0070232 | 0.005 | 9.5986 | 0.3495 | 3 | 29 | regulation of T cell apoptotic process |
| GO:0009611 | 0.0053 | 2.2354 | 7.1228 | 15 | 591 | response to wounding |
| GO:0010608 | 0.0056 | 2.1598 | 7.87 | 16 | 653 | posttranscriptional regulation of gene expression |
| GO:0017144 | 0.0066 | 8.6039 | 0.3857 | 3 | 32 | drug metabolic process |
| GO:0006873 | 0.0066 | 2.2437 | 6.6046 | 14 | 548 | cellular ion homeostasis |
| GO:0070227 | 0.007 | 5.6588 | 0.7593 | 4 | 63 | lymphocyte apoptotic process |
| GO:0002756 | 0.0072 | 8.3166 | 0.3977 | 3 | 33 | MyD88-independent toll-like receptor signaling pathway |
| GO:0019725 | 0.0075 | 1.9992 | 9.5694 | 18 | 794 | cellular homeostasis |
| GO:0002761 | 0.0075 | 4.3607 | 1.2173 | 5 | 101 | regulation of myeloid leukocyte differentiation |
| GO:0043604 | 0.0082 | 1.9403 | 10.413 | 19 | 864 | amide biosynthetic process |
| GO:0043029 | 0.0085 | 7.7958 | 0.4218 | 3 | 35 | T cell homeostasis |
| GO:0006140 | 0.0085 | 2.9225 | 2.8805 | 8 | 239 | regulation of nucleotide metabolic process |
| GO:0048663 | 0.0091 | 5.2149 | 0.8195 | 4 | 68 | neuron fate commitment |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009952 | 0 | 4.947 | 2.6722 | 12 | 188 | anterior/posterior pattern specification |
| GO:0048704 | 0 | 7.0738 | 1.265 | 8 | 89 | embryonic skeletal system morphogenesis |
| GO:0007156 | 0 | 5.2977 | 2.0752 | 10 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0009889 | 1e-04 | 1.7166 | 58.7309 | 84 | 4132 | regulation of biosynthetic process |
| GO:0007416 | 1e-04 | 5.1663 | 1.9046 | 9 | 134 | synapse assembly |
| GO:0044657 | 2e-04 | Inf | 0.0284 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0046960 | 2e-04 | Inf | 0.0284 | 2 | 2 | sensitization |
| GO:0052043 | 2e-04 | Inf | 0.0284 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 2e-04 | Inf | 0.0284 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 2e-04 | Inf | 0.0284 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:1902957 | 2e-04 | Inf | 0.0284 | 2 | 2 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
| GO:0009790 | 2e-04 | 2.3602 | 11.5548 | 25 | 829 | embryo development |
| GO:0007389 | 3e-04 | 3.1923 | 4.725 | 14 | 339 | pattern specification process |
| GO:0032501 | 3e-04 | 1.6431 | 81.9375 | 106 | 6154 | multicellular organismal process |
| GO:0032502 | 4e-04 | 1.7673 | 41.2776 | 61 | 3211 | developmental process |
| GO:0009712 | 4e-04 | 8.8502 | 0.6396 | 5 | 45 | catechol-containing compound metabolic process |
| GO:0051934 | 4e-04 | 26.3586 | 0.1564 | 3 | 11 | catecholamine uptake involved in synaptic transmission |
| GO:0090494 | 4e-04 | 26.3586 | 0.1564 | 3 | 11 | dopamine uptake |
| GO:1901856 | 6e-04 | 139.9907 | 0.0426 | 2 | 3 | negative regulation of cellular respiration |
| GO:0006355 | 7e-04 | 1.6488 | 46.5497 | 67 | 3275 | regulation of transcription, DNA-templated |
| GO:0048731 | 7e-04 | 2.1374 | 14.0661 | 27 | 1083 | system development |
| GO:0001501 | 8e-04 | 2.6618 | 6.4388 | 16 | 453 | skeletal system development |
| GO:0001963 | 8e-04 | 10.8516 | 0.4264 | 4 | 30 | synaptic transmission, dopaminergic |
| GO:2001141 | 9e-04 | 1.6313 | 46.9335 | 67 | 3302 | regulation of RNA biosynthetic process |
| GO:0009653 | 9e-04 | 1.7249 | 32.3503 | 50 | 2276 | anatomical structure morphogenesis |
| GO:0071867 | 9e-04 | 10.449 | 0.4406 | 4 | 31 | response to monoamine |
| GO:0009617 | 0.0011 | 2.5592 | 6.6804 | 16 | 470 | response to bacterium |
| GO:2000249 | 0.0012 | 9.7271 | 0.4691 | 4 | 33 | regulation of actin cytoskeleton reorganization |
| GO:0009880 | 0.0013 | 6.8024 | 0.8102 | 5 | 57 | embryonic pattern specification |
| GO:0019731 | 0.0013 | 9.4022 | 0.4833 | 4 | 34 | antibacterial humoral response |
| GO:0043009 | 0.0014 | 2.4382 | 7.448 | 17 | 524 | chordate embryonic development |
| GO:0060021 | 0.0014 | 5.3211 | 1.2224 | 6 | 86 | palate development |
| GO:0060255 | 0.0015 | 1.5195 | 78.431 | 100 | 5518 | regulation of macromolecule metabolic process |
| GO:0019219 | 0.0016 | 1.5616 | 54.2962 | 74 | 3820 | regulation of nucleobase-containing compound metabolic process |
| GO:0042053 | 0.0017 | 15.0561 | 0.2416 | 3 | 17 | regulation of dopamine metabolic process |
| GO:0035609 | 0.002 | 46.6574 | 0.0711 | 2 | 5 | C-terminal protein deglutamylation |
| GO:0045409 | 0.002 | 46.6574 | 0.0711 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
| GO:0051673 | 0.002 | 46.6574 | 0.0711 | 2 | 5 | membrane disruption in other organism |
| GO:0002227 | 0.002 | 14.0514 | 0.2558 | 3 | 18 | innate immune response in mucosa |
| GO:0042423 | 0.0023 | 13.1723 | 0.2701 | 3 | 19 | catecholamine biosynthetic process |
| GO:0032496 | 0.0025 | 2.8903 | 4.0367 | 11 | 284 | response to lipopolysaccharide |
| GO:0097659 | 0.0027 | 1.5445 | 48.9376 | 67 | 3443 | nucleic acid-templated transcription |
| GO:0001504 | 0.0027 | 12.3966 | 0.2843 | 3 | 20 | neurotransmitter uptake |
| GO:0009888 | 0.0028 | 1.7104 | 24.8455 | 39 | 1748 | tissue development |
| GO:0006771 | 0.0029 | 34.9907 | 0.0853 | 2 | 6 | riboflavin metabolic process |
| GO:0090324 | 0.0029 | 34.9907 | 0.0853 | 2 | 6 | negative regulation of oxidative phosphorylation |
| GO:1905446 | 0.0029 | 34.9907 | 0.0853 | 2 | 6 | regulation of mitochondrial ATP synthesis coupled electron transport |
| GO:0021545 | 0.0035 | 7.0469 | 0.6254 | 4 | 44 | cranial nerve development |
| GO:0048562 | 0.0036 | 3.404 | 2.4924 | 8 | 181 | embryonic organ morphogenesis |
| GO:0044249 | 0.0039 | 1.4564 | 81.4727 | 101 | 5732 | cellular biosynthetic process |
| GO:0051584 | 0.004 | 27.9907 | 0.0995 | 2 | 7 | regulation of dopamine uptake involved in synaptic transmission |
| GO:0001964 | 0.0041 | 10.535 | 0.3269 | 3 | 23 | startle response |
| GO:0042220 | 0.0051 | 6.2619 | 0.6965 | 4 | 49 | response to cocaine |
| GO:0007191 | 0.0053 | 23.324 | 0.1137 | 2 | 8 | adenylate cyclase-activating dopamine receptor signaling pathway |
| GO:0021603 | 0.0053 | 23.324 | 0.1137 | 2 | 8 | cranial nerve formation |
| GO:0018149 | 0.0067 | 5.7492 | 0.7533 | 4 | 53 | peptide cross-linking |
| GO:0001714 | 0.0068 | 19.9907 | 0.1279 | 2 | 9 | endodermal cell fate specification |
| GO:0010579 | 0.0068 | 19.9907 | 0.1279 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
| GO:0010764 | 0.0068 | 19.9907 | 0.1279 | 2 | 9 | negative regulation of fibroblast migration |
| GO:0002251 | 0.0071 | 8.4252 | 0.398 | 3 | 28 | organ or tissue specific immune response |
| GO:0009059 | 0.0076 | 1.4235 | 68.7373 | 86 | 4836 | macromolecule biosynthetic process |
| GO:0001906 | 0.0076 | 3.693 | 1.7199 | 6 | 121 | cell killing |
| GO:0071870 | 0.0079 | 8.1006 | 0.4122 | 3 | 29 | cellular response to catecholamine stimulus |
| GO:0030432 | 0.0084 | 17.4907 | 0.1421 | 2 | 10 | peristalsis |
| GO:0031115 | 0.0084 | 17.4907 | 0.1421 | 2 | 10 | negative regulation of microtubule polymerization |
| GO:0051937 | 0.0087 | 5.3138 | 0.8102 | 4 | 57 | catecholamine transport |
| GO:0043207 | 0.0091 | 1.9127 | 10.4897 | 19 | 738 | response to external biotic stimulus |
| GO:0034654 | 0.0093 | 1.4341 | 55.1774 | 71 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:0042472 | 0.0096 | 4.1038 | 1.2934 | 5 | 91 | inner ear morphogenesis |
| GO:0035295 | 0.0096 | 2.0749 | 7.6043 | 15 | 535 | tube development |
| GO:0048513 | 0.01 | 1.4646 | 43.4796 | 58 | 3059 | animal organ development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 11.2547 | 4.2493 | 36 | 326 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0007606 | 0 | 9.123 | 5.4485 | 38 | 418 | sensory perception of chemical stimulus |
| GO:0050906 | 0 | 8.998 | 5.3442 | 37 | 410 | detection of stimulus involved in sensory perception |
| GO:0009593 | 0 | 8.8967 | 5.2269 | 36 | 401 | detection of chemical stimulus |
| GO:0050877 | 0 | 4.2607 | 14.6249 | 49 | 1122 | nervous system process |
| GO:0007186 | 0 | 3.8103 | 14.9638 | 46 | 1148 | G-protein coupled receptor signaling pathway |
| GO:0051716 | 0 | 1.7873 | 83.6955 | 112 | 6421 | cellular response to stimulus |
| GO:0023052 | 1e-04 | 1.7484 | 74.1541 | 101 | 5689 | signaling |
| GO:0007154 | 1e-04 | 1.739 | 74.4018 | 101 | 5708 | cell communication |
| GO:0060513 | 2e-04 | 38.4235 | 0.1173 | 3 | 9 | prostatic bud formation |
| GO:0051967 | 4e-04 | 25.6105 | 0.1564 | 3 | 12 | negative regulation of synaptic transmission, glutamatergic |
| GO:0060603 | 4e-04 | 12.8581 | 0.365 | 4 | 28 | mammary gland duct morphogenesis |
| GO:0048807 | 5e-04 | 152.9645 | 0.0391 | 2 | 3 | female genitalia morphogenesis |
| GO:0060750 | 5e-04 | 152.9645 | 0.0391 | 2 | 3 | epithelial cell proliferation involved in mammary gland duct elongation |
| GO:0050891 | 8e-04 | 7.5889 | 0.7299 | 5 | 56 | multicellular organismal water homeostasis |
| GO:0061436 | 0.0013 | 16.4585 | 0.2216 | 3 | 17 | establishment of skin barrier |
| GO:0060602 | 0.0015 | 15.3602 | 0.2346 | 3 | 18 | branch elongation of an epithelium |
| GO:0021983 | 0.0016 | 8.8105 | 0.5084 | 4 | 39 | pituitary gland development |
| GO:0060157 | 0.0016 | 50.9814 | 0.0652 | 2 | 5 | urinary bladder development |
| GO:0060744 | 0.0016 | 50.9814 | 0.0652 | 2 | 5 | mammary gland branching involved in thelarche |
| GO:0032501 | 0.002 | 1.5254 | 85.377 | 106 | 6550 | multicellular organismal process |
| GO:0060571 | 0.0032 | 11.5163 | 0.2998 | 3 | 23 | morphogenesis of an epithelial fold |
| GO:0046543 | 0.0034 | 30.5848 | 0.0912 | 2 | 7 | development of secondary female sexual characteristics |
| GO:0060907 | 0.0034 | 30.5848 | 0.0912 | 2 | 7 | positive regulation of macrophage cytokine production |
| GO:0042221 | 0.0034 | 1.6708 | 31.5499 | 46 | 3033 | response to chemical |
| GO:1900542 | 0.0035 | 3.139 | 3.0371 | 9 | 233 | regulation of purine nucleotide metabolic process |
| GO:0015758 | 0.0036 | 4.3468 | 1.4729 | 6 | 113 | glucose transport |
| GO:0030799 | 0.0038 | 3.7522 | 1.9813 | 7 | 152 | regulation of cyclic nucleotide metabolic process |
| GO:0051450 | 0.0041 | 10.468 | 0.3259 | 3 | 25 | myoblast proliferation |
| GO:0048146 | 0.0043 | 6.5558 | 0.6648 | 4 | 51 | positive regulation of fibroblast proliferation |
| GO:0030817 | 0.0045 | 4.1514 | 1.5381 | 6 | 118 | regulation of cAMP biosynthetic process |
| GO:0007195 | 0.0045 | 25.4856 | 0.1043 | 2 | 8 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
| GO:0043455 | 0.0045 | 25.4856 | 0.1043 | 2 | 8 | regulation of secondary metabolic process |
| GO:0060638 | 0.0045 | 25.4856 | 0.1043 | 2 | 8 | mesenchymal-epithelial cell signaling |
| GO:0060512 | 0.0045 | 10.0122 | 0.3389 | 3 | 26 | prostate gland morphogenesis |
| GO:0015749 | 0.0051 | 4.0423 | 1.5772 | 6 | 121 | monosaccharide transport |
| GO:0031279 | 0.0056 | 4.7102 | 1.134 | 5 | 87 | regulation of cyclase activity |
| GO:0045740 | 0.0057 | 6.04 | 0.7169 | 4 | 55 | positive regulation of DNA replication |
| GO:0006857 | 0.0057 | 21.8434 | 0.1173 | 2 | 9 | oligopeptide transport |
| GO:0010838 | 0.0057 | 21.8434 | 0.1173 | 2 | 9 | positive regulation of keratinocyte proliferation |
| GO:0051339 | 0.0061 | 4.5974 | 1.1601 | 5 | 89 | regulation of lyase activity |
| GO:0009954 | 0.0062 | 8.8552 | 0.378 | 3 | 29 | proximal/distal pattern formation |
| GO:0007194 | 0.0068 | 8.5266 | 0.391 | 3 | 30 | negative regulation of adenylate cyclase activity |
| GO:0007494 | 0.0071 | 19.1117 | 0.1303 | 2 | 10 | midgut development |
| GO:0010035 | 0.0074 | 2.2861 | 5.9959 | 13 | 460 | response to inorganic substance |
| GO:0019932 | 0.0079 | 2.7516 | 3.4411 | 9 | 264 | second-messenger-mediated signaling |
| GO:1901385 | 0.0082 | 7.9375 | 0.4171 | 3 | 32 | regulation of voltage-gated calcium channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001141 | 0 | 1.7957 | 50.6103 | 77 | 3302 | regulation of RNA biosynthetic process |
| GO:0001826 | 1e-04 | 48.7955 | 0.1073 | 3 | 7 | inner cell mass cell differentiation |
| GO:0010453 | 1e-04 | 11.7007 | 0.5058 | 5 | 33 | regulation of cell fate commitment |
| GO:0099537 | 1e-04 | 2.6614 | 8.5526 | 21 | 558 | trans-synaptic signaling |
| GO:0055123 | 2e-04 | 4.971 | 1.9772 | 9 | 129 | digestive system development |
| GO:0045944 | 2e-04 | 2.1756 | 15.5877 | 31 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0019219 | 2e-04 | 1.6615 | 58.5498 | 83 | 3820 | regulation of nucleobase-containing compound metabolic process |
| GO:0009889 | 3e-04 | 1.6379 | 63.3319 | 88 | 4132 | regulation of biosynthetic process |
| GO:0048562 | 3e-04 | 3.382 | 4.1383 | 13 | 270 | embryonic organ morphogenesis |
| GO:0034654 | 4e-04 | 1.6254 | 59.5001 | 83 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:0001964 | 4e-04 | 13.7428 | 0.3525 | 4 | 23 | startle response |
| GO:0060562 | 6e-04 | 3.1221 | 4.4602 | 13 | 291 | epithelial tube morphogenesis |
| GO:0006355 | 6e-04 | 1.7611 | 32.6636 | 51 | 2234 | regulation of transcription, DNA-templated |
| GO:0035295 | 6e-04 | 2.4862 | 8.2 | 19 | 535 | tube development |
| GO:0009952 | 7e-04 | 3.7257 | 2.8815 | 10 | 188 | anterior/posterior pattern specification |
| GO:0009653 | 8e-04 | 2.0422 | 15.5144 | 29 | 1075 | anatomical structure morphogenesis |
| GO:0048384 | 9e-04 | 10.4403 | 0.4445 | 4 | 29 | retinoic acid receptor signaling pathway |
| GO:0048705 | 0.001 | 3.5251 | 3.0348 | 10 | 198 | skeletal system morphogenesis |
| GO:0001963 | 0.0011 | 10.0381 | 0.4598 | 4 | 30 | synaptic transmission, dopaminergic |
| GO:0007267 | 0.0012 | 1.8218 | 22.1018 | 37 | 1442 | cell-cell signaling |
| GO:0051142 | 0.0014 | 64.7888 | 0.0613 | 2 | 4 | positive regulation of NK T cell proliferation |
| GO:2000330 | 0.0014 | 64.7888 | 0.0613 | 2 | 4 | positive regulation of T-helper 17 cell lineage commitment |
| GO:0048729 | 0.0016 | 2.2713 | 8.9204 | 19 | 582 | tissue morphogenesis |
| GO:0045986 | 0.0017 | 15.005 | 0.2452 | 3 | 16 | negative regulation of smooth muscle contraction |
| GO:0060008 | 0.0021 | 13.9323 | 0.2606 | 3 | 17 | Sertoli cell differentiation |
| GO:0060023 | 0.0023 | 43.1897 | 0.0766 | 2 | 5 | soft palate development |
| GO:0031328 | 0.0024 | 1.7119 | 25.3818 | 40 | 1656 | positive regulation of cellular biosynthetic process |
| GO:0048148 | 0.0024 | 13.0026 | 0.2759 | 3 | 18 | behavioral response to cocaine |
| GO:0007268 | 0.0027 | 2.2687 | 7.955 | 17 | 527 | chemical synaptic transmission |
| GO:0010002 | 0.0029 | 12.1891 | 0.2912 | 3 | 19 | cardioblast differentiation |
| GO:0007218 | 0.0029 | 4.5737 | 1.4101 | 6 | 92 | neuropeptide signaling pathway |
| GO:0006811 | 0.0029 | 1.7484 | 21.596 | 35 | 1409 | ion transport |
| GO:0019226 | 0.0032 | 5.4487 | 0.9963 | 5 | 65 | transmission of nerve impulse |
| GO:0003279 | 0.0032 | 4.4692 | 1.4408 | 6 | 94 | cardiac septum development |
| GO:1903508 | 0.0032 | 1.764 | 20.1246 | 33 | 1313 | positive regulation of nucleic acid-templated transcription |
| GO:0010536 | 0.0034 | 32.3901 | 0.092 | 2 | 6 | positive regulation of activation of Janus kinase activity |
| GO:0043382 | 0.0034 | 32.3901 | 0.092 | 2 | 6 | positive regulation of memory T cell differentiation |
| GO:0060956 | 0.0034 | 32.3901 | 0.092 | 2 | 6 | endocardial cell differentiation |
| GO:0007507 | 0.0035 | 2.2692 | 7.4643 | 16 | 487 | heart development |
| GO:0001914 | 0.0039 | 10.8333 | 0.3219 | 3 | 21 | regulation of T cell mediated cytotoxicity |
| GO:0045624 | 0.0039 | 10.8333 | 0.3219 | 3 | 21 | positive regulation of T-helper cell differentiation |
| GO:0051952 | 0.0041 | 5.1068 | 1.0576 | 5 | 69 | regulation of amine transport |
| GO:0032680 | 0.0042 | 4.2275 | 1.5174 | 6 | 99 | regulation of tumor necrosis factor production |
| GO:0007399 | 0.0042 | 1.6018 | 31.2368 | 46 | 2038 | nervous system development |
| GO:0045672 | 0.0044 | 10.2625 | 0.3372 | 3 | 22 | positive regulation of osteoclast differentiation |
| GO:0001708 | 0.0045 | 4.9927 | 1.0796 | 5 | 71 | cell fate specification |
| GO:0097659 | 0.0045 | 1.6135 | 30.6937 | 45 | 2131 | nucleic acid-templated transcription |
| GO:0002573 | 0.0046 | 3.2698 | 2.5903 | 8 | 169 | myeloid leukocyte differentiation |
| GO:0001766 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | membrane raft polarization |
| GO:0002291 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0021826 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | substrate-independent telencephalic tangential migration |
| GO:0021830 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | interneuron migration from the subpallium to the cortex |
| GO:0032819 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | positive regulation of natural killer cell proliferation |
| GO:0051584 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | regulation of dopamine uptake involved in synaptic transmission |
| GO:2000318 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | positive regulation of T-helper 17 type immune response |
| GO:0040012 | 0.0048 | 1.9355 | 12.0625 | 22 | 787 | regulation of locomotion |
| GO:0048546 | 0.0049 | 6.3593 | 0.6897 | 4 | 45 | digestive tract morphogenesis |
| GO:0030878 | 0.005 | 9.7487 | 0.3525 | 3 | 23 | thyroid gland development |
| GO:0042832 | 0.005 | 9.7487 | 0.3525 | 3 | 23 | defense response to protozoan |
| GO:0007275 | 0.0053 | 1.4985 | 50.4964 | 67 | 3525 | multicellular organism development |
| GO:0046633 | 0.0057 | 9.2839 | 0.3679 | 3 | 24 | alpha-beta T cell proliferation |
| GO:0051239 | 0.0057 | 1.5206 | 39.5748 | 55 | 2582 | regulation of multicellular organismal process |
| GO:0014706 | 0.0058 | 2.454 | 5.1499 | 12 | 336 | striated muscle tissue development |
| GO:0071706 | 0.0058 | 3.9297 | 1.6247 | 6 | 106 | tumor necrosis factor superfamily cytokine production |
| GO:0007626 | 0.006 | 3.1134 | 2.7129 | 8 | 177 | locomotory behavior |
| GO:0007368 | 0.0061 | 3.8906 | 1.64 | 6 | 107 | determination of left/right symmetry |
| GO:0051133 | 0.0062 | 21.5905 | 0.1226 | 2 | 8 | regulation of NK T cell activation |
| GO:0051665 | 0.0062 | 21.5905 | 0.1226 | 2 | 8 | membrane raft localization |
| GO:1903715 | 0.0062 | 21.5905 | 0.1226 | 2 | 8 | regulation of aerobic respiration |
| GO:0003148 | 0.0064 | 8.8613 | 0.3832 | 3 | 25 | outflow tract septum morphogenesis |
| GO:0060292 | 0.0064 | 8.8613 | 0.3832 | 3 | 25 | long term synaptic depression |
| GO:0048468 | 0.0064 | 1.5949 | 27.7115 | 41 | 1808 | cell development |
| GO:0032649 | 0.0065 | 4.5369 | 1.1802 | 5 | 77 | regulation of interferon-gamma production |
| GO:0048870 | 0.0068 | 1.682 | 20.3238 | 32 | 1326 | cell motility |
| GO:0006937 | 0.007 | 3.3284 | 2.2224 | 7 | 145 | regulation of muscle contraction |
| GO:0051254 | 0.0071 | 1.664 | 21.1975 | 33 | 1383 | positive regulation of RNA metabolic process |
| GO:0016358 | 0.0073 | 3.0054 | 2.8049 | 8 | 183 | dendrite development |
| GO:0048513 | 0.0075 | 1.533 | 34.9635 | 49 | 2411 | animal organ development |
| GO:0045597 | 0.0077 | 1.8511 | 12.5683 | 22 | 820 | positive regulation of cell differentiation |
| GO:0003018 | 0.0078 | 3.2569 | 2.2684 | 7 | 148 | vascular process in circulatory system |
| GO:0001714 | 0.0078 | 18.5049 | 0.1379 | 2 | 9 | endodermal cell fate specification |
| GO:0048617 | 0.0078 | 18.5049 | 0.1379 | 2 | 9 | embryonic foregut morphogenesis |
| GO:0090715 | 0.0078 | 18.5049 | 0.1379 | 2 | 9 | immunological memory formation process |
| GO:2001054 | 0.0078 | 18.5049 | 0.1379 | 2 | 9 | negative regulation of mesenchymal cell apoptotic process |
| GO:0043467 | 0.0079 | 3.6709 | 1.732 | 6 | 113 | regulation of generation of precursor metabolites and energy |
| GO:0098660 | 0.008 | 1.9022 | 11.0969 | 20 | 724 | inorganic ion transmembrane transport |
| GO:0030816 | 0.0081 | 4.297 | 1.2415 | 5 | 81 | positive regulation of cAMP metabolic process |
| GO:0001824 | 0.0082 | 5.4293 | 0.797 | 4 | 52 | blastocyst development |
| GO:0048869 | 0.0082 | 1.5823 | 28.3063 | 41 | 1981 | cellular developmental process |
| GO:0030001 | 0.0084 | 1.8619 | 11.9092 | 21 | 777 | metal ion transport |
| GO:0021885 | 0.0088 | 5.3182 | 0.8123 | 4 | 53 | forebrain cell migration |
| GO:0090022 | 0.0088 | 7.7964 | 0.4292 | 3 | 28 | regulation of neutrophil chemotaxis |
| GO:2000516 | 0.0088 | 7.7964 | 0.4292 | 3 | 28 | positive regulation of CD4-positive, alpha-beta T cell activation |
| GO:0048706 | 0.0089 | 3.5701 | 1.778 | 6 | 116 | embryonic skeletal system development |
| GO:0003206 | 0.0093 | 3.5377 | 1.7933 | 6 | 117 | cardiac chamber morphogenesis |
| GO:0009799 | 0.0093 | 3.5377 | 1.7933 | 6 | 117 | specification of symmetry |
| GO:0008406 | 0.0093 | 2.8725 | 2.9275 | 8 | 191 | gonad development |
| GO:0001843 | 0.0094 | 4.133 | 1.2875 | 5 | 84 | neural tube closure |
| GO:0009790 | 0.0094 | 1.7898 | 13.5799 | 23 | 886 | embryo development |
| GO:0045892 | 0.0095 | 1.7264 | 15.9556 | 26 | 1041 | negative regulation of transcription, DNA-templated |
| GO:0001838 | 0.0097 | 3.5059 | 1.8086 | 6 | 118 | embryonic epithelial tube formation |
| GO:0043368 | 0.0097 | 7.496 | 0.4445 | 3 | 29 | positive T cell selection |
| GO:0071888 | 0.0097 | 16.1907 | 0.1533 | 2 | 10 | macrophage apoptotic process |
| GO:0048646 | 0.0098 | 1.7613 | 14.4075 | 24 | 940 | anatomical structure formation involved in morphogenesis |
| GO:0007389 | 0.0098 | 2.4987 | 4.1988 | 10 | 279 | pattern specification process |
| GO:1900542 | 0.0099 | 2.6445 | 3.5712 | 9 | 233 | regulation of purine nucleotide metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000183 | 0 | 214.9857 | 0.4905 | 26 | 36 | chromatin silencing at rDNA |
| GO:0006335 | 0 | 280.472 | 0.4223 | 24 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0051290 | 0 | 103.2494 | 0.5858 | 24 | 43 | protein heterotetramerization |
| GO:0045815 | 0 | 43.8973 | 1.0627 | 27 | 78 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 29.3268 | 1.3488 | 26 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 28.9286 | 1.3624 | 26 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0045814 | 0 | 23.4976 | 1.594 | 26 | 117 | negative regulation of gene expression, epigenetic |
| GO:0045653 | 0 | 362.1718 | 0.2316 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0060968 | 0 | 22.5023 | 1.6485 | 26 | 121 | regulation of gene silencing |
| GO:0031497 | 0 | 18.2442 | 1.9483 | 26 | 143 | chromatin assembly |
| GO:0034728 | 0 | 16.7964 | 2.0845 | 26 | 153 | nucleosome organization |
| GO:0002244 | 0 | 14.2506 | 2.4932 | 27 | 183 | hematopoietic progenitor cell differentiation |
| GO:0032200 | 0 | 15.3812 | 2.0514 | 24 | 152 | telomere organization |
| GO:0048863 | 0 | 10.6394 | 3.3379 | 28 | 245 | stem cell differentiation |
| GO:0065004 | 0 | 11.4857 | 2.8747 | 26 | 211 | protein-DNA complex assembly |
| GO:0034080 | 0 | 41.7252 | 0.545 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:0030099 | 0 | 7.8905 | 4.8774 | 31 | 358 | myeloid cell differentiation |
| GO:1904837 | 0 | 38.7397 | 0.5722 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0035194 | 0 | 9.1334 | 3.6649 | 27 | 269 | posttranscriptional gene silencing by RNA |
| GO:0071103 | 0 | 9.2514 | 3.4742 | 26 | 255 | DNA conformation change |
| GO:0016233 | 0 | 30.1148 | 0.6812 | 14 | 50 | telomere capping |
| GO:0043044 | 0 | 20.1014 | 0.9946 | 15 | 73 | ATP-dependent chromatin remodeling |
| GO:0045652 | 0 | 26.3031 | 0.687 | 13 | 54 | regulation of megakaryocyte differentiation |
| GO:0006303 | 0 | 20.8265 | 0.8992 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0017148 | 0 | 6.7205 | 4.823 | 27 | 354 | negative regulation of translation |
| GO:0051259 | 0 | 5.1302 | 6.6758 | 29 | 490 | protein oligomerization |
| GO:0038111 | 0 | 29.2016 | 0.4905 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 29.2016 | 0.4905 | 10 | 36 | response to interleukin-7 |
| GO:0034248 | 0 | 4.6799 | 7.5466 | 30 | 559 | regulation of cellular amide metabolic process |
| GO:1903707 | 0 | 10.3722 | 1.7303 | 15 | 127 | negative regulation of hemopoiesis |
| GO:0010608 | 0 | 4.2272 | 8.8966 | 32 | 653 | posttranscriptional regulation of gene expression |
| GO:0045892 | 0 | 3.3438 | 14.1827 | 40 | 1041 | negative regulation of transcription, DNA-templated |
| GO:0048534 | 0 | 3.6064 | 11.0083 | 34 | 808 | hematopoietic or lymphoid organ development |
| GO:1902679 | 0 | 3.2295 | 14.6323 | 40 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0007596 | 0 | 5.5345 | 4.1417 | 20 | 304 | blood coagulation |
| GO:0045596 | 0 | 3.7644 | 8.1881 | 27 | 601 | negative regulation of cell differentiation |
| GO:0045934 | 0 | 2.8098 | 17.5207 | 42 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0006352 | 0 | 5.9211 | 3.0654 | 16 | 225 | DNA-templated transcription, initiation |
| GO:0043043 | 0 | 3.2952 | 10.7767 | 31 | 791 | peptide biosynthetic process |
| GO:0050878 | 0 | 4.1025 | 6.0491 | 22 | 444 | regulation of body fluid levels |
| GO:0048869 | 0 | 2.0597 | 51.9217 | 84 | 3811 | cellular developmental process |
| GO:0070271 | 0 | 2.5763 | 17.9021 | 40 | 1314 | protein complex biogenesis |
| GO:0009611 | 0 | 3.3338 | 8.0519 | 24 | 591 | response to wounding |
| GO:1903706 | 0 | 4.496 | 3.6968 | 15 | 290 | regulation of hemopoiesis |
| GO:0060249 | 0 | 3.9974 | 4.7003 | 17 | 345 | anatomical structure homeostasis |
| GO:0051248 | 0 | 2.4595 | 16.5806 | 36 | 1217 | negative regulation of protein metabolic process |
| GO:0009890 | 0 | 2.2569 | 21.2537 | 42 | 1560 | negative regulation of biosynthetic process |
| GO:0048731 | 0 | 1.8471 | 57.0171 | 85 | 4185 | system development |
| GO:0065003 | 0 | 2.183 | 22.4662 | 43 | 1649 | macromolecular complex assembly |
| GO:0071822 | 0 | 2.1459 | 21.0357 | 40 | 1544 | protein complex subunit organization |
| GO:0048518 | 1e-04 | 1.7278 | 68.4478 | 95 | 5024 | positive regulation of biological process |
| GO:0045595 | 1e-04 | 2.4254 | 11.8848 | 26 | 963 | regulation of cell differentiation |
| GO:1902340 | 2e-04 | Inf | 0.0272 | 2 | 2 | negative regulation of chromosome condensation |
| GO:0031509 | 5e-04 | 146.1942 | 0.0409 | 2 | 3 | telomeric heterochromatin assembly |
| GO:2000566 | 5e-04 | 146.1942 | 0.0409 | 2 | 3 | positive regulation of CD8-positive, alpha-beta T cell proliferation |
| GO:0007166 | 6e-04 | 1.7512 | 33.5154 | 52 | 2460 | cell surface receptor signaling pathway |
| GO:0022610 | 6e-04 | 2.0227 | 16.7713 | 31 | 1231 | biological adhesion |
| GO:0006950 | 7e-04 | 1.7463 | 34.8416 | 53 | 2779 | response to stress |
| GO:0098657 | 9e-04 | 2.3976 | 8.5151 | 19 | 625 | import into cell |
| GO:0048646 | 0.001 | 2.1117 | 12.8067 | 25 | 940 | anatomical structure formation involved in morphogenesis |
| GO:0010604 | 0.0011 | 1.6758 | 37.7389 | 56 | 2770 | positive regulation of macromolecule metabolic process |
| GO:0003164 | 0.0011 | 73.0922 | 0.0545 | 2 | 4 | His-Purkinje system development |
| GO:0031508 | 0.0011 | 73.0922 | 0.0545 | 2 | 4 | pericentric heterochromatin assembly |
| GO:2000360 | 0.0011 | 73.0922 | 0.0545 | 2 | 4 | negative regulation of binding of sperm to zona pellucida |
| GO:0048856 | 0.0014 | 2.2546 | 10.4109 | 21 | 938 | anatomical structure development |
| GO:0001775 | 0.0016 | 4.4399 | 1.694 | 7 | 131 | cell activation |
| GO:0002263 | 0.0016 | 2.3398 | 8.229 | 18 | 604 | cell activation involved in immune response |
| GO:0002682 | 0.0016 | 2.1942 | 10.3564 | 21 | 864 | regulation of immune system process |
| GO:0051891 | 0.0018 | 48.7249 | 0.0681 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0003197 | 0.0019 | 8.4168 | 0.5313 | 4 | 39 | endocardial cushion development |
| GO:0032268 | 0.002 | 1.6616 | 32.7661 | 49 | 2405 | regulation of cellular protein metabolic process |
| GO:0043090 | 0.0021 | 13.7588 | 0.2589 | 3 | 19 | amino acid import |
| GO:0070527 | 0.0022 | 8.0359 | 0.5535 | 4 | 41 | platelet aggregation |
| GO:0098609 | 0.0022 | 2.1628 | 9.8911 | 20 | 726 | cell-cell adhesion |
| GO:0070661 | 0.0024 | 3.1053 | 3.4197 | 10 | 251 | leukocyte proliferation |
| GO:0045603 | 0.0024 | 12.9486 | 0.2725 | 3 | 20 | positive regulation of endothelial cell differentiation |
| GO:0002275 | 0.0024 | 2.4447 | 6.526 | 15 | 479 | myeloid cell activation involved in immune response |
| GO:0002444 | 0.0026 | 2.4178 | 6.5941 | 15 | 484 | myeloid leukocyte mediated immunity |
| GO:0090230 | 0.0027 | 36.5413 | 0.0817 | 2 | 6 | regulation of centromere complex assembly |
| GO:0006281 | 0.0027 | 2.4125 | 6.6077 | 15 | 485 | DNA repair |
| GO:0046640 | 0.0032 | 11.5841 | 0.2997 | 3 | 22 | regulation of alpha-beta T cell proliferation |
| GO:1903506 | 0.0032 | 1.5534 | 44.8916 | 62 | 3295 | regulation of nucleic acid-templated transcription |
| GO:0045055 | 0.0036 | 2.1555 | 8.883 | 18 | 652 | regulated exocytosis |
| GO:0002703 | 0.0043 | 3.6584 | 2.03 | 7 | 149 | regulation of leukocyte mediated immunity |
| GO:2000242 | 0.0044 | 6.542 | 0.6676 | 4 | 49 | negative regulation of reproductive process |
| GO:0051252 | 0.0045 | 1.5171 | 47.3576 | 64 | 3476 | regulation of RNA metabolic process |
| GO:0002449 | 0.0049 | 3.2337 | 2.6158 | 8 | 192 | lymphocyte mediated immunity |
| GO:0098712 | 0.0049 | 24.3576 | 0.109 | 2 | 8 | L-glutamate import across plasma membrane |
| GO:1904714 | 0.0049 | 24.3576 | 0.109 | 2 | 8 | regulation of chaperone-mediated autophagy |
| GO:2001185 | 0.0049 | 24.3576 | 0.109 | 2 | 8 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0046651 | 0.005 | 2.9683 | 3.2017 | 9 | 235 | lymphocyte proliferation |
| GO:0002460 | 0.005 | 3.216 | 2.6295 | 8 | 193 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0045137 | 0.0053 | 3.1812 | 2.6567 | 8 | 195 | development of primary sexual characteristics |
| GO:0006336 | 0.0055 | 22.3601 | 0.1147 | 2 | 9 | DNA replication-independent nucleosome assembly |
| GO:0016192 | 0.0057 | 1.6748 | 22.5889 | 35 | 1658 | vesicle-mediated transport |
| GO:0034219 | 0.0057 | 9.1677 | 0.3679 | 3 | 27 | carbohydrate transmembrane transport |
| GO:0043304 | 0.0057 | 9.1677 | 0.3679 | 3 | 27 | regulation of mast cell degranulation |
| GO:0019755 | 0.0062 | 20.8766 | 0.1226 | 2 | 9 | one-carbon compound transport |
| GO:0045602 | 0.0062 | 20.8766 | 0.1226 | 2 | 9 | negative regulation of endothelial cell differentiation |
| GO:0051938 | 0.0062 | 20.8766 | 0.1226 | 2 | 9 | L-glutamate import |
| GO:0090331 | 0.0062 | 20.8766 | 0.1226 | 2 | 9 | negative regulation of platelet aggregation |
| GO:0043312 | 0.0063 | 2.3351 | 5.872 | 13 | 431 | neutrophil degranulation |
| GO:2000026 | 0.0063 | 1.8051 | 15.5345 | 26 | 1296 | regulation of multicellular organismal development |
| GO:0002699 | 0.0066 | 3.3706 | 2.1935 | 7 | 161 | positive regulation of immune effector process |
| GO:0051241 | 0.0068 | 1.9415 | 10.963 | 20 | 860 | negative regulation of multicellular organismal process |
| GO:0006909 | 0.0069 | 3.0333 | 2.7793 | 8 | 204 | phagocytosis |
| GO:0002711 | 0.007 | 8.4614 | 0.3951 | 3 | 29 | positive regulation of T cell mediated immunity |
| GO:0007169 | 0.0072 | 2.0453 | 8.7876 | 17 | 645 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0045321 | 0.0074 | 1.8124 | 14.101 | 24 | 1035 | leukocyte activation |
| GO:0071345 | 0.0075 | 1.9189 | 11.0492 | 20 | 811 | cellular response to cytokine stimulus |
| GO:0042119 | 0.0075 | 2.279 | 6.0083 | 13 | 441 | neutrophil activation |
| GO:0006996 | 0.0092 | 1.4656 | 46.1041 | 61 | 3384 | organelle organization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 219.8095 | 0.5239 | 24 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 128.1795 | 0.6084 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 80.9177 | 0.7267 | 24 | 43 | protein heterotetramerization |
| GO:0045815 | 0 | 30.2778 | 1.3181 | 25 | 78 | positive regulation of gene expression, epigenetic |
| GO:0060964 | 0 | 24.2484 | 1.673 | 27 | 99 | regulation of gene silencing by miRNA |
| GO:0060968 | 0 | 18.5459 | 2.0448 | 27 | 121 | regulation of gene silencing |
| GO:0045653 | 0 | 287 | 0.2873 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:1902036 | 0 | 20.1525 | 1.6899 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0045814 | 0 | 17.3971 | 1.9772 | 25 | 117 | negative regulation of gene expression, epigenetic |
| GO:0031497 | 0 | 14.2644 | 2.4166 | 26 | 143 | chromatin assembly |
| GO:0002244 | 0 | 11.1286 | 3.0926 | 27 | 183 | hematopoietic progenitor cell differentiation |
| GO:0065004 | 0 | 9.8629 | 3.5657 | 28 | 211 | protein-DNA complex assembly |
| GO:1904837 | 0 | 34.2524 | 0.7098 | 15 | 42 | beta-catenin-TCF complex assembly |
| GO:0032200 | 0 | 11.6485 | 2.6194 | 24 | 155 | telomere organization |
| GO:0035194 | 0 | 8.1315 | 4.5459 | 30 | 269 | posttranscriptional gene silencing by RNA |
| GO:0034080 | 0 | 33.0646 | 0.676 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:0048863 | 0 | 8.3978 | 3.7795 | 26 | 226 | stem cell differentiation |
| GO:0071103 | 0 | 7.5774 | 4.3093 | 27 | 255 | DNA conformation change |
| GO:0016233 | 0 | 23.8641 | 0.845 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 23.8641 | 0.845 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0030099 | 0 | 6.1316 | 6.0499 | 31 | 358 | myeloid cell differentiation |
| GO:0006303 | 0 | 18.1046 | 1.1153 | 15 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0017148 | 0 | 5.9637 | 5.9823 | 30 | 354 | negative regulation of translation |
| GO:0002520 | 0 | 3.9563 | 14.3136 | 47 | 847 | immune system development |
| GO:0043044 | 0 | 15.9121 | 1.2336 | 15 | 73 | ATP-dependent chromatin remodeling |
| GO:0038111 | 0 | 26.6921 | 0.6084 | 11 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 26.6921 | 0.6084 | 11 | 36 | response to interleukin-7 |
| GO:1902679 | 0 | 3.283 | 18.1497 | 50 | 1074 | negative regulation of RNA biosynthetic process |
| GO:1903707 | 0 | 9.5542 | 2.1462 | 17 | 127 | negative regulation of hemopoiesis |
| GO:0051259 | 0 | 4.4985 | 8.2806 | 32 | 490 | protein oligomerization |
| GO:0045892 | 0 | 3.2262 | 17.5921 | 48 | 1041 | negative regulation of transcription, DNA-templated |
| GO:0034248 | 0 | 3.9757 | 9.5818 | 33 | 567 | regulation of cellular amide metabolic process |
| GO:0045652 | 0 | 16.4281 | 0.864 | 11 | 54 | regulation of megakaryocyte differentiation |
| GO:0007275 | 0 | 2.2383 | 66.0237 | 109 | 4084 | multicellular organism development |
| GO:0045934 | 0 | 2.8178 | 21.7324 | 52 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0009890 | 0 | 2.6079 | 26.3627 | 58 | 1560 | negative regulation of biosynthetic process |
| GO:0045596 | 0 | 3.5933 | 10.1564 | 32 | 601 | negative regulation of cell differentiation |
| GO:0051248 | 0 | 2.7061 | 20.5663 | 48 | 1217 | negative regulation of protein metabolic process |
| GO:0006352 | 0 | 5.363 | 3.8023 | 18 | 225 | DNA-templated transcription, initiation |
| GO:0034728 | 0 | 8.4589 | 1.6516 | 12 | 103 | nucleosome organization |
| GO:0048513 | 0 | 2.0606 | 51.6946 | 87 | 3059 | animal organ development |
| GO:0007156 | 0 | 6.4667 | 2.4673 | 14 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0032268 | 0 | 2.1451 | 40.6426 | 73 | 2405 | regulation of cellular protein metabolic process |
| GO:0010608 | 0 | 3.1588 | 11.0352 | 31 | 653 | posttranscriptional regulation of gene expression |
| GO:0043043 | 0 | 2.7574 | 13.3673 | 33 | 791 | peptide biosynthetic process |
| GO:0070271 | 0 | 2.2875 | 22.2055 | 45 | 1314 | protein complex biogenesis |
| GO:1903506 | 0 | 1.8386 | 55.6828 | 86 | 3295 | regulation of nucleic acid-templated transcription |
| GO:0051252 | 0 | 1.807 | 58.7416 | 89 | 3476 | regulation of RNA metabolic process |
| GO:0071822 | 0 | 2.1193 | 26.0924 | 49 | 1544 | protein complex subunit organization |
| GO:0065003 | 0 | 2.0677 | 27.8668 | 51 | 1649 | macromolecular complex assembly |
| GO:0045165 | 0 | 4.0743 | 4.0389 | 15 | 239 | cell fate commitment |
| GO:0080090 | 0 | 1.7114 | 92.9456 | 126 | 5500 | regulation of primary metabolic process |
| GO:0048869 | 0 | 1.8083 | 57.7586 | 87 | 3572 | cellular developmental process |
| GO:0007399 | 0 | 1.9521 | 34.4406 | 59 | 2038 | nervous system development |
| GO:2000112 | 0 | 1.7172 | 64.2507 | 93 | 3802 | regulation of cellular macromolecule biosynthetic process |
| GO:0060037 | 1e-04 | 14.8113 | 0.4225 | 5 | 25 | pharyngeal system development |
| GO:0010604 | 1e-04 | 1.7663 | 46.8108 | 72 | 2770 | positive regulation of macromolecule metabolic process |
| GO:0045595 | 1e-04 | 2.3041 | 14.8396 | 31 | 963 | regulation of cell differentiation |
| GO:0060249 | 1e-04 | 3.1573 | 5.8302 | 17 | 345 | anatomical structure homeostasis |
| GO:0034654 | 2e-04 | 1.6406 | 65.6027 | 92 | 3882 | nucleobase-containing compound biosynthetic process |
| GO:0060538 | 2e-04 | 4.3772 | 2.4842 | 10 | 147 | skeletal muscle organ development |
| GO:0022610 | 2e-04 | 2.0003 | 20.8029 | 38 | 1231 | biological adhesion |
| GO:0007596 | 2e-04 | 3.1441 | 5.1374 | 15 | 304 | blood coagulation |
| GO:0006281 | 2e-04 | 2.6284 | 8.1961 | 20 | 485 | DNA repair |
| GO:1903706 | 2e-04 | 3.2676 | 4.6162 | 14 | 290 | regulation of hemopoiesis |
| GO:0003165 | 3e-04 | Inf | 0.0338 | 2 | 2 | Purkinje myocyte development |
| GO:1902963 | 3e-04 | Inf | 0.0338 | 2 | 2 | negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process |
| GO:1901861 | 3e-04 | 4.5226 | 2.1631 | 9 | 128 | regulation of muscle tissue development |
| GO:0048518 | 4e-04 | 1.5517 | 84.9016 | 111 | 5024 | positive regulation of biological process |
| GO:0048634 | 4e-04 | 4.3744 | 2.2307 | 9 | 132 | regulation of muscle organ development |
| GO:0009611 | 5e-04 | 2.3657 | 9.9874 | 22 | 591 | response to wounding |
| GO:0050878 | 6e-04 | 2.5674 | 7.5032 | 18 | 444 | regulation of body fluid levels |
| GO:0021884 | 8e-04 | 11.2396 | 0.4225 | 4 | 25 | forebrain neuron development |
| GO:0032502 | 8e-04 | 1.9558 | 20.3645 | 35 | 1513 | developmental process |
| GO:0003350 | 8e-04 | 117.25 | 0.0507 | 2 | 3 | pulmonary myocardium development |
| GO:0007045 | 9e-04 | 5.8345 | 1.1322 | 6 | 67 | cell-substrate adherens junction assembly |
| GO:0048641 | 9e-04 | 7.3958 | 0.7605 | 5 | 45 | regulation of skeletal muscle tissue development |
| GO:0031589 | 0.001 | 2.9075 | 4.7656 | 13 | 282 | cell-substrate adhesion |
| GO:0034113 | 0.0011 | 7.0426 | 0.7943 | 5 | 47 | heterotypic cell-cell adhesion |
| GO:0030097 | 0.0012 | 3.7318 | 2.5842 | 9 | 170 | hemopoiesis |
| GO:0051893 | 0.0013 | 6.8784 | 0.8112 | 5 | 48 | regulation of focal adhesion assembly |
| GO:0010467 | 0.0014 | 1.4825 | 83.8369 | 107 | 4961 | gene expression |
| GO:1901888 | 0.0015 | 5.3099 | 1.2336 | 6 | 73 | regulation of cell junction assembly |
| GO:0021953 | 0.0015 | 3.6048 | 2.6701 | 9 | 158 | central nervous system neuron differentiation |
| GO:0014706 | 0.0015 | 2.6639 | 5.5849 | 14 | 333 | striated muscle tissue development |
| GO:0048699 | 0.0016 | 1.7991 | 21.5803 | 36 | 1277 | generation of neurons |
| GO:0051454 | 0.0017 | 58.6211 | 0.0676 | 2 | 4 | intracellular pH elevation |
| GO:0090191 | 0.0017 | 58.6211 | 0.0676 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
| GO:2000275 | 0.0017 | 58.6211 | 0.0676 | 2 | 4 | regulation of oxidative phosphorylation uncoupler activity |
| GO:0035295 | 0.0019 | 2.2329 | 9.0411 | 19 | 535 | tube development |
| GO:0048523 | 0.002 | 1.5374 | 55.4907 | 75 | 3601 | negative regulation of cellular process |
| GO:0001568 | 0.002 | 2.1722 | 9.7846 | 20 | 579 | blood vessel development |
| GO:0001525 | 0.0021 | 2.3901 | 7.0977 | 16 | 420 | angiogenesis |
| GO:0098609 | 0.0022 | 2.0744 | 11.2869 | 22 | 679 | cell-cell adhesion |
| GO:2000811 | 0.0023 | 13.571 | 0.2704 | 3 | 16 | negative regulation of anoikis |
| GO:0030509 | 0.0023 | 3.6912 | 2.3152 | 8 | 137 | BMP signaling pathway |
| GO:0016043 | 0.0024 | 1.4448 | 92.6414 | 115 | 5482 | cellular component organization |
| GO:0051241 | 0.0027 | 1.9494 | 13.6896 | 25 | 860 | negative regulation of multicellular organismal process |
| GO:0065008 | 0.0027 | 1.5527 | 44.2663 | 62 | 2734 | regulation of biological quality |
| GO:0003002 | 0.0027 | 2.5928 | 5.3063 | 13 | 314 | regionalization |
| GO:0031947 | 0.0028 | 39.0781 | 0.0845 | 2 | 5 | negative regulation of glucocorticoid biosynthetic process |
| GO:0032353 | 0.0028 | 39.0781 | 0.0845 | 2 | 5 | negative regulation of hormone biosynthetic process |
| GO:0033864 | 0.0028 | 39.0781 | 0.0845 | 2 | 5 | positive regulation of NAD(P)H oxidase activity |
| GO:0061196 | 0.0028 | 39.0781 | 0.0845 | 2 | 5 | fungiform papilla development |
| GO:1900086 | 0.0028 | 39.0781 | 0.0845 | 2 | 5 | positive regulation of peptidyl-tyrosine autophosphorylation |
| GO:0072080 | 0.003 | 4.5577 | 1.4195 | 6 | 84 | nephron tubule development |
| GO:0023052 | 0.003 | 1.4279 | 96.1395 | 118 | 5689 | signaling |
| GO:0033135 | 0.0031 | 3.921 | 1.9096 | 7 | 113 | regulation of peptidyl-serine phosphorylation |
| GO:0072171 | 0.0034 | 5.3733 | 1.014 | 5 | 60 | mesonephric tubule morphogenesis |
| GO:0007154 | 0.0034 | 1.4202 | 96.4606 | 118 | 5708 | cell communication |
| GO:0071772 | 0.0035 | 3.4233 | 2.4842 | 8 | 147 | response to BMP |
| GO:0048589 | 0.0038 | 2.1365 | 8.9059 | 18 | 527 | developmental growth |
| GO:0010002 | 0.0038 | 11.0243 | 0.3211 | 3 | 19 | cardioblast differentiation |
| GO:0072358 | 0.0038 | 2.0465 | 10.3423 | 20 | 612 | cardiovascular system development |
| GO:0009792 | 0.0038 | 2.1322 | 8.9228 | 18 | 528 | embryo development ending in birth or egg hatching |
| GO:0007256 | 0.0041 | 29.3066 | 0.1014 | 2 | 6 | activation of JNKK activity |
| GO:0060676 | 0.0041 | 29.3066 | 0.1014 | 2 | 6 | ureteric bud formation |
| GO:0070257 | 0.0041 | 29.3066 | 0.1014 | 2 | 6 | positive regulation of mucus secretion |
| GO:0071676 | 0.0041 | 29.3066 | 0.1014 | 2 | 6 | negative regulation of mononuclear cell migration |
| GO:1902959 | 0.0041 | 29.3066 | 0.1014 | 2 | 6 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
| GO:0010894 | 0.0044 | 10.3751 | 0.338 | 3 | 20 | negative regulation of steroid biosynthetic process |
| GO:0051093 | 0.0046 | 3.0139 | 3.1592 | 9 | 205 | negative regulation of developmental process |
| GO:0051239 | 0.0053 | 1.6592 | 24.1261 | 37 | 1595 | regulation of multicellular organismal process |
| GO:0048598 | 0.0054 | 2.057 | 9.227 | 18 | 546 | embryonic morphogenesis |
| GO:0002866 | 0.0056 | 23.4438 | 0.1183 | 2 | 7 | positive regulation of acute inflammatory response to antigenic stimulus |
| GO:0061564 | 0.0058 | 2.2035 | 7.1653 | 15 | 424 | axon development |
| GO:0043524 | 0.0058 | 3.4603 | 2.1462 | 7 | 127 | negative regulation of neuron apoptotic process |
| GO:0072006 | 0.0058 | 3.4603 | 2.1462 | 7 | 127 | nephron development |
| GO:0048736 | 0.0059 | 3.1278 | 2.7039 | 8 | 160 | appendage development |
| GO:0001952 | 0.006 | 5.9944 | 0.7315 | 4 | 44 | regulation of cell-matrix adhesion |
| GO:0072073 | 0.0061 | 3.4314 | 2.1631 | 7 | 128 | kidney epithelium development |
| GO:0009059 | 0.0063 | 1.3959 | 81.7245 | 101 | 4836 | macromolecule biosynthetic process |
| GO:0072088 | 0.0066 | 4.5436 | 1.1829 | 5 | 70 | nephron epithelium morphogenesis |
| GO:0030878 | 0.0066 | 8.8171 | 0.3887 | 3 | 23 | thyroid gland development |
| GO:0055067 | 0.0069 | 3.3477 | 2.2138 | 7 | 131 | monovalent inorganic cation homeostasis |
| GO:0061383 | 0.0069 | 5.7492 | 0.7605 | 4 | 45 | trabecula morphogenesis |
| GO:0061333 | 0.007 | 4.4745 | 1.1998 | 5 | 71 | renal tubule morphogenesis |
| GO:0014902 | 0.007 | 3.7779 | 1.6899 | 6 | 100 | myotube differentiation |
| GO:0090304 | 0.0071 | 1.3903 | 79.2234 | 98 | 4688 | nucleic acid metabolic process |
| GO:0048666 | 0.0071 | 1.7673 | 15.5642 | 26 | 921 | neuron development |
| GO:0035630 | 0.0074 | 19.5352 | 0.1352 | 2 | 8 | bone mineralization involved in bone maturation |
| GO:0048743 | 0.0074 | 19.5352 | 0.1352 | 2 | 8 | positive regulation of skeletal muscle fiber development |
| GO:0060346 | 0.0074 | 19.5352 | 0.1352 | 2 | 8 | bone trabecula formation |
| GO:0090030 | 0.0074 | 19.5352 | 0.1352 | 2 | 8 | regulation of steroid hormone biosynthetic process |
| GO:0032768 | 0.0075 | 5.6119 | 0.7774 | 4 | 46 | regulation of monooxygenase activity |
| GO:0071310 | 0.0076 | 1.5024 | 37.3641 | 52 | 2211 | cellular response to organic substance |
| GO:0051716 | 0.0081 | 1.3637 | 108.5097 | 128 | 6421 | cellular response to stimulus |
| GO:0008344 | 0.0083 | 4.2791 | 1.2505 | 5 | 74 | adult locomotory behavior |
| GO:0035108 | 0.0084 | 3.2169 | 2.2983 | 7 | 136 | limb morphogenesis |
| GO:0048754 | 0.0087 | 3.1919 | 2.3152 | 7 | 137 | branching morphogenesis of an epithelial tube |
| GO:0071695 | 0.009 | 3.1674 | 2.3321 | 7 | 138 | anatomical structure maturation |
| GO:0061756 | 0.0093 | 7.6655 | 0.4394 | 3 | 26 | leukocyte adhesion to vascular endothelial cell |
| GO:1903671 | 0.0093 | 7.6655 | 0.4394 | 3 | 26 | negative regulation of sprouting angiogenesis |
| GO:0001714 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | endodermal cell fate specification |
| GO:0007262 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | STAT protein import into nucleus |
| GO:0031943 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | regulation of glucocorticoid metabolic process |
| GO:0033689 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | negative regulation of osteoblast proliferation |
| GO:0048263 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | determination of dorsal identity |
| GO:0051956 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | negative regulation of amino acid transport |
| GO:2000288 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | positive regulation of myoblast proliferation |
| GO:0070997 | 0.0096 | 2.3861 | 4.8332 | 11 | 286 | neuron death |
| GO:0031623 | 0.0098 | 4.1 | 1.3012 | 5 | 77 | receptor internalization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 255.0657 | 0.3207 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 0 | 44.9695 | 0.5848 | 14 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0051290 | 0 | 29.3387 | 0.8112 | 15 | 43 | protein heterotetramerization |
| GO:0000183 | 0 | 34.7376 | 0.6791 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 29.3855 | 0.7546 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 27.2828 | 0.7923 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0016233 | 0 | 21.2086 | 0.9432 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 21.2086 | 0.9432 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0006303 | 0 | 14.6672 | 1.245 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 0 | 12.9209 | 1.3771 | 14 | 73 | ATP-dependent chromatin remodeling |
| GO:0045815 | 0 | 11.9075 | 1.4714 | 14 | 78 | positive regulation of gene expression, epigenetic |
| GO:0099537 | 0 | 3.8238 | 10.5262 | 35 | 558 | trans-synaptic signaling |
| GO:1903707 | 0 | 7.8792 | 2.3958 | 16 | 127 | negative regulation of hemopoiesis |
| GO:0060964 | 0 | 8.953 | 1.8676 | 14 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 8.8483 | 1.8864 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0048863 | 0 | 5.4483 | 4.1945 | 20 | 226 | stem cell differentiation |
| GO:0007268 | 0 | 3.7105 | 9.1591 | 30 | 492 | chemical synaptic transmission |
| GO:0045814 | 0 | 7.3795 | 2.2071 | 14 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 7.1017 | 2.2826 | 14 | 121 | regulation of gene silencing |
| GO:0045596 | 0 | 3.1656 | 11.3374 | 32 | 601 | negative regulation of cell differentiation |
| GO:0048731 | 0 | 2.3059 | 32.1076 | 61 | 1989 | system development |
| GO:0006352 | 0 | 4.7575 | 4.2444 | 18 | 225 | DNA-templated transcription, initiation |
| GO:0045637 | 0 | 4.7575 | 4.2444 | 18 | 225 | regulation of myeloid cell differentiation |
| GO:0002244 | 0 | 5.2173 | 3.4522 | 16 | 183 | hematopoietic progenitor cell differentiation |
| GO:0031497 | 0 | 5.8819 | 2.6976 | 14 | 143 | chromatin assembly |
| GO:0032200 | 0 | 5.3769 | 2.924 | 14 | 155 | telomere organization |
| GO:0007389 | 0 | 3.3986 | 7.4702 | 23 | 396 | pattern specification process |
| GO:0023061 | 0 | 3.3022 | 7.3193 | 22 | 388 | signal release |
| GO:0007267 | 0 | 2.3737 | 18.8429 | 40 | 1054 | cell-cell signaling |
| GO:0032502 | 0 | 2.3179 | 23.0459 | 45 | 1464 | developmental process |
| GO:0032501 | 0 | 1.9563 | 53.7165 | 82 | 3487 | multicellular organismal process |
| GO:0045934 | 0 | 2.1627 | 24.2594 | 47 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0065008 | 0 | 1.8708 | 48.1752 | 77 | 2711 | regulation of biological quality |
| GO:0007218 | 0 | 6.5349 | 1.7355 | 10 | 92 | neuropeptide signaling pathway |
| GO:0009914 | 0 | 3.6182 | 5.4518 | 18 | 289 | hormone transport |
| GO:1902679 | 0 | 2.241 | 20.2602 | 41 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0003206 | 0 | 5.5719 | 2.2071 | 11 | 117 | cardiac chamber morphogenesis |
| GO:0045892 | 0 | 2.2523 | 19.6376 | 40 | 1041 | negative regulation of transcription, DNA-templated |
| GO:0007188 | 0 | 5.0445 | 2.641 | 12 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0051259 | 0 | 2.8313 | 9.2435 | 24 | 490 | protein oligomerization |
| GO:2000026 | 0 | 1.9406 | 32.3144 | 56 | 1713 | regulation of multicellular organismal development |
| GO:0048869 | 0 | 1.702 | 65.6023 | 95 | 3572 | cellular developmental process |
| GO:0007548 | 0 | 3.6357 | 4.4897 | 15 | 238 | sex differentiation |
| GO:0065004 | 0 | 3.8339 | 3.9803 | 14 | 211 | protein-DNA complex assembly |
| GO:0046887 | 1e-04 | 5.2465 | 2.1128 | 10 | 112 | positive regulation of hormone secretion |
| GO:0007215 | 1e-04 | 6.7646 | 1.3394 | 8 | 71 | glutamate receptor signaling pathway |
| GO:0009952 | 1e-04 | 3.999 | 3.5465 | 13 | 188 | anterior/posterior pattern specification |
| GO:0048534 | 1e-04 | 2.2879 | 15.2423 | 32 | 808 | hematopoietic or lymphoid organ development |
| GO:0003148 | 1e-04 | 13.2147 | 0.4716 | 5 | 25 | outflow tract septum morphogenesis |
| GO:0007399 | 1e-04 | 2.4021 | 11.7954 | 26 | 672 | nervous system development |
| GO:0035194 | 2e-04 | 3.1853 | 5.0745 | 15 | 269 | posttranscriptional gene silencing by RNA |
| GO:0021953 | 2e-04 | 4.0068 | 2.9805 | 11 | 158 | central nervous system neuron differentiation |
| GO:0007420 | 3e-04 | 2.3265 | 11.5638 | 25 | 613 | brain development |
| GO:0003231 | 3e-04 | 4.6589 | 2.1128 | 9 | 112 | cardiac ventricle development |
| GO:0022008 | 3e-04 | 1.8629 | 25.7685 | 44 | 1366 | neurogenesis |
| GO:0021515 | 3e-04 | 7.222 | 0.9432 | 6 | 50 | cell differentiation in spinal cord |
| GO:0007493 | 4e-04 | Inf | 0.0377 | 2 | 2 | endodermal cell fate determination |
| GO:2000043 | 4e-04 | Inf | 0.0377 | 2 | 2 | regulation of cardiac cell fate specification |
| GO:0071103 | 4e-04 | 3.1246 | 4.8104 | 14 | 255 | DNA conformation change |
| GO:0003279 | 4e-04 | 4.9478 | 1.7732 | 8 | 94 | cardiac septum development |
| GO:0048167 | 4e-04 | 3.985 | 2.7164 | 10 | 144 | regulation of synaptic plasticity |
| GO:0048636 | 4e-04 | 5.7157 | 1.3582 | 7 | 72 | positive regulation of muscle organ development |
| GO:1901863 | 4e-04 | 5.7157 | 1.3582 | 7 | 72 | positive regulation of muscle tissue development |
| GO:0030539 | 5e-04 | 13.1717 | 0.3773 | 4 | 20 | male genitalia development |
| GO:0019932 | 5e-04 | 3.0103 | 4.9802 | 14 | 264 | second-messenger-mediated signaling |
| GO:0060923 | 5e-04 | 26.2684 | 0.1698 | 3 | 9 | cardiac muscle cell fate commitment |
| GO:0045956 | 6e-04 | 12.396 | 0.3961 | 4 | 21 | positive regulation of calcium ion-dependent exocytosis |
| GO:0048639 | 6e-04 | 3.7585 | 2.8674 | 10 | 152 | positive regulation of developmental growth |
| GO:0009790 | 7e-04 | 1.9926 | 16.7137 | 31 | 886 | embryo development |
| GO:0120039 | 7e-04 | 2.2725 | 10.3376 | 22 | 548 | plasma membrane bounded cell projection morphogenesis |
| GO:0045944 | 8e-04 | 1.9059 | 19.1849 | 34 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0060914 | 8e-04 | 11.0897 | 0.4339 | 4 | 23 | heart formation |
| GO:0003008 | 8e-04 | 2.7387 | 5.8658 | 15 | 342 | system process |
| GO:0072210 | 9e-04 | 7.5437 | 0.7546 | 5 | 40 | metanephric nephron development |
| GO:0002009 | 9e-04 | 2.3345 | 9.1303 | 20 | 484 | morphogenesis of an epithelium |
| GO:0060173 | 9e-04 | 3.5561 | 3.0183 | 10 | 160 | limb development |
| GO:0008406 | 0.001 | 3.2649 | 3.6031 | 11 | 191 | gonad development |
| GO:0042391 | 0.001 | 2.6755 | 5.9699 | 15 | 320 | regulation of membrane potential |
| GO:0001560 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | regulation of cell growth by extracellular stimulus |
| GO:0003166 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | bundle of His development |
| GO:0021524 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | visceral motor neuron differentiation |
| GO:0035880 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | embryonic nail plate morphogenesis |
| GO:0060913 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | cardiac cell fate determination |
| GO:0061364 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | apoptotic process involved in luteolysis |
| GO:0021517 | 0.0011 | 7.1349 | 0.7923 | 5 | 42 | ventral spinal cord development |
| GO:0048791 | 0.0011 | 10.0322 | 0.4716 | 4 | 25 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0017148 | 0.0012 | 2.548 | 6.6779 | 16 | 354 | negative regulation of translation |
| GO:0032990 | 0.0012 | 2.1863 | 10.7149 | 22 | 568 | cell part morphogenesis |
| GO:0007610 | 0.0013 | 2.4433 | 7.3976 | 17 | 400 | behavior |
| GO:0051047 | 0.0013 | 2.5175 | 6.7534 | 16 | 358 | positive regulation of secretion |
| GO:0035282 | 0.0014 | 4.5818 | 1.6601 | 7 | 88 | segmentation |
| GO:0060986 | 0.0014 | 6.7681 | 0.83 | 5 | 44 | endocrine hormone secretion |
| GO:0031175 | 0.0014 | 1.9657 | 15.2046 | 28 | 806 | neuron projection development |
| GO:0009893 | 0.0016 | 1.5193 | 56.1776 | 77 | 2978 | positive regulation of metabolic process |
| GO:0003214 | 0.0017 | 15.7568 | 0.2452 | 3 | 13 | cardiac left ventricle morphogenesis |
| GO:0042472 | 0.0017 | 4.4173 | 1.7166 | 7 | 91 | inner ear morphogenesis |
| GO:0009888 | 0.0017 | 1.6432 | 32.9747 | 50 | 1748 | tissue development |
| GO:0021761 | 0.0018 | 4.365 | 1.7355 | 7 | 92 | limbic system development |
| GO:0035113 | 0.0018 | 3.8621 | 2.226 | 8 | 118 | embryonic appendage morphogenesis |
| GO:0045165 | 0.002 | 2.8255 | 4.5085 | 12 | 239 | cell fate commitment |
| GO:0010002 | 0.002 | 14.4218 | 0.2624 | 3 | 14 | cardioblast differentiation |
| GO:0009887 | 0.002 | 2.218 | 9.0959 | 19 | 506 | animal organ morphogenesis |
| GO:0021794 | 0.0021 | 14.3234 | 0.2641 | 3 | 14 | thalamus development |
| GO:0002865 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
| GO:0007198 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0034287 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | detection of monosaccharide stimulus |
| GO:0048880 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | sensory system development |
| GO:0051414 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | response to cortisol |
| GO:0051594 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | detection of glucose |
| GO:0070253 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | somatostatin secretion |
| GO:0072268 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | pattern specification involved in metanephros development |
| GO:0030879 | 0.0021 | 3.7588 | 2.2826 | 8 | 121 | mammary gland development |
| GO:0055025 | 0.0022 | 5.997 | 0.9243 | 5 | 49 | positive regulation of cardiac muscle tissue development |
| GO:0035239 | 0.0023 | 3.1239 | 3.4052 | 10 | 184 | tube morphogenesis |
| GO:0035115 | 0.0023 | 8.1002 | 0.5659 | 4 | 30 | embryonic forelimb morphogenesis |
| GO:0060249 | 0.0024 | 2.4391 | 6.5082 | 15 | 345 | anatomical structure homeostasis |
| GO:0008284 | 0.0025 | 1.9037 | 15.0725 | 27 | 799 | positive regulation of cell proliferation |
| GO:1903530 | 0.0025 | 2.0459 | 11.394 | 22 | 604 | regulation of secretion by cell |
| GO:1990138 | 0.0026 | 3.6293 | 2.358 | 8 | 125 | neuron projection extension |
| GO:0071371 | 0.0026 | 13.1289 | 0.283 | 3 | 15 | cellular response to gonadotropin stimulus |
| GO:0098911 | 0.0026 | 13.1289 | 0.283 | 3 | 15 | regulation of ventricular cardiac muscle cell action potential |
| GO:0030534 | 0.0028 | 3.5678 | 2.3958 | 8 | 127 | adult behavior |
| GO:0032753 | 0.0031 | 12.1182 | 0.3018 | 3 | 16 | positive regulation of interleukin-4 production |
| GO:0060413 | 0.0031 | 12.1182 | 0.3018 | 3 | 16 | atrial septum morphogenesis |
| GO:0050877 | 0.0032 | 1.847 | 16.1194 | 28 | 874 | nervous system process |
| GO:0003156 | 0.0033 | 7.2608 | 0.6225 | 4 | 33 | regulation of animal organ formation |
| GO:0048646 | 0.0034 | 1.7977 | 17.7324 | 30 | 940 | anatomical structure formation involved in morphogenesis |
| GO:0051891 | 0.0034 | 34.9091 | 0.0943 | 2 | 5 | positive regulation of cardioblast differentiation |
| GO:0070100 | 0.0034 | 34.9091 | 0.0943 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
| GO:0071205 | 0.0034 | 34.9091 | 0.0943 | 2 | 5 | protein localization to juxtaparanode region of axon |
| GO:0014706 | 0.0035 | 2.9351 | 3.6097 | 10 | 195 | striated muscle tissue development |
| GO:0061061 | 0.0036 | 2.0177 | 10.9978 | 21 | 583 | muscle structure development |
| GO:0051716 | 0.0037 | 1.3863 | 121.1271 | 144 | 6421 | cellular response to stimulus |
| GO:0006836 | 0.0038 | 3.1054 | 3.0749 | 9 | 163 | neurotransmitter transport |
| GO:0048644 | 0.004 | 4.2855 | 1.5091 | 6 | 80 | muscle organ morphogenesis |
| GO:0001755 | 0.0041 | 6.7915 | 0.6602 | 4 | 35 | neural crest cell migration |
| GO:0035137 | 0.0041 | 6.7915 | 0.6602 | 4 | 35 | hindlimb morphogenesis |
| GO:0009890 | 0.0043 | 1.6014 | 29.4282 | 44 | 1560 | negative regulation of biosynthetic process |
| GO:0048846 | 0.0044 | 10.5011 | 0.3396 | 3 | 18 | axon extension involved in axon guidance |
| GO:0051252 | 0.0044 | 1.4309 | 65.572 | 85 | 3476 | regulation of RNA metabolic process |
| GO:0048754 | 0.0045 | 3.289 | 2.5844 | 8 | 137 | branching morphogenesis of an epithelial tube |
| GO:0044057 | 0.0046 | 2.0901 | 9.0737 | 18 | 481 | regulation of system process |
| GO:0003143 | 0.005 | 4.8832 | 1.113 | 5 | 59 | embryonic heart tube morphogenesis |
| GO:0009996 | 0.0051 | 26.1801 | 0.1132 | 2 | 6 | negative regulation of cell fate specification |
| GO:0086073 | 0.0051 | 26.1801 | 0.1132 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0007210 | 0.0051 | 9.8441 | 0.3584 | 3 | 19 | serotonin receptor signaling pathway |
| GO:1903508 | 0.0053 | 1.6337 | 24.7687 | 38 | 1313 | positive regulation of nucleic acid-templated transcription |
| GO:0007519 | 0.0053 | 3.1893 | 2.6599 | 8 | 141 | skeletal muscle tissue development |
| GO:0090596 | 0.0056 | 2.5807 | 4.4897 | 11 | 238 | sensory organ morphogenesis |
| GO:0055008 | 0.0058 | 4.7082 | 1.1507 | 5 | 61 | cardiac muscle tissue morphogenesis |
| GO:0002861 | 0.006 | 9.2644 | 0.3773 | 3 | 20 | regulation of inflammatory response to antigenic stimulus |
| GO:0031290 | 0.006 | 9.2644 | 0.3773 | 3 | 20 | retinal ganglion cell axon guidance |
| GO:0060039 | 0.006 | 9.2644 | 0.3773 | 3 | 20 | pericardium development |
| GO:0022603 | 0.006 | 1.7529 | 16.8835 | 28 | 895 | regulation of anatomical structure morphogenesis |
| GO:0003197 | 0.0061 | 6.0137 | 0.7357 | 4 | 39 | endocardial cushion development |
| GO:0051240 | 0.0061 | 1.6277 | 24.1887 | 37 | 1308 | positive regulation of multicellular organismal process |
| GO:0048562 | 0.0062 | 2.6833 | 3.9264 | 10 | 211 | embryonic organ morphogenesis |
| GO:0001763 | 0.0065 | 2.8439 | 3.339 | 9 | 177 | morphogenesis of a branching structure |
| GO:0060421 | 0.0066 | 5.8462 | 0.7546 | 4 | 40 | positive regulation of heart growth |
| GO:0008015 | 0.0067 | 2.0536 | 8.6964 | 17 | 461 | blood circulation |
| GO:0071773 | 0.0068 | 3.0504 | 2.773 | 8 | 147 | cellular response to BMP stimulus |
| GO:0001574 | 0.007 | 20.9427 | 0.132 | 2 | 7 | ganglioside biosynthetic process |
| GO:0001766 | 0.007 | 20.9427 | 0.132 | 2 | 7 | membrane raft polarization |
| GO:0035385 | 0.007 | 20.9427 | 0.132 | 2 | 7 | Roundabout signaling pathway |
| GO:0042661 | 0.007 | 20.9427 | 0.132 | 2 | 7 | regulation of mesodermal cell fate specification |
| GO:0071415 | 0.007 | 20.9427 | 0.132 | 2 | 7 | cellular response to purine-containing compound |
| GO:1902668 | 0.007 | 20.9427 | 0.132 | 2 | 7 | negative regulation of axon guidance |
| GO:2000049 | 0.007 | 20.9427 | 0.132 | 2 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:0006812 | 0.0071 | 1.6961 | 18.6944 | 30 | 991 | cation transport |
| GO:0097485 | 0.0073 | 2.6183 | 4.0181 | 10 | 213 | neuron projection guidance |
| GO:0050805 | 0.0076 | 4.3931 | 1.2262 | 5 | 65 | negative regulation of synaptic transmission |
| GO:0032102 | 0.0076 | 2.4701 | 4.6783 | 11 | 248 | negative regulation of response to external stimulus |
| GO:0050890 | 0.0076 | 2.4701 | 4.6783 | 11 | 248 | cognition |
| GO:0002790 | 0.0077 | 1.9796 | 9.5453 | 18 | 506 | peptide secretion |
| GO:0035270 | 0.0077 | 3.2772 | 2.2637 | 7 | 120 | endocrine system development |
| GO:0060079 | 0.0078 | 4.3612 | 1.2339 | 5 | 66 | excitatory postsynaptic potential |
| GO:1901700 | 0.0078 | 1.5799 | 26.2213 | 39 | 1390 | response to oxygen-containing compound |
| GO:0006821 | 0.0079 | 3.6846 | 1.7355 | 6 | 92 | chloride transport |
| GO:0019933 | 0.0079 | 3.6846 | 1.7355 | 6 | 92 | cAMP-mediated signaling |
| GO:0060976 | 0.0079 | 5.5378 | 0.7923 | 4 | 42 | coronary vasculature development |
| GO:0090278 | 0.0079 | 5.5378 | 0.7923 | 4 | 42 | negative regulation of peptide hormone secretion |
| GO:0010628 | 0.008 | 1.5554 | 28.8089 | 42 | 1597 | positive regulation of gene expression |
| GO:0071322 | 0.008 | 3.2483 | 2.2826 | 7 | 121 | cellular response to carbohydrate stimulus |
| GO:0032024 | 0.0081 | 4.3208 | 1.245 | 5 | 66 | positive regulation of insulin secretion |
| GO:1900543 | 0.0081 | 4.3208 | 1.245 | 5 | 66 | negative regulation of purine nucleotide metabolic process |
| GO:0001655 | 0.0085 | 2.3247 | 5.414 | 12 | 287 | urogenital system development |
| GO:0045471 | 0.0088 | 3.1918 | 2.3203 | 7 | 123 | response to ethanol |
| GO:0001964 | 0.0089 | 7.8732 | 0.4339 | 3 | 23 | startle response |
| GO:2000463 | 0.0089 | 7.8732 | 0.4339 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
| GO:0003056 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | regulation of vascular smooth muscle contraction |
| GO:0007196 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway |
| GO:0033278 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | cell proliferation in midbrain |
| GO:0045630 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | positive regulation of T-helper 2 cell differentiation |
| GO:0051665 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | membrane raft localization |
| GO:0070445 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | regulation of oligodendrocyte progenitor proliferation |
| GO:0098900 | 0.0093 | 5.2602 | 0.83 | 4 | 44 | regulation of action potential |
| GO:0030182 | 0.0095 | 1.6711 | 18.3151 | 29 | 999 | neuron differentiation |
| GO:0001678 | 0.0095 | 3.1373 | 2.358 | 7 | 125 | cellular glucose homeostasis |
| GO:0000904 | 0.0097 | 1.8593 | 11.2808 | 20 | 598 | cell morphogenesis involved in differentiation |
| GO:0006325 | 0.0097 | 1.8029 | 12.8088 | 22 | 679 | chromatin organization |
| GO:0007612 | 0.0099 | 3.1107 | 2.3769 | 7 | 126 | learning |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 5.624 | 2.3812 | 12 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0045199 | 6e-04 | 22.8811 | 0.1794 | 3 | 11 | maintenance of epithelial cell apical/basal polarity |
| GO:0010159 | 8e-04 | 121.5951 | 0.0489 | 2 | 3 | specification of animal organ position |
| GO:0051030 | 8e-04 | 121.5951 | 0.0489 | 2 | 3 | snRNA transport |
| GO:0060197 | 8e-04 | 121.5951 | 0.0489 | 2 | 3 | cloacal septation |
| GO:0007267 | 0.0011 | 1.8022 | 23.5186 | 39 | 1442 | cell-cell signaling |
| GO:0007198 | 0.0016 | 60.7935 | 0.0652 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0098609 | 0.0018 | 2.0723 | 11.8408 | 23 | 726 | cell-cell adhesion |
| GO:0030011 | 0.0021 | 14.076 | 0.261 | 3 | 16 | maintenance of cell polarity |
| GO:0060438 | 0.0029 | 12.1976 | 0.2936 | 3 | 18 | trachea development |
| GO:0043648 | 0.0037 | 4.3378 | 1.4842 | 6 | 91 | dicarboxylic acid metabolic process |
| GO:0009952 | 0.0038 | 3.1087 | 3.0662 | 9 | 188 | anterior/posterior pattern specification |
| GO:0007218 | 0.0039 | 4.2871 | 1.5005 | 6 | 92 | neuropeptide signaling pathway |
| GO:0007157 | 0.0048 | 6.4361 | 0.685 | 4 | 42 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0006678 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | glucosylceramide metabolic process |
| GO:0048341 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | paraxial mesoderm formation |
| GO:0072201 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | negative regulation of mesenchymal cell proliferation |
| GO:0019935 | 0.0068 | 3.7981 | 1.6799 | 6 | 103 | cyclic-nucleotide-mediated signaling |
| GO:0060441 | 0.0076 | 8.3126 | 0.4077 | 3 | 25 | epithelial tube branching involved in lung morphogenesis |
| GO:0007188 | 0.0081 | 3.2373 | 2.2834 | 7 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0007399 | 0.0083 | 1.5224 | 33.2391 | 47 | 2038 | nervous system development |
| GO:0048570 | 0.0088 | 17.3638 | 0.1468 | 2 | 9 | notochord morphogenesis |
| GO:0061004 | 0.0088 | 17.3638 | 0.1468 | 2 | 9 | pattern specification involved in kidney development |
| GO:0030510 | 0.0094 | 4.1382 | 1.2885 | 5 | 79 | regulation of BMP signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1901750 | 0 | 68.0452 | 0.1179 | 4 | 8 | leukotriene D4 biosynthetic process |
| GO:0006751 | 0 | 54.4326 | 0.1326 | 4 | 9 | glutathione catabolic process |
| GO:0006691 | 1e-04 | 14.2216 | 0.4274 | 5 | 29 | leukotriene metabolic process |
| GO:1901568 | 2e-04 | 4.7064 | 2.078 | 9 | 141 | fatty acid derivative metabolic process |
| GO:0046456 | 5e-04 | 8.743 | 0.6485 | 5 | 44 | icosanoid biosynthetic process |
| GO:0009109 | 5e-04 | 25.3953 | 0.1621 | 3 | 11 | coenzyme catabolic process |
| GO:0051966 | 0.001 | 7.251 | 0.7664 | 5 | 52 | regulation of synaptic transmission, glutamatergic |
| GO:0016053 | 0.0011 | 3.0365 | 4.215 | 12 | 286 | organic acid biosynthetic process |
| GO:0032914 | 0.0013 | 67.4439 | 0.059 | 2 | 4 | positive regulation of transforming growth factor beta1 production |
| GO:0060591 | 0.0021 | 44.9596 | 0.0737 | 2 | 5 | chondroblast differentiation |
| GO:0016338 | 0.0026 | 12.6909 | 0.28 | 3 | 19 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GO:0001502 | 0.003 | 11.9436 | 0.2948 | 3 | 20 | cartilage condensation |
| GO:0048169 | 0.004 | 10.6849 | 0.3242 | 3 | 22 | regulation of long-term neuronal synaptic plasticity |
| GO:1990776 | 0.004 | 10.6849 | 0.3242 | 3 | 22 | response to angiotensin |
| GO:0071634 | 0.0045 | 10.15 | 0.339 | 3 | 23 | regulation of transforming growth factor beta production |
| GO:0060042 | 0.0046 | 6.4641 | 0.6779 | 4 | 46 | retina morphogenesis in camera-type eye |
| GO:0008652 | 0.005 | 4.861 | 1.1053 | 5 | 75 | cellular amino acid biosynthetic process |
| GO:0048167 | 0.0055 | 3.4934 | 2.1222 | 7 | 144 | regulation of synaptic plasticity |
| GO:0006776 | 0.0057 | 22.4753 | 0.1179 | 2 | 8 | vitamin A metabolic process |
| GO:1904714 | 0.0057 | 22.4753 | 0.1179 | 2 | 8 | regulation of chaperone-mediated autophagy |
| GO:2000544 | 0.0057 | 22.4753 | 0.1179 | 2 | 8 | regulation of endothelial cell chemotaxis to fibroblast growth factor |
| GO:0034308 | 0.0058 | 6.032 | 0.7221 | 4 | 49 | primary alcohol metabolic process |
| GO:0044282 | 0.0061 | 2.4361 | 5.1877 | 12 | 352 | small molecule catabolic process |
| GO:0009435 | 0.0064 | 8.8243 | 0.3832 | 3 | 26 | NAD biosynthetic process |
| GO:1904018 | 0.0068 | 3.3455 | 2.2107 | 7 | 150 | positive regulation of vasculature development |
| GO:0006766 | 0.0071 | 3.7534 | 1.6948 | 6 | 115 | vitamin metabolic process |
| GO:0071805 | 0.0072 | 3.0101 | 2.8002 | 8 | 190 | potassium ion transmembrane transport |
| GO:0007168 | 0.0073 | 19.2633 | 0.1326 | 2 | 9 | receptor guanylyl cyclase signaling pathway |
| GO:0014842 | 0.0073 | 19.2633 | 0.1326 | 2 | 9 | regulation of skeletal muscle satellite cell proliferation |
| GO:0035766 | 0.0073 | 19.2633 | 0.1326 | 2 | 9 | cell chemotaxis to fibroblast growth factor |
| GO:0042574 | 0.0073 | 19.2633 | 0.1326 | 2 | 9 | retinal metabolic process |
| GO:0006536 | 0.0079 | 8.1173 | 0.4127 | 3 | 28 | glutamate metabolic process |
| GO:0051588 | 0.0093 | 5.2175 | 0.8253 | 4 | 56 | regulation of neurotransmitter transport |
| GO:0019363 | 0.0096 | 7.515 | 0.4421 | 3 | 30 | pyridine nucleotide biosynthetic process |
| GO:0060419 | 0.0097 | 4.0961 | 1.2969 | 5 | 88 | heart growth |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 242.9757 | 0.4792 | 24 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 141.6887 | 0.5565 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 89.4459 | 0.6647 | 24 | 43 | protein heterotetramerization |
| GO:0045815 | 0 | 31.3983 | 1.2057 | 24 | 78 | positive regulation of gene expression, epigenetic |
| GO:0045653 | 0 | 315.9039 | 0.2628 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0060964 | 0 | 22.5751 | 1.5304 | 24 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 22.2766 | 1.5458 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0045814 | 0 | 18.1838 | 1.8086 | 24 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 17.4293 | 1.8704 | 24 | 121 | regulation of gene silencing |
| GO:0031497 | 0 | 14.1861 | 2.2105 | 24 | 143 | chromatin assembly |
| GO:0032200 | 0 | 12.8763 | 2.396 | 24 | 155 | telomere organization |
| GO:0002244 | 0 | 11.1532 | 2.8288 | 25 | 183 | hematopoietic progenitor cell differentiation |
| GO:0034080 | 0 | 36.3947 | 0.6183 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 33.7905 | 0.6492 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0065004 | 0 | 9.4564 | 3.2617 | 25 | 211 | protein-DNA complex assembly |
| GO:0016233 | 0 | 26.2675 | 0.7729 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 26.2675 | 0.7729 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0048863 | 0 | 7.9766 | 3.7873 | 25 | 245 | stem cell differentiation |
| GO:0051259 | 0 | 5.3799 | 7.5745 | 34 | 490 | protein oligomerization |
| GO:0006303 | 0 | 18.1658 | 1.0202 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0071103 | 0 | 7.2531 | 3.9418 | 24 | 255 | DNA conformation change |
| GO:0030099 | 0 | 5.9969 | 5.534 | 28 | 358 | myeloid cell differentiation |
| GO:0035194 | 0 | 6.8322 | 4.1582 | 24 | 269 | posttranscriptional gene silencing by RNA |
| GO:0043044 | 0 | 16.0031 | 1.1284 | 14 | 73 | ATP-dependent chromatin remodeling |
| GO:0038111 | 0 | 25.5361 | 0.5565 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 25.5361 | 0.5565 | 10 | 36 | response to interleukin-7 |
| GO:0017148 | 0 | 5.0432 | 5.4722 | 24 | 354 | negative regulation of translation |
| GO:0045652 | 0 | 16.0635 | 0.7861 | 10 | 54 | regulation of megakaryocyte differentiation |
| GO:1903707 | 0 | 8.3254 | 1.9632 | 14 | 127 | negative regulation of hemopoiesis |
| GO:0051239 | 0 | 2.2352 | 39.913 | 73 | 2582 | regulation of multicellular organismal process |
| GO:0006352 | 0 | 5.1577 | 3.4781 | 16 | 225 | DNA-templated transcription, initiation |
| GO:1902679 | 0 | 2.6771 | 16.6021 | 39 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0045892 | 0 | 2.6842 | 16.092 | 38 | 1041 | negative regulation of transcription, DNA-templated |
| GO:0048534 | 0 | 2.8815 | 12.4902 | 32 | 808 | hematopoietic or lymphoid organ development |
| GO:0034248 | 0 | 3.246 | 8.5724 | 25 | 559 | regulation of cellular amide metabolic process |
| GO:0034728 | 0 | 7.5583 | 1.5027 | 10 | 103 | nucleosome organization |
| GO:0045934 | 0 | 2.2578 | 19.8792 | 40 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0048731 | 0 | 1.7702 | 64.6925 | 94 | 4185 | system development |
| GO:0070271 | 0 | 2.2037 | 20.312 | 40 | 1314 | protein complex biogenesis |
| GO:0010608 | 0 | 2.7174 | 10.0942 | 25 | 653 | posttranscriptional regulation of gene expression |
| GO:0045596 | 1e-04 | 2.7001 | 9.2904 | 23 | 601 | negative regulation of cell differentiation |
| GO:0060249 | 1e-04 | 3.25 | 5.3331 | 16 | 345 | anatomical structure homeostasis |
| GO:0071822 | 1e-04 | 2.0083 | 23.8674 | 43 | 1544 | protein complex subunit organization |
| GO:0050911 | 2e-04 | 3.2125 | 5.0394 | 15 | 326 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0043043 | 2e-04 | 2.3088 | 12.2274 | 26 | 791 | peptide biosynthetic process |
| GO:0051248 | 3e-04 | 2.0402 | 18.8126 | 35 | 1217 | negative regulation of protein metabolic process |
| GO:0050877 | 3e-04 | 2.0812 | 17.3441 | 33 | 1122 | nervous system process |
| GO:0048869 | 3e-04 | 1.6448 | 58.9111 | 83 | 3811 | cellular developmental process |
| GO:0007606 | 3e-04 | 2.8321 | 6.4615 | 17 | 418 | sensory perception of chemical stimulus |
| GO:0007596 | 3e-04 | 3.2056 | 4.6993 | 14 | 304 | blood coagulation |
| GO:0065007 | 5e-04 | 1.6824 | 164.1504 | 187 | 10619 | biological regulation |
| GO:0051252 | 5e-04 | 1.6249 | 53.7326 | 76 | 3476 | regulation of RNA metabolic process |
| GO:0009593 | 5e-04 | 2.7667 | 6.1987 | 16 | 401 | detection of chemical stimulus |
| GO:0048518 | 5e-04 | 1.5634 | 77.6619 | 102 | 5024 | positive regulation of biological process |
| GO:0032501 | 6e-04 | 1.7072 | 51.0058 | 71 | 3970 | multicellular organismal process |
| GO:0010604 | 7e-04 | 1.6579 | 42.8192 | 63 | 2770 | positive regulation of macromolecule metabolic process |
| GO:1903506 | 8e-04 | 1.6084 | 50.9347 | 72 | 3295 | regulation of nucleic acid-templated transcription |
| GO:0009890 | 9e-04 | 1.814 | 24.1148 | 40 | 1560 | negative regulation of biosynthetic process |
| GO:1903706 | 0.0012 | 3.0092 | 4.2523 | 12 | 290 | regulation of hemopoiesis |
| GO:0065003 | 0.0014 | 1.7551 | 25.4905 | 41 | 1649 | macromolecular complex assembly |
| GO:0045595 | 0.0016 | 2.0056 | 13.986 | 26 | 963 | regulation of cell differentiation |
| GO:0050906 | 0.0018 | 2.5149 | 6.3379 | 15 | 410 | detection of stimulus involved in sensory perception |
| GO:0019800 | 0.0023 | 42.8148 | 0.0773 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
| GO:0050896 | 0.0032 | 1.4485 | 118.7343 | 140 | 7681 | response to stimulus |
| GO:0042359 | 0.0034 | 11.3714 | 0.3092 | 3 | 20 | vitamin D metabolic process |
| GO:0060372 | 0.0034 | 32.109 | 0.0927 | 2 | 6 | regulation of atrial cardiac muscle cell membrane repolarization |
| GO:0071345 | 0.0037 | 1.9517 | 12.5366 | 23 | 811 | cellular response to cytokine stimulus |
| GO:0050878 | 0.0039 | 2.3102 | 6.8634 | 15 | 444 | regulation of body fluid levels |
| GO:0007186 | 0.006 | 1.7418 | 17.746 | 29 | 1148 | G-protein coupled receptor signaling pathway |
| GO:0006570 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | tyrosine metabolic process |
| GO:0070445 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | regulation of oligodendrocyte progenitor proliferation |
| GO:1904714 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | regulation of chaperone-mediated autophagy |
| GO:0070207 | 0.0073 | 8.4016 | 0.4019 | 3 | 26 | protein homotrimerization |
| GO:0001714 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | endodermal cell fate specification |
| GO:0007168 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | receptor guanylyl cyclase signaling pathway |
| GO:0019896 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | axonal transport of mitochondrion |
| GO:0086015 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | SA node cell action potential |
| GO:0006813 | 0.0082 | 2.7322 | 3.4626 | 9 | 224 | potassium ion transport |
| GO:0006281 | 0.0086 | 2.1028 | 7.4972 | 15 | 485 | DNA repair |
| GO:0071805 | 0.0095 | 2.8627 | 2.9371 | 8 | 190 | potassium ion transmembrane transport |
| GO:0006768 | 0.0099 | 16.0502 | 0.1546 | 2 | 10 | biotin metabolic process |
| GO:0071888 | 0.0099 | 16.0502 | 0.1546 | 2 | 10 | macrophage apoptotic process |
| GO:0086070 | 0.0099 | 16.0502 | 0.1546 | 2 | 10 | SA node cell to atrial cardiac muscle cell communication |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 10.5726 | 1.817 | 16 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0098609 | 0 | 3.7162 | 9.0352 | 29 | 726 | cell-cell adhesion |
| GO:0022610 | 1e-04 | 2.3442 | 15.32 | 32 | 1231 | biological adhesion |
| GO:1902715 | 1e-04 | 60.4532 | 0.0871 | 3 | 7 | positive regulation of interferon-gamma secretion |
| GO:0002374 | 1e-04 | 21.5943 | 0.2365 | 4 | 19 | cytokine secretion involved in immune response |
| GO:0002440 | 1e-04 | 5.2672 | 1.8668 | 9 | 150 | production of molecular mediator of immune response |
| GO:0002407 | 1e-04 | 17.9916 | 0.2738 | 4 | 22 | dendritic cell chemotaxis |
| GO:0050710 | 4e-04 | 8.8314 | 0.6347 | 5 | 51 | negative regulation of cytokine secretion |
| GO:0043309 | 5e-04 | 160.383 | 0.0373 | 2 | 3 | regulation of eosinophil degranulation |
| GO:0030101 | 8e-04 | 7.519 | 0.7343 | 5 | 59 | natural killer cell activation |
| GO:0035459 | 0.0011 | 17.2609 | 0.2116 | 3 | 17 | cargo loading into vesicle |
| GO:0002278 | 0.0015 | 53.4539 | 0.0622 | 2 | 5 | eosinophil activation involved in immune response |
| GO:0002447 | 0.0015 | 53.4539 | 0.0622 | 2 | 5 | eosinophil mediated immunity |
| GO:0070945 | 0.0015 | 53.4539 | 0.0622 | 2 | 5 | neutrophil mediated killing of gram-negative bacterium |
| GO:0002250 | 0.0019 | 3.0167 | 3.8829 | 11 | 312 | adaptive immune response |
| GO:0050900 | 0.0027 | 2.7173 | 4.6918 | 12 | 377 | leukocyte migration |
| GO:0045577 | 0.0028 | 12.0778 | 0.2862 | 3 | 23 | regulation of B cell differentiation |
| GO:0002521 | 0.0028 | 2.5885 | 5.339 | 13 | 429 | leukocyte differentiation |
| GO:0002792 | 0.003 | 4.5196 | 1.4187 | 6 | 114 | negative regulation of peptide secretion |
| GO:0034141 | 0.0031 | 32.0681 | 0.0871 | 2 | 7 | positive regulation of toll-like receptor 3 signaling pathway |
| GO:0070943 | 0.0031 | 32.0681 | 0.0871 | 2 | 7 | neutrophil mediated killing of symbiont cell |
| GO:0007267 | 0.0035 | 1.8146 | 17.9459 | 30 | 1442 | cell-cell signaling |
| GO:0048247 | 0.0037 | 6.8771 | 0.6347 | 4 | 51 | lymphocyte chemotaxis |
| GO:0098711 | 0.0041 | 26.7216 | 0.0996 | 2 | 8 | iron ion import across plasma membrane |
| GO:0032501 | 0.0042 | 1.4861 | 81.5157 | 100 | 6550 | multicellular organismal process |
| GO:0070661 | 0.0042 | 3.0481 | 3.1237 | 9 | 251 | leukocyte proliferation |
| GO:0032609 | 0.0044 | 5.0037 | 1.0703 | 5 | 86 | interferon-gamma production |
| GO:0016339 | 0.0045 | 10.0622 | 0.336 | 3 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:1903531 | 0.0046 | 3.6118 | 2.0534 | 7 | 165 | negative regulation of secretion by cell |
| GO:0050865 | 0.0049 | 2.415 | 5.6999 | 13 | 458 | regulation of cell activation |
| GO:0002718 | 0.0052 | 6.2138 | 0.6969 | 4 | 56 | regulation of cytokine production involved in immune response |
| GO:0032817 | 0.0052 | 22.9027 | 0.112 | 2 | 9 | regulation of natural killer cell proliferation |
| GO:0034145 | 0.0052 | 22.9027 | 0.112 | 2 | 9 | positive regulation of toll-like receptor 4 signaling pathway |
| GO:0002369 | 0.006 | 8.9424 | 0.3734 | 3 | 30 | T cell cytokine production |
| GO:0048311 | 0.0065 | 20.0386 | 0.1245 | 2 | 10 | mitochondrion distribution |
| GO:0072672 | 0.0065 | 20.0386 | 0.1245 | 2 | 10 | neutrophil extravasation |
| GO:0046329 | 0.0072 | 8.3245 | 0.3982 | 3 | 32 | negative regulation of JNK cascade |
| GO:0002696 | 0.0074 | 2.7793 | 3.41 | 9 | 274 | positive regulation of leukocyte activation |
| GO:0044272 | 0.0078 | 3.2573 | 2.265 | 7 | 182 | sulfur compound biosynthetic process |
| GO:0035745 | 0.0079 | 17.8109 | 0.1369 | 2 | 11 | T-helper 2 cell cytokine production |
| GO:0002443 | 0.0082 | 2.0675 | 8.1889 | 16 | 658 | leukocyte mediated immunity |
| GO:0048856 | 0.0082 | 1.447 | 63.7565 | 80 | 5123 | anatomical structure development |
| GO:0006970 | 0.0083 | 5.3824 | 0.7965 | 4 | 64 | response to osmotic stress |
| GO:0046649 | 0.009 | 2.6931 | 3.5169 | 9 | 293 | lymphocyte activation |
| GO:0046651 | 0.0093 | 2.8755 | 2.9246 | 8 | 235 | lymphocyte proliferation |
| GO:0061158 | 0.0094 | 16.0287 | 0.1493 | 2 | 12 | 3'-UTR-mediated mRNA destabilization |
| GO:2000484 | 0.0094 | 16.0287 | 0.1493 | 2 | 12 | positive regulation of interleukin-8 secretion |
| GO:0050863 | 0.0095 | 2.6665 | 3.5469 | 9 | 285 | regulation of T cell activation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009719 | 0 | 4.8328 | 2.9809 | 13 | 192 | response to endogenous stimulus |
| GO:0007166 | 0 | 1.8619 | 40.1218 | 65 | 2460 | cell surface receptor signaling pathway |
| GO:0023052 | 1e-04 | 1.6308 | 92.7858 | 122 | 5689 | signaling |
| GO:0007154 | 1e-04 | 1.622 | 93.0957 | 122 | 5708 | cell communication |
| GO:0030308 | 1e-04 | 4.7185 | 2.316 | 10 | 142 | negative regulation of cell growth |
| GO:0030198 | 1e-04 | 3.302 | 4.9092 | 15 | 301 | extracellular matrix organization |
| GO:1902622 | 1e-04 | 11.8159 | 0.5056 | 5 | 31 | regulation of neutrophil migration |
| GO:0051716 | 2e-04 | 1.5918 | 104.7245 | 133 | 6421 | cellular response to stimulus |
| GO:0071310 | 4e-04 | 1.7319 | 36.0607 | 56 | 2211 | cellular response to organic substance |
| GO:0042345 | 5e-04 | 8.528 | 0.6687 | 5 | 41 | regulation of NF-kappaB import into nucleus |
| GO:0001525 | 5e-04 | 2.6574 | 6.8501 | 17 | 420 | angiogenesis |
| GO:0007039 | 6e-04 | 22.8811 | 0.1794 | 3 | 11 | protein catabolic process in the vacuole |
| GO:0032536 | 6e-04 | 22.8811 | 0.1794 | 3 | 11 | regulation of cell projection size |
| GO:2000774 | 6e-04 | 22.8811 | 0.1794 | 3 | 11 | positive regulation of cellular senescence |
| GO:0090023 | 7e-04 | 11.6595 | 0.4077 | 4 | 25 | positive regulation of neutrophil chemotaxis |
| GO:0070340 | 8e-04 | 121.5951 | 0.0489 | 2 | 3 | detection of bacterial lipopeptide |
| GO:0006584 | 8e-04 | 7.6732 | 0.7339 | 5 | 45 | catecholamine metabolic process |
| GO:0022610 | 9e-04 | 1.8901 | 20.0772 | 35 | 1231 | biological adhesion |
| GO:0006790 | 0.0013 | 2.719 | 5.4801 | 14 | 336 | sulfur compound metabolic process |
| GO:0044236 | 0.0014 | 3.9872 | 2.1529 | 8 | 132 | multicellular organism metabolic process |
| GO:0040008 | 0.0015 | 2.2382 | 9.5249 | 20 | 584 | regulation of growth |
| GO:0044571 | 0.0016 | 60.7935 | 0.0652 | 2 | 4 | [2Fe-2S] cluster assembly |
| GO:1901668 | 0.0016 | 60.7935 | 0.0652 | 2 | 4 | regulation of superoxide dismutase activity |
| GO:1902731 | 0.0016 | 60.7935 | 0.0652 | 2 | 4 | negative regulation of chondrocyte proliferation |
| GO:0048545 | 0.0021 | 2.5641 | 5.7899 | 14 | 355 | response to steroid hormone |
| GO:0002687 | 0.0023 | 4.148 | 1.8104 | 7 | 111 | positive regulation of leukocyte migration |
| GO:0042246 | 0.0023 | 5.8977 | 0.9297 | 5 | 57 | tissue regeneration |
| GO:0006637 | 0.0023 | 4.7911 | 1.3537 | 6 | 83 | acyl-CoA metabolic process |
| GO:0018958 | 0.0023 | 4.7911 | 1.3537 | 6 | 83 | phenol-containing compound metabolic process |
| GO:1901700 | 0.0024 | 2.3628 | 7.2021 | 16 | 461 | response to oxygen-containing compound |
| GO:0009438 | 0.0026 | 40.5263 | 0.0815 | 2 | 5 | methylglyoxal metabolic process |
| GO:0033993 | 0.0029 | 2.3205 | 7.3122 | 16 | 464 | response to lipid |
| GO:0001568 | 0.0031 | 2.1328 | 9.4433 | 19 | 579 | blood vessel development |
| GO:0043434 | 0.0032 | 2.4396 | 6.0672 | 14 | 372 | response to peptide hormone |
| GO:0006925 | 0.0034 | 11.4345 | 0.3099 | 3 | 19 | inflammatory cell apoptotic process |
| GO:0030325 | 0.0034 | 11.4345 | 0.3099 | 3 | 19 | adrenal gland development |
| GO:0051239 | 0.0036 | 1.5379 | 42.1116 | 59 | 2582 | regulation of multicellular organismal process |
| GO:0032637 | 0.0036 | 5.2855 | 1.0275 | 5 | 63 | interleukin-8 production |
| GO:0071221 | 0.0038 | 30.3927 | 0.0979 | 2 | 6 | cellular response to bacterial lipopeptide |
| GO:0086073 | 0.0038 | 30.3927 | 0.0979 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:1905165 | 0.0038 | 30.3927 | 0.0979 | 2 | 6 | regulation of lysosomal protein catabolic process |
| GO:0001952 | 0.0039 | 4.2871 | 1.5005 | 6 | 92 | regulation of cell-matrix adhesion |
| GO:0070613 | 0.0039 | 4.2871 | 1.5005 | 6 | 92 | regulation of protein processing |
| GO:0009653 | 0.0041 | 1.5564 | 37.1208 | 53 | 2276 | anatomical structure morphogenesis |
| GO:0002274 | 0.0043 | 2.1094 | 9.0193 | 18 | 553 | myeloid leukocyte activation |
| GO:0010469 | 0.0043 | 2.1589 | 8.3179 | 17 | 510 | regulation of receptor activity |
| GO:0090342 | 0.0044 | 6.6105 | 0.6687 | 4 | 41 | regulation of cell aging |
| GO:0046688 | 0.0046 | 10.1626 | 0.3425 | 3 | 21 | response to copper ion |
| GO:0031667 | 0.0046 | 2.3391 | 6.3118 | 14 | 387 | response to nutrient levels |
| GO:0009409 | 0.0048 | 6.4361 | 0.685 | 4 | 42 | response to cold |
| GO:0007179 | 0.0048 | 3.2466 | 2.6096 | 8 | 160 | transforming growth factor beta receptor signaling pathway |
| GO:0007566 | 0.0052 | 6.2706 | 0.7013 | 4 | 43 | embryo implantation |
| GO:0071622 | 0.0052 | 6.2706 | 0.7013 | 4 | 43 | regulation of granulocyte chemotaxis |
| GO:0032493 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | response to bacterial lipoprotein |
| GO:0048752 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | semicircular canal morphogenesis |
| GO:0097428 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | protein maturation by iron-sulfur cluster transfer |
| GO:0048870 | 0.0055 | 1.68 | 21.6266 | 34 | 1326 | cell motility |
| GO:0072358 | 0.0056 | 2.0095 | 9.9815 | 19 | 612 | cardiovascular system development |
| GO:0010226 | 0.006 | 9.1451 | 0.3751 | 3 | 23 | response to lithium ion |
| GO:0090103 | 0.006 | 9.1451 | 0.3751 | 3 | 23 | cochlea morphogenesis |
| GO:0006954 | 0.0062 | 1.9885 | 10.0794 | 19 | 618 | inflammatory response |
| GO:0034135 | 0.007 | 20.2591 | 0.1305 | 2 | 8 | regulation of toll-like receptor 2 signaling pathway |
| GO:0045410 | 0.007 | 20.2591 | 0.1305 | 2 | 8 | positive regulation of interleukin-6 biosynthetic process |
| GO:1901299 | 0.007 | 20.2591 | 0.1305 | 2 | 8 | negative regulation of hydrogen peroxide-mediated programmed cell death |
| GO:1904996 | 0.007 | 20.2591 | 0.1305 | 2 | 8 | positive regulation of leukocyte adhesion to vascular endothelial cell |
| GO:2000252 | 0.007 | 20.2591 | 0.1305 | 2 | 8 | negative regulation of feeding behavior |
| GO:1901343 | 0.0074 | 3.7209 | 1.7125 | 6 | 105 | negative regulation of vasculature development |
| GO:0051384 | 0.0075 | 3.2871 | 2.2507 | 7 | 138 | response to glucocorticoid |
| GO:0000303 | 0.0076 | 8.3126 | 0.4077 | 3 | 25 | response to superoxide |
| GO:0035235 | 0.0076 | 8.3126 | 0.4077 | 3 | 25 | ionotropic glutamate receptor signaling pathway |
| GO:0071495 | 0.0081 | 1.682 | 18.9355 | 30 | 1161 | cellular response to endogenous stimulus |
| GO:0009605 | 0.0084 | 1.6686 | 19.8181 | 31 | 1260 | response to external stimulus |
| GO:0010035 | 0.0087 | 2.0993 | 7.5025 | 15 | 460 | response to inorganic substance |
| GO:0010243 | 0.0087 | 1.8025 | 13.4686 | 23 | 832 | response to organonitrogen compound |
| GO:0018158 | 0.0088 | 17.3638 | 0.1468 | 2 | 9 | protein oxidation |
| GO:0034776 | 0.0088 | 17.3638 | 0.1468 | 2 | 9 | response to histamine |
| GO:1990001 | 0.0088 | 17.3638 | 0.1468 | 2 | 9 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0051272 | 0.0089 | 2.155 | 6.8174 | 14 | 418 | positive regulation of cellular component movement |
| GO:0003158 | 0.0093 | 3.5408 | 1.7941 | 6 | 110 | endothelium development |
| GO:0070482 | 0.0093 | 2.2963 | 5.4801 | 12 | 336 | response to oxygen levels |
| GO:0030155 | 0.0093 | 1.9397 | 9.7532 | 18 | 598 | regulation of cell adhesion |
| GO:0032101 | 0.0094 | 1.9024 | 10.5034 | 19 | 644 | regulation of response to external stimulus |
| GO:1901701 | 0.0096 | 1.7425 | 15.1517 | 25 | 929 | cellular response to oxygen-containing compound |
| GO:0032963 | 0.0097 | 3.5069 | 1.8104 | 6 | 111 | collagen metabolic process |
| GO:0048731 | 0.0098 | 1.4219 | 56.0757 | 72 | 3573 | system development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007389 | 0 | 4.0872 | 5.7583 | 21 | 396 | pattern specification process |
| GO:0099537 | 0 | 3.2938 | 8.114 | 24 | 558 | trans-synaptic signaling |
| GO:0007218 | 0 | 7.6168 | 1.3378 | 9 | 92 | neuropeptide signaling pathway |
| GO:0060078 | 0 | 6.3463 | 1.7595 | 10 | 121 | regulation of postsynaptic membrane potential |
| GO:0050877 | 0 | 2.4563 | 15.0318 | 33 | 1058 | nervous system process |
| GO:0099565 | 0 | 6.7933 | 1.4832 | 9 | 102 | chemical synaptic transmission, postsynaptic |
| GO:0009952 | 0 | 4.8276 | 2.7337 | 12 | 188 | anterior/posterior pattern specification |
| GO:0021517 | 0 | 11.581 | 0.6107 | 6 | 42 | ventral spinal cord development |
| GO:0048699 | 0 | 2.2266 | 18.5691 | 37 | 1277 | generation of neurons |
| GO:0048646 | 0 | 2.427 | 13.6687 | 30 | 940 | anatomical structure formation involved in morphogenesis |
| GO:0009593 | 1e-04 | 3.1661 | 5.831 | 17 | 401 | detection of chemical stimulus |
| GO:0050911 | 1e-04 | 3.4331 | 4.7404 | 15 | 326 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0060219 | 1e-04 | 21.2167 | 0.2472 | 4 | 17 | camera-type eye photoreceptor cell differentiation |
| GO:0007267 | 1e-04 | 2.0722 | 20.9684 | 39 | 1442 | cell-cell signaling |
| GO:0048665 | 1e-04 | 12.3576 | 0.4799 | 5 | 33 | neuron fate specification |
| GO:0021953 | 1e-04 | 4.7479 | 2.2975 | 10 | 158 | central nervous system neuron differentiation |
| GO:0030900 | 1e-04 | 3.3028 | 4.9149 | 15 | 338 | forebrain development |
| GO:0007606 | 1e-04 | 3.0284 | 6.0782 | 17 | 418 | sensory perception of chemical stimulus |
| GO:0048644 | 2e-04 | 6.6775 | 1.1633 | 7 | 80 | muscle organ morphogenesis |
| GO:0071695 | 2e-04 | 4.8857 | 2.0067 | 9 | 138 | anatomical structure maturation |
| GO:0060322 | 2e-04 | 2.5422 | 9.3936 | 22 | 646 | head development |
| GO:0007188 | 2e-04 | 4.8105 | 2.0358 | 9 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0055008 | 3e-04 | 7.5707 | 0.887 | 6 | 61 | cardiac muscle tissue morphogenesis |
| GO:0007610 | 3e-04 | 2.7125 | 7.1572 | 18 | 498 | behavior |
| GO:0007187 | 3e-04 | 14.2526 | 0.3379 | 4 | 24 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0031644 | 3e-04 | 7.1777 | 0.9306 | 6 | 64 | regulation of neurological system process |
| GO:0050906 | 3e-04 | 2.8882 | 5.9619 | 16 | 410 | detection of stimulus involved in sensory perception |
| GO:0021559 | 3e-04 | 29.4286 | 0.1454 | 3 | 10 | trigeminal nerve development |
| GO:0031960 | 3e-04 | 4.4663 | 2.1812 | 9 | 150 | response to corticosteroid |
| GO:0021675 | 4e-04 | 6.9375 | 0.9597 | 6 | 66 | nerve development |
| GO:0120039 | 4e-04 | 2.5683 | 7.9686 | 19 | 548 | plasma membrane bounded cell projection morphogenesis |
| GO:0003148 | 4e-04 | 13.1271 | 0.3635 | 4 | 25 | outflow tract septum morphogenesis |
| GO:0008306 | 5e-04 | 6.7128 | 0.9888 | 6 | 68 | associative learning |
| GO:0060379 | 5e-04 | 25.7483 | 0.16 | 3 | 11 | cardiac muscle cell myoblast differentiation |
| GO:0006355 | 5e-04 | 1.6654 | 47.6223 | 69 | 3275 | regulation of transcription, DNA-templated |
| GO:0003016 | 6e-04 | 11.984 | 0.3926 | 4 | 27 | respiratory system process |
| GO:2001141 | 6e-04 | 1.6477 | 48.0149 | 69 | 3302 | regulation of RNA biosynthetic process |
| GO:0048636 | 6e-04 | 6.3043 | 1.047 | 6 | 72 | positive regulation of muscle organ development |
| GO:1901863 | 6e-04 | 6.3043 | 1.047 | 6 | 72 | positive regulation of muscle tissue development |
| GO:0010159 | 6e-04 | 136.7636 | 0.0436 | 2 | 3 | specification of animal organ position |
| GO:0021524 | 6e-04 | 136.7636 | 0.0436 | 2 | 3 | visceral motor neuron differentiation |
| GO:0061364 | 6e-04 | 136.7636 | 0.0436 | 2 | 3 | apoptotic process involved in luteolysis |
| GO:0032990 | 7e-04 | 2.4713 | 8.2594 | 19 | 568 | cell part morphogenesis |
| GO:0050886 | 7e-04 | 6.2098 | 1.0615 | 6 | 73 | endocrine process |
| GO:0031175 | 7e-04 | 2.2108 | 11.7202 | 24 | 806 | neuron projection development |
| GO:0055025 | 7e-04 | 7.8556 | 0.7125 | 5 | 49 | positive regulation of cardiac muscle tissue development |
| GO:0021515 | 8e-04 | 7.6805 | 0.7271 | 5 | 50 | cell differentiation in spinal cord |
| GO:1901213 | 8e-04 | 20.5959 | 0.189 | 3 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
| GO:0003229 | 8e-04 | 7.513 | 0.7416 | 5 | 51 | ventricular cardiac muscle tissue development |
| GO:0045597 | 9e-04 | 2.8257 | 5.3035 | 14 | 378 | positive regulation of cell differentiation |
| GO:0021794 | 0.001 | 18.7223 | 0.2036 | 3 | 14 | thalamus development |
| GO:0050884 | 0.001 | 18.7223 | 0.2036 | 3 | 14 | neuromuscular process controlling posture |
| GO:0048598 | 0.0011 | 2.426 | 7.9395 | 18 | 546 | embryonic morphogenesis |
| GO:0001763 | 0.0011 | 3.7417 | 2.5738 | 9 | 177 | morphogenesis of a branching structure |
| GO:0065007 | 0.0012 | 1.6403 | 154.4127 | 175 | 10619 | biological regulation |
| GO:0001992 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0003257 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
| GO:0007198 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0048880 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | sensory system development |
| GO:0051414 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | response to cortisol |
| GO:0070253 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | somatostatin secretion |
| GO:0090027 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | negative regulation of monocyte chemotaxis |
| GO:0060428 | 0.0014 | 9.1835 | 0.4944 | 4 | 34 | lung epithelium development |
| GO:0060485 | 0.0014 | 3.3322 | 3.1991 | 10 | 220 | mesenchyme development |
| GO:0071385 | 0.0015 | 6.5177 | 0.8434 | 5 | 58 | cellular response to glucocorticoid stimulus |
| GO:0048639 | 0.0017 | 3.8684 | 2.2103 | 8 | 152 | positive regulation of developmental growth |
| GO:0007409 | 0.0018 | 2.6188 | 5.6856 | 14 | 391 | axonogenesis |
| GO:0007268 | 0.0019 | 2.51 | 6.3635 | 15 | 453 | chemical synaptic transmission |
| GO:0061180 | 0.0019 | 6.1673 | 0.887 | 5 | 61 | mammary gland epithelium development |
| GO:0097659 | 0.0019 | 1.56 | 50.0652 | 69 | 3443 | nucleic acid-templated transcription |
| GO:0019219 | 0.002 | 1.5395 | 55.5473 | 75 | 3820 | regulation of nucleobase-containing compound metabolic process |
| GO:0051970 | 0.002 | 45.5818 | 0.0727 | 2 | 5 | negative regulation of transmission of nerve impulse |
| GO:0060012 | 0.002 | 45.5818 | 0.0727 | 2 | 5 | synaptic transmission, glycinergic |
| GO:0070100 | 0.002 | 45.5818 | 0.0727 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
| GO:0071205 | 0.002 | 45.5818 | 0.0727 | 2 | 5 | protein localization to juxtaparanode region of axon |
| GO:0048846 | 0.0021 | 13.726 | 0.2617 | 3 | 18 | axon extension involved in axon guidance |
| GO:0019933 | 0.0022 | 4.8317 | 1.3378 | 6 | 92 | cAMP-mediated signaling |
| GO:1990138 | 0.0023 | 4.1186 | 1.8176 | 7 | 125 | neuron projection extension |
| GO:0001709 | 0.0024 | 7.8689 | 0.5671 | 4 | 39 | cell fate determination |
| GO:0007210 | 0.0025 | 12.8673 | 0.2763 | 3 | 19 | serotonin receptor signaling pathway |
| GO:0050794 | 0.0027 | 1.5281 | 131.1652 | 151 | 9261 | regulation of cellular process |
| GO:0031290 | 0.0029 | 12.1096 | 0.2908 | 3 | 20 | retinal ganglion cell axon guidance |
| GO:0002069 | 0.003 | 34.1841 | 0.0872 | 2 | 6 | columnar/cuboidal epithelial cell maturation |
| GO:0021800 | 0.003 | 34.1841 | 0.0872 | 2 | 6 | cerebral cortex tangential migration |
| GO:0060430 | 0.003 | 34.1841 | 0.0872 | 2 | 6 | lung saccule development |
| GO:0003208 | 0.0031 | 5.4795 | 0.9888 | 5 | 68 | cardiac ventricle morphogenesis |
| GO:0008015 | 0.0031 | 2.372 | 6.7035 | 15 | 461 | blood circulation |
| GO:0042692 | 0.0033 | 2.5373 | 5.4239 | 13 | 373 | muscle cell differentiation |
| GO:0097120 | 0.0033 | 11.4361 | 0.3054 | 3 | 21 | receptor localization to synapse |
| GO:0009914 | 0.0034 | 2.7692 | 4.2024 | 11 | 289 | hormone transport |
| GO:0042310 | 0.0035 | 5.3102 | 1.0179 | 5 | 70 | vasoconstriction |
| GO:0060479 | 0.0038 | 10.8335 | 0.3199 | 3 | 22 | lung cell differentiation |
| GO:0014706 | 0.0038 | 2.5963 | 4.8858 | 12 | 336 | striated muscle tissue development |
| GO:0051240 | 0.0038 | 1.8308 | 16.4344 | 28 | 1167 | positive regulation of multicellular organismal process |
| GO:0045664 | 0.004 | 2.2363 | 7.5759 | 16 | 521 | regulation of neuron differentiation |
| GO:0002067 | 0.0041 | 6.7147 | 0.6544 | 4 | 45 | glandular epithelial cell differentiation |
| GO:0048593 | 0.0041 | 4.2367 | 1.5123 | 6 | 104 | camera-type eye morphogenesis |
| GO:0003223 | 0.0042 | 27.3455 | 0.1018 | 2 | 7 | ventricular compact myocardium morphogenesis |
| GO:0035385 | 0.0042 | 27.3455 | 0.1018 | 2 | 7 | Roundabout signaling pathway |
| GO:0044851 | 0.0042 | 27.3455 | 0.1018 | 2 | 7 | hair cycle phase |
| GO:0048819 | 0.0042 | 27.3455 | 0.1018 | 2 | 7 | regulation of hair follicle maturation |
| GO:0090394 | 0.0042 | 27.3455 | 0.1018 | 2 | 7 | negative regulation of excitatory postsynaptic potential |
| GO:0010460 | 0.0043 | 10.2911 | 0.3344 | 3 | 23 | positive regulation of heart rate |
| GO:0021602 | 0.0043 | 10.2911 | 0.3344 | 3 | 23 | cranial nerve morphogenesis |
| GO:0045662 | 0.0043 | 10.2911 | 0.3344 | 3 | 23 | negative regulation of myoblast differentiation |
| GO:2000463 | 0.0043 | 10.2911 | 0.3344 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
| GO:0035637 | 0.0047 | 3.2517 | 2.6029 | 8 | 179 | multicellular organismal signaling |
| GO:0051241 | 0.0048 | 1.8578 | 14.3521 | 25 | 987 | negative regulation of multicellular organismal process |
| GO:0021511 | 0.0049 | 9.8004 | 0.349 | 3 | 24 | spinal cord patterning |
| GO:0007399 | 0.005 | 1.7779 | 17.581 | 29 | 1282 | nervous system development |
| GO:0048729 | 0.005 | 2.1253 | 8.463 | 17 | 582 | tissue morphogenesis |
| GO:0003206 | 0.0052 | 6.2335 | 0.6996 | 4 | 49 | cardiac chamber morphogenesis |
| GO:0040008 | 0.0052 | 2.1175 | 8.492 | 17 | 584 | regulation of growth |
| GO:0010720 | 0.0053 | 2.2987 | 6.4272 | 14 | 442 | positive regulation of cell development |
| GO:0060441 | 0.0055 | 9.3543 | 0.3635 | 3 | 25 | epithelial tube branching involved in lung morphogenesis |
| GO:0000902 | 0.0055 | 1.9132 | 12.2146 | 22 | 840 | cell morphogenesis |
| GO:0048754 | 0.0056 | 3.9641 | 1.6092 | 6 | 112 | branching morphogenesis of an epithelial tube |
| GO:0008343 | 0.0056 | 22.7864 | 0.1163 | 2 | 8 | adult feeding behavior |
| GO:0045924 | 0.0056 | 22.7864 | 0.1163 | 2 | 8 | regulation of female receptivity |
| GO:0060346 | 0.0056 | 22.7864 | 0.1163 | 2 | 8 | bone trabecula formation |
| GO:0061140 | 0.0056 | 22.7864 | 0.1163 | 2 | 8 | lung secretory cell differentiation |
| GO:0006813 | 0.0056 | 2.9145 | 3.2572 | 9 | 224 | potassium ion transport |
| GO:0022603 | 0.0057 | 1.8785 | 13.0143 | 23 | 895 | regulation of anatomical structure morphogenesis |
| GO:0003018 | 0.0059 | 3.4415 | 2.1521 | 7 | 148 | vascular process in circulatory system |
| GO:0010769 | 0.0061 | 2.8738 | 3.3008 | 9 | 227 | regulation of cell morphogenesis involved in differentiation |
| GO:0090287 | 0.0062 | 2.8605 | 3.3154 | 9 | 228 | regulation of cellular response to growth factor stimulus |
| GO:1904018 | 0.0064 | 3.3929 | 2.1812 | 7 | 150 | positive regulation of vasculature development |
| GO:0071805 | 0.0067 | 3.0529 | 2.7628 | 8 | 190 | potassium ion transmembrane transport |
| GO:0046530 | 0.0068 | 5.7328 | 0.7561 | 4 | 52 | photoreceptor cell differentiation |
| GO:0048469 | 0.0071 | 3.3225 | 2.2248 | 7 | 153 | cell maturation |
| GO:0010579 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
| GO:0021562 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | vestibulocochlear nerve development |
| GO:0046549 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | retinal cone cell development |
| GO:0046855 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | inositol phosphate dephosphorylation |
| GO:0046877 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | regulation of saliva secretion |
| GO:0098598 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | learned vocalization behavior or vocal learning |
| GO:0009889 | 0.0072 | 1.4392 | 60.0841 | 77 | 4132 | regulation of biosynthetic process |
| GO:0030326 | 0.0076 | 3.7036 | 1.7159 | 6 | 118 | embryonic limb morphogenesis |
| GO:0010092 | 0.0076 | 8.2301 | 0.4072 | 3 | 28 | specification of animal organ identity |
| GO:0031128 | 0.0076 | 8.2301 | 0.4072 | 3 | 28 | developmental induction |
| GO:0060045 | 0.0076 | 8.2301 | 0.4072 | 3 | 28 | positive regulation of cardiac muscle cell proliferation |
| GO:0046883 | 0.008 | 2.7459 | 3.4463 | 9 | 237 | regulation of hormone secretion |
| GO:0090596 | 0.0082 | 2.7337 | 3.4608 | 9 | 238 | sensory organ morphogenesis |
| GO:0035270 | 0.0082 | 3.6382 | 1.7449 | 6 | 120 | endocrine system development |
| GO:0045165 | 0.0082 | 2.9401 | 2.8631 | 8 | 200 | cell fate commitment |
| GO:0003203 | 0.0084 | 7.9131 | 0.4217 | 3 | 29 | endocardial cushion morphogenesis |
| GO:0019098 | 0.0084 | 7.9131 | 0.4217 | 3 | 29 | reproductive behavior |
| GO:1905332 | 0.0084 | 7.9131 | 0.4217 | 3 | 29 | positive regulation of morphogenesis of an epithelium |
| GO:0032275 | 0.0088 | 17.0875 | 0.1454 | 2 | 10 | luteinizing hormone secretion |
| GO:0048845 | 0.0088 | 17.0875 | 0.1454 | 2 | 10 | venous blood vessel morphogenesis |
| GO:0060947 | 0.0088 | 17.0875 | 0.1454 | 2 | 10 | cardiac vascular smooth muscle cell differentiation |
| GO:0097746 | 0.0088 | 3.575 | 1.774 | 6 | 122 | regulation of blood vessel diameter |
| GO:0051960 | 0.009 | 1.9152 | 10.4696 | 19 | 720 | regulation of nervous system development |
| GO:0051954 | 0.0092 | 7.6195 | 0.4362 | 3 | 30 | positive regulation of amine transport |
| GO:0048704 | 0.0096 | 4.1039 | 1.2942 | 5 | 89 | embryonic skeletal system morphogenesis |
| GO:0048863 | 0.0098 | 2.6514 | 3.5626 | 9 | 245 | stem cell differentiation |
| GO:0003008 | 0.0099 | 2.0765 | 7.6479 | 15 | 605 | system process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045653 | 0 | 263.8868 | 0.3107 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 0 | 46.5248 | 0.5665 | 14 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 35.9389 | 0.6579 | 14 | 36 | chromatin silencing at rDNA |
| GO:0034080 | 0 | 30.4017 | 0.731 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 28.2264 | 0.7675 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0051290 | 0 | 27.2513 | 0.7858 | 14 | 43 | protein heterotetramerization |
| GO:0016233 | 0 | 21.9421 | 0.9137 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 21.9421 | 0.9137 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0043044 | 0 | 14.6258 | 1.3341 | 15 | 73 | ATP-dependent chromatin remodeling |
| GO:0006303 | 0 | 15.1745 | 1.2061 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0045815 | 0 | 12.3193 | 1.4254 | 14 | 78 | positive regulation of gene expression, epigenetic |
| GO:0031497 | 0 | 7.6534 | 2.6133 | 17 | 143 | chromatin assembly |
| GO:0060964 | 0 | 9.2627 | 1.8092 | 14 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 9.1544 | 1.8275 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:1903707 | 0 | 7.5467 | 2.3209 | 15 | 127 | negative regulation of hemopoiesis |
| GO:0045814 | 0 | 7.6347 | 2.1381 | 14 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 7.3473 | 2.2112 | 14 | 121 | regulation of gene silencing |
| GO:0065004 | 0 | 4.948 | 3.856 | 17 | 211 | protein-DNA complex assembly |
| GO:0006352 | 0 | 4.6106 | 4.1118 | 17 | 225 | DNA-templated transcription, initiation |
| GO:0045637 | 0 | 4.6106 | 4.1118 | 17 | 225 | regulation of myeloid cell differentiation |
| GO:0032200 | 0 | 5.5629 | 2.8326 | 14 | 155 | telomere organization |
| GO:0071103 | 0 | 4.0213 | 4.6601 | 17 | 255 | DNA conformation change |
| GO:0002244 | 0 | 4.6325 | 3.3443 | 14 | 183 | hematopoietic progenitor cell differentiation |
| GO:0048863 | 0 | 3.6458 | 4.4773 | 15 | 245 | stem cell differentiation |
| GO:0051259 | 1e-04 | 2.6559 | 8.9546 | 22 | 490 | protein oligomerization |
| GO:0045596 | 1e-04 | 2.4627 | 10.9831 | 25 | 601 | negative regulation of cell differentiation |
| GO:0035194 | 1e-04 | 3.2959 | 4.9159 | 15 | 269 | posttranscriptional gene silencing by RNA |
| GO:0043652 | 2e-04 | 40.7174 | 0.1279 | 3 | 7 | engulfment of apoptotic cell |
| GO:0060249 | 2e-04 | 2.9001 | 6.3048 | 17 | 345 | anatomical structure homeostasis |
| GO:0045602 | 5e-04 | 27.1413 | 0.1645 | 3 | 9 | negative regulation of endothelial cell differentiation |
| GO:0017148 | 8e-04 | 2.6368 | 6.4692 | 16 | 354 | negative regulation of translation |
| GO:2000026 | 0.001 | 1.7059 | 31.3046 | 49 | 1713 | regulation of multicellular organismal development |
| GO:0036337 | 0.001 | 108.2094 | 0.0548 | 2 | 3 | Fas signaling pathway |
| GO:0002040 | 0.0011 | 4.7958 | 1.5899 | 7 | 87 | sprouting angiogenesis |
| GO:0017015 | 0.0017 | 4.4078 | 1.7178 | 7 | 94 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0045926 | 0.0018 | 3.0349 | 3.856 | 11 | 211 | negative regulation of growth |
| GO:0051895 | 0.0019 | 14.7994 | 0.2558 | 3 | 14 | negative regulation of focal adhesion assembly |
| GO:0007264 | 0.0019 | 2.2856 | 8.3515 | 18 | 457 | small GTPase mediated signal transduction |
| GO:0032502 | 0.0019 | 1.4358 | 100.2733 | 124 | 5487 | developmental process |
| GO:0043537 | 0.0023 | 8.0598 | 0.5665 | 4 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0071294 | 0.0023 | 13.5652 | 0.2741 | 3 | 15 | cellular response to zinc ion |
| GO:0010812 | 0.0025 | 5.801 | 0.9503 | 5 | 52 | negative regulation of cell-substrate adhesion |
| GO:0055114 | 0.003 | 1.8555 | 16.0452 | 28 | 878 | oxidation-reduction process |
| GO:0009438 | 0.0032 | 36.065 | 0.0914 | 2 | 5 | methylglyoxal metabolic process |
| GO:1902041 | 0.0032 | 5.4518 | 1.0051 | 5 | 55 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0006281 | 0.0036 | 2.1444 | 8.8632 | 18 | 485 | DNA repair |
| GO:0070482 | 0.0036 | 2.4062 | 6.1403 | 14 | 336 | response to oxygen levels |
| GO:0030198 | 0.0037 | 2.4945 | 5.5007 | 13 | 301 | extracellular matrix organization |
| GO:0002578 | 0.0048 | 27.0469 | 0.1096 | 2 | 6 | negative regulation of antigen processing and presentation |
| GO:0001666 | 0.0049 | 2.4092 | 5.6834 | 13 | 311 | response to hypoxia |
| GO:0030574 | 0.0051 | 4.8657 | 1.1148 | 5 | 61 | collagen catabolic process |
| GO:0048514 | 0.0051 | 2.0667 | 9.1739 | 18 | 502 | blood vessel morphogenesis |
| GO:0035987 | 0.0065 | 5.8775 | 0.7493 | 4 | 41 | endodermal cell differentiation |
| GO:0001952 | 0.0068 | 3.8083 | 1.6813 | 6 | 92 | regulation of cell-matrix adhesion |
| GO:0048731 | 0.0082 | 1.3757 | 76.4797 | 95 | 4185 | system development |
| GO:0034248 | 0.0083 | 1.9256 | 10.3618 | 19 | 567 | regulation of cellular amide metabolic process |
| GO:0035912 | 0.0087 | 18.0289 | 0.1462 | 2 | 8 | dorsal aorta morphogenesis |
| GO:0060155 | 0.0087 | 18.0289 | 0.1462 | 2 | 8 | platelet dense granule organization |
| GO:0097049 | 0.0087 | 18.0289 | 0.1462 | 2 | 8 | motor neuron apoptotic process |
| GO:0098711 | 0.0087 | 18.0289 | 0.1462 | 2 | 8 | iron ion import across plasma membrane |
| GO:0010608 | 0.0088 | 1.8489 | 11.9334 | 21 | 653 | posttranscriptional regulation of gene expression |
| GO:0042692 | 0.0089 | 2.1528 | 6.8165 | 14 | 373 | muscle cell differentiation |
| GO:0090287 | 0.0093 | 2.5187 | 4.1666 | 10 | 228 | regulation of cellular response to growth factor stimulus |
| GO:0010038 | 0.0093 | 2.294 | 5.4824 | 12 | 300 | response to metal ion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006335 | 0 | 229.7755 | 0.5036 | 24 | 31 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0 | 133.9911 | 0.5848 | 24 | 36 | chromatin silencing at rDNA |
| GO:0051290 | 0 | 84.5865 | 0.6985 | 24 | 43 | protein heterotetramerization |
| GO:0045815 | 0 | 29.6925 | 1.267 | 24 | 78 | positive regulation of gene expression, epigenetic |
| GO:0045653 | 0 | 299.4644 | 0.2762 | 14 | 17 | negative regulation of megakaryocyte differentiation |
| GO:0060964 | 0 | 21.3486 | 1.6082 | 24 | 99 | regulation of gene silencing by miRNA |
| GO:1902036 | 0 | 21.0663 | 1.6244 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
| GO:0045814 | 0 | 17.1959 | 1.9006 | 24 | 117 | negative regulation of gene expression, epigenetic |
| GO:0060968 | 0 | 16.4823 | 1.9655 | 24 | 121 | regulation of gene silencing |
| GO:0031497 | 0 | 13.4154 | 2.3229 | 24 | 143 | chromatin assembly |
| GO:0032200 | 0 | 12.1767 | 2.5178 | 24 | 155 | telomere organization |
| GO:0002244 | 0 | 10.5445 | 2.9727 | 25 | 183 | hematopoietic progenitor cell differentiation |
| GO:0034080 | 0 | 34.5007 | 0.6498 | 14 | 40 | CENP-A containing nucleosome assembly |
| GO:1904837 | 0 | 32.0321 | 0.6823 | 14 | 42 | beta-catenin-TCF complex assembly |
| GO:0016233 | 0 | 24.9005 | 0.8122 | 14 | 50 | telomere capping |
| GO:0034724 | 0 | 24.9005 | 0.8122 | 14 | 50 | DNA replication-independent nucleosome organization |
| GO:0065004 | 0 | 8.4981 | 3.4275 | 24 | 211 | protein-DNA complex assembly |
| GO:0048863 | 0 | 7.5413 | 3.9798 | 25 | 245 | stem cell differentiation |
| GO:0006303 | 0 | 17.2204 | 1.0721 | 14 | 66 | double-strand break repair via nonhomologous end joining |
| GO:0071103 | 0 | 6.859 | 4.1423 | 24 | 255 | DNA conformation change |
| GO:0030099 | 0 | 5.6652 | 5.8154 | 28 | 358 | myeloid cell differentiation |
| GO:0043044 | 0 | 15.1702 | 1.1858 | 14 | 73 | ATP-dependent chromatin remodeling |
| GO:0035194 | 0 | 6.4609 | 4.3697 | 24 | 269 | posttranscriptional gene silencing by RNA |
| GO:0038111 | 0 | 24.2292 | 0.5848 | 10 | 36 | interleukin-7-mediated signaling pathway |
| GO:0098760 | 0 | 24.2292 | 0.5848 | 10 | 36 | response to interleukin-7 |
| GO:0017148 | 0 | 5.0057 | 5.7504 | 25 | 354 | negative regulation of translation |
| GO:1903707 | 0 | 8.5686 | 2.063 | 15 | 127 | negative regulation of hemopoiesis |
| GO:0045652 | 0 | 15.1907 | 0.8286 | 10 | 54 | regulation of megakaryocyte differentiation |
| GO:0006352 | 0 | 4.887 | 3.6549 | 16 | 225 | DNA-templated transcription, initiation |
| GO:0032501 | 0 | 1.8616 | 106.3994 | 144 | 6550 | multicellular organismal process |
| GO:0034248 | 0 | 3.2106 | 9.012 | 26 | 559 | regulation of cellular amide metabolic process |
| GO:0045892 | 0 | 2.5286 | 16.9102 | 38 | 1041 | negative regulation of transcription, DNA-templated |
| GO:0034728 | 0 | 7.1477 | 1.5839 | 10 | 103 | nucleosome organization |
| GO:1902679 | 0 | 2.4423 | 17.4463 | 38 | 1074 | negative regulation of RNA biosynthetic process |
| GO:0048534 | 0 | 2.6185 | 13.1253 | 31 | 808 | hematopoietic or lymphoid organ development |
| GO:0010608 | 0 | 2.6883 | 10.6075 | 26 | 653 | posttranscriptional regulation of gene expression |
| GO:0070271 | 0 | 2.1388 | 21.3449 | 41 | 1314 | protein complex biogenesis |
| GO:0048731 | 0 | 1.7177 | 67.9819 | 97 | 4185 | system development |
| GO:0045596 | 0 | 2.6817 | 9.7628 | 24 | 601 | negative regulation of cell differentiation |
| GO:0050911 | 1e-04 | 3.2723 | 5.2956 | 16 | 326 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0045934 | 1e-04 | 2.0609 | 20.89 | 39 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0071822 | 2e-04 | 1.9439 | 25.081 | 44 | 1544 | protein complex subunit organization |
| GO:0051248 | 2e-04 | 2.0566 | 19.7692 | 37 | 1217 | negative regulation of protein metabolic process |
| GO:0060249 | 2e-04 | 3.0793 | 5.6042 | 16 | 345 | anatomical structure homeostasis |
| GO:0048518 | 3e-04 | 1.5854 | 81.6108 | 108 | 5024 | positive regulation of biological process |
| GO:0009593 | 3e-04 | 2.8048 | 6.5139 | 17 | 401 | detection of chemical stimulus |
| GO:0007606 | 5e-04 | 2.6828 | 6.7901 | 17 | 418 | sensory perception of chemical stimulus |
| GO:0043043 | 5e-04 | 2.1822 | 12.8492 | 26 | 791 | peptide biosynthetic process |
| GO:0048869 | 6e-04 | 1.5805 | 61.9066 | 85 | 3811 | cellular developmental process |
| GO:0045595 | 8e-04 | 2.0637 | 14.7083 | 28 | 963 | regulation of cell differentiation |
| GO:0050906 | 0.0011 | 2.56 | 6.6601 | 16 | 410 | detection of stimulus involved in sensory perception |
| GO:0065007 | 0.0013 | 1.5832 | 172.497 | 194 | 10619 | biological regulation |
| GO:0051716 | 0.0014 | 1.4791 | 104.3039 | 128 | 6421 | cellular response to stimulus |
| GO:0007596 | 0.0014 | 2.7998 | 4.9382 | 13 | 304 | blood coagulation |
| GO:0015803 | 0.0015 | 61.0447 | 0.065 | 2 | 4 | branched-chain amino acid transport |
| GO:0065003 | 0.0021 | 1.7016 | 26.7867 | 42 | 1649 | macromolecular complex assembly |
| GO:0051252 | 0.0024 | 1.51 | 56.4648 | 76 | 3476 | regulation of RNA metabolic process |
| GO:0019800 | 0.0025 | 40.6938 | 0.0812 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
| GO:0060591 | 0.0025 | 40.6938 | 0.0812 | 2 | 5 | chondroblast differentiation |
| GO:0010604 | 0.0025 | 1.5488 | 44.9964 | 63 | 2770 | positive regulation of macromolecule metabolic process |
| GO:0030574 | 0.0031 | 5.4979 | 0.9909 | 5 | 61 | collagen catabolic process |
| GO:2000026 | 0.0033 | 1.7807 | 19.3745 | 32 | 1296 | regulation of multicellular organismal development |
| GO:1903506 | 0.0033 | 1.4972 | 53.5246 | 72 | 3295 | regulation of nucleic acid-templated transcription |
| GO:0006813 | 0.0037 | 2.9068 | 3.6387 | 10 | 224 | potassium ion transport |
| GO:0060372 | 0.0038 | 30.5183 | 0.0975 | 2 | 6 | regulation of atrial cardiac muscle cell membrane repolarization |
| GO:0007218 | 0.0039 | 4.3051 | 1.4945 | 6 | 92 | neuropeptide signaling pathway |
| GO:0071805 | 0.0039 | 3.087 | 3.0864 | 9 | 190 | potassium ion transmembrane transport |
| GO:0042359 | 0.0039 | 10.8058 | 0.3249 | 3 | 20 | vitamin D metabolic process |
| GO:0051962 | 0.0041 | 2.2939 | 6.9038 | 15 | 425 | positive regulation of nervous system development |
| GO:0009890 | 0.0042 | 1.656 | 25.3409 | 39 | 1560 | negative regulation of biosynthetic process |
| GO:0051291 | 0.0044 | 5.0134 | 1.0741 | 5 | 73 | protein heterooligomerization |
| GO:0050877 | 0.0048 | 1.7551 | 18.226 | 30 | 1122 | nervous system process |
| GO:0061337 | 0.0049 | 3.5762 | 2.0793 | 7 | 128 | cardiac conduction |
| GO:0021796 | 0.0052 | 24.413 | 0.1137 | 2 | 7 | cerebral cortex regionalization |
| GO:1903706 | 0.0054 | 2.5979 | 4.463 | 11 | 290 | regulation of hemopoiesis |
| GO:0050878 | 0.0061 | 2.1894 | 7.2124 | 15 | 444 | regulation of body fluid levels |
| GO:0071345 | 0.0067 | 1.8461 | 13.174 | 23 | 811 | cellular response to cytokine stimulus |
| GO:0006570 | 0.0069 | 20.3428 | 0.13 | 2 | 8 | tyrosine metabolic process |
| GO:0060534 | 0.0069 | 20.3428 | 0.13 | 2 | 8 | trachea cartilage development |
| GO:0070445 | 0.0069 | 20.3428 | 0.13 | 2 | 8 | regulation of oligodendrocyte progenitor proliferation |
| GO:1904714 | 0.0069 | 20.3428 | 0.13 | 2 | 8 | regulation of chaperone-mediated autophagy |
| GO:0009611 | 0.008 | 1.973 | 9.6003 | 18 | 591 | response to wounding |
| GO:0002828 | 0.0084 | 7.9837 | 0.4223 | 3 | 26 | regulation of type 2 immune response |
| GO:0070207 | 0.0084 | 7.9837 | 0.4223 | 3 | 26 | protein homotrimerization |
| GO:0007168 | 0.0088 | 17.4355 | 0.1462 | 2 | 9 | receptor guanylyl cyclase signaling pathway |
| GO:0072520 | 0.0088 | 17.4355 | 0.1462 | 2 | 9 | seminiferous tubule development |
| GO:0086015 | 0.0088 | 17.4355 | 0.1462 | 2 | 9 | SA node cell action potential |
| GO:0034121 | 0.01 | 5.113 | 0.8447 | 4 | 52 | regulation of toll-like receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004872 | 1e-04 | 2.0787 | 19.7323 | 37 | 1351 | receptor activity |
| GO:0017034 | 0.0012 | 68.0679 | 0.0584 | 2 | 4 | Rap guanyl-nucleotide exchange factor activity |
| GO:0005328 | 0.0018 | 14.6406 | 0.2483 | 3 | 17 | neurotransmitter:sodium symporter activity |
| GO:0004468 | 0.0031 | 34.0294 | 0.0876 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0004888 | 0.0036 | 1.857 | 15.5697 | 27 | 1066 | transmembrane signaling receptor activity |
| GO:0004966 | 0.0042 | 27.2217 | 0.1022 | 2 | 7 | galanin receptor activity |
| GO:0022890 | 0.0054 | 2.2266 | 7.113 | 15 | 487 | inorganic cation transmembrane transporter activity |
| GO:0005215 | 0.007 | 1.7231 | 17.965 | 29 | 1230 | transporter activity |
| GO:0008331 | 0.0071 | 19.4415 | 0.1315 | 2 | 9 | high voltage-gated calcium channel activity |
| GO:0015085 | 0.0083 | 3.6214 | 1.7527 | 6 | 120 | calcium ion transmembrane transporter activity |
| GO:0035240 | 0.0088 | 17.0102 | 0.1461 | 2 | 10 | dopamine binding |
| GO:0022891 | 0.0094 | 1.8438 | 12.0351 | 21 | 824 | substrate-specific transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 5.1308 | 3.0417 | 14 | 180 | histone binding |
| GO:0046982 | 3e-04 | 2.6448 | 7.7224 | 19 | 457 | protein heterodimerization activity |
| GO:0019863 | 0.0028 | 39.0807 | 0.0845 | 2 | 5 | IgE binding |
| GO:0019904 | 0.0045 | 2.0147 | 10.4937 | 20 | 621 | protein domain specific binding |
| GO:0008432 | 0.0074 | 19.5365 | 0.1352 | 2 | 8 | JUN kinase binding |
| GO:0008066 | 0.0083 | 8.015 | 0.4225 | 3 | 25 | glutamate receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 8.7793 | 6.7945 | 45 | 457 | protein heterodimerization activity |
| GO:0042393 | 0 | 11.2808 | 2.6762 | 24 | 180 | histone binding |
| GO:0003677 | 0 | 2.7448 | 33.4375 | 72 | 2249 | DNA binding |
| GO:0031492 | 0 | 20.958 | 0.6393 | 10 | 43 | nucleosomal DNA binding |
| GO:1901363 | 0 | 1.9503 | 80.6573 | 117 | 5425 | heterocyclic compound binding |
| GO:0097159 | 0 | 1.9434 | 81.7575 | 118 | 5499 | organic cyclic compound binding |
| GO:0045296 | 4e-04 | 3.2618 | 4.2819 | 13 | 288 | cadherin binding |
| GO:0003682 | 0.0035 | 2.337 | 6.7945 | 15 | 457 | chromatin binding |
| GO:0019904 | 0.0054 | 2.0621 | 9.2328 | 18 | 621 | protein domain specific binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 6.4299 | 7.3034 | 38 | 457 | protein heterodimerization activity |
| GO:0042393 | 0 | 10.3972 | 2.8766 | 24 | 180 | histone binding |
| GO:0031492 | 0 | 19.4134 | 0.6872 | 10 | 43 | nucleosomal DNA binding |
| GO:0003677 | 0 | 2.0678 | 32.6384 | 58 | 2153 | DNA binding |
| GO:0019904 | 0 | 2.7635 | 9.9243 | 25 | 621 | protein domain specific binding |
| GO:0016508 | 8e-04 | 124.157 | 0.0479 | 2 | 3 | long-chain-enoyl-CoA hydratase activity |
| GO:0005184 | 0.0011 | 9.9993 | 0.4635 | 4 | 29 | neuropeptide hormone activity |
| GO:0005237 | 0.0015 | 62.0744 | 0.0639 | 2 | 4 | inhibitory extracellular ligand-gated ion channel activity |
| GO:0044323 | 0.0015 | 62.0744 | 0.0639 | 2 | 4 | retinoic acid-responsive element binding |
| GO:0000981 | 0.002 | 2.0936 | 11.2028 | 22 | 701 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0005328 | 0.0023 | 13.3462 | 0.2717 | 3 | 17 | neurotransmitter:sodium symporter activity |
| GO:0045296 | 0.0024 | 2.7639 | 4.6026 | 12 | 288 | cadherin binding |
| GO:0030883 | 0.0025 | 41.3802 | 0.0799 | 2 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0025 | 41.3802 | 0.0799 | 2 | 5 | exogenous lipid antigen binding |
| GO:1901363 | 0.0028 | 1.4498 | 86.6977 | 108 | 5425 | heterocyclic compound binding |
| GO:0051428 | 0.0032 | 11.6763 | 0.3036 | 3 | 19 | peptide hormone receptor binding |
| GO:0004957 | 0.0037 | 31.0331 | 0.0959 | 2 | 6 | prostaglandin E receptor activity |
| GO:0097159 | 0.0046 | 1.419 | 87.8803 | 108 | 5499 | organic cyclic compound binding |
| GO:0003857 | 0.0051 | 24.8248 | 0.1119 | 2 | 7 | 3-hydroxyacyl-CoA dehydrogenase activity |
| GO:0030371 | 0.0056 | 9.3386 | 0.3676 | 3 | 23 | translation repressor activity |
| GO:0004983 | 0.0067 | 20.686 | 0.1278 | 2 | 8 | neuropeptide Y receptor activity |
| GO:0030881 | 0.0067 | 20.686 | 0.1278 | 2 | 8 | beta-2-microglobulin binding |
| GO:0071855 | 0.008 | 8.1189 | 0.4155 | 3 | 26 | neuropeptide receptor binding |
| GO:0070700 | 0.0085 | 17.7296 | 0.1438 | 2 | 9 | BMP receptor binding |
| GO:0031490 | 0.0088 | 5.3033 | 0.8146 | 4 | 53 | chromatin DNA binding |
| GO:0005539 | 0.0096 | 2.8598 | 2.9405 | 8 | 184 | glycosaminoglycan binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 7.6253 | 7.0639 | 42 | 457 | protein heterodimerization activity |
| GO:0042393 | 0 | 10.7954 | 2.7823 | 24 | 180 | histone binding |
| GO:0031492 | 0 | 20.1113 | 0.6647 | 10 | 43 | nucleosomal DNA binding |
| GO:0003677 | 0 | 2.2361 | 34.7632 | 65 | 2249 | DNA binding |
| GO:0045296 | 0 | 4.2282 | 4.4517 | 17 | 288 | cadherin binding |
| GO:0043546 | 1e-04 | 64.5021 | 0.0927 | 3 | 6 | molybdopterin cofactor binding |
| GO:1901363 | 2e-04 | 1.6089 | 82.7301 | 109 | 5419 | heterocyclic compound binding |
| GO:0005178 | 2e-04 | 5.3469 | 1.6385 | 8 | 106 | integrin binding |
| GO:0097159 | 4e-04 | 1.5747 | 83.8598 | 109 | 5493 | organic cyclic compound binding |
| GO:0008940 | 7e-04 | 128.4701 | 0.0464 | 2 | 3 | nitrate reductase activity |
| GO:0016836 | 8e-04 | 7.5451 | 0.7419 | 5 | 48 | hydro-lyase activity |
| GO:0004459 | 0.0014 | 64.2308 | 0.0618 | 2 | 4 | L-lactate dehydrogenase activity |
| GO:0030151 | 0.0014 | 64.2308 | 0.0618 | 2 | 4 | molybdenum ion binding |
| GO:0019904 | 0.0016 | 2.2233 | 9.5989 | 20 | 621 | protein domain specific binding |
| GO:0050072 | 0.0023 | 42.8177 | 0.0773 | 2 | 5 | m7G(5')pppN diphosphatase activity |
| GO:0032027 | 0.0034 | 32.1111 | 0.0927 | 2 | 6 | myosin light chain binding |
| GO:0016829 | 0.004 | 3.3459 | 2.535 | 8 | 164 | lyase activity |
| GO:0003682 | 0.0051 | 2.2404 | 7.0639 | 15 | 457 | chromatin binding |
| GO:0030170 | 0.0068 | 5.7421 | 0.7574 | 4 | 49 | pyridoxal phosphate binding |
| GO:0070410 | 0.008 | 18.3455 | 0.1391 | 2 | 9 | co-SMAD binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 20.668 | 0.6478 | 10 | 43 | nucleosomal DNA binding |
| GO:0046982 | 0 | 3.3651 | 6.8843 | 21 | 457 | protein heterodimerization activity |
| GO:0042393 | 1e-04 | 4.4192 | 2.7116 | 11 | 180 | histone binding |
| GO:0045296 | 4e-04 | 3.2161 | 4.3385 | 13 | 288 | cadherin binding |
| GO:0005509 | 5e-04 | 2.4178 | 9.3549 | 21 | 621 | calcium ion binding |
| GO:0005412 | 0.0033 | 32.9693 | 0.0904 | 2 | 6 | glucose:sodium symporter activity |
| GO:0003682 | 0.004 | 2.3039 | 6.8843 | 15 | 457 | chromatin binding |
| GO:0004222 | 0.0053 | 4.0012 | 1.5968 | 6 | 106 | metalloendopeptidase activity |
| GO:0060089 | 0.0059 | 1.6875 | 20.9543 | 33 | 1391 | molecular transducer activity |
| GO:0030414 | 0.008 | 3.2467 | 2.2747 | 7 | 151 | peptidase inhibitor activity |
| GO:0099600 | 0.0088 | 1.7207 | 16.661 | 27 | 1106 | transmembrane receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 6.961 | 4.8469 | 28 | 326 | olfactory receptor activity |
| GO:0060089 | 0 | 2.9628 | 20.681 | 51 | 1391 | molecular transducer activity |
| GO:0004930 | 0 | 3.7493 | 10.5412 | 34 | 709 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 2.9823 | 16.4437 | 42 | 1106 | transmembrane receptor activity |
| GO:0038023 | 0 | 2.9022 | 16.8738 | 42 | 1149 | signaling receptor activity |
| GO:0008329 | 0.0013 | 16.7734 | 0.223 | 3 | 15 | signaling pattern recognition receptor activity |
| GO:0046870 | 0.0021 | 44.557 | 0.0743 | 2 | 5 | cadmium ion binding |
| GO:0001591 | 0.0032 | 33.4156 | 0.0892 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0004111 | 0.0032 | 33.4156 | 0.0892 | 2 | 6 | creatine kinase activity |
| GO:0005104 | 0.0059 | 9.1431 | 0.3717 | 3 | 25 | fibroblast growth factor receptor binding |
| GO:0005549 | 0.0061 | 4.618 | 1.1597 | 5 | 78 | odorant binding |
| GO:0048018 | 0.0076 | 2.2761 | 6.0065 | 13 | 404 | receptor ligand activity |
| GO:0035240 | 0.0092 | 16.7033 | 0.1487 | 2 | 10 | dopamine binding |
| GO:0035325 | 0.0092 | 16.7033 | 0.1487 | 2 | 10 | Toll-like receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005102 | 0 | 2.3379 | 17.9436 | 37 | 1363 | receptor binding |
| GO:0001609 | 0.0035 | 30.2754 | 0.0922 | 2 | 7 | G-protein coupled adenosine receptor activity |
| GO:0005125 | 0.0037 | 3.3901 | 2.5013 | 8 | 190 | cytokine activity |
| GO:0030545 | 0.0047 | 2.4234 | 5.674 | 13 | 431 | receptor regulator activity |
| GO:0004629 | 0.0064 | 8.7652 | 0.3818 | 3 | 29 | phospholipase C activity |
| GO:0030957 | 0.0072 | 18.9183 | 0.1316 | 2 | 10 | Tat protein binding |
| GO:0004062 | 0.0088 | 16.8152 | 0.1448 | 2 | 11 | aryl sulfotransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 15.8312 | 4.8896 | 52 | 326 | olfactory receptor activity |
| GO:0004930 | 0 | 7.3126 | 10.6341 | 57 | 709 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 4.6381 | 16.5886 | 59 | 1106 | transmembrane receptor activity |
| GO:0038023 | 0 | 4.4201 | 15.9463 | 55 | 1081 | signaling receptor activity |
| GO:0060089 | 0 | 3.7426 | 20.8632 | 61 | 1391 | molecular transducer activity |
| GO:0031492 | 0 | 30.1106 | 0.6449 | 13 | 43 | nucleosomal DNA binding |
| GO:0005549 | 0 | 15.2362 | 1.1699 | 14 | 78 | odorant binding |
| GO:0046982 | 0 | 3.7573 | 6.8544 | 23 | 457 | protein heterodimerization activity |
| GO:0042393 | 0 | 5.3597 | 2.6998 | 13 | 180 | histone binding |
| GO:0003682 | 0.0015 | 2.4865 | 6.8544 | 16 | 457 | chromatin binding |
| GO:0004993 | 0.0027 | 12.4638 | 0.285 | 3 | 19 | G-protein coupled serotonin receptor activity |
| GO:0001591 | 0.0032 | 33.1167 | 0.09 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0045296 | 0.0042 | 2.6891 | 4.3196 | 11 | 288 | cadherin binding |
| GO:0030594 | 0.0082 | 4.2814 | 1.2449 | 5 | 83 | neurotransmitter receptor activity |
| GO:0035240 | 0.0093 | 16.554 | 0.15 | 2 | 10 | dopamine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 13.2427 | 2.7705 | 28 | 180 | histone binding |
| GO:0046982 | 0 | 6.2788 | 7.034 | 36 | 457 | protein heterodimerization activity |
| GO:0031492 | 0 | 23.0205 | 0.6618 | 11 | 43 | nucleosomal DNA binding |
| GO:0003677 | 0 | 2.3488 | 34.6159 | 67 | 2249 | DNA binding |
| GO:0045296 | 0 | 3.9648 | 4.4328 | 16 | 288 | cadherin binding |
| GO:1901363 | 0 | 1.7246 | 83.4998 | 114 | 5425 | heterocyclic compound binding |
| GO:0019904 | 0 | 2.7504 | 9.5582 | 24 | 621 | protein domain specific binding |
| GO:0097159 | 1e-04 | 1.688 | 84.6388 | 114 | 5499 | organic cyclic compound binding |
| GO:0003723 | 1e-04 | 2.0339 | 24.8268 | 45 | 1613 | RNA binding |
| GO:0035663 | 7e-04 | 129.03 | 0.0462 | 2 | 3 | Toll-like receptor 2 binding |
| GO:0044877 | 0.0016 | 2.0032 | 13.9295 | 26 | 905 | macromolecular complex binding |
| GO:0005078 | 0.0047 | 25.7991 | 0.1077 | 2 | 7 | MAP-kinase scaffold activity |
| GO:0019864 | 0.0047 | 25.7991 | 0.1077 | 2 | 7 | IgG binding |
| GO:0019900 | 0.0047 | 2.0893 | 9.1148 | 18 | 597 | kinase binding |
| GO:0003682 | 0.0049 | 2.2508 | 7.034 | 15 | 457 | chromatin binding |
| GO:0008432 | 0.0062 | 21.4979 | 0.1231 | 2 | 8 | JUN kinase binding |
| GO:0016667 | 0.0083 | 5.4058 | 0.8004 | 4 | 52 | oxidoreductase activity, acting on a sulfur group of donors |
| GO:0043236 | 0.0089 | 7.7628 | 0.431 | 3 | 28 | laminin binding |
| GO:0031625 | 0.0096 | 2.5057 | 4.1865 | 10 | 272 | ubiquitin protein ligase binding |
| GO:0008484 | 0.0098 | 16.1212 | 0.1539 | 2 | 10 | sulfuric ester hydrolase activity |
| GO:0071723 | 0.0098 | 16.1212 | 0.1539 | 2 | 10 | lipopeptide binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 6e-04 | 2.4808 | 8.2567 | 19 | 621 | calcium ion binding |
| GO:0030492 | 0.001 | 74.9403 | 0.0532 | 2 | 4 | hemoglobin binding |
| GO:0004468 | 0.0025 | 37.4652 | 0.0798 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
| GO:0005488 | 0.0088 | 1.8056 | 174.4008 | 186 | 13117 | binding |
| GO:0050664 | 0.0089 | 16.6457 | 0.1463 | 2 | 11 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor |
| GO:0005547 | 0.0094 | 7.5175 | 0.4388 | 3 | 33 | phosphatidylinositol-3,4,5-trisphosphate binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008528 | 0.001 | 4.8609 | 1.557 | 7 | 108 | G-protein coupled peptide receptor activity |
| GO:0005313 | 0.001 | 18.7235 | 0.2036 | 3 | 14 | L-glutamate transmembrane transporter activity |
| GO:0042923 | 0.0029 | 12.1104 | 0.2908 | 3 | 20 | neuropeptide binding |
| GO:0055131 | 0.003 | 34.1864 | 0.0872 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0004972 | 0.0042 | 27.3473 | 0.1018 | 2 | 7 | NMDA glutamate receptor activity |
| GO:0004683 | 0.0043 | 10.2918 | 0.3344 | 3 | 23 | calmodulin-dependent protein kinase activity |
| GO:0004985 | 0.0056 | 22.7879 | 0.1163 | 2 | 8 | opioid receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 17.936 | 4.5479 | 53 | 326 | olfactory receptor activity |
| GO:0004930 | 0 | 8.4905 | 9.8911 | 59 | 709 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 5.5104 | 15.4295 | 62 | 1106 | transmembrane receptor activity |
| GO:0038023 | 0 | 5.3231 | 16.2387 | 63 | 1164 | signaling receptor activity |
| GO:0005549 | 0 | 18.0279 | 1.0882 | 15 | 78 | odorant binding |
| GO:0036374 | 1e-04 | 71.6762 | 0.0837 | 3 | 6 | glutathione hydrolase activity |
| GO:0005198 | 0.0014 | 2.3113 | 8.8029 | 19 | 631 | structural molecule activity |
| GO:0004252 | 0.0018 | 3.8262 | 2.2321 | 8 | 160 | serine-type endopeptidase activity |
| GO:0005044 | 0.0025 | 7.7683 | 0.572 | 4 | 41 | scavenger receptor activity |
| GO:0004872 | 0.0051 | 4.0414 | 1.5784 | 6 | 148 | receptor activity |
| GO:0017171 | 0.0051 | 3.2069 | 2.6367 | 8 | 189 | serine hydrolase activity |
| GO:0004497 | 0.0058 | 4.6759 | 1.144 | 5 | 82 | monooxygenase activity |
| GO:0042056 | 0.0068 | 8.5886 | 0.3906 | 3 | 28 | chemoattractant activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036374 | 0 | 85.226 | 0.0707 | 3 | 6 | glutathione hydrolase activity |
| GO:0008528 | 1e-04 | 6.4513 | 1.3676 | 8 | 116 | G-protein coupled peptide receptor activity |
| GO:0004872 | 2e-04 | 2.1701 | 15.9274 | 31 | 1351 | receptor activity |
| GO:0004888 | 3e-04 | 2.2805 | 12.5675 | 26 | 1066 | transmembrane signaling receptor activity |
| GO:0004871 | 0.0018 | 1.9132 | 17.1889 | 30 | 1458 | signal transducer activity |
| GO:0004683 | 0.0024 | 12.7695 | 0.2712 | 3 | 23 | calmodulin-dependent protein kinase activity |
| GO:0008020 | 0.0037 | 28.2434 | 0.0943 | 2 | 8 | G-protein coupled photoreceptor activity |
| GO:0017171 | 0.0072 | 3.3139 | 2.2282 | 7 | 189 | serine hydrolase activity |
| GO:0005201 | 0.0076 | 5.5081 | 0.7781 | 4 | 66 | extracellular matrix structural constituent |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 5.7893 | 3.3482 | 17 | 180 | histone binding |
| GO:0050431 | 3e-04 | 15.2755 | 0.3348 | 4 | 18 | transforming growth factor beta binding |
| GO:0019904 | 6e-04 | 2.2245 | 11.5512 | 24 | 621 | protein domain specific binding |
| GO:0046982 | 9e-04 | 2.3811 | 8.5007 | 19 | 457 | protein heterodimerization activity |
| GO:0016829 | 0.001 | 3.5146 | 3.0506 | 10 | 164 | lyase activity |
| GO:0004351 | 0.001 | 106.2624 | 0.0558 | 2 | 3 | glutamate decarboxylase activity |
| GO:0016836 | 0.0019 | 6.227 | 0.8928 | 5 | 48 | hydro-lyase activity |
| GO:0005123 | 0.0025 | 13.3203 | 0.279 | 3 | 15 | death receptor binding |
| GO:0016661 | 0.0033 | 35.4161 | 0.093 | 2 | 5 | oxidoreductase activity, acting on other nitrogenous compounds as donors |
| GO:0004222 | 0.0036 | 3.7995 | 1.9717 | 7 | 106 | metalloendopeptidase activity |
| GO:0043546 | 0.0049 | 26.5603 | 0.1116 | 2 | 6 | molybdopterin cofactor binding |
| GO:0016723 | 0.0068 | 21.2468 | 0.1302 | 2 | 7 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor |
| GO:0005201 | 0.0076 | 4.3842 | 1.2277 | 5 | 66 | extracellular matrix structural constituent |
| GO:0019842 | 0.0081 | 3.239 | 2.2879 | 7 | 123 | vitamin binding |
| GO:0005089 | 0.0092 | 4.1779 | 1.2835 | 5 | 69 | Rho guanyl-nucleotide exchange factor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030492 | 0.001 | 78.0881 | 0.0511 | 2 | 4 | hemoglobin binding |
| GO:0005509 | 0.001 | 2.4403 | 7.9313 | 18 | 621 | calcium ion binding |
| GO:0005488 | 0.0082 | 1.8461 | 167.5278 | 179 | 13117 | binding |
| GO:0050664 | 0.0083 | 17.3448 | 0.1405 | 2 | 11 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor |
| GO:0005547 | 0.0084 | 7.8349 | 0.4215 | 3 | 33 | phosphatidylinositol-3,4,5-trisphosphate binding |
| GO:0005092 | 0.0098 | 15.6093 | 0.1533 | 2 | 12 | GDP-dissociation inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031492 | 0 | 25.9108 | 0.5238 | 10 | 43 | nucleosomal DNA binding |
| GO:0042393 | 0 | 7.3138 | 2.1928 | 14 | 180 | histone binding |
| GO:0003682 | 0 | 3.5738 | 5.5673 | 18 | 457 | chromatin binding |
| GO:0046982 | 0 | 3.5738 | 5.5673 | 18 | 457 | protein heterodimerization activity |
| GO:0045296 | 2e-04 | 3.6997 | 3.5085 | 12 | 288 | cadherin binding |
| GO:0003677 | 8e-04 | 1.8095 | 27.3981 | 44 | 2249 | DNA binding |
| GO:0008528 | 0.003 | 4.537 | 1.4132 | 6 | 116 | G-protein coupled peptide receptor activity |
| GO:0004065 | 0.003 | 32.7761 | 0.0853 | 2 | 7 | arylsulfatase activity |
| GO:0000979 | 0.0042 | 6.6075 | 0.6578 | 4 | 54 | RNA polymerase II core promoter sequence-specific DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 20.0839 | 4.5479 | 57 | 326 | olfactory receptor activity |
| GO:0004930 | 0 | 9.5962 | 9.8911 | 64 | 709 | G-protein coupled receptor activity |
| GO:0099600 | 0 | 6.3328 | 15.4295 | 68 | 1106 | transmembrane receptor activity |
| GO:0060089 | 0 | 5.2027 | 19.4055 | 71 | 1391 | molecular transducer activity |
| GO:0038023 | 0 | 5.7573 | 14.6649 | 61 | 1081 | signaling receptor activity |
| GO:0005549 | 0 | 14.99 | 1.0882 | 13 | 78 | odorant binding |
| GO:0008392 | 0 | 43.6087 | 0.2232 | 6 | 16 | arachidonic acid epoxygenase activity |
| GO:0005506 | 0 | 5.5269 | 1.995 | 10 | 143 | iron ion binding |
| GO:0008395 | 1e-04 | 13.3796 | 0.4464 | 5 | 32 | steroid hydroxylase activity |
| GO:0030594 | 2e-04 | 6.6973 | 1.1579 | 7 | 83 | neurotransmitter receptor activity |
| GO:0008389 | 2e-04 | Inf | 0.0279 | 2 | 2 | coumarin 7-hydroxylase activity |
| GO:0020037 | 2e-04 | 5.5035 | 1.5904 | 8 | 114 | heme binding |
| GO:0019825 | 2e-04 | 10.6201 | 0.5441 | 5 | 39 | oxygen binding |
| GO:0005198 | 2e-04 | 2.59 | 8.8029 | 21 | 631 | structural molecule activity |
| GO:0003779 | 5e-04 | 2.9996 | 5.0083 | 14 | 359 | actin binding |
| GO:0016709 | 8e-04 | 11.0629 | 0.4185 | 4 | 30 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
| GO:0070330 | 0.0019 | 14.3238 | 0.2511 | 3 | 18 | aromatase activity |
| GO:0019863 | 0.0019 | 47.5577 | 0.0698 | 2 | 5 | IgE binding |
| GO:0030883 | 0.0019 | 47.5577 | 0.0698 | 2 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0019 | 47.5577 | 0.0698 | 2 | 5 | exogenous lipid antigen binding |
| GO:0001591 | 0.0028 | 35.6659 | 0.0837 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0016705 | 0.0031 | 4.5017 | 1.4266 | 6 | 105 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0030881 | 0.0051 | 23.7741 | 0.1116 | 2 | 8 | beta-2-microglobulin binding |
| GO:0039706 | 0.0065 | 20.3764 | 0.1256 | 2 | 9 | co-receptor binding |
| GO:0035240 | 0.0081 | 17.8282 | 0.1395 | 2 | 10 | dopamine binding |
| GO:0071723 | 0.0081 | 17.8282 | 0.1395 | 2 | 10 | lipopeptide binding |
| GO:0005518 | 0.0092 | 5.2197 | 0.8231 | 4 | 59 | collagen binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 11.3257 | 4.2277 | 36 | 326 | olfactory receptor activity |
| GO:0004930 | 0 | 5.4497 | 9.1945 | 40 | 709 | G-protein coupled receptor activity |
| GO:0060089 | 0 | 3.7513 | 18.0389 | 53 | 1391 | molecular transducer activity |
| GO:0038023 | 0 | 3.9657 | 14.8596 | 47 | 1157 | signaling receptor activity |
| GO:0099600 | 0 | 3.9999 | 14.3429 | 46 | 1106 | transmembrane receptor activity |
| GO:0005549 | 0 | 13.1721 | 1.0115 | 11 | 78 | odorant binding |
| GO:0004028 | 0.0016 | 51.2483 | 0.0648 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
| GO:0015198 | 0.0016 | 51.2483 | 0.0648 | 2 | 5 | oligopeptide transporter activity |
| GO:0001591 | 0.0024 | 38.4337 | 0.0778 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
| GO:0004887 | 0.0034 | 30.7449 | 0.0908 | 2 | 7 | thyroid hormone receptor activity |
| GO:0035240 | 0.007 | 19.2117 | 0.1297 | 2 | 10 | dopamine binding |
| GO:0035325 | 0.007 | 19.2117 | 0.1297 | 2 | 10 | Toll-like receptor binding |
| GO:0042887 | 0.0074 | 8.2648 | 0.402 | 3 | 31 | amide transmembrane transporter activity |
| GO:0015250 | 0.0085 | 17.076 | 0.1427 | 2 | 11 | water channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 14.062 | 2.5229 | 27 | 180 | histone binding |
| GO:0031492 | 0 | 32.39 | 0.6027 | 13 | 43 | nucleosomal DNA binding |
| GO:0046982 | 0 | 5.3568 | 6.4054 | 29 | 457 | protein heterodimerization activity |
| GO:0045296 | 2e-04 | 3.4758 | 4.0367 | 13 | 288 | cadherin binding |
| GO:0003682 | 2e-04 | 2.8662 | 6.4054 | 17 | 457 | chromatin binding |
| GO:0003677 | 3e-04 | 1.83 | 31.5225 | 51 | 2249 | DNA binding |
| GO:0044877 | 9e-04 | 2.1305 | 12.6847 | 25 | 905 | macromolecular complex binding |
| GO:0030492 | 0.0012 | 71 | 0.0561 | 2 | 4 | hemoglobin binding |
| GO:0019904 | 0.0012 | 2.3391 | 8.7041 | 19 | 621 | protein domain specific binding |
| GO:0015144 | 0.0023 | 7.946 | 0.5606 | 4 | 40 | carbohydrate transmembrane transporter activity |
| GO:0016801 | 0.0066 | 20.279 | 0.1261 | 2 | 9 | hydrolase activity, acting on ether bonds |
| GO:0022857 | 0.0078 | 1.8523 | 12.6006 | 22 | 899 | transmembrane transporter activity |
| GO:0042887 | 0.0091 | 7.63 | 0.4345 | 3 | 31 | amide transmembrane transporter activity |
| GO:0015250 | 0.0099 | 15.7704 | 0.1542 | 2 | 11 | water channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 11.4506 | 3.0181 | 27 | 180 | histone binding |
| GO:0046982 | 0 | 5.2822 | 7.6626 | 34 | 457 | protein heterodimerization activity |
| GO:0031492 | 0 | 18.4516 | 0.721 | 10 | 43 | nucleosomal DNA binding |
| GO:0045296 | 0 | 4.1294 | 4.8289 | 18 | 288 | cadherin binding |
| GO:0003677 | 0 | 2.0414 | 37.7092 | 66 | 2249 | DNA binding |
| GO:0003682 | 0 | 2.9875 | 7.6626 | 21 | 457 | chromatin binding |
| GO:0019904 | 0 | 2.6177 | 10.4124 | 25 | 621 | protein domain specific binding |
| GO:0005488 | 4e-04 | 2.1994 | 200.871 | 218 | 12660 | binding |
| GO:0005088 | 0.0018 | 3.0328 | 3.8564 | 11 | 230 | Ras guanyl-nucleotide exchange factor activity |
| GO:0003700 | 0.0022 | 1.8228 | 18.8294 | 32 | 1123 | DNA binding transcription factor activity |
| GO:0001190 | 0.0024 | 5.8437 | 0.939 | 5 | 56 | transcriptional activator activity, RNA polymerase II transcription factor binding |
| GO:0001191 | 0.0027 | 7.6708 | 0.5868 | 4 | 35 | transcriptional repressor activity, RNA polymerase II transcription factor binding |
| GO:0022853 | 0.0036 | 3.8085 | 1.9618 | 7 | 117 | active ion transmembrane transporter activity |
| GO:0030215 | 0.0073 | 19.6929 | 0.1341 | 2 | 8 | semaphorin receptor binding |
| GO:0016208 | 0.0093 | 16.8785 | 0.1509 | 2 | 9 | AMP binding |
| GO:0016846 | 0.0093 | 16.8785 | 0.1509 | 2 | 9 | carbon-sulfur lyase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046982 | 0 | 4.1908 | 5.3877 | 20 | 457 | protein heterodimerization activity |
| GO:0019838 | 5e-04 | 5.3622 | 1.4147 | 7 | 120 | growth factor binding |
| GO:0004656 | 8e-04 | 84.7528 | 0.0472 | 2 | 4 | procollagen-proline 4-dioxygenase activity |
| GO:0055131 | 0.002 | 42.3708 | 0.0707 | 2 | 6 | C3HC4-type RING finger domain binding |
| GO:0008331 | 0.0047 | 24.2071 | 0.1061 | 2 | 9 | high voltage-gated calcium channel activity |
| GO:0015932 | 0.0057 | 9.1162 | 0.3655 | 3 | 31 | nucleobase-containing compound transmembrane transporter activity |
| GO:0032036 | 0.0058 | 21.1798 | 0.1179 | 2 | 10 | myosin heavy chain binding |
| GO:0048029 | 0.0061 | 5.8895 | 0.7309 | 4 | 62 | monosaccharide binding |
| GO:0046332 | 0.008 | 5.4203 | 0.7899 | 4 | 67 | SMAD binding |
| GO:0031543 | 0.0099 | 15.4004 | 0.1533 | 2 | 13 | peptidyl-proline dioxygenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008188 | 0.0039 | 6.8377 | 0.6472 | 4 | 41 | neuropeptide receptor activity |
| GO:0004683 | 0.0054 | 9.4582 | 0.363 | 3 | 23 | calmodulin-dependent protein kinase activity |
| GO:0000340 | 0.0065 | 20.9498 | 0.1263 | 2 | 8 | RNA 7-methylguanosine cap binding |
| GO:0004435 | 0.0077 | 8.2229 | 0.4104 | 3 | 26 | phosphatidylinositol phospholipase C activity |
| GO:0008331 | 0.0083 | 17.9558 | 0.1421 | 2 | 9 | high voltage-gated calcium channel activity |
| GO:0016832 | 0.0083 | 17.9558 | 0.1421 | 2 | 9 | aldehyde-lyase activity |
| GO:0035250 | 0.0095 | 7.564 | 0.442 | 3 | 28 | UDP-galactosyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003700 | 0.0013 | 1.8914 | 18.241 | 32 | 1123 | DNA binding transcription factor activity |
| GO:0005509 | 0.0029 | 2.1045 | 10.087 | 20 | 621 | calcium ion binding |
| GO:0004983 | 0.0069 | 20.3442 | 0.1299 | 2 | 8 | neuropeptide Y receptor activity |
| GO:0071933 | 0.0069 | 20.3442 | 0.1299 | 2 | 8 | Arp2/3 complex binding |
| GO:0036312 | 0.0088 | 17.4367 | 0.1462 | 2 | 9 | phosphatidylinositol 3-kinase regulatory subunit binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036374 | 1e-04 | 71.6762 | 0.0837 | 3 | 6 | glutathione hydrolase activity |
| GO:0008503 | 0.0011 | 71.3412 | 0.0558 | 2 | 4 | benzodiazepine receptor activity |
| GO:0015277 | 0.0019 | 47.5577 | 0.0698 | 2 | 5 | kainate selective glutamate receptor activity |
| GO:0005201 | 0.0023 | 5.9087 | 0.9207 | 5 | 66 | extracellular matrix structural constituent |
| GO:0001228 | 0.0024 | 2.6382 | 5.2315 | 13 | 375 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0016702 | 0.003 | 11.9341 | 0.293 | 3 | 21 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
| GO:0005104 | 0.0049 | 9.7617 | 0.3488 | 3 | 25 | fibroblast growth factor receptor binding |
| GO:0008066 | 0.0049 | 9.7617 | 0.3488 | 3 | 25 | glutamate receptor activity |
| GO:0031995 | 0.0051 | 23.7741 | 0.1116 | 2 | 8 | insulin-like growth factor II binding |
| GO:0001653 | 0.006 | 3.9023 | 1.6322 | 6 | 117 | peptide receptor activity |
| GO:0019842 | 0.0076 | 3.7007 | 1.7159 | 6 | 123 | vitamin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 11.427 | 2.7705 | 25 | 180 | histone binding |
| GO:0031492 | 0 | 20.202 | 0.6618 | 10 | 43 | nucleosomal DNA binding |
| GO:0046982 | 0 | 4.4083 | 7.034 | 27 | 457 | protein heterodimerization activity |
| GO:0003677 | 0 | 1.9206 | 34.6159 | 58 | 2249 | DNA binding |
| GO:0045296 | 2e-04 | 3.4123 | 4.4328 | 14 | 288 | cadherin binding |
| GO:0004984 | 2e-04 | 3.2276 | 5.0177 | 15 | 326 | olfactory receptor activity |
| GO:0019904 | 6e-04 | 2.3605 | 9.5582 | 21 | 621 | protein domain specific binding |
| GO:0004930 | 0.0014 | 2.1568 | 10.9127 | 22 | 709 | G-protein coupled receptor activity |
| GO:0015079 | 0.0022 | 3.7222 | 2.2934 | 8 | 149 | potassium ion transmembrane transporter activity |
| GO:0005249 | 0.0022 | 4.8365 | 1.3391 | 6 | 87 | voltage-gated potassium channel activity |
| GO:0009374 | 0.0023 | 43.0043 | 0.077 | 2 | 5 | biotin binding |
| GO:0004872 | 0.0029 | 1.7617 | 20.7941 | 34 | 1351 | receptor activity |
| GO:0005201 | 0.0035 | 5.3357 | 1.0159 | 5 | 66 | extracellular matrix structural constituent |
| GO:0005044 | 0.0035 | 7.0181 | 0.6311 | 4 | 41 | scavenger receptor activity |
| GO:0003682 | 0.0049 | 2.2508 | 7.034 | 15 | 457 | chromatin binding |
| GO:0004683 | 0.0051 | 9.7067 | 0.354 | 3 | 23 | calmodulin-dependent protein kinase activity |
| GO:0008061 | 0.0062 | 21.4979 | 0.1231 | 2 | 8 | chitin binding |
| GO:0004303 | 0.0098 | 16.1212 | 0.1539 | 2 | 10 | estradiol 17-beta-dehydrogenase activity |
| GO:0005184 | 0.0098 | 7.4637 | 0.4464 | 3 | 29 | neuropeptide hormone activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 1e-04 | 2.9208 | 7.5246 | 20 | 621 | calcium ion binding |
| GO:0016493 | 0.0089 | 16.4732 | 0.1454 | 2 | 12 | C-C chemokine receptor activity |
| GO:0019894 | 0.0093 | 7.5175 | 0.4362 | 3 | 36 | kinesin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 11.3177 | 2.7941 | 25 | 180 | histone binding |
| GO:0046982 | 0 | 5.1592 | 7.0939 | 31 | 457 | protein heterodimerization activity |
| GO:0031492 | 0 | 22.8137 | 0.6675 | 11 | 43 | nucleosomal DNA binding |
| GO:0003682 | 0 | 3.078 | 7.0939 | 20 | 457 | chromatin binding |
| GO:0003677 | 1e-04 | 1.8548 | 34.9105 | 57 | 2249 | DNA binding |
| GO:0019904 | 3e-04 | 2.4654 | 9.6396 | 22 | 621 | protein domain specific binding |
| GO:0022853 | 5e-04 | 4.7825 | 1.8162 | 8 | 117 | active ion transmembrane transporter activity |
| GO:0045296 | 6e-04 | 3.1141 | 4.4705 | 13 | 288 | cadherin binding |
| GO:0030492 | 0.0014 | 63.9532 | 0.0621 | 2 | 4 | hemoglobin binding |
| GO:1990837 | 0.002 | 2.1338 | 10.4933 | 21 | 676 | sequence-specific double-stranded DNA binding |
| GO:0015057 | 0.0023 | 42.6326 | 0.0776 | 2 | 5 | thrombin-activated receptor activity |
| GO:0001965 | 0.003 | 12.0312 | 0.2949 | 3 | 19 | G-protein alpha-subunit binding |
| GO:0043184 | 0.0048 | 25.5762 | 0.1087 | 2 | 7 | vascular endothelial growth factor receptor 2 binding |
| GO:0044212 | 0.005 | 1.9295 | 12.0922 | 22 | 779 | transcription regulatory region DNA binding |
| GO:0001067 | 0.0051 | 1.9241 | 12.1232 | 22 | 781 | regulatory region nucleic acid binding |
| GO:0031681 | 0.0063 | 21.3121 | 0.1242 | 2 | 8 | G-protein beta-subunit binding |
| GO:0000977 | 0.0068 | 2.0539 | 8.7237 | 17 | 562 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0044877 | 0.0073 | 1.8097 | 14.048 | 24 | 905 | macromolecular complex binding |
| GO:0008510 | 0.008 | 18.2663 | 0.1397 | 2 | 9 | sodium:bicarbonate symporter activity |
| GO:0036312 | 0.008 | 18.2663 | 0.1397 | 2 | 9 | phosphatidylinositol 3-kinase regulatory subunit binding |
| GO:0005436 | 0.0099 | 15.9819 | 0.1552 | 2 | 10 | sodium:phosphate symporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0098631 | 2e-04 | 10.6369 | 0.5502 | 5 | 35 | cell adhesion mediator activity |
| GO:0035663 | 7e-04 | 126.2773 | 0.0472 | 2 | 3 | Toll-like receptor 2 binding |
| GO:0043120 | 7e-04 | 126.2773 | 0.0472 | 2 | 3 | tumor necrosis factor binding |
| GO:0098641 | 0.0018 | 14.6203 | 0.2515 | 3 | 16 | cadherin binding involved in cell-cell adhesion |
| GO:0048018 | 0.0019 | 2.5088 | 6.3505 | 15 | 404 | receptor ligand activity |
| GO:0003996 | 0.0024 | 42.0868 | 0.0786 | 2 | 5 | acyl-CoA ligase activity |
| GO:0022849 | 0.0024 | 42.0868 | 0.0786 | 2 | 5 | glutamate-gated calcium ion channel activity |
| GO:0019001 | 0.0034 | 2.5195 | 5.4545 | 13 | 347 | guanyl nucleotide binding |
| GO:0050839 | 0.0035 | 2.3417 | 6.775 | 15 | 431 | cell adhesion molecule binding |
| GO:0086083 | 0.0035 | 31.563 | 0.0943 | 2 | 6 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication |
| GO:0004972 | 0.0049 | 25.2487 | 0.11 | 2 | 7 | NMDA glutamate receptor activity |
| GO:0030306 | 0.0049 | 25.2487 | 0.11 | 2 | 7 | ADP-ribosylation factor binding |
| GO:0050840 | 0.0058 | 6.0476 | 0.7231 | 4 | 46 | extracellular matrix binding |
| GO:0005525 | 0.0061 | 2.4346 | 5.1873 | 12 | 330 | GTP binding |
| GO:0019966 | 0.0065 | 21.0392 | 0.1258 | 2 | 8 | interleukin-1 binding |
| GO:0001883 | 0.0066 | 2.4114 | 5.2345 | 12 | 333 | purine nucleoside binding |
| GO:0032549 | 0.0069 | 2.3961 | 5.2659 | 12 | 335 | ribonucleoside binding |
| GO:0017124 | 0.0085 | 3.6096 | 1.7605 | 6 | 112 | SH3 domain binding |
| GO:0030594 | 0.0099 | 4.078 | 1.3047 | 5 | 83 | neurotransmitter receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 5.9248 | 3.2774 | 17 | 180 | histone binding |
| GO:0050431 | 0 | 21.1003 | 0.3277 | 5 | 18 | transforming growth factor beta binding |
| GO:0016723 | 2e-04 | 40.8709 | 0.1275 | 3 | 7 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor |
| GO:0046982 | 3e-04 | 2.5816 | 8.3211 | 20 | 457 | protein heterodimerization activity |
| GO:0019904 | 0.001 | 2.1707 | 11.3072 | 23 | 621 | protein domain specific binding |
| GO:0004864 | 0.0023 | 8.0903 | 0.5644 | 4 | 31 | protein phosphatase inhibitor activity |
| GO:0005123 | 0.0023 | 13.6164 | 0.2731 | 3 | 15 | death receptor binding |
| GO:0004222 | 0.0032 | 3.8852 | 1.93 | 7 | 106 | metalloendopeptidase activity |
| GO:0016491 | 0.0034 | 1.9918 | 11.6895 | 22 | 642 | oxidoreductase activity |
| GO:0043546 | 0.0047 | 27.1486 | 0.1092 | 2 | 6 | molybdopterin cofactor binding |
| GO:0019842 | 0.0073 | 3.3121 | 2.2396 | 7 | 123 | vitamin binding |
| GO:0050660 | 0.0074 | 4.4098 | 1.2199 | 5 | 67 | flavin adenine dinucleotide binding |
| GO:0005024 | 0.0086 | 18.0966 | 0.1457 | 2 | 8 | transforming growth factor beta-activated receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042393 | 0 | 10.6066 | 2.9591 | 25 | 180 | histone binding |
| GO:0046982 | 0 | 4.4527 | 7.5129 | 29 | 457 | protein heterodimerization activity |
| GO:0031492 | 0 | 18.8407 | 0.7069 | 10 | 43 | nucleosomal DNA binding |
| GO:0004984 | 1e-04 | 3.2301 | 5.3593 | 16 | 326 | olfactory receptor activity |
| GO:0003677 | 3e-04 | 1.7592 | 36.9727 | 58 | 2249 | DNA binding |
| GO:0004930 | 3e-04 | 2.318 | 11.6557 | 25 | 709 | G-protein coupled receptor activity |
| GO:0005249 | 6e-04 | 5.3565 | 1.4302 | 7 | 87 | voltage-gated potassium channel activity |
| GO:0019904 | 6e-04 | 2.3124 | 10.209 | 22 | 621 | protein domain specific binding |
| GO:0015079 | 8e-04 | 3.952 | 2.4495 | 9 | 149 | potassium ion transmembrane transporter activity |
| GO:0045296 | 0.001 | 2.9281 | 4.7346 | 13 | 288 | cadherin binding |
| GO:0090722 | 0.0016 | 60.3012 | 0.0658 | 2 | 4 | receptor-receptor interaction |
| GO:0060089 | 0.0023 | 1.7447 | 22.8675 | 37 | 1391 | molecular transducer activity |
| GO:0099600 | 0.0025 | 1.8275 | 18.1822 | 31 | 1106 | transmembrane receptor activity |
| GO:0038023 | 0.0028 | 1.7923 | 19.1357 | 32 | 1164 | signaling receptor activity |
| GO:0004683 | 0.0061 | 9.0708 | 0.3781 | 3 | 23 | calmodulin-dependent protein kinase activity |
| GO:0005261 | 0.0067 | 2.5128 | 4.6031 | 11 | 280 | cation channel activity |
| GO:0003682 | 0.0088 | 2.0959 | 7.5129 | 15 | 457 | chromatin binding |
| GO:0005244 | 0.0093 | 2.8752 | 2.9263 | 8 | 178 | voltage-gated ion channel activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007606 | 0 | 3.1377 | 10.206 | 29 | 406 | sensory perception of chemical stimulus |
| GO:0006955 | 0 | 1.9447 | 39.5871 | 69 | 1611 | immune response |
| GO:0050906 | 0 | 2.9376 | 10.0552 | 27 | 400 | detection of stimulus involved in sensory perception |
| GO:0009593 | 0 | 2.9091 | 9.7535 | 26 | 388 | detection of chemical stimulus |
| GO:0007186 | 0 | 2.0364 | 29.6879 | 55 | 1181 | G-protein coupled receptor signaling pathway |
| GO:0050911 | 0 | 2.9082 | 7.8179 | 21 | 311 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0031338 | 2e-04 | 5.5333 | 1.634 | 8 | 65 | regulation of vesicle fusion |
| GO:0090630 | 3e-04 | 4.7376 | 2.1116 | 9 | 84 | activation of GTPase activity |
| GO:0051673 | 3e-04 | 39.0653 | 0.1508 | 3 | 6 | membrane disruption in other organism |
| GO:0051852 | 3e-04 | 15.6584 | 0.3519 | 4 | 14 | disruption by host of symbiont cells |
| GO:0050832 | 3e-04 | 7.3666 | 0.9552 | 6 | 38 | defense response to fungus |
| GO:0001775 | 4e-04 | 1.7521 | 31.2967 | 51 | 1245 | cell activation |
| GO:0051707 | 4e-04 | 1.9464 | 19.7584 | 36 | 786 | response to other organism |
| GO:0031640 | 4e-04 | 5.7382 | 1.3826 | 7 | 55 | killing of cells of other organism |
| GO:0009607 | 5e-04 | 1.8942 | 20.8393 | 37 | 829 | response to biotic stimulus |
| GO:0042231 | 6e-04 | Inf | 0.0503 | 2 | 2 | interleukin-13 biosynthetic process |
| GO:0044657 | 6e-04 | Inf | 0.0503 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0052043 | 6e-04 | Inf | 0.0503 | 2 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 6e-04 | Inf | 0.0503 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 6e-04 | Inf | 0.0503 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0006959 | 6e-04 | 2.9404 | 5.103 | 14 | 203 | humoral immune response |
| GO:0048671 | 8e-04 | 23.4362 | 0.2011 | 3 | 8 | negative regulation of collateral sprouting |
| GO:0042742 | 9e-04 | 2.9588 | 4.703 | 13 | 189 | defense response to bacterium |
| GO:0030814 | 9e-04 | 3.32 | 3.5696 | 11 | 142 | regulation of cAMP metabolic process |
| GO:0006954 | 0.001 | 2.3765 | 8.4951 | 19 | 346 | inflammatory response |
| GO:0072676 | 0.0012 | 4.1449 | 2.1116 | 8 | 84 | lymphocyte migration |
| GO:0042107 | 0.0013 | 3.6962 | 2.6395 | 9 | 105 | cytokine metabolic process |
| GO:0010818 | 0.0017 | 9.2067 | 0.5279 | 4 | 21 | T cell chemotaxis |
| GO:1903238 | 0.0019 | 77.9449 | 0.0754 | 2 | 3 | positive regulation of leukocyte tethering or rolling |
| GO:1903413 | 0.0019 | 77.9449 | 0.0754 | 2 | 3 | cellular response to bile acid |
| GO:0035036 | 0.0019 | 5.12 | 1.3072 | 6 | 52 | sperm-egg recognition |
| GO:0050877 | 0.002 | 1.6557 | 28.8583 | 45 | 1148 | nervous system process |
| GO:0042119 | 0.0022 | 2.028 | 11.9656 | 23 | 476 | neutrophil activation |
| GO:0002274 | 0.0024 | 1.9009 | 14.9822 | 27 | 596 | myeloid leukocyte activation |
| GO:0042832 | 0.0024 | 8.2365 | 0.5782 | 4 | 23 | defense response to protozoan |
| GO:0050727 | 0.0024 | 2.2895 | 7.843 | 17 | 312 | regulation of inflammatory response |
| GO:0008037 | 0.0024 | 3.1061 | 3.4439 | 10 | 137 | cell recognition |
| GO:0051607 | 0.0025 | 2.6249 | 5.2538 | 13 | 209 | defense response to virus |
| GO:0019731 | 0.0025 | 5.9374 | 0.9552 | 5 | 38 | antibacterial humoral response |
| GO:0034105 | 0.0025 | 5.9374 | 0.9552 | 5 | 38 | positive regulation of tissue remodeling |
| GO:0070098 | 0.003 | 3.9864 | 1.9105 | 7 | 76 | chemokine-mediated signaling pathway |
| GO:0043312 | 0.0035 | 1.9796 | 11.6891 | 22 | 465 | neutrophil degranulation |
| GO:2000360 | 0.0037 | 38.9699 | 0.1006 | 2 | 4 | negative regulation of binding of sperm to zona pellucida |
| GO:0030802 | 0.0037 | 2.9205 | 3.645 | 10 | 145 | regulation of cyclic nucleotide biosynthetic process |
| GO:0030819 | 0.004 | 3.767 | 2.011 | 7 | 80 | positive regulation of cAMP biosynthetic process |
| GO:0048660 | 0.0041 | 3.0817 | 3.1171 | 9 | 124 | regulation of smooth muscle cell proliferation |
| GO:0070528 | 0.0044 | 6.8023 | 0.6787 | 4 | 27 | protein kinase C signaling |
| GO:0042033 | 0.0047 | 10.6487 | 0.3519 | 3 | 14 | chemokine biosynthetic process |
| GO:1900371 | 0.0054 | 2.7557 | 3.8461 | 10 | 153 | regulation of purine nucleotide biosynthetic process |
| GO:0001866 | 0.006 | 25.9783 | 0.1257 | 2 | 5 | NK T cell proliferation |
| GO:0010951 | 0.0062 | 2.3349 | 5.8571 | 13 | 233 | negative regulation of endopeptidase activity |
| GO:0030801 | 0.0062 | 3.1139 | 2.74 | 8 | 109 | positive regulation of cyclic nucleotide metabolic process |
| GO:0002366 | 0.0063 | 1.7563 | 16.1134 | 27 | 641 | leukocyte activation involved in immune response |
| GO:0052652 | 0.0064 | 2.68 | 3.9467 | 10 | 157 | cyclic purine nucleotide metabolic process |
| GO:0002385 | 0.0064 | 6.0163 | 0.7541 | 4 | 30 | mucosal immune response |
| GO:0002444 | 0.0066 | 1.8392 | 13.0969 | 23 | 521 | myeloid leukocyte mediated immunity |
| GO:0010518 | 0.0069 | 4.5537 | 1.2066 | 5 | 48 | positive regulation of phospholipase activity |
| GO:0010744 | 0.0069 | 9.0093 | 0.4022 | 3 | 16 | positive regulation of macrophage derived foam cell differentiation |
| GO:0032611 | 0.0077 | 3.7343 | 1.7345 | 6 | 69 | interleukin-1 beta production |
| GO:0050794 | 0.0085 | 1.2982 | 248.7899 | 272 | 9897 | regulation of cellular process |
| GO:0001547 | 0.0088 | 19.4825 | 0.1508 | 2 | 6 | antral ovarian follicle growth |
| GO:0001878 | 0.0088 | 19.4825 | 0.1508 | 2 | 6 | response to yeast |
| GO:0007256 | 0.0088 | 19.4825 | 0.1508 | 2 | 6 | activation of JNKK activity |
| GO:0045416 | 0.0088 | 19.4825 | 0.1508 | 2 | 6 | positive regulation of interleukin-8 biosynthetic process |
| GO:0010771 | 0.0094 | 3.5639 | 1.8099 | 6 | 72 | negative regulation of cell morphogenesis involved in differentiation |
| GO:0042454 | 0.0097 | 7.807 | 0.4525 | 3 | 18 | ribonucleoside catabolic process |
| GO:0002687 | 0.0099 | 2.8575 | 2.9663 | 8 | 118 | positive regulation of leukocyte migration |